Clustering O 0 8.64182425175386e-07
of O 0 6.636908977952771e-08
missense O 0 1.4338814935399569e-07
mutations O 0 2.33072450228633e-09
in O 0 7.667040891057297e-10
the O 0 6.416073006221268e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 1.4885523036411996e-08
in O 0 5.64496782651247e-11
a O 0 3.041551385751795e-11
sporadic B-Disease 0 7.236657893372467e-06
T I-Disease 1 1.0
- I-Disease 0 8.124242594931275e-05
cell I-Disease 0 3.6432993510970846e-05
leukaemia I-Disease 1 0.9999828338623047
. O 0 5.273607106559552e-10

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.692923226277344e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 8.077349206159212e-11
is O 0 1.7915844589128094e-13
a O 0 1.2857281428760303e-12
recessive B-Disease 0 6.667092975476407e-07
multi I-Disease 1 0.9999994039535522
- I-Disease 1 1.0
system I-Disease 1 0.9999998807907104
disorder I-Disease 1 0.9999998807907104
caused O 0 4.755700278025188e-10
by O 0 4.550542343113861e-13
mutations O 0 2.780880560548926e-12
in O 0 1.5364716877269702e-12
the O 0 3.2782344547288567e-12
ATM O 0 4.1703955844241136e-07
gene O 0 1.9662553529808946e-10
at O 0 3.3045544078902367e-10
11q22 O 0 3.959483407811604e-08
- O 0 9.002593337470444e-09
q23 O 0 6.359030635394447e-08
( O 0 1.61201330062255e-11
ref O 0 1.2243609681661383e-08
. O 0 4.048952145785378e-12
3 O 0 5.112574252841284e-10
) O 0 2.0194230402476032e-12
. O 0 1.4250898204559714e-11

The O 0 1.778114722128521e-08
risk O 0 7.296560244896e-09
of O 0 8.449322308479168e-08
cancer B-Disease 0 3.818675395450555e-06
, O 0 4.968182809594879e-11
especially O 0 7.051672579194701e-10
lymphoid B-Disease 0 2.429673031656421e-06
neoplasias I-Disease 0 0.0002159125288017094
, O 0 4.278245119282431e-11
is O 0 1.8861644288537677e-13
substantially O 0 2.1515483838996374e-11
elevated O 0 4.322840396753236e-08
in O 0 1.0649728876543918e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 4.718792467883759e-09
and O 0 1.804625719692421e-11
has O 0 1.9564845620337334e-13
long O 0 2.6396110774581927e-13
been O 0 4.415037603631815e-14
associated O 0 1.3046863936438946e-11
with O 0 7.882430125283335e-11
chromosomal O 1 1.0
instability O 1 1.0
. O 0 5.758528764943094e-09

By O 0 1.671355276400277e-09
analysing O 0 1.8970924884342821e-06
tumour B-Disease 1 1.0
DNA O 0 2.266393948957557e-06
from O 0 4.6069457276809445e-11
patients O 0 1.5920533120994396e-12
with O 0 3.79237900848331e-13
sporadic B-Disease 0 1.4489061186395702e-06
T I-Disease 1 0.9999996423721313
- I-Disease 0 3.39454300046782e-06
cell I-Disease 0 4.217482114654558e-07
prolymphocytic I-Disease 0 0.14252686500549316
leukaemia I-Disease 1 0.9999939203262329
( O 0 1.71137548576894e-09
T B-Disease 1 0.9809209108352661
- I-Disease 0 5.758986958426249e-07
PLL I-Disease 1 0.7506751418113708
) O 0 5.221217121847976e-12
, O 0 2.295084424158017e-13
a O 0 3.9977805679596023e-13
rare O 0 2.3179068386891544e-10
clonal B-Disease 0 5.972703434053983e-07
malignancy I-Disease 0 1.8363858771408559e-06
with O 0 4.2060062030446765e-12
similarities O 0 8.39985095368867e-11
to O 0 1.0933129401813346e-11
a O 0 1.2290016226934597e-10
mature B-Disease 0 4.664406461074577e-08
T I-Disease 0 0.42094406485557556
- I-Disease 0 9.148884032583737e-07
cell I-Disease 0 1.2558059836464963e-07
leukaemia I-Disease 0 3.395551539142616e-05
seen O 0 4.091504565706394e-11
in O 0 1.3776449599156582e-11
A B-Disease 1 1.0
- I-Disease 1 0.9999172687530518
T I-Disease 1 1.0
, O 0 2.087983085041767e-11
we O 0 2.4317038589986503e-14
demonstrate O 0 2.4634827055884656e-13
a O 0 4.130885832508667e-14
high O 0 1.4163391596697106e-12
frequency O 0 2.9497541562117924e-12
of O 0 1.3622859784678809e-11
ATM O 0 4.893554432783276e-07
mutations O 0 1.4978502882456723e-09
in O 0 3.161956474428962e-09
T B-Disease 1 0.9998639822006226
- I-Disease 0 1.6810627130325884e-05
PLL I-Disease 0 0.002545891795307398
. O 0 1.2529410842176958e-09

In O 0 1.8047581207270014e-09
marked O 0 2.9504607090835577e-10
contrast O 0 6.527075321199893e-12
to O 0 5.169942165345054e-13
the O 0 8.73627472447458e-12
ATM O 0 8.286228307952115e-07
mutation O 0 1.1183103748590995e-10
pattern O 0 6.582717704262109e-10
in O 0 8.14026554496472e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 3.7077133030472e-11
the O 0 8.794031583665707e-13
most O 0 3.184546573111683e-15
frequent O 0 7.371857166588516e-14
nucleotide O 0 1.0216642636062812e-11
changes O 0 1.0432772674191446e-13
in O 0 5.05109517580371e-13
this O 0 2.911191795441914e-13
leukaemia B-Disease 0 2.4700489120732527e-06
were O 0 9.040579396213388e-11
missense O 0 1.436971075463589e-07
mutations O 0 1.2666667714711366e-08
. O 0 4.166949452155677e-09

These O 0 9.005229895109323e-11
clustered O 0 9.740472872721284e-10
in O 0 5.962680436205625e-12
the O 0 5.461101622999953e-12
region O 0 7.59272679451417e-12
corresponding O 0 1.035093885604077e-12
to O 0 1.017746650844309e-12
the O 0 4.804234267352658e-12
kinase O 0 3.1471037581498607e-11
domain O 0 1.4088632170616844e-11
, O 0 3.36922465838177e-13
which O 0 3.814401458536107e-14
is O 0 4.700336596178724e-15
highly O 0 1.282950200069688e-12
conserved O 0 1.1813147682282477e-11
in O 0 2.745600621856248e-12
ATM O 0 4.4766640172611005e-08
- O 0 4.4157372203201817e-10
related O 0 8.28729238011583e-11
proteins O 0 5.938513569780923e-13
in O 0 1.997065056727476e-12
mouse O 0 2.508257143651882e-11
, O 0 1.8816190467708938e-13
yeast O 0 1.5201458147817704e-11
and O 0 1.5154733370992268e-11
Drosophila O 0 5.725672824752337e-09
. O 0 4.266030237398688e-11

The O 0 1.116959946756424e-08
resulting O 0 2.509082941415386e-09
amino O 0 1.9322237143626353e-09
- O 0 2.1210158074325136e-09
acid O 0 1.3272895282856467e-10
substitutions O 0 7.903044330070941e-10
are O 0 2.6237597706459115e-13
predicted O 0 1.9399988560042658e-11
to O 0 1.0076677990286664e-12
interfere O 0 2.4350230165559594e-10
with O 0 1.5188357516127127e-11
ATP O 1 0.9998290538787842
binding O 0 6.78654799024514e-10
or O 0 2.154899696182877e-11
substrate O 0 9.395987321525467e-10
recognition O 0 3.7224401339130964e-10
. O 0 2.198073112413823e-10

Two O 0 4.140764620075288e-09
of O 0 2.1555605300704883e-08
seventeen O 0 9.678220180830976e-08
mutated O 0 1.3481776761636866e-07
T B-Disease 0 0.00017972064961213619
- I-Disease 0 3.5221216876379913e-07
PLL I-Disease 0 3.858503987430595e-05
samples O 0 1.3496121997746968e-09
had O 0 2.9003967196711278e-12
a O 0 2.881361327918691e-13
previously O 0 4.3774872615642835e-11
reported O 0 1.0584886300790686e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
allele O 0 7.314061356566981e-09
. O 0 1.8480633690032278e-10

In O 0 1.9499057923866303e-09
contrast O 0 4.148066889975155e-10
, O 0 1.7533115584389414e-11
no O 0 5.567718595195226e-12
mutations O 0 2.6696899899092408e-11
were O 0 3.47207713968789e-11
detected O 0 6.498609983474068e-10
in O 0 6.50284427000658e-12
the O 0 2.753463082538765e-11
p53 O 0 3.1273393596986665e-11
gene O 0 1.787405917719198e-10
, O 0 1.319873680835637e-12
suggesting O 0 6.386878872999269e-12
that O 0 5.4426799980973606e-14
this O 0 1.210491342579223e-12
tumour B-Disease 1 1.0
suppressor O 0 1.1072982886162208e-07
is O 0 2.194049629478112e-12
not O 0 8.089424854799965e-14
frequently O 0 2.424384694735271e-12
altered O 0 1.4009589321961613e-10
in O 0 8.565568393459344e-12
this O 0 5.183708930850406e-12
leukaemia B-Disease 0 3.728229785338044e-05
. O 0 2.1407672856632587e-10

Occasional O 0 1.111854317059624e-06
missense O 0 3.364914960002352e-07
mutations O 0 8.455182665123573e-10
in O 0 1.4436253581440184e-10
ATM O 0 1.5417788290505996e-06
were O 0 1.7939133512001604e-09
also O 0 6.145131278834093e-12
found O 0 9.479465823414301e-12
in O 0 1.2256464072823992e-11
tumour B-Disease 1 1.0
DNA O 0 1.648240413487656e-06
from O 0 1.264213317364593e-10
patients O 0 8.434846571203636e-12
with O 0 3.3082215352558952e-12
B B-Disease 0 0.00037369015626609325
- I-Disease 0 3.1948275136528537e-08
cell I-Disease 0 4.6888199989325585e-08
non I-Disease 0 0.00048436311772093177
- I-Disease 0 0.0055060191079974174
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 0 0.1576734185218811
( O 0 1.695962398295947e-10
B B-Disease 0 7.968057502694137e-07
- I-Disease 0 3.2825739348929517e-10
NHL I-Disease 0 8.389085905946558e-07
) O 0 1.8618801975438942e-13
and O 0 4.420938441718203e-13
a O 0 5.823788933739804e-12
B B-Disease 0 4.704631919594249e-07
- I-Disease 0 7.142805458215662e-09
NHL I-Disease 0 1.4179959180182777e-05
cell O 0 4.339469938940965e-08
line O 0 1.8125831502402434e-08
. O 0 4.785908475080092e-11

The O 0 3.161642725402203e-09
evidence O 0 3.1459785887477665e-09
of O 0 5.406468051027957e-10
a O 0 7.98835498617978e-13
significant O 0 4.651113478734703e-13
proportion O 0 1.8188582150829857e-12
of O 0 7.425238895963915e-11
loss O 0 4.016115440208523e-09
- O 0 3.579434526557179e-09
of O 0 2.701095125345887e-09
- O 0 5.712481043751438e-10
function O 0 7.844073697874099e-13
mutations O 0 7.133260453671963e-13
and O 0 3.1467222490894065e-13
a O 0 3.419443818809126e-13
complete O 0 4.7671044195451984e-11
absence O 0 5.029031080461266e-10
of O 0 2.9923027944356306e-10
the O 0 2.094903027091699e-12
normal O 0 1.8265588694332813e-12
copy O 0 1.8984451163883698e-11
of O 0 1.20565996422628e-11
ATM O 0 5.181244766561122e-09
in O 0 1.8129287134016625e-12
the O 0 2.29643431007287e-12
majority O 0 3.770695574897322e-14
of O 0 2.1179171263985275e-11
mutated O 0 5.932333291269742e-09
tumours B-Disease 1 0.9999966621398926
establishes O 0 1.4971219819415182e-09
somatic O 0 2.1945229633502095e-08
inactivation O 0 2.7719295303541003e-07
of O 0 8.951740682050513e-09
this O 0 4.316090128526906e-13
gene O 0 1.7688831085646561e-12
in O 0 8.170933547824166e-13
the O 0 1.4616979501780314e-11
pathogenesis O 0 1.3850506519474948e-08
of O 0 1.3051556502219341e-09
sporadic B-Disease 0 1.0161184036405757e-06
T I-Disease 1 0.9996121525764465
- I-Disease 0 8.861857736519596e-07
PLL I-Disease 0 0.0011773064034059644
and O 0 1.527627330188963e-11
suggests O 0 1.1328173642188855e-12
that O 0 3.841648052053731e-15
ATM O 0 1.5581716183987737e-07
acts O 0 1.062891463732285e-08
as O 0 1.2660544834730558e-10
a O 0 5.306419748052349e-10
tumour B-Disease 1 1.0
suppressor O 0 6.281642072281102e-06
. O 0 2.524670250636518e-09

As O 0 1.2849945552062536e-09
constitutional O 0 4.417989085681029e-09
DNA O 0 7.864166917670445e-08
was O 0 3.734143202982487e-11
not O 0 1.625768992696776e-15
available O 0 1.3798894481480833e-13
, O 0 3.4060086565382286e-13
a O 0 2.2329410456073395e-12
putative O 0 1.9336005152581492e-07
hereditary O 1 1.0
predisposition O 1 0.9995444416999817
to O 0 1.9871915810654173e-06
T B-Disease 1 1.0
- I-Disease 0 0.005832357797771692
PLL I-Disease 1 0.9980624318122864
will O 0 3.360209463107444e-12
require O 0 2.243652312550193e-12
further O 0 2.7493422035534953e-12
investigation O 0 7.757043618550341e-11
. O 0 1.776246684459526e-12
. O 0 1.298118470355325e-11

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 2.5740005185070913e-06
kinase O 0 1.5249977280973326e-08
is O 0 2.537483461198531e-12
involved O 0 7.627588339588487e-13
in O 0 1.0344084258855774e-13
the O 0 1.6349130437052356e-13
modulation O 0 2.1370036816514837e-12
of O 0 9.3061574071851e-12
the O 0 4.847178973303723e-13
Ca2 O 0 8.011639854137165e-13
+ O 0 5.6259639308331444e-11
homeostasis O 0 5.629511967697454e-09
in O 0 4.770627226591273e-10
skeletal O 0 3.852702502626926e-05
muscle O 0 4.5762308786834183e-07
cells O 0 6.687097986457502e-09
. O 0 2.197779735979566e-10

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.3182082176208496
DM B-Disease 1 1.0
) O 0 1.2999135101665615e-09
, O 0 2.5561857318334713e-12
the O 0 1.597187226226593e-12
most O 0 3.937950660004574e-12
prevalent O 0 0.25877803564071655
muscular B-Disease 1 1.0
disorder I-Disease 1 0.9936569333076477
in O 0 7.349672259682194e-11
adults O 0 7.594667950083789e-12
, O 0 3.557653303898345e-13
is O 0 6.688867396163062e-14
caused O 0 1.453075992863262e-10
by O 0 3.222933725455235e-11
( O 0 1.3265073761647983e-10
CTG O 0 2.235536703665275e-05
) O 0 7.2005465825975e-12
n O 0 9.449337146083536e-12
- O 0 3.596484915435738e-11
repeat O 0 1.2063523791017161e-11
expansion O 0 3.1041034326273476e-11
in O 0 3.597613201268557e-13
a O 0 5.378142186153803e-14
gene O 0 2.79978710842569e-14
encoding O 0 8.594902269282514e-14
a O 0 5.407212763479385e-13
protein O 0 3.3356375387511017e-12
kinase O 0 2.962692036145853e-10
( O 0 4.422216412502955e-11
DM B-Disease 1 1.0
protein O 0 2.473118931867191e-10
kinase O 0 1.8946659519070153e-10
; O 0 3.769247067242354e-12
DMPK O 0 0.00041075338958762586
) O 0 2.1760196455052755e-13
and O 0 1.5156913267880268e-13
involves O 0 7.323594313456139e-13
changes O 0 1.495044322716299e-13
in O 0 2.6541319055745083e-12
cytoarchitecture O 0 3.433484252468588e-08
and O 0 1.0740970612932443e-10
ion O 0 4.063667802256532e-08
homeostasis O 0 1.3058945114607923e-05
. O 0 1.589271469981668e-08

To O 0 2.6514429540824835e-10
obtain O 0 6.628098625505174e-10
clues O 0 4.564495004188984e-09
to O 0 3.9356976878901495e-12
the O 0 3.9733203706371345e-12
normal O 0 1.236520434655386e-11
biological O 0 2.1498594571234264e-10
role O 0 2.334699968076226e-11
of O 0 3.3521216358245454e-10
DMPK O 0 0.0034373344387859106
in O 0 4.831363087376417e-11
cellular O 0 1.222731360606133e-09
ion O 0 3.4259137748904323e-09
homeostasis O 0 1.6912485989450943e-07
, O 0 4.621229093837442e-11
we O 0 2.9026642743047726e-13
have O 0 1.1113378893903327e-14
compared O 0 3.7343812395694564e-13
the O 0 2.8385533940716856e-12
resting O 0 3.8552392389590295e-09
[ O 0 2.2389725490290502e-11
Ca2 O 0 3.234662158350249e-13
+ O 0 4.7114018415783665e-12
] O 0 2.0460556859891454e-11
i O 0 1.9144946045157596e-12
, O 0 3.911305077020609e-14
the O 0 3.473462904563136e-14
amplitude O 0 1.107923106556663e-12
and O 0 7.778681670143894e-13
shape O 0 3.731914430260552e-11
of O 0 4.058495206571422e-11
depolarization O 0 3.958722585850616e-11
- O 0 5.551118453794857e-10
induced O 0 1.5091691230040283e-09
Ca2 O 0 8.881415568262607e-13
+ O 0 1.7663073694634823e-12
transients O 0 4.924802579631127e-11
, O 0 1.5332068839350732e-13
and O 0 7.609057562632179e-14
the O 0 4.2946573489306694e-13
content O 0 9.694676702046157e-13
of O 0 2.244830710207424e-11
ATP O 0 1.919807073136326e-05
- O 0 6.162779175866717e-10
driven O 0 2.660499251461168e-11
ion O 0 1.1521022851013196e-11
pumps O 0 1.8062862316980954e-10
in O 0 2.733562855239402e-11
cultured O 0 1.9637489412360765e-09
skeletal O 0 1.1908888097877934e-07
muscle O 0 1.840603003344654e-09
cells O 0 6.178464684314378e-11
of O 0 2.775669138976866e-10
wild O 0 1.1743293004684574e-09
- O 0 1.044676775641129e-10
type O 0 5.541784739437894e-11
and O 0 1.8504397666929684e-11
DMPK O 0 0.28563863039016724
[ O 0 1.5985978096821896e-09
- O 0 1.9665038486493813e-09
/ O 0 3.745474153049599e-09
- O 0 4.794721064627083e-09
] O 0 1.4597937303406638e-09
knockout O 0 0.0001993284677155316
mice O 0 5.89567328290741e-09
. O 0 6.309391897829641e-11

In O 0 2.5775994672017077e-09
vitro O 0 1.5451032453484004e-08
- O 0 1.9271492845973626e-08
differentiated O 0 1.8888115960180585e-08
DMPK O 0 0.022087886929512024
[ O 0 2.612095428844441e-09
- O 0 1.1620993944916336e-08
/ O 0 4.343069459622484e-09
- O 0 4.357806560051358e-09
] O 0 9.329266525970326e-11
myotubes O 0 1.221864742717571e-08
exhibit O 0 1.173831587486518e-10
a O 0 4.291858968913376e-12
higher O 0 2.8825516626418413e-11
resting O 0 6.469822011467841e-09
[ O 0 3.8853982531339426e-11
Ca2 O 0 8.877012623240144e-13
+ O 0 2.5875621090243328e-11
] O 0 9.604758655079593e-11
i O 0 4.538340189763623e-12
than O 0 1.4623155117354791e-13
do O 0 8.188140920503684e-13
wild O 0 5.89788606841779e-10
- O 0 1.9971584108713358e-10
type O 0 3.3323599435419737e-10
myotubes O 0 2.4373393969767676e-08
because O 0 7.385456721013817e-13
of O 0 1.0687893278737981e-11
an O 0 1.8998113832427964e-14
altered O 0 8.114188140839751e-12
open O 0 3.0527321122353346e-12
probability O 0 2.4589244486047934e-13
of O 0 3.2299228396037716e-12
voltage O 0 3.644256840740212e-10
- O 0 6.200153723767698e-10
dependent O 0 2.5596949906891986e-11
l O 0 3.80658482165841e-12
- O 0 1.5901573460763707e-11
type O 0 2.6799686601852724e-12
Ca2 O 0 7.274724849208256e-14
+ O 0 4.196476065948529e-13
and O 0 1.1017907506488678e-12
Na O 0 2.6984725565171175e-10
+ O 0 1.9261090118682933e-12
channels O 0 1.8697389556759925e-12
. O 0 6.584896256739414e-12

The O 0 6.759141513157374e-08
mutant O 0 1.707427976782583e-08
myotubes O 0 2.079073198046899e-07
exhibit O 0 6.269387786694836e-10
smaller O 0 9.646668013008064e-12
and O 0 6.996522285140916e-12
slower O 0 3.1674354805666383e-10
Ca2 O 0 9.577637077526346e-13
+ O 0 1.0680123235448646e-12
responses O 0 3.078786683062551e-13
upon O 0 3.565351573003861e-12
triggering O 0 7.866045315108039e-11
by O 0 4.000175841609166e-13
acetylcholine O 0 1.9457363498176505e-10
or O 0 9.33146789006134e-12
high O 0 2.9836003112571063e-10
external O 0 2.6887227999594643e-09
K O 0 2.5545240589508467e-08
+ O 0 8.470000256721733e-10
. O 0 5.416631726484766e-11

In O 0 1.875327892975065e-09
addition O 0 2.0714784054742807e-10
, O 0 8.49228239813149e-12
we O 0 5.651358423114719e-14
observed O 0 4.501757853211247e-13
that O 0 8.724650585560515e-16
these O 0 7.186294440108317e-15
Ca2 O 0 7.774395276854973e-13
+ O 0 1.4689787580790536e-11
transients O 0 3.4303060392204543e-10
partially O 0 2.2830548562779995e-10
result O 0 5.690972866567723e-13
from O 0 2.1841946654110878e-13
an O 0 3.642362640086271e-16
influx O 0 3.892971472393763e-15
of O 0 1.2287566797386518e-12
extracellular O 0 7.817576338879639e-13
Ca2 O 0 1.9695329351795965e-13
+ O 0 9.143648295115159e-13
through O 0 5.888378977123021e-13
the O 0 5.325412420070785e-13
l O 0 6.296617415836592e-13
- O 0 8.711233123737117e-12
type O 0 4.543615483854069e-12
Ca2 O 0 2.202082483374057e-12
+ O 0 2.464824698511503e-11
channel O 0 1.1510967873329392e-10
. O 0 3.7802070501635754e-11

Neither O 0 3.034295659176678e-08
the O 0 3.228515510489416e-10
content O 0 6.374891066418531e-12
nor O 0 2.2665921223241625e-11
the O 0 4.901725184601469e-13
activity O 0 7.521187990987277e-13
of O 0 5.4126841897428335e-12
Na O 0 9.677172257971378e-11
+ O 0 1.5121144354007798e-12
/ O 0 6.297308507985377e-11
K O 0 8.806880918976745e-11
+ O 0 2.3174400766434733e-12
ATPase O 0 3.7699392219092687e-11
and O 0 3.477591478673325e-11
sarcoplasmic O 0 1.2305181762428674e-08
reticulum O 0 6.834637300556778e-10
Ca2 O 0 2.4445426585750774e-11
+ O 0 4.781693097033468e-11
- O 0 1.0333530559014648e-10
ATPase O 0 1.1646567044110157e-10
are O 0 2.91761216965683e-13
affected O 0 2.0825658905709865e-11
by O 0 3.404265064288481e-11
DMPK O 1 0.9999990463256836
absence O 0 2.659727726950223e-07
. O 0 7.415023595136461e-10

In O 0 4.365351635726711e-09
conclusion O 0 1.1086582762942498e-09
, O 0 8.805734787176167e-12
our O 0 8.436584764126565e-12
data O 0 7.999215005660698e-12
suggest O 0 1.6071985322468896e-12
that O 0 6.870408918429466e-14
DMPK O 0 0.04432935640215874
is O 0 8.065487297134744e-13
involved O 0 1.4875785065565639e-12
in O 0 1.0514588331955732e-11
modulating O 0 4.761157690325035e-09
the O 0 9.711916687527022e-11
initial O 0 2.1496533719744804e-11
events O 0 6.508006373390218e-12
of O 0 3.572507914495482e-11
excitation O 0 7.349609365547849e-09
- O 0 2.0412487700127713e-08
contraction O 0 4.945824860769221e-10
coupling O 0 2.0133100742114607e-10
in O 0 1.4230371048196133e-10
skeletal O 0 1.2891958249383606e-05
muscle O 0 1.09061367936647e-07
. O 0 7.504716292849878e-11
. O 0 7.204657703763218e-11

Constitutional O 0 1.24137459351914e-05
RB1 O 1 0.9999544620513916
- O 0 1.0963511158479378e-05
gene O 0 1.2581424790880646e-09
mutations O 0 4.757829893953236e-11
in O 0 3.676557322473961e-12
patients O 0 2.403487478486177e-11
with O 0 5.9871825379420596e-12
isolated O 0 5.618593945655448e-07
unilateral B-Disease 0 0.00022027530940249562
retinoblastoma I-Disease 1 0.9999994039535522
. O 0 8.02948179057239e-08

In O 0 3.5414662313826284e-09
most O 0 2.3065185178472447e-11
patients O 0 2.1228510269089007e-11
with O 0 3.2400171955104806e-12
isolated O 0 5.446549522503119e-08
unilateral B-Disease 0 6.058351573301479e-06
retinoblastoma I-Disease 1 0.9999768733978271
, O 0 2.3320676501015214e-09
tumor B-Disease 0 1.6372769096051343e-07
development O 0 1.4403009895858077e-09
is O 0 3.5337130357276925e-13
initiated O 0 2.025155737550577e-11
by O 0 9.803043793388255e-13
somatic O 0 1.0243331516335275e-08
inactivation O 0 1.0946483541829366e-07
of O 0 1.495067403212147e-09
both O 0 4.674800043596994e-12
alleles O 0 3.2701287424469205e-12
of O 0 2.1547733042304174e-10
the O 0 6.76017963829878e-10
RB1 O 0 0.0002902696141973138
gene O 0 9.180084248328058e-09
. O 0 2.564813084138251e-10

However O 0 8.574289056539897e-10
, O 0 3.706912381218341e-12
some O 0 1.9545403842505596e-14
of O 0 4.212348352072848e-12
these O 0 2.915909701195485e-13
patients O 0 7.011648206489696e-11
can O 0 1.0932628934090527e-11
transmit O 0 1.0647728231560905e-05
retinoblastoma B-Disease 1 0.6266180872917175
predisposition O 0 3.7011805034126155e-06
to O 0 2.3604559973300354e-10
their O 0 1.4875410903059105e-09
offspring O 0 1.1295574253722407e-08
. O 0 3.080536103983178e-10

To O 0 8.28830476473641e-11
determine O 0 4.9814003616477365e-11
the O 0 4.2162549493407475e-12
frequency O 0 1.1529728560777386e-11
and O 0 6.481925998551297e-13
nature O 0 9.644447046541771e-11
of O 0 7.381746602863615e-11
constitutional O 0 2.33211627787e-09
RB1 O 0 0.0011622038437053561
- O 0 4.3276333627773056e-08
gene O 0 5.831450600179977e-11
mutations O 0 4.7582267986845395e-12
in O 0 1.8147070218049732e-12
patients O 0 3.7113060021021216e-12
with O 0 1.3348310087465953e-12
isolated O 0 3.640099421886589e-08
unilateral B-Disease 0 2.9300613277882803e-06
retinoblastoma I-Disease 1 0.9935835003852844
, O 0 3.7923561513331094e-10
we O 0 9.518741047112589e-13
analyzed O 0 1.077916506053711e-10
DNA O 0 3.0004844830955335e-08
from O 0 6.202114516407065e-11
peripheral O 0 4.6267221165408046e-08
blood O 0 1.0500871283625202e-09
and O 0 5.854185192166739e-11
from O 0 6.291501208899319e-10
tumor B-Disease 0 9.94546326182899e-07
tissue O 0 5.952862807134807e-07
. O 0 8.968039089118918e-10

The O 0 2.1098229829874526e-09
analysis O 0 1.751310485520463e-10
of O 0 1.7621778480858552e-09
tumors B-Disease 1 0.9999998807907104
from O 0 5.547117210014108e-10
54 O 0 7.440354998777821e-10
( O 0 1.1942956389468518e-12
71 O 0 7.114520084172682e-10
% O 0 8.247401242847396e-14
) O 0 7.367021624899231e-14
of O 0 1.2316157815828177e-10
76 O 0 8.827155006940757e-09
informative O 0 6.185153500481988e-10
patients O 0 1.3452527980462037e-10
showed O 0 1.8441795313073328e-10
loss O 0 7.254790101995923e-09
of O 0 5.074677567051822e-09
constitutional O 0 1.8190979389487438e-08
heterozygosity O 0 1.6299516573781148e-05
( O 0 1.4839202755467795e-08
LOH O 1 1.0
) O 0 1.1672007804719442e-10
at O 0 2.0406210055057272e-09
intragenic O 0 3.500827915559057e-06
loci O 0 2.8559318465681827e-08
. O 0 8.734784562314246e-10

Three O 0 9.437355785735235e-09
of O 0 4.492205718520381e-08
13 O 0 1.166959791021327e-07
uninformative O 0 0.001931438921019435
patients O 0 9.401100342643076e-09
had O 0 5.2807709594038243e-11
constitutional O 0 7.099937970878045e-09
deletions O 0 1.0350311896445419e-07
. O 0 6.25651397356819e-09

For O 0 3.932004499773711e-09
39 O 0 1.2684510330984722e-08
randomly O 0 3.73882008686266e-10
selected O 0 2.714509150791855e-08
tumors B-Disease 1 1.0
, O 0 6.0017351088959e-09
SSCP O 1 0.9999998807907104
, O 0 1.7361486692735184e-09
hetero O 0 2.2481940220586694e-07
- O 0 9.815295243242872e-10
duplex O 0 7.554266656661923e-10
analysis O 0 9.10479157345545e-12
, O 0 6.53274838196237e-14
sequencing O 0 3.7163284602459434e-12
, O 0 2.3079552591981356e-13
and O 0 8.519712713095373e-13
Southern O 0 4.622324467629113e-10
blot O 0 9.630983122121961e-09
analysis O 0 2.8877119879339164e-12
were O 0 5.036482298922951e-13
used O 0 4.425713539136372e-13
to O 0 7.174276906059263e-13
identify O 0 1.361722956616518e-10
mutations O 0 1.0943489447967636e-09
. O 0 6.212405589955949e-10

Mutations O 0 2.4809404308712146e-08
were O 0 8.705162701794222e-10
detected O 0 7.622669717655128e-10
in O 0 8.394433585745542e-12
21 O 0 2.910297003388962e-10
( O 0 4.447401919394772e-13
91 O 0 1.1132028632232505e-10
% O 0 7.611989651882395e-14
) O 0 6.204506851868741e-14
of O 0 2.430484702387048e-10
23 O 0 5.4272527449938934e-06
tumors B-Disease 1 1.0
with O 0 3.192220674463897e-07
LOH O 1 1.0
. O 0 2.7966629900788575e-08

In O 0 1.851882203141031e-09
6 O 0 4.634129524561104e-09
( O 0 3.6412309799283005e-12
38 O 0 4.1231146968856436e-11
% O 0 2.3114077316098262e-14
) O 0 4.0221003746532605e-14
of O 0 8.707017745690493e-11
16 O 0 1.4344230692131532e-07
tumors B-Disease 1 1.0
without O 0 5.2887926926814544e-08
LOH O 1 1.0
, O 0 1.0708794268010635e-10
one O 0 7.494466744244199e-13
mutation O 0 9.47532091850889e-13
was O 0 2.2156667126016494e-11
detected O 0 5.5932234538369485e-11
, O 0 1.6317199327819942e-13
and O 0 2.142160960335454e-13
in O 0 2.103575777109845e-12
9 O 0 2.8851496192139336e-10
( O 0 3.7997280018589596e-13
56 O 0 1.4158374125883277e-11
% O 0 3.5642262118064025e-14
) O 0 2.63484133328825e-14
of O 0 4.3787064252232e-11
the O 0 9.131885470026191e-09
tumors B-Disease 1 1.0
without O 0 1.0795840807986679e-06
LOH O 1 1.0
, O 0 2.0976359538238398e-10
both O 0 4.454977619444689e-12
mutations O 0 9.645017423620672e-11
were O 0 1.291155654614684e-10
found O 0 3.4408823013087897e-10
. O 0 2.1788554294133178e-10

Thus O 0 4.957954935491671e-09
, O 0 6.892835260896568e-12
a O 0 3.872055670886554e-13
total O 0 4.5335884026921625e-13
of O 0 6.76670386390299e-11
45 O 0 6.950690023543871e-11
mutations O 0 1.957102362115659e-11
were O 0 2.1486612836185692e-11
identified O 0 7.64411173248547e-11
in O 0 4.584027046838912e-10
tumors B-Disease 1 1.0
of O 0 2.8799731808248907e-06
36 O 0 2.6863824587053386e-07
patients O 0 1.8075693164476547e-09
. O 0 5.461492369462917e-10

Thirty O 0 3.879103189774469e-07
- O 0 6.1406177920275695e-09
nine O 0 6.488553028205502e-10
of O 0 1.5555309818005014e-10
the O 0 7.413064953554205e-12
mutations O 0 5.9964624411767975e-12
- O 0 2.147896166482255e-10
including O 0 1.577232094929215e-11
34 O 0 2.9840499515820795e-10
small O 0 1.0419137341094453e-12
mutations O 0 8.411197953417382e-12
, O 0 8.474322805984702e-12
2 O 0 1.4612583365547493e-10
large O 0 3.2843365613960396e-12
structural O 0 7.816965741369586e-09
alterations O 0 1.3888751482227235e-07
, O 0 1.364910962031729e-10
and O 0 1.0590958665623873e-10
hypermethylation O 0 1.267046627617674e-05
in O 0 3.326823705407378e-09
3 O 0 3.836726989447925e-07
tumors O 1 1.0
- O 0 3.2427116547495416e-09
were O 0 1.2249032517452907e-11
not O 0 9.147516050840229e-14
detected O 0 3.04623097580059e-11
in O 0 2.7539120072903045e-13
the O 0 1.3360101870293906e-12
corresponding O 0 3.6500986261289725e-11
peripheral O 0 4.58117369817046e-07
blood O 0 6.022321485943394e-08
DNA O 0 6.070636118238326e-06
. O 0 1.0265603922476885e-09

In O 0 5.758638899067137e-09
6 O 0 1.1177442083010192e-08
( O 0 7.599899008725597e-12
17 O 0 8.927093092525595e-11
% O 0 1.972705005804428e-14
) O 0 3.2109928475490936e-15
of O 0 2.5721833517289294e-12
the O 0 1.292852890716345e-11
36 O 0 8.774442283865369e-10
patients O 0 1.4734543446470738e-11
, O 0 1.2662439456342933e-12
a O 0 2.6805719102740433e-12
mutation O 0 5.786253854528356e-12
was O 0 1.7597115431478016e-10
detected O 0 9.404031720006145e-11
in O 0 4.156083029810409e-13
constitutional O 0 4.128103761602553e-11
DNA O 0 4.754215243707449e-09
, O 0 2.280710071755204e-13
and O 0 2.1998983852026394e-13
1 O 0 1.4868474507157003e-11
of O 0 3.5684881698888615e-12
these O 0 1.1978767045124628e-13
mutations O 0 6.794428734913094e-12
is O 0 5.308332102333356e-14
known O 0 3.9569519535986863e-13
to O 0 7.016038954237719e-14
be O 0 4.641167617868043e-14
associated O 0 1.468090753131701e-11
with O 0 4.102810539224899e-12
reduced O 0 1.583551734185562e-09
expressivity O 0 2.892775910368073e-06
. O 0 1.0438407915813741e-09

The O 0 7.811213009745188e-09
presence O 0 1.400136118157036e-10
of O 0 3.4349020849866463e-10
a O 0 1.6630404735609727e-12
constitutional O 0 9.398151007422584e-11
mutation O 0 5.085405620913752e-12
was O 0 8.351633620784504e-12
not O 0 1.0727620607965931e-14
associated O 0 1.427532029217582e-12
with O 0 3.87025955446256e-14
an O 0 1.401121667283069e-14
early O 0 3.706836573802441e-11
age O 0 1.5507185379542987e-12
at O 0 1.391615728901785e-11
treatment O 0 9.882791252024958e-10
. O 0 1.42065872954511e-10

In O 0 3.3818181588429752e-09
1 O 0 6.061997126494134e-09
patient O 0 2.172275248568667e-09
, O 0 7.59143789497152e-12
somatic O 0 1.1340885066601913e-06
mosaicism O 0 4.002565401606262e-05
was O 0 2.5546493809258664e-09
demonstrated O 0 1.2433647861298525e-11
by O 0 1.6876152981581266e-13
molecular O 0 1.1707475267019873e-11
analysis O 0 3.4257630911714576e-13
of O 0 7.848236817376009e-12
DNA O 0 1.6935195468192887e-09
and O 0 4.85008517722707e-12
RNA O 0 1.4762605582419042e-09
from O 0 1.1719837600399075e-10
peripheral O 0 7.142630806811212e-07
blood O 0 2.5983723617173382e-08
. O 0 5.908593614378788e-10

In O 0 1.3752422312052204e-08
2 O 0 4.084602167608864e-08
patients O 0 1.14846899351706e-11
without O 0 5.07979248942636e-12
a O 0 3.4592515484044295e-12
detectable O 0 2.225632123042942e-08
mutation O 0 1.421029179743405e-11
in O 0 1.695321313888165e-11
peripheral O 0 1.6463333452065854e-07
blood O 0 2.6576074674267147e-08
, O 0 1.140817440514752e-10
mosaicism O 0 1.0584234360067057e-06
was O 0 1.2821522732409107e-09
suggested O 0 1.1164875447777778e-11
because O 0 2.491405736229635e-12
1 O 0 3.191139574809654e-10
of O 0 9.978647769193216e-11
the O 0 1.3246888828921666e-11
patients O 0 1.3298159795560593e-10
showed O 0 4.5727990283239706e-09
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 5.467120089974742e-10
the O 0 3.214530863715481e-10
other O 0 2.578048018120338e-12
later O 0 1.8780829669218235e-10
developed O 0 5.042372630548186e-10
bilateral B-Disease 0 2.3126055737066054e-08
retinoblastoma I-Disease 0 7.389576057903469e-05
. O 0 2.599818360593531e-09

In O 0 9.553222657388005e-10
conclusion O 0 2.1048580933769045e-10
, O 0 5.577283860441762e-12
our O 0 4.143239137194277e-12
results O 0 4.4568723711613245e-12
emphasize O 0 4.8030364407924964e-11
that O 0 3.7615157706281585e-14
the O 0 9.908880356859773e-13
manifestation O 0 2.240481550286333e-10
and O 0 4.665455955593645e-12
transmissibility O 0 8.34643820724068e-09
of O 0 7.437176430258319e-10
retinoblastoma B-Disease 0 1.0184478149710685e-08
depend O 0 1.3275014767999416e-11
on O 0 1.3720759250990255e-10
the O 0 9.806658957112191e-12
nature O 0 1.0363809810343128e-10
of O 0 7.077918112718962e-11
the O 0 3.2713575771892156e-12
first O 0 2.482298654821191e-12
mutation O 0 1.0280200356347496e-13
, O 0 1.7929713906606436e-14
its O 0 7.104633857136014e-14
time O 0 5.63762090396297e-14
in O 0 2.3835713134148784e-13
development O 0 3.956584192221779e-12
, O 0 2.529948364519974e-13
and O 0 1.8638415192739205e-13
the O 0 2.187413119560111e-13
number O 0 1.05807408597473e-14
and O 0 4.654536169467968e-14
types O 0 2.894899077399149e-11
of O 0 8.274356894100166e-11
cells O 0 1.6808219312908212e-12
that O 0 1.1749133024992198e-14
are O 0 3.8502326462708583e-14
affected O 0 1.8162070805627373e-11
. O 0 4.610398000870486e-12
. O 0 9.656337535135506e-11

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9999992847442627
the I-Disease 0 9.038519692694535e-07
fifth I-Disease 0 1.3663732261193218e-06
component I-Disease 0 4.469990155797632e-09
of I-Disease 0 3.6688572180310075e-09
complement I-Disease 0 1.446586517239723e-09
in O 0 5.039670347706249e-10
man O 0 1.2892964917909921e-08
. O 0 1.2706678764740076e-10

I O 0 0.0010061287321150303
. O 0 1.1258904919486667e-07

Clinical O 0 0.00011196590639883652
, O 0 1.912329850028982e-09
immunochemical O 0 5.215726105234353e-06
, O 0 6.833916765813797e-11
and O 0 1.1111785103157246e-11
family O 0 5.29897046380734e-12
studies O 0 2.837040602443608e-10
. O 0 5.1790863264677967e-11

The O 0 3.81321063613882e-09
first O 0 1.0677141115689182e-10
recognized O 0 2.701861512299786e-10
human O 0 6.882726055756905e-10
kindred O 0 2.583631157904165e-06
with O 0 7.183931227672247e-09
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9999997615814209
the I-Disease 0 8.411628868998378e-07
fifth I-Disease 0 1.237392780240043e-06
component I-Disease 0 2.031917079037271e-09
of I-Disease 0 2.8529740792038183e-09
complement I-Disease 0 6.993811307864917e-09
( O 0 1.1928177334752377e-09
C5 O 1 0.999988317489624
) O 0 2.4550137964207686e-11
is O 0 4.308843592256556e-13
described O 0 4.3962465612334967e-11
. O 0 2.0158229252498217e-10

The O 0 2.611713796341064e-07
proband O 0 1.1641385754046496e-05
, O 0 3.082452071367925e-10
a O 0 2.7428958410125048e-11
20 O 0 1.305403840579089e-10
- O 0 1.261936666274721e-10
year O 0 3.746561654666136e-12
- O 0 4.959995747455537e-10
old O 0 4.178233037333001e-10
black O 0 1.1506265558403062e-11
female O 0 3.189803889774856e-12
with O 0 2.0695867242181976e-10
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 0 7.828800335119013e-06
age O 0 1.0346576928554896e-08
11 O 0 3.039055229692167e-09
, O 0 7.2189186052507015e-12
lacked O 0 2.182134650752232e-08
serum O 0 2.5341282139379473e-07
hemolytic O 1 0.8815693259239197
complement O 0 4.424760557952823e-09
activity O 0 3.5476861448557884e-09
, O 0 6.1582492577594294e-12
even O 0 2.009467679059407e-12
during O 0 1.282190742468714e-10
remission O 0 1.77911871901415e-08
. O 0 6.475469466193928e-11

C5 O 1 0.9990812540054321
was O 0 7.833968425075e-07
undetectable O 0 1.0173060900342534e-06
in O 0 4.759236754692253e-11
her O 0 7.873036424188573e-12
serum O 0 5.825491478095302e-11
by O 0 7.440996603602645e-13
both O 0 1.8890755279499238e-11
immunodiffusion O 0 4.250724487064872e-06
and O 0 3.324406749882769e-09
hemolytic O 1 0.9999973773956299
assays O 0 1.9653182334877783e-06
. O 0 9.076335238944466e-09

Other O 0 2.6560439958522863e-10
complement O 0 1.1165248725575339e-09
components O 0 5.077875186998426e-08
were O 0 1.839180890916836e-10
normal O 0 6.323511159145312e-11
during O 0 6.179133593686714e-12
remission O 0 6.037876865150338e-10
of O 0 5.133377056765198e-10
lupus O 0 3.3518870168336434e-06
, O 0 1.8497807452444448e-10
but O 0 4.765559127872798e-11
C1 O 0 2.934280564659275e-05
, O 0 4.083359761430927e-10
C4 O 1 0.9994848966598511
, O 0 7.521041567315478e-10
C2 O 0 2.193189857280231e-06
, O 0 3.4285251721000165e-11
and O 0 2.920110819815136e-10
C3 O 1 0.9999977350234985
levels O 0 2.0486952223564003e-07
fell O 0 1.0776964245451381e-06
during O 0 2.844107171995347e-09
exacerbations O 0 1.3042479622527026e-05
. O 0 1.0999235966480114e-09

A O 0 1.2753336704918183e-05
younger O 0 4.097373551559258e-09
half O 0 2.064252796474264e-10
- O 0 2.953626454527125e-09
sister O 0 1.157455575828692e-09
, O 0 1.1182948664312242e-11
who O 0 2.435967877065237e-12
had O 0 1.4434677411689911e-11
no O 0 1.7202859969867035e-10
underlying O 1 0.9999053478240967
disease O 1 0.9999738931655884
, O 0 4.082514274555971e-12
was O 0 2.525213371740165e-10
also O 0 1.5992296462791211e-12
found O 0 3.1415126576506136e-12
to O 0 1.459188152252988e-11
lack O 0 7.130761048301792e-08
immunochemically O 1 0.8527169227600098
detectable O 0 0.16065768897533417
C5 O 1 0.9967505931854248
. O 0 1.991052123173631e-08

By O 0 1.4019921223962228e-08
hemolytic O 1 0.9974876642227173
assay O 0 8.502478010541381e-08
, O 0 3.3018263123629765e-10
she O 0 1.8893231163580326e-12
exhibited O 0 5.831386484800305e-10
1 O 0 4.923950136515032e-10
- O 0 7.780574101667881e-11
2 O 0 8.693406237936241e-12
% O 0 7.309353080751316e-15
of O 0 1.8650043261039112e-13
the O 0 5.02146121992425e-13
normal O 0 1.4900676525986256e-10
serum O 0 2.5819246740610424e-09
C5 O 0 2.1791167910123477e-06
level O 0 3.1101080044670937e-10
and O 0 2.485661416279372e-13
normal O 0 8.523158849700618e-13
concentrations O 0 2.51917800855872e-12
of O 0 3.8493847866194475e-12
other O 0 1.1602692548060012e-13
complement O 0 1.4057607855555432e-10
components O 0 3.876040821637616e-08
. O 0 7.035806381949783e-10

C5 O 0 0.000910456757992506
levels O 0 5.269205960445333e-09
of O 0 7.682469105319001e-10
other O 0 4.940452886202651e-13
family O 0 6.707612980674793e-13
members O 0 3.2029524974115653e-13
were O 0 3.830824980149972e-12
either O 0 5.550880068094788e-12
normal O 0 1.0679217926634621e-10
or O 0 5.1837284464895106e-12
approximately O 0 3.3728460562681972e-12
half O 0 2.258935920262939e-11
- O 0 4.302452560889236e-10
normal O 0 8.685587665757666e-11
, O 0 1.1858222737082258e-12
consistent O 0 2.1495313862196497e-10
with O 0 5.001629319045797e-12
autosomal O 0 2.959708353955648e-07
codominant O 0 4.5535929871221015e-07
inheritance O 0 2.217828282136125e-10
of O 0 1.8640764487543038e-09
the O 0 3.3943015065318605e-10
gene O 0 3.566930217857589e-08
determining O 0 0.000882025808095932
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.7540260444093292e-07

Normal O 0 0.0007341390009969473
hemolytic O 1 1.0
titers O 0 6.227861013030633e-05
were O 0 1.7255219475487138e-09
restored O 0 1.072929034506842e-08
to O 0 2.2471354638176066e-11
both O 0 2.052751718606416e-11
homozygous O 0 3.205637995051802e-07
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 5.0335177803617626e-08
C5D B-Disease 1 1.0
) O 0 5.163541122454873e-11
sera O 0 9.043865212277069e-09
by O 0 5.429866625772384e-13
addition O 0 2.959588303597105e-12
of O 0 2.3822840922171906e-10
highly O 0 9.437122194810854e-09
purified O 0 5.762453838542569e-07
human O 0 7.996439421731338e-08
C5 O 1 0.8886957764625549
. O 0 7.725715067685712e-10

In O 0 6.2448415327764906e-09
specific O 0 1.635614976791544e-09
C5 O 0 0.0004365567583590746
titrations O 0 8.890112326298549e-07
, O 0 4.4964594547725056e-11
however O 0 2.937480770778822e-12
, O 0 3.1264473974133844e-13
it O 0 3.0913897201660656e-14
was O 0 9.273766650441662e-12
noted O 0 3.355314615559324e-13
that O 0 2.901897396085317e-15
when O 0 1.776366834389028e-14
limited O 0 6.397076743108396e-14
amounts O 0 1.2386158721941487e-12
of O 0 4.025362543291777e-10
C5 O 0 3.6047840694664046e-06
were O 0 9.133199752042742e-11
assayed O 0 2.526379105916021e-10
in O 0 1.4653819607399199e-12
the O 0 7.186630305612562e-13
presence O 0 2.7340190658295405e-13
of O 0 1.8376650895435276e-11
low O 0 1.8909618315632315e-10
dilutions O 0 1.8803786971943737e-08
of O 0 1.9633970005372703e-09
either O 0 1.3768774564937303e-08
C5D B-Disease 1 1.0
serum O 0 1.9817078111827868e-07
, O 0 5.2146113815876305e-11
curving O 0 4.711139478530413e-09
rather O 0 6.831137652069108e-12
than O 0 6.990299317036555e-14
linear O 0 1.3022847557275785e-11
dose O 0 3.313093410728385e-10
- O 0 3.17951109884973e-10
response O 0 2.8756090390824607e-12
plots O 0 4.894461919091597e-11
were O 0 2.08033867910018e-11
consistently O 0 3.524427624745918e-11
obtained O 0 1.0569461972309568e-11
, O 0 5.026002942824792e-13
suggesting O 0 3.3963299837444505e-13
some O 0 8.222787143026544e-14
inhibitory O 0 2.8470256707713304e-10
effect O 0 7.976567739653717e-10
. O 0 2.0553343749174502e-10

Further O 0 4.2091241603259277e-10
studies O 0 4.990035468166454e-11
suggested O 0 1.923564823050339e-12
that O 0 2.9434398305218726e-14
low O 0 4.1047087950829564e-10
dilutions O 0 1.5704537759120285e-07
of O 0 1.699379339470397e-07
C5D B-Disease 1 1.0
serum O 0 1.0787896798092333e-08
contain O 0 1.4937859976749124e-11
a O 0 3.6128375681745983e-13
factor O 0 2.394745101004514e-13
( O 0 3.317791462571773e-14
or O 0 1.7106833256810144e-13
factors O 0 1.1511220579171755e-12
) O 0 1.033130761387939e-13
interfering O 0 2.6717376575002838e-11
at O 0 2.2101132035601267e-10
some O 0 1.526251049372221e-13
step O 0 1.7161428528256195e-11
in O 0 3.260792243858779e-12
the O 0 8.714461097181214e-11
hemolytic O 0 0.0004760605515912175
assay O 0 2.8666340412542013e-08
of O 0 5.187517331251001e-07
C5 O 1 0.9999828338623047
, O 0 7.982925431804233e-11
rather O 0 6.407890711102038e-12
than O 0 1.1446670434428485e-13
a O 0 4.574502235343836e-12
true O 0 4.3867756649440537e-10
C5 O 0 0.00017237388237845153
inhibitor O 0 8.361001668788504e-09
or O 0 5.283534165734238e-10
inactivator O 0 1.423898538632784e-06
. O 0 9.027281144824428e-10

Of O 0 2.3731762155421166e-07
clinical O 0 4.0470615658705356e-07
interest O 0 4.307453282947904e-10
are O 0 1.2041172095869634e-12
( O 0 1.2100157030861536e-12
a O 0 1.3916256385096415e-12
) O 0 4.007757057537635e-14
the O 0 6.642867408489933e-14
documentation O 0 1.9230688153015763e-09
of O 0 1.0228591307281931e-08
membranous O 1 0.9999986886978149
glomerulonephritis B-Disease 1 1.0
, O 0 1.0888719970125749e-07
vasculitis B-Disease 1 1.0
, O 0 1.787178547374424e-07
and O 0 5.2926836360711604e-05
arthritis B-Disease 1 1.0
in O 0 3.3324758508257446e-09
an O 0 2.042015645117856e-12
individual O 0 8.890657307580874e-12
lacking O 0 4.064517327151407e-07
C5 O 0 0.42821401357650757
( O 0 2.352903462343736e-11
and O 0 7.360228420662251e-13
its O 0 8.591595859232248e-13
biologic O 0 9.76919989348346e-10
functions O 0 1.3616280412215298e-12
) O 0 2.1660555226082727e-14
, O 0 2.180447290008481e-14
and O 0 8.3152255426263e-14
( O 0 6.546222439986205e-13
b O 0 4.634841122008737e-11
) O 0 1.5065883653478385e-14
a O 0 7.709771812939789e-14
remarkable O 0 3.630454227174229e-12
propensity O 0 8.672552453958815e-09
to O 0 7.765751375288232e-10
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 9.15447231908395e-12
the O 0 2.9129389872428746e-11
proband O 0 1.0466207100989777e-07
, O 0 1.2469978391896341e-12
even O 0 1.0894026837311027e-13
during O 0 1.7518801079946522e-12
periods O 0 9.152818086777259e-11
of O 0 1.447332878545815e-11
low O 0 1.8294231407534056e-10
- O 0 5.238716752065109e-11
dose O 0 6.543108416190435e-11
or O 0 8.355165517781593e-13
alternate O 0 3.6417555082657316e-10
- O 0 6.724493184506741e-10
day O 0 1.228828150345862e-10
corticosteroid O 0 3.8052683066780446e-06
therapy O 0 4.932480806019157e-07
. O 0 3.991021402249828e-10

Other O 0 3.163233563974188e-10
observations O 0 5.2315725085350095e-09
indicate O 0 1.429887874770941e-10
that O 0 1.7010524933080973e-13
the O 0 5.365097602294533e-11
C5D B-Disease 1 1.0
state O 0 7.488130254751368e-11
is O 0 5.972668513194376e-14
compatible O 0 2.5446290907726876e-11
with O 0 8.652900309246911e-14
normal O 0 1.57144262880049e-11
coagulation O 0 2.0678624090830766e-10
function O 0 2.0600303147350063e-12
and O 0 1.021367669259976e-12
the O 0 2.8582691768974655e-12
capacity O 0 2.1197345094481346e-12
to O 0 1.3056118686183282e-12
mount O 0 3.3631312135185e-07
a O 0 7.502959364913409e-10
neutrophilic O 0 0.12586483359336853
leukocytosis O 0 0.00038048584247007966
during O 0 3.8851453609822784e-07
pyogenic B-Disease 0 0.18953558802604675
infection I-Disease 0 2.1809432837471832e-07
. O 0 9.953399215945069e-12
. O 0 9.472439499447205e-11

Susceptibility O 0 0.00040874487604014575
to O 0 3.1964448226062814e-06
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 1.6143995651418663e-07
twins O 0 6.304840383108967e-08
: O 0 2.6627506623244646e-13
the O 0 3.9766237178162633e-13
role O 0 8.009119084086136e-13
of O 0 7.047500777401794e-11
genes O 0 2.113686612889576e-12
, O 0 2.7246915661194304e-12
HLA O 0 1.301591456837059e-08
, O 0 4.297626057109261e-12
and O 0 6.4367018659527986e-12
the O 0 4.4216259126317325e-11
environment O 0 1.6070231811937674e-09
. O 0 1.6657278334442083e-10

OBJECTIVE O 0 1.332689862465486e-06
To O 0 1.444514299842048e-11
determine O 0 4.545342227602056e-11
the O 0 5.013922003277438e-12
relative O 0 2.792628975289979e-11
effects O 0 3.7728202784137466e-09
of O 0 2.2329474380633485e-10
genetic O 0 2.901273665756321e-10
and O 0 1.0077523667981203e-12
environmental O 0 1.25620902569068e-10
factors O 0 2.8621261177058654e-12
in O 0 9.471292023235933e-13
susceptibility O 0 1.1708141123278892e-08
to O 0 8.956863695175343e-09
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 1.2873552002190536e-08
AS B-Disease 1 1.0
) O 0 5.604775758089042e-12
. O 0 5.569651510828333e-12

METHODS O 0 2.1283136447891593e-05
Twins O 0 1.1409945273044286e-06
with O 0 6.77377685193159e-12
AS B-Disease 1 1.0
were O 0 5.294000047367797e-12
identified O 0 6.703123299478531e-13
from O 0 3.486686850698306e-13
the O 0 1.2113828820256578e-12
Royal O 0 6.0156257752908004e-09
National O 0 2.449214093758201e-07
Hospital O 1 0.9999691247940063
for O 0 2.7735760355085404e-08
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 0 2.4121884489858303e-09
. O 0 6.810628172537747e-10

Clinical O 0 1.127019822888542e-05
and O 0 5.162618110787776e-10
radiographic O 0 1.2175780739198672e-06
examinations O 0 2.435285395563369e-08
were O 0 4.713867143846251e-11
performed O 0 2.4019855549006763e-10
to O 0 3.602914407790925e-13
establish O 0 1.3271730936459392e-10
diagnoses O 0 3.899343028024305e-06
, O 0 1.8322691974770322e-10
and O 0 1.7851556677328517e-08
disease O 1 0.9999985694885254
severity O 0 5.081461858935654e-05
was O 0 1.174132124859284e-09
assessed O 0 5.062996133453623e-10
using O 0 7.163013671790397e-12
a O 0 1.472110953103234e-12
combination O 0 1.7609396579798542e-11
of O 0 4.2666405131175367e-11
validated O 0 3.1333788896859005e-09
scoring O 0 1.8446518756931596e-09
systems O 0 1.0988342324935729e-07
. O 0 5.296610927629786e-10

HLA O 0 9.90449007076677e-06
typing O 0 8.035621945623461e-09
for O 0 3.338580106815314e-11
HLA O 0 9.380523380286832e-08
- O 0 5.80364911684228e-09
B27 O 0 3.891307542858158e-08
, O 0 9.551518430350736e-12
HLA O 0 5.452897244850874e-09
- O 0 3.12167347527037e-10
B60 O 0 3.780434187916626e-09
, O 0 1.090916961800359e-12
and O 0 3.988095010482029e-12
HLA O 0 1.5013426946097752e-07
- O 0 3.3359178530645295e-08
DR1 O 0 0.002581350738182664
was O 0 1.5519665552687911e-09
performed O 0 3.645563573240196e-10
by O 0 4.713448598439585e-13
polymerase O 0 6.538570240799402e-10
chain O 0 1.0078880091635156e-10
reaction O 0 9.880081778754213e-13
with O 0 2.2883705022049006e-13
sequence O 0 5.164600301241218e-13
- O 0 2.0636404911289485e-12
specific O 0 3.307782921267016e-14
primers O 0 4.393271163527501e-11
, O 0 3.789718105301487e-13
and O 0 1.153192125125102e-12
zygosity O 0 7.676588609228929e-08
was O 0 5.851237550036359e-11
assessed O 0 2.45564263368081e-10
using O 0 7.411146002445079e-11
microsatellite O 0 2.6806745268004306e-08
markers O 0 8.788688177219228e-08
. O 0 6.880875313974855e-10

Genetic O 0 5.6919638780073e-08
and O 0 2.446557713364772e-11
environmental O 0 1.7995256673675186e-10
variance O 0 6.4949733959152045e-12
components O 0 8.201079260139466e-10
were O 0 9.08454821785254e-12
assessed O 0 3.50972473306399e-10
with O 0 1.9725705986163578e-13
the O 0 2.787539730292332e-12
program O 0 8.500364583226283e-13
Mx O 0 2.0145440871033315e-09
, O 0 1.1824129322142093e-14
using O 0 4.841906718367492e-15
data O 0 3.767288469570286e-14
from O 0 3.738997907945171e-14
this O 0 5.267278088270011e-16
and O 0 3.034327143388617e-14
previous O 0 7.691122586896137e-13
studies O 0 3.775994816303252e-13
of O 0 7.036241814889488e-12
twins O 0 4.196020420010882e-09
with O 0 6.269668378217075e-12
AS B-Disease 1 1.0
. O 0 6.696565524322295e-10

RESULTS O 0 2.472980895618093e-06
Six O 0 4.093514416325661e-09
of O 0 1.1810725730754257e-09
8 O 0 1.3197982262624919e-08
monozygotic O 0 3.192251369910082e-07
( O 0 1.846633734814418e-09
MZ O 1 0.9999902248382568
) O 0 4.5369427659203154e-10
twin O 0 1.033102279279774e-07
pairs O 0 2.428626744155338e-10
were O 0 1.1327440319064408e-08
disease O 0 3.992670656316477e-07
concordant O 0 1.4434589523659724e-08
, O 0 7.311651284425125e-12
compared O 0 1.3095924084743915e-12
with O 0 3.843073591563301e-13
4 O 0 6.324575863025927e-10
of O 0 1.053977904952319e-09
15 O 0 3.560890193821109e-10
B27 O 0 8.727077727144206e-09
- O 0 8.210783719597714e-10
positive O 0 2.859452475148516e-12
dizygotic O 0 5.7248453089187024e-08
( O 0 3.928507519290747e-11
DZ O 0 0.0009169604745693505
) O 0 2.060679751836325e-11
twin O 0 1.84031878625035e-09
pairs O 0 3.1798658758214193e-12
( O 0 1.108115444022062e-12
27 O 0 1.9101342729754833e-10
% O 0 5.293025200536934e-14
) O 0 2.7223079883008025e-15
and O 0 1.6377594809838247e-13
4 O 0 2.996489167905736e-10
of O 0 2.7168800542654026e-09
32 O 0 3.655405933500333e-08
DZ O 1 0.9995946288108826
twin O 0 7.391124654532177e-07
pairs O 0 1.6121985690897844e-10
overall O 0 2.866774595489119e-09
( O 0 2.5555337360150254e-11
12 O 0 3.70190683662841e-10
. O 0 1.1963971751228347e-13
5 O 0 1.3545235245937537e-11
% O 0 1.0259789572824099e-13
) O 0 4.0293506378685784e-13
. O 0 2.8725515022198778e-11

Nonsignificant O 0 9.01959265320329e-06
increases O 0 1.386852160889518e-10
in O 0 3.0074625515658093e-12
similarity O 0 1.4458974382375311e-12
with O 0 3.084027987414889e-14
regard O 0 2.595994166160187e-12
to O 0 3.051414915015982e-13
age O 0 9.434820980036562e-12
at O 0 1.70289005119173e-09
disease O 0 1.0905866787425111e-07
onset O 0 1.2210213284902238e-08
and O 0 1.099143887885179e-12
all O 0 6.026660832707254e-13
of O 0 9.552707236348823e-11
the O 0 7.492333975456233e-10
disease O 0 4.030775926366914e-07
severity O 0 1.5341168335680777e-09
scores O 0 3.9654331901450846e-11
assessed O 0 1.460884746506963e-10
were O 0 1.43632441010344e-11
noted O 0 9.106980794482133e-12
in O 0 1.4129435121912337e-10
disease O 0 1.4707520676893182e-06
- O 0 3.693369876600627e-08
concordant O 0 8.699254067323636e-06
MZ O 1 0.9999979734420776
twins O 0 2.3870813947723946e-07
compared O 0 4.691818808466586e-11
with O 0 2.1822188153719502e-11
concordant O 0 0.00020500514074228704
DZ O 1 1.0
twins O 0 0.002782075433060527
. O 0 7.873948604242287e-09

HLA O 0 1.950678779394366e-05
- O 0 1.190657101801662e-07
B27 O 0 1.0741867129127058e-07
and O 0 1.2746821827225308e-11
B60 O 0 1.0887842627482769e-08
were O 0 2.1535682959150648e-11
associated O 0 8.644204102514763e-11
with O 0 4.528733724834533e-12
the O 0 1.613534417188589e-09
disease O 0 1.2435919849451693e-08
in O 0 2.7269477908403728e-12
probands O 0 1.6650218981340004e-07
, O 0 2.6874164785889443e-12
and O 0 7.001858402973238e-13
the O 0 3.977445109382138e-12
rate O 0 2.2394166382389002e-11
of O 0 1.0007485812257855e-10
disease O 0 4.030035416491273e-09
concordance O 0 5.163987015777138e-10
was O 0 1.475332876699209e-11
significantly O 0 2.0960529590208915e-13
increased O 0 2.9264082476720965e-12
among O 0 1.9239988074959413e-11
DZ O 0 0.005196635145694017
twin O 0 4.26519051188734e-08
pairs O 0 8.206610738192843e-12
in O 0 2.1125380091080448e-12
which O 0 1.5261878132805107e-12
the O 0 4.3769862734244214e-11
co O 0 2.4334594339592286e-09
- O 0 6.228153104359535e-09
twin O 0 5.904192246219964e-09
was O 0 1.0866525734787302e-10
positive O 0 1.3235888622099845e-13
for O 0 2.1972357201922865e-13
both O 0 7.319898159829918e-12
B27 O 0 8.95714080684229e-08
and O 0 4.126029740092463e-09
DR1 O 1 0.991843044757843
. O 0 6.7211631815666806e-09

Additive O 0 6.700916088675513e-08
genetic O 0 6.448385381219168e-09
effects O 0 6.3686904638871056e-09
were O 0 3.1498647006661384e-12
estimated O 0 1.977942041110712e-14
to O 0 5.752495512269598e-15
contribute O 0 2.512554780117332e-13
97 O 0 8.574922716331201e-11
% O 0 1.530372203473792e-14
of O 0 1.206576749320301e-13
the O 0 5.301472151900133e-14
population O 0 1.0458578512311393e-16
variance O 0 3.284975806996937e-12
. O 0 5.6813692639323676e-11

CONCLUSION O 0 6.36816230326076e-06
Susceptibility O 0 1.4715614327087678e-07
to O 0 3.5863417791048846e-10
AS B-Disease 1 1.0
is O 0 1.3880575291599917e-12
largely O 0 1.3838339328609006e-11
genetically O 0 7.247618477590478e-11
determined O 0 3.431999476277703e-11
, O 0 1.6309334525260732e-12
and O 0 2.0206366961594835e-12
the O 0 4.452369462698558e-12
environmental O 0 1.6923925594269917e-09
trigger O 0 7.242840771581882e-10
for O 0 1.4626147515350851e-12
the O 0 5.169022987416838e-10
disease O 0 1.6591458518178115e-07
is O 0 7.161940718215451e-14
probably O 0 7.81401766208889e-12
ubiquitous O 0 3.5980805002111538e-09
. O 0 1.2829073914311095e-10

HLA O 0 4.006774179288186e-05
- O 0 9.001069400937922e-08
B27 O 0 1.9741902335113082e-08
accounts O 0 2.1909884930643164e-12
for O 0 3.9131800013900153e-13
a O 0 4.937767859522491e-13
minority O 0 2.883459733460901e-14
of O 0 1.1993227591600153e-11
the O 0 7.753638009422303e-12
overall O 0 1.4440303119922504e-10
genetic O 0 3.5950875609813693e-10
susceptibility O 0 1.2140168870189427e-09
to O 0 9.988816024320002e-11
AS B-Disease 1 1.0
. O 0 7.255755440915834e-10

Cell O 0 1.5087272231539828e-06
cycle O 0 1.4966888173262305e-08
- O 0 3.659869074468247e-09
dependent O 0 3.0157198960267806e-10
colocalization O 0 4.4362388962326804e-07
of O 0 2.2971789803705178e-08
BARD1 O 1 0.9999992847442627
and O 0 5.380615952788048e-10
BRCA1 O 0 1.998210069631412e-10
proteins O 0 1.289807887230876e-12
in O 0 1.6486419434497135e-12
discrete O 0 3.784081034630127e-11
nuclear O 0 2.3311464758535294e-07
domains O 0 1.1408554989600361e-08
. O 0 6.963286058869755e-10

Germ O 0 0.0065641808323562145
- O 0 1.4655577160738176e-06
line O 0 1.4440207252164328e-08
mutations O 0 3.4541056126435876e-10
of O 0 2.168797808010936e-09
the O 0 2.0962731550611124e-09
BRCA1 O 0 4.4177468794259767e-07
gene O 0 2.0116950327775385e-09
predispose O 0 1.0664832350570919e-09
women O 0 1.2240595906667928e-12
to O 0 1.2972119038667795e-12
early O 0 5.701535883417819e-07
- O 0 0.002210131613537669
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 5.0940678758548685e-11
compromising O 0 1.3229416140347894e-07
the O 0 7.570767901476927e-10
genes O 0 1.0506114728192628e-10
presumptive O 0 5.680898418347624e-09
function O 0 4.6882922891122725e-12
as O 0 3.0491939268656454e-12
a O 0 1.0651221224455831e-11
tumor B-Disease 0 1.376294633814723e-08
suppressor O 0 2.4589292024757015e-07
. O 0 1.5339763903554626e-09

Although O 0 9.358749331056515e-10
the O 0 4.5501824530447266e-11
biochemical O 0 4.1330086020252566e-09
properties O 0 1.2303797092272362e-08
of O 0 7.697657622429688e-08
BRCA1 O 0 2.250287067795398e-08
polypeptides O 0 1.1070291350279149e-09
are O 0 3.174930750162591e-13
not O 0 5.407869993283819e-14
understood O 0 4.312175616583147e-12
, O 0 2.1103420660278926e-13
their O 0 2.483718254935735e-13
expression O 0 2.4973384905174756e-12
pattern O 0 2.2759452308895867e-11
and O 0 1.2655629582497552e-12
subcellular O 0 3.467593545636305e-09
localization O 0 5.819000836737587e-09
suggest O 0 2.771650747454557e-12
a O 0 4.761338350499356e-13
role O 0 2.27998913152061e-12
in O 0 3.899189998657349e-12
cell O 0 1.6125445867487542e-08
- O 0 1.5885804671711412e-08
cycle O 0 1.019518247602491e-09
regulation O 0 1.2983581321179827e-08
. O 0 6.6376848462113e-11

When O 0 1.415915207303442e-08
resting O 0 2.8381937227095477e-06
cells O 0 2.0613226681120977e-09
are O 0 1.2442537234910733e-12
induced O 0 2.4262446274292415e-08
to O 0 2.8332308287665198e-12
proliferate O 0 8.819627805856101e-10
, O 0 5.23046449901754e-13
the O 0 5.358158578286365e-13
steady O 0 2.019235126327068e-11
- O 0 1.7684614623397765e-12
state O 0 1.7898630169134455e-13
levels O 0 1.5369494956243845e-12
of O 0 5.586014290015484e-12
BRCA1 O 0 8.459481379285982e-12
increase O 0 1.2693379096569927e-14
in O 0 3.444146823208122e-13
late O 0 1.5711444367738636e-09
G1 O 0 1.4111808610550725e-08
and O 0 5.868522356435035e-13
reach O 0 4.075899231840985e-13
a O 0 5.91480311858952e-15
maximum O 0 1.5338738037964234e-13
during O 0 1.5280178164434055e-11
S O 0 9.731660099987494e-08
phase O 0 8.322704303509454e-09
. O 0 6.050970141613377e-11

Moreover O 0 2.4285409239155342e-08
, O 0 5.6763645867041745e-11
in O 0 4.703018530172187e-11
S O 0 2.8433336751731986e-07
phase O 0 1.657555870338001e-08
cells O 0 1.5655170215733705e-10
, O 0 2.4019980449097034e-11
BRCA1 O 0 8.928017214415718e-10
polypeptides O 0 4.5293771511190073e-10
are O 0 7.485866310510958e-13
hyperphosphorylated O 0 2.086636463616287e-08
and O 0 1.4706130410657714e-11
accumulate O 0 3.262388137414973e-10
into O 0 4.33217767215055e-11
discrete O 0 9.482042928610213e-10
subnuclear O 0 1.038818140841613e-06
foci O 0 1.4285175211625756e-06
termed O 0 6.277386432884668e-07
" O 0 6.794739704218955e-08
BRCA1 O 0 4.1030699549082783e-07
nuclear O 0 5.552210859605111e-05
dots O 0 8.428508522229095e-07
. O 0 4.0552339264365855e-09

" O 0 3.1648380627302686e-06
BRCA1 O 0 1.1527237120390055e-06
associates O 0 1.2076806399363704e-07
in O 0 2.2889630468814204e-10
vivo O 0 8.032801979140913e-09
with O 0 6.509446627556148e-12
a O 0 3.511008497825152e-11
structurally O 0 2.8467061952142103e-07
related O 0 2.924071793586336e-07
protein O 0 4.2349620343884453e-07
termed O 0 1.5202605027297977e-05
BARD1 O 1 1.0
. O 0 3.799416781191667e-09

Here O 0 6.651277750790996e-09
we O 0 7.261978345052267e-12
show O 0 3.1123719053394172e-12
that O 0 1.2813837346064855e-14
the O 0 1.0270268793396986e-12
steady O 0 5.0877756868628055e-11
- O 0 1.3869228682183987e-11
state O 0 4.65491143894492e-13
levels O 0 4.736269102606494e-12
of O 0 8.019170050221902e-11
BARD1 O 0 0.2432028353214264
, O 0 6.488819030703308e-12
unlike O 0 1.7115948415524773e-12
those O 0 7.092695571489505e-13
of O 0 4.051675384086906e-10
BRCA1 O 0 2.534865650716256e-09
, O 0 7.920632032198949e-12
remain O 0 1.0914336275036352e-11
relatively O 0 1.005208720081252e-12
constant O 0 2.105140931366045e-12
during O 0 1.4409158588524207e-10
cell O 0 1.0528351523930723e-08
cycle O 0 1.3555121469721598e-09
progression O 0 3.638556345109123e-09
. O 0 1.7290354911714267e-11

However O 0 5.655427237627464e-09
, O 0 4.4296727397252766e-10
immunostaining O 0 1.5249185025822953e-06
revealed O 0 1.650791325857881e-08
that O 0 2.31485264984288e-11
BARD1 O 1 0.9999853372573853
resides O 0 1.0696784613628552e-07
within O 0 3.937084880334396e-09
BRCA1 O 0 1.867390331256047e-08
nuclear O 0 9.209004474541871e-07
dots O 0 1.4286734462132245e-08
during O 0 2.613052219047063e-09
S O 0 7.313060024216611e-08
phase O 0 5.459513396921523e-10
of O 0 3.2473627953333306e-11
the O 0 1.7296546139800029e-12
cell O 0 8.836782000587462e-11
cycle O 0 1.0064159575162712e-11
, O 0 3.502101427322983e-14
but O 0 3.360729849657051e-15
not O 0 7.978723408417869e-15
during O 0 5.5491123848727675e-12
the O 0 1.5710410403158015e-11
G1 O 0 2.2424040935220546e-07
phase O 0 3.145846472207836e-09
. O 0 2.3394874579252267e-11

Nevertheless O 0 2.7503608635015553e-07
, O 0 1.6865761010009805e-09
BARD1 O 0 0.08479681611061096
polypeptides O 0 3.228350919926015e-09
are O 0 1.5679859212240632e-13
found O 0 3.886669360918943e-13
exclusively O 0 2.2566783511313027e-12
in O 0 5.884045421039596e-13
the O 0 3.510469096402319e-13
nuclear O 0 5.549254944448023e-10
fractions O 0 7.426541326349678e-11
of O 0 1.2037028318534482e-10
both O 0 2.547196611621394e-12
G1 O 0 4.335490544349341e-08
- O 0 2.700243917352907e-10
and O 0 7.624391569482913e-12
S O 0 9.3483556895535e-08
- O 0 8.670149043155106e-10
phase O 0 3.3602016724643136e-09
cells O 0 8.524337485882327e-11
. O 0 3.837876891288339e-11

Therefore O 0 7.310839045260309e-09
, O 0 1.1629697205250977e-10
progression O 0 3.476545162861555e-10
to O 0 7.63453449764695e-12
S O 0 6.110010986049019e-08
phase O 0 2.843911772743013e-09
is O 0 1.0545126512447045e-13
accompanied O 0 6.3750003539975175e-12
by O 0 1.229135743923207e-13
the O 0 1.2379451847302492e-12
aggregation O 0 3.3096369395080316e-11
of O 0 1.2756240508338124e-10
nuclear O 0 9.054220981852268e-07
BARD1 O 1 0.9999997615814209
polypeptides O 0 1.2825776707359182e-07
into O 0 1.6040956341001333e-09
BRCA1 O 0 7.244173616527405e-08
nuclear O 0 2.0266579667804763e-06
dots O 0 3.5019624533561e-07
. O 0 2.3663941917106968e-09

This O 0 1.5427781274723884e-10
cell O 0 2.1144963557873098e-09
cycle O 0 3.6479497200758715e-10
- O 0 7.357712772382285e-10
dependent O 0 1.729052734322778e-10
colocalization O 0 9.169168890821311e-08
of O 0 7.106264909850779e-09
BARD1 O 1 1.0
and O 0 3.562712791449485e-09
BRCA1 O 0 1.176939967706403e-08
indicates O 0 2.107050298127966e-11
a O 0 8.448995626395006e-13
role O 0 6.285125631749766e-12
for O 0 1.2155216937148605e-11
BARD1 O 1 0.9999998807907104
in O 0 3.822291372301834e-09
BRCA1 O 0 7.998862088243186e-07
- O 0 4.6975301870588737e-07
mediated O 0 1.3358469459490152e-06
tumor B-Disease 0 2.1304736037564e-06
suppression O 0 8.876550054992549e-06
. O 0 3.9022443609759705e-10

Ethnic O 0 3.9049714573025085e-09
differences O 0 5.504096622921395e-10
in O 0 2.0025701583104016e-11
the O 0 1.386846887330151e-10
HFE O 0 0.00024716544430702925
codon O 0 1.9939099260568582e-08
282 O 0 4.310260237616603e-08
( O 0 2.8890259629044124e-10
Cys O 1 0.9083009362220764
/ O 0 2.2249903395277215e-06
Tyr O 0 0.00026658509159460664
) O 0 1.1216556156101731e-10
polymorphism O 0 4.40933689560552e-08
. O 0 4.0135178513978076e-10

Recent O 0 3.9904504700594146e-10
studies O 0 4.850402371414653e-11
have O 0 7.760465040767064e-14
shown O 0 3.4193281886474303e-12
that O 0 6.095207671918956e-11
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 8.53910631093413e-09
HH B-Disease 1 1.0
) O 0 8.9525288224368e-12
is O 0 1.2820152654312994e-13
likely O 0 7.245786544547717e-13
to O 0 5.266091382405413e-13
be O 0 2.598733945050058e-12
caused O 0 1.8214404429173214e-09
by O 0 1.8799134124392047e-11
homozygosity O 0 3.1470909789277357e-07
for O 0 1.0154882143509347e-11
a O 0 1.382696734886224e-11
Cys282Tyr O 0 2.8440280175345833e-07
mutation O 0 4.396428533726127e-12
in O 0 9.222220426555183e-13
the O 0 2.5397559055839736e-11
HFE O 0 2.0434148609638214e-05
gene O 0 3.2535640848152525e-10
located O 0 3.736362774731106e-09
4 O 0 1.319131381904981e-08
. O 0 7.423542891515922e-10

5 O 0 7.553299496976251e-07
Mb O 0 1.2904523600809625e-06
telomeric O 0 2.7130372473038733e-06
to O 0 9.937020095662774e-10
HLA O 0 9.396545465278905e-06
- O 0 1.077169855534521e-07
A O 0 3.346286092664741e-08
. O 0 1.1973577684898373e-10

Population O 0 8.386315730399274e-13
studies O 0 2.9293457850382287e-12
of O 0 1.6595073839414942e-12
this O 0 3.164830822473155e-15
polymorphism O 0 9.43483919463306e-12
are O 0 1.9047385738969747e-14
facilitated O 0 9.052458760892834e-13
by O 0 2.1165095500860764e-13
the O 0 2.623670811857659e-12
fact O 0 2.861338553247772e-13
that O 0 6.8685457000553906e-15
the O 0 5.7031887892855515e-12
Cys282Tyr O 0 8.844245712680276e-06
mutation O 0 1.8355607311892896e-10
creates O 0 4.9999816786883144e-11
a O 0 3.03707614612847e-11
Rsal O 0 4.254210352883092e-07
restriction O 0 4.0531134004595515e-10
site O 0 7.52728812614123e-09
. O 0 1.6991710816149919e-10

We O 0 2.9294605630170167e-10
have O 0 1.8868697023669695e-13
studied O 0 2.381920771732382e-10
the O 0 8.460562112011516e-12
codon O 0 4.546706067198869e-10
282 O 0 7.298091464491563e-09
( O 0 1.6981439865393355e-10
Cys O 0 0.4153587222099304
/ O 0 8.685846637490613e-07
Tyr O 0 1.553035508550238e-05
) O 0 1.4269603294120303e-12
polymorphism O 0 1.3006811773463856e-11
in O 0 1.2524463616821885e-13
different O 0 2.0745820629420285e-14
ethnic O 0 2.9811141619498494e-14
groups O 0 1.0228546254344856e-13
. O 0 4.796031193715633e-12

In O 0 1.220650469591078e-09
agreement O 0 2.3575541518994214e-10
with O 0 5.552129068997491e-12
previous O 0 1.0704341579792498e-10
observations O 0 1.5361019123361075e-09
the O 0 1.6786930179257809e-10
Tyr O 0 5.6830471294233575e-05
allele O 0 4.4567051438182403e-11
appeared O 0 5.91961132889729e-11
to O 0 4.247700552840322e-13
be O 0 1.563953637819318e-13
rare O 0 4.826334470964255e-11
or O 0 1.422648197163534e-11
absent O 0 5.634557820322073e-10
in O 0 8.464549373921049e-12
Asiatic O 0 7.594157303003612e-09
( O 0 1.6343090075698896e-12
Indian O 0 7.335509803751972e-12
, O 0 1.2923165413226273e-13
Chinese O 0 3.3341664390333647e-13
) O 0 2.7353319668977846e-14
populations O 0 1.1409483655164948e-13
. O 0 1.81976395757788e-12

The O 0 2.400081688946898e-09
highest O 0 1.3518045571814241e-09
allele O 0 1.1455063243445696e-12
frequency O 0 1.5611954437555475e-11
( O 0 4.644163200707985e-13
7 O 0 4.1160196778688984e-11
. O 0 2.7690958860214672e-14
5 O 0 1.652010125918757e-12
% O 0 7.855324260530074e-15
) O 0 3.862573153982701e-15
was O 0 1.7105798114785964e-12
found O 0 4.922628060385903e-13
in O 0 2.785706344418659e-12
Swedes O 0 1.3320435421348975e-08
. O 0 1.7978241118044025e-10

Saamis O 0 2.9822500437148847e-05
( O 0 6.288178311386616e-10
2 O 0 4.67324456909779e-10
% O 0 1.3608406936038708e-13
) O 0 1.9239297993829153e-14
and O 0 3.796345020030262e-13
Mordvinians O 0 1.157477669266882e-07
( O 0 7.225640658720112e-12
1 O 0 1.1761885736205624e-11
. O 0 1.481545836262265e-14
8 O 0 3.729699275117904e-12
% O 0 6.235396195279326e-15
) O 0 1.3824382380490073e-15
had O 0 1.327681793173753e-14
significantly O 0 1.1303433097289636e-13
lower O 0 2.8356596584733218e-11
frequencies O 0 6.061250806821405e-11
of O 0 2.1058740862223146e-10
the O 0 1.8547585689532298e-10
Tyr O 0 3.169467527186498e-05
allele O 0 3.9574488130966756e-10
. O 0 1.1538885125172982e-10

Comparisons O 0 1.5678942588692735e-08
with O 0 8.54657230403566e-12
allele O 0 1.89788310935024e-12
frequencies O 0 1.8582633695696238e-11
based O 0 1.0374306448623916e-11
on O 0 5.200923719472783e-11
prevalence O 0 4.877231257749415e-11
estimates O 0 8.696818222173053e-13
of O 0 2.0032005568215716e-11
HH B-Disease 1 0.9999827146530151
showed O 0 1.8156340875208343e-09
some O 0 5.093440860054477e-13
disagreements O 0 7.968371518174422e-10
with O 0 1.1832940226622068e-12
the O 0 1.4300071543571491e-11
RFLP O 0 2.3588614794789464e-07
data O 0 4.9234592097713303e-11
, O 0 2.383521440114944e-13
particularly O 0 5.680756429496392e-13
in O 0 2.761514107663121e-12
Finns O 0 5.445954354144078e-09
. O 0 1.3653561614646037e-10

The O 0 2.4572335277639468e-08
newly O 0 4.0234942844108446e-07
described O 0 4.084586535668677e-08
HFE O 1 0.7884284257888794
marker O 0 1.6439352990005318e-08
provides O 0 9.862614197553299e-12
a O 0 6.952884448740981e-13
new O 0 8.186407823330966e-13
approach O 0 4.3028011709189684e-12
to O 0 9.158969291539823e-14
the O 0 3.412778143852685e-13
screening O 0 8.660240927160778e-12
of O 0 2.1884419623696694e-11
HH B-Disease 0 0.0012141041224822402
as O 0 9.995329217082904e-12
well O 0 5.903830484384198e-13
as O 0 2.913345766345464e-14
studies O 0 1.307789461576711e-13
of O 0 7.640168337395836e-13
the O 0 9.589116610128623e-13
relationship O 0 4.710698519629075e-13
between O 0 5.085211331884443e-12
the O 0 1.49388654224758e-10
HFE O 1 0.9417716860771179
Tyr O 0 0.00010561099043115973
allele O 0 7.063434559473336e-11
and O 0 1.201436086034624e-11
different O 0 2.97868757437314e-10
disorders O 1 1.0
including O 0 0.00011190846998943016
cancer B-Disease 1 1.0

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
associated O 0 1.382882715006417e-07
with O 0 1.2197189092066907e-10
a O 0 2.274284371939217e-10
missense O 0 5.668183788998249e-08
mutation O 0 1.4187144514732353e-10
encoding O 0 1.9333434853052722e-10
Gly23 O 0 3.5984264741273364e-06
- O 0 1.1727119897386729e-07
- O 0 1.9789366589861856e-08
> O 0 1.4659125024962805e-09
Val O 0 5.930571589374267e-08
in O 0 7.170836147096793e-11
neurophysin O 0 1.9883778804796748e-05
II O 1 1.0
. O 0 9.994162830651021e-09

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 3.054582293771091e-07
ADNDI B-Disease 1 1.0
) O 0 1.5725475366323849e-09
is O 0 4.5613634397367875e-12
an O 0 1.547517114453001e-10
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 0.0009054930997081101
by O 0 1.0007333156591969e-10
progressive O 1 0.9999825954437256
degeneration O 1 1.0
of O 0 2.006033383850081e-07
the O 0 8.787204852644948e-10
magnocellular O 0 9.164463108390919e-07
neurons O 0 6.912462602315372e-09
of O 0 5.1010953683316984e-08
the O 0 1.2645860358873051e-08
hypothalamus O 0 5.379610001909896e-07
leading O 0 4.100542128071538e-08
to O 0 8.163756129442312e-12
decreased O 0 5.207455300304531e-11
ability O 0 1.5948190034212328e-12
to O 0 3.41706399504052e-13
produce O 0 5.0333567175320226e-11
the O 0 1.164818935750489e-10
hormone O 0 3.0401101636101657e-09
arginine O 0 5.1357133656892984e-08
vasopressin O 0 1.4341557275088235e-08
( O 0 5.214882414783517e-10
AVP O 0 0.0002619729202706367
) O 0 1.3523834829776149e-11
. O 0 2.5864419980758946e-11

Affected O 0 6.866067536748233e-08
individuals O 0 4.589219195633154e-12
are O 0 1.216117159232033e-12
not O 0 4.803574638750918e-12
symptomatic O 0 1.3229637829681451e-08
at O 0 9.81142056488693e-10
birth O 0 2.575702540141833e-09
, O 0 7.421734125705182e-13
but O 0 1.5807208244168064e-13
usually O 0 2.041032481914229e-10
develop O 0 2.70894197456073e-05
diabetes B-Disease 1 1.0
insipidus I-Disease 0 0.0007838417077437043
at O 0 2.3159299189501326e-07
1 O 0 3.5726632319210694e-08
- O 0 4.602096126404831e-08
6 O 0 6.43322835003346e-08
yr O 0 5.35684932856384e-07
of O 0 1.8872117202306526e-09
age O 0 1.7074652802762103e-10
. O 0 3.402642057004357e-11

The O 0 8.67804494930624e-09
genetic O 0 2.6179760581612754e-09
locus O 0 1.939940569295473e-10
of O 0 5.868698860211907e-10
the O 0 1.743961419720108e-09
disease O 0 2.5944359549612273e-06
is O 0 1.6676899661574596e-13
the O 0 1.3034683055135332e-10
AVP O 1 0.9974881410598755
- O 0 6.244307826364093e-08
neurophysin O 0 5.4003326113161165e-06
II O 1 1.0
( O 0 1.091409740361371e-09
NPII O 1 0.9999983310699463
) O 0 8.88930075382266e-12
gene O 0 8.751751927327245e-12
, O 0 3.6297874428381505e-13
and O 0 5.712006822394811e-12
mutations O 0 1.1188330817368808e-10
that O 0 1.8589075591324278e-12
cause O 0 4.0616608742993776e-08
ADNDI B-Disease 1 1.0
have O 0 8.690417634647785e-13
been O 0 2.2319093188200023e-13
found O 0 7.663180257456298e-14
in O 0 2.29361258582755e-14
both O 0 1.485195701231984e-14
the O 0 1.4287196642773226e-12
signal O 0 1.819515788037407e-10
peptide O 0 2.030149659493219e-10
of O 0 1.4641018397654193e-09
the O 0 3.306344920073201e-10
prepro O 0 3.735810241778381e-05
- O 0 6.237753041204996e-06
AVP O 1 0.9999067783355713
- O 0 1.766062354136011e-07
NPII O 1 0.9339168071746826
precursor O 0 2.1116600024129184e-08
and O 0 6.239001676400235e-11
within O 0 8.823413666370072e-10
NPII O 1 0.9999862909317017
itself O 0 1.4194061037642314e-08
. O 0 4.408920450948983e-10

An O 0 8.795454364829425e-10
affected O 0 4.045854762324552e-09
girl O 0 1.234328550481223e-08
who O 0 9.658726943251317e-12
presented O 0 1.9064762268872215e-10
at O 0 1.7616872405312733e-09
9 O 0 1.168399710316237e-09
months O 0 2.983665398081925e-12
of O 0 2.8003254229358454e-11
age O 0 1.1769426579155695e-11
and O 0 2.7572297743583274e-12
her O 0 3.2741292316229575e-12
similarly O 0 7.803104690173868e-11
affected O 0 1.3975620660744426e-09
younger O 0 1.1060730109591077e-09
brother O 0 1.3349864325107319e-08
and O 0 2.1174496878106908e-10
father O 0 2.4206825433026324e-09
were O 0 7.894964543231353e-11
all O 0 1.113218675227734e-12
found O 0 4.839816156350374e-13
to O 0 1.2454783298448957e-13
have O 0 1.2033262603852127e-14
a O 0 1.0036742487465333e-12
novel O 0 2.7180488762490462e-11
missense O 0 1.8609040974837399e-09
mutation O 0 5.564026323012783e-11
( O 0 1.2974699439838311e-11
G1758 O 0 1.844480301826934e-08
- O 0 6.663810836471384e-09
- O 0 5.190780250075022e-09
> O 0 3.626084155161635e-10
T O 0 2.132903453855306e-08
) O 0 6.31578732997358e-14
encoding O 0 1.1685087847410763e-13
the O 0 1.842739502655455e-12
amino O 0 6.1059677279595714e-12
acid O 0 7.0213878114455675e-12
substitution O 0 3.347392155128581e-11
Gly23 O 0 5.141447445566882e-07
- O 0 1.8794249712072997e-08
- O 0 6.224329052173516e-09
> O 0 3.2177223108220687e-09
Val O 0 3.402401489438489e-07
within O 0 8.288170150194674e-09
NPII O 1 0.9999871253967285
. O 0 1.3579912749861478e-09

The O 0 3.803414116987369e-08
mutation O 0 1.1141932931835186e-09
was O 0 2.2808264998896988e-10
confirmed O 0 6.0290791456529824e-12
by O 0 4.117371591241814e-14
restriction O 0 7.545158074717673e-12
endonuclease O 0 4.4813437405366585e-09
analysis O 0 3.741402465617938e-10
. O 0 8.970361259352799e-11

A O 0 1.7454854969400913e-05
T1 O 0 0.0005275634466670454
- O 0 6.9063608165720325e-09
weighted O 0 1.0262505428793034e-10
magnetic O 0 3.068777731929373e-10
resonance O 0 6.97073787581104e-11
imaging O 0 4.4932768616945395e-08
of O 0 2.971119794636934e-09
the O 0 5.1914339493919215e-09
fathers O 0 4.877728861174546e-05
pituitary O 1 0.9828930497169495
gland O 0 1.2891982805740554e-05
demonstrates O 0 2.906404006353114e-09
an O 0 1.3838179734049216e-11
attenuated O 0 1.199977850774303e-05
posterior O 0 2.950260750367306e-06
pituitary O 1 0.68949955701828
bright O 0 1.7206055417773314e-05
spot O 0 7.49443688619067e-06
. O 0 3.4481832944521784e-09

This O 0 5.372678413273491e-10
mutation O 0 1.8857501671298849e-10
may O 0 8.923802669036363e-12
be O 0 8.908929908894858e-14
valuable O 0 8.379652874368482e-12
for O 0 3.54569021712714e-13
developing O 0 2.5904792633896223e-12
models O 0 3.216933316951831e-11
of O 0 7.913089627997749e-10
dominantly B-Disease 1 0.9849019646644592
inherited I-Disease 1 0.9994533658027649
neurodegeneration I-Disease 1 1.0
, O 0 3.7426872712131853e-10
as O 0 2.3225158775341814e-12
the O 0 2.6851723969323338e-12
early O 0 2.8788920899969206e-11
age O 0 6.435323736571352e-13
of O 0 9.362524644451753e-12
onset O 0 0.0025872974656522274
of O 0 1.6292631698888727e-05
symptoms O 1 0.9999998807907104
suggests O 0 9.610732348841466e-11
that O 0 8.864859123462396e-14
this O 0 1.6806158244578318e-13
mutation O 0 8.675152610160275e-12
may O 0 2.9996998808512476e-12
be O 0 7.831963701708522e-13
particularly O 0 4.932586283867835e-11
deleterious O 0 1.545689021220653e-09
to O 0 1.9911629636770733e-11
the O 0 3.054167752036818e-10
magnocellular O 0 1.3381803682932514e-06
neuron O 0 7.190500639353559e-08
. O 0 1.0822695517553882e-10
. O 0 3.2356542445377556e-10

Frequent O 0 6.654503437175663e-08
inactivation O 0 3.6738627386512235e-05
of O 0 3.6925699532730505e-05
PTEN O 1 1.0
/ O 0 0.01191451121121645
MMAC1 O 1 1.0
in O 0 1.3105820428904735e-08
primary O 1 0.9999282360076904
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.6847564171816884e-09

Sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 1.4739612308467542e-10
the O 0 7.569926629980017e-11
most O 0 4.4905583158200146e-13
common O 0 2.5724153709938413e-11
male B-Disease 0 1.3034825822877405e-11
cancer I-Disease 0 9.548458378139113e-12
in O 0 2.7196016163903713e-13
the O 0 1.254106540837796e-11
Western O 0 8.232706738553475e-10
world O 0 2.5812522258528148e-11
, O 0 1.1370033603866347e-13
yet O 0 2.7092250562106915e-14
many O 0 2.2025666660414325e-15
of O 0 6.679754947953864e-13
the O 0 3.4433716186547947e-13
major O 0 1.3950066796164506e-11
genetic O 0 1.5907398662196037e-11
events O 0 2.705210621484211e-12
involved O 0 2.4367068692660032e-12
in O 0 2.2970386443638136e-12
the O 0 1.7737760912850398e-11
progression O 0 1.0072734868415978e-09
of O 0 3.060370706853277e-11
this O 0 5.907806795851789e-13
often O 0 7.707317561944649e-10
fatal O 1 0.9999988079071045
cancer B-Disease 0 3.0499173590214923e-05
remain O 0 3.071764509421371e-10
to O 0 2.8224233714069236e-11
be O 0 4.7043282463965497e-11
elucidated O 0 7.528592959715752e-06
. O 0 4.909005202335948e-09

Numerous O 0 2.0332291228442045e-07
cytogenetic O 0 5.307897663442418e-05
and O 0 5.606163533400377e-09
allelotype O 0 2.166743570342078e-06
studies O 0 8.300280601725163e-11
have O 0 2.3425245033667497e-14
reported O 0 7.934478269723544e-13
frequent O 0 6.865085323132236e-12
loss O 0 3.6223411825631047e-08
of O 0 1.4294754180355085e-07
heterozygosity O 0 6.700829544570297e-05
on O 0 5.145811155671254e-05
chromosomal O 1 0.999873161315918
arm O 1 0.9998874664306641
10q O 0 3.8578127714572474e-05
in O 0 1.3907554219372287e-08
sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.253189190781768e-09

Deletion O 0 1.543067327247627e-07
mapping O 0 5.066243868867559e-09
studies O 0 1.2789592995776644e-10
have O 0 3.1381334705295194e-13
unambiguously O 0 3.010991234120297e-09
identified O 0 2.088731965166346e-11
a O 0 3.9155714261218666e-12
region O 0 9.338042838979987e-11
of O 0 8.271697993222915e-09
chromosome O 0 3.744374144076801e-09
10q23 O 0 1.422294992892148e-08
to O 0 4.333001405593118e-12
be O 0 1.6138358824215743e-13
the O 0 2.617023785178585e-12
minimal O 0 1.044887995571564e-10
area O 0 3.329506947924443e-10
of O 0 2.550392952382907e-10
loss O 0 4.5481332477947944e-08
. O 0 6.387299578136663e-10

A O 0 2.6470047487237025e-07
new O 0 5.462596486260907e-10
tumor B-Disease 0 4.8104031868945185e-09
suppressor O 0 1.72303309398103e-08
gene O 0 1.20869358966047e-09
, O 0 7.316425937320403e-11
PTEN O 0 0.18814653158187866
/ O 0 1.417544126525172e-06
MMAC1 O 1 1.0
, O 0 7.731459916726635e-11
was O 0 1.8632827225584236e-10
isolated O 0 3.6305478068321406e-10
recently O 0 2.1284541837363058e-11
at O 0 2.197112283774949e-11
this O 0 6.349361937233551e-15
region O 0 9.953057475420302e-12
of O 0 3.2060315513504634e-10
chromosome O 0 6.051665835116182e-10
10q23 O 0 1.7266453156139505e-08
and O 0 2.961317649430306e-11
found O 0 6.750831230833976e-12
to O 0 1.710334212581474e-13
be O 0 2.3019322450794355e-13
inactivated O 0 1.8496592701922054e-08
by O 0 2.6074277285903502e-12
mutation O 0 2.9393432132707176e-11
in O 0 1.2739165625164084e-11
three O 0 5.489274812475742e-09
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 1.0307398952136282e-06
lines O 0 1.898933277288961e-08
. O 0 1.631296070447874e-10

We O 0 4.711103507304415e-09
screened O 0 1.7135341749963118e-06
80 O 0 4.192241704004118e-06
prostate B-Disease 1 0.999995231628418
tumors I-Disease 1 1.0
by O 0 1.0409309698922176e-11
microsatellite O 0 1.569847363214194e-09
analysis O 0 2.2208707095572322e-11
and O 0 1.8901493217815535e-11
found O 0 1.3001212606500445e-10
chromosome O 0 7.250429145955195e-10
10q23 O 0 5.592802221343618e-09
to O 0 3.960321653950771e-12
be O 0 1.1279190472238132e-12
deleted O 0 1.4650983204411716e-10
in O 0 9.822252386437746e-12
23 O 0 5.842230033081819e-10
cases O 0 1.681778327711214e-11
. O 0 2.5283638030448863e-11

We O 0 3.7336750358107906e-10
then O 0 1.0764941889285229e-11
proceeded O 0 4.481373258591326e-11
with O 0 2.53997008565739e-14
sequence O 0 6.673345686811216e-14
analysis O 0 1.0477121964056965e-13
of O 0 2.7130439821804186e-12
the O 0 3.464256442473057e-12
entire O 0 2.741136206907413e-09
PTEN O 0 0.11871346086263657
/ O 0 1.7892824644150096e-06
MMAC1 O 1 0.999998927116394
coding O 0 1.1711268399494656e-08
region O 0 2.984727187627101e-10
and O 0 2.955752396310851e-12
tested O 0 4.667576394834505e-11
for O 0 3.4103251364374365e-13
homozygous O 0 9.410833223810755e-11
deletion O 0 1.8762489825685513e-11
with O 0 7.558492135135986e-13
new O 0 8.596670597604827e-11
intragenic O 0 3.447902940934e-07
markers O 0 3.727557373878199e-09
in O 0 5.093773493280995e-12
these O 0 5.288405889418424e-13
23 O 0 2.357882222803198e-10
cases O 0 7.371973582796787e-13
with O 0 1.7037085175801436e-13
10q23 O 0 1.9304970066968963e-08
loss O 0 5.500386990320294e-08
of O 0 4.807507281157086e-08
heterozygosity O 0 5.5418378906324506e-05
. O 0 3.6824879146024614e-08

The O 0 4.689558186221632e-10
identification O 0 8.390247940859297e-10
of O 0 1.5137010533905482e-09
the O 0 5.578222952995482e-11
second O 0 1.8407390889318975e-10
mutational O 0 4.209286696976733e-09
event O 0 1.4861280261957432e-10
in O 0 1.9335011022802995e-11
10 O 0 3.097650608241409e-11
( O 0 1.1480523563062173e-12
43 O 0 8.423242658928132e-11
% O 0 1.4313490713860344e-12
) O 0 8.86345233319652e-11
tumors B-Disease 1 1.0
establishes O 0 1.1463540431577712e-05
PTEN O 1 1.0
/ O 0 8.816921035759151e-05
MMAC1 O 1 1.0
as O 0 1.4392402547525052e-10
a O 0 3.320466297751512e-12
main O 0 1.1843565017599644e-10
inactivation O 0 2.8843489374708042e-08
target O 0 1.7695944709572586e-09
of O 0 2.8416777819728622e-09
10q O 0 6.216085921550984e-07
loss O 0 2.1729690047322947e-07
in O 0 2.8342512781165397e-09
sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.895203438628812e-11
. O 0 1.9153722011222563e-11

Risk O 0 3.072464949127607e-08
reversals O 0 1.2964700424333842e-08
in O 0 2.6280044113091705e-11
predictive O 0 3.7940703356831307e-10
testing O 0 4.9847512784140235e-09
for O 0 2.2093642471077146e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.9703925990821602e-10

The O 0 1.8380315047750173e-09
first O 0 1.6070584099581176e-11
predictive O 0 8.454872219010312e-11
testing O 0 3.2561156548815973e-10
for O 0 5.3198341565252605e-11
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 9.18578060837838e-12
HD B-Disease 0 7.218931727948075e-07
) O 0 1.8117041341528944e-13
was O 0 4.727820999278487e-12
based O 0 3.4896959454078225e-12
on O 0 6.2272760732728916e-12
analysis O 0 1.8071734430094577e-12
of O 0 9.8900974215832e-12
linked O 0 1.8253903943943328e-10
polymorphic O 0 1.6754727605317044e-09
DNA O 0 3.013003180285523e-08
markers O 0 1.0960404112081434e-10
to O 0 1.7455419163044106e-13
estimate O 0 8.996893941654038e-13
the O 0 2.5411731096117163e-13
likelihood O 0 8.381634795939785e-12
of O 0 7.55783699513124e-11
inheriting O 0 7.875056162731653e-10
the O 0 6.047059381009134e-11
mutation O 0 5.154898643361383e-12
for O 0 1.0522935821322132e-11
HD B-Disease 0 4.1359253373229876e-05
. O 0 1.5952685838982461e-09

Limits O 0 1.6541282787940759e-09
to O 0 1.88694632835551e-12
accuracy O 0 1.6122200796608865e-10
included O 0 2.3803207668815496e-11
recombination O 0 2.2748547837125876e-12
between O 0 2.3022935554534163e-12
the O 0 8.027364038244722e-13
DNA O 0 2.545660793273896e-09
markers O 0 6.993550183409525e-11
and O 0 7.275311538108842e-13
the O 0 1.6109918303877646e-12
mutation O 0 1.998528079139028e-12
, O 0 8.604715789721495e-13
pedigree O 0 1.7885791459004707e-10
structure O 0 1.1994995274822173e-10
, O 0 2.2578666367123468e-12
and O 0 6.312201737863898e-13
whether O 0 4.4120428339435025e-13
DNA O 0 8.472520462987632e-10
samples O 0 5.4923457275257714e-12
were O 0 3.639255373834652e-14
available O 0 5.170649268449422e-14
from O 0 2.6005484658059297e-12
family O 0 3.923173851755335e-12
members O 0 9.579615746491132e-12
. O 0 1.2617032418837937e-10

With O 0 1.5629206262524065e-11
direct O 0 9.358114110014082e-12
tests O 0 4.229208303008214e-11
for O 0 5.041133526242914e-13
the O 0 7.24370346691372e-12
HD B-Disease 0 3.2356999781768536e-06
mutation O 0 1.4920746929658613e-11
, O 0 4.443569535765579e-13
we O 0 1.99016523475936e-14
have O 0 1.0325228924285067e-15
assessed O 0 3.293798567227668e-11
the O 0 3.1935415683442825e-12
accuracy O 0 4.1119177507376037e-10
of O 0 5.280751183556198e-11
results O 0 2.0104185243646766e-12
obtained O 0 4.2293512442226344e-12
by O 0 1.9833075882557533e-13
linkage O 0 6.429772686500357e-11
approaches O 0 3.8891057041468e-11
when O 0 1.319792392777755e-13
requested O 0 4.00327644298204e-12
to O 0 1.166943603379822e-12
do O 0 7.258470625763624e-13
so O 0 3.2460697947959624e-14
by O 0 1.1191195133141221e-13
the O 0 1.4087334814297248e-12
test O 0 2.2432897553437137e-11
individuals O 0 8.361809644219856e-14
. O 0 2.219380235146673e-11

For O 0 1.586211828552564e-09
six O 0 6.92726431772428e-11
such O 0 4.289960314068919e-12
individuals O 0 2.816827446208009e-13
, O 0 1.5201478313978112e-12
there O 0 2.823357324842346e-13
was O 0 3.426367869985292e-11
significant O 0 5.746560345631924e-12
disparity O 0 5.89467780143238e-11
between O 0 4.010016711047948e-12
the O 0 9.979917933722326e-12
tests O 0 4.988400803540571e-10
. O 0 1.8741171808889234e-11

Three O 0 7.483797581642193e-09
went O 0 3.159370098870795e-09
from O 0 2.2241052749505386e-11
a O 0 3.4602017431883958e-12
decreased O 0 4.692534902317469e-11
risk O 0 6.6158402541038885e-12
to O 0 2.200603387665298e-13
an O 0 3.392845019148903e-14
increased O 0 3.3780335299826714e-13
risk O 0 4.872105323350251e-12
, O 0 2.551440233134611e-13
while O 0 1.4016623961759372e-13
in O 0 1.8684722822778776e-13
another O 0 2.542045621310024e-13
three O 0 1.4274196516624038e-13
the O 0 1.911597399470444e-12
risk O 0 1.3919023919561901e-11
was O 0 1.9013160490466419e-10
decreased O 0 2.562985379483962e-09
. O 0 2.277587840548989e-10

Knowledge O 0 1.2480775524181809e-07
of O 0 4.114252050158029e-08
the O 0 1.0619945894907445e-10
potential O 0 3.120170354725671e-12
reasons O 0 3.5443867892753778e-12
for O 0 6.794667909912344e-14
these O 0 4.078463302216277e-14
changes O 0 2.621673494615506e-13
in O 0 6.274534385987407e-13
results O 0 2.334752183252853e-12
and O 0 9.211847864371014e-13
impact O 0 3.245715501920543e-11
of O 0 2.9679619872879925e-11
these O 0 5.081776470981791e-13
risk O 0 6.615815100613487e-12
reversals O 0 4.445399048869092e-10
on O 0 8.109462545924373e-10
both O 0 5.705691561580517e-12
patients O 0 4.40081651675861e-12
and O 0 2.3906252411692863e-12
the O 0 2.448336325344691e-11
counseling O 0 3.142900384389691e-10
team O 0 6.205758823485397e-11
can O 0 2.7934289403104204e-14
assist O 0 6.21767437883336e-12
in O 0 5.21392987378605e-13
the O 0 7.893089393889996e-13
development O 0 5.2661638071105354e-12
of O 0 6.34348866837553e-12
strategies O 0 2.3373362707107548e-12
for O 0 4.66135952807787e-14
the O 0 8.558051728217719e-13
prevention O 0 1.6823191728576603e-09
and O 0 2.3588954140701945e-13
, O 0 1.8247391919408266e-14
where O 0 1.962804207090562e-14
necessary O 0 1.2306987026700078e-12
, O 0 1.0748379183217471e-12
management O 0 1.6946366532266666e-10
of O 0 3.675901805166859e-10
a O 0 1.5161266339602797e-11
risk O 0 2.4623813404955897e-11
reversal O 0 4.015024077097529e-11
in O 0 1.4270963967846773e-12
any O 0 1.1790675857534239e-12
predictive O 0 9.447683607666235e-11
testing O 0 4.381373597261984e-10
program O 0 1.5379237813806235e-11
. O 0 6.093632543002769e-13
. O 0 6.241057583927789e-12

A O 0 1.4274880868470063e-06
novel O 0 2.6465483138338186e-09
common O 0 2.7281887859942344e-10
missense O 0 1.3124606290659813e-08
mutation O 0 7.841268606645357e-11
G301C O 0 7.0747940839055445e-09
in O 0 2.846014396373775e-11
the O 0 6.936360513742912e-11
N O 0 1.6257562407417936e-08
- O 0 2.958012723652814e-09
acetylgalactosamine O 0 4.579452763664449e-07
- O 0 9.247762555730787e-09
6 O 0 6.563614096677384e-09
- O 0 7.910493926566176e-10
sulfate O 0 2.2476767669310505e-10
sulfatase O 0 2.770034654986375e-07
gene O 0 2.076474547862972e-10
in O 0 7.524093847965929e-11
mucopolysaccharidosis B-Disease 0 0.0018564766505733132
IVA I-Disease 1 1.0
. O 0 2.131236165325845e-08

Mucopolysaccharidosis B-Disease 1 0.9999942779541016
IVA I-Disease 1 1.0
( O 0 5.127735130372457e-05
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 2.764991346992929e-09
is O 0 2.556614859053341e-12
an O 0 8.763177683501766e-12
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 0.3640923500061035
by O 0 5.085420418105002e-10
a O 0 1.1417306211569667e-08
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 8.795135730821357e-10
N O 0 7.054651973703585e-08
- O 0 3.268493697916597e-09
acetylgalactosamine O 0 5.815630856886855e-07
- O 0 9.40289357487245e-09
6 O 0 1.5425795751866644e-08
- O 0 5.6236952872268375e-09
sulfate O 0 9.62130153325802e-10
sulfatase O 0 1.4414114275496104e-06
( O 0 8.453054367585366e-10
GALNS O 1 0.9999998807907104
) O 0 5.5298324946884136e-11
. O 0 2.6215512399785368e-11

In O 0 2.5236059908451125e-09
previous O 0 8.198358658617622e-10
studies O 0 6.13691181206022e-11
, O 0 1.29201163656667e-12
we O 0 5.893679641544303e-14
have O 0 2.8664922659230345e-15
found O 0 5.916025048319229e-14
two O 0 2.3808803575040872e-14
common O 0 7.444115853252886e-14
mutations O 0 3.101549236623341e-13
in O 0 1.3844165614243509e-12
Caucasians O 0 2.2369289753854105e-10
and O 0 7.078265491095026e-12
Japanese O 0 5.562167615380531e-08
, O 0 2.0499855285516233e-11
respectively O 0 6.670254348861704e-10
. O 0 9.127591737989604e-11

To O 0 2.3053641218240273e-09
characterize O 0 7.739113527804875e-08
the O 0 5.408963832387315e-10
mutational O 0 6.68549375859584e-08
spectrum O 0 1.017631756639048e-09
in O 0 3.176348344503116e-13
various O 0 4.956753323764884e-13
ethnic O 0 1.2437037704094095e-15
groups O 0 1.0421783268733768e-15
, O 0 3.6863538785370745e-15
mutations O 0 3.128104193858214e-14
in O 0 2.7519219542027074e-13
the O 0 1.3589044819961593e-11
GALNS O 1 0.5032538175582886
gene O 0 7.647713712310988e-11
in O 0 3.435103590465616e-11
Colombian O 0 2.008887349802535e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 3.145728300069095e-08
were O 0 7.297652759863382e-11
investigated O 0 4.8809956076922845e-09
, O 0 5.406060581830685e-12
and O 0 1.1814178108027207e-12
genetic O 0 2.3454340900008752e-11
backgrounds O 0 3.6051986049279172e-12
were O 0 1.7728484695903046e-12
extensively O 0 2.2729127607812316e-11
analyzed O 0 2.277582289433866e-11
to O 0 2.6880404911493183e-13
identify O 0 5.219902635134055e-12
racial O 0 2.2306039394043298e-12
origin O 0 2.3803002754604896e-13
, O 0 2.0335094353296675e-14
based O 0 8.696155232544578e-13
on O 0 1.765766005634717e-11
mitochondrial O 0 5.802835642554349e-11
DNA O 0 5.843034944774672e-09
( O 0 4.327294599038023e-12
mtDNA O 0 4.7305388772844736e-11
) O 0 1.220585698485932e-12
lineages O 0 6.82081613412322e-11
. O 0 2.6569902528139622e-11

Three O 0 5.886066745119933e-09
novel O 0 1.870804844372742e-09
missense O 0 1.451984985578747e-07
mutations O 0 2.820074618270496e-09
never O 0 5.551732407127474e-10
identified O 0 4.4879083088700256e-11
previously O 0 4.625100302746432e-11
in O 0 4.599565628544966e-13
other O 0 4.4976876904931004e-14
populations O 0 1.999845466093761e-14
and O 0 7.065686604594903e-14
found O 0 9.631165222984128e-13
in O 0 1.792152689271409e-12
16 O 0 8.340987622812435e-11
out O 0 1.5153625966893292e-12
of O 0 2.0836783687361304e-11
19 O 0 2.113186070573647e-09
Colombian O 0 7.063375733196153e-07
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
unrelated O 0 2.6237367478643137e-07
alleles O 0 1.7063957668747576e-12
account O 0 3.538501685673018e-13
for O 0 6.438420976917492e-12
84 O 0 4.817530552259086e-08
. O 0 6.392381624031884e-10

2 O 0 1.8820939473584986e-08
% O 0 2.7059123171302435e-12
of O 0 1.0698214016058305e-11
the O 0 4.88536348961649e-13
alleles O 0 2.637134082069878e-14
in O 0 1.9396158670078462e-13
this O 0 1.6384397162031057e-14
study O 0 6.13353812184414e-12
. O 0 3.218523017545216e-11

The O 0 3.5510119289483555e-08
G301C O 0 1.3709519635085599e-06
and O 0 5.474947162298349e-10
S162F O 0 4.6513644491597006e-08
mutations O 0 1.7902745258480124e-11
account O 0 2.552960230370327e-12
for O 0 4.1449562532269724e-11
68 O 0 2.0011877666092914e-07
. O 0 6.178632605546852e-10

4 O 0 5.558932869575983e-08
% O 0 1.845586183879533e-11
and O 0 8.723969463497738e-12
10 O 0 3.972444873046044e-10
. O 0 7.361639769998263e-11

5 O 0 9.768124087372598e-09
% O 0 2.0721718611838025e-12
of O 0 3.812014245929696e-11
mutations O 0 8.841447539376102e-12
, O 0 1.122395492519912e-11
respectively O 0 2.2102902841325545e-10
, O 0 3.0228577887342345e-12
whereas O 0 1.259853332769012e-11
the O 0 2.3732127374387346e-11
remaining O 0 1.7759038684062034e-09
F69V O 1 0.9999991655349731
is O 0 1.1228339221944217e-12
limited O 0 9.077650740471621e-13
to O 0 2.7096087960171156e-13
a O 0 3.812492422455849e-12
single O 0 2.1837438801686204e-10
allele O 0 7.805427137963505e-11
. O 0 6.051732726053416e-11

The O 0 3.0183802124383874e-09
skewed O 0 2.1527943872001742e-09
prevalence O 0 1.8259416201260592e-09
of O 0 1.5179472956372564e-10
G301C O 0 3.384418745255857e-09
in O 0 4.365345324802705e-12
only O 0 4.2565002087227577e-13
Colombian O 0 1.1382597087106205e-09
patients O 0 7.451595764040864e-12
and O 0 1.3009161890092935e-12
haplotype O 0 1.5357605812060804e-11
analysis O 0 1.7049155056486631e-12
by O 0 8.149606206889204e-14
restriction O 0 1.1794679816157227e-12
fragment O 0 1.781735314843047e-10
length O 0 1.2254991292592887e-11
polymorphisms O 0 1.0005596351447821e-10
in O 0 3.072112659749382e-12
the O 0 8.950484797765057e-11
GALNS O 1 0.9999998807907104
gene O 0 1.83677600906762e-10
suggest O 0 3.426418220334182e-12
that O 0 4.4992150603035894e-14
G301C O 0 4.951112853035511e-09
originated O 0 1.6381805634235747e-10
from O 0 5.9231434861029e-12
a O 0 2.1642652947573282e-12
common O 0 4.9164214366292924e-11
ancestor O 0 3.639993195747593e-09
. O 0 2.7317711981389436e-10

Investigation O 0 4.246269824648152e-08
of O 0 2.139626609221068e-08
the O 0 9.872593714765898e-11
genetic O 0 4.658575608607052e-11
background O 0 4.800991635495189e-12
by O 0 4.641025993959262e-14
means O 0 1.4687453727194044e-12
of O 0 1.893902569494177e-11
mtDNA O 0 1.1319199744175279e-10
lineages O 0 5.98416845590255e-12
indicate O 0 9.174814770765427e-13
that O 0 3.010053550812561e-14
all O 0 4.9346629213409265e-12
our O 0 4.0220986263772573e-11
patients O 0 5.157082226536769e-12
are O 0 3.5152450069721175e-14
probably O 0 6.068350683063883e-12
of O 0 1.3454093394926758e-10
native O 0 1.4400722281315836e-10
American O 0 6.154677212322213e-09
descent O 0 7.392493017732704e-08

Low O 0 3.343134480360277e-08
frequency O 0 1.6763613830406143e-09
of O 0 2.1689383622458536e-09
BRCA1 O 0 1.4713615215100617e-08
germline O 0 2.430013079646187e-09
mutations O 0 1.4692197111698668e-11
in O 0 6.643558533164784e-12
45 O 0 1.5526209207195052e-09
German O 1 1.0
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.3014527783526972e-10
. O 0 1.3928989905931388e-10

In O 0 2.562451362209117e-10
this O 0 1.1636380064811852e-13
study O 0 6.417709245976067e-13
we O 0 1.3576977609124248e-14
investigated O 0 8.056393052680022e-11
45 O 0 9.488790864153884e-10
German O 1 1.0
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 7.472357151441789e-13
for O 0 1.7407882860892565e-12
germline O 0 4.973212952563699e-09
mutations O 0 1.5968812383526654e-10
in O 0 2.7367452054560815e-11
the O 0 4.244896656402375e-10
BRCA1 O 0 3.351166100173941e-08
gene O 0 1.6223913323898387e-09
. O 0 2.5611907039646553e-10

We O 0 1.366492807797215e-09
identified O 0 1.094461632433763e-09
four O 0 2.6636487460152125e-10
germline O 0 3.314032070989015e-08
mutations O 0 5.350691001382302e-10
in O 0 4.68838634581914e-10
three O 0 5.309915174223079e-09
breast B-Disease 0 0.20889946818351746
cancer I-Disease 0 7.966963266881066e-07
families O 0 1.3086335400730453e-12
and O 0 8.673436274753143e-11
in O 0 6.894791404477019e-09
one O 0 6.79644726915285e-05
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 8.757600894471196e-11
. O 0 7.007599795577635e-14
among O 0 1.319701048744723e-14
these O 0 2.191579674627655e-14
were O 0 8.94479802726611e-12
one O 0 3.2223603126102507e-12
frameshift O 0 3.715865837250476e-09
mutation O 0 5.2508310199872454e-11
, O 0 7.63572885476016e-12
one O 0 1.3318408875750976e-11
nonsense O 0 1.0428645680349291e-07
mutation O 0 3.7966188526361577e-10
, O 0 2.4986882354860462e-11
one O 0 1.0159662824568705e-12
novel O 0 1.942701902124533e-11
splice O 0 2.707569990434422e-08
site O 0 4.723454405386462e-10
mutation O 0 3.1985660647881886e-11
, O 0 2.596286467065889e-12
and O 0 7.916885896852577e-12
one O 0 1.0477653467066972e-11
missense O 0 1.5302431677355344e-07
mutation O 0 1.5743099268661354e-08
. O 0 3.0669127237814564e-09

The O 0 2.808256738262571e-08
missense O 0 2.0348333862330037e-07
mutation O 0 1.4346338561566085e-09
was O 0 1.967224161347758e-09
also O 0 1.855535256695129e-12
found O 0 1.1989380842292174e-12
in O 0 2.9052691242342776e-12
2 O 0 4.859370683618636e-09
. O 0 1.5476883663545493e-10

8 O 0 2.7645130629139203e-08
% O 0 8.458916726794552e-12
of O 0 3.7634159677502055e-11
the O 0 2.407358600658993e-12
general O 0 7.906443728888934e-12
population O 0 1.4482806501379258e-14
, O 0 6.660299346544427e-14
suggesting O 0 4.842789580808415e-13
that O 0 6.173033818054202e-15
it O 0 6.543123519126698e-14
is O 0 1.323599162130623e-13
not O 0 2.7228625170544474e-12
disease O 0 6.813427688712181e-08
associated O 0 4.116257057429351e-10
. O 0 3.6879738152251207e-10

The O 0 1.5900496475040882e-09
average O 0 6.302981053751822e-11
age O 0 4.381313020718203e-11
of O 0 3.169141393755126e-09
disease O 0 0.00029803032521158457
onset O 0 8.328026979143033e-08
in O 0 1.288374463538633e-12
those O 0 2.550788085527861e-13
families O 0 3.645752861929086e-13
harbouring O 0 2.2133002985924577e-08
causative O 0 7.720106331987608e-09
mutations O 0 5.990752338647098e-10
was O 0 1.6693640914056118e-09
between O 0 2.530960996338649e-10
32 O 0 3.540833048987224e-08
. O 0 5.043911399660317e-10

3 O 0 4.843356009587296e-07
and O 0 1.3885044225503407e-09
37 O 0 2.593604087053336e-08
. O 0 2.975905077917673e-10

4 O 0 1.406025518235765e-07
years O 0 3.5371826995200806e-11
, O 0 9.017011312964507e-13
whereas O 0 3.2050135115313516e-12
the O 0 4.511189598960241e-12
family O 0 1.319076445294165e-11
harbouring O 0 1.3483409588843642e-07
the O 0 3.391383007755877e-10
missense O 0 8.10943490137106e-09
mutation O 0 4.8150435028038174e-11
had O 0 3.855719129391977e-12
an O 0 7.936426309976957e-14
average O 0 1.3438254415493178e-12
age O 0 5.504636677033936e-12
of O 0 2.4896504302596156e-10
onset O 0 2.6594411792757455e-06
of O 0 1.8564281845101505e-07
51 O 0 1.510970832896419e-07
. O 0 9.819040025504933e-10

2 O 0 6.913822971910122e-07
years O 0 7.213585284659985e-10
. O 0 1.3571568868719908e-10

These O 0 5.646887402122047e-10
findings O 0 1.149600969974074e-09
show O 0 9.209415868793869e-11
that O 0 2.2618059768858556e-12
BRCA1 O 0 2.0108663623119583e-09
is O 0 4.069104428405801e-12
implicated O 0 1.9901198744509685e-10
in O 0 4.49877565755763e-11
a O 0 2.798407339188458e-12
small O 0 1.4029408060625692e-13
fraction O 0 3.504650779653784e-12
of O 0 1.889884373440509e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.4644766519258945e-12
suggesting O 0 5.531359224819621e-12
the O 0 2.4875787194011956e-12
involvement O 0 7.495642995181129e-12
of O 0 8.206020585266316e-11
another O 0 4.3248603483203585e-12
susceptibility O 0 3.0012725638073334e-09
gene O 0 4.259178565391153e-10
( O 0 9.098737735468987e-11
s O 0 3.596620246071325e-08
) O 0 1.6048605777641e-09

Paternal O 0 4.940568396705203e-05
transmission O 1 0.9931694269180298
of O 1 0.9999995231628418
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 4.188748789601959e-05

We O 0 2.690379696801415e-09
report O 0 1.0535754213503168e-10
a O 0 4.306520851732332e-12
rare O 0 2.0604282169323085e-11
case O 0 1.5682927179128114e-11
of O 0 1.053369391712522e-08
paternally O 1 1.0
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.0010050643468275666
DM B-Disease 1 1.0
) O 0 1.7233806604011193e-09
. O 0 1.1265247068514839e-10

The O 0 7.073582963812441e-08
proband O 0 1.2892682207166217e-05
is O 0 2.5154532970472765e-11
a O 0 9.31528552211569e-12
23 O 0 1.0657816851278312e-09
year O 0 1.2822193827533024e-11
old O 0 8.130967188435534e-08
, O 0 1.8452852579287082e-09
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 2.3150003869432112e-07
who O 0 5.349683807054362e-09
suffers O 1 0.9999998807907104
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 0 4.392801656649681e-06

He O 0 7.047682881733408e-09
presented O 0 1.1673265909450947e-08
with O 0 5.676652481412248e-09
respiratory O 1 1.0
and O 0 2.1596388677380673e-08
feeding O 0 5.346698230823677e-07
difficulties O 0 6.6938996567955655e-09
at O 0 1.390914583510039e-08
birth O 0 2.591092318482424e-08
. O 0 2.3030644058508187e-10

His O 0 1.407413037668448e-06
two O 0 1.3569252388379027e-08
sibs O 1 0.9968481659889221
suffer O 0 4.907612947135931e-07
from O 0 4.652570950725021e-08
childhood O 1 0.9999957084655762
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 1.025794063025387e-07

Their O 0 7.295888337921497e-10
late O 0 3.880123955468662e-08
father O 0 1.2353312817126039e-09
had O 0 1.065101240711741e-12
the O 0 8.350577174187634e-13
adult O 0 1.2714472487004858e-12
type O 0 4.9753996061996375e-11
of O 0 6.778776651117369e-09
DM B-Disease 1 1.0
, O 0 1.6569671190680424e-09
with O 0 5.935236330190108e-11
onset O 0 8.783589146332815e-05
around O 0 1.3526033071364907e-10
30 O 0 1.7316897915620189e-10
years O 0 4.83079852162116e-12
. O 0 2.626686541884471e-11

Only O 0 9.274302159578696e-11
six O 0 9.367757437817037e-12
other O 0 1.2493582659037477e-14
cases O 0 7.760124872335447e-14
of O 0 4.211448897950554e-12
paternal O 0 8.594695621866322e-09
transmission O 0 0.004470064304769039
of O 1 0.9997283816337585
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 4.328231661965276e-10
been O 0 1.1480178786771322e-11
reported O 0 4.497351102639158e-11
recently O 0 1.2733851473267777e-10
. O 0 1.2453305053838903e-10

We O 0 3.150023852871442e-10
review O 0 1.9418064378662336e-10
the O 0 4.430073929223566e-12
sex O 0 1.4774217006047197e-12
related O 0 1.3547457426710263e-11
effects O 0 1.4526443381512877e-09
on O 0 2.641629970323578e-10
transmission O 0 2.457534264976857e-07
of O 0 8.971605325314158e-08
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 2.6087218429893255e-07

Decreased O 0 2.154237321860819e-08
fertility O 0 7.872522189700248e-09
of O 0 8.91996129737116e-11
males O 0 3.3901409511680886e-14
with O 0 7.040503976259854e-14
adult O 0 4.26508051099006e-10
onset O 0 4.6686815039720386e-05
DM B-Disease 1 1.0
and O 0 8.711308341347035e-10
contraction O 0 2.064687087965922e-09
of O 0 2.36640651518627e-10
the O 0 4.903420551538584e-12
repeat O 0 1.2523472710246342e-11
upon O 0 5.625510474116524e-12
male O 0 5.68470487696815e-12
transmission O 0 1.5941902312133216e-11
contribute O 0 7.441971843456796e-14
to O 0 4.711057932649254e-13
the O 0 4.971289872812701e-12
almost O 0 2.3348846727583306e-13
absent O 0 4.36492075123196e-12
occurrence O 0 3.5933630203321965e-12
of O 0 5.621112950104923e-12
paternal O 0 5.237023703585919e-09
transmission O 0 8.16587203189556e-07
of O 0 5.569642326008761e-06
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 3.9183663602671004e-07

Also O 0 1.5478722747985785e-09
the O 0 2.270002658066872e-10
fathers O 0 1.5561995025947795e-09
of O 0 5.887287324313206e-10
the O 0 5.3720604353824086e-11
reported O 0 7.907763888148622e-10
congenitally O 0 3.7807071748829912e-06
affected O 0 3.099946965789968e-09
children O 0 4.3028938051525856e-11
showed O 0 7.434223375790694e-11
, O 0 4.60818015690645e-13
on O 0 2.7545715708399143e-11
average O 0 1.4970033893058066e-11
, O 0 1.0637740688324016e-11
shorter O 0 4.9728836160056744e-08
CTG O 0 0.00024245835084002465
repeat O 0 5.90322635218854e-08
lengths O 0 1.2691243966855836e-07
and O 0 1.080106212802967e-10
hence O 0 3.366807943550043e-10
less O 0 1.051329162615744e-10
severe O 0 0.005314523819833994
clinical O 1 0.9999997615814209
symptoms O 1 0.9447265863418579
than O 0 2.1761109895383074e-13
the O 0 4.6251596302893105e-12
mothers O 0 6.654309265066716e-13
of O 0 6.788638227950283e-12
children O 0 1.1500033564315615e-11
with O 0 3.665366898886191e-09
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 3.352852672833251e-06

We O 0 3.3413211086852357e-10
conclude O 0 5.42149269922021e-10
that O 0 4.0202463211756745e-13
paternal O 0 1.1173029612621121e-08
transmission O 0 3.8387875065382104e-06
of O 0 0.05725336819887161
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 2.664320764012018e-09
rare O 0 4.977119827387355e-10
and O 0 3.363915916654303e-12
preferentially O 0 2.988257558067531e-11
occurs O 0 9.83315750872904e-13
with O 0 5.5073407992248594e-14
onset O 0 1.1856170800683685e-07
of O 0 1.5211632842238032e-08
DM B-Disease 1 1.0
past O 0 1.5684415544114927e-08
30 O 0 2.4499853534809546e-11
years O 0 3.339925111109886e-14
in O 0 4.915345067817503e-14
the O 0 4.053184383175784e-13
father O 0 5.701538546842855e-11
. O 0 1.1925157042402823e-12
. O 0 1.1587047293870611e-11

The O 0 2.464739736751653e-07
RB1 O 0 0.005832136608660221
gene O 0 4.420003030247699e-09
mutation O 0 7.800600443363948e-12
in O 0 2.6440568484664695e-12
a O 0 4.388765045826304e-11
child O 0 1.3920372410325399e-08
with O 0 9.003074730173921e-09
ectopic B-Disease 1 0.9999991655349731
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 3.693743622079637e-07

The O 0 4.429111584158818e-07
RB1 O 0 0.012157519347965717
gene O 0 1.572335506239142e-08
mutation O 0 1.642642272203787e-10
was O 0 2.304140905851071e-10
investigated O 0 4.6049536406300717e-10
in O 0 1.343103579742877e-11
a O 0 2.1258089039077888e-11
child O 0 2.9896742859136793e-09
with O 0 1.1774552166610164e-10
ectopic B-Disease 0 0.0001588676532264799
intracranial I-Disease 0 7.459932385245338e-05
retinoblastoma I-Disease 0 9.797637176234275e-06
using O 0 4.1828418506639764e-10
DNA O 0 6.90440131734249e-08
obtained O 0 2.9420299529903104e-11
from O 0 2.7483999451294316e-11
both O 0 1.3555851319929646e-12
the O 0 6.710895728012645e-11
pineal B-Disease 0 0.0003136199957225472
and I-Disease 0 3.814644156108216e-09
retinal I-Disease 1 0.9927010536193848
tumours I-Disease 1 1.0
of O 0 3.200864966856898e-06
the O 0 9.701558667529753e-09
patient O 0 6.772936558263609e-07
. O 0 1.0757481572198913e-09

A O 0 2.8618701435334515e-06
nonsense O 0 5.698806830878311e-07
mutation O 0 1.551690581580445e-10
in O 0 9.9411284759654e-11
exon O 0 5.153363069609895e-09
17 O 0 1.090478107812487e-08
( O 0 1.9161687861424248e-11
codon O 0 2.240840568656921e-10
556 O 0 1.1394934995578865e-09
) O 0 3.0711972678551525e-13
of O 0 6.819333292495955e-11
the O 0 1.5114728912912767e-10
RB1 O 0 0.0007721958681941032
gene O 0 1.6896532784027585e-10
was O 0 2.353649775077571e-10
found O 0 2.6422470982001567e-12
to O 0 8.759140602502408e-14
be O 0 3.1839060467969693e-13
present O 0 2.834810511331831e-11
homozygously O 0 1.4685585369988985e-07
in O 0 4.125002769916897e-11
both O 0 1.1939363560309335e-11
the O 0 1.7825477205413165e-10
retinal B-Disease 0 1.4051811092485877e-07
and I-Disease 0 1.7770592775079308e-09
the I-Disease 0 4.395624486619454e-08
pineal I-Disease 1 0.9999998807907104
tumours I-Disease 1 1.0
. O 0 2.5802915359918188e-08

The O 0 1.3917073049540818e-09
same O 0 7.000633579778981e-12
mutation O 0 4.332869566608943e-12
was O 0 3.0759606667318806e-11
present O 0 1.2024494247531159e-11
heterozygously O 0 1.9279175589304032e-08
in O 0 6.989559972470083e-12
the O 0 4.211641452256387e-12
DNA O 0 1.6214880549370037e-09
from O 0 2.0839953027151914e-12
the O 0 9.250407514635461e-13
constitutional O 0 3.021262753866161e-11
cells O 0 1.492922972745614e-11
of O 0 3.9785091887623025e-11
the O 0 1.6208060935052337e-11
patient O 0 1.577164510102591e-09
, O 0 2.7225977548839264e-12
proving O 0 1.3118243158416476e-09
it O 0 2.904989278101032e-14
to O 0 5.148015870472429e-14
be O 0 2.591708314972352e-13
of O 0 8.77000416732443e-11
germline O 0 6.829740772928972e-09
origin O 0 3.942636495057883e-10
. O 0 4.0989192595652924e-10

The O 0 2.4419120059349098e-09
initial O 0 2.67150468413746e-10
mutation O 0 2.2680409633712983e-11
was O 0 8.65918795001086e-11
shown O 0 1.1342053598401014e-12
to O 0 2.1853113936487478e-13
have O 0 7.333596010734682e-15
occurred O 0 3.501483825107954e-12
in O 0 6.126716023619264e-14
the O 0 1.6033375798904514e-12
paternally O 0 1.1792971932322871e-08
derived O 0 1.8531578493963252e-09
RB1 O 0 4.5650009269593284e-05
allele O 0 6.165874921748582e-09
. O 0 5.735867336653655e-10

The O 0 7.567364512794938e-09
mutation O 0 3.5601414177799384e-11
is O 0 1.9234391640185478e-13
in O 0 2.0778620794456581e-13
an O 0 1.2981040802819907e-14
area O 0 7.699815611494909e-12
of O 0 1.6873079322632378e-11
the O 0 8.63141589452221e-12
gene O 0 5.841262803313318e-13
that O 0 1.7800365199297126e-14
encodes O 0 2.2870393729876315e-13
the O 0 2.992385202474357e-12
protein O 0 3.0160563716657984e-12
- O 0 2.971502210957766e-11
binding O 0 2.9873742368735634e-11
region O 0 7.45879469299382e-11
known O 0 2.0361982933092548e-11
as O 0 5.721981048700808e-13
the O 0 2.832663357349441e-12
pocket O 0 1.6293199678329984e-08
region O 0 2.2199063420824672e-10
and O 0 2.8696820961182645e-11
has O 0 3.3664686164593116e-13
been O 0 1.5528665864034813e-13
detected O 0 3.285027458388434e-11
in O 0 7.699103263562532e-14
other O 0 1.209100907503119e-14
cases O 0 8.596841771443819e-13
of O 0 5.741370573408844e-11
retinoblastoma B-Disease 0 8.001305928928559e-08
. O 0 7.37040706244585e-11
. O 0 2.6685204046472677e-10

Low O 0 5.16381533088861e-07
levels O 0 2.598053550073587e-09
of O 0 1.7426713405654937e-09
beta O 0 2.127595877254862e-09
hexosaminidase O 0 2.8271941232560494e-07
A O 0 2.4758528560653303e-09
in O 0 6.323556261955687e-12
healthy O 0 2.0897162472666153e-11
individuals O 0 9.294541658132378e-15
with O 0 3.2095526323466794e-12
apparent O 0 1.8508982975617982e-05
deficiency O 1 0.9890310168266296
of O 0 7.562205428257585e-05
this O 0 1.6799037161341346e-10
enzyme O 0 1.0443550912953015e-08
. O 0 5.052895879487096e-10

Appreciable O 0 6.890895747346804e-07
beta O 0 1.3677625076979893e-07
hexosaminidase O 0 7.465717771992786e-06
A O 0 6.191781380948669e-07
( O 0 1.707413238571931e-10
hex O 0 1.4819714344582735e-08
A O 0 1.1167212932150505e-08
) O 0 2.822280441034525e-13
activity O 0 6.333055607710136e-12
has O 0 1.525121276827173e-14
been O 0 3.54224062462747e-14
detected O 0 4.0414543239775114e-11
in O 0 5.973996037439422e-12
cultured O 0 2.105064922375277e-08
skin O 0 2.496639899618458e-05
fibroblasts O 0 3.002509352256766e-09
and O 0 1.8416038694013537e-09
melanoma B-Disease 1 0.6447218656539917
tissue O 0 3.2654330084369576e-07
from O 0 4.7678003767259725e-09
healthy O 0 5.158533045168667e-10
individuals O 0 1.457111883408635e-13
previously O 0 7.004991725567677e-11
reported O 0 3.7131204361218195e-11
as O 0 7.607531271602852e-11
having O 0 8.876403612134709e-09
deficiency B-Disease 0 7.478024053853005e-05
of I-Disease 0 1.3777379535895307e-05
hex I-Disease 0 2.03085321004437e-07
A I-Disease 0 1.3028407686022092e-08
activity O 0 2.0439183331943944e-11
indistinguishable O 0 3.965947362183364e-11
from O 0 9.93002744918356e-14
that O 0 4.0086321272754435e-16
of O 0 4.217000826225309e-13
patients O 0 1.9442837097261023e-12
with O 0 3.3313049541128237e-10
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 1.5159264066255673e-08
TSD B-Disease 1 1.0
) O 0 5.94954252530755e-10
. O 0 1.959195028433669e-10

Identification O 0 4.597016456386882e-08
and O 0 4.704097666952123e-10
quantitation O 0 1.4800336430198513e-05
of O 0 1.157227529802185e-06
hex O 0 4.51169768211912e-07
A O 0 1.4321226160518563e-07
, O 0 5.20531794750978e-12
amounting O 0 1.0102180376947434e-11
to O 0 2.282361452610182e-11
3 O 0 1.0133827110792026e-08
. O 0 1.4587882291028365e-10

5 O 0 1.0236207259595176e-07
% O 0 1.0864058958004463e-10
- O 0 8.523420191863806e-09
6 O 0 1.6983594974817606e-08
. O 0 1.8115756117431658e-10

9 O 0 5.329988894686721e-08
% O 0 3.9686773832536826e-12
of O 0 1.2975491341105094e-11
total O 0 1.628384601638777e-12
beta O 0 1.1233063090809736e-10
hexosaminidase O 0 6.139543273775416e-08
activity O 0 1.26839885816743e-10
, O 0 1.1028188995690358e-12
has O 0 5.88853027414806e-15
been O 0 1.1368726293215555e-14
obtained O 0 1.6505391888313459e-12
by O 0 6.088732816544873e-12
cellulose O 0 1.2201237041153945e-05
acetate O 0 1.3215179706094204e-07
gel O 0 2.962953438157001e-09
electrophoresis O 0 6.92168100613344e-10
, O 0 1.447401920540159e-11
DEAE O 0 6.358043901855126e-05
- O 0 1.6219025011920962e-09
cellulose O 0 3.771390666429397e-08
ion O 0 3.164349893225449e-10
- O 0 1.4246284707475354e-10
exchange O 0 8.879421503626972e-12
chromatography O 0 7.101576660062392e-09
, O 0 2.7690629303411818e-11
radial O 0 6.51756870695408e-09
immunodiffusion O 0 5.283378641252057e-07
, O 0 5.0121271716330185e-11
and O 0 7.885994635081772e-11
radioimmunoassay O 0 5.769954896095442e-06
. O 0 1.023299556202062e-09

Previous O 0 2.52747867079961e-07
family O 0 9.829378283532364e-11
studies O 0 2.2861214657443618e-11
suggested O 0 2.4769259993756565e-12
that O 0 6.2226127740393645e-15
these O 0 1.8954245996089664e-14
individuals O 0 5.656251393637828e-15
may O 0 4.3611070158801335e-13
be O 0 1.0078556370550495e-13
compound O 0 6.828223403365641e-11
heterozygotes O 0 1.1936523991451509e-10
for O 0 1.7403368243046335e-12
the O 0 1.6957739032430474e-11
common O 0 5.466971667034137e-11
mutant O 0 5.80601877686604e-09
TSD B-Disease 0 0.01204520184546709
gene O 0 3.7043931810920583e-10
and O 0 6.9525960509631e-12
a O 0 5.118257380420932e-12
rare O 0 8.082897545724776e-11
( O 0 1.116743156281963e-11
allelic O 0 2.208151883564824e-08
) O 0 1.5330212793651654e-11
mutant O 0 2.6298321298412475e-09
gene O 0 9.199957462513453e-10
. O 0 7.504143834102805e-11

Thus O 0 3.632482092896794e-09
, O 0 2.043879301916185e-11
the O 0 2.7743217879266924e-12
postulated O 0 7.559450981853288e-11
rate O 0 2.29636969162339e-11
mutant O 0 1.1601140187389447e-10
gene O 0 7.251625081666768e-12
appears O 0 2.004123321290574e-13
to O 0 1.0958290549392853e-14
code O 0 3.352025146168003e-14
for O 0 1.500743499198605e-14
the O 0 3.3161483541793713e-13
expression O 0 1.919056276736275e-13
of O 0 2.9292505920874845e-12
low O 0 6.399927029304697e-12
amounts O 0 1.0590766544998909e-12
of O 0 8.105499604837973e-11
hex O 0 2.791099440457856e-08
A O 0 4.9640604515843734e-08
. O 0 2.0521614962909496e-10

Heterozygotes O 0 2.1995322185830446e-06
for O 0 1.1632630414482037e-09
the O 0 4.3485295919687417e-10
rare O 0 2.0638166731146157e-09
mutant O 0 1.275009209322775e-09
may O 0 2.9735246383222336e-12
be O 0 9.733134979407476e-14
indistinguishable O 0 2.258432885149375e-10
from O 0 1.0380575522425661e-12
heterozygotes O 0 6.440942224017476e-11
for O 0 9.285337256026427e-13
the O 0 2.5888060792289558e-11
common O 0 1.943808669579994e-09
TSD B-Disease 0 0.008994927629828453
mutant O 0 4.095140937465658e-08
. O 0 1.887682510304245e-10

However O 0 1.0520898596766415e-09
, O 0 1.83474329479294e-12
direct O 0 2.4199125776142028e-12
visualization O 0 1.4422004701586388e-09
and O 0 5.072233952296834e-11
quantitation O 0 8.02302747615613e-06
of O 0 4.946641070091573e-07
hex O 0 1.3866332437828532e-07
A O 0 4.593043723133405e-09
by O 0 5.768477058867849e-13
the O 0 1.7698787314196496e-12
methods O 0 7.128712203874343e-11
described O 0 6.870865681962712e-11
may O 0 1.1052636670477733e-12
prevent O 0 9.547238000173763e-12
false O 0 2.5938981518258686e-10
- O 0 9.656785371348064e-10
positive O 0 4.336912339669707e-12
prenatal O 0 1.242423142144844e-08
diagnosis O 0 4.882599569100421e-08
of O 0 4.39734115786905e-09
TSD B-Disease 1 0.9999644756317139
in O 0 3.3769453899878954e-09
fetuses O 0 4.1609709455769917e-08
having O 0 8.300247988923815e-11
the O 0 2.9523675171283514e-11
incomplete O 0 3.272363073847373e-07
hex B-Disease 0 6.37208631815156e-06
A I-Disease 1 0.669975221157074
deficiency I-Disease 0 0.07911605387926102
of O 0 5.505337867361959e-06
the O 0 1.142196226489034e-09
type O 0 3.0346139823222984e-08
described O 0 5.2286144164304105e-11
in O 0 4.547464401566392e-12
the O 0 1.8999014167464523e-11
four O 0 1.5707024222932908e-11
healthy O 0 2.4539617560215277e-10
individuals O 0 9.317115655382846e-12

The O 0 1.9335519851892968e-08
tumor B-Disease 0 4.022503929945742e-08
suppressor O 0 1.6935841529175377e-07
gene O 0 5.548729031801258e-09
Smad4 O 0 1.5532339602941647e-05
/ O 0 1.1399163213354768e-07
Dpc4 O 0 1.4554844938174938e-06
is O 0 3.941352452740965e-13
required O 0 1.0778044038858847e-12
for O 0 7.780729185946633e-13
gastrulation O 0 6.697197107996544e-08
and O 0 8.237001358768481e-12
later O 0 5.919634227247172e-11
for O 0 7.931118869292098e-13
anterior O 0 2.041068425384651e-09
development O 0 3.604982146132585e-10
of O 0 1.9316046540041043e-09
the O 0 4.0298028802787655e-10
mouse O 0 4.896285599187422e-10
embryo O 0 1.8321642814012051e-10
. O 0 6.208399072615833e-11

Mutations O 0 1.7463888113411485e-08
in O 0 1.1064064109334026e-09
the O 0 4.7499373323489635e-09
SMAD4 O 1 1.0
/ O 0 1.1219990483368747e-05
DPC4 O 1 0.9999228715896606
tumor B-Disease 0 5.4853423137046775e-08
suppressor O 0 1.6994029294892243e-08
gene O 0 1.465562393665465e-10
, O 0 1.2126843583135094e-12
a O 0 2.546667087280352e-12
key O 0 5.352283616311126e-10
signal O 0 3.3633629215046312e-09
transducer O 0 2.3712162899869327e-08
in O 0 7.098224785728746e-11
most O 0 7.664211279512223e-12
TGFbeta O 0 3.7687484564230544e-06
- O 0 7.150397607347259e-09
related O 0 5.015747372993928e-09
pathways O 0 3.5710245871456436e-10
, O 0 3.59836807703115e-13
are O 0 1.997930705764845e-15
involved O 0 9.093415717685918e-14
in O 0 3.0175219419524557e-13
50 O 0 1.1179984021891798e-11
% O 0 7.435094749076721e-13
of O 0 1.0046985465805847e-09
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 3.681006077727034e-08

Homozygous O 0 3.825865496764891e-05
Smad4 O 0 0.004864526446908712
mutant O 0 1.8211759424957563e-06
mice O 0 4.660769192810221e-08
die O 0 8.265658379968954e-09
before O 0 2.0807604250716594e-10
day O 0 3.2337538202753535e-10
7 O 0 1.1133164612431301e-08
. O 0 1.4657412783503077e-10

5 O 0 2.448567215651565e-07
of O 0 2.7748619402245822e-08
embryogenesis O 0 3.1028939702082425e-06
. O 0 3.6023377614213814e-09

Mutant O 0 2.6675563091771437e-08
embryos O 0 7.501943510845877e-10
have O 0 6.950282092476473e-14
reduced O 0 3.3485139574324085e-12
size O 0 5.7764071303978426e-12
, O 0 7.93566254375655e-12
fail O 0 1.3047170288604804e-10
to O 0 1.665580694198976e-11
gastrulate O 0 4.873463694821112e-07
or O 0 7.255820944074287e-11
express O 0 3.8609899999375585e-11
a O 0 1.0389316143499805e-11
mesodermal O 0 1.2857520914622e-07
marker O 0 1.4034850615018968e-08
, O 0 1.4550387804346254e-11
and O 0 1.8014032973634464e-11
show O 0 2.758284711745773e-10
abnormal O 0 5.545166459341999e-08
visceral O 0 1.1033165492335684e-06
endoderm O 0 0.009518246166408062
development O 0 4.815803933411189e-08
. O 0 6.500258664665637e-10

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 4.660194827010855e-05
the O 0 1.5456455670914693e-08
Smad4 O 1 0.6889562010765076
- O 0 3.093802831699577e-07
deficient O 0 3.5360732120182092e-09
embryos O 0 6.400491942004649e-11
results O 0 9.232855799345963e-12
from O 0 5.995501838051975e-12
reduced O 0 1.5696251243202397e-10
cell O 0 2.529495057856934e-09
proliferation O 0 1.0646727943708356e-08
rather O 0 1.5763619793177086e-12
than O 0 1.3950790189406516e-14
increased O 0 7.386160910324846e-13
apoptosis O 0 5.1148226987152157e-08
. O 0 1.7939842666958583e-10

Aggregation O 0 2.2424632817319434e-08
of O 0 8.46989465230763e-08
mutant O 0 1.4487961941256344e-08
Smad4 O 0 8.210451596823987e-06
ES O 0 3.388541881577112e-05
cells O 0 1.5525994379039787e-10
with O 0 1.4105509295314622e-12
wild O 0 2.5376147405609117e-08
- O 0 6.0029372583869645e-09
type O 0 5.4413855643531406e-09
tetraploid O 0 2.5804104097915115e-07
morulae O 0 3.7732581859017955e-06
rescues O 0 2.634319855587819e-07
the O 0 1.8189650896616172e-09
gastrulation B-Disease 0 0.0005781261716037989
defect I-Disease 0 1.8415050817566225e-06
. O 0 3.516943847259313e-09

These O 0 2.0529768995913855e-09
results O 0 8.742367940683948e-10
indicate O 0 9.490144087243024e-11
that O 0 4.739511192362877e-13
Smad4 O 0 1.3910026552821364e-07
is O 0 3.950662767846641e-13
initially O 0 4.913079491852823e-13
required O 0 4.804818652323628e-13
for O 0 8.220074604716257e-14
the O 0 1.1480434658484029e-12
differentiation O 0 7.428733843350965e-12
of O 0 3.403362661136278e-11
the O 0 5.908813369148724e-12
visceral O 0 4.168276834803919e-09
endoderm O 0 2.4705459509277716e-06
and O 0 1.4276660582901446e-11
that O 0 2.0015713804270863e-13
the O 0 8.224693495706425e-12
gastrulation B-Disease 0 1.7049991356543615e-06
defect I-Disease 0 7.981331151540871e-10
in O 0 4.969137514659883e-12
the O 0 4.36447301910281e-11
epiblast O 0 4.394287600462121e-07
is O 0 3.259372752164452e-13
secondary O 0 3.038114759768007e-10
and O 0 1.428758500399141e-11
non O 0 2.0091657404464058e-07
- O 0 4.092376926223551e-08
cell O 0 2.5725272578824843e-08
autonomous O 0 1.1402925537140618e-07
. O 0 8.068545831463325e-10

Rescued O 0 7.328430911002215e-06
embryos O 0 4.6504908368660836e-07
show O 0 5.707259731480008e-08
severe O 1 0.9054986238479614
anterior O 0 0.0006964144413359463
truncations O 1 0.9999996423721313
, O 0 1.9923247052133775e-08
indicating O 0 2.7010912617697613e-08
a O 0 1.0113831300229137e-10
second O 0 5.697041172147976e-10
important O 0 1.2692622994303626e-11
role O 0 3.693103461932523e-11
for O 0 1.962309308101151e-11
Smad4 O 0 1.6141351807164028e-05
in O 0 1.322728482300306e-09
anterior O 0 1.2514493619164568e-07
patterning O 0 5.884025995328557e-07
during O 0 6.657016626832046e-08
embryogenesis O 0 3.873303285217844e-06
. O 0 1.1129613897153945e-09

Prevalence O 0 4.5773919055136503e-07
of O 0 1.1582689474209928e-08
p16 O 0 1.580137087842104e-08
and O 0 5.386183943301148e-09
CDK4 O 1 1.0
germline O 0 8.887984677130589e-07
mutations O 0 2.882670102621887e-09
in O 0 6.080058123636434e-10
48 O 0 1.018049488266115e-06
melanoma B-Disease 1 0.9999995231628418
- O 0 3.159418702125549e-05
prone O 0 2.36347896134248e-05
families O 0 9.542813587948284e-12
in O 0 1.1117683856864957e-10
France O 0 4.851732455790625e-07
. O 0 8.470844470309657e-09

The O 0 8.415258179184093e-08
French O 0 6.570010009454563e-05
Familial B-Disease 1 1.0
Melanoma I-Disease 1 1.0
Study O 0 3.2502182278904e-08
Group O 0 1.0507608116938627e-08
. O 0 3.6104871870001887e-10

Germline O 0 4.343715772847645e-06
mutations O 0 8.882280688737865e-09
in O 0 3.3460023640685677e-10
the O 0 6.154591836171619e-10
p16 O 0 1.74852454737362e-09
and O 0 1.1302637714649677e-09
CDK4 O 1 0.9999996423721313
genes O 0 7.046210143135667e-11
have O 0 3.8656557609876435e-14
been O 0 1.43590936124878e-13
reported O 0 2.7224666206311643e-13
in O 0 4.741645444339415e-13
a O 0 1.0856590149446732e-12
subset O 0 1.0642717956921288e-10
of O 0 5.352194243357644e-09
melanoma B-Disease 0 0.0005790317081846297
pedigrees O 0 3.6801775848971374e-08
, O 0 1.6187731710637365e-11
but O 0 1.356611220929005e-13
their O 0 3.647257409283844e-12
prevalence O 0 1.2616117872621402e-10
is O 0 5.963808633269391e-15
not O 0 5.54433208328417e-15
well O 0 2.6153170341186582e-12
known O 0 4.413219512056088e-10
. O 0 1.3463564985105592e-10

We O 0 1.6327526830561823e-10
searched O 0 2.2499198337744275e-10
for O 0 6.741203190281653e-13
such O 0 7.76146508174591e-12
germline O 0 6.2835412428796644e-09
mutations O 0 2.455722569738583e-10
in O 0 2.574114810194317e-10
48 O 0 1.8339843421699698e-08
French O 0 2.4254038635262987e-06
melanoma B-Disease 1 1.0
- O 0 9.383667929796502e-06
prone O 0 2.6195166356046684e-06
families O 0 4.65011113382624e-13
selected O 0 2.2536425850483432e-11
according O 0 2.280093431769603e-12
to O 0 5.768543195200371e-13
two O 0 4.109379123876794e-13
major O 0 1.941220274803701e-11
criteria O 0 5.4714364983166064e-11
families O 0 6.785964476972717e-14
with O 0 1.067113858757053e-13
at O 0 9.613684154308189e-11
least O 0 2.1438695274340197e-13
three O 0 1.0580832000492424e-12
affected O 0 1.7140655214631373e-11
members O 0 2.4413077896051627e-12
( O 0 1.4469070473005496e-12
n O 0 5.1702010728238434e-12
= O 0 6.94615415533506e-12
20 O 0 4.30477962304332e-12
) O 0 2.0707316205704e-14
or O 0 1.0453967471410822e-13
families O 0 3.3669790469836565e-15
with O 0 1.8838983446693193e-14
two O 0 2.5248626431793875e-13
affected O 0 1.826169597485272e-11
members O 0 2.2090489160131455e-12
, O 0 1.0368024798076969e-13
one O 0 5.2730738476841274e-14
of O 0 6.9616192151233935e-12
them O 0 5.647449738757637e-13
affected O 0 6.13353812184414e-12
before O 0 9.818580844200842e-12
the O 0 1.004405651532092e-12
age O 0 1.2328031932969108e-13
of O 0 1.7168163592151675e-12
50 O 0 2.5161621917957344e-12
( O 0 1.7222762929355873e-13
n O 0 1.1316640983680126e-12
= O 0 2.593613691870278e-12
28 O 0 1.0645601067338362e-10
) O 0 1.7295514250382366e-13
, O 0 6.210580416913733e-14
and O 0 7.787421694906843e-14
one O 0 2.948733108815854e-14
additional O 0 2.424374449024741e-13
minor O 0 1.4314849750007852e-07
criterion O 0 1.9798067114606965e-06
. O 0 1.9563952680101693e-09

Sixteen O 0 3.910526800154912e-07
different O 0 1.2085638045888913e-10
p16 O 0 9.597076910949909e-09
germline O 0 1.3512973850993149e-08
mutations O 0 1.0230746805284241e-10
were O 0 4.3768943330801946e-11
found O 0 2.5863864001884895e-12
in O 0 5.672873737601336e-13
21 O 0 1.8657579647918254e-10
families O 0 3.9028916681621215e-14
, O 0 3.3063588217134565e-13
while O 0 1.852423379619661e-12
one O 0 1.433909414816359e-12
germline O 0 2.535484489030182e-09
mutation O 0 4.761071051295751e-11
, O 0 3.2147621370492985e-11
Arg24His O 0 5.133332251716638e-06
, O 0 1.234489732659938e-10
was O 0 2.7036348160258683e-10
detected O 0 2.7093749466189365e-10
in O 0 4.3698105030298695e-12
the O 0 1.139762520474541e-10
CDK4 O 1 0.9999988079071045
gene O 0 8.385964811452595e-09
. O 0 2.416529476523266e-10

The O 0 4.854032731316238e-10
frequency O 0 1.999018311993339e-10
of O 0 1.9258318550985365e-10
p16 O 0 3.528175807065992e-10
gene O 0 9.350656533790858e-12
mutation O 0 2.2407046378937479e-13
in O 0 2.6767948751657555e-13
our O 0 1.255453315092414e-12
sample O 0 3.036794990821101e-13
( O 0 7.94571114633158e-14
44 O 0 1.2301307975720599e-12
% O 0 1.1363392526746695e-14
) O 0 5.3976441880280914e-15
is O 0 4.643272833555149e-15
among O 0 2.0598277654403953e-14
the O 0 5.505852392929944e-13
highest O 0 1.0825172702677577e-10
rates O 0 5.511728226603729e-12
yet O 0 4.130399635596943e-13
reported O 0 2.8976320041312897e-12
and O 0 3.934767008745288e-12
the O 0 7.427108927871018e-11
CDK4 O 1 0.9999673366546631
mutation O 0 5.921949042253516e-11
is O 0 1.9966336526830442e-13
the O 0 6.607841444156159e-13
second O 0 2.104812851788651e-11
mutation O 0 1.24277617277041e-12
detected O 0 1.833278494289825e-11
in O 0 2.3817807535270186e-13
this O 0 3.2166462419006003e-14
gene O 0 4.045094120774806e-11
worldwide O 0 8.968119996621837e-11
. O 0 2.5177201989912135e-10

In O 0 4.598829317359332e-09
summary O 0 6.303650224026569e-08
, O 0 4.0778627002913126e-11
our O 0 2.138680899044232e-11
results O 0 8.420411937160033e-12
show O 0 2.5264196117091853e-12
frequent O 0 9.742910688295692e-13
involvement O 0 1.2211009113582971e-11
of O 0 8.125900646804851e-11
the O 0 5.1515399585033705e-11
p16 O 0 1.1696260626692379e-09
gene O 0 1.5706883016441964e-10
in O 0 2.407920043911993e-11
familial B-Disease 0 9.426192946193623e-07
melanoma I-Disease 0 0.0002289734111400321
and O 0 6.269970653782764e-11
confirm O 0 6.917061923239487e-10
the O 0 7.478281882633553e-11
role O 0 8.06754107962604e-11
of O 0 2.560014866759275e-09
the O 0 1.7169400345906638e-09
CDK4 O 1 1.0
gene O 0 3.1728608629322252e-09
as O 0 2.2009500125208525e-11
a O 0 1.280658218361097e-10
melanoma B-Disease 0 4.776874993694946e-05
- O 0 1.3211928262535366e-07
predisposing O 0 1.4046318597138452e-07
gene O 0 8.825315478411255e-10
. O 0 2.1951182191393137e-11
. O 0 1.8976568927353554e-10

Progression O 0 6.220798695721896e-06
of O 0 2.607334010917839e-07
somatic O 0 6.651191506534815e-05
CTG O 0 0.002150228014215827
repeat O 0 8.31042612503552e-09
length O 0 4.151151297704381e-11
heterogeneity O 0 2.838637380708775e-10
in O 0 4.764993087602587e-12
the O 0 6.9857743721646326e-12
blood O 0 1.4943367376840655e-10
cells O 0 4.6174783441266243e-10
of O 0 7.137469992812839e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 3.1701788429927547e-06
. O 0 1.1587434345372571e-09

The O 0 7.744244689966706e-10
genetic O 0 2.4096258322003905e-10
basis O 0 3.858827701819223e-10
of O 0 1.0656891191729301e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 6.694516741845291e-06
DM B-Disease 1 1.0
) O 0 2.6895714821950634e-11
is O 0 5.967088937764223e-14
the O 0 1.4206484025194172e-13
expansion O 0 1.9393625594332775e-11
of O 0 1.029913584971176e-10
an O 0 2.07745496152989e-12
unstable O 0 3.760924371931651e-08
CTG O 0 4.500929935602471e-05
repeat O 0 9.977320081233643e-10
in O 0 1.1294329187172547e-11
the O 0 1.858164143386798e-11
34 O 0 1.3648795982312834e-10
UTR O 0 2.2071828880143585e-06
of O 0 8.918299432281174e-10
the O 0 1.9543802687316258e-10
DM B-Disease 1 1.0
protein O 0 1.1675064248706235e-09
kinase O 0 6.484078607371657e-09
gene O 0 5.338529618370558e-10
on O 0 1.1762885110400134e-09
chromosome O 0 5.329264141096246e-09
19 O 0 4.926639096680674e-09
. O 0 8.691951325356939e-11

One O 0 6.696668219952073e-10
of O 0 1.7710057864661621e-09
the O 0 2.7939607225024865e-11
principal O 0 3.8004221991627674e-10
features O 0 1.4626720667987314e-10
of O 0 3.1445626103021596e-09
the O 0 3.393642922233653e-09
DM B-Disease 1 1.0
mutation O 0 3.662464775899821e-10
is O 0 1.7132073483385607e-13
an O 0 2.1237469045192782e-14
extraordinarily O 0 1.044708625164148e-10
high O 0 3.0549618390551814e-09
level O 0 8.009803376118896e-10
of O 0 2.31125368843621e-10
somatic O 0 3.261483811911603e-07
mosaicism O 0 1.9394026367081096e-06
, O 0 4.920565691013401e-12
due O 0 6.159826121399092e-11
to O 0 8.714236472175119e-13
an O 0 4.2789888657097236e-14
extremely O 0 2.6527606066667486e-12
high O 0 2.924373243562428e-11
degree O 0 9.619095103774455e-11
of O 0 8.60479049125118e-11
somatic O 0 1.8267947154981812e-07
instability O 0 2.357526951435318e-10
both O 0 3.747240798906981e-12
within O 0 2.913266849979834e-11
and O 0 9.383364311249531e-13
between O 0 1.648421850408699e-12
different O 0 1.3562996212246325e-11
tissues O 0 5.011971992985309e-08
. O 0 4.683649579284577e-10

This O 0 5.260226143555258e-10
instability O 0 1.822159756414976e-09
appears O 0 7.460043000007133e-12
to O 0 9.421737885316125e-14
be O 0 2.3526306228670302e-14
biased O 0 2.1360390886626668e-11
towards O 0 7.648119117187324e-12
further O 0 1.7053894375233108e-13
expansion O 0 3.5338090960401747e-12
and O 0 6.470524528505439e-13
continuous O 0 8.175399940357764e-11
throughout O 0 4.2197708001456835e-12
the O 0 9.9952663333569e-13
life O 0 7.191059271487166e-13
of O 0 2.7738772650359733e-12
an O 0 1.410135283687981e-14
individual O 0 5.139715286402516e-14
, O 0 3.322289004233786e-13
features O 0 5.563716154455278e-12
that O 0 6.35796609791176e-15
could O 0 4.420059153756317e-14
be O 0 6.594970067014955e-14
associated O 0 1.0086874044357153e-11
with O 0 1.5543134270976089e-12
the O 0 1.4286311023070652e-10
progressive O 0 1.9382117244504116e-08
nature O 0 1.7014453179697853e-09
of O 0 1.2459916431950546e-09
the O 0 5.656333179615558e-09
disease O 0 1.753714286678587e-06
. O 0 5.115995474480606e-11

Although O 0 1.3092239792289462e-10
increasing O 0 1.2599583919595259e-12
measured O 0 2.5342250867255167e-11
allele O 0 5.603019675830267e-13
size O 0 1.9816975751346666e-12
between O 0 2.9758905843030314e-12
patients O 0 1.7004897490124904e-11
clearly O 0 4.545920931353642e-12
correlates O 0 4.715719481573899e-11
with O 0 1.2940184676828864e-13
an O 0 1.854493087685618e-14
increased O 0 3.5472392709810785e-13
severity O 0 2.2249826869824574e-08
of O 0 1.2884607158980543e-08
symptoms O 0 3.410380031709792e-07
and O 0 1.5947155705339777e-12
an O 0 3.240279816381711e-14
earlier O 0 6.0839731690076615e-12
age O 0 1.870402270565119e-12
of O 0 2.9896370101756276e-11
onset O 0 1.2806449234403772e-08
, O 0 2.0428870726139914e-13
this O 0 1.2054343983359866e-15
correlation O 0 2.762491061911957e-14
is O 0 2.214538206201451e-15
not O 0 2.1514289576750854e-15
precise O 0 2.7959705731217532e-11
and O 0 4.477731119917339e-12
measured O 0 2.0473528428155419e-10
allele O 0 4.610697240670092e-12
length O 0 1.4688714654320645e-12
cannot O 0 8.216160499348313e-13
be O 0 3.0964407470371325e-14
used O 0 1.0327116765906919e-12
as O 0 9.281188691938683e-14
an O 0 8.91446696327106e-15
accurate O 0 1.0951271833814502e-10
predictor O 0 8.145352836663733e-09
of O 0 2.2186448511707368e-10
age O 0 3.6222112115291694e-11
of O 0 1.1348563200286321e-09
onset O 0 3.4572542062960565e-05
. O 0 9.305368697809513e-10

In O 0 5.774385969381512e-10
order O 0 1.0442225556461793e-10
to O 0 2.6109012955105593e-12
further O 0 2.0522064950179164e-12
characterize O 0 3.714680785193991e-10
the O 0 3.5388966063143457e-11
dynamics O 0 1.485500344955426e-08
of O 0 2.2082008399593178e-07
DM B-Disease 1 1.0
CTG O 1 0.9994812607765198
repeat O 0 5.827411797554305e-08
somatic O 0 1.2615043942787452e-06
instability O 0 3.062808895393232e-09
, O 0 3.086702551544085e-12
we O 0 4.183918565336259e-14
have O 0 3.50098410616226e-15
studied O 0 2.549273118990225e-11
repeat O 0 1.0912004806684639e-11
length O 0 2.2682775796534216e-12
changes O 0 1.8329864806976987e-13
over O 0 4.583460889474866e-13
time O 0 4.587028998824516e-13
in O 0 9.018873321775533e-12
111 O 0 0.0021455141250044107
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 1.928622817004566e-09
with O 0 5.121672942524913e-13
varying O 0 1.0029327368599184e-10
clinical O 0 5.945339580648579e-07
severity O 0 7.90723515819991e-06
and O 0 2.7070417019103843e-09
CTG O 0 1.336904642812442e-05
repeat O 0 1.5240278483652503e-10
size O 0 2.5906176075868315e-12
over O 0 2.169866066339954e-12
time O 0 7.415433284779782e-14
intervals O 0 9.476356331583613e-12
of O 0 2.3094989462513205e-11
1 O 0 9.502278824902177e-11
- O 0 4.6205528292375675e-10
7 O 0 6.463527491007426e-10
years O 0 8.579875525327463e-12
. O 0 4.658431192877677e-12

We O 0 5.967078497981504e-10
have O 0 3.183650988235892e-13
found O 0 2.1805650275881494e-13
a O 0 4.424040547421591e-14
direct O 0 1.5187624378618092e-12
progression O 0 1.1086979251340168e-10
of O 0 2.8087934755838262e-11
the O 0 2.6338189441921234e-12
size O 0 1.5439660184038417e-12
heterogeneity O 0 6.57082235844264e-11
over O 0 4.13982693611703e-12
time O 0 1.4586439966036285e-13
related O 0 2.306672387819564e-11
to O 0 1.5918225938771347e-12
initial O 0 1.0838911712607313e-10
CTG O 0 5.663017645929358e-07
repeat O 0 7.084442060767415e-11
size O 0 1.8906317483802226e-12
and O 0 2.182704754785658e-12
the O 0 2.5015291487545666e-12
time O 0 1.4253167060235966e-13
interval O 0 9.986863766520138e-13
and O 0 8.178444629424603e-14
always O 0 5.061665604884358e-13
biased O 0 4.1982497339665414e-11
towards O 0 1.7418519751566386e-11
further O 0 3.56461041239875e-12
expansion O 0 1.257609905103152e-09
. O 0 2.4904817097493037e-10

Attempts O 0 1.4003084025659973e-08
to O 0 3.112094609791782e-11
mathematically O 0 1.186274301012702e-09
model O 0 3.641788259844958e-11
the O 0 3.844434146027531e-11
dynamics O 0 2.7006263891848903e-09
have O 0 2.1523848241916665e-12
proved O 0 2.2781873609822867e-10
only O 0 1.2694256453296693e-13
partially O 0 4.6321918523162253e-10
successful O 0 1.8528659509464696e-11
suggesting O 0 1.227594740270399e-12
that O 0 1.1901641942420045e-15
individual O 0 6.686844427375134e-16
specific O 0 2.0822101367331397e-13
genetic O 0 6.633508325970539e-11
and O 0 3.190438191413847e-11
/ O 0 4.076886828130455e-09
or O 0 1.531384741237929e-11
environmental O 0 7.402899404596042e-10
factors O 0 4.278245119282431e-11
also O 0 7.702852570200258e-13
play O 0 6.036618427351925e-11
a O 0 2.0475927810931216e-12
role O 0 2.619670756362491e-12
in O 0 5.210870363675513e-12
somatic O 0 2.272565780003788e-07
mosaicism O 0 2.4157914140232606e-06
. O 0 1.0734560462744014e-10
. O 0 1.3516078534170362e-10

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 3.586863694948761e-09
Palestinian O 0 1.0230658986642993e-08
Arabs O 0 2.4038291357442176e-09
. O 0 6.981306088782446e-10

Aspartylglucosaminuria B-Disease 1 1.0
( O 1 0.9991979002952576
AGU B-Disease 1 1.0
) O 0 3.832986816831863e-09
is O 0 4.961504297684716e-12
a O 0 1.1523219878295521e-11
rare O 0 3.37990542220723e-07
disorder B-Disease 1 1.0
of I-Disease 1 1.0
glycoprotein I-Disease 1 1.0
metabolism I-Disease 1 1.0
caused O 0 1.3363833204493858e-06
by O 0 1.902984020363263e-11
the O 0 1.504118074535654e-08
deficiency B-Disease 0 6.599497282877564e-05
of I-Disease 0 7.876235486037331e-08
the I-Disease 0 1.8266940182698477e-09
lysosomal I-Disease 0 1.5074910152179655e-05
enzyme I-Disease 0 3.295561379346168e-09
aspartylglucosaminidase I-Disease 0 1.7780793086785707e-06
( O 0 1.7730329704424008e-10
AGA O 0 0.0005704075447283685
) O 0 2.1778331915633942e-10
. O 0 9.36985350419306e-11

AGU B-Disease 1 1.0
is O 0 1.848603403686866e-07
inherited O 0 6.749833119101822e-05
as O 0 7.012240232917577e-10
an O 0 1.0638151470843127e-10
autosomal O 1 0.9999992847442627
recessive O 0 0.0019128686981275678
trait O 0 8.434693499204116e-10
and O 0 6.414106051844115e-11
occurs O 0 3.167595526154532e-12
with O 0 2.2611480152449556e-14
a O 0 5.215979015892047e-13
high O 0 1.8286626379815374e-10
frequency O 0 7.228980608564584e-11
in O 0 4.473880901162408e-12
Finland O 0 1.812412886437187e-09
because O 0 3.090608498290681e-12
of O 0 8.830412789873066e-11
a O 0 2.581877767138252e-11
founder O 0 2.65935700127784e-08
effect O 0 2.8563171827755696e-09
. O 0 2.1103695180269e-10

While O 0 3.430250572478144e-08
very O 0 1.3219661476604472e-10
few O 0 4.579393114712005e-11
patients O 0 1.843767916120953e-10
with O 0 1.5694305577351741e-10
AGU B-Disease 1 1.0
have O 0 1.9080395249893023e-11
been O 0 1.2577230923405125e-12
reported O 0 1.8962221116219924e-12
from O 0 5.8061871283099364e-12
non O 0 1.229464796637103e-08
- O 0 2.4896993355838504e-09
Finnish O 0 8.661777428642381e-08
origin O 0 1.5342799253303951e-10
, O 0 1.3777684722271477e-11
we O 0 9.387755330048098e-12
diagnosed O 0 1.8666823109469988e-07
the O 0 6.628718129952915e-10
disorder O 0 4.6263608055596706e-06
in O 0 1.6102563726860808e-10
8 O 0 2.597084147737405e-08
patients O 0 1.7801175464238206e-11
originating O 0 1.1973851077318187e-10
from O 0 1.20011528492725e-10
3 O 0 1.2438783336676806e-09
unrelated O 0 3.0549368590371273e-10
families O 0 1.770374076287204e-13
, O 0 1.3006102813663267e-13
all O 0 3.8597543130375334e-14
Palestinian O 0 2.94937303746412e-11
Arabs O 0 2.0153826524316187e-12
from O 0 2.3402538587569133e-12
the O 0 1.4944321821697137e-12
region O 0 1.1121581086626087e-11
of O 0 5.904523397992634e-11
Jerusalem O 0 1.0212727374891983e-07
. O 0 3.601877462955372e-09

The O 0 7.806893798090186e-09
clinical O 0 4.578353582473937e-06
diagnosis O 1 0.9999982118606567
of O 1 0.9999966621398926
AGU B-Disease 1 1.0
is O 0 4.735226100116563e-10
often O 0 3.8626233288263645e-12
difficult O 0 5.063415832451401e-12
, O 0 4.638547914368775e-14
in O 0 9.066709107672169e-14
particular O 0 2.1450711283729947e-14
early O 0 4.868455031475927e-12
in O 0 5.966076563985664e-14
the O 0 5.382763462388751e-13
course O 0 5.114522347304806e-11
of O 0 4.189610464111482e-11
the O 0 4.4008632849035223e-10
disease O 0 1.779770464338526e-08
, O 0 8.268980254211647e-14
and O 0 2.376417205379733e-13
most O 0 1.2216891723520334e-13
of O 0 9.902768188796429e-11
the O 0 3.448870355970968e-11
patients O 0 6.384177908547173e-11
are O 0 1.7164758113127898e-12
diagnosed O 0 1.4615655352656631e-09
after O 0 3.062940526210589e-11
the O 0 1.4557438587914362e-11
age O 0 1.378168065779839e-11
of O 0 3.149819571834911e-10
5 O 0 2.2834045765307565e-09
years O 0 5.205528716412111e-11
. O 0 1.9400553386006436e-10

However O 0 1.6337380337461127e-09
, O 0 1.1288342656456951e-11
since O 0 8.478537425089805e-13
these O 0 2.416129633604075e-13
patients O 0 1.324812004890874e-12
excrete O 0 9.629282787804172e-11
early O 0 4.143233325870632e-11
large O 0 2.453836558859862e-13
amounts O 0 4.723098648296009e-12
of O 0 9.97874782804331e-10
aspartylglucosamine O 0 1.6054777063345682e-07
in O 0 1.6944684544384359e-10
urine O 0 4.281708321229871e-10
, O 0 3.229945878899937e-13
biochemical O 0 1.0775916964300691e-10
screening O 0 1.3876670645895928e-10
is O 0 4.3403280101939057e-13
easy O 0 6.262007839347161e-12
by O 0 1.069918676224746e-12
urine O 0 3.239569446034096e-10
chromatography O 0 1.0036149689085505e-08
. O 0 1.1180330966586993e-10
. O 0 2.9078334184973187e-10

Detection O 0 1.919357828228385e-06
of O 0 2.0332985073423515e-08
heterozygous O 0 2.592047236571471e-11
carriers O 0 8.416622433726761e-12
of O 0 1.1928040777320348e-09
the O 0 1.8991723749195444e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.3586888947259013e-08
ATM O 0 0.003811652073636651
) O 0 8.929647993261014e-11
gene O 0 1.642039976212928e-11
by O 0 6.855598120442119e-12
G2 O 0 1.7698588635539636e-05
phase O 0 1.6129021673805255e-07
chromosomal O 0 2.5461386599090474e-07
radiosensitivity O 0 3.855263912555529e-06
of O 0 1.4812597726177046e-07
peripheral O 0 0.0005477149388752878
blood O 0 4.714405349659501e-06
lymphocytes O 0 6.827274887655221e-07
. O 0 1.056646881103518e-09

In O 0 3.356002480359166e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 4.635207005776465e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 4.245404722214019e-11
patients O 0 8.300022127927242e-12
, O 0 1.605537127942827e-13
mutations O 0 1.992765327751833e-12
in O 0 2.7956866422568227e-12
a O 0 1.7798686786571483e-12
single O 0 2.134039646384256e-11
gene O 0 3.1945893413237725e-12
, O 0 4.3102983205214884e-13
ATM O 0 2.7631512011794257e-07
, O 0 1.8723867942216366e-12
result O 0 8.671839830422245e-13
in O 0 3.710102971371532e-12
an O 0 3.6597991304176958e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 1.2898904167002456e-10
embraces O 0 1.1575350677972551e-09
a O 0 4.2413880567415685e-12
variety O 0 8.557227842986848e-11
of O 0 6.268598973235839e-10
clinical O 0 2.5225469357792463e-07
features O 0 3.548768834349403e-09
and O 0 8.301895282336602e-11
manifests O 0 3.429300177160144e-09
extreme O 0 1.423396014388345e-07
radiosensitivity O 0 5.856359734934813e-07
and O 0 4.157704389107231e-11
a O 0 1.0284446905206579e-11
strong O 0 5.67671153139937e-11
pre O 0 4.3250805902061984e-05
- O 0 8.353449487685793e-08
disposition O 0 1.4821503100392874e-06
to O 0 1.6801161573098966e-09
malignancy B-Disease 0 0.0002793728490360081
. O 0 6.653735340478306e-10

Heterozygotes O 0 2.388843824974174e-07
for O 0 1.888831452356854e-10
the O 0 2.6059085445062635e-10
ATM O 0 5.465985850605648e-06
gene O 0 2.311646152275415e-10
have O 0 7.739710700680261e-14
no O 0 2.4855947378457643e-13
clinical O 0 2.52214693574615e-10
expression O 0 5.3200169963796284e-11
of O 0 3.171985341055006e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 1.2074826381824888e-11
may O 0 1.1858749225657217e-11
be O 0 5.547746723816305e-12
cancer B-Disease 0 1.2164633744760067e-07
prone O 0 4.79787054530334e-08
with O 0 3.937657491737134e-12
a O 0 2.0565962127738757e-11
moderate O 0 1.2128428816815529e-10
increase O 0 8.972457108888388e-13
in O 0 6.323580548084351e-12
in O 0 1.552435784091255e-11
vitro O 0 3.5087847294335006e-08
radiosensitivity O 0 1.6400193771914928e-06
. O 0 3.735968756579666e-10

We O 0 3.3163194412821895e-09
performed O 0 1.3536272547298722e-07
a O 0 2.680876354244077e-10
blind O 0 9.17791354027031e-09
chromosomal O 0 5.081990384070423e-09
analysis O 0 1.262781823552217e-10
on O 0 1.3318751657109829e-09
G2 O 0 1.1820173995147343e-06
- O 0 1.3622041272753904e-09
phase O 0 1.7707288968438206e-09
lymphocytes O 0 1.595139992316419e-10
from O 0 1.2403950089279192e-10
7 O 0 2.0511254916755206e-09
unrelated O 0 4.6979245382772206e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 6.008149089353765e-09
, O 0 2.702920569655487e-12
13 O 0 9.952056539974663e-11
obligate O 0 1.7789821837865816e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999994039535522
T I-Disease 1 1.0
heterozygotes O 0 1.4452028018752117e-08
( O 0 3.5896914780952915e-12
parents O 0 5.03067368578386e-13
of O 0 1.1694486524993497e-11
the O 0 1.0663981633504682e-12
patients O 0 1.820357666687533e-12
) O 0 2.0309280177196153e-14
, O 0 1.431654003247046e-13
and O 0 2.6418387876619986e-12
14 O 0 2.0356402674615026e-10
normal O 0 3.9369459081672886e-11
controls O 0 4.625373695166246e-11
following O 0 1.0149324089492318e-11
X O 0 6.611675207324197e-09
- O 0 4.553177626598348e-11
irradiation O 0 1.3903640738721634e-10
with O 0 2.9277689756086744e-13
1 O 0 1.8563149281614066e-11
Gy O 0 1.3282051014584795e-08
in O 0 3.194350166324522e-13
order O 0 7.599633812874207e-13
to O 0 3.7373150228855664e-14
evaluate O 0 1.4070584974934519e-11
this O 0 4.961044867014125e-14
cytogenetic O 0 2.9060880368803055e-09
method O 0 7.556463267610614e-12
as O 0 5.897446566467332e-14
a O 0 2.171606807137988e-14
tool O 0 4.1531586655006725e-13
for O 0 1.973592272816677e-15
detection O 0 5.875743780414666e-10
of O 0 5.374028305693557e-11
ATM O 0 2.9243051358207595e-06
carriers O 0 2.924521069758157e-09
. O 0 8.140720320071182e-10

Both O 0 1.320614586575175e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 0 9.993915455197566e-07
and O 0 1.3323368797113488e-10
heterozygotes O 0 1.739539623457631e-09
showed O 0 9.623035875094832e-12
significantly O 0 7.487904068494144e-14
increased O 0 2.4799347620482574e-14
levels O 0 2.452639870711981e-12
of O 0 4.993412367620964e-12
radiation O 0 0.00015066018386278301
- O 0 3.192659221440408e-07
induced O 0 9.516124009678606e-06
chromatid O 0 1.1803529531562162e-07
damage O 0 1.4716646568047054e-08
relative O 0 1.237221089467333e-11
to O 0 1.2382515802641936e-13
that O 0 1.1813985255565776e-14
of O 0 1.8427124409692297e-11
normal O 0 7.970590854000648e-10
controls O 0 8.783421101554723e-09
. O 0 2.766789020114402e-10

These O 0 2.4302901358019824e-10
results O 0 1.8961082703938814e-10
show O 0 3.119463715117732e-11
that O 0 5.29136975934482e-14
the O 0 4.304418366879448e-12
G2 O 0 2.276950908708386e-06
- O 0 1.7711848654400342e-09
phase O 0 3.8784424560844855e-09
chromosomal O 0 8.54174508901906e-09
radiosensitivity O 0 5.895068966310646e-08
assay O 0 7.34923788492381e-11
can O 0 1.194572344281929e-14
be O 0 3.3192203648021437e-15
used O 0 7.348385544806921e-14
for O 0 1.0368216905149406e-14
the O 0 1.1104103883130892e-13
detection O 0 1.8359713749305229e-09
of O 0 2.498031781428267e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 6.269070240705332e-07
. O 0 5.645692247036038e-10

In O 0 3.625615585534092e-09
combination O 0 2.361186801635995e-09
with O 0 6.410714407240059e-12
molecular O 0 1.1131827015731233e-08
genetic O 0 5.286941440196813e-10
analyses O 0 6.991220380392349e-10
, O 0 6.254162227166404e-13
this O 0 1.999142809912366e-15
test O 0 3.528077786515982e-12
may O 0 5.1874225536841304e-14
be O 0 9.212120270166851e-15
of O 0 1.0372915634077051e-12
value O 0 6.753606463134887e-14
in O 0 4.809711927778598e-14
studies O 0 6.164697658600504e-13
of O 0 6.569190504068789e-12
familial B-Disease 0 1.9976004184130147e-10
and I-Disease 0 2.717519959061221e-11
sporadic I-Disease 0 1.4885812049669767e-07
cancers I-Disease 0 1.1157014796481235e-06
aimed O 0 2.9702909576379e-10
at O 0 1.0452407689376386e-10
determination O 0 5.1415663393505895e-11
of O 0 2.0043862403174018e-10
the O 0 4.009175803842968e-12
potential O 0 2.8012804749455444e-12
involvement O 0 1.1311279690673359e-10
of O 0 8.113209659654785e-09
ATM O 0 0.3342360258102417
mutations O 0 6.976836885996818e-09
in O 0 6.748855363447603e-10
tumor B-Disease 0 4.050424422530341e-07
risk O 0 3.3499802931657996e-10
or O 0 2.3928206638323957e-11
development O 0 3.243588175827483e-10
. O 0 7.546669018865249e-12
. O 0 3.798405687205353e-11

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 5.704565708697373e-10
identification O 0 7.710346250355826e-10
and O 0 3.250744725485921e-12
detection O 0 1.3164198264803417e-07
of O 0 1.4829694805484905e-08
founder O 0 1.5021275885374052e-06
- O 0 3.9195673373626505e-09
effect O 0 8.784133143091566e-11
mutations O 0 5.4525563751572914e-12
in O 0 6.525304927472442e-13
the O 0 1.1613680937078152e-12
ATM O 0 1.1292669910289987e-07
gene O 0 6.917833059866263e-12
in O 0 2.966555224127171e-13
ethnic O 0 7.500926691838411e-14
populations O 0 2.7747544388036227e-13
. O 0 2.252038616354368e-12

To O 0 3.4098990991937583e-11
facilitate O 0 9.847430509912769e-11
the O 0 5.797444555671882e-12
evaluation O 0 2.8845936750343526e-10
of O 0 3.1112354359486005e-10
ATM O 0 7.52833159367583e-07
heterozygotes O 0 1.8382980693232298e-09
for O 0 1.0263557365108866e-11
susceptibility O 0 5.633572275343113e-09
to O 0 2.77112898600107e-11
other O 0 6.668854912739164e-10
diseases O 1 1.0
, O 0 2.4372322736387897e-12
such O 0 1.2065479691736325e-11
as O 0 2.579719549089532e-09
breast B-Disease 1 0.9924803972244263
cancer I-Disease 0 5.786695851384138e-07
, O 0 5.898442324847597e-12
we O 0 1.246069897655258e-13
have O 0 6.2162778146268496e-15
attempted O 0 4.655759805460846e-11
to O 0 3.620501251230812e-13
define O 0 9.578775272967022e-12
the O 0 5.016779634943458e-13
most O 0 2.021359255921073e-14
common O 0 5.478184569927651e-14
mutations O 0 3.7388552675968537e-14
and O 0 4.8909362887830654e-14
their O 0 1.7857130975729857e-13
frequencies O 0 3.794495620490501e-11
in O 0 8.751973451515127e-11
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.0805776184952265e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.0460121484257012e-11
homozygotes O 0 2.3074273602929907e-09
from O 0 7.307468866124545e-12
10 O 0 3.872744572946951e-12
ethnic O 0 8.669685114129702e-14
populations O 0 9.049989490444998e-13
. O 0 5.91415761849734e-12

Both O 0 1.1546068545698063e-09
genomic O 0 3.6819101101315255e-09
mutations O 0 1.5623043136958614e-10
and O 0 1.895116702455013e-11
their O 0 7.06258185614872e-12
effects O 0 3.530641334847928e-09
on O 0 1.826358508871806e-10
cDNA O 0 1.6157200577460173e-10
were O 0 1.1905753292962284e-11
characterized O 0 1.1788556797398542e-09
. O 0 1.4359115285689228e-10

Protein O 0 2.170276047763764e-08
- O 0 7.229925103047208e-09
truncation O 0 1.904105140226875e-08
testing O 0 5.297846161766984e-09
of O 0 2.3091079048853658e-10
the O 0 7.573793155135622e-12
entire O 0 4.99152039146189e-11
ATM O 0 1.9189917210837848e-08
cDNA O 0 7.759944076202174e-11
detected O 0 2.0041032722240004e-10
92 O 0 4.721679713881599e-10
( O 0 7.635855923254775e-13
66 O 0 3.0526536853869857e-10
% O 0 9.664522600174447e-14
) O 0 5.2539986657119606e-14
truncating O 0 1.1100441676958894e-09
mutations O 0 3.5657820446344246e-11
in O 0 1.4674665996250447e-11
140 O 0 8.815541074902455e-10
mutant O 0 2.0956006374639458e-10
alleles O 0 2.2697837533114384e-12
screened O 0 6.1565672559993345e-09
. O 0 3.208858179171159e-10

The O 0 1.9594889977270213e-07
haplotyping O 0 9.407741890754551e-05
of O 0 3.17536347438363e-07
patients O 0 1.0643352865713496e-09
with O 0 2.2881894296000738e-11
identical O 0 1.3262073252917617e-06
mutations O 0 7.407507496282051e-09
indicates O 0 1.491768097938717e-10
that O 0 7.072725787199766e-14
almost O 0 6.619194125104255e-13
all O 0 1.7200276576298523e-13
of O 0 4.108456196777466e-12
these O 0 2.799044938157306e-14
represent O 0 2.7841907924118503e-13
common O 0 2.907725058995392e-12
ancestry O 0 2.396263092466211e-12
and O 0 1.631191601063342e-12
that O 0 9.094560228604248e-14
very O 0 1.5021424859193444e-12
few O 0 8.90827689392637e-12
spontaneously O 0 1.4187719887814865e-09
recurring O 0 2.2007684563618568e-08
ATM O 0 6.18184931227006e-05
mutations O 0 1.509526903475944e-08
exist O 0 5.342474462821656e-09
. O 0 2.3418915695572196e-09

Assays O 0 4.934683062174372e-08
requiring O 0 1.9247421434442913e-09
minimal O 0 6.85871859307241e-10
amounts O 0 1.0483730203403319e-11
of O 0 1.0766568886433348e-10
genomic O 0 9.859327243511018e-11
DNA O 0 5.187979379428498e-09
were O 0 5.466632463542453e-13
designed O 0 3.211715962625483e-11
to O 0 1.831931009882784e-13
allow O 0 4.986881133733911e-13
rapid O 0 1.4271788612019165e-11
screening O 0 1.7438024765489835e-12
for O 0 2.090326880772181e-14
common O 0 8.862395409550694e-13
ethnic O 0 1.9593637964280403e-13
mutations O 0 4.01262009730452e-11
. O 0 3.407565202229179e-11

These O 0 4.4495554463175324e-10
rapid O 0 4.31446922632972e-09
assays O 0 4.936581810000007e-09
detected O 0 1.3488143935092012e-09
mutations O 0 2.900153424703622e-12
in O 0 1.232018718815009e-12
76 O 0 2.673232746275289e-10
% O 0 6.270248128223757e-14
of O 0 4.8726630369477775e-12
Costa O 0 3.043852725426177e-09
Rican O 0 1.0764858870970784e-07
patients O 0 2.3573686405709005e-11
( O 0 4.3524979085295123e-13
3 O 0 6.276515418512929e-11
) O 0 2.9633528974854634e-14
, O 0 1.6597463217715193e-14
50 O 0 1.9614466843266565e-13
% O 0 4.651392067871055e-15
of O 0 5.26809010911039e-13
Norwegian O 0 2.5256383651139913e-09
patients O 0 2.5018641672258646e-11
( O 0 6.160442707174585e-13
1 O 0 1.1917050679599583e-10
) O 0 7.662405052902971e-14
, O 0 3.348293796628758e-14
25 O 0 6.2272962394333e-13
% O 0 3.659411031034336e-15
of O 0 4.3020358868155195e-13
Polish O 0 3.431304307355276e-08
patients O 0 2.9160199255251484e-10
( O 0 2.1113657697191535e-12
4 O 0 3.592284247844191e-10
) O 0 6.085313053157473e-14
, O 0 2.5421803334299553e-14
and O 0 1.4242838679290326e-13
14 O 0 6.239331967750061e-12
% O 0 8.671632781688619e-15
of O 0 9.289163405493128e-13
Italian O 0 8.491841896329788e-09
patients O 0 8.09508571286699e-11
( O 0 8.790879265849205e-13
1 O 0 5.400191405158239e-10
) O 0 3.2403555750085133e-13
, O 0 1.425245961831842e-13
as O 0 1.1902699420703045e-13
well O 0 3.324774266663666e-13
as O 0 6.771018750025004e-14
in O 0 1.279782215531794e-13
patients O 0 3.215844203343504e-13
of O 0 6.38424816484795e-12
Amish O 0 9.02398369362345e-08
/ O 0 1.2976649976792487e-08
Mennonite O 0 3.5885696547666157e-07
and O 0 4.1792989208255804e-11
Irish O 0 7.740734275785144e-09
English O 0 1.506029079223481e-09
backgrounds O 0 2.571636514847597e-10
. O 0 5.3279679279594205e-11

Additional O 0 2.2231614327239413e-09
mutations O 0 9.332491446301105e-10
were O 0 4.7797595742471444e-11
observed O 0 2.125516949946782e-11
in O 0 4.468806834995176e-12
Japanese O 0 4.278510434829741e-09
, O 0 1.5311327509689998e-12
Utah O 0 1.1013595591080616e-09
Mormon O 0 7.403149621110217e-11
, O 0 2.5540791812224406e-13
and O 0 1.3758901786994904e-12
African O 0 3.7558577775653745e-11
American O 0 1.515991360223623e-10
patients O 0 4.64039605352351e-11
. O 0 1.0020186763659567e-10

These O 0 4.334425526830721e-11
assays O 0 5.565388150330364e-10
should O 0 6.736858792176503e-13
facilitate O 0 1.5822753263866618e-12
screening O 0 9.92950686951044e-12
for O 0 1.2357700583318088e-12
A B-Disease 1 1.0
- I-Disease 1 0.9998551607131958
T I-Disease 1 1.0
heterozygotes O 0 1.5266035102712294e-09
in O 0 4.710572752177067e-13
the O 0 6.641220776440471e-14
populations O 0 5.420879148804224e-15
studied O 0 1.889024093398861e-12
. O 0 2.104072124864409e-13
. O 0 1.198115565093083e-11

The O 0 8.91007800873922e-08
von B-Disease 1 0.999988317489624
Hippel I-Disease 1 0.9999998807907104
- I-Disease 0 0.24625512957572937
Lindau I-Disease 0 0.2579883635044098
tumor I-Disease 0 3.723310442182992e-07
suppressor O 0 2.936383225460304e-08
gene O 0 2.594065066918727e-11
is O 0 7.796304698831288e-15
required O 0 7.146765953558801e-14
for O 0 4.1425337552608577e-13
cell O 0 1.5734387126542515e-09
cycle O 0 6.140565139700627e-11
exit O 0 9.148209967335674e-11
upon O 0 1.5045345178044123e-11
serum O 0 1.4766773359653484e-09
withdrawal O 0 1.3108538698958228e-09
. O 0 8.110699334373805e-10

The O 0 1.278645989089e-08
inactivation O 0 6.931952043487399e-07
of O 0 2.1656902049471682e-08
the O 0 1.8197319207047258e-09
von B-Disease 1 0.9998525381088257
Hippel I-Disease 1 1.0
- I-Disease 1 0.9975990653038025
Lindau I-Disease 1 0.9999669790267944
( I-Disease 0 2.1091603130685144e-08
VHL I-Disease 1 1.0
) I-Disease 0 1.5253104335144485e-10
tumor I-Disease 0 3.712241323228227e-07
suppressor O 0 1.419750969944289e-05
gene O 0 7.246633515478607e-08
predisposes O 0 7.233639109927026e-08
affected O 0 9.555263247307266e-10
individuals O 0 3.337863297390997e-13
to O 0 1.5081288648466362e-11
the O 0 6.954224751609672e-09
human O 1 0.9999998807907104
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 0.9957725405693054
and O 0 3.153519546189587e-12
is O 0 2.8849342484154814e-14
associated O 0 9.611204193626932e-12
with O 0 1.0441064679511669e-11
sporadic B-Disease 1 0.7911527752876282
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 2.2807446953265753e-07
RCC B-Disease 1 1.0
) O 0 8.059629408307956e-09
and O 0 4.1769382619349926e-08
brain B-Disease 1 0.9999998807907104
hemangioblastomas I-Disease 1 0.9999430179595947
. O 0 8.368324699858931e-09

VHL O 1 0.9986786246299744
- O 0 6.341697940115409e-07
negative O 0 2.3491748546433655e-09
786 O 0 3.317191215046478e-07
- O 0 4.9088576759004354e-08
0 O 0 7.584560535178753e-09
RCC B-Disease 1 0.9855136871337891
cells O 0 1.560771178965581e-09
are O 0 5.930174754031903e-12
tumorigenic O 0 4.183596047369065e-07
in O 0 3.125582015428563e-10
nude O 0 2.605836968427866e-08
mice O 0 5.322127807905197e-11
which O 0 9.343070208559651e-14
is O 0 2.1814498382048512e-14
suppressed O 0 1.751850921272169e-11
by O 0 4.621277319150074e-13
the O 0 3.5672768992217607e-12
reintroduction O 0 1.3516497920917914e-09
of O 0 4.267163289384257e-10
VHL B-Disease 0 0.22428689897060394
. O 0 8.346164315220506e-10

Remarkably O 0 8.108585802801827e-07
, O 0 2.2575014774206537e-11
this O 0 3.7298377548403844e-14
occurs O 0 4.365534355451478e-13
without O 0 2.440864350916616e-13
affecting O 0 7.780006673618889e-12
the O 0 1.4102766263818234e-12
growth O 0 2.993194342555683e-13
rate O 0 6.61937085005837e-13
and O 0 2.8002158426222723e-13
cell O 0 8.504119630714513e-11
cycle O 0 7.64718496859551e-12
profile O 0 1.2954020451802495e-12
of O 0 6.285221908902683e-12
these O 0 1.04036218659051e-13
cells O 0 1.3903758786654175e-12
in O 0 8.18019588698371e-13
culture O 0 6.917203615453005e-11
. O 0 2.1321232973603443e-11

The O 0 2.2120977050121837e-08
786 O 0 1.426367788326388e-07
- O 0 7.838330873255472e-09
0 O 0 1.91411692052057e-10
cell O 0 5.075255771203047e-10
line O 0 4.362502858956674e-10
, O 0 1.4142767902972087e-12
like O 0 1.4901058902408448e-12
many O 0 5.492614826504982e-13
cancer B-Disease 0 1.0090925872674461e-09
cells O 0 9.455628988130904e-12
, O 0 4.235920696236267e-13
fails O 0 2.685930254250901e-12
to O 0 5.841385318158809e-13
exit O 0 1.0147317708320003e-10
the O 0 1.981517207261252e-11
cell O 0 3.0174229781465556e-10
cycle O 0 1.90682799411368e-11
upon O 0 9.824313237927207e-12
serum O 0 3.2407868055805977e-10
withdrawal O 0 1.4849811380557298e-09
. O 0 5.708952199867667e-10

Here O 0 3.054897890208963e-09
, O 0 9.232327576047528e-12
it O 0 1.480515471503907e-13
is O 0 6.582223999927967e-15
shown O 0 3.085404585360767e-14
that O 0 3.3537117581725756e-15
reintroduction O 0 5.3622536966280165e-11
of O 0 1.0307306223811263e-11
the O 0 6.9919864169321055e-12
wild O 0 5.547522441418096e-09
- O 0 5.619717136085001e-09
type O 0 1.920738412763967e-08
VHL B-Disease 1 0.9950148463249207
gene O 0 1.8294196713064537e-10
restores O 0 2.342731342253046e-09
the O 0 1.813303153463952e-11
ability O 0 2.4540916174209393e-11
of O 0 5.537384328846429e-09
VHL O 1 1.0
- O 0 2.447075758027495e-06
negative O 0 1.396334514680575e-08
RCC B-Disease 1 1.0
cancer I-Disease 0 1.5778684883116512e-06
cells O 0 1.8555646602580467e-11
to O 0 2.0989184782577164e-12
exit O 0 2.1578949738199071e-10
the O 0 1.6762573967765704e-11
cell O 0 3.982747742714565e-10
cycle O 0 5.426362831295606e-11
and O 0 1.4787523419310111e-12
enter O 0 5.207646536220523e-10
G0 O 0 0.0005018942756578326
/ O 0 8.014406915890504e-09
quiescence O 0 4.789346697009478e-09
in O 0 3.3717157538193376e-11
low O 0 4.572747069886418e-09
serum O 0 1.514562342208592e-08
. O 0 1.1867580529401067e-10

Both O 0 2.4628366190881934e-07
VHL O 1 0.9999600648880005
- O 0 2.7879767117156007e-07
positive O 0 1.5626769322985012e-10
and O 0 3.548929761176822e-10
VHL O 1 0.9999973773956299
- O 0 3.727879160919656e-08
negative O 0 1.930897441937418e-09
RCC B-Disease 1 0.9999926090240479
cells O 0 3.731590592082057e-09
exit O 0 3.6768714739565667e-09
the O 0 6.239025268639509e-11
cell O 0 1.337128963108114e-09
cycle O 0 2.15116691820727e-11
by O 0 7.182628515393918e-13
contact O 0 9.863375671770314e-10
inhibition O 0 2.0065982209160893e-09
. O 0 3.0202212952801233e-10

The O 0 1.437776564472415e-08
cyclin O 0 2.9018192293506218e-08
- O 0 6.155815857056268e-09
dependent O 0 6.654725659416272e-10
kinase O 0 9.134719647363454e-10
inhibitor O 0 6.163919374913007e-10
, O 0 5.888988515584392e-12
p27 O 0 1.3463725689888406e-09
, O 0 2.830420630945546e-13
accumulates O 0 1.598058816353054e-12
upon O 0 3.157353285071496e-12
serum O 0 2.2476326355658216e-11
withdrawal O 0 2.456236429526637e-11
, O 0 5.692492375912461e-13
only O 0 6.006297499969561e-15
in O 0 9.99173549345693e-14
the O 0 9.248432098277193e-13
presence O 0 1.9050893675098823e-12
of O 0 2.0868304861920706e-09
VHL B-Disease 1 0.9999879598617554
, O 0 2.071888320631654e-11
as O 0 5.292786066195265e-13
a O 0 1.2515101531062472e-13
result O 0 6.588636971074924e-13
of O 0 1.1774635953754053e-11
the O 0 2.3493327509088724e-12
stabilization O 0 1.3849917879227291e-09
of O 0 1.1181743309052194e-09
the O 0 2.3246053693082303e-10
protein O 0 8.326415668058473e-10
. O 0 1.2099708734947257e-10

We O 0 3.5914207718867885e-10
propose O 0 1.0019231971858389e-10
that O 0 3.0356367918503435e-13
the O 0 2.798793141689515e-11
loss O 0 3.613878751806965e-09
of O 0 7.870615270633152e-09
wild O 0 2.2078576478179457e-07
- O 0 1.565952203463894e-07
type O 0 4.1813663642642496e-07
VHL B-Disease 1 0.9999995231628418
gene O 0 5.3561814705727073e-11
results O 0 4.535346057044087e-12
in O 0 1.3482875840103992e-12
a O 0 7.439009803121566e-13
specific O 0 3.003239323895457e-11
cellular O 0 2.349745784613333e-07
defect O 0 7.088993925208342e-08
in O 0 1.6378930156601967e-10
serum O 0 4.096764261163344e-09
- O 0 1.1010360401186858e-09
dependent O 0 9.591101524097922e-11
growth O 0 4.1119841906467336e-12
control O 0 6.630168636334588e-11
, O 0 3.1868344768648527e-13
which O 0 7.30133117052105e-14
may O 0 1.4205813175099946e-12
initiate O 0 1.0250342796780387e-09
tumor B-Disease 0 1.415444614849548e-07
formation O 0 1.6582409898546757e-06
. O 0 1.7722359135774468e-09

This O 0 1.6639431499321233e-10
is O 0 8.908769555393548e-12
corrected O 0 3.364644396430805e-10
by O 0 8.702377468812472e-13
the O 0 2.7949079682565436e-12
reintroduction O 0 6.82913836591581e-10
of O 0 7.044947264445156e-11
wild O 0 1.2387578074424255e-08
- O 0 2.908307727977899e-08
type O 0 1.3848309663444525e-06
VHL B-Disease 1 1.0
, O 0 7.777388177920841e-10
implicating O 0 0.12329062819480896
VHL B-Disease 1 1.0
as O 0 2.606495297374778e-10
the O 0 7.598742468584163e-11
first O 0 3.5043849766491775e-11
tumor B-Disease 0 2.725577818996072e-10
suppressor O 0 4.589381374930923e-10
involved O 0 9.43170888612066e-12
in O 0 5.682883417318374e-12
the O 0 3.478068874573914e-11
regulation O 0 7.830276871345632e-09
of O 0 1.3587114766622221e-09
cell O 0 5.549646853175716e-10
cycle O 0 2.8766582865769053e-11
exit O 0 3.139321788636629e-11
, O 0 7.126512379350414e-14
which O 0 1.469438686127391e-14
is O 0 5.4461379254012315e-14
consistent O 0 4.9568342486150385e-11
with O 0 6.422081291236614e-13
its O 0 1.0309507587902278e-11
gatekeeper O 0 6.14091943962336e-10
function O 0 1.5330497288301714e-12
in O 0 1.9185597121412767e-12
the O 0 5.827981153228023e-11
kidney O 0 5.578037143294523e-09
. O 0 1.6583439482742435e-11
. O 0 7.911968302742878e-11

Piebaldism B-Disease 1 1.0
with O 0 0.0015647835098206997
deafness B-Disease 1 1.0
: O 0 2.0338559725274763e-09
molecular O 0 9.611145657117959e-09
evidence O 0 7.776260191327822e-10
for O 0 3.924139225369716e-12
an O 0 1.5455746491671585e-12
expanded O 0 3.258899994307285e-07
syndrome O 1 0.9985595345497131
. O 0 8.065314527350154e-10

In O 0 6.496156390589647e-10
a O 0 3.634086087611621e-11
South O 0 1.4235562728615037e-09
African O 0 1.198056792661717e-10
girl O 0 2.31571484210491e-10
of O 0 4.140660037066368e-10
Xhosa O 0 9.897702568650857e-08
stock O 0 1.0653502385826741e-10
with O 0 1.6429642368809283e-11
severe O 1 0.9998321533203125
piebaldism B-Disease 1 1.0
and O 0 2.3535241780336946e-05
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 5.860617591224582e-08
identified O 0 9.536127443254827e-10
a O 0 1.3062849413270072e-11
novel O 0 4.287361091148689e-11
missense O 0 1.071341682035154e-09
substitution O 0 2.5182307350490873e-09
at O 0 8.375522497772181e-10
a O 0 3.138242920738832e-12
highly O 0 5.013006676435339e-11
conserved O 0 3.946639126617413e-10
residue O 0 2.219158190541748e-09
in O 0 1.0539883852841991e-12
the O 0 8.868617645818588e-13
intracellular O 0 9.70559244951874e-13
kinase O 0 2.546279853632427e-11
domain O 0 5.064758074740938e-12
of O 0 1.2007700389560227e-10
the O 0 4.059718533566681e-11
KIT O 1 0.9867157340049744
proto O 0 1.5166760931606404e-06
- O 0 1.2696322215788314e-08
oncogene O 0 1.2440966656868113e-07
, O 0 5.680859949119821e-11
R796G O 0 1.2665900328556745e-07
. O 0 3.0258603955779506e-10

Though O 0 4.6733916292396316e-08
auditory B-Disease 0 1.5102465113159269e-05
anomalies I-Disease 0 8.673769116285257e-07
have O 0 8.18741168612247e-12
been O 0 1.4771145461292545e-12
observed O 0 1.0489590966666906e-11
in O 0 4.1569408505692795e-12
mice O 0 6.342874836473555e-11
with O 0 9.732917596871893e-13
dominant O 0 1.8942043489289517e-09
white O 0 6.212046849141117e-11
spotting O 0 4.142070153534405e-08
( O 0 3.9348160840724233e-10
W O 0 0.04965147003531456
) O 0 1.190793297300985e-11
due O 0 8.007282614741484e-10
to O 0 2.9979640991939505e-10
KIT O 1 1.0
mutations O 0 9.831883289734833e-07
, O 0 9.361324160295226e-09
deafness B-Disease 1 1.0
is O 0 1.1165152136172196e-11
not O 0 1.5481554569134887e-13
typical O 0 4.375241835496979e-11
in O 0 1.0894141491690768e-11
human O 0 2.8433461141119665e-10
piebaldism B-Disease 0 1.765837964740058e-06
. O 0 3.0240948634130405e-10

Thus O 0 8.359183567563377e-09
, O 0 1.50635511009245e-11
the O 0 2.0883605175020525e-12
occurrence O 0 6.877792224635471e-10
of O 0 1.2876455457444536e-07
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 5.289912508033012e-08
this O 0 5.078039117673017e-12
patient O 0 6.916362482733973e-10
extends O 0 2.798387389868484e-11
considerably O 0 1.8418118592766763e-12
the O 0 1.819069851347055e-12
phenotypic O 0 2.457759343266197e-11
range O 0 3.581263063878737e-10
of O 0 4.895145955252644e-10
piebaldism B-Disease 0 1.0165501862502424e-07
due O 0 6.156822829339603e-10
to O 0 3.387308836200198e-11
KIT O 1 0.9999996423721313
gene O 0 1.3706112633737888e-10
mutation O 0 2.8306920609594277e-12
in O 0 9.718781768947027e-13
humans O 0 4.5003350004901854e-12
and O 0 3.819443025743219e-12
tightens O 0 2.9740213070006405e-10
the O 0 6.834291813029303e-12
clinical O 0 2.0431523140018726e-09
similarity O 0 4.521278837432696e-11
between O 0 2.8845094715568287e-11
piebaldism B-Disease 0 8.871448642366886e-08
and O 0 5.5217349789749015e-12
the O 0 5.800361818457389e-13
various O 0 3.703461962014515e-13
forms O 0 1.813833250263741e-10
of O 0 1.8960594871941794e-08
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 0.9999998807907104
. O 0 3.290647754283782e-10
. O 0 6.342696368122347e-10

Cycloheximide O 0 1.6448893802589737e-05
facilitates O 0 1.3748534533064571e-09
the O 0 1.2431371036736305e-11
identification O 0 2.5672700076917465e-10
of O 0 1.0991351162559226e-09
aberrant O 0 1.9533612061195527e-08
transcripts O 0 3.8500388654938433e-08
resulting O 0 7.825644021686173e-10
from O 0 6.088201470744181e-11
a O 0 3.6261495108685926e-12
novel O 0 2.3154884259968256e-11
splice O 0 6.291254806001234e-08
- O 0 7.877610230799803e-10
site O 0 8.649317373432552e-11
mutation O 0 6.765990545609668e-12
in O 0 1.1769672909889284e-11
COL17A1 O 1 0.999987006187439
in O 0 2.961509509846749e-11
a O 0 1.370255037907997e-11
patient O 0 2.670212051469889e-09
with O 0 1.2237549862348374e-10
generalized O 1 0.9994933605194092
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999970197677612
. O 0 7.083465902724129e-08

Patients O 0 4.672580757869582e-07
with O 0 1.1044497538748033e-09
generalized O 1 0.9999998807907104
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999982118606567
often O 0 2.8350135572452473e-09
show O 0 7.473333757390677e-11
decreased O 0 3.241644799811816e-11
expression O 0 1.0161043881296017e-11
of O 0 1.6754048148825973e-10
type O 0 1.7790992501431901e-07
XVII O 1 1.0
collagen O 1 0.9868355989456177
, O 0 3.1424030044746587e-10
a O 0 2.6566556246554462e-11
transmembrane O 0 3.8779246480658e-09
hemidesmosomal O 0 8.256324122157821e-07
protein O 0 5.28036114832986e-10
encoded O 0 9.384251015154277e-11
by O 0 4.4730986276109164e-11
COL17A1 O 1 0.9985260963439941
. O 0 3.2375944147844393e-09

This O 0 1.2876584520871148e-10
report O 0 3.513547439104592e-11
documents O 0 8.38436042815971e-10
a O 0 3.0139241796733884e-11
novel O 0 1.4439145712419332e-10
splice O 0 2.2378515041054925e-07
- O 0 2.773511420528507e-09
site O 0 4.642886075600927e-10
mutation O 0 1.9357482630710798e-11
in O 0 1.7479224664884718e-11
COL17A1 O 1 0.999998927116394
in O 0 8.722443600728269e-11
a O 0 2.1642788256004408e-11
patient O 0 6.384245576640524e-09
with O 0 2.1429980012754868e-10
generalized O 1 0.9999897480010986
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999891519546509
, O 0 1.6704374550258194e-09
and O 0 2.4190325090267528e-11
applies O 0 7.612901281595086e-11
a O 0 1.0217456221373045e-12
new O 0 8.420953279304755e-13
methodology O 0 1.7876708793829188e-11
to O 0 2.5353005285444485e-13
define O 0 3.1987613946515836e-11
and O 0 2.8320098002798666e-12
characterize O 0 6.092270021795798e-10
the O 0 4.04271668225098e-12
resulting O 0 7.635904061831233e-12
mRNA O 0 1.8787171818246406e-10
splice O 0 5.532098512617267e-08
variants O 0 2.5244968338000717e-09
. O 0 1.4058304520503384e-10

Mutational O 0 9.357002454635222e-06
analysis O 0 1.1501586349993431e-08
of O 0 5.976172445798511e-08
COL17A1 O 1 0.9999960660934448
identified O 0 4.5934993586627115e-09
a O 0 1.4935361281054327e-10
maternally O 0 9.648895371583421e-08
inherited O 0 2.122422756656306e-06
G O 0 0.00346460216678679
- O 0 4.466881478037976e-07
to O 0 1.1631343665996496e-09
- O 0 2.493491422228544e-07
T O 0 1.5323489606089424e-06
transversion O 0 1.213548017631183e-07
at O 0 6.521080897492482e-11
the O 0 1.1775349575623983e-12
- O 0 5.8376684562710945e-12
1 O 0 2.957912343878877e-12
position O 0 1.440860018103729e-11
of O 0 5.88672305346094e-11
exon O 0 8.901105630343409e-09
32 O 0 1.205130661929843e-08
. O 0 2.6888238857658564e-10

This O 0 8.533236617314088e-11
acceptor O 0 2.434814017071574e-10
splice O 0 5.542490271182032e-07
- O 0 6.3994849419657385e-09
site O 0 4.015271448665203e-10
mutation O 0 9.55366862009921e-12
led O 0 3.016995681059953e-11
to O 0 4.900482146810714e-13
the O 0 9.757011171229735e-12
formation O 0 3.644378665512704e-08
of O 0 5.5268962739774e-09
aberrant O 0 2.899694528935015e-08
transcripts O 0 2.484330963170578e-08
present O 0 4.726581348535319e-10
at O 0 2.648593566689783e-09
extremely O 0 9.794013378083832e-10
low O 0 1.5182472168362438e-08
levels O 0 8.812313101458358e-10
. O 0 5.274318828907276e-11

Based O 0 4.6658389152298696e-08
on O 0 8.619566393974765e-09
our O 0 1.6228082766467367e-10
recent O 0 8.425873714024146e-12
finding O 0 9.53806391507106e-12
that O 0 9.711809400301044e-14
cycloheximide O 0 1.9403947248974873e-07
stabilized O 0 2.7176261596650875e-07
mutant O 0 1.4351217991759313e-08
COL17A1 O 0 0.00024262878287117928
transcripts O 0 5.50491785489271e-09
in O 0 1.4334808513816188e-11
keratinocytes O 0 6.885247372245829e-10
homozygous O 0 1.696514803639637e-11
for O 0 3.4779544695606734e-12
a O 0 2.0584563567571657e-11
frameshift O 0 7.961629577835083e-09
mutation O 0 6.698159388252023e-11
, O 0 4.3050424336499304e-12
the O 0 1.5721561205661594e-11
effects O 0 8.504257742458776e-09
of O 0 3.874019161020925e-10
the O 0 2.596287768108496e-11
splice O 0 2.0889302732030046e-08
- O 0 1.1646524022967952e-10
site O 0 1.0579687299838714e-11
mutation O 0 1.2783232859834431e-13
on O 0 4.538444273172182e-12
splicing O 0 5.808164504905733e-10
of O 0 1.6028935956313717e-09
COL17A1 O 0 0.42669662833213806
transcripts O 0 1.461663856616724e-08
were O 0 1.8354791644914492e-11
determined O 0 2.4618070169207806e-12
using O 0 6.925301803371864e-13
reverse O 0 4.5176067747787485e-11
transcriptase O 0 1.0577816400569873e-10
polymerase O 0 6.341628611128414e-11
chain O 0 4.020794808212713e-11
reaction O 0 6.411176385785755e-13
of O 0 3.002265797080739e-11
total O 0 3.517151034391347e-13
RNA O 0 1.5371681705289575e-10
from O 0 1.277639539304376e-11
keratinocytes O 0 1.0505232794777442e-10
incubated O 0 8.539484223912819e-12
for O 0 1.5667431544838517e-12
2 O 0 1.0157489294115862e-09
. O 0 5.2832495323063e-11

5 O 0 6.852395983969473e-08
h O 0 1.6566700233866527e-09
in O 0 6.497562904383969e-12
the O 0 3.2696109274893415e-12
presence O 0 1.787295029857805e-12
or O 0 1.0401411502936053e-11
absence O 0 1.4879496523789726e-09
of O 0 3.315642649326378e-09
10 O 0 7.135598223406703e-10
microg O 0 2.5949802306968195e-07
cycloheximide O 0 2.7572994554248e-07
per O 0 2.700496215535253e-10
ml O 0 1.5020882315752715e-08
. O 0 1.3513301588830018e-09

Using O 0 1.2349136990774667e-10
this O 0 3.894074732807562e-13
approach O 0 5.84946327486513e-11
, O 0 8.620140734029447e-13
an O 0 1.2417471835935584e-13
abnormally O 0 5.452668982997011e-09
spliced O 0 9.202120843099237e-09
transcript O 0 2.3540875915273318e-08
was O 0 2.270271054483075e-10
identified O 0 5.9825482241759875e-12
that O 0 9.337293105046197e-15
contains O 0 7.947928881875399e-13
an O 0 2.0619346751933956e-14
extra O 0 1.4576547434363984e-12
264 O 0 6.317351503026813e-11
bases O 0 1.0494739105526563e-10
upstream O 0 5.1594853389680395e-11
from O 0 1.2861016071563647e-11
exon O 0 1.5485396298586807e-09
32 O 0 5.53497414568227e-10
, O 0 4.3792449050741866e-13
resulting O 0 4.242083680855435e-12
in O 0 6.961898505603026e-12
a O 0 3.5779771506705416e-11
premature O 0 1.3028010670268486e-08
termination O 0 1.116319339189431e-07
codon O 0 2.7014314341045065e-08
27 O 0 2.6881036063741703e-08
bp O 0 1.598372989519703e-08
downstream O 0 6.150323361708843e-09
from O 0 4.876247738927475e-10
the O 0 4.985975521343278e-10
cryptic O 0 2.9571680215667584e-08
splice O 0 7.090047802194022e-07
site O 0 2.239736218712096e-08
. O 0 8.444062671308927e-10

Three O 0 7.144463909369847e-10
other O 0 2.9776279098642222e-12
splice O 0 1.4204514897642184e-08
variants O 0 5.933246671752102e-10
, O 0 1.6739273812557687e-12
including O 0 1.0342491836914935e-12
one O 0 3.345957002133873e-14
derived O 0 8.228393010359381e-13
from O 0 7.035168021057858e-12
the O 0 1.5283033519275513e-11
skipping O 0 2.807884202926658e-10
of O 0 5.721586537887902e-10
exon O 0 3.158701300520761e-09
32 O 0 7.308061378274999e-10
, O 0 1.0407597093170518e-12
were O 0 3.5790944860614182e-12
also O 0 2.629552608643393e-12
identified O 0 6.254347734158117e-11
. O 0 4.124107721992232e-10

These O 0 4.682265131172869e-10
results O 0 2.0245659315687448e-10
indicate O 0 3.342925589122636e-11
the O 0 1.7236869483822082e-12
usefulness O 0 1.4064339970421003e-10
of O 0 1.1230213980972792e-10
cycloheximide O 0 3.670146497825044e-08
treatment O 0 2.6793581242579023e-10
in O 0 1.469398170847458e-12
evaluating O 0 9.002362050258839e-11
the O 0 1.1072138865475534e-11
abnormal O 0 7.987859679259302e-11
processing O 0 1.1592933557569296e-10
of O 0 6.180810724343289e-11
mRNA O 0 3.4382284345990666e-12
due O 0 3.485220792520671e-11
to O 0 1.3170747045071485e-12
splice O 0 2.8938821117208136e-08
- O 0 2.690311584618854e-10
site O 0 1.2961126616417573e-10
mutations O 0 1.0241714594461104e-11
, O 0 3.980220829574027e-13
because O 0 6.501848755571804e-13
( O 0 9.523866070781928e-12
i O 0 9.524307037489521e-11
) O 0 4.846913235351247e-12
aberrant O 0 1.1990548109963584e-08
splicing O 0 2.8309878885579565e-09
often O 0 1.5046343077723678e-12
generates O 0 2.364292789325262e-12
a O 0 2.981236568375123e-12
premature O 0 5.116017609552159e-10
termination O 0 1.329164889263268e-09
codon O 0 3.9778358384978674e-10
, O 0 6.562940729065714e-12
( O 0 2.543050839354244e-12
ii O 0 2.486704715920496e-06
) O 0 2.3209316413197456e-11
transcripts O 0 4.672812181638619e-08
with O 0 3.6992790775070006e-11
premature O 0 4.221622518230106e-08
termination O 0 1.3419730748864822e-07
codons O 0 5.942817349335883e-10
can O 0 2.864183499748374e-13
occur O 0 1.8134994374252589e-12
at O 0 7.93825560840844e-11
low O 0 7.031392135203873e-10
or O 0 1.3471521641272854e-11
undetectable O 0 1.9836605247292027e-08
levels O 0 4.458709009641515e-12
due O 0 3.70340737243513e-12
to O 0 8.458004804347274e-14
nonsense O 0 7.06480846046631e-11
- O 0 1.1460007422192664e-11
mediated O 0 7.932212178762832e-12
mRNA O 0 1.0417050251912419e-12
decay O 0 5.693421081809369e-11
, O 0 2.992987530991281e-14
and O 0 1.334275300923088e-13
( O 0 6.193017561446912e-13
iii O 0 2.3129038595470774e-07
) O 0 4.4066794484265426e-12
the O 0 1.8722798918874295e-12
levels O 0 1.0318931473185522e-11
of O 0 2.238394799375376e-12
these O 0 4.900271100081576e-15
transcripts O 0 6.861829160431654e-11
can O 0 1.602290552299955e-14
be O 0 1.3403964353383979e-14
increased O 0 1.7278072147932505e-13
by O 0 5.122075940472426e-12
cycloheximide O 0 8.668204145578784e-07
. O 0 6.490694648420003e-10

A O 0 8.293604309983493e-07
deletion O 0 5.024489269089827e-09
mutation O 0 2.0428356228840983e-10
in O 0 8.541085200208798e-11
COL17A1 O 1 0.9999486207962036
in O 0 7.442110816491265e-11
five O 0 6.775263076269633e-12
Austrian O 0 1.661030779587236e-08
families O 0 1.6325082561816084e-12
with O 0 1.5785721341199377e-10
generalized O 1 0.9999871253967285
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999635219573975
represents O 0 1.2532380466723225e-08
propagation O 0 3.297511284472421e-06
of O 0 8.236669124528362e-09
an O 0 7.01983436657283e-12
ancestral O 0 2.4481673577270158e-08
allele O 0 2.187016123755825e-10
. O 0 1.216979156337672e-10

Patients O 0 1.394162268297805e-06
with O 0 1.2751996791848796e-08
generalized O 1 1.0
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 1.6816100734118322e-09
a O 0 1.0205269788954308e-11
usually O 0 3.4832056943628897e-12
nonlethal O 0 7.868200100347167e-07
form O 0 2.5277792303768365e-08
of O 0 2.180330739065539e-06
junctional B-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999991655349731
, O 0 3.4102800583468706e-09
have O 0 6.22499577926372e-12
generalized O 0 5.208635300846254e-08
blistering B-Disease 0 0.3829425871372223
, O 0 6.129498046902881e-07
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 9.520585990685504e-07
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 0 2.6990835522155976e-07
and O 0 1.4095598089625128e-05
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 0 1.7130832929979078e-06

Skin B-Disease 1 1.0
fragility I-Disease 0 0.0025149767752736807
in O 0 1.3124223929850132e-09
most O 0 1.6497365539630549e-12
cases O 0 1.3512509253882365e-12
is O 0 4.331936979945885e-15
due O 0 2.038548149729813e-12
to O 0 3.065023549634477e-13
mutations O 0 7.270608811185686e-13
in O 0 3.037339531362232e-13
the O 0 6.405968962751307e-13
gene O 0 6.939185554291627e-13
encoding O 0 1.9142573810804198e-12
type O 0 2.2767736140849593e-08
XVII O 1 1.0
collagen O 0 0.3089459538459778
( O 0 9.557418856331878e-09
COL17A1 O 1 1.0
) O 0 7.112983813062357e-11
. O 0 2.083245208284179e-11

Recently O 0 1.290853361979316e-07
, O 0 2.273069926728155e-10
we O 0 1.4280657819470965e-12
reported O 0 7.43433266336968e-12
five O 0 2.463685939285698e-12
Austrian O 0 1.3922283770284594e-08
families O 0 2.9497825623087115e-12
with O 0 4.8919510803324684e-11
generalized O 1 0.9924004077911377
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999992847442627
who O 0 3.5160652167576245e-09
share O 0 1.2256892722994905e-10
the O 0 2.5379992552032604e-10
same O 0 2.8225108361645823e-10
COL17A1 O 1 1.0
mutation O 0 1.313397213209555e-08
. O 0 2.8259261597440855e-10

Affected O 0 2.1077084966236725e-08
individuals O 0 2.6653128488984823e-12
in O 0 5.602478116845111e-12
three O 0 2.3961993413784688e-12
families O 0 6.80504067538442e-15
are O 0 6.6326601532557504e-15
homozygous O 0 3.933401347688825e-12
for O 0 7.269503141810185e-12
4003delTC O 0 4.220575888780331e-08
, O 0 1.646031748403498e-11
whereas O 0 9.086732234708794e-12
those O 0 2.8283807045580145e-13
in O 0 4.751522526130758e-13
two O 0 1.8459821345129246e-13
others O 0 7.565877178233871e-13
are O 0 4.4955779008280794e-14
compound O 0 1.067042787461503e-09
heterozygotes O 0 6.443617905915744e-08
. O 0 5.592962981637584e-09

To O 0 4.802626629718532e-10
determine O 0 3.174021601104471e-10
if O 0 6.600409238263771e-13
the O 0 1.1461816738778108e-12
occurrence O 0 5.7499404543248644e-11
of O 0 1.233049634619121e-10
4003delTC O 0 2.7783770839562294e-09
in O 0 1.393750674767713e-12
these O 0 6.862813404584847e-14
unrelated O 0 2.1408111394727314e-11
families O 0 1.3179202466764156e-14
signifies O 0 5.518994549563727e-13
propagation O 0 1.4399164083300775e-09
of O 0 3.6055856217354076e-11
an O 0 6.016390998678928e-14
ancestral O 0 1.2358797318867687e-10
allele O 0 2.03024055900336e-12
or O 0 6.292154731274424e-12
a O 0 5.973133099246297e-11
mutational O 0 9.450307061342755e-07
hot O 0 3.693577309604734e-05
spot O 0 4.1281975882156985e-07
, O 0 2.0218712121211624e-11
haplotypes O 0 9.341516449268283e-11
were O 0 8.701468365290843e-12
determined O 0 1.0672044845061457e-11
for O 0 2.0921838480431054e-12
polymorphisms O 0 8.652802918618363e-10
both O 0 2.3085870021199995e-11
within O 0 8.702456533171699e-10
and O 0 5.188501850383886e-10
flanking O 0 9.119670721702278e-05
COL17A1 O 1 1.0
. O 0 3.589890340549573e-08

Five O 0 8.458449229920006e-08
intragenic O 0 5.450890057545621e-06
polymorphisms O 0 5.211474363164825e-09
were O 0 4.005462975187335e-11
chosen O 0 2.6294584565267343e-11
based O 0 7.955185815644583e-11
on O 0 1.8067627394202646e-09
their O 0 9.002349421471934e-10
informativeness O 0 1.748164140735753e-05
. O 0 9.80019843055402e-10

One O 0 3.9772213300537373e-10
of O 0 3.2621952361644446e-10
these O 0 4.2642037362088103e-13
, O 0 2.6754371829952606e-13
not O 0 2.4992039145653455e-14
previously O 0 8.203355529590173e-12
reported O 0 7.721789353765107e-12
, O 0 1.894747162986543e-12
was O 0 3.817203775291489e-10
2988 O 0 3.1145998491410865e-07
A O 0 1.4028294081924741e-08
or O 0 9.03399438589858e-11
C O 0 6.988892096160271e-07
that O 0 5.557042456402761e-13
introduces O 0 2.5344764481571858e-11
a O 0 4.435964941727766e-13
new O 0 2.8150173706810444e-13
restriction O 0 3.2109471331809303e-13
site O 0 1.5707444026014095e-11
for O 0 9.238364196903492e-13
Eco0109 O 0 4.3700109131350473e-07
I O 0 7.840201305953087e-07
. O 0 1.3377028373895428e-09

All O 0 6.094167837034092e-09
the O 0 1.1072889272156772e-09
4003delTC O 0 8.133169160373654e-08
alleles O 0 1.1437994648644256e-11
showed O 0 1.818574804635098e-11
the O 0 5.580132710070185e-13
same O 0 7.610770602064706e-14
haplotype O 0 6.672283385522615e-12
for O 0 2.0188173778089985e-13
these O 0 4.119557613872088e-13
five O 0 4.50622742245721e-12
polymorphic O 0 2.841444857182296e-09
markers O 0 2.3419062245011446e-08
. O 0 5.358105625852261e-10

Fourteen O 0 1.276450007026142e-06
microsatellite O 0 9.76522116502565e-08
polymorphisms O 0 8.52610337886972e-09
were O 0 8.87272200156275e-11
selected O 0 8.254747579927724e-11
based O 0 4.568688483086447e-11
on O 0 8.240085697108768e-11
their O 0 4.974798784723733e-12
high O 0 2.7200106056390894e-10
heterozygosity O 0 1.6620386844579116e-08
and O 0 9.540539365471279e-12
their O 0 1.9455526599487794e-12
location O 0 8.763967329628031e-11
within O 0 1.0958146889894493e-10
10q23 O 0 9.05178936250195e-08
- O 0 3.3304946356338405e-08
q25 O 0 8.682633279022411e-07
near O 0 1.68718861459638e-06
COL17A1 O 1 0.9997170567512512
. O 0 6.097178761876876e-09

Three O 0 6.192554247164139e-10
families O 0 2.0771856457102444e-12
shared O 0 5.909515238267105e-11
microsatellite O 0 1.718605346923141e-08
polymorphisms O 0 1.552526995851622e-08
covering O 0 6.065458251214295e-07
at O 0 1.2543548422172535e-08
most O 0 1.0976150544017571e-11
19 O 0 5.510157330412824e-10
cM O 0 3.815442406462921e-10
, O 0 7.849371109688863e-13
whereas O 0 1.3334923443242275e-12
the O 0 1.5963132508553524e-12
others O 0 1.1426781829776411e-12
shared O 0 1.0450742918624578e-12
smaller O 0 2.7593446191159776e-12
regions O 0 2.4854741528801405e-11
consistent O 0 7.083729158807728e-10
with O 0 3.927898804823027e-12
cross O 0 2.524241482504408e-09
- O 0 6.829555254661557e-10
over O 0 2.873684580226299e-12
events O 0 2.8814713744391984e-13
during O 0 1.2555227040314532e-12
passage O 0 3.7400339986462527e-13
of O 0 1.547818812138932e-13
this O 0 7.240553041368823e-16
mutation O 0 2.9347729894055666e-14
through O 0 1.209641382286103e-13
several O 0 8.343318440642844e-13
generations O 0 8.744381607694862e-11
. O 0 2.8201416896189713e-11

These O 0 9.164719538823363e-10
results O 0 5.777834322095998e-10
indicate O 0 5.337009653660907e-11
that O 0 1.2548661654059046e-13
4003delTC O 0 6.735253688106013e-09
occurs O 0 2.11828775006917e-12
on O 0 4.500747430996599e-12
a O 0 4.928283801018674e-13
single O 0 3.94677866777382e-12
ancestral O 0 7.399323515011602e-11
allele O 0 1.1948128033831273e-12
. O 0 1.2168943153492706e-12
. O 0 6.6724396841078e-11

The O 0 3.7060786439724325e-08
haptoglobin O 0 3.483782165858429e-06
- O 0 1.5068782488469878e-07
gene O 0 8.708513077326785e-11
deletion O 0 1.0711510844974015e-10
responsible O 0 1.2164784735091416e-09
for O 0 1.7542090002820032e-10
anhaptoglobinemia B-Disease 0 0.000370278226910159
. O 0 8.989622379829143e-09

We O 0 3.8996850193484534e-10
have O 0 8.254608476788994e-14
found O 0 2.8772313307931507e-13
an O 0 2.3379034727713565e-15
allelic O 0 3.117068270164225e-10
deletion O 0 2.657270237182985e-10
of O 0 2.315349467707506e-09
the O 0 1.760466911138181e-10
haptoglobin O 0 6.66080168798544e-08
( O 0 4.399023159629145e-11
Hp O 0 1.3618923766500757e-09
) O 0 1.0276447227897112e-11
gene O 0 1.8101273951964814e-11
from O 0 4.213425615351429e-12
an O 0 5.710966503305256e-14
individual O 0 2.74668851031612e-13
with O 0 3.2895922097431196e-11
anhaptoglobinemia B-Disease 0 0.0004885407397523522
. O 0 2.960383271854994e-09

The O 0 3.4364454393198685e-08
Hp O 0 1.8231236964538766e-08
gene O 0 2.40468089884871e-10
cluster O 0 2.510016194889886e-09
consists O 0 1.0862172966641381e-10
of O 0 5.397511257387855e-11
coding O 0 2.4518051477961933e-10
regions O 0 1.0549748574728568e-10
of O 0 1.004047178732037e-09
the O 0 6.461700619020405e-11
alpha O 0 1.7686453690490822e-10
chain O 0 2.8498384208042182e-11
and O 0 4.844248916932581e-13
beta O 0 3.421358682476061e-11
chain O 0 4.659544278196037e-11
of O 0 2.3673084326159e-11
the O 0 2.6159107432283113e-12
haptoglobin O 0 3.0216520396919577e-09
gene O 0 3.550429264823074e-12
( O 0 7.262746448081364e-14
Hp O 0 1.3189280397007952e-11
) O 0 2.239961146253966e-13
and O 0 4.4940882070430843e-13
of O 0 3.8069065261270296e-11
the O 0 1.2463184130562244e-11
alpha O 0 8.535613188476177e-11
chain O 0 3.11817273390691e-11
and O 0 7.384245125086064e-13
beta O 0 5.38199866617628e-11
chain O 0 7.982468852585356e-11
of O 0 2.403317996002574e-11
the O 0 6.987400241742492e-12
haptoglobin O 0 3.6085683330355778e-09
- O 0 1.9252369143352155e-10
related O 0 1.2116845027332346e-10
gene O 0 4.956179130294336e-12
( O 0 7.217937185444168e-13
Hpr O 0 4.7726040897089206e-09
) O 0 1.4800616244745046e-12
, O 0 1.8258926814083976e-13
in O 0 8.946225921527273e-13
tandem O 0 5.781185530295829e-10
from O 0 1.4552281601964978e-10
the O 0 2.667706056058705e-10
5 O 0 4.773842654515192e-09
side O 0 4.06635614069728e-09
. O 0 3.310838270209615e-10

Southern O 0 1.034424826684699e-06
blot O 0 1.5487050859519513e-06
and O 0 2.8160365705964807e-10
PCR O 0 2.4527944120222855e-08
analyses O 0 5.18262655013757e-10
have O 0 1.1351397523774037e-13
indicated O 0 7.002833642827389e-13
that O 0 1.3692653510598979e-14
the O 0 3.2720424677015747e-13
individual O 0 3.277312435648848e-14
with O 0 2.2110121350969736e-13
anhaptoglobinemia B-Disease 0 1.3281980670853955e-07
was O 0 2.8207777780231424e-10
homozygous O 0 1.1941527627845616e-11
for O 0 8.409332800420055e-13
the O 0 9.21095751754697e-12
gene O 0 1.6570308493391028e-12
deletion O 0 1.8930495192248653e-12
and O 0 3.60929737703089e-13
that O 0 1.0075667818793769e-14
the O 0 2.3702799705621613e-12
gene O 0 9.967756871634426e-13
deletion O 0 2.2610726225363864e-12
was O 0 1.653792207345628e-11
included O 0 1.51891971222895e-11
at O 0 2.6429591154508714e-11
least O 0 4.8633081069227035e-14
from O 0 1.958991345876737e-12
the O 0 2.5557484947813514e-11
promoter O 0 8.921979883780295e-07
region O 0 4.901136829715824e-09
of O 0 1.397927995583359e-08
Hp O 0 7.738194973683221e-09
to O 0 6.890712445084546e-10
Hpr O 0 3.4191208442280185e-07
alpha O 0 1.1193138638176947e-09
but O 0 3.07558232354177e-13
not O 0 1.92610328592557e-14
to O 0 3.819382960942863e-13
Hpr O 0 2.691736256110744e-08
beta O 0 4.614962190174765e-09
( O 0 5.667839808598529e-11
Hpdel O 0 2.9925538456154754e-06
) O 0 4.9835580107071564e-11
. O 0 9.177904963797445e-11

In O 0 7.257056622300695e-10
addition O 0 2.826382704268493e-11
, O 0 5.972879742882631e-12
we O 0 1.884115015697227e-13
found O 0 3.6008259633561746e-13
seven O 0 5.649054900074002e-13
individuals O 0 3.8844418506149125e-15
with O 0 6.295044238484315e-13
hypohaptoglobinemia B-Disease 0 9.149497515181793e-08
in O 0 1.1485500051033881e-11
three O 0 7.515781074753092e-13
families O 0 1.6451222979371738e-14
, O 0 1.3684044945349444e-13
and O 0 1.0517613256016967e-12
the O 0 3.389434913292355e-11
genotypes O 0 1.114359049481095e-09
of O 0 1.6518172385460161e-09
six O 0 1.1213326794878853e-10
of O 0 1.1264070787220248e-09
the O 0 1.1896453266935225e-10
seven O 0 2.3295042977933278e-11
individuals O 0 1.6138320538326527e-14
were O 0 6.194213544863381e-12
found O 0 3.0363331206956223e-12
to O 0 1.179357718254781e-12
be O 0 2.6049879267575626e-11
Hp2 O 0 0.0005621658056043088
/ O 0 1.231123496836517e-05
Hpdel O 0 0.0005813847528770566
. O 0 1.1891156503907041e-08

The O 0 8.43067660127872e-09
phenotypes O 0 1.9286604313606404e-08
and O 0 1.0845239289958286e-10
genotypes O 0 8.556220731925634e-10
in O 0 7.284896644255134e-12
one O 0 4.91118701696075e-13
of O 0 1.2623332934502685e-11
these O 0 7.449285464736569e-14
three O 0 5.390859742111787e-13
families O 0 1.128348174443683e-14
showed O 0 1.786671288347974e-12
the O 0 1.1588941611906378e-12
father O 0 1.3819479414978186e-11
to O 0 4.954825070201119e-13
be O 0 6.398800760087919e-13
hypohaptoglobinemic B-Disease 0 5.010213044442935e-08
( O 0 3.258201347611234e-11
Hp2 O 0 4.7207711872943037e-07
) O 0 2.9352798403686764e-12
and O 0 2.013236105602445e-11
Hp2 O 0 6.747227416781243e-06
/ O 0 2.601828974491127e-08
Hpdel O 0 1.4491660067506018e-06
, O 0 7.38216432427663e-12
the O 0 6.9198917429513784e-12
mother O 0 2.1885453518888376e-12
to O 0 3.9304895601242895e-13
be O 0 4.69492066751398e-13
Hp2 O 0 1.2628991896690422e-07
- O 0 2.395508236219257e-09
1 O 0 1.321454334846095e-10
and O 0 2.4574630524965002e-12
Hp1 O 0 7.769801868562354e-07
/ O 0 3.476043008987517e-09
Hp2 O 0 1.9134296280753915e-07
, O 0 1.8230816162256858e-12
one O 0 4.8933625299571806e-14
of O 0 7.58970056941033e-12
the O 0 1.9768201832415233e-12
two O 0 3.0878549500332197e-13
children O 0 7.741305155500172e-14
to O 0 1.3383661312451473e-13
be O 0 1.1898210281607868e-12
hypohaptoglobinemic B-Disease 0 1.4345543775107217e-07
( O 0 4.1496233532667404e-11
Hp2 O 0 9.840288157647592e-07
) O 0 4.873174346692322e-12
and O 0 1.0986937921952933e-11
Hp2 O 0 7.324546004383592e-06
/ O 0 2.598882709037298e-08
Hpdel O 0 2.0776194560312433e-06
, O 0 6.083578519416877e-12
and O 0 7.487122900828869e-13
the O 0 2.273067801691897e-12
other O 0 6.083668182936541e-13
child O 0 9.134483967832008e-12
to O 0 1.0080978207153285e-13
be O 0 3.845948353623646e-13
Hp1 O 0 2.648929182669235e-07
and O 0 3.987840613284277e-10
Hp1 O 0 7.477147300960496e-05
/ O 0 1.5064341596371378e-07
Hpdel O 0 6.634202691202518e-06
, O 0 2.6983890816234535e-11
showing O 0 9.346756008055124e-11
an O 0 9.220140655737813e-14
anomalous O 0 2.704435564382379e-09
inheritance O 0 1.5591735680331453e-09
of O 0 2.061068755665474e-07
Hp O 0 2.142407673488833e-08
phenotypes O 0 1.7719933964599477e-08
in O 0 1.6601076069377996e-10
the O 0 1.8481832730898873e-10
child O 0 3.03234853893386e-10
with O 0 1.2448454593527725e-11
Hp1 O 0 0.00018067251949105412
. O 0 5.277906556244716e-09

The O 0 5.7063893166287016e-08
Hp2 O 0 0.0005129522178322077
/ O 0 5.772728854935849e-07
Hpdel O 0 1.2936437769894837e-06
individuals O 0 8.137742866717868e-13
had O 0 3.2241186716935877e-12
an O 0 1.3887320655416036e-13
extremely O 0 4.3781301500844805e-11
low O 0 1.044776931635738e-09
level O 0 2.6517463225239624e-10
of O 0 1.6034737426728896e-10
Hp O 0 1.1904532914996935e-10
( O 0 1.5148885834995185e-12
mean O 0 1.1621480687507013e-12
+ O 0 7.367447580827746e-13
/ O 0 2.17152736764481e-11
- O 0 4.7145322368269404e-11
SD O 0 2.5627471700317983e-08
= O 0 3.5829056735381393e-12
0 O 0 8.048029473753382e-13
. O 0 1.1079473012057684e-14
049 O 0 2.3007287741627636e-10
+ O 0 1.2740763305485459e-12
/ O 0 1.7256189532854904e-11
- O 0 1.3025555460621785e-11
0 O 0 1.4843871574618528e-12
. O 0 1.6606582374425333e-14
043 O 0 5.013104931173018e-10
mg O 0 5.515025103264293e-10
/ O 0 7.80685655010771e-11
ml O 0 4.855990609620164e-12
; O 0 1.1530376263155229e-13
n O 0 3.801975552962522e-13
= O 0 3.909099606513866e-13
6 O 0 1.4103929829589745e-11
) O 0 5.1820793851495555e-15
, O 0 1.999165679801942e-15
compared O 0 4.472688444791132e-15
with O 0 1.814977518388547e-15
the O 0 1.006809110908058e-12
level O 0 2.6816165607512765e-11
( O 0 4.265039249507982e-14
1 O 0 1.3004769787092196e-12
. O 0 1.2616670098800683e-14
64 O 0 1.3512535274734505e-12
+ O 0 1.3230740017033255e-13
/ O 0 9.368097443618328e-12
- O 0 1.6581793230163733e-11
1 O 0 5.57224405506318e-12
. O 0 5.383869145316779e-14
07 O 0 8.115461080926423e-11
mg O 0 1.7323603662688924e-10
/ O 0 2.960402756269076e-11
ml O 0 3.667417498159908e-12
) O 0 1.534422312686912e-15
obtained O 0 1.0785626271226853e-13
from O 0 4.698802111291478e-12
52 O 0 1.7548315578430618e-10
healthy O 0 5.1476503615255353e-11
volunteers O 0 5.4151651912581755e-11
having O 0 1.6105932559851155e-11
phenotype O 0 2.6950058851227254e-10
Hp2 O 0 3.297959665360395e-07
, O 0 1.613299077662944e-11
whereas O 0 8.837233028691216e-12
the O 0 6.522918923751453e-12
serum O 0 7.413421959645561e-11
Hp O 0 1.3379700125604188e-10
level O 0 2.2800610011142197e-10
of O 0 3.983368496163209e-11
an O 0 1.2218562919525267e-14
individual O 0 4.151231902714894e-14
with O 0 1.4006983507092174e-12
Hp1 O 0 4.73582731501665e-05
/ O 0 9.290957336816064e-08
Hpdel O 0 5.120121386426035e-06
was O 0 3.917392632502015e-09
0 O 0 1.6324733786987622e-09
. O 0 2.2716342695794367e-11

50 O 0 2.573381330250868e-08
mg O 0 5.683046921944879e-08
/ O 0 6.574264244108008e-09
ml O 0 2.1975953001796e-10
, O 0 4.738308812153591e-13
which O 0 3.0638936754454754e-14
was O 0 3.7454258444702404e-12
approximately O 0 1.681526418757448e-13
half O 0 2.106308698420975e-13
the O 0 3.456387465735483e-13
level O 0 6.3740276078083635e-12
of O 0 7.138708461168486e-12
Hp O 0 2.4300153902978572e-11
in O 0 1.6037574046556813e-11
control O 0 4.11402800715166e-10
sera O 0 1.1362777385670597e-08
from O 0 1.4689142263657473e-11
the O 0 2.0265235670113846e-11
Hp1 O 0 1.2351155476153508e-07
phenotype O 0 9.695499958439768e-11
( O 0 2.4167529956431455e-12
1 O 0 2.2230873392148354e-11
. O 0 3.461282367493712e-13
26 O 0 6.107159222779046e-11
+ O 0 6.592633882383792e-13
/ O 0 1.6369740632460328e-11
- O 0 1.2235395856208253e-11
0 O 0 8.221082235110311e-13
. O 0 2.512178172328324e-15
33 O 0 1.0937629925031334e-12
mg O 0 4.4816123034863153e-11
/ O 0 1.9008400756193033e-11
ml O 0 2.0703939864613607e-12
; O 0 1.490372224504516e-13
n O 0 7.109164602489559e-13
= O 0 1.9840273087629035e-12
9 O 0 1.1075607792010445e-10
) O 0 1.2672484318420468e-13
, O 0 2.1089620121875902e-13
showing O 0 9.934016283186242e-12
a O 0 3.31542887761771e-12
gene O 0 4.0394815964406305e-11
- O 0 4.815008947112176e-10
dosage O 0 1.7546458508377327e-08
effect O 0 1.8031204307433768e-09
. O 0 1.6134105162990409e-10

The O 0 2.8864717283028085e-09
other O 0 9.716543541982148e-12
allele O 0 4.634087384658425e-12
( O 0 1.6035853200868644e-12
Hp2 O 0 8.736142120824297e-08
) O 0 5.213671291567912e-13
of O 0 2.3040035157517735e-11
individuals O 0 7.176596759895203e-15
with O 0 8.573398067868165e-12
Hp2 O 1 0.9998866319656372
/ O 0 1.78939171746606e-06
Hpdel O 0 0.0001118325162678957
was O 0 2.9047915184321482e-09
found O 0 1.1634389198572626e-12
to O 0 1.2300317014934947e-13
have O 0 1.7872352835418374e-14
, O 0 7.266751219855982e-14
in O 0 1.5612057274131536e-13
all O 0 7.37343617152747e-13
exons O 0 1.4730112962713093e-10
, O 0 3.6476030529364323e-13
no O 0 3.776030594974944e-13
mutation O 0 9.032244895589014e-13
, O 0 8.329607484444321e-14
by O 0 3.194758368442463e-13
DNA O 0 2.060981607598933e-08
sequencing O 0 1.7270234131672169e-09
. O 0 9.671950740308688e-11

On O 0 1.4288152883068506e-08
the O 0 2.5513258172793485e-11
basis O 0 7.126953974895267e-12
of O 0 1.8173542531974007e-11
the O 0 5.068128534034544e-13
present O 0 1.9946734151551904e-13
study O 0 2.4897512979245306e-13
, O 0 3.344846711346612e-14
the O 0 4.762837260002817e-13
mechanism O 0 1.5528918428930893e-11
of O 0 1.7263274143530793e-10
anhaptoglobinemia B-Disease 0 1.340280846306996e-07
and O 0 1.938526769662552e-11
the O 0 1.8290768205586616e-11
mechanism O 0 8.661864281389597e-11
of O 0 5.378294337665679e-11
anomalous O 0 3.3247935515845484e-09
inheritance O 0 6.919622097534273e-10
of O 0 3.61718370811559e-08
Hp O 0 1.1219285056540684e-08
phenotypes O 0 3.2790417492378765e-08
were O 0 7.644451183175249e-10
well O 0 2.218479844273702e-10
explained O 0 2.4182504887448886e-09
. O 0 2.9404548240741235e-10

However O 0 1.8117284339425055e-09
, O 0 1.838899345296685e-11
the O 0 6.038711631434213e-12
mechanism O 0 6.046381728630479e-10
of O 0 1.08033548773534e-09
hypohaptoglobinemia B-Disease 0 5.480731124407612e-05
remains O 0 5.933716806794109e-08
unknown O 0 5.599359198527054e-08

ATM O 0 0.00022460537729784846
mutations O 0 3.406582749221343e-08
and O 0 6.401618124485253e-10
phenotypes O 0 8.870772205682442e-08
in O 0 1.482746014858094e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 1.0052653848235948e-10
in O 0 4.375792436728254e-11
the O 0 7.2412624507745e-11
British O 0 2.2163282320519784e-09
Isles O 0 8.944915919073537e-08
: O 0 1.6496548051192494e-12
expression O 0 3.739943250924416e-12
of O 0 8.997263351018248e-11
mutant O 0 4.48345909009884e-11
ATM O 0 3.563686590268844e-08
and O 0 6.157708891396663e-12
the O 0 4.7005589524917735e-12
risk O 0 1.3741651913590225e-11
of O 0 4.015518140221275e-09
leukemia B-Disease 1 1.0
, O 0 1.6657587309509836e-07
lymphoma B-Disease 1 1.0
, O 0 2.993133989548369e-07
and O 0 0.00015647678810637444
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999966621398926
. O 0 8.720888011737316e-09

We O 0 1.487494988294813e-10
report O 0 7.165937981890025e-12
the O 0 2.952743301601335e-12
spectrum O 0 5.17568210511854e-10
of O 0 9.91388637849866e-10
59 O 0 5.0437214405008035e-09
ATM O 0 1.1032544762201724e-06
mutations O 0 4.904968653463015e-10
observed O 0 6.982397993127165e-10
in O 0 1.2925706061039932e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.0885246410907712e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.9834722406186778e-11
patients O 0 5.985055658540295e-13
in O 0 1.5759973621271017e-13
the O 0 1.1415154411997808e-11
British O 0 5.8492237720031426e-09
Isles O 0 1.4381448636413552e-06
. O 0 4.2423956014836506e-10

Of O 0 1.1947466873607482e-06
51 O 0 6.815923114800171e-08
ATM O 0 3.070232196478173e-06
mutations O 0 1.9240217752347633e-10
identified O 0 1.7015831452193986e-11
in O 0 3.1860584049497875e-12
families O 0 1.2862867509403492e-13
native O 0 2.526988384168871e-12
to O 0 5.082649253730642e-13
the O 0 2.1326886437411652e-11
British O 0 1.3877101689985238e-09
Isles O 0 8.941641027604419e-08
, O 0 1.3354325457959337e-11
11 O 0 2.2437532387620251e-10
were O 0 2.466047505089719e-11
founder O 0 3.5120102381824836e-09
mutations O 0 2.7518567286000106e-11
, O 0 3.132501636554652e-12
and O 0 7.873771946942387e-12
2 O 0 6.912537764414139e-10
of O 0 1.8490929620806895e-10
these O 0 2.1841957496132602e-12
11 O 0 3.0352015345513905e-10
conferred O 0 9.940717138334776e-10
a O 0 4.421946489530093e-11
milder O 0 2.939661669643101e-08
clinical O 0 2.2938779764558603e-08
phenotype O 0 3.0455336169632474e-11
with O 0 2.8449638478367234e-13
respect O 0 3.569468505493223e-12
to O 0 6.143302880290413e-12
both O 0 3.7715017220385505e-10
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 0 6.329044399677741e-09
cellular O 0 3.0381733040485415e-07
features O 0 2.0393105870653017e-08
. O 0 4.5608289367393695e-10

We O 0 3.9645881022565277e-10
report O 0 2.8465788753928578e-11
, O 0 5.701902708668549e-13
in O 0 1.0274678243632485e-12
two O 0 2.163258504619958e-12
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.5338630080223083
T I-Disease 1 1.0
families O 0 2.5514315053071224e-12
, O 0 1.086563835867721e-13
an O 0 1.943610609912369e-14
ATM O 0 1.501710755746899e-07
mutation O 0 4.45769948731467e-11
( O 0 2.4495355830517207e-12
7271T O 0 5.716909612374366e-09
- O 0 2.0398231992402316e-09
- O 0 1.2789355130493618e-09
> O 0 2.1398040284115183e-10
G O 0 5.99661120759265e-08
) O 0 3.114092371556826e-13
that O 0 4.8230483768298225e-15
may O 0 7.145035973467329e-14
be O 0 4.632924632038543e-14
associated O 0 3.793900523602067e-12
with O 0 7.345723150847111e-14
an O 0 3.288370281368663e-14
increased O 0 1.1771104924118703e-12
risk O 0 3.050959762607164e-10
of O 0 4.3734797117167545e-08
breast B-Disease 1 0.9186847805976868
cancer I-Disease 0 2.0598655225967377e-08
in O 0 7.906353523268184e-12
both O 0 2.1315976327790365e-12
homozygotes O 0 1.1987842940541782e-09
and O 0 6.730903161222823e-12
heterozygotes O 0 2.8592916923031453e-10
( O 0 1.753223976587448e-12
relative O 0 1.581413298923362e-11
risk O 0 1.3797987058472572e-11
12 O 0 5.513876161211684e-11
. O 0 1.3776330879018694e-13
7 O 0 6.508853178655016e-11
; O 0 1.0378536138139216e-12
P O 0 1.530732096632903e-09
= O 0 9.660237887398893e-12
. O 0 4.941028055455154e-13
0025 O 0 4.508738271624679e-08
) O 0 4.864210705231298e-13
, O 0 5.675598473186064e-14
although O 0 7.119338349100349e-14
there O 0 2.7714416590655933e-14
is O 0 1.512935183221615e-14
a O 0 6.955802578888226e-13
less O 0 3.020139346943118e-11
severe O 1 0.999913215637207
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 9.045425519715877e-11
in O 0 1.6427713410514105e-13
terms O 0 4.773869017107857e-13
of O 0 1.7049252634682155e-12
the O 0 6.409669073715457e-14
degree O 0 1.528671494943623e-10
of O 0 7.938869117651848e-09
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 0 1.265717752829687e-08

This O 0 2.210543276204291e-10
mutation O 0 6.195281093690497e-11
( O 0 7.507031454800916e-12
7271T O 0 5.122737789520215e-09
- O 0 1.0268698114046515e-09
- O 0 2.3971113982668157e-10
> O 0 3.368084283694728e-11
G O 0 8.024778175297342e-09
) O 0 7.510490032626091e-14
also O 0 1.9889877319077343e-15
allows O 0 1.7684552925517887e-15
expression O 0 1.0204831364700809e-13
of O 0 1.847969693935525e-12
full O 0 2.4884376243622386e-12
- O 0 8.517344815550665e-12
length O 0 4.888980388063902e-13
ATM O 0 3.1224729468704027e-09
protein O 0 7.91425865814821e-12
at O 0 1.8905460530405094e-11
a O 0 1.5575087335302495e-13
level O 0 2.1509196333757696e-12
comparable O 0 3.7174145706142525e-11
with O 0 6.514519555311099e-14
that O 0 1.0182621822010622e-14
in O 0 1.0682018420846151e-12
unaffected O 0 3.92602977905554e-10
individuals O 0 2.3552042477739676e-13
. O 0 3.369440143563551e-11

In O 0 1.3486419758734769e-09
addition O 0 4.3266449450962696e-11
, O 0 1.3096797951694938e-12
we O 0 1.4171808190399475e-14
have O 0 2.5648066586818384e-15
studied O 0 5.950039072555313e-11
18 O 0 6.495065596467953e-10
A B-Disease 1 1.0
- I-Disease 1 0.9999914169311523
T I-Disease 1 1.0
patients O 0 6.510619821042951e-10
, O 0 3.855158108977824e-13
in O 0 2.3108888392263383e-13
15 O 0 3.958297665335175e-12
families O 0 7.335834718814275e-15
, O 0 1.137059738899604e-13
who O 0 2.399024175928771e-13
developed O 0 9.039797532750526e-08
leukemia B-Disease 1 1.0
, O 0 2.985075298056472e-07
lymphoma B-Disease 1 1.0
, O 0 1.3561158596075984e-07
preleukemic O 1 1.0
T O 1 1.0
- O 0 1.5032229384814855e-05
cell O 0 1.3270246199681424e-06
proliferation O 1 0.825078010559082
, O 0 5.320240081818639e-11
or O 0 1.3589537672942242e-07
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 2.895292339211153e-10
mostly O 0 2.6686704061862354e-12
in O 0 9.659132868544695e-12
childhood O 0 2.6293128030374646e-07
. O 0 2.6437066424911393e-10

A O 0 2.0006432350783143e-06
wide O 0 1.848114550284663e-08
variety O 0 2.0708632586519116e-09
of O 0 3.948885218818532e-09
ATM O 0 4.860197805101052e-06
mutation O 0 4.98041226315582e-11
types O 0 3.388079261590349e-10
, O 0 2.9432294275377746e-12
including O 0 9.35440266913723e-12
missense O 0 9.874072226523367e-09
mutations O 0 5.707700423407402e-10
and O 0 2.807236110236033e-10
in O 0 5.990741236416852e-10
- O 0 1.314928699258644e-08
frame O 0 9.295576530732319e-10
deletions O 0 3.700516004734311e-10
, O 0 4.680000744577972e-12
were O 0 9.306584149160191e-12
seen O 0 2.665872297219485e-12
in O 0 5.8699659716277e-13
these O 0 1.2620340970187494e-12
patients O 0 6.938371405196264e-11
. O 0 1.4512395452026539e-10

We O 0 3.618111643621802e-10
also O 0 1.9096221999526097e-12
show O 0 6.903251299587854e-13
that O 0 8.229169875097284e-15
25 O 0 5.425964040052522e-13
% O 0 1.3786103267537757e-14
of O 0 1.6207001019008516e-12
all O 0 7.330908449731943e-12
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 6.296315135934094e-10
carried O 0 5.1966798919611534e-11
in O 0 2.1398927768645493e-11
- O 0 2.5663118297103438e-09
frame O 0 8.729571510102119e-10
deletions O 0 6.748881453688682e-10
or O 0 4.598371128317069e-10
missense O 0 1.298543850225542e-08
mutations O 0 3.6718655893608343e-10
, O 0 3.716831530053977e-12
many O 0 8.48502108960654e-14
of O 0 1.3679857593928979e-11
which O 0 2.818574095907883e-13
were O 0 4.807845961629642e-12
also O 0 1.3865326259094451e-13
associated O 0 3.0511778000008594e-12
with O 0 3.335254164862911e-13
expression O 0 1.0730461658114976e-11
of O 0 3.0944161122370417e-10
mutant O 0 7.42456263136404e-10
ATM O 0 1.4293489130068338e-06
protein O 0 1.2835868368199499e-08
. O 0 6.163989874075071e-10

The O 0 6.988040013311547e-08
DMPK O 1 0.9999998807907104
gene O 0 7.017317926738542e-08
of O 0 2.0733777361670036e-08
severely O 1 0.9999998807907104
affected O 1 0.9999998807907104
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 5.034534842707217e-05
is O 0 4.5423522582188625e-11
hypermethylated O 0 4.690346486313501e-06
proximal O 0 1.2778710356542433e-07
to O 0 1.3817694211049059e-10
the O 0 5.148772519447675e-10
largely O 0 3.684170191142755e-10
expanded O 0 4.3867756649440537e-10
CTG O 0 3.0386096113943495e-05
repeat O 0 2.7864823337608868e-08
. O 0 6.499490390332596e-10

Using O 0 4.4090571194033146e-09
methylation O 0 3.225422773311948e-08
- O 0 2.5183362062364267e-09
sensitive O 0 7.706038585020281e-10
restriction O 0 3.4923192809843684e-12
enzymes O 0 1.2257914301649908e-11
, O 0 8.956332854179183e-13
we O 0 4.64518831386207e-14
characterized O 0 2.5742938596778897e-12
the O 0 1.2111517301224839e-12
methylation O 0 1.56113677540759e-10
pattern O 0 5.317430176732252e-11
on O 0 1.3597159856382213e-11
the O 0 3.0215897058732955e-12
5 O 0 3.162767617248541e-11
side O 0 3.1913572479114194e-11
of O 0 4.2109368075804454e-11
the O 0 6.921585526953322e-11
CTG O 0 2.8253684831724968e-06
repeat O 0 3.681325522197909e-10
in O 0 8.35212714961342e-12
the O 0 3.624954850178774e-11
DMPK O 0 0.12151950597763062
gene O 0 7.917735217466415e-11
of O 0 2.3114024583215098e-11
normal O 0 6.060623791021014e-12
individuals O 0 3.824438036631418e-15
and O 0 1.231154176002669e-12
of O 0 5.803181268859703e-10
patients O 0 1.6480651565675686e-10
affected O 0 2.0908266229469064e-09
with O 0 4.9134573743003784e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 4.723157420727375e-10
showing O 0 9.80406381079213e-11
expansions O 0 1.5447068624219185e-10
of O 0 5.120889268184214e-10
the O 0 6.162976379231466e-11
repetitive O 0 6.933340728210169e-07
sequence O 0 1.3765924511410788e-10
. O 0 4.5110110091783895e-11

The O 0 6.245320349762551e-08
gene O 0 1.063316656946256e-09
segment O 0 1.9081351776417677e-10
analyzed O 0 4.041701001655795e-11
corresponds O 0 5.049277402441321e-12
to O 0 8.632414986824155e-13
the O 0 3.683505757356986e-12
genomic O 0 5.863630136992981e-10
SacI O 0 5.660425586029305e-07
- O 0 1.903254664981091e-09
HindIII O 0 5.510047529355688e-08
fragment O 0 4.1881823009681796e-10
carrying O 0 4.1408573792089953e-10
exons O 0 7.351572683944596e-09
11 O 0 2.971267010209999e-09
- O 0 2.5277973048076774e-09
15 O 0 7.71408215083369e-10
. O 0 1.7411013603085834e-11

There O 0 1.909329222504752e-10
is O 0 1.6970866986015798e-12
constitutive O 0 1.1451585235633388e-09
methylation O 0 6.548421360719203e-09
in O 0 7.559754211516889e-11
intron O 0 8.299528175825799e-09
12 O 0 5.378502088149162e-10
at O 0 9.088465223461295e-12
restriction O 0 1.5053942521801172e-13
sites O 0 8.125029295202868e-12
of O 0 6.078640368833987e-11
SacII O 0 3.0279886686912505e-07
and O 0 3.353925193128049e-10
HhaI O 0 2.2114452349342173e-06
, O 0 4.414379278783187e-11
localized O 0 2.8796420803445244e-09
1 O 0 5.590325424797982e-10
, O 0 1.3699877820724793e-12
159 O 0 2.0079142515339043e-10
- O 0 6.707453342746916e-11
1 O 0 5.934160801635002e-11
, O 0 6.054369787629466e-13
232 O 0 7.512048622038137e-11
bp O 0 2.5808058468079764e-10
upstream O 0 2.1467860822355078e-10
of O 0 3.236049206378766e-10
the O 0 1.470675387027498e-10
CTG O 0 1.3693129403691273e-05
repeat O 0 1.568847607380519e-09
, O 0 2.5644193799717607e-12
whereas O 0 1.3827567563184928e-12
most O 0 3.855229463033301e-14
, O 0 2.7236600222912098e-14
if O 0 1.1303809264621512e-15
not O 0 6.165687818940021e-16
all O 0 4.16083962802901e-14
, O 0 3.4560428249699043e-14
of O 0 1.022876553423424e-12
the O 0 2.2422522009696993e-13
other O 0 1.0152020215692219e-14
sites O 0 3.073572212713982e-12
of O 0 2.4769035780747295e-11
SacII O 0 1.240470197672039e-07
, O 0 1.7874186505895118e-11
HhaI O 0 4.555104169412516e-07
, O 0 2.6322733923112018e-11
and O 0 9.543978454762403e-12
HpaII O 0 2.038926254499529e-07
in O 0 6.403675766736283e-12
this O 0 1.804881927507801e-13
region O 0 2.8588702585818915e-11
are O 0 2.9133024660212004e-13
unmethylated O 0 7.310714256192341e-09
, O 0 1.0302583439147917e-12
in O 0 3.243144414046689e-13
normal O 0 5.292647396737404e-12
individuals O 0 8.999338817552993e-15
and O 0 1.4451419661637432e-12
most O 0 4.944930641175016e-13
of O 0 1.0800856736770115e-10
the O 0 2.952243657872167e-11
patients O 0 1.1430825730407435e-10
. O 0 1.2286875683553689e-10

In O 0 1.5784283879938243e-09
a O 0 8.640441660767717e-12
number O 0 1.2835179967474186e-12
of O 0 2.639021223771465e-10
young O 0 4.592469807218613e-11
and O 0 1.1656278720018065e-10
severely O 0 9.255359327653423e-05
affected O 0 2.226710549280142e-08
patients O 0 3.66046748467852e-10
, O 0 1.4633598152680172e-12
however O 0 5.855563429968402e-13
, O 0 1.683622046031591e-13
complete O 0 1.676260519278827e-11
methylation O 0 1.4150101090848466e-09
of O 0 4.611323822789615e-11
these O 0 1.2930161227744236e-14
restriction O 0 3.931986911087128e-14
sites O 0 1.1522841058056454e-12
was O 0 5.627280759423758e-12
found O 0 9.714662884893754e-14
in O 0 1.1652748807110952e-13
the O 0 1.5866059551242206e-12
mutated O 0 2.0932117150707086e-10
allele O 0 6.481647857325967e-11
. O 0 1.4299451900345872e-10

In O 0 9.41714040081365e-10
most O 0 1.9657283613361276e-12
of O 0 6.845213978978748e-11
these O 0 5.917313622601228e-13
patients O 0 4.922236663401636e-12
, O 0 2.6376635793058656e-13
the O 0 2.4138046162552884e-12
onset O 0 1.2243712035342469e-06
of O 0 9.486764707133943e-10
the O 0 2.179007196900784e-08
disease O 1 1.0
was O 0 5.59867157789995e-06
congenital O 1 1.0
. O 0 3.027237482911005e-08

Preliminary O 0 2.3307575247599743e-07
in O 0 9.136114087482383e-10
vivo O 0 1.0646530057556447e-07
footprinting O 0 1.7317232732239063e-06
data O 0 1.8501265797166155e-10
gave O 0 2.800945239633812e-11
evidence O 0 2.7841831271024908e-11
for O 0 1.9018428054195374e-13
protein O 0 9.157580943552901e-12
- O 0 3.8842740135436316e-10
DNA O 0 3.432546025194938e-09
contact O 0 6.85790009849474e-12
in O 0 3.9057681242883613e-13
normal O 0 3.042566892874632e-11
genes O 0 4.1533172300683985e-13
at O 0 1.0231034769381253e-11
an O 0 6.17730083122929e-14
Sp1 O 0 1.4611251097917943e-09
consensus O 0 2.8408782271061028e-11
binding O 0 6.7507796228105654e-12
site O 0 1.0815389556162458e-10
upstream O 0 1.2670182958363085e-10
of O 0 9.183700327985989e-11
the O 0 1.008316763417838e-10
CTG O 0 5.463661636895267e-06
repeat O 0 4.754593940781149e-10
and O 0 3.637718381729882e-12
for O 0 3.701237721257661e-13
a O 0 9.052332586865011e-14
significant O 0 7.627206429373229e-14
reduction O 0 1.3467693106561374e-11
of O 0 9.301437224606968e-12
this O 0 1.6253846514969594e-15
interaction O 0 5.505534586168134e-14
in O 0 2.501833104833623e-13
cells O 0 9.824082736545336e-13
with O 0 2.9351385688256015e-13
a O 0 3.9604444723728705e-11
hypermethylated O 0 6.458004008891294e-06
DMPK O 1 0.999997615814209
gene O 0 8.986154598211726e-10
. O 0 4.534991739774119e-12
. O 0 5.6527255098970386e-11

The O 0 1.6741211084081442e-06
hemochromatosis B-Disease 1 1.0
gene O 0 3.774891510488487e-10
product O 0 2.347730169993678e-11
complexes O 0 2.836552173701712e-11
with O 0 1.511338905586801e-12
the O 0 1.0724159407726752e-11
transferrin O 0 2.846515245735759e-10
receptor O 0 8.02612837302874e-12
and O 0 2.2449279848263393e-12
lowers O 0 9.039837628455061e-11
its O 0 1.6250203765076632e-13
affinity O 0 1.0781780064019961e-13
for O 0 2.4128402658567076e-14
ligand O 0 5.293356378222036e-11
binding O 0 9.247845267346122e-10
. O 0 3.890012756357919e-10

We O 0 2.1973782793338614e-09
recently O 0 6.745985436928947e-10
reported O 0 3.273250420710028e-11
the O 0 8.006175583608055e-12
positional O 0 1.8012066504979884e-08
cloning O 0 1.2208786204226385e-09
of O 0 4.39345539116065e-11
a O 0 5.398195454010823e-13
candidate O 0 1.263629218622997e-11
gene O 0 1.980472674745215e-09
for O 0 7.193776241365413e-09
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999228715896606
HFE O 1 1.0
. O 0 1.1662005583445989e-08

The O 0 1.2411323524474938e-08
gene O 0 6.655991729997979e-11
product O 0 6.334170687960494e-11
, O 0 1.4800588055488562e-12
a O 0 9.47226780519117e-13
member O 0 1.1510216391119599e-11
of O 0 2.447702596164447e-10
the O 0 4.656337121433651e-11
major O 0 1.0564876751217867e-09
histocompatibility O 0 8.011566023924388e-07
complex O 0 7.402341140050339e-08
class O 0 1.0477163581157356e-09
I O 0 6.584242839835497e-08
- O 0 7.183790784459632e-10
like O 0 2.4382412321805047e-12
family O 0 3.6143538249128193e-13
, O 0 3.821481705298252e-13
was O 0 9.77183698541717e-12
found O 0 3.0431730811512903e-13
to O 0 7.378215334703786e-14
have O 0 1.9240765054893798e-14
a O 0 1.4377133381385243e-12
mutation O 0 5.3976528108234945e-12
, O 0 7.277063500399361e-12
Cys O 0 4.3057430048065726e-06
- O 0 9.430859648773549e-09
282 O 0 1.0965893970649176e-08
- O 0 4.4147201450073226e-09
- O 0 1.7952139774735087e-09
> O 0 4.1638648085040586e-10
Tyr O 0 2.3321144908550195e-06
( O 0 2.0643856415980544e-11
C282Y O 0 4.640214434914469e-09
) O 0 9.958212639910036e-14
, O 0 5.461333018848616e-15
in O 0 2.6966971001076215e-14
85 O 0 5.648389742041182e-12
% O 0 4.6835592451858685e-14
of O 0 5.047543980007951e-12
patient O 0 9.499928621536924e-10
chromosomes O 0 7.164688287097931e-10
. O 0 5.456098906009288e-10

This O 0 1.1585549880566148e-10
mutation O 0 6.267101421153498e-11
eliminates O 0 7.317378925009166e-10
the O 0 1.5969748093369596e-11
ability O 0 9.041177528867905e-12
of O 0 1.2726574238897115e-09
HFE O 0 7.72782732383348e-05
to O 0 4.3849833486486745e-11
associate O 0 1.5498455852025472e-09
with O 0 4.82406779453437e-12
beta2 O 0 5.415789928520098e-06
- O 0 1.5295282196348126e-07
microglobulin O 0 3.508180498101865e-06
( O 0 7.82131304166711e-11
beta2m O 0 9.84830535344372e-07
) O 0 5.473730409905064e-12
and O 0 4.951539612357836e-12
prevents O 0 2.402384402522273e-10
cell O 0 4.56643931556755e-08
- O 0 1.4564736972033643e-08
surface O 0 2.114868458136243e-08
expression O 0 2.070539295573326e-09
. O 0 1.784017100714408e-10

A O 0 2.0766785837622592e-06
second O 0 5.1446518156694765e-09
mutation O 0 1.7988796216505953e-11
that O 0 5.2495107463442284e-14
has O 0 3.651241567664658e-14
no O 0 2.5111220069463924e-13
effect O 0 1.619539224950728e-11
on O 0 4.68809102649459e-10
beta2m O 0 1.0250543027723324e-06
association O 0 8.739154289116868e-09
, O 0 1.4626740790779635e-11
H63D O 1 0.9993677735328674
, O 0 1.5931506114341687e-11
was O 0 4.3436115815254084e-11
found O 0 1.2048938236031148e-12
in O 0 6.016829287407155e-13
eight O 0 1.071733066876357e-11
out O 0 1.881953577351214e-12
of O 0 1.6177986728038718e-10
nine O 0 2.5401836190042104e-10
patients O 0 1.3069429219414452e-11
heterozygous O 0 1.0852553664758569e-12
for O 0 2.1041024825252386e-11
the O 0 2.3431470097534657e-09
C282Y O 0 1.5178669627857744e-06
mutant O 0 1.5297464628361013e-08
. O 0 6.204234903606221e-10

In O 0 4.717556900679654e-10
this O 0 3.3697643200131244e-13
report O 0 2.5363125228522465e-12
, O 0 2.982707939143403e-13
we O 0 5.471842580141674e-15
demonstrate O 0 1.0457541950448235e-12
in O 0 2.26625380787826e-12
cultured O 0 5.005565961724301e-10
293 O 0 4.72169148224566e-09
cells O 0 5.942511482892598e-10
overexpressing O 0 1.2021880024803977e-07
wild O 0 9.097257702705974e-08
- O 0 3.231369616329971e-09
type O 0 2.2727071335992832e-09
or O 0 1.4901473111006425e-10
mutant O 0 2.852027281008418e-09
HFE O 0 1.7928659872268327e-06
proteins O 0 2.152713120609495e-12
that O 0 1.8114785523383817e-14
both O 0 1.5609436215379552e-13
the O 0 3.641744891758059e-12
wild O 0 1.3963018519191905e-09
- O 0 2.1546542328110263e-10
type O 0 3.9416214736576194e-10
and O 0 1.4109667600958886e-10
H63D O 1 0.9999996423721313
HFE O 0 8.777888433542103e-05
proteins O 0 3.327492795190956e-11
form O 0 9.811392150116394e-12
stable O 0 5.61095024609326e-11
complexes O 0 1.74525081886312e-11
with O 0 7.801102428969808e-13
the O 0 1.5556904722768827e-11
transferrin O 0 8.060054845770992e-10
receptor O 0 1.1651411779833865e-10
( O 0 8.583770846892769e-12
TfR O 0 4.596367730869133e-08
) O 0 4.477526422547173e-12
. O 0 1.42558456359132e-11

The O 0 3.7137178310331365e-07
C282Y O 0 1.0832146472239401e-05
mutation O 0 8.623788905204322e-10
nearly O 0 5.2024318880627973e-11
completely O 0 7.32567340122614e-10
prevents O 0 2.8661701484411495e-11
the O 0 1.9424278158153285e-11
association O 0 3.6006664316801107e-10
of O 0 7.294703036064831e-11
the O 0 2.6455464555152908e-11
mutant O 0 8.390744210551304e-10
HFE O 0 1.8426786709824228e-06
protein O 0 9.287224461695942e-11
with O 0 1.1225984334825578e-12
the O 0 1.485309097937204e-10
TfR O 0 2.2046774574846495e-06
. O 0 2.0178617110566677e-10

Studies O 0 7.845476490686565e-10
on O 0 2.853647318445951e-10
cell O 0 7.326735329549194e-10
- O 0 2.031431828308783e-10
associated O 0 2.36888911264721e-11
transferrin O 0 5.831564675595757e-10
at O 0 1.868289828399483e-10
37 O 0 2.8220304565396148e-11
degrees O 0 4.1285153073999936e-10
C O 0 1.7256379436503266e-08
suggest O 0 2.8475167102720578e-12
that O 0 2.9229524752200434e-14
the O 0 4.171645320849571e-11
overexpressed O 0 1.2149700978625333e-07
wild O 0 2.7713339179058494e-08
- O 0 1.201173827070079e-09
type O 0 1.239246372186642e-09
HFE O 0 1.281216214010783e-06
protein O 0 1.2171689003914743e-11
decreases O 0 1.129693018818434e-12
the O 0 2.696194775688582e-13
affinity O 0 3.2587574674315667e-13
of O 0 1.7835195126325587e-11
the O 0 4.761395271113411e-12
TfR O 0 8.061626921573861e-09
for O 0 2.3565943033793113e-12
transferrin O 0 7.339495233793514e-09
. O 0 2.1116336457183138e-10

The O 0 8.904928563424619e-07
overexpressed O 0 0.00021536769054364413
H63D O 1 0.9999680519104004
protein O 0 1.8340043927977945e-09
does O 0 4.021427017341511e-13
not O 0 8.461130694735822e-15
have O 0 4.892386599771178e-16
this O 0 2.9003797777416333e-16
effect O 0 6.658854782674861e-13
, O 0 1.0059466280798457e-13
providing O 0 1.9350596429032474e-13
the O 0 2.9682587767906887e-13
first O 0 5.565918209725178e-14
direct O 0 5.039381523294813e-14
evidence O 0 9.688761294993076e-13
for O 0 6.884918254002753e-14
a O 0 1.6960471384535464e-13
functional O 0 1.298641055802463e-11
consequence O 0 5.1333156475541486e-11
of O 0 1.7565594812030128e-10
the O 0 5.181381435015453e-10
H63D O 1 0.9999980926513672
mutation O 0 8.430805387149576e-09
. O 0 1.8338075502555284e-10

Addition O 0 7.848608873928242e-09
of O 0 1.4516008839393635e-08
soluble O 0 6.114836992310302e-08
wild O 0 9.251714914171316e-07
- O 0 8.673350038179706e-08
type O 0 1.7619392167489423e-07
HFE O 1 1.0
/ O 0 3.951293820136925e-06
beta2m O 0 2.6756897568702698e-06
heterodimers O 0 2.931924143467768e-07
to O 0 9.785340072954174e-12
cultured O 0 2.248954633632394e-10
cells O 0 1.9859894978546677e-11
also O 0 3.6953263799627267e-13
decreased O 0 3.9981486003870526e-12
the O 0 2.302485459237946e-13
apparent O 0 3.5858249963077737e-12
affinity O 0 9.882909378020055e-13
of O 0 3.690955874269264e-11
the O 0 2.8684220797214888e-12
TfR O 0 6.82042977651065e-10
for O 0 3.040966865255554e-14
its O 0 1.033828581011205e-13
ligand O 0 3.09370064288661e-11
under O 0 4.5596282305382374e-10
steady O 0 1.7243210193029768e-09
- O 0 3.5352540339594896e-11
state O 0 6.090680802588178e-13
conditions O 0 6.934441909578481e-11
, O 0 1.947114480283299e-13
both O 0 1.6773134462843946e-14
in O 0 1.1035862165515581e-13
293 O 0 2.3618015529414116e-11
cells O 0 9.685897917055541e-13
and O 0 2.281437842463485e-12
in O 0 3.156602063070224e-11
HeLa O 0 1.3353578651731368e-06
cells O 0 2.9239746179854365e-09
. O 0 1.7470866420232767e-10

Furthermore O 0 8.147419627846375e-09
, O 0 2.5428823977047266e-11
at O 0 3.117060776158809e-11
4 O 0 4.182967167087881e-11
degrees O 0 1.7865992019139298e-09
C O 0 1.443727910555026e-07
, O 0 3.6319640871196324e-12
the O 0 3.659493715002515e-12
added O 0 1.0384139294966621e-12
soluble O 0 9.601278105897393e-11
complex O 0 7.804120683019278e-10
of O 0 5.629629651338064e-09
HFE O 1 0.9970077872276306
/ O 0 6.267361385425829e-08
beta2m O 0 5.930729685132974e-08
inhibited O 0 1.8618759312083455e-10
binding O 0 7.831762321997005e-11
of O 0 8.16231637834619e-10
transferrin O 0 3.5278411303352186e-09
to O 0 1.4924966817986274e-10
HeLa O 0 2.2229562546272064e-06
cell O 0 1.578727193418672e-08
TfR O 0 2.986746139299612e-08
in O 0 1.2148727336624976e-11
a O 0 2.455832412429082e-12
concentration O 0 2.5518054336259866e-09
- O 0 1.2305315655325444e-09
dependent O 0 1.7907399174621474e-10
manner O 0 5.007469106033113e-09
. O 0 2.3477672583815945e-10

Scatchard O 0 1.6800228195279487e-06
plots O 0 1.3188848235756723e-08
of O 0 3.344561738671814e-09
these O 0 8.233982072558543e-13
data O 0 2.3322475894982375e-11
indicate O 0 5.058704757171517e-12
that O 0 4.2784338897226826e-14
the O 0 8.576652409109098e-12
added O 0 1.1423888744699351e-11
heterodimer O 0 6.96322000059979e-10
substantially O 0 2.986062352244856e-12
reduced O 0 3.1596366148467503e-12
the O 0 1.8736435200648188e-13
affinity O 0 5.108832736196167e-13
of O 0 1.4942904552617264e-11
TfR O 0 1.2446787600595144e-08
for O 0 3.460808679564553e-12
transferrin O 0 1.8762158049412392e-08
. O 0 4.6377615636750136e-10

These O 0 1.1891104767514094e-09
results O 0 2.2565771473637142e-10
establish O 0 1.452602066409625e-10
a O 0 2.1131022279186062e-12
molecular O 0 1.8616025387885315e-10
link O 0 7.069594215591835e-11
between O 0 3.1146894091671484e-11
HFE O 0 0.0005112087237648666
and O 0 1.4581280627368187e-11
a O 0 4.453796272757549e-12
key O 0 2.0014752355468346e-10
protein O 0 8.855100680493777e-12
involved O 0 6.241783999383355e-12
in O 0 8.412577925942522e-12
iron O 0 6.766762261634085e-09
transport O 0 2.435668611244779e-10
, O 0 7.931194763444172e-13
the O 0 8.85182010156027e-13
TfR O 0 3.677727011819343e-09
, O 0 2.324335927721133e-13
and O 0 1.5135622247718084e-13
raise O 0 1.0558817275380106e-12
the O 0 1.8227027959866193e-12
possibility O 0 5.047043512285132e-12
that O 0 4.579680988007085e-15
alterations O 0 9.657075139557492e-11
in O 0 2.9934698383277114e-12
this O 0 4.006946955226881e-14
regulatory O 0 2.1275287087618722e-11
mechanism O 0 1.8888098030078737e-10
may O 0 1.870984053450875e-12
play O 0 5.555818652358546e-11
a O 0 3.9714542418578525e-13
role O 0 4.696881989244006e-13
in O 0 7.300945330072917e-13
the O 0 1.1275710400104888e-11
pathogenesis O 0 2.614854338389705e-06
of O 0 5.09490018885117e-06
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 1.1900323393376766e-08
. O 0 3.088330979839071e-10

Genomic O 0 4.892938676448466e-08
organization O 0 2.2939423693912886e-09
of O 0 1.4093645139823252e-09
the O 0 7.168966531523324e-10
UBE3A O 1 0.9999454021453857
/ O 0 5.18667661708605e-07
E6 O 0 9.640594362281263e-05
- O 0 1.0171184072760298e-07
AP O 0 2.45855903813208e-06
gene O 0 5.148651643915869e-11
and O 0 1.3773291318228131e-12
related O 0 3.9081138325514075e-10
pseudogenes O 0 5.521851775824871e-08
. O 0 2.865794268558375e-10

The O 0 1.981815529461528e-07
UBE3A O 0 0.009826635010540485
gene O 0 9.110794896294294e-10
encodes O 0 5.220602422584264e-11
the O 0 1.1791745357925265e-10
E6 O 0 2.945661208286765e-06
- O 0 3.6415020332469794e-08
AP O 0 2.5923534963112616e-07
ubiquitin O 0 3.3787364017712207e-09
- O 0 4.551868881819132e-10
protein O 0 1.5269767872014284e-12
ligase O 0 1.5964450247873962e-11
and O 0 3.7260446464348895e-12
has O 0 4.4188963469263265e-14
recently O 0 7.715468888780386e-13
been O 0 7.934745796609605e-14
shown O 0 8.269169311965474e-14
to O 0 8.168934821119189e-14
be O 0 4.4062905993173807e-13
mutated O 0 8.11906186726219e-09
in O 0 5.746594666788951e-08
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 3.2619993817206705e-08
who O 0 2.501463446102914e-11
lack O 0 2.965335177407269e-08
15q11 O 0 1.1366523722244892e-05
- O 0 5.32695992205845e-07
q13 O 0 2.0126138622345024e-07
deletions O 0 5.078085507648211e-09
or O 0 2.4531208175915253e-09
chromosome O 0 5.368913846837131e-08
15 O 0 1.542409044930082e-08
paternal O 0 1.7756628949427977e-06
uniparental B-Disease 0 0.12652769684791565
disomy I-Disease 0 0.026777729392051697
. O 0 3.093109057772381e-08

Previous O 0 1.055512370840006e-06
UBE3A O 0 0.00024372035113628954
cDNA O 0 1.3215836203173126e-09
analysis O 0 9.636406256285923e-12
has O 0 3.7246766136861745e-14
shown O 0 1.577591274845927e-13
a O 0 2.8216993086700726e-13
coding O 0 4.259704394771191e-11
region O 0 4.451794488602445e-11
of O 0 3.519939895113566e-11
approximately O 0 2.872200914605383e-11
2 O 0 3.0191862343542653e-09
. O 0 1.5231822747541202e-10

6 O 0 1.5930610288705793e-06
kb O 0 5.749964770984661e-07
and O 0 3.2573269082014633e-10
a O 0 1.0366202340961195e-10
3 O 0 4.846143930592461e-09
- O 0 7.303467164376798e-09
untranslated O 0 5.243371197138913e-05
region O 0 1.7393438911383896e-09
( O 0 1.6645105432866458e-11
UTR O 0 6.545196083607152e-05
) O 0 1.587483725203065e-12
of O 0 1.4809893589262657e-10
< O 0 1.8670752444105432e-10
50 O 0 8.023468694995373e-11
bp O 0 1.7700324539404733e-10
, O 0 7.124802592524404e-13
whereas O 0 7.444233489188601e-13
Northern O 0 7.570732235562261e-12
analysis O 0 1.9246060366066853e-13
has O 0 2.0244294962449855e-15
indicated O 0 1.99704771626898e-14
mRNA O 0 9.268912135214358e-14
sizes O 0 1.014877743475695e-12
of O 0 1.7064813104261667e-11
5 O 0 2.492872297477078e-10
- O 0 2.034209023449307e-09
8 O 0 2.4083910421524024e-09
kb O 0 5.179054696213825e-08
. O 0 1.276502653579925e-10

We O 0 3.793614589131522e-10
have O 0 5.67341245055579e-14
analyzed O 0 7.926586470530239e-12
additional O 0 9.23961536621054e-13
cDNA O 0 1.0627727170531287e-10
clones O 0 3.8550906911183347e-10
and O 0 6.410528032886609e-13
provide O 0 3.9286759609402644e-13
evidence O 0 5.190258379333956e-12
for O 0 4.789462080515179e-14
an O 0 9.400587642029775e-15
additional O 0 7.344381721709203e-13
0 O 0 5.186502893828049e-10
. O 0 3.4308018231898885e-11

5 O 0 1.3154698308426305e-07
kb O 0 1.79753158136009e-07
of O 0 3.714273333343954e-08
5 O 0 8.550025576425924e-09
- O 0 1.5451798063281785e-08
UTR O 0 2.5181867385981604e-05
and O 0 1.1305111013992786e-10
> O 0 1.0963666086105661e-10
2 O 0 2.2453713888204163e-10
kb O 0 2.204384674797666e-09
of O 0 9.410137113974315e-10
3 O 0 3.445850893513125e-08
- O 0 2.0569432024331036e-07
UTR O 0 0.06297498196363449
. O 0 4.97027974333264e-10

We O 0 2.2961431367374274e-10
have O 0 1.1781722787044396e-13
established O 0 1.92192286391224e-11
the O 0 1.6807737927143629e-12
genomic O 0 4.248839127751758e-11
organization O 0 4.122642852100178e-11
of O 0 1.9023607689128141e-10
UBE3A O 0 0.0001588444720255211
and O 0 2.317976192933724e-11
the O 0 2.8201403885763643e-12
sequence O 0 1.1822382265866405e-12
of O 0 1.388222349574253e-11
intron O 0 3.678493243342018e-08
- O 0 1.190114051752289e-08
exon O 0 1.2592185960613733e-08
borders O 0 5.021516535919091e-10
. O 0 8.325951039722668e-11

We O 0 1.21769028194052e-09
have O 0 2.565769645357374e-12
also O 0 3.18153424612444e-12
mapped O 0 3.7616812442742287e-10
two O 0 2.9043382282489816e-12
highly O 0 1.1295045454495778e-10
homologous O 0 5.505091174584642e-11
processed O 0 1.0063632149837076e-09
pseudogenes O 0 4.856479662862512e-09
, O 0 1.9117152305625496e-11
UBE3AP1 O 0 0.00012428234913386405
and O 0 6.834298127422755e-10
UBE3AP2 O 1 0.7281573414802551
, O 0 9.558443446466836e-12
to O 0 2.48155906630923e-13
chromosomes O 0 1.1233801432489199e-12
2 O 0 1.530310253516909e-11
and O 0 3.7223563532744197e-13
21 O 0 8.363529313548668e-11
, O 0 8.095614293952141e-14
respectively O 0 1.6676206856386377e-12
, O 0 6.836292464193136e-14
and O 0 1.917742765804309e-13
determined O 0 9.80600409900001e-12
their O 0 9.464398015301967e-12
genomic O 0 1.4218873856108871e-09
organization O 0 2.1644006586996056e-09
. O 0 9.762358976761476e-11

These O 0 6.840427668741711e-10
results O 0 2.984340274903019e-10
will O 0 2.290624721151824e-12
form O 0 5.519955586369418e-12
the O 0 6.658270397703892e-13
basis O 0 1.4753060155903858e-13
for O 0 1.931893476098058e-15
studies O 0 1.1689523589548945e-13
of O 0 9.405547087698585e-13
mutation O 0 7.063696415982035e-13
and O 0 5.549884770500446e-12
imprinting O 0 1.5812337039733393e-07
of O 0 4.36956071325767e-08
UBE3A O 1 0.9996678829193115
. O 0 9.684752555472187e-09

Mutation O 0 2.5562007621715566e-08
spectrum O 0 4.2915729636661126e-08
and O 0 3.849161267499568e-10
genotype O 0 7.389392209233847e-08
- O 0 2.0478937656775997e-08
phenotype O 0 1.977749769510595e-10
analyses O 0 1.5399302943919224e-09
in O 0 1.3907804075063979e-10
Cowden B-Disease 1 1.0
disease I-Disease 1 0.9886654615402222
and O 0 4.86918450004481e-10
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 3.980469287512278e-10
two O 0 8.890039260300853e-10
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
with O 0 8.659412742417771e-07
germline O 1 0.9999992847442627
PTEN O 1 1.0
mutation O 0 2.101596464854083e-06
. O 0 1.5057311841815135e-08

The O 0 4.0100104570228723e-07
tumour B-Disease 1 1.0
suppressor O 0 1.7325992303085513e-05
gene O 0 6.062739288381636e-08
PTEN O 0 0.0005680486210621893
, O 0 3.519362579140761e-11
which O 0 4.4450866056554295e-13
maps O 0 6.271836522353524e-11
to O 0 1.886051211041906e-11
10q23 O 0 6.459824248850055e-07
. O 0 9.168373282797404e-10

3 O 0 1.6158458038262324e-07
and O 0 6.084625858715498e-11
encodes O 0 3.441745369606175e-12
a O 0 5.450505498327818e-13
403 O 0 3.3447860366825344e-12
amino O 0 2.7130233823391414e-12
acid O 0 8.294352617926881e-13
dual O 0 1.1599756528576921e-12
specificity O 0 2.557021087923328e-11
phosphatase O 0 4.8640838912206164e-08
( O 0 2.8320219433441984e-11
protein O 0 3.037186474541542e-11
tyrosine O 0 6.746551650671506e-10
phosphatase O 0 1.5435066558211474e-08
; O 0 3.099149843005522e-12
PTPase O 0 6.829274923347839e-08
) O 0 4.132353638962305e-13
, O 0 7.300997100726653e-14
was O 0 3.4214944245880563e-12
shown O 0 8.137401343033535e-13
recently O 0 3.5025257433957124e-12
to O 0 6.825612124117253e-13
play O 0 2.118499820014108e-10
a O 0 1.0113497712904707e-11
broad O 0 2.0102709774594274e-10
role O 0 2.0050353738421123e-11
in O 0 1.6148166137597286e-11
human O 0 1.5490890792335676e-09
malignancy B-Disease 0 5.761614374932833e-06
. O 0 4.776863904432105e-10

Somatic O 0 0.013805164024233818
PTEN O 1 0.9973456263542175
deletions O 0 3.0492356017930433e-07
and O 0 5.312498441156777e-09
mutations O 0 8.688524344435677e-10
were O 0 8.59811319364745e-11
observed O 0 7.64753885218461e-11
in O 0 2.5283494048400357e-11
sporadic B-Disease 0 1.1382556976968772e-06
breast I-Disease 0 0.003670037491247058
, I-Disease 0 1.4093617384247636e-09
brain I-Disease 1 1.0
, I-Disease 0 2.8849266087149772e-08
prostate I-Disease 1 1.0
and I-Disease 1 0.9973893761634827
kidney I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
cell O 0 3.4056145523209125e-05
lines O 0 2.972736723449998e-08
and O 0 3.05833414149248e-11
in O 0 7.296466382478162e-12
several O 0 2.2725833367931436e-11
primary O 0 4.707342426968353e-08
tumours B-Disease 1 1.0
such O 0 3.0961930241879543e-10
as O 0 7.330932749738395e-09
endometrial B-Disease 1 0.9999995231628418
carcinomas I-Disease 1 1.0
, O 1 0.9997441172599792
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 6.21475237494451e-07

In O 0 1.0478062861807302e-09
addition O 0 2.2786610098801674e-10
, O 0 1.9890042390890983e-10
PTEN O 1 0.5295273661613464
was O 0 2.9251625566217854e-09
identified O 0 3.6958658355956686e-11
as O 0 1.181124859375715e-12
the O 0 3.408388805567486e-12
susceptibility O 0 3.3039748714713824e-10
gene O 0 1.9715156590605076e-11
for O 0 1.9029359251548916e-12
two O 0 4.607554338065256e-10
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 1.0840461861505446e-10
CD B-Disease 1 0.9999997615814209
; O 0 6.167553689984118e-10
MIM O 0 0.0003492750693112612
158350 O 0 1.5955805565681658e-06
) O 0 1.3159472426679808e-12
and O 0 4.6054939376038995e-12
Bannayan B-Disease 0 3.7833866372238845e-05
- I-Disease 0 1.5012683434179053e-06
Zonana I-Disease 0 0.002476828871294856
( I-Disease 0 5.569061878318848e-10
BZS I-Disease 0 0.2641136348247528
) I-Disease 0 1.167587554418148e-11
or I-Disease 0 1.469264467035547e-11
Ruvalcaba I-Disease 0 7.732753601885634e-07
- I-Disease 0 2.520390012250573e-07
Riley I-Disease 0 1.702679401205387e-05
- I-Disease 0 0.014646130613982677
Smith I-Disease 0 0.0041322121396660805
syndrome I-Disease 1 0.9999972581863403
( O 0 2.6714905843050474e-09
MIM O 1 1.0
153480 O 0 0.041699785739183426
) O 0 1.7799180185296137e-10
. O 0 1.7152011755339203e-10

Constitutive O 0 7.606496410517138e-07
DNA O 0 4.3162168594790273e-07
from O 0 1.1790980691817055e-10
37 O 0 4.12502060287423e-10
CD B-Disease 0 1.2461038068067865e-06
families O 0 5.44800044920829e-13
and O 0 3.644677008113328e-12
seven O 0 1.5717971368900407e-10
BZS B-Disease 0 0.00022400122543331236
families O 0 5.2927883430198275e-12
was O 0 1.1315919035137512e-10
screened O 0 9.160560088261605e-10
for O 0 1.1462068100209777e-10
germline O 0 1.071485621650936e-05
PTEN O 1 0.9952632188796997
mutations O 0 4.668923736517172e-07
. O 0 1.8648098176754502e-08

PTEN O 1 0.9938263297080994
mutations O 0 1.7888639902707837e-08
were O 0 5.95879845466385e-10
identified O 0 5.976449196642974e-11
in O 0 2.1851708810471937e-12
30 O 0 1.6746500020037303e-11
of O 0 1.7802304075331676e-10
37 O 0 1.7961582221559524e-10
( O 0 1.1187614419941316e-12
81 O 0 2.816767097346684e-10
% O 0 1.1936915486013971e-13
) O 0 1.6495273774826645e-14
CD B-Disease 0 1.337847265858727e-06
families O 0 4.3958481060930865e-13
, O 0 5.017220363126573e-13
including O 0 4.401908091505868e-12
missense O 0 1.4580802343289179e-08
and O 0 1.7241138516865817e-09
nonsense O 0 2.5766528324311366e-06
point O 0 4.980664769504983e-09
mutations O 0 9.592711347483629e-11
, O 0 7.474784680105984e-12
deletions O 0 6.546432285148285e-10
, O 0 5.888295406819566e-11
insertions O 0 2.5621251786844823e-09
, O 0 4.7807261621679586e-11
a O 0 1.1187919514432654e-11
deletion O 0 4.842907741497982e-10
/ O 0 1.4389233804479318e-08
insertion O 0 3.24415294628011e-09
and O 0 9.729165251215477e-10
splice O 0 1.306184731220128e-05
site O 0 8.074741941754837e-08
mutations O 0 6.523329432184255e-08
. O 0 6.364998750285622e-09

These O 0 4.527511698881881e-10
mutations O 0 2.2432868063138045e-10
were O 0 9.793448690897932e-11
scattered O 0 6.541343466892613e-09
over O 0 3.006036045083427e-11
the O 0 2.26169499795148e-11
entire O 0 9.979218840161508e-11
length O 0 1.3777501708944762e-11
of O 0 4.828841215775981e-10
PTEN O 0 9.589241017238237e-06
, O 0 1.0668300444438561e-11
with O 0 1.9252890839753511e-13
the O 0 2.793948883014763e-12
exception O 0 4.025097529586352e-12
of O 0 1.4106485944631597e-11
the O 0 1.9598656465086295e-12
first O 0 8.209287416516275e-12
, O 0 5.334907862697413e-13
fourth O 0 3.4682595684287776e-10
and O 0 9.96053933777219e-12
last O 0 3.320710650900338e-10
exons O 0 8.301130804966306e-08
. O 0 9.327348893251042e-10

A O 0 3.294894122518599e-05
hot O 0 8.314499609696213e-06
spot O 0 1.166110976669188e-07
for O 0 1.3774460738691374e-10
PTEN O 0 3.059854498133063e-05
mutation O 0 4.037478684715268e-11
in O 0 1.4760394295709744e-11
CD B-Disease 0 0.00020194471289869398
was O 0 2.615259675486925e-10
identified O 0 1.8996757292222277e-12
in O 0 1.4966171748079238e-12
exon O 0 1.5494251714986973e-10
5 O 0 5.152748713821431e-11
that O 0 9.28380551552593e-15
contains O 0 3.078817582824467e-12
the O 0 7.811037407157162e-12
PTPase O 0 2.106244210153818e-07
core O 0 3.304727869135604e-08
motif O 0 2.5422969285315844e-10
, O 0 2.88874582891549e-13
with O 0 1.9957073713332447e-14
13 O 0 2.2517175624070518e-11
of O 0 1.4954766591745994e-11
30 O 0 7.10968393533018e-12
( O 0 2.7634725020472817e-13
43 O 0 3.9025550152560484e-11
% O 0 7.180460246574219e-14
) O 0 1.496547975604265e-13
CD B-Disease 0 0.0008426142740063369
mutations O 0 9.015971302872572e-11
identified O 0 1.7815474789850683e-11
in O 0 2.877616981505904e-12
this O 0 4.308202557722074e-13
exon O 0 1.2982441788267352e-08
. O 0 4.093574923480503e-10

Seven O 0 1.605437027762946e-08
of O 0 4.598636582642257e-09
30 O 0 2.0925171317909275e-10
( O 0 2.202427042824473e-12
23 O 0 6.29081370329132e-11
% O 0 2.0534729854569146e-14
) O 0 4.114135586570124e-15
were O 0 2.5834762389272126e-13
within O 0 1.007418540949212e-11
the O 0 1.8915632948868222e-11
core O 0 4.323662761152036e-09
motif O 0 9.385485444379782e-11
, O 0 2.642664190775912e-13
the O 0 1.530788191518584e-12
majority O 0 3.421686491002912e-14
( O 0 3.513481823189113e-14
five O 0 3.4010489737001937e-13
of O 0 1.431600844814529e-11
seven O 0 1.4037266141131433e-11
) O 0 6.519977157996848e-14
of O 0 2.882535009296472e-11
which O 0 1.1217058098339505e-12
were O 0 1.2711502683782072e-10
missense O 0 8.279262431187817e-08
mutations O 0 3.6521703439262865e-09
, O 0 9.418769930658044e-11
possibly O 0 1.2229085522008631e-09
pointing O 0 1.0194851629563573e-09
to O 0 2.35441961066174e-12
the O 0 5.086210966287474e-12
functional O 0 7.216481752447823e-12
significance O 0 5.946000636303239e-11
of O 0 8.993043115745891e-11
this O 0 1.0750239267569642e-13
region O 0 1.4874211584636754e-10
. O 0 1.60827642869954e-10

Germline O 0 0.0025170529261231422
PTEN O 1 0.9891757369041443
mutations O 0 2.5761019983860933e-08
were O 0 9.901244268917253e-10
identified O 0 2.9178992555500827e-11
in O 0 5.4468599769430526e-12
four O 0 5.3908418527759405e-12
of O 0 1.7290791021196128e-10
seven O 0 6.982500688756943e-11
( O 0 2.430371225450867e-12
57 O 0 4.805714715061526e-10
% O 0 4.654272843865326e-13
) O 0 4.2435564610865395e-12
BZS B-Disease 0 0.000598069338593632
families O 0 2.181707071946537e-11
studied O 0 2.4805052234455616e-08
. O 0 8.668743500805931e-10

Interestingly O 0 6.234133564930744e-08
, O 0 1.3338244397864685e-10
none O 0 1.5728407465331884e-10
of O 0 7.10877953724598e-11
these O 0 1.5874747263250333e-12
mutations O 0 6.657604328941247e-11
was O 0 1.507488300855897e-10
observed O 0 4.402145314941208e-11
in O 0 4.789668661686619e-12
the O 0 4.1688694163433127e-11
PTPase O 0 7.833401468815282e-06
core O 0 1.3705769106309162e-06
motif O 0 4.526980745822584e-08
. O 0 1.874439770066516e-10

It O 0 5.256555746235847e-10
is O 0 1.826144270522523e-12
also O 0 3.344548487986543e-13
worthy O 0 6.190806756123379e-10
of O 0 2.010413835407121e-09
note O 0 3.1206301431829786e-11
that O 0 1.147360066114031e-13
a O 0 4.131252197975277e-12
single O 0 1.4921609781115563e-10
nonsense O 0 6.219925907657853e-09
point O 0 1.2638853852386944e-10
mutation O 0 4.223482674703405e-12
, O 0 6.70350710704759e-13
R233X O 0 2.5577062690018693e-09
, O 0 3.982629764170964e-12
was O 0 1.8699325074478246e-11
observed O 0 7.86449638051634e-12
in O 0 1.7958378924556873e-12
the O 0 1.1460706515753483e-11
germline O 0 7.925913814155194e-10
DNA O 0 1.4696226457999728e-08
from O 0 1.2369592329586343e-11
two O 0 1.5779825363049227e-13
unrelated O 0 2.0473214790150962e-10
CD B-Disease 0 0.0011318476172164083
families O 0 2.3186340000758143e-12
and O 0 9.054449030820866e-12
one O 0 5.729347898886239e-11
BZS B-Disease 0 0.1779659539461136
family O 0 4.670484443636269e-09
. O 0 2.5485806798286603e-09

Genotype O 0 1.7059880974557018e-06
- O 0 1.0232127323206441e-07
phenotype O 0 4.926317687115045e-10
studies O 0 8.024888045743417e-12
were O 0 1.8343375863399958e-12
not O 0 1.6375088269940732e-14
performed O 0 1.0372075420761462e-10
on O 0 1.540671930311266e-11
this O 0 5.407124604290235e-15
small O 0 6.213486756362352e-13
group O 0 1.0789896753848893e-11
of O 0 3.2563948759722905e-10
BZS B-Disease 1 0.9913356304168701
families O 0 6.432998578276283e-11
. O 0 3.834220441145675e-10

However O 0 1.7963716070212854e-09
, O 0 3.175673266020418e-11
genotype O 0 2.5939193015744877e-09
- O 0 2.722357894668903e-09
phenotype O 0 2.29430446863077e-10
analysis O 0 3.531115677635199e-11
inthe O 0 8.477346113977546e-08
group O 0 5.4789558306955755e-11
of O 0 5.296378891017639e-10
CD B-Disease 1 0.9999862909317017
families O 0 3.4303482363690074e-12
revealed O 0 3.9507567356489304e-11
two O 0 1.3755325817179503e-13
possible O 0 1.6428474249388647e-12
associations O 0 3.774040108206478e-11
worthy O 0 3.049338115346245e-09
of O 0 4.928688568384132e-09
follow O 0 2.2728445514541562e-10
- O 0 8.837932607974608e-10
up O 0 5.35797751652356e-12
in O 0 3.133217155778384e-13
independent O 0 6.6666351258848344e-12
analyses O 0 2.127685139186042e-09
. O 0 3.080747601469369e-10

The O 0 1.1642846686754638e-08
first O 0 4.5274772819681175e-10
was O 0 4.045714041556181e-10
an O 0 6.271040544486572e-13
association O 0 2.9612401419853995e-10
noted O 0 3.874207812198938e-12
in O 0 1.463694725319098e-12
the O 0 6.838933499370148e-12
group O 0 2.4392783799787043e-12
of O 0 5.909176620244594e-11
CD B-Disease 1 0.999995231628418
families O 0 2.566025343597733e-11
with O 0 1.6809879044288323e-09
breast B-Disease 1 1.0
disease I-Disease 1 0.9999982118606567
. O 0 1.5304285616579705e-09

A O 0 8.344866131437811e-08
correlation O 0 3.361698419634962e-11
was O 0 3.603914736083347e-11
observed O 0 7.67090904685297e-12
between O 0 3.0473320806849447e-13
the O 0 9.6337748976133e-13
presence O 0 1.0164667718637332e-11
/ O 0 5.0599671119755385e-09
absence O 0 1.914074010400668e-09
of O 0 1.5205532388762322e-09
a O 0 1.3602459436601322e-10
PTEN O 0 0.012190457433462143
mutation O 0 3.4485150846030876e-11
and O 0 5.952987235102736e-12
the O 0 6.375170790579032e-12
type O 0 5.877708542101345e-09
of O 0 5.397128433060061e-08
breast O 0 9.969356142391916e-06
involvement O 0 8.359805292457168e-09
( O 0 8.207385882030849e-10
unaffected O 0 1.2691754136540112e-06
versus O 0 9.077703566617856e-07
benign O 0 4.017609535367228e-05
versus O 0 2.2903905119164847e-06
malignant O 0 9.029855573317036e-05
) O 0 1.3706687174153132e-10
. O 0 2.51826781649811e-10

Specifically O 0 3.3926463860467493e-09
and O 0 3.13951954711289e-11
more O 0 4.6069298685136664e-14
directly O 0 4.24929102321725e-12
, O 0 5.748739158317751e-13
an O 0 9.605220129471279e-14
association O 0 4.266186848234099e-10
was O 0 1.8655088585006752e-10
also O 0 3.333416171130005e-13
observed O 0 5.586312228772483e-12
between O 0 2.353682027923798e-13
the O 0 1.424790081923366e-12
presence O 0 3.763930573469354e-12
of O 0 1.4392458058676283e-10
a O 0 5.697628480128003e-10
PTEN O 1 1.0
mutation O 0 2.7036844585381914e-06
and O 0 1.9530838471837342e-05
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 5.384807266750613e-09

Secondly O 0 4.0930686395768134e-07
, O 0 8.595740230710192e-10
there O 0 5.085192249926207e-12
appeared O 0 6.618405823388684e-11
to O 0 6.064632845394213e-13
be O 0 2.606337454885699e-13
an O 0 9.10503118213557e-13
interdependent O 0 5.3255075016522824e-08
association O 0 1.9178353127813352e-08
between O 0 1.2216491707128796e-10
mutations O 0 2.7228394539058343e-10
upstream O 0 4.0298950287898094e-10
and O 0 9.092383963793527e-12
within O 0 1.7500383087121207e-10
the O 0 6.683368442006454e-11
PTPase O 0 1.8026936459136778e-06
core O 0 2.0977266501631675e-07
motif O 0 1.2476897293112188e-09
, O 0 9.855087666071904e-13
the O 0 1.5030537578453185e-12
core O 0 5.448964612853047e-10
motif O 0 5.067166825023506e-11
containing O 0 4.442122884806832e-12
the O 0 7.52256546984742e-13
majority O 0 2.723550755041014e-14
of O 0 9.754183571963893e-12
missense O 0 1.3977327073533274e-09
mutations O 0 2.931891951440946e-10
, O 0 1.6227517593558893e-11
and O 0 6.384857052788018e-12
the O 0 3.299589768079869e-11
involvement O 0 6.334496815973978e-11
of O 0 5.646348943955104e-10
all O 0 1.0430410875283957e-12
major O 0 7.575328558884209e-11
organ O 0 0.00010355141421314329
systems O 0 0.0007974366890266538
( O 0 6.657760454054085e-10
central O 0 7.313875539693981e-05
nervous O 0 7.050508088468632e-07
system O 0 3.964002098655328e-05
, O 0 3.0844372389537966e-08
thyroid O 1 1.0
, O 0 7.741888339296565e-07
breast O 1 1.0
, O 0 1.6178209705230984e-07
skin O 1 1.0
and O 1 0.9660316109657288
gastrointestinal O 1 1.0
tract O 1 1.0
) O 0 4.9829922410538074e-09
. O 0 3.4372957813388894e-09

However O 0 2.130056575566641e-09
, O 0 4.1176033936662915e-12
these O 0 3.4824048619807105e-14
observations O 0 4.533134978501607e-11
would O 0 5.67609923906448e-13
need O 0 9.096090851021255e-13
to O 0 7.733812505336668e-13
be O 0 2.875815904856971e-13
confirmed O 0 2.4149052983007957e-12
by O 0 4.9482113014236856e-14
studying O 0 3.6284603793790282e-12
a O 0 1.968581649417194e-14
larger O 0 2.564915544767208e-14
number O 0 4.1628240568178376e-14
of O 0 7.430278614606323e-12
CD B-Disease 0 4.6383673179661855e-05
families O 0 4.125488145545475e-12
. O 0 3.287873445723122e-11

Molecular O 1 0.9989707469940186
defects O 1 0.9999998807907104
leading O 0 2.399273455466755e-07
to O 0 2.6146100909341108e-11
human O 0 3.305682949594768e-10
complement B-Disease 0 2.0104883446947497e-07
component I-Disease 1 0.9999997615814209
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.2130990656444851e-11
an O 0 5.704380652733765e-14
African O 0 1.4823669635538606e-12
- O 0 7.856295475283659e-12
American O 0 3.812346705683867e-12
family O 0 2.419903470315954e-12
. O 0 1.0210565899726465e-11

Complement B-Disease 0 1.5484922187170014e-05
component I-Disease 1 0.999931812286377
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 1.1285150591788806e-08
C6D B-Disease 1 1.0
) O 0 1.0469387162759247e-10
was O 0 3.0979194765023976e-09
diagnosed O 0 3.0013698193442906e-09
in O 0 6.726590638661545e-12
a O 0 2.04709808132586e-11
16 O 0 2.4843296309029483e-09
- O 0 4.3823764062089765e-10
year O 0 5.5430508273668355e-12
- O 0 5.222148269368176e-10
old O 0 1.4253684899045993e-09
African O 0 1.2283916939193062e-11
- O 0 2.5794807262391473e-11
American O 0 6.580075026518806e-12
male O 0 6.282812377994551e-12
with O 0 1.3726721148632492e-11
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 2.7032637239798873e-10

The O 0 2.208370908363122e-08
patients O 0 7.632096621357221e-10
father O 0 1.598073451347659e-09
and O 0 6.681635106309258e-11
two O 0 2.2710246183610394e-10
brothers O 0 5.671649319083372e-07
also O 0 1.7194365375949872e-10
had O 0 5.84030268591107e-10
C6D B-Disease 1 1.0
, O 0 4.521451268946208e-11
but O 0 3.540087873451364e-13
gave O 0 8.46096543521968e-12
no O 0 6.375872594645282e-13
history O 0 2.109387525761619e-10
of O 0 2.092587081392594e-08
meningitis B-Disease 1 1.0
or O 0 1.198479648856221e-10
other O 0 5.888114995578064e-11
neisserial B-Disease 1 0.9998422861099243
infection I-Disease 0 1.1535766134329606e-05
. O 0 1.5608568604275064e-10

By O 0 7.639811699933219e-11
using O 0 1.0145614209866594e-10
exon O 0 1.6136452174464466e-09
- O 0 1.3252580977063388e-10
specific O 0 1.8139904725891776e-12
polymerase O 0 1.7019864684275632e-10
chain O 0 5.77925311773253e-11
reaction O 0 1.0369731332296461e-12
( O 0 4.2537731692084135e-13
PCR O 0 4.752565452292856e-09
) O 0 8.772119857759775e-13
/ O 0 2.4083840824418168e-11
single O 0 6.026584179613659e-12
- O 0 1.520827214163134e-11
strand O 0 9.990354030153803e-12
conformation O 0 9.495426146755026e-12
polymorphism O 0 3.8980823777179374e-12
as O 0 2.621552063972188e-14
a O 0 5.0418979734778106e-15
screening O 0 2.0509298198547604e-13
step O 0 2.4635203816139595e-13
and O 0 9.09060153542196e-15
nucleotide O 0 5.166343698334575e-13
sequencing O 0 1.519513031025821e-12
of O 0 4.844204898324378e-12
target O 0 1.5585713275534374e-11
exons O 0 4.904791017779075e-10
, O 0 2.403669928027763e-12
we O 0 1.389895278947409e-13
determined O 0 5.841889472169015e-12
that O 0 8.350254759566592e-14
the O 0 1.6499010491166644e-11
proband O 0 1.3657397346378275e-07
was O 0 3.097132272866787e-10
a O 0 1.8788657695639754e-12
compound O 0 1.668096494267246e-10
heterozygote O 0 4.154355526253539e-09
for O 0 1.341035182206296e-11
two O 0 1.6057172258499008e-10
C6 O 1 0.9998846054077148
gene O 0 1.0266298744454616e-07
mutations O 0 2.2996033521849313e-08
. O 0 1.3649610330901396e-09

The O 0 6.3062817190484566e-09
first O 0 3.442733598202352e-10
, O 0 2.9075307699660824e-12
1195delC O 0 3.639486489959154e-09
located O 0 5.746632059100421e-10
in O 0 1.491633726258268e-11
exon O 0 4.151028853982552e-09
7 O 0 1.3668297604851887e-08
, O 0 1.0964684889203102e-11
is O 0 8.929668663575432e-14
a O 0 1.252484444283497e-13
novel O 0 1.2307362160651758e-12
mutation O 0 2.7577018359842276e-13
, O 0 7.839895724802426e-14
while O 0 1.9410296666407673e-13
the O 0 1.4823613257025636e-12
second O 0 2.337966105436795e-11
, O 0 1.3327212326341015e-13
1936delG O 0 2.703701984518858e-10
in O 0 8.819669820858689e-12
exon O 0 1.374428792999538e-09
12 O 0 6.142395481134599e-10
, O 0 2.837762793847509e-12
has O 0 1.0043132775069963e-13
been O 0 2.667798707639557e-13
described O 0 9.44701174926399e-12
before O 0 5.835055355563057e-11
to O 0 1.4217177782271939e-11
cause O 0 8.182677646573211e-09
C6D B-Disease 1 0.9999986886978149
in O 0 1.0739557854133608e-10
an O 0 4.2919221779000316e-13
unrelated O 0 2.1276689299298823e-09
African O 0 2.2603420524180962e-10
- O 0 5.430931815375573e-10
American O 0 3.480364954566717e-11
individual O 0 2.9377275351932797e-12
. O 0 2.3626621492578437e-11

Both O 0 1.2550655625886975e-08
mutations O 0 2.644035657084487e-09
result O 0 1.1423981899350011e-10
in O 0 1.3145186328333835e-10
premature O 0 3.184788610610667e-08
termination O 0 8.101616089106756e-08
codons O 0 2.5300753492274453e-08
and O 0 4.117256313662665e-09
C6 O 0 0.02493281289935112
null O 0 2.53064570188144e-07
alleles O 0 3.3522173925604193e-10
. O 0 2.2218039907873077e-10

Allele O 0 2.289116896037058e-09
- O 0 6.980853117788399e-10
specific O 0 4.212686189469794e-12
PCR O 0 8.279733343385942e-09
indicated O 0 3.5808647713686526e-11
that O 0 5.106453319003376e-14
the O 0 1.7770226479543738e-12
probands O 0 2.6982645451312237e-08
two O 0 1.3157169798105883e-11
brothers O 0 1.8991759276332232e-08
also O 0 2.5238059905841048e-11
inherited O 0 1.946666294827537e-08
the O 0 8.361666914424859e-10
1195delC O 0 2.122113507141421e-08
mutation O 0 1.3734183929026145e-11
from O 0 7.581164862546785e-12
their O 0 1.2885913690252604e-11
heterozygous O 0 1.2995157033790505e-11
mother O 0 3.168267731501473e-11
and O 0 3.0649608285387986e-12
the O 0 2.881204823335093e-11
1936delG O 0 6.550932685200905e-09
mutation O 0 2.3120229689088667e-12
from O 0 2.615402035568981e-12
their O 0 5.5691627524889764e-12
homozygous O 0 4.438231171466356e-10
father O 0 2.4583479696360655e-09
. O 0 1.2977174022876792e-11
. O 0 1.4369799794522464e-10

PAX6 O 1 0.9999568462371826
mutations O 0 1.1313652521494078e-06
reviewed O 0 1.0549739499765565e-06
. O 0 2.142268584748308e-08

Mutations O 0 6.67728698999781e-08
in O 0 3.1551123935713576e-09
PAX6 O 1 0.9257129430770874
are O 0 3.0546905283035386e-11
responsible O 0 2.311202118576716e-09
for O 0 5.3001252692252976e-11
human O 0 2.852935887531771e-09
aniridia B-Disease 1 1.0
and O 0 4.785725982170419e-11
have O 0 2.0103014102012574e-14
also O 0 2.1854437679577447e-14
been O 0 4.4318102112401656e-14
found O 0 5.893229697642721e-14
in O 0 1.0617378422847837e-13
patients O 0 1.6143446171859588e-12
with O 0 2.751335617667827e-12
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 1.4627465816374752e-07
with O 1 0.9872758984565735
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 6.530189011755283e-07
with O 0 4.5111040236633926e-08
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999997615814209
keratitis I-Disease 1 1.0
, O 0 3.7961989107770933e-10
and O 0 3.154003724858967e-10
with O 0 1.2909470159527814e-09
isolated B-Disease 1 0.9999998807907104
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 5.025124210078502e-07

No O 0 1.8686089120478755e-08
locus O 0 6.532587248919697e-10
other O 0 6.639884822523534e-12
than O 0 1.0575183307173774e-12
chromosome O 0 4.1376754800204196e-10
11p13 O 0 1.0084734824999941e-08
has O 0 6.732735029213455e-13
been O 0 1.2730245460210177e-12
implicated O 0 2.3169963170310837e-10
in O 0 1.7243792505006184e-10
aniridia B-Disease 1 1.0
, O 0 9.93834181617359e-11
and O 0 1.0357249086156983e-10
PAX6 O 1 0.9999562501907349
is O 0 3.83711569462708e-11
clearly O 0 2.453001343716288e-11
the O 0 2.120641509617549e-11
major O 0 2.2573433400285836e-10
, O 0 1.2899235716026802e-12
if O 0 1.6610700648614883e-14
not O 0 8.878357948729609e-15
only O 0 3.283581834711245e-14
, O 0 7.169666878421854e-13
gene O 0 3.582852764472122e-11
responsible O 0 3.919672142416175e-09
. O 0 1.2650532843494489e-09

Twenty O 0 1.860909151218948e-07
- O 0 7.749139996349186e-09
eight O 0 3.2845073882903364e-11
percent O 0 9.24633308287126e-13
of O 0 1.6630507734816113e-11
identified O 0 4.1155742702692066e-10
PAX6 O 1 0.9211682081222534
mutations O 0 8.075920487904398e-10
are O 0 3.892207389721847e-11
C O 0 0.00016579183284193277
- O 0 2.0590955500665586e-06
T O 0 8.817507477942854e-06
changes O 0 1.0141783940431637e-10
at O 0 1.6046525219692853e-09
CpG O 0 3.90716401454938e-08
dinucleotides O 0 6.802598306876462e-08
, O 0 1.966343537648796e-12
20 O 0 4.4712280752867706e-12
% O 0 1.978304232398958e-14
are O 0 2.735935901389177e-15
splicing O 0 1.616120848257907e-10
errors O 0 3.5374174700564254e-08
, O 0 1.3185457066466899e-11
and O 0 2.213097543765641e-12
more O 0 8.25529745338829e-15
than O 0 2.5175133787531945e-14
30 O 0 3.6727864673180566e-12
% O 0 4.031393342524177e-14
are O 0 3.617577767835341e-15
deletion O 0 3.778677024057764e-12
or O 0 4.742181040212623e-12
insertion O 0 5.081067233625447e-10
events O 0 2.4478100102420797e-10
. O 0 1.503537738756222e-09

There O 0 6.348723768923037e-10
is O 0 1.0842255912524301e-11
a O 0 6.747317114752516e-12
noticeably O 0 1.4661669656135246e-09
elevated O 0 2.3927011483237948e-08
level O 0 2.809716348473046e-10
of O 0 7.769955512326732e-11
mutation O 0 2.43959339491992e-13
in O 0 4.2759643482243037e-13
the O 0 4.208140780281866e-12
paired O 0 1.843422463287947e-11
domain O 0 7.915975817548992e-13
compared O 0 2.2385089929691931e-13
with O 0 9.81725416021248e-15
the O 0 1.7220538146497932e-12
rest O 0 7.77733988321927e-11
of O 0 1.0710672626590423e-10
the O 0 8.853315303092302e-11
gene O 0 2.790053466039666e-10
. O 0 1.2176501473781798e-10

Increased O 0 5.617238896249432e-10
mutation O 0 5.219865512051669e-11
in O 0 7.319689125651063e-12
the O 0 2.950639038656888e-11
homeodomain O 0 4.155140231887344e-09
is O 0 4.1789117197037207e-13
accounted O 0 3.9559731358773664e-12
for O 0 6.283921272871515e-14
by O 0 3.062247992072914e-13
the O 0 7.73411473753427e-11
hypermutable O 0 1.216919827129459e-06
CpG O 0 4.319238939842762e-07
dinucleotide O 0 9.354220509294464e-09
in O 0 6.642421335190107e-11
codon O 0 5.993555873828882e-09
240 O 0 5.231173272335354e-09
. O 0 7.428468951076184e-11

Very O 0 5.047589901607807e-09
nearly O 0 1.6255995161085224e-10
all O 0 1.347185557554198e-11
mutations O 0 4.7359376836864087e-11
appear O 0 5.788144616380997e-11
to O 0 9.192405517333135e-12
cause O 0 1.1113576725563235e-09
loss O 0 1.2797024773192334e-08
of O 0 1.6859842411065529e-09
function O 0 1.4119884731919607e-12
of O 0 8.839765724966142e-11
the O 0 2.5675368948985255e-12
mutant O 0 9.58400199480014e-12
allele O 0 1.0126575007143521e-13
, O 0 3.270081823597906e-14
and O 0 2.3528369600929813e-14
more O 0 3.0507236260167393e-16
than O 0 2.226864017891659e-15
80 O 0 3.081549555458696e-12
% O 0 1.4673607449011868e-14
of O 0 3.4596472821973867e-12
exonic O 0 2.355372075157902e-08
substitutions O 0 2.0325259253439754e-09
result O 0 2.404176580039774e-10
in O 0 1.3682080468591096e-10
nonsense O 0 1.832164997495056e-07
codons O 0 4.5658033798190445e-08
. O 0 4.822085508671137e-10

In O 0 5.0568216281021705e-09
a O 0 1.6596674035085357e-10
gene O 0 2.1405417369169122e-11
with O 0 2.5898852290193175e-13
such O 0 1.8722806291449068e-11
extraordinarily O 0 8.230073511583669e-09
high O 0 2.1637578839772686e-08
sequence O 0 1.61040590584971e-11
conservation O 0 3.7745296471713985e-11
throughout O 0 1.0131139633814956e-12
evolution O 0 5.232821988221392e-12
, O 0 8.257096720774848e-14
there O 0 3.7124064944122487e-14
are O 0 1.9117131109473023e-13
presumed O 0 8.898423331515914e-09
undiscovered O 0 5.188801424083067e-06
missense O 0 9.491387231719273e-08
mutations O 0 2.3834763052121843e-09
, O 0 2.1041706571578445e-11
these O 0 1.336152976455507e-12
are O 0 2.056084252508028e-13
hypothesized O 0 4.105769543794047e-12
to O 0 2.1036307190549358e-13
exist O 0 1.3123234270107087e-11
in O 0 9.609224874140843e-12
as O 0 1.872466418029184e-11
- O 0 8.042180810186039e-10
yet O 0 7.574472299376467e-12
unidentified O 0 2.1545679129708617e-10
phenotypes O 0 7.472853447154648e-10
. O 0 5.6511379777079984e-12
. O 0 6.104457217492865e-11

Genetic O 0 5.940998448750179e-08
heterogeneity O 0 2.457158565505324e-08
and O 0 3.406596879584889e-11
penetrance O 0 4.32773861192004e-09
analysis O 0 1.1274640249192558e-10
of O 0 1.1649927689205697e-09
the O 0 1.884187028622364e-09
BRCA1 O 0 1.1876575456426508e-07
and O 0 1.3313908198142599e-08
BRCA2 O 0 8.272867830783071e-07
genes O 0 1.0640917036397468e-09
in O 0 9.549055768331982e-09
breast B-Disease 1 0.9999958276748657
cancer I-Disease 0 1.4205160368874203e-05
families O 0 3.586080044026829e-11
. O 0 3.5474950754732504e-10

The O 0 0.0007047544349916279
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 1.0380089406680781e-05
Consortium O 0 3.060422315570577e-08
. O 0 6.64511168313453e-10

The O 0 9.88650494804233e-10
contribution O 0 2.1554064089102098e-10
of O 0 5.199817909584681e-09
BRCA1 O 0 1.4276008641900262e-07
and O 0 2.1250581738740948e-08
BRCA2 O 0 8.851258462527767e-05
to O 0 1.3723072243010392e-06
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 2.3764056322761462e-07
assessed O 0 1.228013468690392e-09
by O 0 2.559239929353363e-12
linkage O 0 6.091596671531363e-10
and O 0 1.4691208319317361e-12
mutation O 0 7.974588871195731e-14
analysis O 0 2.9796928406643566e-14
in O 0 5.2129331531763565e-14
237 O 0 1.0217500456821682e-11
families O 0 1.2038634486803614e-14
, O 0 2.817803838026968e-14
each O 0 7.0105105395975795e-15
with O 0 8.829826518390316e-14
at O 0 2.1048139620116757e-10
least O 0 3.0339928703063124e-13
four O 0 1.2514391649690038e-12
cases O 0 1.2664933338180084e-11
of O 0 1.524750459225288e-08
breast B-Disease 1 0.9999969005584717
cancer I-Disease 0 0.0002725898812059313
, O 0 1.447305296442547e-11
collected O 0 5.1717123639161144e-11
by O 0 2.0421490887212457e-11
the O 0 1.1317154502421545e-07
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 3.1485620866078534e-07
Consortium O 0 6.860684020892904e-09
. O 0 1.8209879437680598e-10

Families O 0 6.985725192754089e-11
were O 0 3.2093706164859626e-11
included O 0 3.4946531779489476e-11
without O 0 8.562791968536043e-12
regard O 0 3.082756272476672e-11
to O 0 1.087995253785945e-12
the O 0 3.82948056945609e-12
occurrence O 0 5.096162158935158e-09
of O 0 2.4676350562913285e-07
ovarian B-Disease 1 0.966230034828186
or I-Disease 0 3.6480420906315203e-09
other I-Disease 0 1.8163589743380726e-08
cancers I-Disease 1 1.0
. O 0 3.1609794781672917e-09

Overall O 0 7.745337825326715e-06
, O 0 5.7880651382902215e-08
disease O 0 0.00017376767937093973
was O 0 1.836093832530139e-09
linked O 0 4.268338127388915e-09
to O 0 2.2346421588159693e-11
BRCA1 O 0 8.686780461619747e-11
in O 0 8.048367744831197e-13
an O 0 5.7426072496433514e-15
estimated O 0 6.404093394636861e-15
52 O 0 3.7356635796889637e-13
% O 0 2.698506997757667e-15
of O 0 4.689264384780123e-13
families O 0 2.7518995925328998e-14
, O 0 1.9050157230773163e-13
to O 0 1.0900142550715475e-12
BRCA2 O 0 1.1467644195350957e-10
in O 0 5.911202950736882e-12
32 O 0 2.3599238882510143e-11
% O 0 8.182029103450793e-15
of O 0 8.00971431107883e-13
families O 0 9.273823232242538e-15
, O 0 2.1646357937447208e-13
and O 0 8.963220248479897e-13
to O 0 6.98811668253807e-13
neither O 0 5.2372880338102945e-11
gene O 0 1.4842313576096666e-12
in O 0 1.1198973606102447e-12
16 O 0 2.4667906606268275e-11
% O 0 2.133014800214956e-14
( O 0 1.8574172148261292e-14
95 O 0 3.576544269079385e-11
% O 0 8.951888709474165e-14
confidence O 0 1.4968414008276199e-10
interval O 0 2.0831756319950046e-09
[ O 0 2.366452811486397e-09
CI O 0 1.5648965927539393e-05
] O 0 6.673716024252485e-10
6 O 0 7.444357907893107e-10
% O 0 1.5301540416678971e-13
- O 0 3.2745663819389037e-12
28 O 0 5.905174352976994e-12
% O 0 2.7158163277930455e-14
) O 0 1.3533645097608613e-14
, O 0 6.248638623673405e-14
suggesting O 0 7.97696977916651e-12
other O 0 2.84021191981898e-11
predisposition O 0 2.0161382963124197e-06
genes O 0 8.213356217368073e-09
. O 0 2.5504380829488582e-09

The O 0 5.399112712467513e-09
majority O 0 3.859133065192699e-12
( O 0 5.305035382340006e-13
81 O 0 2.7002541869158847e-10
% O 0 6.412041443594127e-14
) O 0 5.358278585914332e-14
of O 0 9.44208114472822e-11
the O 0 9.496602615399752e-08
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 7.905384246525982e-13
were O 0 4.8329461092844195e-12
due O 0 1.161050353082338e-10
to O 0 1.8936064521968277e-11
BRCA1 O 0 1.1376259934081645e-09
, O 0 9.436058705236672e-13
with O 0 7.45687691282304e-14
most O 0 1.8123435423841178e-13
others O 0 1.5704260808435677e-12
( O 0 3.6434660084967707e-13
14 O 0 3.411434676414693e-11
% O 0 7.679875615659859e-14
) O 0 1.773908744776096e-14
due O 0 3.461866904252986e-11
to O 0 3.906735213110579e-10
BRCA2 O 0 2.225213165729656e-06
. O 0 5.485391696424813e-09

Conversely O 0 3.315277652404802e-08
, O 0 1.6581541695259716e-11
the O 0 3.2163549167768535e-12
majority O 0 3.599670474890848e-14
of O 0 4.616681169300474e-12
families O 0 1.533691556187492e-14
with O 0 4.855349520875574e-13
male B-Disease 0 2.3000135129791488e-10
and I-Disease 0 1.7458984258311716e-09
female I-Disease 0 1.463685777025603e-07
breast I-Disease 1 0.9999810457229614
cancer I-Disease 0 0.008981863036751747
were O 0 2.231420159759523e-09
due O 0 6.202915869835124e-08
to O 0 4.277748988368302e-10
BRCA2 O 0 1.236647406699376e-08
( O 0 1.5888203946934354e-11
76 O 0 3.0917866045143683e-09
% O 0 8.224658475976254e-13
) O 0 6.232358379376635e-13
. O 0 2.539973960324904e-11

The O 0 1.0034350239607193e-08
largest O 0 1.4930015002079244e-09
proportion O 0 1.6161200849795776e-11
( O 0 3.2577712229253653e-12
67 O 0 3.4642533286444177e-10
% O 0 2.565096640411331e-14
) O 0 5.2480065005331995e-15
of O 0 1.341144534837413e-12
families O 0 1.3471705813340642e-14
due O 0 8.043817695257971e-11
to O 0 2.197064795719794e-12
other O 0 4.210260178688641e-12
genes O 0 3.751238035476501e-12
was O 0 5.2880682471778684e-11
found O 0 4.819954656752612e-13
in O 0 1.6301737249587583e-13
families O 0 1.6707350072511914e-15
with O 0 3.1131645655477214e-14
four O 0 4.277108181516276e-12
or O 0 4.925795882293471e-12
five O 0 3.2340345679227056e-12
cases O 0 1.4930681691005532e-11
of O 0 7.187549222464895e-09
female O 0 4.8429033228103435e-08
breast B-Disease 1 0.9989160299301147
cancer I-Disease 0 9.374382898386102e-06
only O 0 8.910931714734005e-11
. O 0 1.388538839464104e-09

These O 0 1.443953151492039e-10
estimates O 0 5.508294861900076e-11
were O 0 3.8184893615123006e-12
not O 0 3.9285686249251883e-14
substantially O 0 7.944809740645375e-12
affected O 0 9.385929533589632e-12
either O 0 3.459786060075465e-12
by O 0 4.99266697862738e-13
changing O 0 2.7273653821491273e-11
the O 0 1.2795881541849408e-11
assumed O 0 5.154911220106584e-11
penetrance O 0 9.652972865481502e-10
model O 0 1.2338817467760776e-11
for O 0 6.136159289016341e-12
BRCA1 O 0 4.2980402570336196e-10
or O 0 1.33772116647779e-12
by O 0 5.858121604994382e-13
including O 0 2.0235532000034695e-11
or O 0 8.109860005767189e-11
excluding O 0 2.3682963146143265e-08
BRCA1 O 0 2.6975286004926602e-08
mutation O 0 5.58861706911884e-11
data O 0 6.036748323445806e-10
. O 0 1.5609878667444121e-10

Among O 0 2.9823485347968415e-10
those O 0 8.551740912632333e-12
families O 0 5.663122423262001e-13
with O 0 4.065467754110763e-11
disease O 0 4.630319745047018e-05
due O 0 3.327851549883576e-09
to O 0 9.906565151540647e-11
BRCA1 O 0 2.3086952349871126e-09
that O 0 3.869479064423642e-13
were O 0 1.4103472729953825e-11
tested O 0 1.1797116235279237e-11
by O 0 1.0124450648511807e-13
one O 0 4.6570759130570155e-14
of O 0 1.039900479095357e-12
the O 0 9.518336910752795e-14
standard O 0 2.7057457836765497e-13
screening O 0 1.0139330645702813e-13
methods O 0 4.71190252614162e-13
, O 0 3.2611002250384005e-14
mutations O 0 4.644393593669638e-13
were O 0 8.899084811067604e-13
detected O 0 1.0982245494950416e-11
in O 0 2.3614882835656936e-13
the O 0 8.175656874588599e-13
coding O 0 7.114404551589182e-12
sequence O 0 3.7998659665854084e-13
or O 0 8.987987898433428e-14
splice O 0 3.4829300554761744e-10
sites O 0 2.368761436999378e-12
in O 0 1.2560011895552253e-13
an O 0 4.7277779225709214e-15
estimated O 0 1.7982558598119737e-14
63 O 0 1.82120239028416e-11
% O 0 1.474897474659266e-14
( O 0 3.8996024698213436e-14
95 O 0 1.4047529806049397e-10
% O 0 5.493798775277337e-13
CI O 0 5.74806222175539e-07
51 O 0 8.946410279264683e-10
% O 0 5.353153358957086e-13
- O 0 7.860855716357307e-11
77 O 0 4.962001920461034e-10
% O 0 3.366911784097315e-13
) O 0 6.05550169469754e-13
. O 0 2.427837965390811e-11

The O 0 3.4346270272322954e-10
estimated O 0 4.2458213594248617e-13
sensitivity O 0 5.872566755799058e-12
was O 0 1.2243146600698918e-11
identical O 0 2.295470671181965e-12
for O 0 8.896631837533673e-15
direct O 0 2.792400811719043e-14
sequencing O 0 1.4511799964825323e-12
and O 0 1.2841197018480938e-13
other O 0 5.71636108673973e-14
techniques O 0 1.7852501699167078e-09
. O 0 2.4164085662969903e-11

The O 0 1.837706342655565e-08
penetrance O 0 1.704147393866151e-06
of O 0 3.24747958302396e-07
BRCA2 O 0 3.102693213463681e-08
was O 0 4.4216366679172836e-10
estimated O 0 3.427344671090571e-13
by O 0 2.414600366439784e-13
maximizing O 0 5.448112516681647e-10
the O 0 1.5392923047308216e-10
LOD O 0 0.0006687481654807925
score O 0 7.899386034182498e-09
in O 0 8.679146290546669e-11
BRCA2 O 0 2.2207471417345914e-08
- O 0 2.905472973324663e-09
mutation O 0 4.901195334999775e-12
families O 0 9.392939442735837e-14
, O 0 2.2716189010136417e-13
over O 0 9.299959890726739e-13
all O 0 4.1919882821060683e-13
possible O 0 7.414224616197895e-12
penetrance O 0 2.7953507952815926e-08
functions O 0 6.952576847574221e-10
. O 0 4.233907668904635e-10

The O 0 2.245920560639547e-09
estimated O 0 2.2244816665767386e-12
cumulative O 0 3.060372510965692e-10
risk O 0 1.1454184267734036e-09
of O 0 4.7391438329214e-08
breast B-Disease 0 0.0003262568498030305
cancer I-Disease 0 1.079160441008753e-07
reached O 0 2.3111258740105e-10
28 O 0 2.462138271042136e-10
% O 0 1.334490921630141e-14
( O 0 9.084084463925786e-15
95 O 0 2.1796358121162207e-11
% O 0 6.095442889580277e-14
CI O 0 5.6633098211023025e-08
9 O 0 4.825673749486725e-10
% O 0 1.0780752104835173e-13
- O 0 2.6174431545789023e-12
44 O 0 3.415677896773106e-12
% O 0 6.934070898305562e-15
) O 0 3.93626004407526e-16
by O 0 9.951181927634646e-15
age O 0 5.443617561926017e-13
50 O 0 5.666893278417906e-13
years O 0 4.94104370862402e-14
and O 0 1.0419489164699425e-13
84 O 0 4.1614812290591274e-11
% O 0 2.0359610027889056e-15
( O 0 2.95591692229646e-15
95 O 0 8.389215537529804e-12
% O 0 6.616339014208286e-14
CI O 0 6.484031445097571e-08
43 O 0 3.123794001247404e-10
% O 0 6.843520026925468e-14
- O 0 3.2771281348320525e-12
95 O 0 1.4195852826581756e-11
% O 0 5.823702184013478e-15
) O 0 1.2162938901153788e-15
by O 0 2.547004355471158e-14
age O 0 3.9388371037007985e-12
70 O 0 6.887187348203483e-11
years O 0 4.507998575126182e-12
. O 0 2.906112850364906e-11

The O 0 1.4447335843215114e-06
corresponding O 1 0.9999994039535522
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 1.8873106455430388e-07
were O 0 3.1313831527768343e-09
0 O 0 4.640276607403848e-09
. O 0 2.139704906312101e-11

4 O 0 1.6486485066025125e-08
% O 0 2.5032090116006156e-12
( O 0 2.0363670873244782e-13
95 O 0 2.605643999176177e-11
% O 0 1.0597671693110197e-13
CI O 0 4.1599314215545746e-08
0 O 0 1.66176985366695e-11
% O 0 9.276831046238238e-15
- O 0 6.486625472867935e-13
1 O 0 6.829140660087607e-13
% O 0 1.3869544059655304e-15
) O 0 2.099210488207601e-16
by O 0 3.645533666742995e-15
age O 0 3.0079945153617393e-13
50 O 0 4.1041700745390874e-13
years O 0 3.264983701694972e-14
and O 0 4.370664596843772e-14
27 O 0 7.928007209057064e-12
% O 0 4.514255316128216e-15
( O 0 2.5524888938046296e-15
95 O 0 3.9356226610998135e-12
% O 0 2.966717989978315e-14
CI O 0 1.8811645574601243e-08
0 O 0 1.2015575166779424e-11
% O 0 2.8149676329063816e-14
- O 0 3.567889039768346e-12
47 O 0 5.237834905386096e-12
% O 0 1.1192896652925666e-14
) O 0 1.5643817621521783e-15
by O 0 3.298144025140441e-14
age O 0 8.228177687807925e-12
70 O 0 1.0837671038377295e-10
years O 0 1.188376914235123e-11
. O 0 4.295021976963298e-11

The O 0 1.6168563377050305e-08
lifetime O 0 7.310647731628706e-08
risk O 0 1.1578640624065883e-07
of O 0 0.00015331426402553916
breast B-Disease 1 1.0
cancer I-Disease 1 0.9990695118904114
appears O 0 8.739129558898995e-11
similar O 0 4.520413991043748e-12
to O 0 1.5996750365315782e-12
the O 0 7.027795012604088e-11
risk O 0 2.7099373092753787e-11
in O 0 2.1881541717450048e-11
BRCA1 O 0 3.3141298039218725e-10
carriers O 0 5.215882413478479e-12
, O 0 1.1027494022097795e-12
but O 0 2.3248579371858667e-14
there O 0 5.326628691620407e-14
was O 0 4.23170743238388e-12
some O 0 2.737106331515693e-14
suggestion O 0 1.2036173273333173e-11
of O 0 2.027143175542534e-10
a O 0 2.509300579822682e-11
lower O 0 1.1170409486283006e-08
risk O 0 1.9866421008263302e-10
in O 0 2.0351859086886748e-10
BRCA2 O 0 5.803029612394539e-09
carriers O 0 7.569030818777023e-11
< O 0 1.126615467583747e-09
50 O 0 2.1088443491468212e-10
years O 0 8.405440406200615e-12
of O 0 6.018419096420757e-11
age O 0 1.425655982156826e-10
. O 0 7.884159991533579e-11

Eye B-Disease 1 1.0
movement I-Disease 0 0.0005144946626387537
abnormalities I-Disease 1 0.9997729659080505
correlate O 0 1.0351254964291456e-08
with O 0 4.5281313421075e-11
genotype O 0 7.906519527978162e-08
in O 0 1.3066899784419661e-09
autosomal O 1 0.9999998807907104
dominant O 1 0.9999129772186279
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 1.0
. O 0 1.3672904231043503e-07

We O 0 6.385061812608228e-09
compared O 0 4.167370892815825e-09
horizontal O 0 1.7700992316349584e-07
eye O 0 0.00012532126856967807
movements O 0 1.3779290384263732e-06
( O 0 1.3196339576637683e-09
visually O 0 4.688621046966546e-09
guided O 0 2.1410885153727577e-07
saccades O 0 8.904146966415283e-07
, O 0 5.673420760965442e-11
antisaccades O 0 5.648907475119813e-08
, O 0 4.595481981062299e-12
and O 0 2.5266269111645645e-12
smooth O 0 9.882748785994266e-11
pursuit O 0 3.097817558028737e-10
) O 0 1.2113499493846686e-13
in O 0 3.2656641063208425e-13
control O 0 3.555269620370005e-11
subjects O 0 5.253147361550248e-10
( O 0 5.1020580989213915e-12
n O 0 2.3570896970359634e-11
= O 0 2.657963432683985e-11
14 O 0 1.2533946103232552e-10
) O 0 1.9583699896116857e-13
and O 0 1.4157368853628949e-12
patients O 0 1.7481016634235402e-12
with O 0 1.7944092121479488e-13
three O 0 3.2558825427408955e-12
forms O 0 1.293487983389241e-09
of O 0 6.93729660383724e-08
autosomal O 1 0.9953266382217407
dominant O 0 0.0005838852957822382
cerebellar B-Disease 1 0.9999921321868896
ataxias I-Disease 0 0.016122234985232353
type I-Disease 0 0.03133750706911087
I I-Disease 1 0.9449134469032288
spinocerebellar B-Disease 1 0.994666576385498
ataxias I-Disease 0 3.187700713169761e-05
1 I-Disease 0 1.8105341226259952e-08
and I-Disease 0 7.617346337029929e-11
2 I-Disease 0 1.227119073021754e-09
( O 0 9.444706301764416e-12
SCA1 B-Disease 0 0.001478556776419282
, O 0 1.3893268480114074e-11
n O 0 2.653337402222511e-12
= O 0 3.141506802958882e-12
11 O 0 1.2968563722903781e-11
; O 0 3.0971332811748076e-13
SCA2 B-Disease 0 5.51381799596129e-06
, O 0 1.8230714247252644e-12
n O 0 4.0324105274498756e-13
= O 0 4.0444964001171146e-13
10 O 0 6.259090468141437e-13
) O 0 1.4830330567110542e-14
and O 0 1.0397457634453433e-12
SCA3 B-Disease 1 1.0
/ O 0 7.45706927318679e-08
Machado B-Disease 0 2.0015153978647504e-08
- I-Disease 0 7.371679711098977e-09
Joseph I-Disease 0 3.3472297218395397e-06
disease I-Disease 0 7.199076890174183e-07
( O 0 1.8633778547938462e-11
MJD B-Disease 1 1.0
) O 0 7.186030850231395e-12
( O 0 4.774652353177478e-13
n O 0 1.1285349391099153e-11
= O 0 3.7175849204595934e-11
16 O 0 3.7786376805293287e-10
) O 0 1.2149323430979408e-12
. O 0 9.588023951179192e-12

In O 0 6.264241392273107e-08
SCA1 B-Disease 1 0.9994800686836243
, O 0 1.1865859683712898e-10
saccade O 0 5.159519922415257e-09
amplitude O 0 1.8433952975183132e-10
was O 0 1.3737380157030632e-11
significantly O 0 1.0976956783858086e-13
increased O 0 1.3529214098854936e-13
, O 0 1.2293678987133905e-13
resulting O 0 1.7526655040484007e-12
in O 0 7.989502288918704e-12
hypermetria B-Disease 0 1.0703842008297215e-06
. O 0 8.000962670173806e-10

The O 0 9.82288881345994e-08
smooth O 0 3.0345098878115095e-08
pursuit O 0 1.2548644789944774e-08
gain O 0 6.789163120579644e-10
was O 0 1.8418673253250972e-09
decreased O 0 1.6166551430885079e-09
. O 0 1.1655189313675152e-10

In O 0 7.306869775902669e-08
SCA2 B-Disease 1 0.9995570778846741
, O 0 6.51557641173639e-10
saccade O 0 2.1132716909733062e-08
velocity O 0 2.092430229083675e-09
was O 0 8.525887218446826e-10
markedly O 0 5.183229401239942e-10
decreased O 0 1.2124016235404156e-09
. O 0 6.174954297888391e-11

The O 0 6.69240618478284e-09
percentage O 0 1.508524527515931e-09
of O 0 8.665569373178528e-10
errors O 0 7.80189495230843e-08
in O 0 4.4229861440037155e-10
antisaccades O 0 4.282196641725022e-06
was O 0 9.98569671395444e-10
greatly O 0 6.609357592474163e-12
increased O 0 3.1337191413842447e-13
and O 0 1.1332452988163655e-12
was O 0 2.483406926281906e-12
significantly O 0 2.312639283633816e-13
correlated O 0 1.2598893282811385e-11
with O 0 1.1637267755340575e-13
age O 0 1.6002924679847652e-11
at O 0 6.797524321200399e-09
disease O 0 5.105098807689501e-06
onset O 0 1.4294906804934726e-06
. O 0 9.556734570370651e-11

In O 0 9.707792347768418e-10
addition O 0 4.356837807195646e-11
, O 0 1.581255525823222e-12
a O 0 3.444803578674105e-13
correlation O 0 4.280281099174055e-13
between O 0 9.20419014442675e-13
smooth O 0 3.6332131747585095e-11
pursuit O 0 1.1811328304300872e-10
gain O 0 6.9554878349975535e-12
and O 0 3.1800519791243265e-13
the O 0 4.2805014632656124e-13
number O 0 6.086799087760136e-14
of O 0 2.1951893428018288e-11
trinucleotide O 0 4.1744692680367734e-07
repeats O 0 3.3258211740161414e-09
was O 0 1.8538753865371405e-09
found O 0 2.5834503980526335e-10
. O 0 1.5464372837836748e-10

In O 0 8.566562996747962e-07
SCA3 B-Disease 1 1.0
, O 0 4.2341461892192456e-08
gaze B-Disease 0 2.1985422336001648e-06
- I-Disease 0 1.3271369425638113e-07
evoked I-Disease 0 2.717014524478145e-07
nystagmus I-Disease 0 5.785432949778624e-05
was O 0 3.6004625947327895e-09
often O 0 1.1070190987852446e-12
present O 0 2.8906987480786794e-12
as O 0 2.7913493998860117e-12
was O 0 1.5496025296268812e-10
saccade O 0 2.0834866276686625e-08
hypometria O 0 4.0314296256838134e-07
and O 0 3.708592322126947e-10
smooth O 0 3.900988865268573e-09
pursuit O 0 3.842246076857236e-09
gain O 0 3.8016403913765373e-10
was O 0 7.741025598306805e-10
markedly O 0 1.232866808642541e-09
decreased O 0 1.1879996986152719e-09
. O 0 1.628293055944141e-10

Three O 0 4.6495878258667744e-09
major O 0 1.1400197452715588e-09
criteria O 0 9.240757603556915e-10
, O 0 4.121775837306885e-12
saccade O 0 2.0948103252038663e-09
amplitude O 0 7.815020158785657e-11
, O 0 1.4080994399992552e-12
saccade O 0 4.628041005982908e-10
velocity O 0 2.8498617354877354e-10
, O 0 3.192128852913534e-12
and O 0 1.5650526664565123e-12
presence O 0 1.0084123640285991e-11
of O 0 6.700743848675472e-10
gaze B-Disease 0 2.36288258292916e-07
- I-Disease 0 4.6308361589808555e-08
evoked I-Disease 0 5.0557350306235094e-08
nystagmus I-Disease 0 3.531546326485113e-07
, O 0 1.2292113941297922e-12
permitted O 0 4.143753049024035e-12
the O 0 2.3788763927473644e-12
correct O 0 1.166612639824649e-11
assignment O 0 3.2861678656015414e-11
of O 0 3.764837400166421e-11
90 O 0 1.1305774025305304e-11
% O 0 1.577644942853465e-14
of O 0 1.9882398678838786e-12
the O 0 5.338300548135555e-12
SCA1 B-Disease 0 9.482532914262265e-05
, O 0 8.891517622004741e-13
90 O 0 2.1660123781380713e-12
% O 0 4.748926217681493e-15
of O 0 4.4610718114360126e-13
the O 0 2.717497884704989e-12
SCA2 B-Disease 0 0.00024292229500133544
, O 0 2.0497106616168548e-12
and O 0 3.904650853949615e-13
93 O 0 1.1031186381016411e-10
% O 0 2.664720589909235e-14
of O 0 2.248720740866128e-12
the O 0 1.4891398661051602e-12
patients O 0 2.610633584310129e-11
with O 0 6.959830628483488e-11
SCA3 B-Disease 1 1.0
to O 0 7.4772155134184e-10
their O 0 2.749255822998009e-10
genetically O 0 5.575462758145022e-09
confirmed O 0 5.938440711394932e-11
patient O 0 7.073576169247531e-10
group O 0 3.705894532218812e-12
and O 0 1.2010252818314693e-12
, O 0 5.386850904579021e-13
therefore O 0 3.985844206771949e-12
, O 0 1.4712351345883001e-12
may O 0 4.023217089338393e-12
help O 0 6.202832518453771e-12
orient O 0 1.1999131288575882e-07
diagnoses O 0 4.23859887632716e-07
of O 0 2.938832608379016e-07
SCA1 B-Disease 1 1.0
, O 0 1.043876540762767e-09
SCA2 B-Disease 1 0.9999998807907104
, O 0 1.3584880442785163e-10
and O 0 1.9174567489343985e-10
SCA3 B-Disease 1 1.0
at O 0 4.6687564925207425e-09
early O 0 9.47910847037825e-11
clinical O 0 1.6962641291584646e-09
stages O 0 6.222761861351955e-09
of O 0 1.271095118049459e-09
the O 0 1.2156464279655665e-08
diseases O 1 0.9999998807907104
. O 0 3.513540847155383e-11
. O 0 5.2374177911262976e-11

Genetic O 0 3.0851783350271944e-08
basis O 0 2.894188222413163e-10
and O 0 4.621896615430998e-12
molecular O 0 3.3741380800478282e-09
mechanism O 0 1.3488639538650204e-08
for O 0 2.959716915995614e-09
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 0 5.553564506044495e-07

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 1.0
causes O 0 1.323744243109104e-07
more O 0 1.2772369967217756e-12
than O 0 2.432067134489069e-13
300 O 0 3.1234466402185745e-11
, O 0 2.172918312295935e-12
000 O 0 1.4083882671211967e-10
sudden O 0 4.470362968689301e-10
deaths O 0 4.124939625982371e-11
each O 0 1.8646014094715613e-14
year O 0 1.0534511495552054e-13
in O 0 1.5403831639046461e-12
the O 0 5.8141914893727886e-11
USA O 0 3.103614290012047e-05
alone O 0 3.6264094505078504e-10
. O 0 3.825000385870858e-11

In O 0 1.00908104094799e-09
approximately O 0 3.942476553553398e-11
5 O 0 2.2175025704562756e-10
- O 0 2.149256744798933e-10
12 O 0 2.2897740994953786e-11
% O 0 2.3469295829122404e-14
of O 0 3.9224613140875775e-13
these O 0 1.06357759784622e-14
cases O 0 4.884217487920173e-13
, O 0 1.2673885649728406e-13
there O 0 1.7530615698782732e-14
are O 0 1.90102568967598e-14
no O 0 2.752548189377535e-12
demonstrable O 0 8.796735073701711e-07
cardiac O 1 0.999858021736145
or O 0 2.1965833596482298e-08
non O 1 0.9999998807907104
- O 1 0.9999910593032837
cardiac O 1 1.0
causes O 0 2.268810206373928e-08
to O 0 2.1274789655661985e-12
account O 0 3.400607974466535e-13
for O 0 3.6277111956778407e-13
the O 0 9.90367076542098e-12
episode O 0 1.628040757761795e-11
, O 0 6.172095305548644e-14
which O 0 5.025441817378554e-15
is O 0 2.3222598330267536e-15
therefore O 0 1.2678818769613215e-13
classified O 0 1.9793046368565825e-10
as O 0 2.5462192354552826e-09
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 9.122180699705495e-07
IVF B-Disease 1 1.0
) O 0 3.2777752734247656e-10
. O 0 1.5158845012575028e-10

A O 0 1.8687891270019463e-06
distinct O 0 5.36837907461063e-09
group O 0 6.719211298467087e-10
of O 0 6.495319837540592e-08
IVF B-Disease 1 1.0
patients O 0 9.140946666263972e-09
has O 0 7.027490162058239e-14
been O 0 1.702071507824962e-13
found O 0 1.261710869246077e-13
to O 0 5.5988081602538833e-14
present O 0 1.927935675688497e-12
with O 0 3.9498035376249463e-13
a O 0 5.961432736345529e-11
characteristic O 0 9.579304105500341e-08
electrocardiographic O 0 5.16647232871037e-05
pattern O 0 6.216180281626293e-08
. O 0 2.6088031734872175e-10

Because O 0 8.91644535983005e-10
of O 0 2.4011073129770466e-09
the O 0 9.582557837506389e-12
small O 0 1.4528298269284035e-13
size O 0 8.806167058582337e-13
of O 0 7.507980348542276e-11
most O 0 2.2595196113445182e-13
pedigrees O 0 1.0767164243530303e-10
and O 0 1.6921865384628143e-12
the O 0 4.845110423978838e-12
high O 0 7.227370923956755e-10
incidence O 0 5.325298535474587e-10
of O 0 3.478519902677668e-11
sudden B-Disease 0 1.4587241137231644e-10
death I-Disease 0 1.4454142327480213e-09
, O 0 9.293380951944097e-13
however O 0 2.2298753555444195e-13
, O 0 4.244588486029474e-14
molecular O 0 2.9008517810069634e-11
genetic O 0 1.989450965078632e-11
studies O 0 3.849634586799988e-12
of O 0 2.5718377427708106e-10
IVF B-Disease 1 1.0
have O 0 6.850444690675861e-13
not O 0 1.118620102688421e-13
yet O 0 3.1367287239847386e-12
been O 0 2.5678944647750113e-12
done O 0 5.0454293520907356e-11
. O 0 8.161252923466478e-11

Because O 0 4.294840323382232e-07
IVF B-Disease 1 1.0
causes O 0 0.000419256481109187
cardiac O 1 1.0
rhythm O 1 1.0
disturbance O 1 1.0
, O 0 5.0722048089424376e-11
we O 0 2.462872028714813e-13
investigated O 0 1.825731649196527e-10
whether O 0 1.7934974685940297e-11
malfunction O 0 2.0185267203487456e-05
of O 0 7.2552883700893744e-09
ion O 0 1.2387483927511767e-08
channels O 0 1.5796119967603772e-09
could O 0 3.543241533510155e-10
cause O 0 1.902137825027239e-08
the O 0 9.284802371389844e-10
disorder O 0 3.384375446557897e-08
by O 0 2.7484075128605956e-13
studying O 0 1.9465297429466233e-11
mutations O 0 1.6377414832277615e-12
in O 0 4.924722738983145e-13
the O 0 4.212943362225108e-12
cardiac O 0 2.587437641921042e-08
sodium O 0 6.154814990999569e-10
channel O 0 4.619013616036227e-09
gene O 0 3.054130104374053e-08
SCN5A O 1 0.9994819760322571
. O 0 2.466162829506402e-09

We O 0 1.1812957279033753e-09
have O 0 3.0435868669104194e-12
now O 0 2.3190275654644266e-12
identified O 0 4.258897921827209e-12
a O 0 3.3672539583029515e-12
missense O 0 8.108909099746597e-09
mutation O 0 7.413803598810276e-11
, O 0 6.3308937085782e-12
a O 0 5.1120817648464545e-12
splice O 0 6.526863671751926e-08
- O 0 4.5622492450547725e-09
donor O 0 1.5647700149501453e-11
mutation O 0 9.116352117644055e-11
, O 0 2.3711935193126976e-12
and O 0 5.038300505966209e-12
a O 0 6.071684821584711e-12
frameshift O 0 3.0969744546638367e-09
mutation O 0 3.5581778409093934e-12
in O 0 1.5429062107802372e-12
the O 0 6.338771955244349e-12
coding O 0 2.645234864484536e-10
region O 0 7.063487988956396e-11
of O 0 2.9120847400143646e-10
SCN5A O 1 0.9998962879180908
in O 0 4.644876497317263e-11
three O 0 9.592084071474716e-12
IVF B-Disease 1 1.0
families O 0 5.028949479068956e-12
. O 0 4.9793297957068106e-11

We O 0 2.7089824827797315e-10
show O 0 3.3218743727969624e-11
that O 0 2.1162945392427454e-14
sodium O 0 8.384268214596535e-13
channels O 0 8.040695388157604e-13
with O 0 5.837406160660516e-14
the O 0 4.848901228454716e-12
missense O 0 2.378344632347762e-09
mutation O 0 4.023794492047372e-11
recover O 0 9.37845801018966e-10
from O 0 6.218781045674859e-11
inactivation O 0 1.5658679686225696e-08
more O 0 9.20931354179283e-14
rapidly O 0 1.76077739628272e-12
than O 0 8.515627100496269e-15
normal O 0 1.1689574004949965e-12
and O 0 2.2841231401941886e-13
that O 0 2.1529736069576984e-14
the O 0 5.545409183932426e-12
frameshift O 0 2.3963901973900192e-09
mutation O 0 7.60568431151798e-12
causes O 0 4.955063703099283e-12
the O 0 3.5230681219577953e-12
sodium O 0 3.5211332547607777e-12
channel O 0 4.921147257058722e-12
to O 0 1.7884501659574253e-13
be O 0 1.5377931946499585e-13
non O 0 3.9289536069020414e-09
- O 0 2.8715794186950916e-09
functional O 0 4.373925666101286e-10
. O 0 1.9792886080116645e-11

Our O 0 8.562204101281168e-08
results O 0 1.4231354983351707e-09
indicate O 0 9.379902410344698e-11
that O 0 9.640533949481847e-14
mutations O 0 2.353620553660618e-12
in O 0 3.1670820480056427e-12
cardiac O 0 1.8660445633145173e-08
ion O 0 2.4197084336208263e-09
- O 0 5.7968705391431286e-08
channel O 0 2.389930198187784e-10
genes O 0 1.2144365374444632e-12
contribute O 0 8.037348591576413e-14
to O 0 9.539910501106183e-14
the O 0 1.5968065628438333e-12
risk O 0 5.24457257136679e-12
of O 0 2.676021730596556e-11
developing O 0 8.556105823842586e-10
IVF B-Disease 1 1.0
. O 0 1.4556966743128896e-11
. O 0 3.215921279275946e-11

Molecular O 0 1.1440417324593e-07
heterogeneity O 0 6.868582147490088e-08
in O 0 1.4861287755962849e-09
mucopolysaccharidosis B-Disease 0 5.5521792091894895e-05
IVA I-Disease 1 1.0
in O 0 2.6281660181481925e-10
Australia O 0 1.1981071690314593e-10
and O 0 2.5258705717290386e-12
Northern O 0 1.8067937146426516e-09
Ireland O 0 6.7306560325164355e-09
: O 0 4.74137612851977e-12
nine O 0 4.322751531726787e-11
novel O 0 5.55833851167975e-12
mutations O 0 2.997190690079421e-11
including O 0 1.4790020597121867e-10
T312S O 0 1.0531042562433868e-06
, O 0 3.561717587530211e-11
a O 0 3.913144981659844e-12
common O 0 3.399223957867292e-11
allele O 0 4.479850084643244e-12
that O 0 5.540127750547179e-14
confers O 0 2.8516233818720593e-10
a O 0 3.664700765071416e-10
mild O 0 1.984604386962019e-05
phenotype O 0 3.6027792305048933e-08
. O 0 8.917023786025879e-10

Mucopolysaccharidosis B-Disease 1 0.9999970197677612
IVA I-Disease 1 1.0
( O 0 6.32794399280101e-05
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 4.820102095237644e-09
is O 0 2.089563765073077e-12
an O 0 1.5443849324392467e-11
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 0.02783369831740856
by O 0 3.121250757853744e-10
a O 0 6.031998012190343e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 7.705495130849727e-10
N O 0 1.3493790618213097e-07
- O 0 6.254401885286143e-09
acetylgalactosamine O 0 1.5093073670868762e-06
- O 0 4.097828920635038e-08
6 O 0 8.274084706272333e-08
- O 0 1.1600199911754316e-08
sulfate O 0 3.818757310369847e-09
sulfatase O 0 2.3119764591683634e-06
( O 0 1.136160165948752e-09
GALNS O 1 0.999998927116394
) O 0 1.842759000947325e-10
. O 0 3.878039209204154e-11

Previous O 0 9.729689054438495e-09
studies O 0 1.749367456449491e-10
of O 0 1.607951410909081e-10
patients O 0 7.603552336366004e-12
from O 0 9.892191232818703e-12
a O 0 6.04596104084032e-12
British O 0 1.159548235207808e-09
- O 0 1.3537146514863707e-08
Irish O 0 6.490248893875616e-10
population O 0 5.241884146390445e-15
showed O 0 2.8322889823392816e-13
that O 0 2.8691727016846207e-15
the O 0 1.6832312453585185e-12
I113F O 0 1.6185472517804556e-08
mutation O 0 1.727048018485e-11
is O 0 5.481100734958458e-14
the O 0 1.564911530438709e-13
most O 0 1.9950565112165745e-14
common O 0 8.169935539724393e-13
single O 0 2.3629506337718986e-11
mutation O 0 5.074692055462293e-11
among O 0 2.8281854635991976e-10
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 1.7309906979789957e-05
and O 0 2.0477053386258603e-09
produces O 0 3.280962346252636e-08
a O 0 1.0158244245772607e-09
severe O 0 0.0198691263794899
clinical O 0 0.006569711957126856
phenotype O 0 6.102835925503314e-08
. O 0 5.810325554023166e-10

We O 0 4.815265963742377e-10
studied O 0 4.3473624700141045e-09
mutations O 0 5.830382704408166e-11
in O 0 1.8932379969305302e-11
the O 0 1.4677471738000492e-10
GALNS O 1 0.998915433883667
gene O 0 6.352112585927827e-11
from O 0 1.892674905690228e-11
23 O 0 2.4944132870352576e-10
additional O 0 7.491001569048805e-11
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 6.529142382305508e-08
( O 0 8.091253361763862e-12
15 O 0 7.601859419725798e-11
from O 0 5.704929584293694e-12
Australia O 0 2.478619046120123e-11
, O 0 1.32821948968867e-13
8 O 0 6.498467562676691e-12
from O 0 4.095841504500597e-13
Northern O 0 2.774132659699724e-11
Ireland O 0 1.559877782497665e-10
) O 0 1.7413121725790015e-13
, O 0 5.239887435623883e-14
with O 0 3.590096630894622e-15
various O 0 4.2927762039512984e-12
clinical O 0 4.5739662368760037e-07
phenotypes O 0 8.694534159303657e-08
( O 0 4.069333758849325e-10
severe O 1 0.8353243470191956
, O 0 7.175789129565402e-11
16 O 0 1.7293000365015132e-10
cases O 0 1.2000956868887802e-12
; O 0 1.0318113551066599e-13
intermediate O 0 4.1799705363665396e-10
, O 0 3.976062643192002e-13
4 O 0 2.9481639352013644e-11
cases O 0 1.176998277487018e-12
; O 0 1.254149019878914e-12
mild O 0 7.137728630368656e-08
, O 0 6.453592434757516e-12
3 O 0 2.3180615760232115e-10
cases O 0 1.1474902625319139e-11
) O 0 2.3262355583475447e-12
. O 0 2.650233331402685e-11

We O 0 1.6894737830952522e-09
found O 0 5.56012284824714e-11
two O 0 6.843640237841342e-13
common O 0 3.1956741940175615e-12
mutations O 0 1.1291976468458254e-12
that O 0 4.0186492236129676e-14
together O 0 3.1858134294689144e-13
accounted O 0 7.828084534755586e-12
for O 0 2.126098640675353e-13
32 O 0 2.55044041441721e-11
% O 0 7.862163204546205e-14
of O 0 5.869588235590806e-12
the O 0 1.2658267663223643e-11
44 O 0 1.771697649699533e-10
unrelated O 0 3.455100650029408e-10
alleles O 0 1.175690079145697e-12
in O 0 1.5832594566986269e-12
these O 0 5.1072180339006845e-12
patients O 0 2.337102456007045e-10
. O 0 1.4924740610045006e-10

One O 0 6.175349120951523e-09
is O 0 1.4436935154293895e-11
the O 0 8.069742096772359e-11
T312S O 0 2.905824487697828e-07
mutation O 0 2.8082700054277154e-10
, O 0 2.541436028638544e-12
a O 0 9.14937179838371e-13
novel O 0 1.1477659968284204e-11
mutation O 0 1.8986615665100848e-12
found O 0 3.5117416787022737e-13
exclusively O 0 2.800929280177833e-11
in O 0 4.913625496066887e-12
milder O 0 2.590035705907212e-07
patients O 0 1.1487768514228947e-09
. O 0 8.058195222204745e-10

The O 0 1.1633435548219495e-08
other O 0 1.2938600191247929e-10
is O 0 7.894580171877164e-13
the O 0 1.518716142429044e-12
previously O 0 9.853104443457994e-11
described O 0 1.1613515010777675e-10
I113F O 0 1.1460221216452737e-08
that O 0 5.384313871495405e-13
produces O 0 1.1662372456644476e-10
a O 0 7.210858299355749e-11
severe O 0 3.546221705619246e-05
phenotype O 0 2.164724435260723e-07
. O 0 2.8631241821841513e-09

The O 0 2.4273369092497887e-08
I113F O 0 2.406725911896501e-07
and O 0 2.011294880643888e-10
T312S O 0 1.6815276282500236e-08
mutations O 0 8.021001397795491e-12
accounted O 0 5.960182347664045e-11
for O 0 1.1588853791530407e-12
8 O 0 2.9996227723927404e-10
( O 0 5.796535126889601e-13
18 O 0 1.218323272128563e-11
% O 0 1.1667399427779841e-14
) O 0 4.001835111390201e-15
and O 0 1.8610777524109834e-13
6 O 0 1.6122692070297262e-10
( O 0 3.2073722475677025e-13
14 O 0 3.267717346711052e-11
% O 0 8.20619156530417e-15
) O 0 3.594207281787647e-15
of O 0 3.169009759468322e-12
44 O 0 4.906397857440403e-11
unrelated O 0 9.441365467210971e-10
alleles O 0 3.08898783288325e-12
, O 0 1.065552941020842e-11
respectively O 0 3.623844002653698e-10
. O 0 2.1896080781846905e-10

The O 0 8.893485947680801e-09
relatively O 0 3.7219002879673724e-10
high O 0 2.039819424481948e-09
residual O 0 1.2898873080757767e-07
GALNS O 1 0.979518711566925
activity O 0 2.3308477370420633e-10
seen O 0 5.715777677550715e-12
when O 0 1.5690809654182736e-13
the O 0 1.0709518124749073e-12
T312S O 0 3.3041952507417705e-10
mutant O 0 3.023914799116234e-11
cDNA O 0 3.093063305481536e-11
is O 0 2.5727122797587765e-13
overexpressed O 0 1.6848012984738148e-09
in O 0 1.0942058890905937e-11
mutant O 0 1.49582249364677e-10
cells O 0 6.991906185971342e-12
provides O 0 1.8084622341318912e-13
an O 0 1.3932150382369238e-14
explanation O 0 9.592959022627912e-13
for O 0 2.343487816997003e-12
the O 0 3.284465477371157e-10
mild O 0 6.728426342306193e-06
phenotype O 0 1.415357553380403e-10
in O 0 2.028800521677865e-12
patients O 0 4.653396157988654e-12
with O 0 1.077388571695155e-13
this O 0 4.3991191440474753e-13
mutation O 0 2.348183869571585e-10
. O 0 2.238277618804574e-10

The O 0 4.827054866929359e-10
distribution O 0 1.572480166911472e-11
and O 0 2.277453941580687e-13
relative O 0 5.522258540203995e-13
frequencies O 0 7.181700980435357e-12
of O 0 3.3442332236788275e-11
the O 0 2.693122417782301e-12
I113F O 0 6.138533237276533e-09
and O 0 9.675617078375165e-12
T312S O 0 5.0541024698702586e-09
mutations O 0 4.408831806579361e-12
in O 0 1.5633102451451109e-12
Australia O 0 5.646214398802307e-12
corresponded O 0 5.423056751927002e-13
to O 0 7.617944632314771e-14
those O 0 6.504549638708737e-14
observed O 0 1.2431270205934264e-12
in O 0 8.290335648877822e-13
Northern O 0 2.4568935774738065e-10
Ireland O 0 2.1672418026863483e-10
and O 0 2.898372731055532e-12
are O 0 2.4929101209540672e-14
unique O 0 1.866029168207453e-13
to O 0 8.684382152204101e-14
these O 0 3.737999425506948e-14
two O 0 1.1848246721842676e-13
populations O 0 1.14223748189958e-13
, O 0 3.139700413719304e-14
suggesting O 0 4.70781508395135e-13
that O 0 2.729295586599177e-15
both O 0 2.2004480757040895e-13
mutations O 0 1.681796737464103e-12
were O 0 6.120706372292339e-12
probably O 0 1.3002116744376124e-12
introduced O 0 4.428466328452313e-13
to O 0 1.8051779147008895e-13
Australia O 0 1.2668478462443677e-12
by O 0 8.285019670100854e-14
Irish O 0 7.92102841651321e-11
migrants O 0 7.836382909763573e-14
during O 0 3.1447484590343966e-13
the O 0 3.489274570233486e-13
19th O 0 9.141726264871863e-10
century O 0 1.1526902765623959e-09
. O 0 3.4413204924588214e-11

Haplotype O 0 9.953417645647278e-08
analysis O 0 1.731683130223871e-10
using O 0 1.3464669657015094e-10
6 O 0 6.898921878217834e-09
RFLPs O 0 2.565356851391698e-07
provides O 0 1.4705562071878897e-12
additional O 0 1.1823865725488908e-13
data O 0 4.0060112345419174e-12
that O 0 5.863089639577277e-15
the O 0 9.939128513269946e-13
I113F O 0 2.8164568455224526e-09
mutation O 0 1.13466842258797e-12
originated O 0 1.5550992568322264e-12
from O 0 1.652547998616527e-13
a O 0 1.0467055146885437e-13
common O 0 2.7361591724978096e-12
ancestor O 0 4.987373292131281e-10
. O 0 8.711553006746087e-11

The O 0 7.562270809557958e-09
other O 0 5.779517489590269e-11
9 O 0 4.5414125793286075e-09
novel O 0 1.5826321156375833e-11
mutations O 0 3.718902356203424e-12
identified O 0 3.002435973453732e-12
in O 0 8.258108823502863e-13
these O 0 1.4625785391825241e-12
23 O 0 8.71376748534658e-10
patients O 0 3.8686770800766546e-12
were O 0 3.756028040674542e-12
each O 0 1.698338159287962e-14
limited O 0 2.7115852965775566e-12
to O 0 1.3480278091698716e-12
a O 0 6.610593582950797e-12
single O 0 1.2620257616724473e-10
family O 0 8.191441448757164e-12
. O 0 6.513821426690214e-11

These O 0 1.5993960322813194e-10
data O 0 7.774432486673533e-11
provide O 0 8.981771489752211e-13
further O 0 3.1126194829055043e-13
evidence O 0 4.124670223426552e-12
for O 0 4.4881585698364895e-14
extensive O 0 1.763157675416238e-11
allelic O 0 4.8890367310150395e-09
heterogeneity O 0 1.0112486403812682e-09
in O 0 1.9294460473773256e-10
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
in O 0 1.7147891440139063e-10
British O 0 1.1792493648243862e-09
- O 0 2.337376869832042e-08
Irish O 0 2.1846573439177064e-09
patients O 0 3.833916691065031e-12
and O 0 1.1435039655623147e-13
provide O 0 7.361263156110617e-14
evidence O 0 2.2698325857772872e-11
for O 0 1.5451081711824466e-13
their O 0 1.4973995350955893e-12
transmission O 0 1.4302126150056438e-10
to O 0 1.2330853569123001e-13
Australia O 0 2.7855096701445703e-12
by O 0 6.31044085801051e-14
British O 0 4.860135210948968e-11
- O 0 7.178598826484972e-10
Irish O 0 9.609742168681379e-11
migrants O 0 1.2952779040315e-13
. O 0 3.849175210339506e-14
. O 0 2.567874732295472e-12

Identification O 0 2.6149689347221283e-07
of O 0 1.1253043652459382e-07
constitutional O 0 4.876508796769485e-07
WT1 O 1 0.9999997615814209
mutations O 0 3.3782017183625612e-09
, O 0 5.8865850562084265e-12
in O 0 8.693567784059941e-13
patients O 0 9.051530358572535e-12
with O 0 2.0491800964417273e-11
isolated O 0 0.0014133104123175144
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 3.182913307919755e-11
and O 0 7.74181120686418e-13
analysis O 0 5.436657634499964e-12
of O 0 4.194249947353512e-10
genotype O 0 3.2614215683679504e-07
/ O 0 2.096672631068941e-07
phenotype O 0 1.1527578197556565e-10
correlations O 0 3.8957056330835016e-11
by O 0 9.020275439130046e-14
use O 0 1.2874097621295988e-11
of O 0 1.374978603196908e-10
a O 0 1.7876495639682077e-12
computerized O 0 2.138539656471039e-07
mutation O 0 7.399789808681945e-11
database O 0 5.463781857506511e-11
. O 0 4.4970596690951936e-11

Constitutional O 0 1.2707411656265322e-07
mutations O 0 3.450729257892249e-09
of O 0 1.305634445003534e-08
the O 0 2.979363700195137e-10
WT1 O 0 0.0012030090438202024
gene O 0 2.322965569900859e-10
, O 0 1.329340283684477e-12
encoding O 0 3.5887876871643076e-12
a O 0 2.3700732348919118e-11
zinc O 0 2.6121169227621976e-08
- O 0 4.121690011515966e-08
finger O 0 5.12989792866847e-08
transcription O 0 2.4645734342243486e-09
factor O 0 1.5792067306619195e-11
involved O 0 2.551772378470152e-12
in O 0 4.398301514663139e-11
renal O 0 0.0009299328085035086
and O 0 8.12039324671332e-09
gonadal O 1 0.8747785091400146
development O 0 3.318491437198645e-08
, O 0 1.1536546891399713e-11
are O 0 1.9975276451368942e-14
found O 0 2.2404011968107235e-13
in O 0 9.494184952107965e-14
most O 0 8.821747179326225e-14
patients O 0 2.8877338888178006e-12
with O 0 3.7813155384647246e-12
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.1258470600239434e-08
DDS B-Disease 1 1.0
) O 0 1.9009244178747053e-10
, O 0 5.407607087809518e-12
or O 0 8.216298197361027e-10
diffuse B-Disease 1 0.9999998807907104
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 2.2202558014328133e-08
DMS B-Disease 1 1.0
) O 0 4.119190231965941e-12
associated O 0 4.4831343498641374e-11
with O 0 3.376631006052344e-12
pseudohermaphroditism B-Disease 1 1.0
and O 0 8.613899638021394e-08
/ O 0 8.13344684047479e-07
or O 0 3.020384164997836e-09
Wilms B-Disease 1 0.9999995231628418
tumor I-Disease 0 0.00019978989439550787
( O 0 6.0946678814843835e-09
WT B-Disease 1 1.0
) O 0 7.600801238405452e-11
. O 0 5.7943084358358377e-11

Most O 0 1.4041376950046924e-09
mutations O 0 4.684366228246972e-09
in O 0 5.009322290305818e-09
DDS B-Disease 1 1.0
patients O 0 1.6532735003238486e-07
lie O 0 1.2111685521176696e-07
in O 0 5.607561637255287e-10
exon O 0 7.863113715700365e-09
8 O 0 7.904796817115312e-09
or O 0 1.3224628336860889e-10
exon O 0 2.4645827600977555e-09
9 O 0 1.5006135001272014e-08
, O 0 7.523372549944618e-12
encoding O 0 5.783355044863825e-11
zinc O 0 1.0951244888701694e-07
finger O 0 2.9618485086757573e-07
2 O 0 4.3248671310891496e-09
or O 0 5.482073128781906e-10
zinc O 0 1.0612752276983883e-07
finger O 0 9.373101761411817e-08
3 O 0 7.44824979470593e-10
, O 0 4.998717910952022e-13
respectively O 0 4.696535261389245e-12
, O 0 7.149043455747378e-14
with O 0 3.6460641634778607e-14
a O 0 5.717195380311457e-12
hot O 0 9.266428691034889e-08
spot O 0 1.0200438715912696e-08
( O 0 2.806778247321784e-12
R394W O 0 2.0642223486078137e-09
) O 0 1.2100106886511058e-13
in O 0 1.111462050867873e-12
exon O 0 4.31284030710799e-09
9 O 0 5.126064195337676e-08
. O 0 2.54405774224864e-10

We O 0 4.766261274546935e-10
analyzed O 0 4.4732798021307474e-10
a O 0 8.231630654886857e-12
series O 0 2.700448545334133e-11
of O 0 1.2652263958745635e-10
24 O 0 5.871206854024535e-10
patients O 0 6.671799831353686e-12
, O 0 7.745577725211394e-13
10 O 0 1.1144280810670981e-11
with O 0 2.202805212542236e-12
isolated B-Disease 0 3.7366140759331756e-07
DMS I-Disease 1 1.0
( O 0 7.57816831509217e-09
IDMS B-Disease 1 0.9999992847442627
) O 0 3.949175014783535e-11
, O 0 2.110423814871698e-12
10 O 0 3.8269396332446526e-12
with O 0 1.5897653202548434e-12
DDS B-Disease 1 1.0
, O 0 2.0231376296475645e-10
and O 0 1.5956716850618058e-11
4 O 0 2.137520604961196e-09
with O 0 1.638754756894123e-11
urogenital B-Disease 1 1.0
abnormalities I-Disease 1 1.0
and O 0 1.2024653983644384e-07
/ O 0 1.12394600364496e-05
or O 0 1.8089572506596596e-07
WT B-Disease 1 1.0
. O 0 1.0753260504259288e-08

We O 0 7.118093670044345e-09
report O 0 3.9120089390110024e-09
WT1 O 0 0.0006639880011789501
heterozygous O 0 2.033848200966304e-09
mutations O 0 2.170816304492007e-10
in O 0 1.0830480262624675e-10
16 O 0 2.5014184057425837e-09
patients O 0 4.169505712914301e-11
, O 0 2.808620740493706e-12
4 O 0 8.956210773014561e-10
of O 0 6.057475077092533e-10
whom O 0 2.9354327996111707e-11
presented O 0 5.6000719617088635e-09
with O 0 6.10886630170171e-09
IDMS B-Disease 1 1.0
. O 0 1.0459262966833194e-07

One O 0 4.173599243983972e-09
male O 0 8.712836563340431e-10
and O 0 2.1538888728134253e-11
two O 0 4.035284606462852e-11
female O 0 2.4735069548142974e-09
IDMS B-Disease 1 1.0
patients O 0 8.875426260601671e-08
with O 0 3.67739190210159e-08
WT1 O 1 1.0
mutations O 0 0.00040809583151713014
underwent O 1 0.5318930149078369
normal O 0 9.695551852928475e-05
puberty O 0 0.0002472708001732826
. O 0 2.822241884636867e-10

Two O 0 8.3982731879928e-09
mutations O 0 6.142023778465955e-09
associated O 0 9.415546564639499e-09
with O 0 1.0707207342974812e-09
IDMS B-Disease 1 1.0
are O 0 1.0339322280283891e-11
different O 0 1.0034846217865656e-12
from O 0 8.111063036497779e-12
those O 0 1.3522899163301294e-12
described O 0 6.353518405832759e-11
in O 0 8.798440309654154e-10
DDS B-Disease 1 1.0
patients O 0 3.251737723530823e-07
. O 0 1.0584381149314481e-09

No O 0 1.0339198297515395e-06
WT1 O 1 0.9996627569198608
mutations O 0 2.0955866375516052e-08
were O 0 7.56454676675844e-10
detected O 0 4.819743715245295e-09
in O 0 2.277590963051246e-11
the O 0 3.128258069251544e-11
six O 0 2.5155780236651992e-11
other O 0 7.180909339377095e-11
IDMS B-Disease 1 1.0
patients O 0 3.054578812111686e-08
, O 0 2.1987092702069333e-11
suggesting O 0 8.909759041664245e-11
genetic O 0 1.416862849268341e-09
heterogeneity O 0 7.394492129719765e-09
of O 0 1.368454949357556e-08
this O 0 1.4489190403033092e-10
disease O 0 0.00034739432157948613
. O 0 3.0814703566584e-10

We O 0 1.5564687039226754e-10
analyzed O 0 1.2012608685552095e-09
genotype O 0 2.1354884083280012e-08
/ O 0 1.4542640869308343e-08
phenotype O 0 5.7743167886092905e-11
correlations O 0 1.1735763749687322e-10
, O 0 7.013487013374231e-13
on O 0 5.059515306715667e-12
the O 0 2.1832533068748272e-13
basis O 0 1.4059256146434218e-12
of O 0 5.455802476461713e-12
the O 0 1.60872584784727e-12
constitution O 0 5.370242011498716e-13
of O 0 2.1991077361893652e-11
a O 0 7.722864014958475e-12
WT1 O 0 8.243261618190445e-06
mutation O 0 3.328646603142915e-12
database O 0 1.9819016219835284e-12
of O 0 8.76799674531803e-11
84 O 0 5.315823337070924e-09
germ O 0 5.634258741338272e-06
- O 0 5.817960513354592e-08
line O 0 2.129349807589165e-09
mutations O 0 1.4895553540617e-11
, O 0 1.7726243378961976e-13
to O 0 4.559219213100263e-14
compare O 0 7.2491357534787415e-12
the O 0 8.146626277218127e-13
distribution O 0 1.068189590600066e-12
and O 0 2.663390612656774e-13
type O 0 1.2936403337437952e-10
of O 0 1.502556551402634e-10
mutations O 0 2.822186408180105e-11
, O 0 2.7866451550798144e-13
according O 0 8.913671938146767e-14
to O 0 7.276112627989037e-14
the O 0 2.5514948227139955e-12
different O 0 1.0585157750320207e-11
symptoms O 0 6.690111149509903e-07
. O 0 4.031917022473408e-10

This O 0 3.040588961167323e-11
demonstrated O 0 2.813770882958977e-10
( O 0 7.472488773585528e-12
1 O 0 1.3282569488737295e-10
) O 0 1.476204006039747e-13
the O 0 1.35898161213871e-12
association O 0 1.2881417287002872e-11
between O 0 5.705514728206185e-13
mutations O 0 1.5581663563579706e-12
in O 0 1.0310923989620413e-11
exons O 0 2.7856611461984926e-10
8 O 0 2.2220328355082586e-10
and O 0 6.086839799551713e-12
9 O 0 7.465729701117141e-10
and O 0 2.8559109938042226e-11
DMS B-Disease 0 6.920829764567316e-05
; O 0 3.095695574883983e-11
( O 0 7.684044373013066e-12
2 O 0 5.481090581405113e-10
) O 0 4.826587805643878e-13
among O 0 3.052136722612314e-13
patients O 0 1.070384124217394e-12
with O 0 1.371190270701983e-12
DMS B-Disease 1 1.0
, O 0 6.7131582411061874e-12
a O 0 1.843227176792639e-13
higher O 0 1.2857600184199014e-12
frequency O 0 1.1952054797259581e-11
of O 0 6.574733812936273e-11
exon O 0 5.305043071501814e-10
8 O 0 4.4114945030315766e-10
mutations O 0 3.637399192610302e-12
among O 0 9.221833366379606e-13
46 O 0 5.901295563326414e-10
, O 0 4.0721655214515096e-11
XY O 0 1.4846250451228116e-05
patients O 0 1.3772142280765731e-11
with O 0 6.544574452684027e-13
female O 0 1.3912732944876272e-11
phenotype O 0 1.9516227175997436e-11
than O 0 3.421237902354046e-13
among O 0 6.562227757717087e-12
46 O 0 2.8085069825323217e-09
, O 0 2.6067736857982027e-10
XY O 0 0.00012310592865105718
patients O 0 5.386997705553176e-12
with O 0 1.1149563124970494e-13
sexual O 0 1.908964132601998e-11
ambiguity O 0 4.128434399897074e-11
or O 0 3.590864411373573e-11
male O 0 2.02668112327109e-12
phenotype O 0 5.485495412939356e-13
; O 0 1.9399747379269389e-13
and O 0 6.495431796593731e-12
( O 0 3.758973167455881e-12
3 O 0 6.098129223808257e-10
) O 0 1.0789720489680701e-13
statistically O 0 1.5400013078994967e-12
significant O 0 2.2483763169409837e-13
evidence O 0 1.1008460636119377e-11
that O 0 2.6460419887629726e-14
mutations O 0 5.688359939332033e-12
in O 0 2.69733940044814e-11
exons O 0 8.968895071070904e-10
8 O 0 5.276444281498982e-10
and O 0 3.2178519831366215e-12
9 O 0 3.53835183375395e-10
preferentially O 0 5.570440636537555e-11
affect O 0 1.247118103231415e-10
amino O 0 9.843074272319896e-11
acids O 0 9.301791975557805e-12
with O 0 8.578651433969672e-15
different O 0 3.5477853023001965e-14
functions O 0 2.371998431005551e-12
. O 0 2.771317897387604e-12
. O 0 2.3148614969326076e-11

The O 0 1.0819923801363984e-07
185delAG O 0 6.192470209498424e-06
BRCA1 O 0 3.032172557482227e-08
mutation O 0 1.666477025819013e-11
originated O 0 2.059501007234399e-11
before O 0 2.0445177668915182e-12
the O 0 8.886290412280645e-14
dispersion O 0 3.6758297794481365e-11
of O 0 1.3431368864336157e-11
Jews O 0 2.095422576772754e-12
in O 0 3.6135818729660096e-13
the O 0 4.5256742689341045e-13
diaspora O 0 1.9097707627552946e-13
and O 0 5.481374902582825e-13
is O 0 1.3693018581799245e-14
not O 0 3.074300364587089e-15
limited O 0 3.1373569107234767e-12
to O 0 2.946168309314601e-11
Ashkenazim O 0 3.6937615277565783e-06
. O 0 1.4585495033969664e-09

The O 0 3.8669803359425714e-08
185delAG O 0 6.368522917910013e-07
mutation O 0 2.3257142045540746e-10
in O 0 1.1568194319133696e-10
BRCA1 O 0 2.5074753384757287e-09
is O 0 7.898345606022206e-13
detected O 0 1.0630889918372688e-10
in O 0 2.0742517946314987e-12
Ashkenazi O 0 1.1112517572797742e-09
Jews O 0 1.035596539078476e-10
both O 0 4.639499721903473e-12
in O 0 1.641132924001809e-10
familial B-Disease 1 0.999997615814209
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 7.065374674208869e-11
in O 0 5.775085271109148e-12
the O 0 3.868204367929451e-12
general O 0 8.450111270430494e-12
population O 0 3.627737081004709e-14
. O 0 1.3961347269247915e-12

All O 0 2.3935260440310913e-09
tested O 0 1.463633481080251e-08
Ashkenazi O 0 3.006820747941674e-08
mutation O 0 3.1545922124509573e-11
carriers O 0 3.854233772415672e-12
share O 0 2.241705952810147e-12
the O 0 9.648784375648756e-12
same O 0 3.688891640069025e-12
allelic O 0 2.2448082503956357e-08
pattern O 0 3.6844249873269064e-09
at O 0 6.824580900399724e-10
the O 0 5.5553520117435085e-11
BRCA1 O 0 9.546032408991323e-09
locus O 0 9.407481460499412e-10
. O 0 2.8753815994875254e-10

Our O 0 8.371840465315472e-08
previous O 0 7.476449681576014e-09
study O 0 1.7681755365428486e-11
showed O 0 5.0016765902605176e-12
that O 0 2.589393484041789e-15
this O 0 6.8158996377682204e-15
Ashkenazi O 0 1.7521567530209836e-09
mutation O 0 3.4126906162113e-11
also O 0 4.77964564628286e-13
occurs O 0 3.819331732390213e-13
in O 0 1.320149908444132e-13
Iraqi O 0 2.1796812618712913e-11
Jews O 0 8.956782364399896e-12
with O 0 8.681996907424633e-14
a O 0 3.4730671030075433e-13
similar O 0 5.945997166856287e-12
allelic O 0 3.0824998020761996e-07
pattern O 0 1.0875166367441125e-07
. O 0 8.758507252792924e-10

We O 0 1.6026481530762027e-10
extended O 0 5.154943139018542e-10
our O 0 8.297062689677226e-12
analysis O 0 5.291735474290127e-13
to O 0 8.413017868079062e-14
other O 0 2.0014645865130964e-13
non O 0 3.539960102827422e-09
- O 0 9.663564393136426e-10
Ashkenazi O 0 1.8077209729128185e-09
subsets O 0 6.360432736052246e-10
354 O 0 9.903755593398955e-10
of O 0 2.8555187728263043e-11
Moroccan O 0 4.859664892720161e-10
origin O 0 9.558443446466836e-12
, O 0 8.937016166173095e-13
200 O 0 5.099100395394851e-12
Yemenites O 0 7.306796501183044e-09
and O 0 9.99359362624519e-12
150 O 0 2.373538518507523e-11
Iranian O 0 1.695438373028324e-10
Jews O 0 1.4309963214387267e-09
. O 0 4.160133904029806e-10

Heteroduplex O 0 1.9325516404933296e-05
analysis O 0 4.1363895642021475e-10
complemented O 0 8.950131191731714e-10
by O 0 4.4405784930222347e-13
direct O 0 1.0545499369574163e-11
DNA O 0 2.5747595167047166e-09
sequencing O 0 1.707823743535286e-10
of O 0 4.512336337914036e-11
abnormally O 0 9.245235688126741e-10
migrating O 0 2.532176378300388e-11
bands O 0 1.4317362850846393e-09
were O 0 5.2075917363059165e-12
employed O 0 1.3308569801750991e-09
. O 0 1.1355724000017275e-10

Four O 0 1.2371633717478403e-09
of O 0 1.0900491620446928e-09
Moroccan O 0 4.454559388022972e-09
origin O 0 3.4145464233859e-11
( O 0 7.277768340231694e-13
1 O 0 6.762043182340083e-12
. O 0 1.0468887617963527e-14
1 O 0 1.2379026840050877e-12
% O 0 7.626140014892636e-15
) O 0 3.4632731405593144e-15
and O 0 1.3894580744213542e-13
none O 0 1.4879483062335552e-11
of O 0 6.83306952686813e-11
the O 0 3.866443276656639e-11
Yemenites O 0 5.061263053107723e-08
or O 0 1.543819586058426e-11
Iranians O 0 7.280839993406563e-12
was O 0 6.229797927526093e-11
a O 0 4.462228926204598e-13
carrier O 0 3.868374370830097e-12
of O 0 1.4376215495826017e-10
the O 0 8.338267576402103e-11
185delAG O 0 1.1818578826705561e-07
mutation O 0 4.817672927259764e-10
. O 0 2.6835672573000124e-10

BRCA1 O 0 5.616937778540887e-05
allelic O 0 1.0981269042531494e-05
patterns O 0 9.643559195637863e-08
were O 0 1.8407321500379936e-10
determined O 0 1.2980961791586587e-11
for O 0 4.006406209393354e-13
four O 0 8.413471742213519e-13
of O 0 4.372845401751091e-12
these O 0 1.5846958145129993e-14
individuals O 0 1.1834321881354641e-15
and O 0 7.366127022581659e-13
for O 0 1.0180593347508538e-12
12 O 0 1.2678734798154956e-11
additional O 0 1.010200278463158e-12
non O 0 1.7222379966597146e-08
- O 0 2.406807908528208e-08
Ashkenazi O 0 1.9274359885912418e-08
185delAG O 0 2.361728590472012e-08
mutation O 0 4.4257351256016264e-11
carriers O 0 2.7856704790107933e-11
who O 0 6.695873022710686e-11
had O 0 1.0314995790849935e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 9.616022644820532e-09

Six O 0 4.3023010931619865e-08
non O 0 1.2813920875487383e-06
- O 0 2.6117033868899853e-08
Ashkenazi O 0 3.4938372195369993e-09
individuals O 0 4.3948587716106935e-13
shared O 0 1.0113150768209511e-11
the O 0 1.487613331130344e-11
common O 0 2.3617521133223462e-11
Ashkenazi O 0 3.2562352814125006e-09
haplotype O 0 7.806651436403911e-10
, O 0 1.0450708874676362e-11
four O 0 9.679382295679773e-12
had O 0 3.717455596824459e-12
a O 0 4.0637445665459015e-12
closely O 0 3.19174062179961e-11
related O 0 4.001618592042178e-09
pattern O 0 8.355406144744393e-09
, O 0 1.6479378625589014e-12
and O 0 8.195469042987513e-13
the O 0 4.77530124817771e-12
rest O 0 1.3138017063152319e-10
( O 0 2.4814560128927354e-12
n O 0 2.2897087004203343e-11
= O 0 1.340813432504362e-10
6 O 0 2.6821818099875827e-09
) O 0 1.6701003644273293e-12
displayed O 0 4.5807757587112974e-10
a O 0 6.20997420153202e-11
distinct O 0 2.1284198847837388e-09
BRCA1 O 0 6.620245471822273e-07
allelic O 0 4.387359240354272e-06
pattern O 0 4.0654865074429836e-07
. O 0 1.5305540168597531e-09

We O 0 7.345023478322332e-10
conclude O 0 1.8577691607291058e-09
that O 0 1.2855320107030277e-12
the O 0 5.7643254752770545e-11
185delAG O 0 5.099004170006083e-07
BRCA1 O 0 4.045223889193039e-08
mutation O 0 2.1800514518610647e-11
occurs O 0 7.880438380840349e-13
in O 0 9.274110884631426e-14
some O 0 1.7400960365546517e-14
non O 0 1.886355294189457e-09
- O 0 2.771924689781713e-09
Ashkenazi O 0 2.153200950871792e-09
populations O 0 1.1355213644370643e-12
at O 0 3.668501700332394e-12
rates O 0 7.558377209705702e-13
comparable O 0 4.46401899820148e-12
with O 0 9.207101091734601e-14
that O 0 2.355316733749363e-13
of O 0 5.909337463805286e-10
Ashkenazim O 0 4.545064712146996e-06
. O 0 2.722337244520645e-09

The O 0 5.9364082538593266e-09
majority O 0 4.065713911372004e-12
of O 0 3.8580454803094355e-11
Jewish O 0 2.2967354684766406e-09
185delAG O 0 6.712313052048557e-07
mutation O 0 2.0794749255870215e-10
carriers O 0 7.821488248738184e-12
have O 0 6.104447866249127e-14
a O 0 4.860751016098896e-13
common O 0 1.0282916879100767e-11
allelic O 0 5.849402295865502e-09
pattern O 0 2.326731474155963e-09
, O 0 1.4434614527963907e-12
supporting O 0 8.530530448691565e-12
the O 0 1.984262927579028e-11
founder O 0 4.094600214443744e-09
effect O 0 3.521235733550121e-11
notion O 0 3.7290611570872656e-11
, O 0 1.7876179052647712e-13
but O 0 3.0577389646441362e-15
dating O 0 5.336661234450757e-12
the O 0 2.0036492538906547e-13
mutations O 0 8.602057325994561e-13
origin O 0 6.873938809652536e-13
to O 0 8.023288522278349e-14
an O 0 2.2960464502981906e-14
earlier O 0 3.798186591630337e-12
date O 0 6.763284376987144e-11
than O 0 1.5714530642464003e-13
currently O 0 3.4961851122505827e-12
estimated O 0 1.0557171456482273e-11
. O 0 2.5679752768681396e-10

However O 0 5.217339893448525e-10
, O 0 6.792044791176233e-12
the O 0 5.784960184496146e-13
different O 0 1.5304779470669272e-13
allelic O 0 7.414405978067862e-09
pattern O 0 1.7149665021420901e-09
at O 0 5.718487905426173e-10
the O 0 1.2753539890830723e-10
BRCA1 O 0 4.4696149004153085e-09
locus O 0 7.00362892680495e-11
even O 0 1.4862907996363028e-12
in O 0 8.700368984287943e-13
some O 0 3.3867348622805896e-14
Jewish O 0 9.170834924798754e-11
mutation O 0 2.5092717834129807e-11
carriers O 0 8.67622813871538e-12
, O 0 4.408268455130537e-12
might O 0 4.1573849397791296e-12
suggest O 0 5.043588810482724e-12
that O 0 1.2891997311272746e-13
the O 0 3.6511761496160755e-12
mutation O 0 2.642105935077299e-12
arose O 0 6.869682774024444e-12
independently O 0 2.9170978133041814e-11
. O 0 2.9787411686549303e-12
. O 0 7.659742978782802e-11

Crystal O 0 1.0034475963038858e-05
structure O 0 1.2700724028036348e-07
of O 0 2.3833553086660686e-07
the O 0 7.309044747216831e-08
hemochromatosis B-Disease 1 1.0
protein O 0 1.3290696188050788e-07
HFE O 0 0.00030016270466148853
and O 0 3.1832595587255597e-11
characterization O 0 9.749988594265346e-10
of O 0 7.348988639854781e-10
its O 0 5.565520266870294e-12
interaction O 0 2.5894022169514752e-12
with O 0 9.3073064446475e-13
transferrin O 0 2.050644321016648e-09
receptor O 0 5.860957830172708e-10
. O 0 6.353687714844014e-11

HFE O 1 0.9997493624687195
is O 0 4.768473171878895e-09
an O 0 5.534654679006934e-11
MHC O 0 1.669107223278843e-05
- O 0 2.392897897607327e-07
related O 0 3.559949846021482e-08
protein O 0 1.5250108120756778e-10
that O 0 4.602397903432677e-14
is O 0 2.4796840402958702e-14
mutated O 0 2.748838700064593e-12
in O 0 4.033612853449053e-12
the O 0 8.91564599925232e-10
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 2.5731068831191806e-07

HFE O 0 0.0005061187548562884
binds O 0 5.482554410463081e-10
to O 0 8.643342985781288e-12
transferrin O 0 5.452011064832618e-10
receptor O 0 2.1082923601367654e-11
( O 0 9.034053886913807e-13
TfR O 0 1.8921497701995804e-09
) O 0 5.384505775279935e-14
and O 0 6.190015134580756e-14
reduces O 0 1.1374028888871957e-12
its O 0 1.1331091230235013e-12
affinity O 0 2.6626606735441483e-12
for O 0 9.896286914945485e-12
iron O 0 3.929817182779516e-08
- O 0 1.7123386042428024e-09
loaded O 0 2.598603776604591e-09
transferrin O 0 2.9973710180541957e-09
, O 0 1.6623594861764346e-11
implicating O 0 1.5108338402569643e-06
HFE O 1 0.9938282370567322
in O 0 4.848171286653269e-08
iron O 0 0.07664614915847778
metabolism O 0 0.0003452337405178696
. O 0 2.8638560412019842e-09

The O 0 2.8589082035068714e-07
2 O 0 4.3181063347219606e-07
. O 0 1.6845571604306997e-09

6 O 0 1.9421404431341216e-05
A O 0 1.0378239494457375e-06
crystal O 0 1.0420866374261095e-06
structure O 0 1.5839090039548864e-08
of O 0 3.5665090081238304e-07
HFE O 1 0.9999988079071045
reveals O 0 1.0763248070588816e-09
the O 0 4.326494457834729e-12
locations O 0 8.996371009262205e-11
of O 0 7.322132233866796e-08
hemochromatosis B-Disease 1 1.0
mutations O 0 3.5463145309222455e-08
and O 0 4.201490266808605e-09
a O 0 1.0092393587513016e-08
patch O 1 0.996421217918396
of O 0 0.05462862178683281
histidines O 1 0.9986214637756348
that O 0 4.675005174648028e-12
could O 0 2.907974642335498e-12
be O 0 3.3801734740206146e-13
involved O 0 8.905575062112536e-12
in O 0 4.375467349548856e-11
pH O 0 1.5805770914312234e-08
- O 0 2.909865237654685e-09
dependent O 0 4.4706530144544843e-10
interactions O 0 6.768901550380235e-10
. O 0 3.6349337428909223e-10

We O 0 4.5239037516076053e-10
also O 0 3.9716003923107035e-12
demonstrate O 0 3.009558574573745e-11
that O 0 3.506206555561192e-13
soluble O 0 8.423283404113135e-09
TfR O 0 3.9955921238288283e-07
and O 0 4.769407646598722e-10
HFE O 0 4.150889071752317e-05
bind O 0 9.18109130387812e-11
tightly O 0 7.624835762776172e-10
at O 0 7.389690942494198e-11
the O 0 2.312053977091e-12
basic O 0 7.544068147957717e-11
pH O 0 2.400304677241394e-10
of O 0 2.7773477961900994e-10
the O 0 3.260426997830912e-11
cell O 0 1.3514506180811736e-10
surface O 0 2.3019576522731455e-10
, O 0 4.241054122472443e-13
but O 0 1.0384327471806183e-14
not O 0 1.3444624475951027e-14
at O 0 1.1871194999235612e-11
the O 0 2.067501551905604e-12
acidic O 0 1.215291089984305e-09
pH O 0 8.874676993286812e-09
of O 0 5.138905301294017e-09
intracellular O 0 1.949806183176861e-08
vesicles O 0 8.821265282676904e-07
. O 0 4.40942704571512e-09

TfR O 0 0.0008768364205025136
HFE O 0 0.0010031701531261206
stoichiometry O 0 5.878517868040944e-07
( O 0 1.130837312679489e-09
2 O 0 2.8954321162899532e-09
1 O 0 3.2100702651582935e-10
) O 0 1.7450957671104328e-13
differs O 0 3.094901451002746e-13
from O 0 1.2867193205021166e-12
TfR O 0 3.818625859963731e-09
transferrin O 0 1.5713805257000502e-10
stoichiometry O 0 2.9969521309070046e-10
( O 0 6.233586129916757e-12
2 O 0 1.6212396702908194e-10
2 O 0 9.10859998537461e-11
) O 0 1.4769531897409344e-13
, O 0 5.5066262422305556e-14
implying O 0 1.075440734729649e-12
a O 0 1.3042869464584966e-13
different O 0 2.458472980043907e-14
mode O 0 2.1702190391992282e-11
of O 0 2.061472737305281e-12
binding O 0 4.8862793151915884e-12
for O 0 7.340940355593517e-12
HFE O 0 5.498005702975206e-05
and O 0 8.035307835774219e-11
transferrin O 0 1.2544331129404895e-09
to O 0 1.2347387001732102e-11
TfR O 0 4.8227715154780526e-08
, O 0 1.7420040019852645e-12
consistent O 0 1.9725510114199096e-10
with O 0 3.4018729673512826e-13
our O 0 1.1673627342556614e-11
demonstration O 0 1.6399437363645575e-10
that O 0 1.3325611772883883e-13
HFE O 0 5.053323093306972e-06
, O 0 4.618380764626062e-12
transferrin O 0 4.2923870013922283e-10
, O 0 2.7232471919852452e-12
and O 0 5.4287715815781734e-12
TfR O 0 6.831763244008471e-08
form O 0 2.7383637024591678e-11
a O 0 7.122320528490933e-12
ternary O 0 2.5489171662229637e-08
complex O 0 3.2282176221087866e-07
. O 0 3.228763700846571e-09

Identification O 0 1.6285486026390572e-07
of O 0 4.844824985639207e-08
three O 0 6.253333961758756e-11
novel O 0 4.2231464852937606e-11
mutations O 0 5.957587721761026e-12
and O 0 5.587121910954895e-12
a O 0 1.7230032504922388e-12
high O 0 7.544082719634915e-11
frequency O 0 4.026404903934022e-11
of O 0 3.697698744420386e-11
the O 0 1.2392262563332146e-11
Arg778Leu O 0 2.979861903895653e-07
mutation O 0 7.171995636268136e-12
in O 0 1.6046990125584415e-12
Korean O 0 4.822833243878222e-09
patients O 0 3.714492689127491e-12
with O 0 2.8752744542920317e-12
Wilson B-Disease 0 0.09185504913330078
disease I-Disease 1 0.9917612075805664
. O 0 4.949212706328865e-10

Four O 0 4.601077918664487e-08
mutations O 0 1.5633900840583692e-09
- O 0 3.09393541897407e-08
- O 0 8.429229758633028e-09
R778L O 0 2.2851486036756796e-08
, O 0 7.1744168765597305e-12
A874V O 0 2.9853324257089753e-09
, O 0 2.2703119766098734e-12
L1083F O 0 1.2175346286724675e-09
, O 0 4.859620193232994e-13
and O 0 4.0720606140493e-13
2304delC O 0 1.278730565879016e-09
- O 0 2.231376611261382e-10
- O 0 3.712150031809358e-11
in O 0 7.179560765346871e-13
the O 0 1.4950651393980108e-12
copper O 0 9.640511999808865e-11
- O 0 2.994927916777357e-11
transporting O 0 3.311678153927744e-10
enzyme O 0 8.821788785584594e-12
, O 0 1.3023337833498183e-12
P O 0 1.2737647603344726e-09
- O 0 2.1620961965229668e-11
type O 0 2.4947927404483927e-11
ATPase O 0 5.762456137259342e-11
( O 0 1.0993017260374494e-11
ATP7B O 1 0.9995710253715515
) O 0 4.994286234571987e-13
, O 0 1.5269549337513892e-14
were O 0 7.965042471066996e-14
identified O 0 1.7556321793479185e-13
in O 0 4.19952673981136e-13
Korean O 0 1.9382561333713966e-08
Patients O 0 1.15249400300943e-10
with O 0 1.7648937866709957e-11
Wilson B-Disease 1 0.9985781908035278
disease I-Disease 1 0.999968409538269
. O 0 6.018445741773348e-10

Arg778Leu O 0 0.0009174004080705345
, O 0 5.12934472673976e-10
the O 0 4.410987200498262e-11
most O 0 1.2597870880162731e-13
frequently O 0 6.449454685586442e-13
reported O 0 1.6118463985401177e-12
mutation O 0 1.4325944944215685e-12
of O 0 1.6946617720225987e-11
this O 0 3.6969037585984216e-14
enzyme O 0 2.727608286803851e-12
, O 0 1.8355414844323237e-12
was O 0 4.066724387796761e-11
found O 0 9.57100826544377e-13
in O 0 7.196972510135902e-13
six O 0 9.173769383030717e-12
of O 0 7.391565831627034e-11
eight O 0 2.7675370675717126e-11
unrelated O 0 6.707866484489955e-10
patients O 0 9.80045038179167e-12
studied O 0 2.844962876391577e-10
, O 0 7.016001820313311e-13
an O 0 2.9054324457390354e-14
allele O 0 9.788732324711447e-13
frequency O 0 1.967170731864698e-10
of O 0 2.548371513810821e-09
37 O 0 2.6222501503525564e-08
. O 0 8.061284972882277e-10

5 O 0 3.6968021532857165e-08
% O 0 1.7938909038783812e-11
, O 0 3.6303414701482906e-13
which O 0 1.192792609475135e-13
is O 0 1.6218056831849258e-14
considerably O 0 1.1346981432800232e-13
higher O 0 2.0135653127500985e-12
than O 0 5.3268089402315824e-15
those O 0 7.218714626164476e-15
in O 0 6.553315019548062e-14
other O 0 3.2530317957586707e-13
Asian O 0 9.085674920750186e-12
populations O 0 5.72212362128649e-13
. O 0 8.407135664717513e-13

The O 0 7.312498606637519e-09
novel O 0 7.796142204030687e-11
single O 0 5.8747629157196446e-12
nucleotide O 0 2.292286846450331e-11
deletion O 0 2.5192656988304307e-11
, O 0 1.1007216188865798e-12
2304delC O 0 4.082240323555197e-09
, O 0 8.500871881422789e-12
was O 0 1.5750924176050063e-10
found O 0 3.5829672562215364e-12
in O 0 2.7299037596434372e-12
one O 0 3.945807656308142e-12
patient O 0 7.257142886629708e-09
. O 0 1.0909352310406462e-09

Since O 0 2.936056953117827e-09
a O 0 1.8077123131732264e-11
mutation O 0 6.4537646060625065e-12
at O 0 5.082014323254391e-11
cDNA O 0 1.7170966037927116e-10
nucleotide O 0 1.739154820157296e-09
2302 O 0 8.77556942668889e-07
( O 0 1.4584063123823654e-11
2302insC O 0 1.2826959050471487e-08
) O 0 4.322782149596138e-12
had O 0 1.6724272791299177e-12
been O 0 6.007632542479047e-13
previously O 0 6.840437244415298e-11
described O 0 1.1819142019253714e-11
, O 0 1.3311284041174487e-13
this O 0 2.9739794763801843e-15
region O 0 3.4590665835138035e-12
of O 0 3.10899334055037e-10
the O 0 2.879014526779855e-10
ATP7B O 1 1.0
gene O 0 6.471299607291314e-10
may O 0 2.333105063312413e-12
be O 0 6.275539441401301e-13
susceptible O 0 3.5660987496299867e-09
to O 0 1.082001155339185e-10
gene O 0 1.1815400569048506e-07
rearrangements O 0 0.2855546176433563
causing O 1 0.9999827146530151
Wilson B-Disease 1 0.9999501705169678
disease I-Disease 1 0.9996787309646606
. O 0 7.56290252645897e-10

Disruption O 0 3.888992068823427e-06
of O 0 1.740052368859324e-07
splicing O 0 7.701119741909679e-09
regulated O 0 1.940752225593201e-09
by O 0 7.0236247373678395e-12
a O 0 2.8675589680560165e-11
CUG O 0 0.0032889421563595533
- O 0 2.3842217089509177e-09
binding O 0 3.914738810895102e-10
protein O 0 2.165623014249718e-09
in O 0 1.521446635344148e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 2.8241077032475914e-08

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.21351419389247894
DM B-Disease 1 1.0
) O 0 4.440638079472592e-09
is O 0 1.7244499014509862e-12
caused O 0 7.860510853330283e-11
by O 0 6.758226357012065e-12
a O 0 2.4382563676428326e-11
CTG O 0 2.150195541616995e-06
expansion O 0 4.397859298954643e-10
in O 0 5.13383259514999e-12
the O 0 1.0980569752072622e-11
3 O 0 2.997975478979953e-10
untranslated O 0 1.3418301705314661e-06
region O 0 6.95383264859295e-11
of O 0 1.2434554774731765e-10
the O 0 1.6791293910856098e-09
DM B-Disease 1 1.0
gene O 0 1.6135190605837124e-07
. O 0 1.2958116801797814e-09

One O 0 2.619193473218928e-10
model O 0 3.93390070518862e-10
of O 0 6.5789834025054e-08
DM B-Disease 1 1.0
pathogenesis O 0 0.0006455083494074643
suggests O 0 6.730469653826177e-11
that O 0 2.4771126176745956e-14
RNAs O 0 2.3290525064112444e-10
from O 0 6.618696563043258e-11
the O 0 3.4354095089506043e-12
expanded O 0 5.931260690927864e-12
allele O 0 3.048541237157809e-13
create O 0 1.008844226148449e-13
a O 0 2.5355954315353646e-13
gain O 0 6.145998640572081e-12
- O 0 5.829337013096847e-11
of O 0 5.180252060643653e-11
- O 0 1.5795659225048553e-10
function O 0 2.6647829992967886e-13
mutation O 0 7.091176875296396e-14
by O 0 2.560628711021154e-14
the O 0 4.620157880406983e-13
inappropriate O 0 6.137212699847128e-12
binding O 0 1.2989685715947275e-10
of O 0 6.517303918762707e-10
proteins O 0 8.833171173672216e-12
to O 0 1.0611274879612775e-11
the O 0 5.617302734073348e-10
CUG O 1 0.9999508857727051
repeats O 0 6.147042341808628e-08
. O 0 5.825439020057388e-10

Data O 0 2.3651544722724793e-08
presented O 0 6.132542029746446e-09
here O 0 1.8783150382284397e-11
indicate O 0 6.084181769505648e-12
that O 0 2.1295146906703116e-14
the O 0 1.5052284505628899e-12
conserved O 0 3.0344488033406947e-10
heterogeneous O 0 3.859248920434766e-09
nuclear O 0 1.2452200053303386e-06
ribonucleoprotein O 0 1.2602297374542104e-06
, O 0 2.2421915713000118e-10
CUG O 0 0.00026464101392775774
- O 0 1.396232574002454e-09
binding O 0 1.188470571955591e-10
protein O 0 7.751245478804236e-11
( O 0 2.482563850672581e-12
CUG O 0 0.06082024425268173
- O 0 6.835501498159147e-09
BP O 0 4.823847916668456e-07
) O 0 3.1782163706362e-12
, O 0 1.0363877724767212e-12
may O 0 3.3214418628663145e-12
mediate O 0 2.1293740104511016e-09
the O 0 6.143168751471251e-10
trans O 0 2.4646624741109235e-09
- O 0 1.2360453771620428e-09
dominant O 0 1.6301016092512555e-10
effect O 0 6.835282340134086e-12
of O 0 4.953523702333484e-12
the O 0 2.7189288147322355e-12
RNA O 0 4.281293985997081e-09
. O 0 1.4530308380111823e-11

CUG O 1 0.9999966621398926
- O 0 9.627745384932496e-06
BP O 0 1.7144533558166586e-05
was O 0 3.813087179338481e-09
found O 0 1.9280976554930662e-12
to O 0 7.44627409320249e-14
bind O 0 9.173064868459035e-13
to O 0 8.103543877591157e-13
the O 0 1.5545988107934505e-11
human O 0 8.575515852982107e-10
cardiac O 0 0.10330227017402649
troponin O 0 0.000634676543995738
T O 0 0.029718292877078056
( O 0 1.4002242421096156e-10
cTNT O 0 5.1034795944815414e-08
) O 0 1.3650858872102378e-13
pre O 0 8.40099723120602e-09
- O 0 1.7898110771241704e-10
messenger O 0 3.115057864433446e-11
RNA O 0 2.451631953004352e-10
and O 0 5.785357544592362e-13
regulate O 0 1.170738592876086e-11
its O 0 8.029997565321689e-13
alternative O 0 2.1972096364564209e-10
splicing O 0 6.755426884552662e-09
. O 0 7.295244963678726e-11

Splicing O 0 4.728881606297364e-07
of O 0 5.50086895145796e-07
cTNT O 0 1.1067319974245038e-05
was O 0 2.1471816324947213e-08
disrupted O 0 3.871778062602971e-07
in O 0 7.884679575909104e-09
DM B-Disease 1 1.0
striated O 0 0.0002774664026219398
muscle O 0 8.604037020631949e-07
and O 0 1.1424439866347669e-10
in O 0 1.4915853274732882e-11
normal O 0 1.323638837424923e-10
cells O 0 6.906086379848686e-12
expressing O 0 3.5668549277362294e-12
transcripts O 0 1.5389700624979241e-09
that O 0 1.2769957617383976e-12
contain O 0 3.578860985342658e-09
CUG O 1 0.9999967813491821
repeats O 0 6.30064533879704e-08
. O 0 3.5195657499542676e-10

Altered O 0 1.9688229713210603e-07
expression O 0 2.7752045106410606e-09
of O 0 8.98794194625907e-09
genes O 0 8.210795238161595e-11
regulated O 0 2.5738411402187467e-09
posttranscriptionally O 0 6.985747518228891e-07
by O 0 8.439119403291784e-10
CUG O 1 1.0
- O 0 8.487391482958628e-07
BP O 0 5.331340844350052e-07
therefore O 0 1.876971841840991e-11
may O 0 4.386503313358325e-12
contribute O 0 3.478557936489879e-12
to O 0 1.6750247022745413e-10
DM B-Disease 1 1.0
pathogenesis O 0 0.0002887564478442073
. O 0 8.451276484189307e-11
. O 0 9.74732516922927e-11

Identification O 0 3.28066874999422e-07
of O 0 6.790943274381789e-08
a O 0 9.170730147500805e-11
novel O 0 2.608962212935495e-10
nonsense O 0 3.3641022412211896e-08
mutation O 0 5.5038414797925483e-11
and O 0 6.804038669289136e-12
a O 0 2.835133603579232e-12
missense O 0 1.5388518237458015e-10
substitution O 0 2.767918672041958e-10
in O 0 2.7049485915031646e-11
the O 0 8.160615239116709e-11
vasopressin O 0 4.597970004738272e-09
- O 0 4.3647188086026745e-09
neurophysin O 0 7.965451231939369e-07
II O 1 1.0
gene O 0 7.66116059480737e-11
in O 0 1.0658755779033302e-12
two O 0 2.2631988514168477e-13
Spanish O 0 1.5705751144068358e-09
kindreds O 0 6.733997537367031e-08
with O 0 9.563955877256447e-11
familial B-Disease 1 0.999976634979248
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999998807907104
. O 0 7.341878927036305e-08

Familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 0.0008498778915964067
FNDI B-Disease 1 1.0
) O 0 4.83219730895712e-09
is O 0 3.221125189495355e-12
an O 0 2.3620176994865183e-11
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 2.6166249881498516e-05
by O 0 1.4346256405062263e-09
deficiency O 0 0.02585134282708168
in O 0 1.0533287575498207e-09
the O 0 7.226988785191679e-09
antidiuretic O 0 1.6830665572342696e-06
hormone O 0 4.319510793493464e-08
arginine O 0 1.0150583307222405e-07
vasopressin O 0 1.5230096295226758e-08
( O 0 1.1588864590184045e-10
AVP O 0 1.4310225196823012e-05
) O 0 1.756348972509203e-13
encoded O 0 3.5683093849506187e-13
by O 0 2.4769436176609594e-13
the O 0 7.473932583934584e-11
AVP O 0 0.003436540486291051
- O 0 3.64321799395384e-08
neurophysin O 0 9.956623216567095e-06
II O 1 1.0
( O 0 7.098665211202615e-09
AVP O 1 0.9997250437736511
- O 0 6.51877698487624e-08
NPII O 1 0.6927206516265869
) O 0 8.747729970948193e-12
gene O 0 2.8612707689279482e-11
on O 0 2.9062030559856566e-10
chromosome O 0 1.3505012219638957e-08
20p13 O 0 5.8155637816526e-07
. O 0 5.645153788869095e-10

In O 0 4.364175687499028e-10
this O 0 9.725638399011097e-14
study O 0 7.129574166285513e-13
, O 0 8.735482633472416e-14
we O 0 6.260565355790514e-15
analyzed O 0 1.1675915225980993e-12
two O 0 3.331691950862574e-14
families O 0 4.350916447195012e-15
with O 0 5.998164204906731e-13
FNDI B-Disease 1 1.0
using O 0 1.7396705603855978e-11
direct O 0 9.274279261228813e-12
automated O 0 6.576496236476714e-09
fluorescent O 0 6.041278588497789e-09
, O 0 6.708562958618325e-12
solid O 0 4.226404226592706e-10
phase O 0 9.84548220728243e-10
, O 0 5.498380071557174e-13
single O 0 8.372314885644883e-13
- O 0 3.081943554528177e-12
stranded O 0 5.602082599892588e-12
DNA O 0 3.08922505631859e-11
sequencing O 0 1.2783385461290209e-12
of O 0 1.4911074111556566e-11
PCR O 0 2.948054032003711e-07
- O 0 1.0215571677463231e-07
amplified O 0 3.989978267782135e-06
AVP O 1 0.9967879056930542
- O 0 4.807163236364431e-07
NPII O 1 0.9290246963500977
DNA O 0 1.3312329656400834e-06
. O 0 1.5969511824032168e-10

In O 0 7.113082345355792e-10
one O 0 3.652318465025006e-12
of O 0 2.878820792862058e-11
the O 0 1.2956591095153458e-12
families O 0 1.0141801610216543e-14
, O 0 9.484049017047941e-14
affected O 0 9.29171561740716e-13
individuals O 0 2.345953970363593e-14
presented O 0 3.2801708571561505e-10
a O 0 2.6342825490410782e-11
novel O 0 7.197693829841256e-11
nonsense O 0 2.557730693908411e-09
mutation O 0 1.55936743552465e-12
in O 0 2.2155005694607377e-12
exon O 0 2.2758031570369042e-10
3 O 0 3.635183265515707e-10
of O 0 7.099497378870723e-11
the O 0 8.707047235989585e-12
gene O 0 1.5964136479765245e-12
, O 0 1.421819476390973e-13
consisting O 0 7.009478934782987e-12
in O 0 1.6498058344818767e-12
a O 0 2.2964704790573442e-11
G O 0 3.295199348940514e-07
to O 0 4.0370418119550777e-10
T O 0 4.462335709831677e-06
transition O 0 8.090506042890411e-10
at O 0 1.6367439348297097e-10
nucleotide O 0 3.5152519783920866e-10
2101 O 0 3.247300242037454e-07
, O 0 6.853372036541572e-13
which O 0 5.288564725036693e-14
produces O 0 1.1704945823351465e-12
a O 0 3.129472321474619e-13
stop O 0 2.080838799878304e-11
signal O 0 6.184926876207086e-11
in O 0 9.250870902643982e-12
codon O 0 6.847868938564261e-10
82 O 0 3.405522086552537e-09
( O 0 2.4682072358173102e-11
Glu O 0 0.00012155289732618257
) O 0 9.283115248726048e-11
of O 0 9.683755131106864e-09
NPII O 1 1.0
. O 0 1.5660202024037062e-08

The O 0 1.194042340557644e-07
premature O 0 4.991613167248943e-08
termination O 0 4.959789912106771e-09
eliminates O 0 1.2622501932568753e-09
part O 0 9.683709389918249e-11
of O 0 3.9272879392981963e-10
the O 0 1.0217622581354391e-10
C O 0 1.4583841334570025e-07
- O 0 5.893339982687706e-11
terminal O 0 5.411063524335402e-12
domain O 0 7.211731212208861e-13
of O 0 2.7092961554786577e-11
NPII O 0 0.4163082540035248
, O 0 2.0757954816846835e-12
including O 0 1.5536376438834987e-12
a O 0 9.914513871348007e-13
cysteine O 0 2.7783161188343897e-11
residue O 0 1.756949030706778e-09
in O 0 2.3037518073754093e-12
position O 0 4.7875061554014664e-11
85 O 0 2.9575711324447695e-10
, O 0 2.946643038077845e-13
which O 0 2.1740604921795942e-14
could O 0 7.552406643867096e-14
be O 0 1.3109711883771413e-13
involved O 0 3.967163403340024e-12
in O 0 6.9420216103344146e-12
the O 0 3.179685334475657e-11
correct O 0 1.6933385804662748e-09
folding O 0 1.0662010829776136e-08
of O 0 1.5263647012986326e-09
the O 0 1.5394838737137206e-09
prohormone O 0 6.999487959546968e-05
. O 0 4.584921331485248e-09

In O 0 1.880327671344162e-09
the O 0 4.616393031731114e-11
second O 0 7.043617078483777e-11
family O 0 1.1446456846600506e-12
, O 0 2.5925786582663146e-13
a O 0 2.0608467460759422e-13
G279A O 0 1.1777381847544177e-10
substitution O 0 4.229966724111911e-11
at O 0 2.7871158506109772e-11
position O 0 7.650511300860696e-12
- O 0 3.2912863406897586e-11
1 O 0 1.5430601241206432e-11
of O 0 3.691376197767493e-12
the O 0 8.184409096625989e-13
signal O 0 4.847294787779788e-11
peptide O 0 5.7615991838622094e-11
was O 0 1.752328664117453e-11
observed O 0 1.0851146370338682e-12
in O 0 2.341208010878809e-13
all O 0 1.3094917945127849e-13
affected O 0 3.5722880816629887e-12
individuals O 0 1.6461337230388312e-13
. O 0 5.346067338818372e-11

This O 0 1.0535693151236813e-10
missense O 0 6.676496866475645e-08
mutation O 0 2.800407128411564e-10
, O 0 2.0255266214297407e-11
which O 0 1.5551266871471903e-11
replaces O 0 4.79766470107279e-07
Ala O 0 9.341079930891283e-06
with O 0 6.077460756870323e-10
Thr O 0 0.0655483528971672
, O 0 3.1604652228622854e-10
is O 0 5.367425796355685e-13
frequent O 0 2.556411332621522e-11
among O 0 2.366307150225566e-10
FNDI B-Disease 1 1.0
patients O 0 1.4873262621506456e-08
and O 0 3.6437197009631106e-11
is O 0 1.2177674233587732e-12
thought O 0 2.3488890953798913e-12
to O 0 2.1630757623437857e-13
reduce O 0 4.7268838149205905e-12
the O 0 2.725990874002937e-12
efficiency O 0 4.823610261217581e-11
of O 0 7.728629541903231e-11
cleavage O 0 3.38974508184986e-11
by O 0 2.0837606813650655e-12
signal O 0 4.523387886479213e-09
peptidases O 0 2.2839398639007413e-07
. O 0 1.266713817171805e-10
. O 0 2.5212668064433785e-10

Genetic O 0 1.640639055722204e-07
heterogeneity O 0 4.196286909063929e-07
of O 0 7.395150873890088e-07
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 6.162811927445944e-11
due O 0 2.919070984930272e-09
to O 0 1.7045692635164755e-10
TWIST O 0 0.0003356850356794894
and O 0 2.3763675471855095e-09
FGFR O 1 1.0
mutations O 0 5.806099068195181e-08
. O 0 1.7962414888827993e-09

Thirty O 0 4.7141174945863895e-06
- O 0 8.858631872499245e-08
two O 0 3.825217486513877e-12
unrelated O 0 5.504453559623812e-10
patients O 0 4.321059569184493e-12
with O 0 2.65866023857822e-13
features O 0 1.2601886201224488e-09
of O 0 1.3732588968196069e-06
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 2.2937431468084135e-11
a O 0 9.127309151535368e-12
common O 0 1.097097790392354e-08
autosomal B-Disease 1 0.9972785115242004
dominant I-Disease 0 0.00010184657003264874
condition I-Disease 0 4.891389380645705e-06
of O 1 0.9986211061477661
craniosynostosis B-Disease 1 1.0
and O 0 0.04182915389537811
limb B-Disease 1 1.0
anomalies I-Disease 1 0.999995231628418
, O 0 1.9125632189087582e-09
were O 0 1.4401355108439873e-10
screened O 0 2.6346957948675254e-10
for O 0 3.844468580288529e-12
mutations O 0 8.236216396395601e-12
in O 0 4.5777340251795806e-11
TWIST O 0 5.198658072913531e-06
, O 0 2.911401675298464e-10
FGFR2 O 1 0.9997578263282776
, O 0 2.044886343588459e-10
and O 0 8.822656494267278e-10
FGFR3 O 1 0.9999951124191284
. O 0 8.461494616085474e-09

Nine O 0 2.1126616900346562e-07
novel O 0 1.1039380520827535e-09
and O 0 8.384357097490636e-11
three O 0 1.7297949184147399e-10
recurrent O 0 2.1120738892932422e-05
TWIST O 0 0.0014958654064685106
mutations O 0 5.257959068138973e-10
were O 0 1.1945314182248978e-10
found O 0 5.755884917996168e-12
in O 0 2.4808785668156697e-12
12 O 0 4.0209888196862664e-10
families O 0 7.690433576415523e-13
. O 0 9.118091004456375e-11

Seven O 0 6.4697722734763374e-09
families O 0 3.5448854680646125e-13
were O 0 3.1116418035964655e-12
found O 0 2.0099429932918245e-12
to O 0 4.856470043820837e-13
have O 0 2.2594504934560222e-13
the O 0 1.759302148407471e-10
FGFR3 O 1 0.9998989105224609
P250R O 0 9.200369532891273e-08
mutation O 0 3.361993669570573e-11
, O 0 1.3770033290699812e-12
and O 0 1.7864464248174006e-12
one O 0 1.4683274127819113e-13
individual O 0 3.717042136325982e-13
was O 0 1.7284690345675813e-10
found O 0 2.604971793829236e-12
to O 0 4.5210672228526705e-13
have O 0 1.0077672068153562e-13
an O 0 2.0260626943519044e-12
FGFR2 O 1 0.8283268213272095
VV269 O 0 5.699877760889649e-07
- O 0 1.2722066955461742e-08
270 O 0 2.9752480479317e-09
deletion O 0 2.4754795990844514e-09
. O 0 4.4225140216624936e-10

To O 0 1.6713927464273581e-10
date O 0 2.3472355170639503e-09
, O 0 2.52407404872923e-12
our O 0 8.331644835851693e-13
detection O 0 5.07977881980537e-10
rate O 0 2.274915499034247e-12
for O 0 1.9184634891984687e-13
TWIST O 0 5.80905705760415e-08
or O 0 1.0883575290998593e-10
FGFR O 1 0.8957257866859436
mutations O 0 7.345019731319624e-11
is O 0 2.873852956823686e-13
68 O 0 1.5321889590413917e-10
% O 0 5.285045472547441e-14
in O 0 7.080260856773268e-13
our O 0 5.511996414853115e-10
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 5.982565554063513e-10
, O 0 6.719845166425209e-12
including O 0 8.713019750139495e-10
our O 0 2.3142160188172056e-08
five O 0 7.422636949527828e-10
patients O 0 2.6864134181070476e-11
elsewhere O 0 7.346995234414067e-11
reported O 0 9.253382088347806e-11
with O 0 6.189387197208518e-11
TWIST O 0 0.04146316275000572
mutations O 0 4.331126390866302e-08
. O 0 1.366492807797215e-09

More O 0 1.1070301793314474e-11
than O 0 1.7869781175627875e-12
35 O 0 5.784303591660489e-11
different O 0 1.1265988142383776e-12
TWIST O 0 7.136925717077247e-08
mutations O 0 9.917545083781842e-12
are O 0 1.450075140258661e-13
now O 0 4.994019520837556e-13
known O 0 1.6696289533227326e-12
in O 0 4.2837437698624303e-13
the O 0 3.603321850967345e-12
literature O 0 2.510296137625545e-11
. O 0 1.6047519216244588e-11

The O 0 4.824857402496718e-09
most O 0 1.2222631760872016e-12
common O 0 3.585693211533708e-13
phenotypic O 0 4.638951115604195e-12
features O 0 1.6505054267756947e-11
, O 0 3.328416372811588e-13
present O 0 9.372542889365953e-13
in O 0 5.196872663107421e-13
more O 0 3.3148295577618142e-15
than O 0 8.528369864154763e-15
a O 0 2.464037274999692e-13
third O 0 2.1076571043998626e-11
of O 0 6.205510411083637e-11
our O 0 2.8674933955086246e-11
patients O 0 1.3336608727099186e-11
with O 0 5.138975616575392e-12
TWIST O 0 0.00018191765411756933
mutations O 0 1.6700009153325368e-09
, O 0 2.6722573806536865e-11
are O 0 1.3920583435966805e-12
coronal B-Disease 0 7.043820460239658e-06
synostosis I-Disease 0 2.350684371776879e-05
, O 0 8.77832639911702e-10
brachycephaly B-Disease 0 1.2522015822469257e-05
, O 0 2.920323760591259e-09
low B-Disease 0 0.0008414312032982707
frontal I-Disease 1 1.0
hairline I-Disease 1 1.0
, O 0 8.001656937040025e-08
facial B-Disease 1 1.0
asymmetry I-Disease 0 0.0012476673582568765
, O 0 2.7924624390607278e-08
ptosis B-Disease 1 0.9999722242355347
, O 0 7.423065273570728e-09
hypertelorism B-Disease 0 0.002337394282221794
, O 0 1.0904635416864039e-08
broad B-Disease 0 4.3139384615642484e-06
great I-Disease 0 0.00038765385397709906
toes I-Disease 1 0.846343994140625
, O 0 1.3034614498863561e-09
and O 0 2.038438529083919e-09
clinodactyly B-Disease 0 0.001060952665284276
. O 0 1.455346243517397e-08

Significant O 0 5.654081647321618e-08
intra O 0 2.5471454137004912e-05
- O 0 5.92237618946001e-08
and O 0 3.2671251121163536e-11
interfamilial O 0 1.8650415256615815e-07
phenotypic O 0 1.7469576896189665e-09
variability O 0 1.263220861247305e-09
is O 0 1.0103365626762395e-13
present O 0 4.137085368293575e-13
for O 0 1.0039862821317747e-12
either O 0 1.8305514881689078e-09
TWIST O 0 0.03294068202376366
mutations O 0 1.1561940738147314e-08
or O 0 6.372639305141092e-09
FGFR O 1 1.0
mutations O 0 1.5611985304531117e-07
. O 0 1.872718424777986e-09

The O 0 2.8974487253918824e-09
overlap O 0 1.1155600748713468e-10
in O 0 2.1131746526237283e-12
clinical O 0 8.048533506332944e-10
features O 0 6.499970700568625e-11
and O 0 2.8102925802436785e-12
the O 0 5.375081456315822e-12
presence O 0 1.1744082269171674e-12
, O 0 8.82410260854595e-14
in O 0 1.4091089677471108e-13
the O 0 2.797066506361745e-13
same O 0 4.8119694399896204e-14
genes O 0 3.351366832161397e-14
, O 0 8.983737825917285e-14
of O 0 6.1207766285931164e-12
mutations O 0 7.236491679322998e-13
for O 0 1.119991252518382e-12
more O 0 1.626145202380299e-14
than O 0 1.7486476134274953e-13
one O 0 1.2589951867494897e-12
craniosynostotic B-Disease 0 2.7234500876716083e-08
condition I-Disease 0 1.4224841304866231e-09
- O 0 5.519655843500004e-10
such O 0 2.0352507873466763e-11
as O 0 1.844678056139859e-11
Saethre B-Disease 0 1.7794500308809802e-06
- I-Disease 0 7.292553227955523e-09
Chotzen I-Disease 0 5.251159791441751e-07
, I-Disease 0 1.329488168860804e-11
Crouzon I-Disease 0 5.083952032691741e-07
, I-Disease 0 2.6006443526460643e-11
and I-Disease 0 2.293512463280578e-10
Pfeiffer I-Disease 0 1.0114612450706773e-05
syndromes I-Disease 1 0.8222602605819702
- O 0 2.507616159164172e-07
support O 0 1.4141406101675358e-10
the O 0 2.5075122533912975e-10
hypothesis O 0 1.6448306605632013e-10
that O 0 4.453774792002006e-14
TWIST O 0 2.4109384710868653e-08
and O 0 5.564268230201508e-12
FGFRs O 0 4.714989287890603e-08
are O 0 3.399244522471999e-14
components O 0 5.05558539476425e-10
of O 0 2.538396159934564e-10
the O 0 6.008782013622316e-12
same O 0 2.1727473878234427e-13
molecular O 0 1.636177998642907e-11
pathway O 0 1.9183695430802228e-12
involved O 0 1.5428759344345705e-13
in O 0 1.3280546909584523e-13
the O 0 1.2713429484514926e-12
modulation O 0 1.2923997982916546e-10
of O 0 2.7952853365320607e-09
craniofacial O 1 1.0
and O 0 2.6361749405623414e-06
limb O 1 0.9999754428863525
development O 0 2.5340052278721714e-09
in O 0 3.799507236612598e-11
humans O 0 3.452082023014391e-11
. O 0 5.836184400337396e-13
. O 0 1.3913740819215814e-11

Mutation O 0 1.1703936708684637e-09
analysis O 0 2.0615928408851403e-10
of O 0 1.1413344047639384e-08
UBE3A O 1 1.0
in O 0 0.07110990583896637
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 2.440201342324144e-06
. O 0 2.871447968288976e-09

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.754942331899656e-06
AS B-Disease 1 1.0
) O 0 5.040427450420104e-11
is O 0 2.4022385643196476e-13
caused O 0 2.7950374653640253e-11
by O 0 8.191879466434848e-12
chromosome O 0 3.938812387360713e-09
15q11 O 0 4.637890071990114e-08
- O 0 5.556227034020367e-09
q13 O 0 8.554120078940741e-09
deletions O 0 2.360392992173388e-10
of O 0 1.7274078001339177e-10
maternal O 0 3.7887989967622104e-10
origin O 0 4.3909732620750486e-12
, O 0 1.8308829929578052e-13
by O 0 6.526387503341669e-13
paternal O 0 4.270335196565611e-08
uniparental B-Disease 0 0.0002999956195708364
disomy I-Disease 0 0.0036361818201839924
( O 0 3.0498053860128493e-08
UPD B-Disease 1 1.0
) O 0 1.6254321499875601e-10
15 O 0 2.815649935428155e-10
, O 0 6.303009871845566e-13
by O 0 2.792382427715956e-12
imprinting O 0 0.007802559062838554
defects O 1 0.9918389916419983
, O 0 8.193602046846493e-11
and O 0 6.7296060217436615e-12
by O 0 1.8217226772226924e-12
mutations O 0 6.816563286049515e-11
in O 0 1.9430948169918416e-11
the O 0 1.2343820410265494e-09
UBE3A O 1 0.9997197985649109
gene O 0 1.4238774603825277e-08
. O 0 3.705509510343319e-10

UBE3A O 1 0.9559390544891357
encodes O 0 9.158030778166903e-09
a O 0 3.5580796642342705e-10
ubiquitin O 0 5.155024407343944e-09
- O 0 5.071368214260019e-09
protein O 0 2.951303437748187e-11
ligase O 0 1.9309627508068417e-10
and O 0 7.351410452605123e-11
shows O 0 4.324839930625046e-10
brain O 0 1.4753331356587296e-07
- O 0 1.5573752287778575e-09
specific O 0 4.669143890967398e-11
imprinting O 0 1.3070167597106774e-06
. O 0 6.612037029007922e-10

Here O 0 1.01799342289155e-08
we O 0 3.020582742263578e-11
describe O 0 6.627419057991801e-09
UBE3A O 0 0.4813341200351715
coding O 0 3.3062511306525266e-07
- O 0 2.1259060645206773e-07
region O 0 6.972310506725421e-10
mutations O 0 1.547620503972169e-10
detected O 0 7.236102828045432e-10
by O 0 4.260133044942105e-12
SSCP O 0 0.023912981152534485
analysis O 0 1.0000439712443132e-11
in O 0 2.5066825785208247e-12
13 O 0 1.6489550003218056e-10
AS B-Disease 0 0.18077509105205536
individuals O 0 1.3809998914012748e-14
or O 0 1.1681906527186148e-12
families O 0 2.751092810591299e-13
. O 0 3.839795495452769e-11

Two O 0 1.7638926985696912e-09
identical O 0 2.7745178599047904e-08
de O 0 1.50873734128254e-06
novo O 0 9.815170187721378e-07
5 O 0 2.9188052863560188e-08
- O 0 3.150434135790192e-09
bp O 0 1.1642308228587694e-09
duplications O 0 4.73439776271789e-09
in O 0 2.040647234524684e-10
exon O 0 6.967607824037714e-09
16 O 0 2.4253179464750474e-09
were O 0 5.900954724857854e-11
found O 0 5.4071663813104465e-11
. O 0 7.950180097582304e-11

Among O 0 4.860223334901548e-09
the O 0 1.094388052402806e-10
other O 0 2.8384991839630613e-12
11 O 0 1.1623864371035353e-10
unique O 0 1.1014061841382872e-12
mutations O 0 6.746094568382821e-12
, O 0 6.6979637981801066e-12
8 O 0 3.6570760308940464e-10
were O 0 3.8843143111699785e-12
small O 0 3.527881112241893e-13
deletions O 0 9.677818962883222e-11
or O 0 1.7568409227397552e-10
insertions O 0 3.4315312813504306e-09
predicted O 0 2.194103343455822e-09
to O 0 6.380623807089592e-11
cause O 0 1.6032338123750378e-08
frameshifts O 0 1.2686788977589458e-05
, O 0 8.815301266729136e-11
1 O 0 2.881365701590255e-10
was O 0 5.796264510027349e-11
a O 0 6.082809494815933e-13
mutation O 0 1.6646264173938302e-13
to O 0 1.5007728404198978e-13
a O 0 2.0455551315301523e-12
stop O 0 2.9651722049939266e-11
codon O 0 1.170491342739055e-10
, O 0 1.927296213247165e-12
1 O 0 7.743192198539361e-11
was O 0 5.980794332005601e-11
a O 0 1.8179947564728183e-12
missense O 0 4.319531121677045e-10
mutation O 0 1.3942857285398347e-11
, O 0 1.3169842820459632e-12
and O 0 2.431873495981063e-12
1 O 0 2.8580593447458114e-10
was O 0 2.2518217845934885e-10
predicted O 0 3.2864311966251947e-11
to O 0 1.0418262389941257e-12
cause O 0 2.2296607268823543e-11
insertion O 0 8.10996825251209e-11
of O 0 5.252005497169421e-10
an O 0 2.6426551918978802e-12
isoleucine O 0 3.41825654004424e-07
in O 0 1.6944265435192563e-10
the O 0 1.5411547038546303e-10
hect O 0 1.1223976770224908e-07
domain O 0 4.4549117866887755e-11
of O 0 2.39433750603979e-10
the O 0 5.5517930530601944e-11
UBE3A O 0 2.2342794181895442e-05
protein O 0 2.0081889276490905e-11
, O 0 1.281374637472632e-13
which O 0 2.352055063979371e-15
functions O 0 4.126759087989644e-14
in O 0 5.046935092067883e-13
E2 O 0 6.168570365616688e-08
binding O 0 5.230968436187311e-11
and O 0 1.6982273226551214e-11
ubiquitin O 0 2.5921043089738305e-09
transfer O 0 3.5764862182929846e-09
. O 0 9.718852389539734e-10

Eight O 0 2.06187280582526e-07
of O 0 9.566318404097274e-09
the O 0 1.779964717285587e-11
cases O 0 1.5189304891985445e-12
were O 0 1.8500435558510553e-12
familial O 0 2.472105020689952e-10
, O 0 4.3755732544170645e-12
and O 0 6.655099648450458e-12
five O 0 3.2948289929723984e-11
were O 0 7.683575130312814e-12
sporadic O 0 2.4552376132191966e-08
. O 0 5.178456552457078e-10

In O 0 4.945534648470584e-09
two O 0 5.113449247362567e-11
familial O 0 5.2098445557646755e-09
cases O 0 1.2320293396594906e-10
and O 0 1.1887351346329122e-11
one O 0 6.792610636290053e-13
sporadic O 0 4.572465461816222e-10
case O 0 1.0444132537978934e-11
, O 0 1.6014426113333813e-12
mosaicism O 0 4.53658408616775e-08
for O 0 2.3410151595015805e-10
UBE3A O 1 0.9999992847442627
mutations O 0 2.3216952804716584e-09
was O 0 3.389559188882174e-10
detected O 0 1.0002963041211288e-10
in O 0 7.29470899917678e-13
the O 0 4.48457763979615e-12
mother O 0 4.595578258215216e-12
of O 0 4.73965137970378e-11
three O 0 9.693498607965534e-12
AS B-Disease 1 1.0
sons O 0 9.853434512763215e-09
, O 0 4.05242679690776e-13
in O 0 1.463080009792353e-13
the O 0 8.677204788032356e-12
maternal O 0 7.290950065907964e-10
grandfather O 0 6.708317012993348e-09
of O 0 1.2442870733764266e-08
two O 0 4.64789873255711e-11
AS B-Disease 1 1.0
first O 0 1.356297713028809e-10
cousins O 0 2.423938827433858e-10
, O 0 1.0970118043129862e-12
and O 0 4.747572777616393e-13
in O 0 2.3058178630352977e-12
the O 0 3.4357849898469794e-11
mother O 0 1.5750135570757884e-11
of O 0 3.613904453469985e-10
an O 0 2.9726700268017936e-11
AS B-Disease 1 1.0
daughter O 0 5.58388876470417e-07
. O 0 1.172319574749281e-09

The O 0 1.3202230420006345e-09
frequencies O 0 2.358219730602684e-10
with O 0 7.337297002613097e-13
which O 0 4.526693147925698e-13
we O 0 1.2967609570781885e-13
detected O 0 9.040648091263037e-11
mutations O 0 2.5569513954076806e-12
were O 0 5.391242573898891e-12
5 O 0 2.0015962845509883e-11
( O 0 9.47804592514416e-14
14 O 0 6.077130552256671e-12
% O 0 3.5756365079355704e-15
) O 0 2.722619696425392e-15
of O 0 1.9838646784370306e-12
35 O 0 1.076892568174781e-11
in O 0 2.451310367797971e-13
sporadic O 0 7.708562954622522e-11
cases O 0 1.6577390501981704e-12
and O 0 7.115432375248698e-13
8 O 0 6.646590916536965e-11
( O 0 1.7427143170385684e-13
80 O 0 5.565106535321274e-12
% O 0 7.396953228156356e-15
) O 0 3.1467731388288775e-15
of O 0 5.523620623393288e-12
10 O 0 9.670008717377332e-12
in O 0 4.43079210474262e-12
familial O 0 5.2140798345590156e-09
cases O 0 1.3112032293260967e-10
. O 0 8.90572858514016e-12
. O 0 6.505675859136417e-11

The O 0 5.29870067111915e-06
hemochromatosis B-Disease 1 1.0
845 O 0 4.452957455214346e-06
G O 0 3.5940979614679236e-06
- O 0 2.6453939483417344e-08
- O 0 2.5053958907506058e-09
> O 0 5.583438919543049e-11
A O 0 1.8624832232028155e-10
and O 0 1.967212607005206e-13
187 O 0 1.2167186529132845e-11
C O 0 1.5054489876931143e-09
- O 0 1.0687735418901667e-10
- O 0 4.107755247062528e-10
> O 0 5.107749223576263e-10
G O 0 3.360941320806887e-07
mutations O 0 1.5633239147661016e-10
: O 0 2.076500213096799e-12
prevalence O 0 6.005736880032586e-11
in O 0 8.094209574512415e-14
non O 0 2.150114752907939e-09
- O 0 2.182017011520543e-09
Caucasian O 0 4.054412361398363e-10
populations O 0 1.730525770425595e-12
. O 0 4.428029557607127e-12

Hemochromatosis B-Disease 1 0.9999992847442627
, O 0 1.1673444433313307e-08
the O 0 9.995500960258141e-08
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 1.0
, O 0 1.5129159036675333e-09
leads O 0 8.373082671653265e-09
, O 0 1.9708049428524e-11
if O 0 6.633631578073507e-12
untreated O 0 0.2708457410335541
, O 0 2.243272755053649e-11
to O 0 1.0807368194809541e-10
progressive O 1 1.0
iron B-Disease 1 1.0
overload I-Disease 1 0.9999924898147583
and O 0 5.473803810218669e-08
premature B-Disease 0 1.1158153029100504e-05
death I-Disease 0 4.4344284333419637e-07
. O 0 5.016290161030668e-10

The O 0 1.5619864370819414e-06
hemochromatosis B-Disease 1 1.0
gene O 0 2.0959024737976506e-08
, O 0 9.309180509786685e-11
HFE O 1 0.7564823627471924
, O 0 8.874059126418032e-11
recently O 0 1.1947063130457458e-11
has O 0 3.3830743246957354e-14
been O 0 4.4971984442627663e-14
identified O 0 1.0557005573549882e-12
, O 0 1.2180920605942697e-13
and O 0 3.894364485838159e-13
characterization O 0 5.145424641916918e-10
of O 0 6.298500609958069e-10
this O 0 4.462722780294165e-13
gene O 0 1.3103699549044112e-11
has O 0 1.2178829451002515e-13
shown O 0 5.55148049925791e-13
that O 0 5.281465572499165e-15
it O 0 9.384321221310703e-15
contains O 0 2.536282273611634e-13
two O 0 3.637895038921361e-14
mutations O 0 3.5871707080442627e-13
that O 0 6.301416907803642e-15
result O 0 3.5682225403566026e-12
in O 0 1.4431704095652087e-11
amino O 0 6.089026505229356e-11
acid O 0 1.9270397777493287e-11
substitutions O 0 9.330890504699596e-10
- O 0 1.721553177791435e-10
cDNA O 0 5.2246668796884776e-11
nucleotides O 0 7.1899790808627184e-12
845 O 0 4.928309982332735e-10
G O 0 1.1236395813796207e-08
- O 0 5.922742851716123e-10
- O 0 2.075267041545814e-10
> O 0 2.9108895849283556e-11
A O 0 2.5307872464352954e-10
( O 0 2.2807884053621663e-13
C282Y O 0 6.33381069814476e-10
) O 0 3.2376296196963417e-14
and O 0 8.14481945429768e-14
187 O 0 1.603849344999908e-11
C O 0 1.6617525133710842e-09
- O 0 8.765873443783434e-11
- O 0 2.685431044202602e-10
> O 0 2.817121813603052e-10
G O 0 1.2631147683350719e-07
( O 0 8.072235241352033e-11
H63D O 1 0.9997631907463074
) O 0 2.589082420678679e-11
. O 0 2.4646460219934774e-11

Although O 0 3.1198189844872104e-06
hemochromatosis B-Disease 1 1.0
is O 0 8.96068289013563e-11
common O 0 2.0171949180469717e-11
in O 0 7.886833547354755e-12
Caucasians O 0 8.94808283025128e-10
, O 0 1.9371509604737547e-12
affecting O 0 2.479460733950667e-11
> O 0 6.029449856059799e-11
= O 0 2.5567332972986634e-11
1 O 0 1.230451296407864e-10
/ O 0 9.833654029955952e-11
300 O 0 9.757266609261572e-13
individuals O 0 2.437237779352947e-15
of O 0 9.335740513982671e-12
northern O 0 4.3462969334662205e-11
European O 0 2.235123891525248e-11
origin O 0 7.380503326548382e-12
, O 0 2.4328279733636105e-13
it O 0 5.134930990206539e-15
has O 0 1.0208401905035017e-15
not O 0 1.2765043801380035e-15
been O 0 1.2870518249796271e-14
recognized O 0 2.8499278674834483e-13
in O 0 9.455727623423546e-14
other O 0 2.1176321059104136e-13
populations O 0 2.5686781261052838e-12
. O 0 1.3972808153572824e-11

The O 0 4.4417056699330715e-09
present O 0 2.3760660106120213e-11
study O 0 1.1016057857582418e-12
used O 0 5.179723295244132e-13
PCR O 0 1.0036910191857373e-09
and O 0 4.351360851501118e-13
restriction O 0 1.7697267262750671e-12
- O 0 1.9236685161461153e-11
enzyme O 0 3.3471204865902215e-13
digestion O 0 6.9809128096232076e-12
to O 0 2.089266564928808e-14
analyze O 0 5.0758117327298624e-12
the O 0 1.868019898921408e-13
frequency O 0 1.7858604135431722e-12
of O 0 3.315840223921951e-12
the O 0 1.488770695265429e-12
845 O 0 4.773766937304913e-10
G O 0 6.33203889321976e-09
- O 0 4.0620676267089095e-10
- O 0 1.0108180958923185e-10
> O 0 5.449738750551436e-12
A O 0 2.088998939109299e-11
and O 0 6.605318099124971e-14
187 O 0 2.1799838410135886e-12
C O 0 1.677396832544531e-10
- O 0 7.493384385215407e-12
- O 0 2.7280521591732665e-11
> O 0 3.9463435991260454e-11
G O 0 7.956225900329628e-09
mutations O 0 7.670689604333258e-12
in O 0 2.8636659016312294e-12
HLA O 0 8.9678895420775e-09
- O 0 2.2771708130253643e-10
typed O 0 1.885511712040877e-11
samples O 0 1.4525597738512808e-11
from O 0 1.339603016188573e-12
non O 0 8.792166439341997e-10
- O 0 9.125072364390974e-10
Caucasian O 0 1.0407707334847416e-10
populations O 0 2.9846543530935576e-13
, O 0 3.3644131724281864e-14
comprising O 0 7.260233213235434e-12
Australian O 0 1.5249351781321252e-10
Aboriginal O 0 5.71035718710533e-10
, O 0 7.026618734562104e-14
Chinese O 0 3.7915544727311346e-13
, O 0 9.669371694390888e-14
and O 0 2.4160523841992854e-12
Pacific O 0 1.8744559682204454e-08
Islanders O 0 1.3787412456167658e-07
. O 0 3.6426375804587963e-10

Results O 0 4.435384326484382e-08
showed O 0 2.6594466628893088e-09
that O 0 2.4885787332749876e-13
the O 0 1.2835749824136045e-11
845 O 0 1.0028648134152718e-08
G O 0 2.70071609520528e-07
- O 0 3.232623058124773e-08
- O 0 6.115721262744955e-09
> O 0 1.0743778089405964e-10
A O 0 2.735055515401541e-10
mutation O 0 8.723815398369028e-13
was O 0 2.2533834607291192e-12
present O 0 5.776776219922411e-14
in O 0 2.6457997373400578e-14
these O 0 6.452942631737964e-15
populations O 0 1.2831544569827207e-14
( O 0 3.4135366364459628e-15
allele O 0 1.846416840291785e-15
frequency O 0 8.445785168237005e-14
0 O 0 2.932530791550231e-13
. O 0 2.4107273421697818e-15
32 O 0 3.237353419192901e-13
% O 0 1.5247771485165274e-15
) O 0 1.3805094381489909e-15
, O 0 9.878035550441554e-15
and O 0 1.147913822373628e-13
, O 0 1.5165588240512867e-13
furthermore O 0 3.685937839670306e-12
, O 0 1.5902405260670438e-13
it O 0 4.017254668568608e-14
was O 0 3.0753156965435124e-11
always O 0 1.2964154489508717e-12
seen O 0 2.325577881309715e-13
in O 0 5.021506078789137e-14
conjunction O 0 2.3864668921569354e-11
with O 0 1.6943180799339208e-12
HLA O 0 1.1938794841626077e-07
haplotypes O 0 2.7484747811001853e-10
common O 0 3.90635137084705e-12
in O 0 1.0809280553969458e-11
Caucasians O 0 1.3982259794431684e-09
, O 0 2.796219852885251e-12
suggesting O 0 2.29541941010325e-11
that O 0 1.2385781419585462e-12
845 O 0 1.9984446097964792e-08
G O 0 2.356735603825655e-05
- O 0 6.386522727552801e-06
- O 0 4.606298489306937e-07
> O 0 3.3316560621443614e-09
A O 0 5.43736033975506e-09
may O 0 7.992774736335917e-13
have O 0 3.4548809498761556e-15
been O 0 1.3281605361955412e-14
introduced O 0 1.5794700616855728e-13
into O 0 1.2794104866525619e-14
these O 0 8.967190529072903e-16
populations O 0 2.791110780540375e-15
by O 0 2.8585881356240836e-14
Caucasian O 0 2.281553140859316e-10
admixture O 0 5.819275616936181e-10
. O 0 2.628181006159025e-10

187 O 0 3.3207264493739785e-08
C O 0 1.474219146757605e-07
- O 0 1.099701218976179e-09
- O 0 4.641717288311753e-10
> O 0 8.626086650531661e-11
G O 0 1.2205719990276975e-08
was O 0 3.8255478645998764e-11
present O 0 1.586972090197869e-12
at O 0 1.8138280591037392e-12
an O 0 8.070152991777445e-16
allele O 0 1.7058994530015116e-14
frequency O 0 2.9349495923869373e-12
of O 0 7.515631866850114e-11
2 O 0 2.657094322344733e-09
. O 0 1.0973729563934498e-10

68 O 0 3.550721601186524e-07
% O 0 2.8663219801133843e-12
in O 0 7.764302980932392e-13
the O 0 6.429741179585224e-13
two O 0 1.3173069101193088e-14
populations O 0 2.071442620026325e-14
analyzed O 0 6.204133994741623e-12
( O 0 1.1636119585239912e-12
Australian O 0 7.732083306954962e-10
Aboriginal O 0 6.172931610315402e-10
and O 0 4.952973252890513e-13
Chinese O 0 2.671950551438873e-12
) O 0 5.170276641715266e-13
. O 0 1.0847820038073497e-11

In O 0 2.093256679103206e-09
the O 0 2.4829546751981013e-10
Australian O 0 1.2581616859463907e-09
Aboriginal O 0 5.829974281112982e-10
samples O 0 3.7062267317644615e-12
, O 0 3.3516544845502844e-14
187 O 0 3.918911202493991e-12
C O 0 1.4434251571771028e-09
- O 0 8.597046685654419e-11
- O 0 1.8111333266457308e-10
> O 0 6.390805940004185e-11
G O 0 1.0871760380837259e-08
was O 0 4.580581053348354e-11
found O 0 7.940862729741496e-14
to O 0 4.051046878592729e-15
be O 0 9.589546293002106e-15
associated O 0 1.2403707401464903e-11
with O 0 1.3736410446607561e-11
HLA O 0 2.1099142486491473e-06
haplotypes O 0 6.029958754538711e-10
common O 0 1.2884341163421631e-11
in O 0 6.955089282278948e-12
Caucasians O 0 1.2402253668497565e-09
, O 0 1.1791418536022391e-12
suggesting O 0 2.0500079498525503e-12
that O 0 1.3907299282729744e-14
it O 0 6.185164685111599e-14
was O 0 1.2717680207552373e-11
introduced O 0 2.7056440855127706e-12
by O 0 2.2880081076287473e-13
recent O 0 3.3629407852203697e-12
admixture O 0 6.290193366176311e-10
. O 0 9.605545525648296e-11

In O 0 1.0159426633293833e-09
the O 0 3.874342513476847e-11
Chinese O 0 1.487439403417834e-12
samples O 0 7.55791588168131e-13
analyzed O 0 1.4081289302983468e-12
, O 0 7.960576913369072e-14
187 O 0 2.7308827942051916e-12
C O 0 5.777999745326667e-10
- O 0 2.4976161763778926e-11
- O 0 8.203750873070348e-11
> O 0 1.3957625853711075e-11
G O 0 4.7047636897445955e-09
was O 0 6.027058019331122e-11
present O 0 2.1767305839748285e-12
in O 0 5.778720817833927e-12
association O 0 1.795788240332996e-10
with O 0 2.0341233309285195e-13
a O 0 1.7688021186623715e-12
wide O 0 2.1542422359854818e-11
variety O 0 9.64897398092468e-11
of O 0 9.404252931943802e-10
HLA O 0 1.4691580929593329e-07
haplotypes O 0 1.1644923914033711e-10
, O 0 9.20557792320753e-13
showing O 0 2.3240888380460234e-12
this O 0 8.289979217413618e-15
mutation O 0 1.7487076511227967e-13
to O 0 1.4621313328914282e-13
be O 0 1.6870616774238012e-13
widespread O 0 5.177901163389009e-11
and O 0 1.8987492134137085e-11
likely O 0 5.6500060706399235e-12
to O 0 7.140288360574232e-12
predate O 0 1.9572397036426992e-08
the O 0 2.809983148943651e-11
more O 0 3.9452538187333824e-14
genetically O 0 1.3369215456915384e-10
restricted O 0 9.517697047156659e-11
845 O 0 1.6946190228850355e-08
G O 0 2.2247040760703385e-06
- O 0 1.5092194871613174e-07
- O 0 3.368461776176446e-08
> O 0 1.7557496567732755e-09
A O 0 2.0021253543944795e-09
mutation O 0 7.135105006828013e-11
. O 0 1.7414899383672022e-11

Genotype O 0 4.2688072426244617e-05
- O 0 1.173769874185382e-06
phenotype O 0 7.52545048499087e-09
correlations O 0 4.4878124327851765e-08
in O 0 4.7707295891541435e-09
attenuated B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 1.3660713449326067e-08

Germ O 1 0.9982064962387085
- O 0 1.0735864634625614e-05
line O 0 4.643271722670761e-08
mutations O 0 3.953789240451755e-10
of O 0 2.162382939374652e-09
the O 0 2.6040702927332404e-10
tumor B-Disease 0 2.4212846483351314e-07
suppressor O 0 4.6271807718767377e-07
APC O 0 2.0227854236054554e-07
are O 0 3.1010007929543892e-12
implicated O 0 2.707300161830517e-09
in O 0 2.7529671875470285e-09
attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 1.3476600315698306e-06
AAPC B-Disease 1 1.0
) O 0 1.3363403439381472e-10
, O 0 7.386667774840483e-13
a O 0 3.5519850949405907e-13
variant O 0 2.739915316851693e-07
of O 0 2.4180979380616918e-05
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.623981091825044e-07
FAP B-Disease 0 0.0008783602970652282
) O 0 3.5749636584370137e-10
. O 0 1.4880056908861405e-10

AAPC B-Disease 1 1.0
is O 0 1.4834524719731235e-09
recognized O 0 1.4650201884958136e-10
by O 0 8.885787613523155e-13
the O 0 3.659507592790323e-12
occurrence O 0 1.3383580355075253e-10
of O 0 2.3638396795533367e-10
< O 0 1.5277102916044782e-09
100 O 0 6.313535250157543e-10
colonic B-Disease 0 6.202150871104095e-06
adenomas I-Disease 0 7.544977620455029e-07
and O 0 1.1818471201685554e-10
a O 0 1.048065106923346e-11
later O 0 1.0822968077306427e-09
onset O 1 0.9460400342941284
of O 0 0.035741060972213745
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 6.71454124939741e-12
age O 0 8.874630197386324e-12
> O 0 2.044768347697623e-11
40 O 0 4.392347163068022e-12
years O 0 7.237112927167832e-13
) O 0 1.4064861471665968e-12
. O 0 2.745507814150283e-11

The O 0 5.950646642105539e-09
aim O 0 1.0815622841775507e-09
of O 0 8.27132737302172e-11
this O 0 6.454198358082268e-15
study O 0 2.6117565683943245e-13
was O 0 3.5727922356731945e-12
to O 0 2.0415160989668835e-13
assess O 0 2.7241133793154404e-09
genotype O 0 4.3679442285338155e-08
- O 0 3.5484998051060757e-08
phenotype O 0 8.963935149708391e-10
correlations O 0 3.091639166896698e-09
in O 0 1.4966367034574546e-09
AAPC B-Disease 1 1.0
families O 0 1.7426869669545653e-10
. O 0 2.6004370878851546e-10

By O 0 1.3999579273615836e-09
protein O 0 1.4189965868993681e-09
- O 0 1.4282478533189646e-09
truncation O 0 1.1248533660079829e-08
test O 0 1.6603142194426823e-09
( O 0 5.514578377274759e-12
PTT O 0 3.370164947114063e-08
) O 0 7.155413821137088e-14
assay O 0 5.751122234692874e-12
, O 0 7.105636744145563e-14
the O 0 1.9973687417559893e-13
entire O 0 9.016414351248336e-12
coding O 0 4.7016730786442196e-11
region O 0 4.606892992087275e-11
of O 0 9.027552316798193e-11
the O 0 3.883761021117316e-11
APC B-Disease 0 2.6973792088824666e-08
gene O 0 4.618691193392088e-11
was O 0 4.798915778647661e-11
screened O 0 5.895577082082326e-11
in O 0 1.379621785736751e-12
affected O 0 7.128558160429677e-12
individuals O 0 5.489219037538122e-14
from O 0 1.4890305655157476e-10
11 O 0 2.507144927221816e-07
AAPC B-Disease 1 1.0
kindreds O 0 2.1708615349780302e-06
, O 0 2.7522607456975656e-11
and O 0 5.16223869206911e-12
their O 0 1.2932771173423951e-11
phenotypic O 0 1.7695404030959594e-09
differences O 0 1.3028567114048428e-10
were O 0 2.525526177077353e-10
examined O 0 1.180296678171544e-07
. O 0 2.1814263728714423e-09

Five O 0 2.585370673102716e-08
novel O 0 2.844714686034422e-09
germ O 0 1.398928179696668e-05
- O 0 7.434048825416539e-07
line O 0 9.831079239575047e-08
APC B-Disease 0 1.2731149467981595e-07
mutations O 0 1.0214836615451972e-10
were O 0 1.6074200998028587e-11
identified O 0 1.7393553611300128e-11
in O 0 2.5449444635006202e-11
seven O 0 9.125333266801761e-10
kindreds O 0 2.939207206509309e-06
. O 0 4.745952519868979e-09

Mutations O 0 5.7125060237694925e-09
were O 0 2.353685579770115e-10
located O 0 4.652504215219011e-10
in O 0 2.3331271810367316e-12
three O 0 4.961312936001272e-13
different O 0 1.0728137806283525e-13
regions O 0 7.261590634355386e-12
of O 0 1.9818280350136774e-10
the O 0 1.9052076583037092e-10
APC B-Disease 0 8.705050902335643e-09
gene O 0 2.6315708293034312e-11
( O 0 7.619459533800277e-13
1 O 0 3.260638634094981e-11
) O 0 3.9394340247593876e-14
at O 0 1.7803212029599003e-11
the O 0 4.274629261669105e-12
5 O 0 3.552720617694405e-11
end O 0 7.008944206271517e-12
spanning O 0 1.3141475407874026e-10
exons O 0 4.791845392704275e-11
4 O 0 1.4286685549869116e-11
and O 0 2.2160279253974347e-13
5 O 0 1.012330150262919e-11
, O 0 1.4700086037756216e-13
( O 0 6.190487440152145e-14
2 O 0 1.5635914438205667e-11
) O 0 1.974813270810144e-14
within O 0 1.6583650685325635e-12
exon O 0 3.929121958345938e-11
9 O 0 1.2012786598791791e-10
, O 0 1.8964526943190257e-13
and O 0 3.653256896215401e-13
( O 0 2.8237666111624593e-13
3 O 0 3.596875922107223e-11
) O 0 2.231533710529872e-14
at O 0 3.3758970011815714e-12
the O 0 1.2843996699540838e-12
3 O 0 1.4182247043414975e-10
distal O 0 3.1028854485803947e-10
end O 0 2.303739837783425e-11
of O 0 5.895745697204191e-11
the O 0 2.760735910711798e-11
gene O 0 2.1985678555491717e-10
. O 0 9.310174159393725e-11

Variability O 0 4.7591896645826637e-07
in O 0 4.282827148482937e-10
the O 0 4.485101526285895e-11
number O 0 8.766219521116891e-12
of O 0 1.611212638863435e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 1.9881603918747714e-08
most O 0 8.495518199515273e-13
apparent O 0 1.086237523539868e-11
in O 0 4.633333647308113e-13
individuals O 0 3.623779319558663e-15
with O 0 6.272604912696197e-14
mutations O 0 4.270024871882994e-12
in O 0 1.392675124528564e-11
region O 0 2.0743330664263482e-10
1 O 0 3.01415137293759e-09
, O 0 8.504196478964499e-12
and O 0 9.663670558213155e-11
upper O 1 0.9406901597976685
- O 0 0.008760255761444569
gastrointestinal O 1 0.9999814033508301
manifestations O 1 0.999996542930603
were O 0 1.1534204702456918e-09
more O 0 3.7115446892103943e-13
severe O 0 1.231703894433167e-08
in O 0 1.5156959021211946e-11
them O 0 4.287058555374479e-11
. O 0 8.06811076281555e-11

In O 0 6.709504063451277e-10
individuals O 0 2.60879940696887e-13
with O 0 8.07882081545197e-13
mutations O 0 4.748082135797027e-12
in O 0 5.225142367393243e-12
either O 0 6.500044946733397e-11
region O 0 1.9968575404316624e-10
2 O 0 5.386345813818139e-10
or O 0 1.123447168627223e-11
region O 0 1.1620251288979588e-10
3 O 0 3.0510355353285945e-10
, O 0 2.9640778221630415e-13
the O 0 1.5199874778965006e-13
average O 0 1.0155356509064864e-13
number O 0 7.838774253180261e-14
of O 0 2.7198016408491732e-11
adenomas B-Disease 0 8.89535556325427e-08
tended O 0 5.488235421680088e-10
to O 0 3.575219113816086e-12
be O 0 1.081742226176352e-12
lower O 0 1.685896561243183e-10
than O 0 2.1178249583718445e-14
those O 0 7.589631200800081e-15
in O 0 3.956859186550303e-14
individuals O 0 7.725662574546753e-16
with O 0 7.582396692397582e-15
mutations O 0 5.461796921853168e-13
in O 0 2.690206347619184e-12
region O 0 7.861995082736328e-11
1 O 0 3.2888158862931505e-10
, O 0 2.977966994093667e-13
although O 0 8.021238024919636e-14
age O 0 5.008652997559593e-13
at O 0 1.349757545315855e-11
diagnosis O 0 1.1491982476741214e-08
was O 0 6.779054401162554e-11
similar O 0 8.274893270598938e-11
. O 0 4.998515490406419e-10

In O 0 1.2450699671262555e-07
all O 0 6.770870442096566e-08
AAPC B-Disease 1 1.0
kindreds O 0 3.258229844504967e-05
, O 0 4.242152740197014e-10
a O 0 4.432205991111715e-11
predominance O 0 5.021895077561567e-08
of O 0 1.5812306628504302e-06
right O 1 1.0
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 0 0.00035169030888937414
rectal B-Disease 1 1.0
polyp I-Disease 0 0.0002765048702713102
sparing O 0 8.313600829978895e-08
was O 0 6.079991177188049e-09
observed O 0 3.142943905132256e-09
. O 0 3.819592697684726e-10

No O 0 8.26419909571996e-06
desmoid B-Disease 1 1.0
tumors I-Disease 1 1.0
were O 0 4.832179101299516e-09
found O 0 4.2728952320825186e-11
in O 0 4.667084427256718e-12
these O 0 1.2743175438478804e-11
kindreds O 0 8.102077799776453e-07
. O 0 1.4620228361295062e-09

Our O 0 2.0039907511204547e-08
data O 0 3.960129169033877e-10
suggest O 0 8.018890239325227e-12
that O 0 4.742429390272758e-14
, O 0 3.149550390456335e-13
in O 0 1.2531762953738035e-11
AAPC B-Disease 1 1.0
families O 0 5.513673718982037e-12
, O 0 1.4955948263693786e-13
the O 0 3.0934553963551936e-13
location O 0 1.007851441192642e-10
of O 0 5.468872577019113e-10
the O 0 3.3436302615541535e-09
APC B-Disease 0 0.00019686433370225132
mutation O 0 6.700248356139582e-09
may O 0 1.9764299918900718e-10
partially O 0 1.3025178269288062e-08
predict O 0 1.6673586122895045e-10
specific O 0 1.8991114236754925e-11
phenotypic O 0 1.7546449848637735e-09
expression O 0 1.2036369678725123e-09
. O 0 4.3655745685100555e-10

This O 0 3.6132891817475254e-11
should O 0 3.776774899766355e-12
help O 0 1.1993176634098046e-12
in O 0 6.063094904612543e-13
the O 0 4.967760686321043e-13
design O 0 4.84627789287817e-11
of O 0 3.027949072031966e-11
tailored O 0 1.8480783570140602e-09
clinical O 0 9.680569519332494e-07
- O 0 6.048982470474584e-08
management O 0 7.571518967353086e-10
protocols O 0 4.1673131612185443e-10
in O 0 2.0616369939344126e-13
this O 0 4.544906156236678e-16
subset O 0 1.6538891567038916e-12
of O 0 1.5805478453811972e-11
FAP B-Disease 0 6.303578743427352e-07
patients O 0 7.908317056770642e-11
. O 0 4.046744276481329e-12
. O 0 9.08739541949366e-11

Wilms B-Disease 1 0.6972134113311768
' I-Disease 0 1.1538010767253581e-05
tumor I-Disease 0 7.481859398694723e-08
1 O 0 4.324883562389914e-09
and O 0 1.2060492882159934e-10
Dax O 0 0.00015375198563560843
- O 0 3.166508477647767e-08
1 O 0 2.4027460576725446e-10
modulate O 0 2.890536421329415e-10
the O 0 1.3147863006657268e-11
orphan O 0 9.634885944631577e-11
nuclear O 0 1.3986741764782096e-09
receptor O 0 6.112717970685466e-11
SF O 0 0.00023989971668925136
- O 0 1.1754318629542126e-09
1 O 0 5.797699126341982e-12
in O 0 2.896269920941996e-14
sex O 0 3.940245482322857e-14
- O 0 3.4108585639062994e-13
specific O 0 5.0774627693506505e-14
gene O 0 6.283852019457747e-13
expression O 0 4.020509185992394e-12
. O 0 1.4344599293114602e-11

Products O 0 2.6432485356053803e-07
of O 0 1.1634561047912939e-07
steroidogenic O 0 7.410661737594637e-07
factor O 0 3.659559877355889e-10
1 O 0 4.727095381795721e-10
( O 0 4.851584411991183e-12
SF O 0 0.0027092949021607637
- O 0 1.3127359643760883e-08
1 O 0 4.389336949461864e-10
) O 0 2.0915921447074715e-13
and O 0 6.78426325534387e-12
Wilms B-Disease 0 0.00028735940577462316
tumor I-Disease 0 1.4443820361975668e-07
1 O 0 6.310769684603201e-09
( O 0 2.873296912897505e-11
WT1 O 0 2.0278224837966263e-05
) O 0 7.147329061062135e-13
genes O 0 2.014355479293406e-13
are O 0 1.2236048432413675e-15
essential O 0 5.42970128494108e-13
for O 0 6.570264623161071e-13
mammalian O 0 1.2685277273050133e-09
gonadogenesis O 0 1.0080446699589629e-08
prior O 0 2.035795421129194e-10
to O 0 8.737770706632175e-13
sexual O 0 3.000062004376858e-11
differentiation O 0 5.777779366056279e-10
. O 0 8.71692162895954e-11

In O 0 8.619874813931006e-10
males O 0 5.693667759487653e-12
, O 0 3.3915281607427294e-12
SF O 0 0.004696844611316919
- O 0 5.409330583461269e-08
1 O 0 3.564178951975805e-10
participates O 0 3.4768665811008015e-12
in O 0 3.591977247325434e-13
sexual O 0 2.721324413642451e-13
development O 0 1.459289503472072e-13
by O 0 8.444943048080845e-15
regulating O 0 3.899303796517373e-11
expression O 0 4.4543318686307565e-12
of O 0 2.1264091182304767e-11
the O 0 1.3282410761539243e-11
polypeptide O 0 4.880064796708439e-09
hormone O 0 4.03557937067589e-10
Mullerian O 0 5.607844855148869e-07
inhibiting O 0 6.278434439010994e-10
substance O 0 4.301322409361319e-09
( O 0 1.4540157966536071e-10
MIS O 1 0.9999920129776001
) O 0 3.499295644915357e-11
. O 0 1.6121609255903557e-11

Here O 0 7.370442034471125e-09
, O 0 8.866395118101167e-11
we O 0 5.958334411797217e-13
show O 0 2.4656416231644274e-12
that O 0 2.553124541209567e-13
WT1 O 0 0.00010819327144417912
- O 0 3.226303419978649e-07
KTS O 0 0.0038515031337738037
isoforms O 0 6.354745618608604e-10
associate O 0 1.1321580339895831e-09
and O 0 7.991513700789099e-12
synergize O 0 8.819148433758528e-08
with O 0 9.3239825582625e-11
SF O 1 0.9999997615814209
- O 0 6.074546377021761e-07
1 O 0 6.780182526533451e-10
to O 0 5.558698900481884e-12
promote O 0 1.1912882236231326e-08
MIS O 1 0.9999904632568359
expression O 0 3.0443170206950754e-09
. O 0 9.473867523812629e-11

In O 0 2.1711856756923e-09
contrast O 0 2.081924632690857e-09
, O 0 7.003872481980977e-10
WT1 O 1 0.6678656935691833
missense O 0 2.273816477327273e-07
mutations O 0 1.0970196973048019e-09
, O 0 1.5669888997482673e-11
associated O 0 1.1275824024492564e-10
with O 0 3.2221347118222e-11
male B-Disease 0 1.8082658703733046e-09
pseudohermaphroditism I-Disease 1 1.0
in O 0 6.396056129176486e-09
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 4.964292310560836e-10
fail O 0 2.36829511557346e-09
to O 0 6.760988990883732e-11
synergize O 0 3.0685755518788937e-06
with O 0 4.6448636048523895e-09
SF O 1 1.0
- O 0 2.002133260248229e-05
1 O 0 6.456658496745149e-08
. O 0 1.6328212393279529e-10

Additionally O 0 2.0769835629153022e-08
, O 0 4.7596544761052684e-11
the O 0 6.910593191439274e-12
X O 0 2.1016955997765763e-07
- O 0 8.931837491843453e-09
linked O 0 7.034105742320662e-09
, O 0 1.1397831463366703e-12
candidate O 0 1.395063806228919e-13
dosage O 0 5.129932034719786e-10
- O 0 2.3655852277038036e-10
sensitive O 0 9.683602808507885e-10
sex O 0 1.1200986319015449e-11
- O 0 1.2955608807985186e-11
reversal O 0 1.463086943265246e-11
gene O 0 1.463225807879498e-12
, O 0 2.6956084933638103e-13
Dax O 0 5.892010790375934e-07
- O 0 5.849034145910537e-09
1 O 0 3.842705598167129e-10
, O 0 2.1381533696351873e-12
antagonizes O 0 5.7263496167081485e-09
synergy O 0 4.651122598176016e-09
between O 0 2.613370075899013e-10
SF O 0 0.3203687071800232
- O 0 5.912658096463019e-08
1 O 0 1.3427795542142462e-09
and O 0 3.496820194515138e-11
WT1 O 0 0.0003947110672015697
, O 0 3.4019850738559176e-12
most O 0 2.530984590746327e-14
likely O 0 3.9825723963235124e-14
through O 0 3.411065036657522e-14
a O 0 1.1004370835789382e-14
direct O 0 1.2101814504932723e-13
interaction O 0 1.328592617866331e-12
with O 0 5.377839666642625e-12
SF O 1 0.9999997615814209
- O 0 3.251165708206827e-06
1 O 0 1.7845396271809477e-08
. O 0 7.770682014518471e-11

We O 0 5.516130330285307e-10
propose O 0 9.649345766860051e-10
that O 0 2.7114366307756654e-11
WT1 O 0 3.6969391658203676e-05
and O 0 1.3849047464375985e-09
Dax O 0 0.00026808687835000455
- O 0 7.190253370481514e-08
1 O 0 3.8391892442923847e-10
functionally O 0 6.497172799768691e-10
oppose O 0 5.41353073479911e-12
each O 0 2.9895625532690585e-15
other O 0 8.838083395560151e-14
in O 0 1.843224574707425e-12
testis O 0 1.1143292955040351e-09
development O 0 1.7749267333666552e-11
by O 0 2.51338511635113e-12
modulating O 0 6.804972940699372e-08
SF O 1 0.9997532963752747
- O 0 1.457349725342283e-07
1 O 0 5.1208624007870185e-09
- O 0 3.2081499679037506e-09
mediated O 0 9.484653062941106e-09
transactivation O 0 1.7119549511335208e-07
. O 0 1.3914749560917095e-11
. O 0 1.4465821769615861e-11

A O 0 2.8033764465362765e-06
mouse O 0 6.05653083241009e-09
model O 0 5.165767466563942e-11
for O 0 5.55130885704358e-10
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9999957084655762
- O 0 1.816630356188398e-05
centre O 0 2.3708919343334856e-06
mutations O 0 1.3523854924812895e-08
. O 0 1.5375375972404015e-10

Imprinting O 0 4.1579828575777356e-06
in O 0 1.126800319717347e-09
the O 0 3.668540471402082e-10
15q11 O 0 1.3417273692084564e-07
- O 0 1.451625841752957e-08
q13 O 0 3.6621191412677945e-08
region O 0 7.06715380660583e-11
involves O 0 4.2124368229701226e-12
an O 0 6.310657698445007e-14
imprinting O 0 6.177858224987176e-09
centre O 0 3.3532057130969406e-08
( O 0 8.783374201570826e-12
IC O 0 0.0012681630905717611
) O 0 1.6143815884800405e-12
, O 0 7.703039595075012e-14
mapping O 0 1.5869418409572567e-12
in O 0 1.2583654279176015e-13
part O 0 3.293420007197123e-12
to O 0 2.0164438695180475e-12
the O 0 9.617406870887635e-11
promoter O 0 4.242497197992634e-07
and O 0 5.4449101477560546e-11
first O 0 2.8168314902821123e-10
exon O 0 2.219764638766719e-08
of O 0 1.1721458470503876e-08
SNRPN O 1 0.9999991655349731
. O 0 8.723300304325221e-09

Deletion O 0 5.925302559717238e-08
of O 0 1.0370384551094958e-08
this O 0 5.7946585897694636e-12
IC O 0 0.13003920018672943
abolishes O 0 6.33218633083743e-08
local O 0 3.5046407442784755e-10
paternally O 0 6.369079041945724e-09
derived O 0 5.518105417046115e-11
gene O 0 4.469045359473123e-12
expression O 0 1.4927628360847378e-12
and O 0 6.27105247071047e-13
results O 0 1.1117975463881269e-11
in O 0 3.1144892220780207e-10
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 3.1792304071132094e-05
PWS B-Disease 1 1.0
) O 0 7.844239036103318e-09
. O 0 5.042410933242536e-10

We O 0 1.1091277896113638e-09
have O 0 1.7828450304610555e-12
created O 0 3.726416050731096e-11
two O 0 1.053630598567279e-12
deletion O 0 3.2124695265034475e-11
mutations O 0 3.912542512196637e-11
in O 0 4.41008687901423e-11
mice O 0 2.625075157247636e-10
to O 0 2.037340435245838e-11
understand O 0 6.565204824227067e-09
PWS B-Disease 1 1.0
and O 0 4.502331563127626e-10
the O 0 5.871136909973984e-11
mechanism O 0 8.49837908378781e-11
of O 0 2.9686243047111205e-11
this O 0 1.9273795612891748e-13
IC O 0 0.005584472790360451
. O 0 1.690318218727782e-09

Mice O 0 2.5617959181545302e-05
harbouring O 0 1.7113659851020202e-05
an O 0 1.7018533804424862e-10
intragenic O 0 2.9522534532588907e-06
deletion O 0 1.6408112646359996e-09
in O 0 1.7310623767752276e-10
Snrpn O 0 0.00024531662347726524
are O 0 5.46034398252182e-11
phenotypically O 0 2.510032572899945e-07
normal O 0 2.4571491508140753e-08
, O 0 9.147455362623624e-12
suggesting O 0 1.3326692180348765e-11
that O 0 4.8004372558193426e-14
mutations O 0 7.495189191519813e-11
of O 0 4.980284185052142e-09
SNRPN O 1 1.0
are O 0 8.943769119404421e-13
not O 0 2.7754621856530305e-14
sufficient O 0 3.774342297035993e-11
to O 0 3.237938528410922e-10
induce O 0 0.00043130674748681486
PWS B-Disease 1 1.0
. O 0 3.0603523271111044e-08

Mice O 0 1.8840555071619747e-07
with O 0 3.0537062462032694e-11
a O 0 1.4031216293008963e-11
larger O 0 1.8527917047816977e-11
deletion O 0 1.7120896367295302e-10
involving O 0 1.2871654853086056e-09
both O 0 1.8028409320969274e-10
Snrpn O 0 8.586343938077334e-06
and O 0 5.027985805483581e-10
the O 0 4.878406012487346e-10
putative O 0 4.350413576048595e-07
PWS O 1 1.0
- O 0 1.2084035461157328e-06
IC O 1 0.5908182263374329
lack O 0 2.614642724552141e-09
expression O 0 8.89332427145284e-11
of O 0 7.464975304571908e-10
the O 0 1.6286555437616812e-11
imprinted O 0 5.5927706910097186e-09
genes O 0 3.8476544866883344e-11
Zfp127 O 0 4.956388011123636e-07
( O 0 5.379473949629343e-11
mouse O 0 5.645121037289869e-10
homologue O 0 2.7612654385222868e-09
of O 0 1.7729323564807942e-09
ZNF127 O 1 0.9999969005584717
) O 0 9.817049950733292e-11
, O 0 5.0439284693393205e-11
Ndn O 0 2.937665703939274e-05
and O 0 1.1494913909615434e-09
Ipw O 0 4.519808499026112e-06
, O 0 1.0451132320676848e-10
and O 0 2.0874375145085722e-11
manifest O 0 5.656959345401447e-09
several O 0 3.850385635328912e-11
phenotypes O 0 1.2737088184167078e-07
common O 0 3.040040663648824e-09
to O 0 2.4331773929020528e-08
PWS B-Disease 1 1.0
infants O 0 7.951877341838554e-05
. O 0 2.5928805769126484e-09

These O 0 1.7622743542222707e-10
data O 0 5.747911521747362e-11
demonstrate O 0 8.628221401241198e-12
that O 0 1.6810671574934467e-14
both O 0 1.2447871509599362e-13
the O 0 1.257070727893328e-12
position O 0 1.50635511009245e-11
of O 0 3.507099818889081e-11
the O 0 8.859340344669064e-12
IC O 0 4.568400527205085e-06
and O 0 6.870311611284485e-12
its O 0 1.2655340100517498e-12
role O 0 8.481805210437676e-13
in O 0 1.7447096556117564e-13
the O 0 1.9309488903662686e-13
coordinate O 0 1.0997645936289269e-12
expression O 0 5.997419900115319e-13
of O 0 9.390710431489424e-12
genes O 0 1.5205850088188116e-13
is O 0 1.1224452018342677e-14
conserved O 0 4.3791554583949566e-12
between O 0 2.1318903673656076e-12
mouse O 0 2.4890369279551017e-11
and O 0 2.323387521870751e-13
human O 0 4.289141958269127e-12
, O 0 1.4443502817373943e-13
and O 0 1.2131256014926567e-13
indicate O 0 4.5006763615441925e-13
that O 0 7.710385911826548e-15
the O 0 2.53272576522523e-12
mouse O 0 1.6366494964836775e-11
is O 0 3.439836797699972e-15
a O 0 1.5563460664606951e-15
suitable O 0 1.6919145663478463e-13
model O 0 1.2473160525272586e-13
system O 0 1.5996445704505313e-12
in O 0 2.639138094260446e-13
which O 0 3.799718989428401e-14
to O 0 5.374901776910787e-14
investigate O 0 1.2680911008755569e-11
the O 0 1.2468289204911609e-12
molecular O 0 1.8635093468333253e-11
mechanisms O 0 4.673473760763436e-11
of O 0 8.34396302051843e-11
imprinting O 0 9.032861680857707e-10
in O 0 2.735615011427439e-13
this O 0 1.679099499956975e-14
region O 0 3.4485264036737684e-12
of O 0 2.0525362659506996e-11
the O 0 5.6364010680987064e-12
genome O 0 2.3565986401880012e-12
. O 0 6.339324139410796e-13
. O 0 3.062700787426209e-11

Mutations O 0 6.706541455514525e-08
of O 0 7.15740071655091e-08
the O 0 2.753322569937211e-10
ATM O 0 1.1956816706515383e-05
gene O 0 1.6275603087478885e-10
detected O 0 2.7675806091309596e-10
in O 0 6.005997782443373e-12
Japanese O 1 0.5369545817375183
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 9.10134258447215e-06
: O 0 7.987612307691627e-12
possible O 0 1.0854447896058161e-10
preponderance O 0 4.582997007673839e-06
of O 0 1.8212057284472394e-07
the O 0 1.8020546166397367e-09
two O 0 7.660327233649511e-11
founder O 0 3.2702948260521225e-07
mutations O 0 7.534527668440205e-09
4612del165 O 0 6.211782874743221e-07
and O 0 3.431014361510165e-09
7883del5 O 0 5.561255875363713e-06
. O 0 3.998925190984437e-09

The O 0 2.821200340008545e-08
ATM O 0 2.6772215278469957e-05
( O 0 1.426998608167196e-08
A O 1 1.0
- O 1 0.9999990463256836
T O 1 1.0
, O 0 1.924776830974917e-11
mutated O 0 2.0211464446528993e-11
) O 0 1.7171987031112945e-13
gene O 0 1.7787284232323453e-12
on O 0 4.303377793002383e-11
human O 0 6.093336252233073e-11
chromosome O 0 1.389063308820937e-09
11q22 O 0 1.3563966660967708e-07
. O 0 3.5484828964094106e-10

3 O 0 2.1882537737383245e-07
has O 0 3.4308389462722744e-12
recently O 0 3.682079814659733e-12
been O 0 2.6405377992651247e-13
identified O 0 4.057438521450074e-13
as O 0 6.754637132825106e-14
the O 0 5.312204127104481e-13
gene O 0 1.6235033066178128e-12
responsible O 0 3.6342647641296466e-12
for O 0 5.592161933173911e-13
the O 0 4.350286103571577e-11
human O 0 2.5823890581477826e-08
recessive B-Disease 1 1.0
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 3.3410615287721157e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 8.948355945115338e-10
. O 0 1.0779863807153234e-10

In O 0 7.188930561952134e-10
order O 0 7.273626145831713e-11
to O 0 1.6886787107539547e-12
define O 0 7.869178399178e-12
the O 0 1.2410185726285938e-12
types O 0 1.6862793106309226e-10
of O 0 2.7207485153724065e-09
disease O 0 9.947275430022273e-07
- O 0 2.4659980724095476e-09
causing O 0 1.0579637166330258e-09
ATM O 0 1.4803971453147824e-06
mutations O 0 1.0629693653063654e-10
in O 0 3.0325322114554965e-11
Japanese O 0 3.7160916690481827e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 3.4564978657058987e-10
as O 0 5.25696890532612e-13
well O 0 8.85982639250299e-13
as O 0 1.2679930076840012e-13
to O 0 9.785553443941719e-14
look O 0 5.154325859353659e-13
for O 0 5.861460541109823e-14
possible O 0 8.917677360442688e-12
mutational O 0 3.829568484547963e-08
hotspots O 0 2.5928125424456994e-08
, O 0 1.6022003602317314e-12
reverse O 0 2.9433656900668126e-11
- O 0 2.3858571368551296e-11
transcribed O 0 2.6969173422264348e-11
RNA O 0 1.4334069521615422e-11
derived O 0 7.970791453086601e-13
from O 0 5.986654314643625e-13
ten O 0 3.789199856663039e-12
patients O 0 3.024655721196867e-13
belonging O 0 4.858865393364553e-11
to O 0 6.750535460481322e-12
eight O 0 1.0170103648121653e-10
unrelated O 0 2.3836854712300237e-09
Japanese O 0 1.145243822975317e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 4.8965232909981005e-12
was O 0 3.317961183579854e-11
analyzed O 0 3.6201392578094627e-11
for O 0 5.128359217322631e-13
mutations O 0 2.038248909930207e-12
by O 0 6.198796901127346e-13
the O 0 1.4290385281362505e-12
restriction O 0 7.270900461570085e-13
endonuclease O 0 2.005315496989013e-10
fingerprinting O 0 2.842587276674635e-10
method O 0 7.884009417535864e-11
. O 0 1.1214539713533256e-11

As O 0 9.34558430643051e-10
has O 0 1.2122102367034815e-12
been O 0 2.3404580140259923e-13
reported O 0 7.063023126432921e-13
by O 0 2.79478398973812e-13
others O 0 1.0877178498180928e-11
, O 0 9.212023505122957e-13
mutations O 0 1.994149420245228e-12
that O 0 1.4314738901611418e-13
lead O 0 2.37163455540923e-10
to O 0 1.5181753423854083e-11
exon O 0 1.3496153528080868e-08
skipping O 0 1.0976356712433244e-08
or O 0 6.371360106172119e-10
premature O 0 1.1986386105888869e-08
protein O 0 7.389300282767408e-10
truncation O 0 1.8166671722497085e-08
were O 0 3.522937219724298e-10
also O 0 3.6155002602900055e-12
predominant O 0 1.8927091005593866e-09
in O 0 3.116246496959185e-11
our O 0 6.538994345994809e-10
mutants O 0 9.975118508975811e-09
. O 0 2.2248063114016503e-10

Six O 0 3.095220524329534e-09
different O 0 3.097802396545557e-12
mutations O 0 5.073740472899546e-12
were O 0 1.9093029240968562e-11
identified O 0 2.3342725322117452e-11
on O 0 1.2890641332141684e-10
12 O 0 2.516452879408604e-10
of O 0 1.1265913202329614e-10
the O 0 1.6206454581113583e-11
16 O 0 1.0336157485468789e-09
alleles O 0 8.726315676998997e-12
examined O 0 2.7395172352839836e-08
. O 0 2.6865389912700266e-09

Four O 0 1.4840844109187401e-08
were O 0 3.043224283683088e-10
deletions O 0 1.7660809481512274e-09
involving O 0 5.661697777270547e-09
a O 0 3.5958760968846093e-10
loss O 0 8.31645579069118e-08
of O 0 1.400820508479228e-07
a O 0 2.747499727728808e-10
single O 0 5.565058969203562e-10
exon O 0 4.33061186910777e-09
exon O 0 1.5759834326445343e-08
7 O 0 2.7107375899504405e-08
, O 0 3.803850984196444e-11
exon O 0 2.4181767699360535e-09
16 O 0 1.6314772866010685e-09
, O 0 1.077204731664283e-11
exon O 0 3.6344016685063707e-09
33 O 0 2.841607393833101e-09
or O 0 2.1004506467470208e-10
exon O 0 7.625134657018862e-08
35 O 0 5.306475614474948e-08
. O 0 4.071880332912059e-10

The O 0 1.5117340268488988e-08
others O 0 1.568472990376435e-10
were O 0 3.624719968620127e-11
minute O 0 4.2095976704459304e-10
deletions O 0 1.3153864109050062e-10
, O 0 3.711858077848351e-12
4649delA O 0 6.151306131130241e-10
in O 0 2.115837713367874e-11
exon O 0 3.958168015572028e-09
33 O 0 4.061952996181617e-09
and O 0 3.8456442891243725e-11
7883del5 O 0 1.4983683627178834e-08
in O 0 7.708886307078444e-11
exon O 0 5.0873758539182745e-08
55 O 0 3.2661581883530744e-08
. O 0 5.450129236805878e-10

The O 0 1.964769147377865e-08
mutations O 0 6.096815274858614e-10
4612del165 O 0 3.473745024962227e-08
and O 0 1.7392169648910993e-10
7883del5 O 0 3.940693460435796e-08
were O 0 7.07995675974793e-11
found O 0 1.885071959639717e-12
in O 0 1.2944381894489099e-13
more O 0 1.1764599423092588e-15
than O 0 2.152520994902333e-15
two O 0 1.4007503280389928e-14
unrelated O 0 9.619713879638336e-12
families O 0 7.680619479994138e-15
; O 0 6.082760434667628e-14
44 O 0 4.010842873103382e-12
% O 0 3.5382975168514116e-14
( O 0 1.151503480241456e-13
7 O 0 2.9063693118835943e-10
of O 0 3.720509178517517e-10
16 O 0 5.518708823259999e-10
) O 0 1.9701867090896052e-13
of O 0 1.0647463813406866e-11
the O 0 7.189567517718043e-12
mutant O 0 7.825222414492572e-11
alleles O 0 8.886596021768015e-14
had O 0 4.209294317183282e-13
one O 0 1.5913358413117973e-13
of O 0 3.455646185868133e-11
the O 0 2.4814619109525538e-11
two O 0 1.5240708001185155e-11
mutations O 0 1.0093101909802726e-09
. O 0 5.16208631395898e-10

The O 0 5.1094307451649e-08
4612del165 O 0 3.8708327565473155e-07
mutations O 0 6.000813734807764e-11
in O 0 2.8858564843359247e-12
three O 0 1.7959979749064547e-13
different O 0 1.7071037644459178e-14
families O 0 4.226538552736664e-15
were O 0 1.3919892799182931e-12
all O 0 1.2931055694536536e-13
ascribed O 0 4.082718885189962e-11
to O 0 3.801875914782871e-12
the O 0 3.6560907079596916e-11
same O 0 1.3706130848334386e-11
T O 0 7.846337268802017e-08
- O 0 2.16595763546934e-09
- O 0 2.415087296814278e-10
> O 0 9.769506384427196e-12
A O 0 2.139080579333097e-11
substitution O 0 8.069168597191201e-12
at O 0 1.0919791980368299e-11
the O 0 1.3290329123685773e-13
splice O 0 3.561515249383973e-10
donor O 0 7.246629511736824e-13
site O 0 5.164979208216458e-11
in O 0 2.249451146185688e-11
intron O 0 2.799403944209189e-07
33 O 0 6.198114022026857e-08
. O 0 3.6592459617956763e-10

Microsatellite O 0 2.1497032776096603e-06
genotyping O 0 4.643369209134107e-07
around O 0 9.341164508569477e-10
the O 0 6.141080699517687e-11
ATM O 0 5.114086434332421e-07
locus O 0 3.189873920561581e-10
also O 0 5.39551172837327e-12
indicated O 0 7.737667277740723e-12
that O 0 1.9734424326883077e-14
a O 0 7.286170907068457e-13
common O 0 5.274788852233092e-12
haplotype O 0 2.542287214080119e-10
was O 0 2.414009825368879e-10
shared O 0 4.3380295015882364e-12
by O 0 2.863719190168007e-13
the O 0 3.959974275574707e-12
mutant O 0 2.3477480376454807e-11
alleles O 0 2.8012455297542725e-14
in O 0 4.53199733600404e-13
both O 0 9.797030374458782e-12
mutations O 0 4.10746769929915e-09
. O 0 1.87449811228646e-09

This O 0 1.3012424471270378e-10
suggests O 0 3.8449691347475223e-11
that O 0 9.083356015591147e-15
these O 0 1.4277164520071217e-13
two O 0 2.5530380760863114e-12
founder O 0 3.107194146423353e-08
mutations O 0 5.11725453677947e-11
may O 0 7.233887100444036e-12
be O 0 4.160556176923541e-13
predominant O 0 9.072574358448549e-10
among O 0 2.1466203380809956e-12
Japanese O 0 4.498934558228029e-09
ATM O 0 1.4657422298114398e-06
mutant O 0 5.362545518750039e-09
alleles O 0 5.902058008988575e-11
. O 0 2.2655127773774097e-10

W474C O 0 1.4834830835752655e-05
amino O 0 5.3875428562832894e-08
acid O 0 1.1559048163078955e-09
substitution O 0 1.6966256177752825e-10
affects O 0 8.852669465542196e-12
early O 0 2.29937076323683e-12
processing O 0 7.671743448844914e-12
of O 0 3.2478937074531533e-12
the O 0 1.8621784886665993e-13
alpha O 0 1.6226581710243604e-12
- O 0 5.071009801307924e-13
subunit O 0 1.1003536677742926e-13
of O 0 1.61409828645237e-12
beta O 0 8.561799186290742e-11
- O 0 4.22108709097202e-10
hexosaminidase O 0 1.187954890013998e-08
A O 0 3.574097684477806e-10
and O 0 3.441927190310501e-13
is O 0 1.5279805212439247e-14
associated O 0 4.0225340419697275e-12
with O 0 2.1293394131260968e-11
subacute O 0 0.001891483785584569
G B-Disease 0 0.24449372291564941
( I-Disease 0 4.565565703273933e-09
M2 I-Disease 0 0.36593636870384216
) I-Disease 0 6.882069913949351e-10
gangliosidosis I-Disease 0 1.6979965948848985e-05
. O 0 1.2337276755758353e-09

Mutations O 0 1.0317785736901897e-08
in O 0 2.5801510927792037e-10
the O 0 7.353251896269342e-10
HEXA O 0 0.26116305589675903
gene O 0 2.6720231929844296e-11
, O 0 4.2694912546787506e-14
encoding O 0 3.5553452407610306e-14
the O 0 3.1888532613100207e-13
alpha O 0 6.833505658034034e-13
- O 0 4.745463462289823e-13
subunit O 0 7.30144230124373e-14
of O 0 3.4832785527488808e-12
beta O 0 8.712632698637535e-11
- O 0 4.398555408791083e-10
hexosaminidase O 0 8.367913295614926e-08
A O 0 2.4060780035028984e-08
( O 0 3.0251417690307925e-12
Hex O 0 2.913408403415474e-09
A O 0 4.305426681838753e-09
) O 0 2.9095709131940484e-13
, O 0 6.224229844638968e-14
that O 0 6.3707850945355065e-15
abolish O 0 6.285588161070166e-10
Hex O 0 2.841927138064193e-09
A O 0 6.656541429173046e-10
enzyme O 0 1.1616477745002296e-11
activity O 0 8.928506545213821e-11
cause O 0 1.6207225144171389e-06
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 2.2591264969840097e-10
TSD B-Disease 1 1.0
) O 0 1.8843253346556565e-11
, O 0 1.6132457782841447e-12
the O 0 3.8682359398967137e-11
fatal O 0 8.443895239906851e-06
infantile B-Disease 0 1.7516683783469489e-06
form I-Disease 0 1.1014645862061911e-09
of I-Disease 0 5.892224521630851e-07
G I-Disease 0 0.0006163241341710091
( I-Disease 0 5.87875970126106e-10
M2 I-Disease 0 0.0011820490472018719
) I-Disease 0 5.4989204162358973e-11
gangliosidosis I-Disease 0 5.135532319400227e-07
, I-Disease 0 1.5218399457284093e-11
Type I-Disease 0 2.6617927417760257e-08
1 I-Disease 0 4.7099558031504785e-08
. O 0 3.6713471152083343e-10

Less O 0 6.569465682559894e-08
severe O 0 0.022971726953983307
, O 0 5.388917312387775e-09
subacute O 0 0.15814848244190216
( O 0 2.1600539135135932e-09
juvenile O 0 0.010409669950604439
- O 0 3.8076532860031875e-07
onset O 0 0.11142951995134354
) O 0 3.2248565796921813e-12
and O 0 1.958765233345261e-10
chronic O 1 0.9990664124488831
( O 0 3.106644108630263e-11
adult O 0 6.488136250482057e-09
- O 0 2.2014150502513985e-08
onset O 0 1.4380514585354831e-05
) O 0 1.4777336797798524e-13
variants O 0 5.514549233920363e-11
are O 0 7.224585919741663e-14
characterized O 0 7.738021161329822e-12
by O 0 3.248505522739087e-13
a O 0 4.28892945464332e-12
broad O 0 2.0276109957695354e-10
spectrum O 0 1.3015312161357429e-09
of O 0 2.1519394599600616e-10
clinical O 0 2.8280533470592673e-08
manifestations O 0 3.3648058206381393e-07
and O 0 2.0900073338658842e-11
are O 0 4.549542031084472e-14
associated O 0 5.434656197289556e-12
with O 0 4.677232451170965e-13
residual O 0 6.151216780381219e-08
levels O 0 3.6013483306618355e-09
of O 0 1.78321513111257e-09
Hex O 0 1.4286026583931744e-08
A O 0 3.3515350494894847e-09
enzyme O 0 4.511338178025959e-11
activity O 0 8.878634494280391e-10
. O 0 2.9539783813481435e-11

We O 0 2.327113168831829e-09
identified O 0 9.138675927111706e-10
a O 0 3.550187227530088e-11
1422 O 0 5.643554459311417e-07
G O 0 1.2469431567296851e-06
- O 0 1.288440998337137e-08
- O 0 6.636891036748693e-10
> O 0 1.1490085272125583e-10
C O 0 2.3501890211719e-08
( O 0 1.3334618782431806e-12
amino O 0 6.7729116585979465e-12
acid O 0 7.0226602311151964e-12
W474C O 0 1.7160847742836438e-10
) O 0 1.403073231193543e-15
substitution O 0 1.228849785600214e-13
in O 0 5.484844620585322e-14
the O 0 2.5141989727119063e-13
first O 0 4.965392788776335e-13
position O 0 8.625951515572883e-12
of O 0 7.050606626313183e-11
exon O 0 3.3724461001582995e-09
13 O 0 3.366481982070013e-09
of O 0 2.8135522800454282e-09
HEXA O 1 0.999991774559021
of O 0 4.140648357520149e-08
a O 0 5.7546911680361745e-11
non O 0 1.813941139516828e-07
- O 0 1.3047283253797559e-08
Jewish O 0 9.44454026097219e-09
proband O 0 0.0002447787846904248
who O 0 9.806944145651642e-11
manifested O 0 1.528491555546907e-09
a O 0 5.45399454765505e-11
subacute O 0 1.6965647091637948e-06
variant O 0 1.3290265599152917e-07
of O 0 1.9558310668799095e-06
G B-Disease 1 0.9483451843261719
( I-Disease 0 1.3564697809442805e-08
M2 I-Disease 1 0.9967185854911804
) I-Disease 0 7.853276917657581e-10
gangliosidosis I-Disease 0 2.2583921236218885e-05
. O 0 1.3128205189616438e-09

On O 0 4.4728576398256337e-08
the O 0 3.0004757012314087e-10
second O 0 7.847377192504723e-10
maternally O 0 6.986933698271969e-08
inherited O 0 1.6758210108491767e-07
allele O 0 1.5486392723751408e-10
, O 0 1.413360574409328e-11
we O 0 3.982285963662069e-13
identified O 0 1.1132404893754444e-11
the O 0 7.072466223778662e-11
common O 0 1.95665634805664e-07
infantile O 1 1.0
disease O 1 0.9997037053108215
- O 0 1.6511817690911812e-08
causing O 0 4.0394567690782424e-08
4 O 0 5.8820852189001016e-08
- O 0 4.147633791973249e-09
bp O 0 1.135700755661162e-09
insertion O 0 4.62747618001913e-10
, O 0 2.9760000019862787e-11
+ O 0 1.001447397230848e-10
TATC O 0 0.043604474514722824
1278 O 0 2.761762516456656e-06
, O 0 1.7038077546049912e-11
in O 0 1.528192676569784e-11
exon O 0 2.1600797595056065e-08
11 O 0 1.1082127215900073e-08
. O 0 1.2871034793526803e-10

Pulse O 0 4.824376810574904e-05
- O 0 2.7101074806523684e-07
chase O 0 1.4140415505181636e-09
analysis O 0 4.5580761387498114e-12
using O 0 1.588423489962132e-11
proband O 0 1.2776094990840647e-06
fibroblasts O 0 3.2495841573165762e-09
revealed O 0 2.8909444282909647e-10
that O 0 1.1770087942480911e-13
the O 0 7.77677228169793e-12
W474C O 0 1.1451716241950294e-09
- O 0 1.4365737766031117e-11
containing O 0 3.023446076833025e-12
alpha O 0 4.265523698143703e-12
- O 0 2.4411401719492964e-12
subunit O 0 8.847662999380418e-14
precursor O 0 4.008787746201392e-11
was O 0 8.311586661979842e-12
normally O 0 5.099506429108447e-13
synthesized O 0 8.444090565662421e-11
, O 0 1.2055552953485482e-13
but O 0 1.0717143657441343e-15
not O 0 1.2538647776446721e-15
phosphorylated O 0 1.3625146150220147e-11
or O 0 4.974741972529895e-12
secreted O 0 1.1814003768317871e-11
, O 0 2.6659789827132574e-12
and O 0 4.247702883874993e-12
the O 0 3.3397774129584334e-11
mature O 0 3.4178515573302093e-10
lysosomal O 0 1.1505492558683272e-08
alpha O 0 5.19077836269588e-10
- O 0 7.794075107536713e-11
subunit O 0 1.3850960309258475e-11
was O 0 4.190553459793023e-11
not O 0 7.929697480243969e-13
detected O 0 2.392348541491174e-09
. O 0 5.324351376456704e-11

When O 0 3.8233847199364845e-09
the O 0 3.086481903391558e-10
W474C O 0 5.856345630661508e-09
- O 0 7.792752554358628e-11
containing O 0 3.2333451888133524e-11
alpha O 0 3.1288131807638564e-11
- O 0 1.151188432774175e-11
subunit O 0 3.79289481766687e-12
was O 0 9.88284315495136e-11
transiently O 0 2.208681681992175e-09
co O 0 6.879366520884389e-10
- O 0 1.0458011540093182e-10
expressed O 0 1.06569668454487e-12
with O 0 4.101507341766099e-14
the O 0 4.554067626477698e-13
beta O 0 1.5717595410955076e-12
- O 0 1.058596027676828e-12
subunit O 0 2.874114588360434e-14
to O 0 1.5737379186809598e-14
produce O 0 5.468616878778754e-12
Hex O 0 1.4991851093881792e-09
A O 0 4.413878595954657e-09
( O 0 9.814193728530096e-13
alphabeta O 0 1.4410601600900463e-08
) O 0 1.6885328042465925e-13
in O 0 1.5074292725528182e-12
COS O 0 4.7362878831336275e-05
- O 0 7.422626513431396e-09
7 O 0 1.1674284872142948e-09
cells O 0 3.5968326841245846e-12
, O 0 7.852151952736017e-14
the O 0 2.2801967020265324e-13
mature O 0 5.110830920800058e-13
alpha O 0 1.3956393549521828e-12
- O 0 7.775314680297241e-13
subunit O 0 2.1613714304099564e-14
was O 0 7.298703199980217e-13
present O 0 1.4438874629350146e-13
, O 0 1.4928696503275184e-14
but O 0 1.1653204002616806e-15
its O 0 5.743661975069272e-14
level O 0 3.494671566017793e-12
was O 0 4.8065440516609215e-12
much O 0 1.0070100948857824e-13
lower O 0 6.172737234549919e-12
than O 0 9.52104949141473e-16
that O 0 1.3263920531626604e-16
from O 0 1.7433092729807198e-13
normal O 0 5.269248145450822e-12
alpha O 0 1.0751358137106592e-11
- O 0 1.2239994608143068e-11
subunit O 0 1.6898224356257097e-12
transfections O 0 4.961322463969964e-09
, O 0 2.5862027363404705e-13
although O 0 7.278638819050928e-14
higher O 0 5.224242804850732e-13
than O 0 3.3644881348440184e-15
in O 0 1.6164051705198218e-13
those O 0 4.606756599453976e-13
cells O 0 5.272395367517113e-12
transfected O 0 2.3089097300754702e-10
with O 0 1.0635132911048645e-13
an O 0 9.890445938371545e-14
alpha O 0 4.064661454639129e-11
- O 0 2.9957675229397296e-11
subunit O 0 7.64321852336769e-12
associated O 0 8.984744892526209e-11
with O 0 4.666991237911589e-10
infantile O 1 0.9997429251670837
TSD B-Disease 1 0.9999856948852539
. O 0 7.777466670688682e-09

Furthermore O 0 2.58737848923829e-08
, O 0 2.8867991330727705e-11
the O 0 3.2624469532144262e-12
precursor O 0 2.101392254649781e-10
level O 0 1.276259237181776e-10
of O 0 3.5626956246259667e-11
the O 0 2.5109749349216948e-12
W474C O 0 6.18865847457073e-10
alpha O 0 2.2295502249969346e-11
- O 0 6.163842439926848e-12
subunit O 0 8.477292760995792e-13
was O 0 7.430647243344968e-12
found O 0 2.0433391849199178e-13
to O 0 3.950539643137428e-14
accumulate O 0 7.7367374659576e-12
in O 0 1.0871386256494642e-12
comparison O 0 1.9026635735691633e-12
to O 0 3.090977994391064e-13
the O 0 4.42849402981782e-12
normal O 0 1.7644023395102515e-11
alpha O 0 5.0423890757267387e-11
- O 0 1.7980904959413735e-11
subunit O 0 2.967162323133654e-12
precursor O 0 3.6968547667548535e-10
levels O 0 6.718016420936834e-11
. O 0 1.0497056349145772e-11

We O 0 7.426177450753357e-10
conclude O 0 2.4956900990247277e-09
that O 0 8.586386809894542e-13
the O 0 3.6658454050098044e-11
1422 O 0 1.1544661902007647e-06
G O 0 1.7278962332056835e-06
- O 0 2.299778856240664e-08
- O 0 4.76232875357141e-09
> O 0 6.503669269797285e-10
C O 0 7.675402713402946e-08
mutation O 0 3.929846899286549e-12
is O 0 8.717236188535843e-15
the O 0 1.7136159570323162e-13
cause O 0 2.318812156176797e-11
of O 0 1.548338790513526e-09
Hex B-Disease 0 3.0555511330021545e-05
A I-Disease 1 0.9987422823905945
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 6.944637642725127e-10
the O 0 6.547131170542286e-10
proband O 0 2.820619783960865e-06
. O 0 3.429508066421505e-10

The O 0 1.020392215167476e-08
resulting O 0 1.6003611769122017e-09
W474C O 0 2.1475091926959067e-08
substitution O 0 1.1877731020959459e-09
clearly O 0 4.946992468446432e-11
interferes O 0 3.0720676003070935e-11
with O 0 2.9635012976578223e-13
alpha O 0 8.676410284680358e-12
- O 0 4.026402909002025e-12
subunit O 0 1.3255493707883814e-13
processing O 0 3.833368518446623e-12
, O 0 1.7648104250764587e-14
but O 0 3.331141824139156e-16
because O 0 6.945556876828568e-16
the O 0 1.677998187718955e-14
base O 0 1.1488780846807822e-12
substitution O 0 1.4799890479810784e-11
falls O 0 5.402684966071547e-10
at O 0 9.5197990115925e-12
the O 0 3.387143538736981e-13
first O 0 1.0906423333900683e-12
position O 0 3.046870394873835e-11
of O 0 5.602943109472847e-10
exon O 0 5.467144070792074e-09
13 O 0 4.065169978417771e-09
, O 0 5.323140365998125e-12
aberrant O 0 4.0387306832201375e-09
splicing O 0 4.857776847444484e-09
may O 0 4.267454445372465e-11
also O 0 1.8366621157978047e-12
contribute O 0 5.191931520126536e-12
to O 0 1.197841964506452e-10
Hex B-Disease 0 5.501314808498137e-05
A I-Disease 1 0.8884029388427734
deficiency I-Disease 0 9.769856887942296e-07
in O 0 5.6500949752180674e-11
this O 0 1.0552294715110433e-12
proband O 0 3.26726166122171e-07
. O 0 8.536227280586672e-12
. O 0 4.4738237420238747e-11

Two O 0 1.335118127165913e-09
frequent O 0 5.711580097766955e-09
missense O 0 4.590043317875825e-06
mutations O 0 8.34342415600986e-07
in O 0 2.1168798411963508e-06
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.2057370213369722e-07

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 1.774497064843672e-07
an O 0 5.727975349145709e-06
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.86033695936203
by O 0 2.4395263586995952e-11
early O 0 1.1271230505371932e-05
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.8051188588142395
goiter B-Disease 1 1.0
. O 0 2.3512119184943003e-07

A O 0 2.4114703478517185e-07
century O 0 4.125904062846075e-09
after O 0 1.0131337609131652e-11
its O 0 1.9514644349245824e-13
recognition O 0 3.501430265520633e-12
as O 0 2.8536241078458424e-11
a O 0 5.52588141911059e-10
syndrome O 0 6.60436754174043e-08
by O 0 1.2726512552130309e-11
Vaughan O 0 7.929133062134497e-06
Pendred O 0 0.00010008098615799099
, O 0 3.336288190158854e-11
the O 0 6.710677846744062e-11
disease O 0 3.434761453036117e-08
gene O 0 3.608034704338792e-11
( O 0 6.526253929634018e-12
PDS O 0 0.00018057142733596265
) O 0 5.9190551765508914e-12
was O 0 1.8576547244908426e-10
mapped O 0 1.044673236805238e-09
to O 0 1.5237722195138304e-10
chromosome O 0 9.636627140707787e-08
7q22 O 0 1.0945594112854451e-05
- O 0 9.03957129594346e-07
q31 O 0 2.830536004694295e-06
. O 0 5.118164780881784e-10

1 O 0 7.70755974599524e-08
and O 0 1.7377446703825683e-10
, O 0 1.015013767480255e-11
recently O 0 2.9202040091602655e-11
, O 0 3.267963428078141e-13
found O 0 1.1043948280843249e-13
to O 0 5.4542674088157994e-14
encode O 0 8.205843990416462e-12
a O 0 1.474452504535151e-11
putative O 0 6.398667817819614e-09
sulfate O 0 1.7882124225820917e-08
transporter O 0 2.2468725546787027e-06
. O 0 7.091289777605425e-09

We O 0 4.0084224828262904e-10
performed O 0 3.0617168800262107e-09
mutation O 0 2.021932100915169e-12
analysis O 0 9.502886758744333e-13
of O 0 3.5868048114950923e-11
the O 0 1.1258953491743995e-10
PDS B-Disease 0 1.508450077380985e-05
gene O 0 8.512331117760397e-11
in O 0 3.548513045903423e-12
patients O 0 8.354724898018695e-12
from O 0 5.479697598453903e-11
14 O 0 1.0367887659512576e-09
Pendred B-Disease 0 8.927123218427369e-08
families O 0 3.666329596147509e-14
originating O 0 2.6371330466568033e-11
from O 0 4.532276463853346e-12
seven O 0 4.615122953938178e-12
countries O 0 8.49959446087064e-15
and O 0 1.862094246157797e-12
identified O 0 5.883175890897263e-11
all O 0 4.005050457944748e-11
mutations O 0 3.409200477477725e-09
. O 0 8.647424443175566e-10

The O 0 2.6483524706577555e-08
mutations O 0 2.4831536826752654e-10
include O 0 5.137616027051095e-11
three O 0 1.6430801164091235e-11
single O 0 2.552075391293318e-11
base O 0 5.038401917900615e-10
deletions O 0 1.058694465427834e-09
, O 0 5.96184213108586e-11
one O 0 2.095182968092635e-12
splice O 0 1.813208960754764e-08
site O 0 3.58434476543934e-10
mutation O 0 2.950267807833029e-11
and O 0 2.7768854923837516e-11
10 O 0 9.702313397141893e-10
missense O 0 1.6567788918564474e-07
mutations O 0 3.3461009962820754e-08
. O 0 6.675603625438953e-09

One O 0 5.759144272587946e-09
missense O 0 8.108882099122638e-08
mutation O 0 5.412194026277461e-10
( O 0 1.1340896971523406e-10
L236P O 0 1.0857736043590194e-07
) O 0 1.7362661655639933e-11
was O 0 1.8690490821704486e-10
found O 0 3.4992870146660637e-12
in O 0 3.7664137217049976e-13
a O 0 5.150355510998017e-13
homozygous O 0 9.377894294448907e-12
state O 0 6.479209963689003e-12
in O 0 5.711745312830807e-12
two O 0 9.909787834078143e-13
consanguineous O 0 1.2953750072597359e-08
families O 0 3.1473407864288094e-13
and O 0 1.210491342579223e-12
in O 0 5.062613956524631e-12
a O 0 1.0754551546185431e-12
heterozygous O 0 9.7785440768966e-13
state O 0 2.264866679618782e-12
in O 0 2.2473657049909557e-12
five O 0 5.871645942893966e-13
additional O 0 1.4128208151997779e-12
non O 0 8.36566371731351e-08
- O 0 1.6552138504266622e-07
consanguineous O 0 2.700483719308977e-06
families O 0 1.1170776109681313e-11
. O 0 1.1906327312960485e-10

Another O 0 1.4426965400105018e-08
missense O 0 2.2113114539479284e-07
mutation O 0 9.551838209276298e-10
( O 0 9.441360887540995e-11
T416P O 0 6.57692567074264e-08
) O 0 8.151432653868973e-12
was O 0 1.0488614837766974e-10
found O 0 1.4154020837320314e-12
in O 0 4.513037621563243e-13
a O 0 3.702995755080346e-13
homozygous O 0 7.31907416617883e-12
state O 0 7.645110130898025e-13
in O 0 9.177125205594994e-13
one O 0 2.2843757593003777e-13
family O 0 2.070282422057812e-13
and O 0 1.6249159136283442e-12
in O 0 2.1055305936268365e-12
a O 0 1.5353907381610021e-12
heterozygous O 0 1.3741828855384774e-12
state O 0 2.4692370544088238e-12
in O 0 3.890869397504826e-12
four O 0 1.258750829263855e-11
families O 0 1.8196529352754176e-12
. O 0 1.398305221611551e-10

Pendred B-Disease 0 0.07924502342939377
patients O 0 2.5901188749344328e-08
in O 0 1.1010859585214305e-10
three O 0 5.4278116723427416e-11
non O 0 1.906340543200713e-07
- O 0 4.7869015418200433e-08
consanguineous O 0 2.3434550655565545e-07
families O 0 9.593214894340618e-13
were O 0 1.8207987201313003e-12
shown O 0 7.424890780330373e-13
to O 0 3.705150606898161e-13
be O 0 1.7515984051651862e-13
compound O 0 1.356054435408538e-10
heterozygotes O 0 4.540371134620358e-10
for O 0 1.425212031724854e-11
L236P O 0 1.13196691131634e-07
and O 0 1.2227220347327261e-09
T416P O 0 1.8973782971443143e-06
. O 0 2.740383475696717e-09

In O 0 5.45305078869518e-10
total O 0 3.3275309591074276e-11
, O 0 7.23722297368834e-13
one O 0 5.426799485589058e-14
or O 0 3.5928131672004204e-13
both O 0 5.380628126210041e-13
of O 0 1.7765254545221154e-11
these O 0 1.3807925885577638e-13
mutations O 0 2.623220651115643e-12
were O 0 3.925951144040374e-12
found O 0 3.216935994931197e-13
in O 0 4.114979299148225e-13
nine O 0 1.841904233301772e-11
of O 0 2.4276296251013463e-11
the O 0 1.4006482605688486e-11
14 O 0 9.532540728995897e-11
families O 0 3.3050900341211054e-14
analyzed O 0 3.908874335323276e-10
. O 0 3.1279553946994554e-10

The O 0 2.7233534871662357e-10
identification O 0 6.909663952114897e-10
of O 0 6.01229621643995e-10
two O 0 1.6347704440144994e-12
frequent O 0 3.347585264545927e-10
PDS B-Disease 0 0.17960390448570251
mutations O 0 6.426453258434606e-10
will O 0 3.6254580067229814e-12
facilitate O 0 1.1146730760636103e-10
the O 0 4.755353055774236e-11
molecular O 0 8.037219600964818e-08
diagnosis O 0 0.26656457781791687
of O 0 1.842371239035856e-05
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.901930879455449e-08

Insertional O 0 0.0003317758091725409
mutation O 0 3.34314409489167e-10
by O 0 6.494502418491477e-12
transposable O 0 2.691280087674386e-07
element O 0 5.435846439638681e-09
, O 0 7.469001805926467e-11
L1 O 0 8.913594342629949e-07
, O 0 1.9043782176209056e-11
in O 0 1.1169093427909615e-11
the O 0 3.203012299834995e-10
DMD B-Disease 1 1.0
gene O 0 3.799763004241896e-10
results O 0 2.3002096755098123e-11
in O 0 7.106556315639168e-11
X B-Disease 1 1.0
- I-Disease 1 1.0
linked I-Disease 1 0.9999995231628418
dilated I-Disease 1 0.9662639498710632
cardiomyopathy I-Disease 1 1.0
. O 0 1.2179881991869479e-08

X B-Disease 1 1.0
- I-Disease 1 1.0
linked I-Disease 1 0.9999971389770508
dilated I-Disease 1 0.9948782920837402
cardiomyopathy I-Disease 1 1.0
( O 0 7.789197553620397e-08
XLDCM B-Disease 1 1.0
) O 0 8.335755002919498e-11
is O 0 3.105669475929329e-13
a O 0 9.133347290274374e-13
clinical O 0 9.882913332148746e-08
phenotype O 0 1.092693402426903e-08
of O 0 3.866999122692505e-06
dystrophinopathy B-Disease 1 0.948786735534668
which O 0 1.1316458881083236e-10
is O 0 3.782886547412656e-13
characterized O 0 1.836085103401608e-11
by O 0 1.1810010434876173e-12
preferential O 0 2.7681695158321418e-08
myocardial B-Disease 0 0.0001628293830435723
involvement I-Disease 0 1.8959285252861946e-09
without O 0 1.194751936273164e-11
any O 0 4.0970391142203244e-12
overt O 0 2.0718193827207187e-09
clinical O 0 9.136624612438027e-07
signs O 0 1.0388191640231526e-06
of O 0 5.38572967343498e-05
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 1.4471110034719459e-06

To O 0 2.1681390016681235e-10
date O 0 3.653145785875722e-09
, O 0 3.224401431620172e-12
several O 0 7.412608938120457e-13
mutations O 0 3.106786355955293e-11
in O 0 3.005921553334012e-11
the O 0 5.8224788546112904e-08
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 0 4.4736625568475574e-05
, O 0 3.854393693103475e-09
DMD O 1 1.0
, O 0 3.54372642341616e-11
have O 0 2.495664672098538e-14
been O 0 4.362019778584095e-14
identified O 0 2.533429737695825e-13
in O 0 1.3108968121081088e-12
patients O 0 1.8138565302527887e-11
with O 0 2.5937484798843613e-11
XLDCM B-Disease 1 1.0
, O 0 1.822913209270638e-10
but O 0 1.9454922427827176e-13
a O 0 1.888727618314795e-13
pathogenic O 0 3.4107449503606446e-11
correlation O 0 7.579367363765022e-13
of O 0 1.518511358322705e-11
these O 0 5.487232846920764e-13
cardiospecific O 0 8.90314666435188e-08
mutations O 0 3.5416061749948824e-10
in O 0 8.5269274974209e-10
DMD O 1 1.0
with O 0 3.524254499343016e-10
the O 0 1.3705497181604187e-08
XLDCM B-Disease 1 1.0
phenotype O 0 1.023401630106946e-08
has O 0 1.91684428746397e-12
remained O 0 1.2880145561222633e-10
to O 0 7.091735510465769e-13
be O 0 3.869245202015037e-12
elucidated O 0 1.03392778783018e-06
. O 0 1.1836841506962514e-09

We O 0 8.976801524340772e-10
report O 0 5.0316674438111164e-11
here O 0 1.4982108435812602e-12
the O 0 4.487030864051833e-13
identification O 0 2.2556078532742774e-11
of O 0 2.1766860883176697e-11
a O 0 4.1849900281332175e-13
unique O 0 6.103033876880826e-12
de O 0 7.801746448876656e-08
novo O 0 1.3236382301329286e-07
L1 O 0 2.1067987177048053e-07
insertion O 0 1.48916975972746e-10
in O 0 1.1424913098911915e-11
the O 0 4.534682698786874e-11
muscle O 0 2.0303132508558974e-09
exon O 0 6.4242011710291536e-09
1 O 0 1.3737891935150515e-09
in O 0 1.9131021766760625e-10
DMD O 1 1.0
in O 0 6.582152600742575e-10
three O 0 1.0896079177813434e-10
XLDCM B-Disease 1 0.9999998807907104
patients O 0 1.3374240603880594e-10
from O 0 3.079553625995324e-11
two O 0 2.8462841892423763e-12
unrelated O 0 1.5831168598268164e-09
Japanese O 0 1.2306360019920248e-07
families O 0 1.009443830607415e-11
. O 0 1.6686500792228998e-10

The O 0 3.947860705011408e-09
insertion O 0 1.6215189191370882e-09
was O 0 9.917706655926395e-10
a O 0 9.851990750986417e-12
5 O 0 9.533649564241742e-11
- O 0 4.281436663533533e-11
truncated O 0 4.931182198686379e-12
form O 0 1.7327187861598814e-12
of O 0 1.0708339596987582e-11
human O 0 4.517216895677523e-12
L1 O 0 1.8516852051675414e-08
inversely O 0 2.3215658562225627e-10
integrated O 0 3.3147764533225654e-09
in O 0 9.820940935489908e-12
the O 0 1.173812956556386e-11
5 O 0 7.131064488907768e-11
- O 0 8.423756830966411e-11
untranslated O 0 4.891156777375727e-07
region O 0 1.8298654258508407e-11
in O 0 1.1976444141970077e-12
the O 0 8.590568360833384e-12
muscle O 0 3.515151503208358e-10
exon O 0 8.140580987081592e-10
1 O 0 2.344075766824716e-10
, O 0 1.0642519038348702e-13
which O 0 1.7405939225210477e-14
affected O 0 5.713573060853183e-13
the O 0 5.358884451640844e-13
transcription O 0 2.804873304104727e-12
or O 0 2.0955333551297278e-13
the O 0 7.144698786591686e-13
stability O 0 5.255277116256174e-12
of O 0 7.191943568463088e-11
the O 0 8.173150524426465e-12
muscle O 0 9.970923392499387e-11
form O 0 2.0983832726972906e-11
of O 0 5.000613256811448e-10
dystrophin O 0 5.524292578940049e-09
transcripts O 0 1.0034708619599542e-09
but O 0 1.384381568799234e-13
not O 0 4.853205714367391e-15
that O 0 2.694680314660209e-15
of O 0 7.944961528949523e-12
the O 0 8.64173108072741e-11
brain O 0 3.911780197540793e-07
or O 0 2.443010238550869e-10
Purkinje O 0 0.00021279095381032676
cell O 0 1.053852116683629e-07
form O 0 1.3391425746078767e-09
, O 0 1.3095130882434525e-11
probably O 0 1.1406970853999887e-11
due O 0 2.307354481090318e-11
to O 0 2.188736252786358e-13
its O 0 4.588236800044665e-13
unique O 0 1.8991203737644263e-13
site O 0 3.160728970219573e-11
of O 0 6.062083474089874e-11
integration O 0 3.729482833669806e-10
. O 0 1.6869998453739043e-10

We O 0 5.927421331541893e-10
speculate O 0 5.886217208095346e-11
that O 0 4.052587123304016e-14
this O 0 1.844354103306984e-15
insertion O 0 6.459048140089463e-12
of O 0 4.388539184829732e-11
an O 0 4.824967465497099e-13
L1 O 0 1.819846175976636e-07
sequence O 0 1.697307745740506e-11
in O 0 3.018284927547299e-11
DMD O 1 1.0
is O 0 4.2717522227841975e-12
responsible O 0 5.478736214703517e-11
for O 0 4.064525951051612e-13
some O 0 6.244492227990006e-14
of O 0 5.888517104479796e-12
the O 0 6.544521462302846e-14
population O 0 2.0465499204812092e-16
of O 0 8.42943336659685e-14
Japanese O 0 5.421317283982319e-10
patients O 0 5.550540929655234e-12
with O 0 5.349747120991788e-12
XLDCM B-Disease 1 1.0
. O 0 2.4942800602723025e-10
. O 0 1.8314130767471681e-10

Severe O 1 0.9999679327011108
early O 0 0.3533605933189392
- O 1 0.9999299049377441
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 9.281690083184913e-09
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 0.09571623802185059
red O 1 1.0
hair O 1 1.0
pigmentation O 1 0.9999983310699463
caused O 0 3.552814860086073e-07
by O 0 6.454227152730141e-10
POMC O 1 1.0
mutations O 0 1.4073980869611091e-09
in O 0 8.799207890097804e-11
humans O 0 5.530004232312535e-10
. O 0 1.89223428592733e-11

Sequential O 0 1.1842215741353357e-07
cleavage O 0 8.733276501970977e-08
of O 0 4.9680672020713246e-08
the O 0 2.4174931501086405e-10
precursor O 0 1.891298007095088e-09
protein O 0 1.9338487755593547e-10
pre O 0 4.76713012176333e-07
- O 0 1.0978806308514777e-08
pro O 0 6.256372842017299e-08
- O 0 1.1464702964758544e-08
opiomelanocortin O 0 3.626637976594793e-07
( O 0 7.476141927753588e-11
POMC O 0 7.004869257798418e-05
) O 0 1.2230187565812067e-12
generates O 0 2.037238216665016e-12
the O 0 1.451028533439036e-11
melanocortin O 0 4.0339986639992276e-07
peptides O 0 6.044932110427226e-09
adrenocorticotrophin O 0 7.562309178865689e-07
( O 0 2.394442699671373e-10
ACTH O 0 2.3984025574463885e-06
) O 0 7.154875650283721e-12
, O 0 1.6641414808671318e-12
melanocyte O 0 6.98245727903668e-08
- O 0 1.8107311205994847e-08
stimulating O 0 7.625043707548684e-09
hormones O 0 5.2995643429198935e-09
( O 0 6.230222501096838e-12
MSH O 0 1.6536864677618723e-06
) O 0 1.807145064017593e-13
alpha O 0 5.1287628657914475e-12
, O 0 1.0784694534984873e-14
beta O 0 7.185588387324804e-13
and O 0 5.81789865307207e-14
gamma O 0 2.3978555252490708e-11
as O 0 3.1212384836009494e-14
well O 0 5.01322819520221e-14
as O 0 3.179098287788354e-14
the O 0 3.6950141974996867e-14
opioid O 0 5.6247086849259276e-11
- O 0 6.5108248653578116e-12
receptor O 0 3.0871778657765025e-13
ligand O 0 2.2205149177723094e-11
beta O 0 3.0233640035959297e-09
- O 0 3.5033596024192093e-09
endorphin O 0 3.670917578801891e-07
. O 0 6.149355330498096e-11

While O 0 5.4018216566475985e-09
a O 0 2.3497103568415056e-11
few O 0 1.2961557825305614e-12
cases O 0 6.791526108856916e-12
of O 0 2.802952092650912e-09
isolated O 1 0.9999983310699463
ACTH B-Disease 1 1.0
deficiency I-Disease 1 0.9999996423721313
have O 0 4.9735753709923e-12
been O 0 3.2920257232033068e-12
reported O 0 1.0619258250521568e-10
( O 0 1.1876070959981888e-10
OMIM O 1 0.9958997368812561
201400 O 0 4.667624580179108e-06
) O 0 1.1949388527277005e-11
, O 0 1.9442873960134888e-12
an O 0 5.780507149333314e-12
inherited O 1 0.9999998807907104
POMC O 1 1.0
defect O 1 0.9999998807907104
has O 0 1.4075476895136774e-10
not O 0 2.8271202653223915e-12
been O 0 3.967095315443592e-12
described O 0 2.919246094856831e-11
so O 0 1.0378813693895372e-12
far O 0 1.7944007391079708e-11
. O 0 5.5518568908841104e-11

Recent O 0 7.134468571479147e-10
studies O 0 6.232388910509812e-11
in O 0 1.7968657161152035e-12
animal O 0 7.396783879842772e-11
models O 0 6.696494487395954e-12
elucidated O 0 6.244040839931131e-10
a O 0 2.8501033998151737e-12
central O 0 1.0902648228672263e-10
role O 0 8.556146242899576e-12
of O 0 4.315940382859651e-10
alpha O 0 4.639347128687632e-09
- O 0 8.963016107088606e-09
MSH O 0 1.418695228494471e-05
in O 0 6.774604315029631e-12
the O 0 1.1361280839727872e-12
regulation O 0 2.926616587961561e-11
of O 0 3.963880872842607e-12
food O 0 3.285674344904142e-14
intake O 0 2.766739948581974e-15
by O 0 9.338286251176853e-16
activation O 0 5.516702979851962e-12
of O 0 8.501233050850487e-11
the O 0 1.0310043790928702e-10
brain O 0 3.6823313287470683e-09
melanocortin O 0 5.757664212069358e-08
- O 0 1.1853785730764343e-09
4 O 0 2.7169616556577125e-10
- O 0 2.411155650139385e-11
receptor O 0 1.4365099821472826e-12
( O 0 8.115329697307161e-13
MC4 O 0 3.2484322218806483e-06
- O 0 3.1008695611234316e-09
R O 0 1.2781923963700592e-08
; O 0 6.000097879481359e-13
refs O 0 6.868274282645359e-10
3 O 0 5.827680699121984e-11
- O 0 9.354545783823998e-12
5 O 0 3.04294848867126e-12
) O 0 4.638793723330068e-15
and O 0 1.6031557117522806e-14
the O 0 1.0655071389000653e-13
linkage O 0 2.1689951223979875e-10
of O 0 8.905104431633504e-11
human O 0 2.9565123682573358e-09
obesity B-Disease 1 0.9999998807907104
to O 0 1.6281735074757941e-12
chromosome O 0 1.2190275698598096e-11
2 O 0 8.782151221520262e-12
in O 0 3.002640725034006e-13
close O 0 3.4006679850567822e-12
proximity O 0 7.144896480015817e-11
to O 0 1.9148198651675052e-12
the O 0 8.85578069209636e-11
POMC O 0 6.576497253263369e-05
locus O 0 7.86034640154476e-11
, O 0 1.477833155329178e-12
led O 0 7.714457544993891e-12
to O 0 1.2975528312399176e-13
the O 0 6.47400590168129e-13
proposal O 0 5.582836710288364e-13
of O 0 1.3654388383854688e-11
an O 0 1.846623033522135e-13
association O 0 7.360183573723589e-10
of O 0 7.499486365247776e-09
POMC O 1 1.0
with O 0 5.781979339758436e-10
human O 0 5.985007646813756e-06
obesity B-Disease 1 1.0
. O 0 3.339307719230078e-10

The O 0 1.8990482519853913e-09
dual O 0 2.4238647200469643e-10
role O 0 1.6798588908795153e-10
of O 0 3.4891420863658595e-09
alpha O 0 1.606328403624957e-08
- O 0 1.579588726485781e-08
MSH O 0 3.577430106815882e-05
in O 0 5.297605670112615e-12
regulating O 0 1.7833978738224232e-10
food O 0 7.529315712573315e-12
intake O 0 3.2589517022507675e-12
and O 0 1.2612694742786257e-11
influencing O 0 6.016213092152611e-07
hair O 0 4.4783195335185155e-05
pigmentation O 0 9.766615676198853e-07
predicts O 0 2.943288668344479e-10
that O 0 5.328783204625043e-14
the O 0 1.5213051087967222e-12
phenotype O 0 3.1498421926290376e-11
associated O 0 3.340306156673911e-11
with O 0 3.790732484854065e-12
a O 0 1.5188247881603445e-10
defect O 0 1.030388574463359e-07
in O 0 5.642882272560712e-10
POMC O 1 0.9999957084655762
function O 0 2.5635011474678393e-11
would O 0 2.671175780566415e-12
include O 0 5.4830199047728456e-08
obesity B-Disease 1 1.0
, O 0 3.736494100237131e-11
alteration O 0 3.553329008809669e-08
in O 0 1.7758970960457532e-09
pigmentation O 1 0.9999911785125732
and O 0 4.858773172600195e-05
ACTH B-Disease 1 1.0
deficiency I-Disease 1 0.9999829530715942
. O 0 4.322557867197929e-09

The O 0 6.155698617504868e-09
observation O 0 3.9733666312713467e-07
of O 0 2.104615326459225e-08
these O 0 1.408012179071605e-10
symptoms O 0 5.9693884395528585e-06
in O 0 5.0412927304899213e-11
two O 0 3.2903825497587746e-11
probands O 0 5.513988980965223e-07
prompted O 0 1.1435891122957287e-09
us O 0 1.1219375255222541e-11
to O 0 4.2700638489510945e-13
search O 0 4.307399489172914e-12
for O 0 2.1848697167887315e-13
mutations O 0 6.724849149764012e-11
within O 0 1.504575630750793e-10
their O 0 2.625826223123795e-10
POMC O 1 0.8927399516105652
genes O 0 2.490079475947482e-09
. O 0 3.743729493077552e-10

Patient O 0 4.253656243236037e-06
1 O 0 4.264092368089223e-08
was O 0 9.881980789216982e-10
found O 0 1.914246539058695e-12
to O 0 9.268770511305577e-14
be O 0 4.426420710003376e-14
a O 0 2.769947628471908e-13
compound O 0 2.1278170198035795e-11
heterozygote O 0 3.0116156790604975e-10
for O 0 9.031400844197734e-13
two O 0 7.985765369290798e-13
mutations O 0 3.930874289265196e-12
in O 0 2.6936479088912613e-11
exon O 0 3.551741789564744e-09
3 O 0 9.609019357981197e-09
( O 0 2.955201014454012e-11
G7013T O 0 2.82916481353368e-08
, O 0 9.41212038862993e-12
C7133delta O 0 1.5089402438661637e-07
) O 0 7.220691601063367e-13
which O 0 1.1184046175066395e-13
interfere O 0 6.110942481207804e-12
with O 0 5.346416397707804e-14
appropriate O 0 1.523977818940203e-11
synthesis O 0 9.60621027168429e-10
of O 0 2.019221900795287e-09
ACTH O 0 4.970322152075823e-06
and O 0 4.702688793933874e-10
alpha O 0 7.401466461942618e-08
- O 0 1.9422034824856382e-07
MSH O 0 0.010666973888874054
. O 0 4.5511394652919535e-10

Patient O 0 7.125749107217416e-06
2 O 0 9.761961905496719e-08
was O 0 9.641012432837215e-10
homozygous O 0 7.319300721064792e-11
for O 0 8.868263111708186e-13
a O 0 1.192185781519195e-12
mutation O 0 1.2603717982478946e-12
in O 0 4.7194062893773925e-12
exon O 0 1.4519407898205827e-09
2 O 0 4.460110947235307e-09
( O 0 1.2867199493393766e-11
C3804A O 0 2.3520366099205603e-08
) O 0 1.6407743219648552e-12
which O 0 2.7757139035161638e-12
abolishes O 0 7.427826744788035e-07
POMC O 0 0.23204432427883148
translation O 0 3.3580636937813324e-08
. O 0 9.966498737412621e-10

These O 0 4.282386112386405e-10
findings O 0 4.00598471061997e-10
represent O 0 5.457946160997151e-12
the O 0 2.10710940883041e-12
first O 0 3.6640731681386596e-13
examples O 0 5.702949397445867e-12
of O 0 7.615239688840703e-11
a O 0 1.565606533304731e-10
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 8.051270761200158e-09
the O 0 6.277764419415632e-10
POMC O 1 0.999956488609314
gene O 0 7.54476259245962e-10
and O 0 1.2316715355953356e-11
define O 0 2.456884140578097e-10
a O 0 2.4336890142029333e-11
new O 0 9.674783640889473e-09
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 1.0
resulting O 0 5.917033085722778e-09
in O 0 2.5918593660190226e-11
early O 0 6.74709781378624e-07
- O 0 0.00010108220885740593
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 5.305400119226533e-09
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 1.0334139005863108e-05
red O 1 0.8617318272590637
hair O 0 0.15913595259189606
pigmentation O 0 3.0475972380372696e-05
. O 0 5.2916403897596e-11
. O 0 1.0064337557791347e-10

A O 0 9.204613888869062e-07
European O 0 5.526358481944271e-09
multicenter O 0 5.343567863747012e-07
study O 0 8.227432068963481e-10
of O 0 1.5241653272823896e-06
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 2.481857386271713e-09
classification O 0 3.848218099733458e-08
of O 0 1.3602005743962309e-08
105 O 0 1.0753551293873898e-07
mutations O 0 3.48174614139829e-11
and O 0 4.51599348194609e-12
a O 0 2.64881692968455e-12
general O 0 1.2017111264417402e-11
system O 0 1.4470044086556388e-11
for O 0 5.75900058977924e-13
genotype O 0 8.243670329699526e-11
- O 0 5.137194489246433e-11
based O 0 3.9019298209153064e-11
prediction O 0 1.7695919396487625e-08
of O 0 6.902435956135378e-09
metabolic O 0 0.11404839158058167
phenotype O 0 5.616002241026763e-08
. O 0 7.56915086164156e-10

Phenylketonuria B-Disease 0 0.48750635981559753
( O 0 8.541977081222285e-08
PKU B-Disease 1 0.9999841451644897
) O 0 1.3717095515008992e-10
and O 0 2.4424839928371966e-10
mild B-Disease 1 1.0
hyperphenylalaninemia I-Disease 1 1.0
( O 1 0.9987517595291138
MHP B-Disease 1 1.0
) O 0 1.667900151325341e-09
are O 0 3.681323648696555e-11
allelic B-Disease 1 1.0
disorders I-Disease 1 1.0
caused O 0 2.909450813604053e-06
by O 0 2.378859262353039e-11
mutations O 0 1.4982232468541135e-11
in O 0 1.4203373720211854e-12
the O 0 8.625128389283532e-12
gene O 0 3.1449059936100587e-12
encoding O 0 3.882857577131027e-11
phenylalanine O 0 4.058912281834637e-07
hydroxylase O 0 1.031364081427455e-05
( O 0 1.186790932194981e-08
PAH O 1 1.0
) O 0 2.2908421826173253e-09
. O 0 3.027939010635805e-10

Previous O 0 5.5213462246683775e-08
studies O 0 3.863776798507246e-10
have O 0 2.449711982745184e-13
suggested O 0 7.132907003763733e-13
that O 0 5.8157324510127624e-15
the O 0 8.165309249054398e-13
highly O 0 1.1354164830557067e-10
variable O 0 9.833026837213765e-09
metabolic O 0 0.086925208568573
phenotypes O 0 7.57885982238804e-06
of O 1 0.8758780360221863
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 0 7.469196816600743e-07
with O 0 1.0706170172625207e-08
PAH O 1 1.0
genotypes O 0 2.275192855449859e-05
. O 0 1.7786225825489055e-09

We O 0 1.193764531670638e-09
identified O 0 2.2003339428255941e-10
both O 0 9.588060380372188e-12
causative O 0 8.154352748590554e-09
mutations O 0 2.920929886851553e-10
in O 0 1.3937360987537062e-10
686 O 0 1.353738383613745e-07
patients O 0 8.25617976762949e-11
from O 0 1.578478736607991e-10
seven O 0 3.6053121599266547e-10
European O 0 2.2604293992145585e-09
centers O 0 1.491030054978637e-08
. O 0 1.1947166589365565e-09

On O 0 2.4871093629030838e-08
the O 0 2.1566677263495926e-11
basis O 0 2.1115279663641573e-11
of O 0 1.7975419763782696e-11
the O 0 6.78877743950923e-13
phenotypic O 0 5.6320836883116954e-11
characteristics O 0 1.4816278759433033e-10
of O 0 9.203906525812044e-10
297 O 0 1.8508202970224374e-08
functionally O 0 4.677306364442302e-08
hemizygous O 0 2.6797908958542394e-07
patients O 0 1.6167805982902905e-10
, O 0 2.222056089476454e-12
105 O 0 2.375370566909396e-09
of O 0 2.471977622597876e-10
the O 0 2.8320542092008516e-11
mutations O 0 5.70248232314996e-12
were O 0 1.473783248218119e-11
assigned O 0 9.257905553283763e-10
to O 0 4.760586889973606e-12
one O 0 2.667713706189234e-12
of O 0 4.5396068848457816e-11
four O 0 4.090386883370822e-12
arbitrary O 0 6.211762354491057e-11
phenotype O 0 7.375965394018635e-10
categories O 0 1.875463784273279e-09
. O 0 4.0088737884858006e-10

We O 0 3.6530464764261694e-10
proposed O 0 4.054984403811801e-10
and O 0 7.080754038657489e-11
tested O 0 4.450675661349379e-10
a O 0 1.0598162972219605e-12
simple O 0 3.2362049780416957e-13
model O 0 4.286863900426936e-14
for O 0 3.2444586957786374e-15
correlation O 0 1.6578289779921145e-14
between O 0 1.0776661274513114e-13
genotype O 0 2.6918656539920427e-11
and O 0 8.573294526560693e-13
phenotypic O 0 2.8811128482963966e-10
outcome O 0 6.376345007552686e-10
. O 0 3.3761965445577857e-10

The O 0 1.522135484322007e-08
observed O 0 1.5905259331816524e-09
phenotype O 0 9.737797235231938e-10
matched O 0 1.3783350016893792e-09
the O 0 1.659641174489579e-11
predicted O 0 2.9858986810848975e-11
phenotype O 0 3.6566400948845335e-12
in O 0 1.6149607692805823e-12
79 O 0 1.3385800801124503e-10
% O 0 5.3378268059962874e-14
of O 0 2.495895634266332e-12
the O 0 3.8196090170958263e-13
cases O 0 5.001369327364835e-13
, O 0 1.3669383821472009e-13
and O 0 1.7968956943052727e-13
in O 0 2.4244712140686353e-13
only O 0 1.3845973250315585e-14
5 O 0 3.236206658555063e-12
of O 0 6.086120322990052e-12
184 O 0 1.6709687800098294e-10
patients O 0 8.503531212511461e-12
was O 0 1.6475246167324542e-10
the O 0 2.882282260086022e-11
observed O 0 2.8752266192921816e-11
phenotype O 0 2.910238239631213e-12
more O 0 8.25038635636011e-15
than O 0 2.1873453569243306e-14
one O 0 2.5521299212415832e-14
category O 0 2.4588412902981638e-12
away O 0 2.166090657534925e-12
from O 0 3.2048287092710515e-13
that O 0 1.8301478784738716e-15
expected O 0 6.7137467460454126e-12
. O 0 1.1670249489004192e-10

Among O 0 2.973375989867577e-09
the O 0 2.8779931215972e-10
seven O 0 6.603652347170197e-11
contributing O 0 3.69968639057916e-12
centers O 0 3.5678366511193715e-11
, O 0 1.6929217901660853e-13
the O 0 3.798431025010124e-13
proportion O 0 4.455136617693284e-13
of O 0 1.2242493477310212e-11
patients O 0 1.1387922939712358e-12
for O 0 1.5074521492186577e-12
whom O 0 8.443184519590918e-12
the O 0 2.8063515053466936e-11
observed O 0 1.0501867431234047e-10
phenotype O 0 1.7769896665242868e-11
did O 0 1.4523263234395012e-12
not O 0 5.360346498270441e-13
match O 0 2.255446496235436e-09
the O 0 2.5361641606269636e-11
predicted O 0 1.1697409534050518e-11
phenotype O 0 5.56665607706619e-12
was O 0 3.212653407191901e-11
4 O 0 2.8901929460811715e-11
% O 0 4.940780111970834e-14
- O 0 1.0320131901830898e-11
23 O 0 3.3418802447560125e-11
% O 0 1.0361264119905164e-13
( O 0 3.533537937076836e-13
P O 0 5.77053560490981e-09
< O 0 1.7689388842612175e-10
. O 0 9.429868995033952e-13
0001 O 0 7.406574908941366e-09
) O 0 9.575043665929761e-13
, O 0 1.114792597969004e-13
suggesting O 0 3.140336840394553e-13
that O 0 3.746148475382597e-15
differences O 0 1.72202990799189e-13
in O 0 2.6299007595135052e-14
methods O 0 1.8253737551435917e-13
used O 0 5.6028891649937546e-14
for O 0 4.0951132594538656e-14
mutation O 0 3.4402357265012062e-12
detection O 0 4.289478283681092e-08
or O 0 1.1230170959830588e-10
phenotype O 0 5.796521596046489e-10
classification O 0 1.675993566152556e-09
may O 0 4.1490969731119987e-13
account O 0 6.560406379382475e-14
for O 0 7.985913362887342e-14
a O 0 1.0725253150878356e-13
considerable O 0 7.694071616805298e-13
proportion O 0 3.865328196406281e-12
of O 0 2.4380994445571957e-10
genotype O 0 1.596402512404893e-07
- O 0 5.985841085021093e-07
phenotype O 0 1.3668010723222324e-08
inconsistencies O 0 2.0501123287886003e-07
. O 0 5.279910286759559e-09

Our O 0 6.030516175314915e-08
data O 0 1.2788720082923533e-09
indicate O 0 7.544816854609948e-11
that O 0 2.9819004795754445e-13
the O 0 8.10948877494333e-11
PAH O 1 1.0
- O 0 8.52493613479055e-08
mutation O 0 5.360165002826767e-12
genotype O 0 2.390877253122259e-11
is O 0 2.992382410653763e-14
the O 0 1.808710651954662e-13
main O 0 2.9083365923887605e-11
determinant O 0 3.9638167748101694e-10
of O 0 8.62269011747685e-09
metabolic O 0 0.09368986636400223
phenotype O 0 1.5202719083617922e-09
in O 0 7.1606505447352475e-12
most O 0 4.411035772755589e-12
patients O 0 1.3392089659447493e-09
with O 0 3.9075817426237336e-07
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 6.694936871554091e-08

In O 0 2.0286099466915175e-09
the O 0 7.021698500420115e-11
present O 0 5.109284089560573e-12
study O 0 1.852239715771642e-12
, O 0 9.650394090614245e-14
the O 0 2.181729731771942e-13
classification O 0 2.489313755127398e-10
of O 0 5.301603600571525e-10
105 O 0 1.6742042134865187e-06
PAH O 1 1.0
mutations O 0 1.6382188938734998e-09
may O 0 4.0887328245364785e-12
allow O 0 2.115485521134164e-12
the O 0 9.427301821129941e-12
prediction O 0 7.487305775377706e-10
of O 0 1.0554277590779648e-10
the O 0 5.041876638411935e-12
biochemical O 0 1.1084404505368184e-09
phenotype O 0 2.8857864015074952e-11
in O 0 1.3211134443358308e-11
> O 0 1.4814244275740407e-10
10 O 0 8.315270000336383e-11
, O 0 1.4740270636026676e-12
000 O 0 1.0470165706655266e-10
genotypes O 0 5.910239520012794e-10
, O 0 1.7639068374333822e-12
which O 0 3.3167744809339816e-13
may O 0 5.193959411869953e-13
be O 0 4.2137259935633165e-14
useful O 0 8.202694708366043e-13
for O 0 8.628213025779416e-14
the O 0 4.110549140651232e-12
management O 0 1.304926611211954e-09
of O 0 9.133208855871544e-09
hyperphenylalaninemia B-Disease 1 1.0
in O 0 2.281798083814124e-09
newborns O 0 3.537356718652518e-08
. O 0 1.1050118459143832e-10

Somatic O 0 8.445439743809402e-05
instability O 0 4.623184679530823e-07
of O 0 3.0035363351998967e-07
the O 0 1.2258821513455587e-08
CTG O 0 0.0019476345041766763
repeat O 0 9.592062255592282e-09
in O 0 2.1280696649306208e-10
mice O 0 2.782310493110174e-10
transgenic O 0 1.2484895339781588e-09
for O 0 4.703823702073562e-12
the O 0 3.435291873188362e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 2.043321671862941e-07
is O 0 2.1864131598964276e-12
age O 0 1.1340777492443999e-12
dependent O 0 6.466700005341997e-13
but O 0 3.198071571696966e-15
not O 0 2.7405422783145826e-15
correlated O 0 1.6325456611565592e-12
to O 0 1.1534202141571387e-13
the O 0 1.946848064704465e-12
relative O 0 2.4929327699374504e-11
intertissue O 0 1.6585582685024747e-08
transcription O 0 3.2673341809896783e-09
levels O 0 3.371048995504111e-10
and O 0 6.161977178509304e-11
proliferative O 0 1.6503843653481454e-05
capacities O 0 4.7415215931323473e-07
. O 0 2.453284464465355e-09

A O 0 1.1428130164858885e-05
( O 0 5.845609774013383e-09
CTG O 0 0.00011291899136267602
) O 0 7.620223202442489e-11
nexpansion O 0 8.305359244786814e-08
in O 0 2.5752922364064013e-11
the O 0 3.3357285683655036e-11
3 O 0 1.5210057657810694e-09
- O 0 2.0346202500576283e-09
untranslated O 0 9.21418541111052e-06
region O 0 8.086880054491985e-10
( O 0 1.7569874374845362e-11
UTR O 0 6.71585657983087e-05
) O 0 1.8031417288108531e-12
of O 0 6.10427125513624e-11
the O 0 2.8006406221914304e-11
DM O 1 1.0
protein O 0 7.1464851814084795e-09
kinase O 0 1.8525684097880912e-08
gene O 0 9.211124085695133e-10
( O 0 8.732793134458294e-12
DMPK O 1 0.9999994039535522
) O 0 1.0010587194256293e-12
is O 0 8.894969111858213e-15
responsible O 0 1.7221073525530706e-11
for O 0 4.594870664509365e-11
causing O 1 0.9999998807907104
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 9.788428542378824e-06
DM B-Disease 1 1.0
) O 0 1.06068342997645e-09
. O 0 2.1310103681670967e-10

Major O 0 3.598525836423505e-06
instability O 0 1.0288921004075746e-07
, O 0 3.1896471575088015e-11
with O 0 5.884134867718827e-13
very O 0 2.008772922307278e-13
large O 0 2.9684059572356036e-13
expansions O 0 6.534116303580362e-11
between O 0 4.585194203488019e-12
generations O 0 3.639314544168215e-12
and O 0 3.6508396674718446e-13
high O 0 8.565981257646627e-11
levels O 0 2.1660463353501136e-11
of O 0 2.0786252927229576e-11
somatic O 0 2.6724553237045257e-08
mosaicism O 0 4.0025676639743324e-07
, O 0 4.760178796275882e-12
is O 0 5.832576039982093e-14
observed O 0 3.835957593234518e-12
in O 0 6.041015777891179e-12
patients O 0 8.818950431033201e-11
. O 0 1.6992326989928586e-10

There O 0 3.7041808509385987e-10
is O 0 2.9842688650111304e-12
a O 0 2.337015346867699e-12
good O 0 1.1418028848797501e-11
correlation O 0 9.081737098459719e-13
between O 0 4.747319074308032e-13
repeat O 0 7.70783957493304e-12
size O 0 4.943405493978981e-12
( O 0 2.2244519594372125e-12
at O 0 3.023804817647857e-11
least O 0 2.99130972812936e-14
in O 0 3.52975217414106e-13
leucocytes O 0 3.714372454055592e-08
) O 0 2.392290142025355e-12
, O 0 1.6680366398021118e-13
clinical O 0 4.847131029883656e-10
severity O 0 7.199104601340878e-08
and O 0 3.293585196240123e-11
age O 0 6.437736455033871e-11
of O 0 8.368192250252093e-10
onset O 0 1.705438808130566e-05
. O 0 5.487544862958771e-10

The O 0 3.180667249580438e-07
trinucleotide O 0 0.001535485964268446
repeat O 0 3.1271983402803016e-07
instability O 0 1.3859280834083165e-08
mechanisms O 0 1.7769991700333776e-08
involved O 0 2.2828328116730745e-10
in O 0 7.10242642476544e-10
DM B-Disease 1 1.0
and O 0 7.393420542456397e-09
other O 0 1.2973246088510137e-10
human O 0 2.140816150131286e-06
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 2.7866028711950874e-13
unknown O 0 1.2171788577042264e-10
. O 0 2.887129597894944e-11

We O 0 3.020232952621882e-10
studied O 0 6.5794574233279945e-09
somatic O 0 2.2130350885163352e-07
instability O 0 8.046400212791127e-10
by O 0 7.058380355889904e-12
measuring O 0 2.3015347494492744e-07
the O 0 7.362457865589533e-10
CTG O 0 1.365156003885204e-05
repeat O 0 9.132942180301029e-10
length O 0 9.764198130590707e-12
at O 0 6.019438419935241e-12
several O 0 3.883288276444047e-14
ages O 0 1.0688539896913651e-12
in O 0 1.0709185952308478e-13
various O 0 9.848965393244313e-12
tissues O 0 3.608630061435747e-09
of O 0 3.061775277757306e-09
transgenic O 0 3.311270901917851e-08
mice O 0 3.627320319110616e-11
carrying O 0 3.065944720326286e-11
a O 0 1.0407126549427659e-11
( O 0 2.8149826220014162e-11
CTG O 0 1.274300302611664e-05
) O 0 2.0681217155482656e-11
55expansion O 0 3.450757546374916e-08
surrounded O 0 7.104675736613331e-10
by O 0 1.7620540443408217e-12
45 O 0 7.171834653929565e-11
kb O 0 4.044234724887019e-09
of O 0 2.1435224706323197e-09
the O 0 1.8644345789464722e-10
human O 0 3.931075021057495e-09
DM B-Disease 1 1.0
region O 0 1.1788428899706105e-08
, O 0 9.679194295023064e-13
using O 0 9.594715430147338e-13
small O 0 4.44451246639499e-12
- O 0 6.417854025997372e-10
pool O 0 1.2049093944810352e-09
PCR O 0 1.9379314153411542e-07
. O 0 1.4181056329221065e-10

These O 0 2.319389347249512e-09
mice O 0 6.54763132601488e-10
have O 0 1.1236303364527481e-13
been O 0 3.0649300371971e-13
shown O 0 2.338672875148995e-13
to O 0 1.2158080531926574e-13
reproduce O 0 3.707749038350805e-11
the O 0 3.4481055163904095e-12
intergenerational O 0 1.658720209796183e-11
and O 0 6.5361821857679026e-12
somatic O 0 1.1834726088011394e-08
instability O 0 4.3191933363218027e-10
of O 0 1.0428974350773501e-09
the O 0 3.6914432621770743e-10
55 O 0 6.122677476128047e-09
CTG O 0 1.3426656551018823e-05
repeat O 0 9.040480031252685e-10
suggesting O 0 1.7913196967422884e-11
that O 0 1.4803594819163407e-14
surrounding O 0 5.969135602468256e-11
sequences O 0 4.982842263800968e-12
and O 0 5.677236025042331e-13
the O 0 4.952963495070961e-13
chromatin O 0 2.595510438518911e-11
environment O 0 7.792183565058508e-12
are O 0 4.7073639203223244e-14
involved O 0 4.162333997435874e-13
in O 0 6.309532757375891e-12
instability O 0 1.5233689865112865e-09
mechanisms O 0 7.474827157238906e-08
. O 0 8.9048202145392e-10

As O 0 2.579649271972073e-10
observed O 0 4.6451956864368427e-11
in O 0 8.417998828384732e-13
some O 0 6.668790682434061e-14
of O 0 1.514464768870294e-11
the O 0 7.587631044303489e-12
tissues O 0 1.2895276846336401e-08
of O 0 1.3292699918565631e-07
DM B-Disease 1 1.0
patients O 0 1.4986142105044564e-08
, O 0 2.3957695636372955e-12
there O 0 2.708921682890303e-13
is O 0 4.4574800529264755e-14
a O 0 3.3468139284259513e-13
tendency O 0 2.718581436356171e-12
for O 0 4.564511746005251e-13
repeat O 0 3.055961039777344e-11
length O 0 2.0193729501072344e-12
and O 0 4.185495266345596e-12
somatic O 0 2.31126495719991e-08
mosaicism O 0 3.120610969631343e-08
to O 0 1.1165168182364349e-12
increase O 0 1.0521439405483668e-13
with O 0 7.106829366535297e-14
the O 0 4.473121525960799e-12
age O 0 1.920584351278176e-12
of O 0 5.953021062210517e-12
the O 0 1.2703812828085415e-11
mouse O 0 7.97056032286747e-10
. O 0 1.4127110939399223e-11

Furthermore O 0 1.6210829301144258e-07
, O 0 1.5865680991211661e-10
we O 0 4.784589066088307e-13
observed O 0 1.178604414585338e-12
no O 0 9.854612378944541e-14
correlation O 0 1.0417541666547098e-13
between O 0 5.798412151900717e-14
the O 0 2.960800550046161e-13
somatic O 0 7.829003556558689e-10
mutation O 0 6.587684824727047e-12
rate O 0 9.752620586112037e-12
and O 0 2.512768118578812e-11
tissue O 0 3.960054471008334e-07
proliferation O 0 2.92112490569707e-05
capacity O 0 6.3503984293333815e-09
. O 0 2.5059440633690144e-10

The O 0 1.4782731483364842e-08
somatic O 0 2.587500205208926e-07
mutation O 0 3.591158620475099e-11
rates O 0 5.954224960302845e-12
in O 0 1.1673415055771241e-13
different O 0 3.93623427309784e-14
tissues O 0 8.132288592532788e-11
were O 0 8.439288330663874e-12
also O 0 1.0888085409405807e-13
not O 0 5.999496248919583e-15
correlated O 0 6.312722480167343e-12
to O 0 3.9181093265672207e-13
the O 0 3.787855445969157e-12
relative O 0 2.3168711740795267e-11
inter O 0 2.8901643744916328e-08
- O 0 1.8087211728357033e-09
tissue O 0 2.021533079821225e-10
difference O 0 1.8021651879140954e-12
in O 0 5.4254333908517263e-14
transcriptional O 0 3.726833945616459e-12
levels O 0 6.6689501143635255e-12
of O 0 7.643860371053801e-12
the O 0 3.3427945199220044e-13
three O 0 1.2223394226049816e-13
genes O 0 5.216655558047678e-13
( O 0 1.6536020599686174e-12
DMAHP O 1 0.9988396763801575
, O 0 1.2831082030206886e-10
DMPK O 0 0.01120271347463131
and O 0 3.0034585929428204e-10
59 O 0 3.739820453318998e-09
) O 0 2.603465674381328e-13
surrounding O 0 8.363130327149193e-11
the O 0 2.5615655430133444e-11
repeat O 0 9.309238380161844e-10
. O 0 1.1798398195927984e-11
. O 0 1.033374705250445e-10

A O 0 7.593254167659325e-07
novel O 0 3.444515339623422e-09
missense O 0 1.0075971346168444e-07
mutation O 0 6.654294337771205e-10
in O 0 1.054478032669337e-10
patients O 0 1.750532357958079e-10
from O 0 7.384045042080345e-10
a O 0 1.303242735950505e-09
retinoblastoma B-Disease 0 0.14447453618049622
pedigree O 0 1.5262627357515157e-06
showing O 0 1.3973894930074948e-08
only O 0 6.19997022471841e-12
mild O 0 2.9385796906922224e-08
expression O 0 2.0884022289280324e-10
of O 0 2.4170563328596018e-09
the O 0 4.4333411941543943e-10
tumor B-Disease 0 5.129252400593032e-08
phenotype O 0 1.1633739527283637e-09
. O 0 1.093242649186088e-10

We O 0 3.500478795714912e-10
have O 0 4.470012413600871e-14
used O 0 8.10060731600698e-13
single O 0 4.625248101186585e-12
strand O 0 8.161373486748058e-12
conformation O 0 6.282201321650138e-12
polymorphism O 0 2.838260876325549e-12
analysis O 0 9.198920786343198e-14
to O 0 2.0001583600644766e-14
study O 0 6.050340892356509e-13
the O 0 1.6091002228574292e-12
27 O 0 5.273868564081852e-10
exons O 0 6.55755449940898e-10
of O 0 1.5404906517080263e-10
the O 0 7.732094131629452e-11
RB1 O 0 2.535104840717395e-06
gene O 0 2.7467857849350352e-11
in O 0 1.0614022681598723e-12
individuals O 0 3.4344234948373645e-14
from O 0 1.0398375736853094e-11
a O 0 1.2183906661356048e-11
family O 0 1.1139371543233967e-11
showing O 0 2.133341725496507e-09
mild O 0 2.1687972662221e-07
expression O 0 3.5143604693033126e-10
of O 0 1.9211991997281075e-09
the O 0 5.10735953529462e-10
retinoblastoma B-Disease 0 5.028910891269334e-06
phenotype O 0 9.245963994430895e-09
. O 0 2.2795478005210867e-10

In O 0 6.390370455022776e-10
this O 0 6.959000433195972e-13
family O 0 6.019369030996202e-12
affected O 0 2.014580516296327e-11
individuals O 0 1.4359585569223565e-13
developed O 0 4.053393620750967e-09
unilateral B-Disease 0 9.143547504208982e-05
tumors I-Disease 1 1.0
and O 0 5.004222813909109e-09
, O 0 1.2738898477748783e-11
as O 0 7.833323291232819e-13
a O 0 2.38563644750292e-13
result O 0 1.831076089364725e-12
of O 0 8.473696744282222e-11
linkage O 0 3.79777043146845e-10
analysis O 0 1.994473683430975e-11
, O 0 1.9226404322780777e-12
unaffected O 0 9.516903931583442e-10
mutation O 0 3.155950544300734e-12
carriers O 0 6.654347212142753e-13
were O 0 5.586142225871837e-12
also O 0 3.1882325555662727e-13
identified O 0 2.127527537823526e-12
within O 0 7.896831799580895e-11
the O 0 1.611620559227589e-10
pedigree O 0 4.3605190569451224e-08
. O 0 1.0969778418967735e-09

A O 0 6.043027269697632e-07
single O 0 8.660645534064315e-10
band O 0 3.764324407740105e-09
shift O 0 1.7931964940709477e-11
using O 0 9.106546246251401e-12
SSCP O 0 0.008158787153661251
was O 0 3.745022070233972e-10
identified O 0 2.225636125050001e-12
in O 0 2.2178177263437737e-12
exon O 0 5.652038281844796e-10
21 O 0 2.0752431717507847e-10
which O 0 1.7875089429464364e-13
resulted O 0 1.7457101736395586e-11
in O 0 3.5882677038023836e-12
a O 0 1.0299091440790775e-11
missense O 0 1.6269195768359168e-08
mutation O 0 1.1285571088759383e-10
converting O 0 6.963024379302851e-09
a O 0 1.374213104421429e-10
cys O 0 4.172055923845619e-06
- O 0 6.000752961199396e-08
- O 0 3.911113655163945e-09
> O 0 3.8544578639942984e-10
arg O 0 1.4899646316735016e-07
at O 0 6.126844587228675e-10
nucleotide O 0 1.1241014369334223e-10
position O 0 2.2010099298697128e-10
28 O 0 3.391369962635338e-10
in O 0 3.927673724452019e-12
the O 0 4.9493520393184554e-11
exon O 0 2.419253064545046e-08
. O 0 5.014874071562758e-10

The O 0 3.6964497240887795e-08
mutation O 0 1.1183941550640952e-09
destroyed O 0 8.927123218427369e-08
an O 0 2.834176686741796e-12
NdeI O 0 5.271058256539618e-08
restriction O 0 2.4071484389098785e-11
enzyme O 0 7.608459695607195e-11
site O 0 5.054756058164855e-10
. O 0 5.085127111059684e-11

Analysis O 0 9.98341187496976e-10
of O 0 2.9343327767605842e-09
all O 0 6.5494979231695005e-12
family O 0 1.2337494307429475e-12
members O 0 1.5993905147764637e-13
demonstrated O 0 3.6046690805868753e-12
that O 0 6.592480467776385e-14
the O 0 2.4339351714641744e-11
missense O 0 3.761685007930282e-08
mutation O 0 1.9709425203018327e-09
co O 0 3.007818705214049e-08
- O 0 5.796196234086892e-08
segregated O 0 1.746337972008405e-07
with O 0 1.4684829741096195e-11
patients O 0 2.0000097411543294e-10
with O 0 2.599633563971082e-10
tumors B-Disease 1 1.0
or O 0 5.189684415540796e-08
who O 0 4.624405580688773e-10
, O 0 1.6428011728741865e-11
as O 0 2.150398565811673e-12
a O 0 9.295579713949897e-13
result O 0 9.265739217556579e-12
of O 0 2.3483584521422074e-10
linkage O 0 2.692149281280365e-10
analysis O 0 1.5734311423210023e-11
had O 0 2.444052122144158e-12
been O 0 7.668476856119433e-13
predicted O 0 7.059389964952922e-12
to O 0 2.7264263980156245e-13
carry O 0 7.794030698615728e-11
the O 0 1.3676837440357303e-10
predisposing O 0 9.041729498449058e-08
mutation O 0 3.074555943172186e-09
. O 0 2.581283242708565e-10

These O 0 3.7075224834648424e-11
observations O 0 2.6465685198928668e-09
point O 0 8.923144168004882e-11
to O 0 2.2349124233125156e-13
another O 0 2.2245185836607118e-13
region O 0 3.751883873026607e-11
of O 0 2.4970364664866906e-10
the O 0 3.1709898595799757e-10
RB1 O 0 1.744167457218282e-05
gene O 0 3.425387751221365e-11
where O 0 2.001793912922989e-12
mutations O 0 3.050216329514299e-13
only O 0 1.0346407500823503e-14
modify O 0 4.774509346910927e-12
the O 0 5.4722897220582656e-12
function O 0 1.3239222543780238e-13
of O 0 8.172231120984197e-12
the O 0 3.726897696704201e-12
gene O 0 4.583008451908288e-12
and O 0 8.244888062211575e-13
raise O 0 2.215403424946083e-12
important O 0 9.392353431461609e-13
questions O 0 5.456319532477771e-13
for O 0 1.1868105239884463e-13
genetic O 0 8.108990041943986e-12
counseling O 0 4.351728179197156e-12
in O 0 8.708665570362345e-14
families O 0 3.030219075946081e-15
with O 0 3.4201337102040055e-14
these O 0 2.921924204327131e-12
distinctive O 0 9.033210623954346e-09
phenotypes O 0 1.5748987891583965e-08
. O 0 1.6155538018480797e-10
. O 0 4.89860152441679e-10

Maternal B-Disease 0 6.890268559800461e-05
disomy I-Disease 0 0.04111112654209137
and O 0 4.8568431338935625e-06
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 0.011319275945425034
with O 0 2.8376576088895433e-10
gamete O 0 3.9788116623640235e-07
complementation O 1 0.6261996626853943
in O 0 2.022967904302675e-10
a O 0 4.704155901619211e-12
case O 0 5.7601128727879924e-12
of O 0 9.140157519738068e-10
familial O 0 6.493682480623875e-09
translocation O 0 4.079593995953701e-09
( O 0 1.2685313736937598e-11
3 O 0 4.47835962757992e-10
; O 0 6.128834419139029e-13
15 O 0 4.8370061428437694e-11
) O 0 1.6212373240773181e-13
( O 0 5.149835093955224e-13
p25 O 0 1.6942690583832132e-09
; O 0 3.726705576079237e-12
q11 O 0 2.831981760209601e-09
. O 0 1.0231458692430695e-12
2 O 0 2.7793189971703214e-10
) O 0 2.1831004885786154e-12
. O 0 1.8956012107218534e-11

Maternal B-Disease 0 0.0001824784412747249
uniparental I-Disease 1 0.8525500297546387
disomy I-Disease 1 0.9465275406837463
( I-Disease 0 3.7572252153950103e-07
UPD I-Disease 1 1.0
) I-Disease 0 2.034894891478345e-10
for I-Disease 0 9.208024100149093e-12
chromosome I-Disease 0 2.5452079333021516e-10
15 I-Disease 0 1.0949997852893745e-10
is O 0 1.5717108333129087e-13
responsible O 0 1.7678284183753057e-11
for O 0 7.127901784434454e-13
an O 0 2.937360505652839e-14
estimated O 0 1.3480342161270847e-14
30 O 0 4.896016318062246e-13
% O 0 1.2396397063284834e-15
of O 0 5.965833889046276e-15
cases O 0 3.96086124781949e-14
of O 0 7.171386817717007e-10
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 5.369228802010184e-06
PWS B-Disease 1 1.0
) O 0 1.5009875564686581e-09
. O 0 1.836135132826655e-10

We O 0 6.548105946357907e-10
report O 0 3.567319356578835e-11
on O 0 3.829365644025806e-11
an O 0 2.73997929786619e-14
unusual O 0 7.123702669420418e-13
case O 0 6.574505263118313e-12
of O 0 2.4211338489621426e-10
maternal B-Disease 0 9.076369877902835e-09
disomy I-Disease 0 6.746821554770577e-07
15 I-Disease 0 3.58981311343598e-09
in O 0 2.808135945997492e-10
PWS B-Disease 1 1.0
that O 0 1.1715629334718702e-11
is O 0 2.1777843200662672e-13
most O 0 8.083070074816484e-14
consistent O 0 9.732667449746657e-11
with O 0 4.412244766598128e-13
adjacent O 0 2.5937214598314995e-09
- O 0 8.624824743286297e-10
1 O 0 1.7318219081019492e-10
segregation O 0 1.47979006825949e-09
of O 0 5.649887675762688e-12
a O 0 7.846003035640037e-13
paternal O 0 4.3030765062290754e-10
t O 0 5.6094873190915e-10
( O 0 4.089809654134191e-12
3 O 0 5.035834249600413e-11
; O 0 9.88637204870843e-14
15 O 0 6.709804153265386e-12
) O 0 6.725455153726301e-14
( O 0 4.801004767894003e-14
p25 O 0 2.0921819832153687e-10
; O 0 3.554038302804735e-13
q11 O 0 4.777683804135791e-10
. O 0 8.251050938410526e-14
2 O 0 4.3728037683876675e-12
) O 0 3.1996091482544694e-15
with O 0 1.6216438363645292e-15
simultaneous O 0 3.518879285180354e-11
maternal O 0 1.488918499603642e-08
meiotic O 0 1.4797930134591297e-06
nondisjunction O 0 1.261855686607305e-06
for O 0 1.988355730064839e-10
chromosome O 0 9.359609975945204e-09
15 O 0 2.0591377491996354e-09
. O 0 1.8941276325179501e-10

The O 0 3.462096742623544e-08
patient O 0 1.966054874458223e-08
( O 0 7.50189702025672e-11
J O 0 4.0591239667264745e-05
. O 0 5.917790996817773e-12
B O 0 3.457792496774914e-09
. O 0 1.7656993014513074e-14
) O 0 6.314796216721997e-15
, O 0 2.169429424243776e-14
a O 0 1.520141299079722e-13
17 O 0 3.69128685950848e-11
- O 0 3.913437629510241e-11
year O 0 3.06832987836958e-12
- O 0 7.954127911879993e-10
old O 0 1.675565353131958e-09
white O 0 3.811896111260982e-12
male O 0 1.148354523451689e-12
with O 0 4.4046605013510487e-13
PWS B-Disease 1 1.0
, O 0 2.5267066217082856e-10
was O 0 2.4646099050507075e-10
found O 0 2.9067989334996547e-12
to O 0 5.774663516464051e-13
have O 0 3.8912682754840833e-13
47 O 0 1.9835752484986813e-10
chromosomes O 0 6.195277364035023e-12
with O 0 9.663920054817088e-13
a O 0 3.578864288256156e-11
supernumerary O 0 8.639371174012922e-08
, O 0 7.458140355298681e-11
paternal O 0 3.236532597483688e-09
der O 0 1.8556416762294248e-05
( O 0 1.169018909452646e-10
15 O 0 6.042047417942342e-10
) O 0 3.622124572933566e-13
consisting O 0 1.2714825026183263e-10
of O 0 1.2076610822475686e-09
the O 0 6.824711351605117e-10
short O 0 6.679156783206963e-09
arm O 0 6.511981155199464e-06
and O 0 4.6415846166603103e-10
the O 0 1.9690560293383896e-09
proximal O 0 4.42952114099171e-07
long O 0 1.957589645940061e-09
arm O 0 9.461471108807018e-07
of O 0 1.438040442280908e-07
chromosome O 0 5.8613407460939015e-09
15 O 0 4.3634451607488245e-09
, O 0 1.111237837858603e-11
and O 0 1.3281277466692387e-10
distal O 0 1.6540286651434144e-06
chromosome O 0 6.8733124862774275e-06
arm O 1 0.626583456993103
3p O 1 0.8211491107940674
. O 0 1.9628424752227147e-07

The O 0 1.9285415930880845e-07
t O 0 1.0621476143057862e-08
( O 0 1.3066313656051598e-11
3 O 0 7.44101863459079e-11
; O 0 1.510735574182867e-13
15 O 0 2.1907378255220378e-12
) O 0 1.801795779905139e-14
was O 0 1.7731628882203254e-12
present O 0 2.1738210190247464e-13
in O 0 1.526617780757064e-13
the O 0 6.689559388199651e-13
balanced O 0 4.5550863428389654e-12
state O 0 2.741271565211839e-13
in O 0 2.798587370959199e-13
the O 0 1.2799780766542534e-12
patients O 0 1.3837909767708267e-12
father O 0 5.8169424138609926e-11
and O 0 5.7258413288518994e-11
a O 0 4.244305740197518e-10
sister O 0 5.658753110537873e-08
. O 0 1.914796987634304e-09

Fluorescent O 0 4.867216603088309e-07
in O 0 7.529208367884621e-10
situ O 0 1.8415697411455767e-08
hybridization O 0 1.3749098214110855e-11
analysis O 0 1.300412577100174e-12
demonstrated O 0 3.820303014906434e-12
that O 0 6.594844706138761e-14
the O 0 6.671421748372097e-11
PWS B-Disease 1 1.0
critical O 0 1.1166276792096141e-08
region O 0 3.813929172480357e-10
resided O 0 5.850983586519476e-10
on O 0 6.355578563432829e-11
the O 0 3.9021143087569765e-12
derivative O 0 8.730266509715534e-11
chromosome O 0 1.1406584704554135e-10
3 O 0 1.260409138170715e-10
and O 0 4.740623583791848e-13
that O 0 5.51202497612647e-15
there O 0 5.919117057389886e-14
was O 0 1.0689238556793601e-11
no O 0 2.288815567196706e-13
deletion O 0 8.500774736908134e-12
of O 0 1.763975909785387e-10
the O 0 3.819731198007048e-10
PWS B-Disease 1 1.0
region O 0 3.194047337728989e-08
on O 0 4.04965350142561e-09
the O 0 3.873640297413772e-11
normal O 0 1.3261229614425218e-10
pair O 0 8.392740669105336e-11
of O 0 2.43638414998415e-10
15s O 0 2.90123800539277e-08
present O 0 1.907120017463626e-10
in O 0 1.377620129083823e-09
J O 1 0.99977046251297
. O 0 6.146113395999464e-09

B O 0 0.0009920481825247407
. O 0 5.631648924975252e-09

Methylation O 0 5.523252610828422e-08
analysis O 0 2.21266921451857e-10
at O 0 2.7723093265485943e-10
exon O 0 1.0673868455768343e-09
alpha O 0 2.540401777828549e-10
of O 0 1.0467270800118555e-10
the O 0 3.354139015143698e-12
small O 0 1.8138315285506912e-12
nuclear O 0 1.8592162476238627e-08
ribonucleoprotein O 0 1.248865828529233e-07
- O 0 8.459590361553637e-09
associated O 0 4.812768517048482e-10
polypeptide O 0 1.7775246163864722e-08
N O 0 2.4433346013097434e-08
( O 0 1.151493744105947e-11
SNRPN O 1 0.7322819828987122
) O 0 8.772224266428985e-12
gene O 0 1.4666689737707905e-11
showed O 0 8.172293571029332e-12
a O 0 1.866738534583856e-12
pattern O 0 1.108932667914786e-10
characteristic O 0 1.2001426241692315e-10
of O 0 5.987162848830607e-11
only O 0 5.619906734530451e-14
the O 0 1.895058112169612e-12
maternal O 0 1.8079028551998277e-10
chromosome O 0 4.2505981373563984e-11
15 O 0 1.1210567890662659e-10
in O 0 8.562910103204757e-11
J O 1 0.9934483170509338
. O 0 2.864659398582603e-09

B O 0 0.0011545988963916898
. O 0 8.852074628862283e-09

Maternal B-Disease 0 6.641449726885185e-05
disomy I-Disease 0 0.00015349635214079171
was O 0 1.5229167260599752e-08
confirmed O 0 1.0859148996678059e-10
by O 0 1.6601691809475794e-12
polymerase O 0 2.2582142822358264e-09
chain O 0 2.2531020105187594e-10
reaction O 0 1.3447870204560952e-12
analysis O 0 3.879479636842431e-12
of O 0 1.1515272763107376e-10
microsatellite O 0 2.684992006507514e-09
repeats O 0 2.458252768011704e-10
at O 0 1.2371628721474792e-10
the O 0 1.2710762347170612e-12
gamma O 0 1.7799188789524578e-09
- O 0 5.151228332778146e-10
aminobutyric O 0 1.1697047774816838e-08
acid O 0 7.483846875544486e-11
receptor O 0 1.982038838610478e-11
beta3 O 0 1.7454063083732763e-08
subunit O 0 1.5562223731890867e-10
( O 0 2.8830686102376823e-11
GABRB3 O 0 0.0008443929255008698
) O 0 3.339981069494513e-11
locus O 0 6.839149246928855e-10
. O 0 1.8517858080269178e-10

A O 0 6.6841694206232205e-06
niece O 0 6.957782261451939e-07
( O 0 1.095133983497476e-09
B O 0 1.0348298218332275e-07
. O 0 5.598565231204611e-13
B O 0 6.716853739874296e-10
. O 0 1.0252976378609564e-14
) O 0 1.1002518586491973e-15
with O 0 6.577354831030675e-15
45 O 0 3.776990872839114e-12
chromosomes O 0 2.7679250493191365e-13
and O 0 4.943601409311549e-13
the O 0 1.716593664088939e-12
derivative O 0 6.989029494031129e-11
3 O 0 6.016675352382705e-11
but O 0 1.4077864613252448e-14
without O 0 1.8495064691998603e-13
the O 0 1.286368364258883e-12
der O 0 4.6795108232799976e-07
( O 0 8.556244254775969e-12
15 O 0 7.58543505785525e-11
) O 0 2.2143208490768562e-13
demonstrated O 0 5.177068843065236e-12
a O 0 3.935014640521484e-12
phenotype O 0 6.308067956872776e-11
consistent O 0 3.9289962949773383e-10
with O 0 3.032558199781571e-13
that O 0 7.499868239467522e-14
reported O 0 8.520773496500933e-12
for O 0 2.2913457155965267e-12
haploinsufficiency O 0 1.7047683513737866e-06
of O 0 7.527865619749718e-08
distal O 0 4.2987866777366435e-07
3 O 0 5.206936748436419e-07
p O 0 6.326958867930443e-08
. O 0 1.311018849037282e-09

Uniparental B-Disease 1 1.0
disomy I-Disease 1 1.0
associated O 0 1.479946831750567e-07
with O 0 9.160241315475659e-11
unbalanced O 0 1.5485292692574149e-07
segregation O 0 1.0459108352733892e-06
of O 0 2.7015021331067146e-09
non O 0 1.224897516749479e-07
- O 0 7.828577963664429e-08
Robertsonian O 0 3.022759983650758e-06
translocations O 0 4.078280824160174e-08
has O 0 2.8956099670796043e-12
been O 0 8.360107311283782e-13
reported O 0 2.5818123680632077e-12
previously O 0 3.255120478717899e-11
but O 0 3.723085546998052e-14
has O 0 4.672091435519582e-15
not O 0 3.914475097825708e-15
, O 0 5.488695571176719e-14
to O 0 9.794254844002273e-14
our O 0 3.602943681249582e-12
knowledge O 0 2.214192197647069e-11
, O 0 1.0650809661311156e-12
been O 0 4.694685192354643e-14
observed O 0 1.5191709652404017e-12
in O 0 5.608312208735255e-13
a O 0 2.142779226624314e-12
case O 0 5.608189954098286e-11
of O 0 1.449647424323075e-08
PWS B-Disease 1 1.0
. O 0 2.771767526610347e-08

Furthermore O 0 8.114913612189412e-07
, O 0 1.0690350826791928e-09
our O 0 5.819450130117865e-11
findings O 0 8.655258454393078e-11
are O 0 2.6512873927547753e-13
best O 0 3.409728445771809e-12
interpreted O 0 3.564631012240027e-12
as O 0 1.4189484006180142e-12
true O 0 2.989967995414844e-11
gamete O 0 6.030905108644902e-09
complementation O 0 1.323232140748587e-06
resulting O 0 5.393078761350978e-10
in O 0 1.5878669212820995e-10
maternal B-Disease 0 1.3693455002794508e-05
UPD I-Disease 1 1.0
15 I-Disease 0 5.057807356934063e-06
and O 0 6.573802693310427e-07
PWS B-Disease 1 1.0

Schwartz B-Disease 0 0.29260849952697754
- I-Disease 1 0.9939321875572205
Jampel I-Disease 1 1.0
syndrome I-Disease 1 0.999962568283081
type I-Disease 0 1.3027459999648272e-06
2 I-Disease 0 3.058552522361424e-07
and O 0 3.7768504990154383e-10
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 1.6480643239003e-11
a O 0 1.3971922577238338e-12
case O 0 5.726362960201126e-12
for O 0 4.446496990051507e-12
" O 0 1.6247966860838403e-10
lumping O 0 5.105797029614223e-08
" O 0 1.2307898034080722e-09
. O 0 1.5419132637362054e-10

Recent O 0 6.346399517020984e-10
studies O 0 1.4716014518079135e-10
demonstrated O 0 2.432797886753324e-11
the O 0 2.0099813740487305e-12
existence O 0 1.338119979404917e-11
of O 0 3.292931552434375e-11
a O 0 3.0753609294581485e-12
genetically O 0 2.0949222356847486e-09
distinct O 0 3.1178455650593406e-11
, O 0 1.3097747712798036e-12
usually O 0 1.9044744351427029e-13
lethal O 0 2.779403929231705e-10
form O 0 4.8302551194923105e-12
of O 0 3.2355170626052754e-11
the O 0 2.50820961222864e-11
Schwartz B-Disease 0 2.466993237248971e-06
- I-Disease 0 0.007389490492641926
Jampel I-Disease 1 1.0
syndrome I-Disease 1 0.9999630451202393
( O 0 5.789803636524482e-10
SJS B-Disease 1 0.9999988079071045
) O 0 4.280448565041617e-11
of O 0 4.9310415306536015e-08
myotonia B-Disease 1 1.0
and O 1 0.9988895058631897
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 1.1945070488295073e-09
which O 0 1.3009193548796372e-11
we O 0 8.862602492165639e-12
called O 0 2.2721740045028582e-09
SJS B-Disease 1 0.9999849796295166
type I-Disease 0 1.4398012808669591e-06
2 I-Disease 0 6.314504616966587e-07
. O 0 1.3337411175484704e-09

This O 0 8.085881297859032e-09
disorder O 1 0.9999376535415649
is O 0 5.011209502914227e-11
reminiscent O 0 5.379069079936016e-06
of O 0 4.947575504843371e-08
another O 0 2.3343393190655704e-11
rare O 0 8.756603220305692e-10
condition O 0 2.8102821403308553e-08
, O 0 2.936737311665105e-11
the O 0 5.682498915859924e-10
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 6.2022507130166105e-09
SWS B-Disease 1 1.0
) O 0 1.5035649808536888e-11
, O 0 6.612708427708447e-13
which O 0 1.585673188890177e-13
comprises O 0 3.2165362040537104e-10
campomelia B-Disease 0 2.428660536679672e-06
at O 0 7.659751055655306e-09
birth O 0 1.1406145006276347e-07
with O 0 1.301838969958169e-09
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 2.8933413886989e-08
contractures B-Disease 1 1.0
, O 0 7.29753091288643e-10
and O 0 6.10816050516938e-11
early B-Disease 0 1.1536740451845162e-08
death I-Disease 0 2.443809776764283e-08
. O 0 2.0621276908272534e-10

To O 0 1.1027952995235069e-09
test O 0 1.5545708054176544e-09
for O 0 2.626595121957287e-12
possible O 0 5.6007393167689656e-11
nosologic O 0 3.2590942282695323e-06
identity O 0 6.925322121320576e-11
between O 0 1.7265770410612724e-11
these O 0 3.89804681588668e-11
disorders O 1 0.9999991655349731
, O 0 6.603976913932552e-12
we O 0 6.728226645529717e-14
reviewed O 0 8.54095006525002e-12
the O 0 2.225924739668317e-12
literature O 0 1.0804225352920027e-12
and O 0 4.458874269157656e-14
obtained O 0 8.353030723703969e-13
a O 0 3.280140644778412e-13
follow O 0 3.826735369555356e-12
- O 0 3.5485895472087137e-11
up O 0 6.938337708192743e-13
of O 0 1.841263903498702e-12
the O 0 1.8198256215764402e-13
only O 0 1.0632043951296598e-14
two O 0 3.842588004515299e-14
surviving O 0 1.0541563455479519e-10
patients O 0 2.4384875629140934e-12
, O 0 6.728999410628156e-13
one O 0 9.01855901156573e-13
with O 0 6.1028942316410095e-12
SJS B-Disease 0 0.02884490229189396
type I-Disease 0 1.3213326610639342e-07
2 I-Disease 0 5.702131655738185e-09
at O 0 2.927823816722963e-10
age O 0 2.8123406381475036e-12
10 O 0 4.947921954968904e-13
years O 0 8.884731871657697e-14
and O 0 1.5878008001284083e-13
another O 0 1.172874731364404e-12
with O 0 2.851348497590056e-12
SWS B-Disease 1 0.9999977350234985
at O 0 7.949278568730733e-09
age O 0 5.054464138898318e-11
7 O 0 5.96293681098814e-10
years O 0 7.680469975290816e-12
. O 0 1.9741533061057304e-11

Patients O 0 4.931822417120202e-08
reported O 0 2.5797919356307375e-10
as O 0 3.265947928765556e-11
having O 0 6.483329845208274e-11
either O 0 2.2034649660440664e-08
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 0.00010634253703756258
SWS B-Disease 1 1.0
presented O 0 9.173065862455587e-09
a O 0 8.290818725997795e-11
combination O 0 1.946041772171725e-09
of O 0 8.661971584444927e-09
a O 0 1.4841056161785104e-10
severe O 0 0.0004443060315679759
, O 0 2.09320366595378e-10
prenatal O 1 0.9973069429397583
- O 1 0.9998668432235718
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 1.2344749222847895e-07
with O 0 8.904201968107373e-05
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 1.0
respiratory O 1 1.0
and O 0 0.032966867089271545
feeding O 0 0.12823952734470367
difficulties O 0 1.6134819134094869e-06
, O 0 5.011116521735914e-10
tendency O 0 1.1684710976567203e-09
to O 0 7.791935152656748e-11
hyperthermia B-Disease 0 0.3141319453716278
, O 0 2.8961969975038748e-11
and O 0 1.7708546217951038e-12
frequent O 0 1.4160750697045366e-11
death O 0 2.742557292378933e-10
in O 0 1.930508877756587e-11
infancy O 0 2.2074445382713748e-08
) O 0 7.267430201466502e-14
with O 0 3.5685660698149546e-14
a O 0 4.118404835912193e-12
distinct O 0 3.5079197324705547e-09
campomelic B-Disease 1 1.0
- I-Disease 1 1.0
metaphyseal I-Disease 1 1.0
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 1.2530568938018405e-07

The O 0 2.8607989310813764e-09
similarity O 0 1.1059148041780986e-09
of O 0 2.1081818513124517e-09
the O 0 5.6425135397386583e-11
clinical O 0 2.7518089495970344e-07
and O 0 1.6477948172610724e-10
radiographic O 0 0.0008498438401147723
findings O 0 1.1147337275474456e-08
is O 0 2.010023441093023e-12
so O 0 1.231106687947514e-13
extensive O 0 2.322921299757752e-10
that O 0 1.3964889357745425e-12
these O 0 7.021274117668952e-10
disorders O 1 1.0
appear O 0 5.868967534183867e-10
to O 0 5.305523381737842e-12
be O 0 6.954701029480981e-13
a O 0 2.3995380335484207e-12
single O 0 8.264199741203626e-11
entity O 0 1.5280892107227828e-09
. O 0 1.1072192052097307e-09

The O 0 1.648830938449919e-08
follow O 0 1.411379346727415e-09
- O 0 1.580775399467882e-09
up O 0 7.208846367068311e-12
observation O 0 9.035256987033335e-10
of O 0 6.258035062378653e-11
an O 0 2.837337942449957e-14
identical O 0 6.575724686985751e-11
and O 0 1.9956104910928696e-12
unique O 0 1.2038928014213024e-11
pattern O 0 2.366281393051395e-09
of O 0 5.2498172919968056e-08
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 9.232689057725452e-10
the O 0 1.060248444595402e-09
two O 0 1.4011345902953387e-11
patients O 0 2.1455325363572975e-11
( O 0 1.7859830368088803e-12
one O 0 4.449126830841088e-12
with O 0 4.4318000658183365e-11
SJS B-Disease 1 0.9999982118606567
type I-Disease 0 2.4208145532611525e-06
2 I-Disease 0 6.703997001977768e-08
, O 0 2.487777778920064e-12
one O 0 1.228282747864004e-13
with O 0 8.159781986379067e-13
SWS B-Disease 1 1.0
) O 0 1.28069664248609e-11
surviving O 0 7.86072895664347e-09
beyond O 0 1.3412854826810872e-08
infancy O 0 3.777178392283531e-08
adds O 0 4.249218164831259e-12
to O 0 2.7895754825014996e-13
the O 0 6.906399280595665e-13
evidence O 0 3.4571011418155217e-12
in O 0 1.1681077654625283e-13
favor O 0 1.6442141701975e-12
of O 0 1.0470580999455414e-11
identity O 0 7.53103829298496e-12
. O 0 1.0404650752082745e-10

The O 0 2.5729443464683754e-08
hypothesis O 0 6.381153383472338e-09
that O 0 1.4119649026367309e-11
SWS B-Disease 1 0.999982476234436
and O 0 1.4792404634533796e-08
SJS B-Disease 1 0.9999533891677856
type I-Disease 0 8.042944728003931e-07
2 I-Disease 0 3.2169321428909825e-08
are O 0 5.365768051233955e-13
the O 0 6.966427434917932e-12
same O 0 5.3204326361244725e-11
disorder O 0 5.094603693578392e-06
should O 0 5.358332592735049e-13
be O 0 2.2440278530776875e-13
testable O 0 1.0211880230315273e-09
by O 0 8.916142021746232e-13
molecular O 0 1.2755607681214087e-10
methods O 0 2.195634507540234e-10
. O 0 2.8377953199126837e-12
. O 0 2.257307708808387e-11

A O 0 2.2318527044262737e-06
mouse O 0 3.907944634562455e-09
model O 0 3.797949454931171e-11
of O 0 9.980727355696217e-10
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 1.6192383554880507e-05
defects O 1 0.9999899864196777
in O 0 3.317040864203591e-09
hemostasis O 1 0.9999988079071045
and O 0 3.335988481012464e-07
thrombosis B-Disease 1 0.9970207810401917
. O 0 1.052782927501994e-08

von B-Disease 1 0.9659857749938965
Willebrand I-Disease 1 0.9999443292617798
factor I-Disease 0 3.681056114146486e-06
( I-Disease 0 9.3021077418598e-07
vWf I-Disease 1 0.9999998807907104
) I-Disease 1 0.7569465637207031
deficiency I-Disease 1 1.0
causes O 1 1.0
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 3.41905490586214e-08
humans O 0 1.132823390648241e-09
. O 0 1.1397379567901211e-11

We O 0 6.054113876885481e-10
generated O 0 6.845148753376051e-11
a O 0 2.2107151179118212e-11
mouse O 0 3.3475451577391624e-11
model O 0 8.938072721190182e-13
for O 0 1.4804222301170733e-13
this O 0 1.1227755785650148e-13
disease O 0 1.9867132244888452e-11
by O 0 6.7442317565845605e-15
using O 0 4.580542217226535e-13
gene O 0 1.4961384561806845e-11
targeting O 0 1.4537744619236292e-10
. O 0 6.212212688705421e-11

vWf B-Disease 0 0.000840839697048068
- I-Disease 0 0.0012785923900082707
deficient I-Disease 0 3.443806053837761e-05
mice O 0 7.739095586600797e-09
appeared O 0 2.097904211462165e-10
normal O 0 9.724280408685004e-11
at O 0 2.013827299363058e-11
birth O 0 1.9038624843314977e-11
; O 0 4.0896180485052586e-14
they O 0 2.4633874652038763e-14
were O 0 2.19388656547137e-12
viable O 0 1.0273047967856996e-09
and O 0 2.6227478522322656e-10
fertile O 0 2.8801489193597263e-08
. O 0 1.042917308069491e-09

Neither O 0 3.821794052782934e-06
vWf O 0 2.434726047795266e-05
nor O 0 6.635314093728084e-07
vWf O 0 3.274664413766004e-05
propolypeptide O 0 7.51550542190671e-05
( O 0 6.562713039670598e-09
von B-Disease 0 0.098829485476017
Willebrand I-Disease 0 0.024053150787949562
antigen O 0 3.6677577099908376e-06
II O 1 1.0
) O 0 1.3014883615269923e-10
were O 0 3.2321551685088323e-11
detectable O 0 5.945651748717751e-10
in O 0 4.667073476814776e-13
plasma O 0 1.3832857082007877e-10
, O 0 1.2871930084312755e-12
platelets O 0 7.417750441662818e-11
, O 0 1.589359069700813e-12
or O 0 1.565222669357158e-12
endothelial O 0 4.6032126027606424e-11
cells O 0 2.0378261578191115e-11
of O 0 2.270734433817978e-10
the O 0 5.896285543149915e-11
homozygous O 0 9.998504246766515e-10
mutant O 0 4.631478311978299e-09
mice O 0 1.7388694928399673e-09
. O 0 4.306670645104482e-11

The O 0 1.402961089524979e-07
mutant O 0 6.867409183541895e-07
mice O 0 5.187240503801149e-08
exhibited O 0 9.817847512749722e-07
defects O 0 0.00041460792999714613
in O 0 3.543277005135792e-09
hemostasis O 0 2.2610511223319918e-05
with O 0 5.955511778177325e-11
a O 0 1.7421386555582785e-10
highly O 0 4.268079862868035e-07
prolonged O 1 0.9999992847442627
bleeding O 0 0.002067748922854662
time O 0 5.588811635703905e-10
and O 0 1.7384342576587386e-10
spontaneous O 0 8.957106700790973e-08
bleeding O 0 1.2808091298666113e-07
events O 0 4.7658772761582924e-11
in O 0 3.686605708208557e-12
approximately O 0 2.424648155863185e-12
10 O 0 1.2276702224256475e-11
% O 0 2.6817569974586786e-13
of O 0 6.369048344279093e-11
neonates O 0 2.539367471854348e-08
. O 0 3.516561486449632e-09

As O 0 2.8516233818720593e-10
in O 0 1.3935015467925194e-11
the O 0 9.645619372666836e-12
human O 0 3.8384498357579844e-10
disease O 0 1.867496379759359e-09
, O 0 7.530281296251867e-15
the O 0 7.554798664910142e-14
factor O 0 7.078221472486823e-13
VIII O 0 0.27917900681495667
level O 0 9.755481755746587e-09
in O 0 1.0874273703720405e-11
these O 0 1.8573304786523304e-12
mice O 0 4.164673120254925e-11
was O 0 1.6370052882686004e-11
reduced O 0 1.550470862810016e-11
strongly O 0 3.912928141225347e-12
as O 0 1.7534770564795604e-13
a O 0 9.811962575984393e-14
result O 0 3.5253920551044093e-13
of O 0 8.878371995924006e-12
the O 0 1.0281068531237114e-12
lack O 0 1.011116364246778e-11
of O 0 1.0079720044742224e-11
protection O 0 1.1263635857350351e-10
provided O 0 4.958476771538267e-12
by O 0 1.0373277757602661e-11
vWf O 0 4.6177692070159537e-07
. O 0 1.0675271777671469e-09

Defective O 1 0.9999994039535522
thrombosis B-Disease 0 0.005951836239546537
in O 0 4.4571365265255736e-08
mutant O 0 5.7438331424464195e-08
mice O 0 1.438922536678433e-09
was O 0 1.554285311566872e-10
also O 0 5.385864822703146e-13
evident O 0 1.773393931703282e-11
in O 0 4.4750818719088703e-13
an O 0 1.0704401740815796e-14
in O 0 5.2210724621731125e-14
vivo O 0 7.695679510311138e-11
model O 0 4.6021506050486494e-11
of O 0 2.801595933021872e-08
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 0 2.1989900744756596e-07

In O 0 4.5416095884043273e-10
this O 0 9.46796420019276e-14
model O 0 2.666584184365939e-12
, O 0 4.622564809229901e-13
the O 0 3.025857342464633e-12
exteriorized O 0 2.5173056883431855e-07
mesentery O 0 8.948446179601888e-07
was O 0 3.1736293593098708e-09
superfused O 0 3.366619125699799e-07
with O 0 4.02512259634058e-11
ferric O 0 4.3655038695078474e-08
chloride O 0 3.7166580924008485e-10
and O 0 5.139226266770436e-10
the O 0 2.3077122157655339e-10
accumulation O 0 3.9105785276660754e-08
of O 0 7.384432620938242e-08
fluorescently O 0 1.4592326806450728e-05
labeled O 0 3.809135193932889e-07
platelets O 0 3.912525770033426e-08
was O 0 6.110610906162606e-10
observed O 0 2.6246631604220916e-11
by O 0 1.3117872673523712e-12
intravital O 0 5.2339601097628474e-08
microscopy O 0 2.033942436696634e-08
. O 0 2.0553070356754688e-10

We O 0 3.5657108377051827e-09
conclude O 0 6.7584942087250965e-09
that O 0 6.822227787035839e-13
these O 0 4.578666005367049e-12
mice O 0 6.352357528882635e-10
very O 0 2.9263358229669745e-12
closely O 0 6.859738888032041e-10
mimic O 0 0.00016385543858632445
severe O 0 0.2619363069534302
human O 0 8.53401161293732e-07
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 9.38105260139821e-10
will O 0 2.463352221857007e-12
be O 0 2.4118386324559205e-13
very O 0 4.3453620286433917e-14
useful O 0 1.9396973176960541e-13
for O 0 8.329225980804877e-14
investigating O 0 2.0575064221817208e-11
the O 0 6.520692406170037e-12
role O 0 8.591042807704063e-12
of O 0 2.3105353741392776e-10
vWf O 0 1.9445465238021598e-09
in O 0 9.477440533756099e-12
normal O 0 3.961171668454e-10
physiology O 0 5.657218249410789e-09
and O 0 1.8829852607704645e-11
in O 0 2.0685252122287778e-10
disease O 0 2.647391417198719e-09
models O 0 3.857131194301422e-12
. O 0 6.097352440656567e-13
. O 0 1.5000674313814244e-11

Oral O 1 0.9986358284950256
contraceptives O 0 0.00023508247977588326
and O 0 7.652868894147957e-10
the O 0 7.494835307930714e-10
risk O 0 8.9917520540439e-08
of O 0 0.06602698564529419
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.311143524977524e-08

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9999935626983643
Study O 0 8.777296045536787e-08
Group O 0 1.0021993901432324e-08
. O 0 3.7301156607938424e-10

BACKGROUND O 0 6.377511454047635e-05
Women O 0 9.04651284439062e-11
with O 0 8.215314279552688e-13
mutations O 0 1.3678500172809027e-11
in O 0 5.4541267335839194e-12
either O 0 7.588806666403158e-11
the O 0 9.076833173971011e-10
BRCA1 O 0 7.286491410241069e-09
or O 0 2.405066146238255e-10
the O 0 1.9292814013027737e-09
BRCA2 O 0 5.261766489184083e-08
gene O 0 4.259940317163924e-11
have O 0 6.949446579177301e-14
a O 0 1.3521067945831966e-12
high O 0 3.2502023294966875e-10
lifetime O 0 1.8678598667776214e-09
risk O 0 9.444147508474998e-08
of O 1 0.9301955699920654
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.664080816534465e-09

Oral O 1 0.9999995231628418
contraceptives O 1 0.9999991655349731
protect O 1 0.9980559349060059
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.3495625450499205e-10
general O 0 6.475299740849039e-10
, O 0 9.727981224380566e-13
but O 0 4.192143509363982e-15
it O 0 2.4103413069040706e-15
is O 0 8.148229841877387e-16
not O 0 1.432450133749335e-15
known O 0 3.2246395224172497e-13
whether O 0 5.670750734222338e-14
they O 0 1.8589420096564585e-13
also O 0 4.263984185268882e-13
protect O 0 1.76285930297837e-10
against O 0 1.0201046052316087e-07
hereditary B-Disease 1 0.9999977350234985
forms I-Disease 0 0.0005356926703825593
of I-Disease 1 0.9999992847442627
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.6626343352376125e-09

METHODS O 0 3.2929542612691876e-06
We O 0 5.686974502427944e-11
enrolled O 0 4.150599308694325e-10
207 O 0 2.140547961104744e-09
women O 0 7.508993427052246e-12
with O 0 1.9208143964277724e-09
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 8.619677194232622e-10
161 O 0 6.926663242978748e-09
of O 0 2.2239419195102528e-09
their O 0 7.09077241367595e-10
sisters O 0 1.467824262135764e-08
as O 0 6.979821234875949e-12
controls O 0 9.5570862335137e-10
in O 0 1.7207414312880864e-11
a O 0 6.4022953605302746e-12
case O 0 3.1486768053978764e-11
- O 0 6.915386596695328e-10
control O 0 7.64549673570869e-11
study O 0 6.695230307662836e-12
. O 0 1.720597102294885e-11

All O 0 8.468776790948596e-09
the O 0 3.676883519876384e-10
patients O 0 1.6014465795133326e-11
carried O 0 2.3664733367345647e-11
a O 0 7.961462435493449e-13
pathogenic O 0 1.356897927351497e-10
mutation O 0 5.454977290188234e-13
in O 0 5.467132822845056e-13
either O 0 7.555574221829175e-11
BRCA1 O 0 1.1415558498484302e-09
( O 0 1.5499447211797523e-11
179 O 0 1.3540960575042504e-09
women O 0 1.700628353418221e-12
) O 0 1.483322904609341e-12
or O 0 1.8840962123789495e-10
BRCA2 O 0 3.761742561891879e-08
( O 0 1.7493241577515306e-10
28 O 0 5.903012478825076e-08
women O 0 7.269808453141957e-12
) O 0 3.4616144586191444e-12
. O 0 4.903030065284142e-11

The O 0 3.206120524623657e-08
control O 0 4.1890317881154715e-09
women O 0 4.986433900337761e-13
were O 0 1.96110727483656e-12
enrolled O 0 1.8143271607318212e-11
regardless O 0 2.14324617081596e-11
of O 0 7.935227475108775e-11
whether O 0 3.280267333802267e-12
or O 0 7.88148019070789e-12
not O 0 2.995307452589857e-13
they O 0 1.825509686990967e-13
had O 0 1.5542273414451135e-12
either O 0 2.8067638491169333e-11
mutation O 0 1.17235041119379e-10
. O 0 1.5132931019401497e-10

Lifetime O 0 7.442448435313054e-08
histories O 0 4.795171903992923e-08
of O 0 2.3950798677674356e-08
oral O 0 3.067124453082215e-06
- O 0 3.4868268272703062e-09
contraceptive O 0 3.3788571940363e-10
use O 0 2.098110097117911e-12
were O 0 8.173645137457553e-13
obtained O 0 1.0134965783281658e-12
by O 0 2.3192344854490454e-13
interview O 0 9.706300867218243e-12
or O 0 9.78212519667232e-13
by O 0 1.196538663506344e-13
written O 0 5.46169283844461e-13
questionnaire O 0 1.084551827686131e-12
and O 0 1.1461531593606744e-12
were O 0 4.5534361871324425e-12
compared O 0 1.927711462679227e-12
between O 0 2.173175268210814e-12
patients O 0 8.749014533682153e-12
and O 0 3.702582684894651e-11
control O 0 1.5948373288665607e-08
women O 0 2.1361805553621327e-12
, O 0 3.28899261341567e-13
after O 0 1.4970569272090839e-12
adjustment O 0 1.4259054874343757e-11
for O 0 1.394236424446041e-13
year O 0 2.5220515779966757e-13
of O 0 1.7205870408987245e-11
birth O 0 3.9306002896921655e-10
and O 0 7.944708085849683e-11
parity O 0 3.841332230081207e-08
. O 0 5.3072696237777e-10

RESULTS O 0 4.660681042878423e-06
The O 0 3.259429393054347e-09
adjusted O 0 1.61689328592729e-08
odds O 0 1.0512499315495916e-08
ratio O 0 2.755355943406812e-10
for O 0 3.520542790624859e-08
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 3.61649887814508e-09
with O 0 2.0739826956522878e-12
any O 0 3.812754365700721e-12
past O 0 1.3946315456647707e-11
use O 0 1.3357860824403378e-12
of O 0 1.5730861058216306e-11
oral O 0 4.8777224037621636e-08
contraceptives O 0 1.553557815725526e-08
was O 0 2.893250083957355e-10
0 O 0 3.974847673227089e-10
. O 0 6.006673023556397e-12

5 O 0 1.6935171487375555e-08
( O 0 1.1010812053791064e-11
95 O 0 3.7615374703925397e-10
percent O 0 5.156186675542296e-12
confidence O 0 9.987120852539277e-11
interval O 0 5.2966690061717614e-11
, O 0 2.485547575051261e-13
0 O 0 7.731334561271452e-13
. O 0 4.1248370008257346e-15
3 O 0 7.057030741025594e-13
to O 0 4.7154784959570206e-14
0 O 0 1.6797098651225029e-12
. O 0 3.175425891742238e-14
8 O 0 8.932492939761616e-11
) O 0 5.285280134555148e-13
. O 0 4.249064208122766e-12

The O 0 1.963540263716368e-08
risk O 0 4.619451210441383e-10
decreased O 0 2.5990872648540275e-11
with O 0 1.3155576346172981e-13
increasing O 0 1.1088907434430792e-13
duration O 0 3.7186059786975534e-11
of O 0 1.0548033800572565e-11
use O 0 3.81305230445772e-12
( O 0 2.4075054016331476e-12
P O 0 2.540436749853825e-09
for O 0 1.7227601723651675e-12
trend O 0 2.4698508863107982e-11
, O 0 4.3965668643708086e-14
< O 0 6.010165780855059e-13
0 O 0 3.890896936240007e-13
. O 0 1.9870766138204918e-15
001 O 0 1.2779052989408957e-11
) O 0 1.7716221369833357e-15
; O 0 5.62657252383634e-16
use O 0 3.6890846280557277e-14
for O 0 1.994817885094674e-13
six O 0 1.911608458332603e-12
or O 0 2.326971081101359e-13
more O 0 3.924312961991593e-15
years O 0 1.2102459605225352e-13
was O 0 6.2902591121960505e-12
associated O 0 2.4606850845126926e-12
with O 0 1.0115417211535929e-13
a O 0 8.042781935238552e-13
60 O 0 4.048086952451735e-12
percent O 0 1.0149430666565873e-13
reduction O 0 1.0721582476003189e-11
in O 0 1.858128755027888e-11
risk O 0 1.4838713591203145e-09
. O 0 4.4301629031906486e-10

Oral O 1 0.9966349005699158
- O 0 6.59385705148452e-07
contraceptive O 0 5.317904694379649e-08
use O 0 1.5064082203863904e-09
protected O 0 0.08694051951169968
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 2.68792773412338e-13
for O 0 1.744302910390485e-14
carriers O 0 1.5122030418233262e-13
of O 0 3.6287115673383497e-11
the O 0 4.7459838142804855e-11
BRCA1 O 0 6.937581620292121e-10
mutation O 0 1.90014692348639e-12
( O 0 2.5019667327513817e-13
odds O 0 2.3929120837595796e-11
ratio O 0 6.463826327483824e-13
, O 0 8.629364990587682e-14
0 O 0 5.374105023839282e-13
. O 0 3.635811846090884e-15
5 O 0 2.333748970982652e-13
; O 0 6.0891648507818176e-15
95 O 0 5.409525691973949e-12
percent O 0 3.2838778896669696e-13
confidence O 0 7.828458367664659e-12
interval O 0 5.733294394794086e-11
, O 0 5.506303421033698e-13
0 O 0 5.796291723501878e-13
. O 0 8.289473538744107e-15
3 O 0 4.687377872999998e-13
to O 0 1.4083881088276795e-14
0 O 0 2.797503981938343e-13
. O 0 4.0603604293642636e-15
9 O 0 3.0799219511573606e-12
) O 0 3.2558030080412142e-15
and O 0 7.141884502683774e-15
for O 0 1.2081096248449472e-14
carriers O 0 1.915998826609866e-13
of O 0 3.8377891142804543e-11
the O 0 1.4647015544877462e-10
BRCA2 O 0 8.319561928260555e-09
mutation O 0 1.687983954001826e-11
( O 0 1.2259007827961077e-12
odds O 0 1.5559997734726494e-10
ratio O 0 3.4246260341430634e-13
, O 0 1.0769653940347068e-13
0 O 0 4.188431827929773e-13
. O 0 1.8478966068506382e-15
4 O 0 2.8729321981287026e-13
; O 0 5.2024606919263885e-15
95 O 0 1.0074473373589132e-11
percent O 0 3.3039822505513683e-13
confidence O 0 9.81081188511368e-12
interval O 0 2.4054870942369355e-11
, O 0 2.1314502625987414e-13
0 O 0 8.51175466914933e-13
. O 0 1.704006673177577e-14
2 O 0 1.3829044246543853e-12
to O 0 4.5690735944086194e-14
1 O 0 9.515695523210077e-12
. O 0 2.2676535670930476e-13
1 O 0 4.774939471596795e-11
) O 0 7.466430360265897e-13
. O 0 1.3897800445195063e-11

CONCLUSIONS O 0 2.346939072594978e-05
Oral O 0 0.005012190900743008
- O 0 4.5069757703686264e-08
contraceptive O 0 6.171993138792686e-09
use O 0 2.6049731816080168e-11
may O 0 4.4406401299157405e-12
reduce O 0 1.0729565846911981e-10
the O 0 7.419561492971738e-11
risk O 0 9.59363610775199e-09
of O 0 0.0018143582856282592
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 4.7978631484424383e-11
women O 0 1.107107095344069e-13
with O 0 1.8835820625668145e-14
pathogenic O 0 1.5687212640003168e-10
mutations O 0 1.1696026092078426e-11
in O 0 2.3170645090109243e-12
the O 0 9.611410972665269e-11
BRCA1 O 0 3.6418217774780715e-08
or O 0 7.518779376880502e-09
BRCA2 O 0 7.0250498538371176e-06
gene O 0 1.7037085626725457e-06

A O 0 1.2509308362496085e-06
Japanese O 0 3.816524269950605e-07
family O 0 2.392338271928196e-10
with O 0 8.227040160235788e-10
adrenoleukodystrophy B-Disease 1 1.0
with O 0 3.424285299757912e-10
a O 0 8.242428267690727e-11
codon O 0 3.018230332330063e-09
291 O 0 1.2826658624121023e-09
deletion O 0 1.7947610064794617e-10
: O 0 1.9400275656777932e-12
a O 0 2.9695965738513186e-12
clinical O 0 1.3060332548775477e-07
, O 0 5.468984987100356e-11
biochemical O 0 8.990600690594874e-07
, O 0 1.4501189138371728e-10
pathological O 0 2.8116146495449357e-05
, O 0 5.949120363002436e-11
and O 0 5.735744518231556e-11
genetic O 0 4.8346220360429015e-09
report O 0 2.6304480815753095e-10
. O 0 1.1777523400979817e-09

We O 0 3.3299071833248206e-10
report O 0 6.74375355905199e-12
a O 0 1.6810976439032843e-12
Japanese O 0 1.8629071618647686e-09
family O 0 7.384135837507078e-12
with O 0 2.676696919667876e-10
adrenoleukodystrophy B-Disease 1 1.0
( O 0 1.8189298316428903e-06
ALD B-Disease 1 1.0
) O 0 2.224270594097799e-11
with O 0 3.292777563199817e-13
a O 0 2.8644747164519035e-12
three O 0 3.1740001252278383e-12
base O 0 1.0659605420570983e-09
pair O 0 3.0437830034202307e-09
deletion O 0 1.0288930818447284e-09
( O 0 3.368604700737521e-11
delGAG O 0 3.4985743013749016e-07
291 O 0 1.0349671120124526e-09
) O 0 1.5090710527975587e-13
in O 0 2.5298094782216785e-12
the O 0 1.0582140719250788e-09
ALD B-Disease 1 1.0
gene O 0 1.3099402451643982e-07
. O 0 6.239445626832207e-10

A O 0 3.7725962442891614e-07
variety O 0 5.424277915722087e-09
of O 0 9.166436498730945e-09
phenotypes O 0 6.0156257752908004e-09
were O 0 9.26818344293423e-11
observed O 0 2.4025800446358936e-11
within O 0 7.264056543776487e-12
this O 0 2.782734810538156e-14
family O 0 1.8198482651388126e-11
. O 0 1.2897821699553447e-10

While O 0 4.0217655872254454e-09
the O 0 4.1139103235110497e-10
proband O 0 9.575538797435001e-07
( O 0 1.0898864449826462e-10
patient O 0 3.584291974334519e-09
1 O 0 2.5106339229807872e-09
) O 0 2.112231830414535e-12
was O 0 2.5890628183034003e-11
classified O 0 2.782246932842014e-10
as O 0 7.455235213893463e-12
having O 0 2.082338424955199e-12
a O 0 4.809292612588389e-13
rare O 0 2.6827561439707326e-12
intermediate O 0 3.8054909917706325e-11
type O 0 1.856808179434566e-10
of O 0 4.701110611904369e-10
adult O 0 2.971510815186207e-09
cerebral O 0 5.4638839230847225e-08
and O 0 4.6564105349311546e-10
cerebello O 1 0.6795057058334351
- O 0 3.2545158319408074e-05
brain O 0 1.1249411500102724e-06
stem O 0 1.0318798593367262e-10
forms O 0 2.7394505067168673e-11
, O 0 3.746088183577412e-13
his O 0 2.617504130109083e-11
younger O 0 6.622231929487299e-11
brother O 0 3.10462144881285e-09
( O 0 4.2046587565847116e-12
patient O 0 6.537536068051963e-10
2 O 0 1.5642194206577642e-09
) O 0 6.899987308947586e-13
and O 0 2.482408723025742e-11
nephew O 0 1.9294018329674145e-06
( O 0 2.64143845685183e-10
patient O 0 6.602452629067557e-08
3 O 0 7.724543138465378e-08
) O 0 8.439899820689156e-12
had O 0 2.369557848547199e-11
a O 0 8.804753037772173e-10
childhood O 1 0.9999901056289673
ALD B-Disease 1 1.0
type O 0 0.0010582957183942199
. O 0 7.360271059297929e-09

Another O 0 5.18953626738039e-08
nephew O 0 5.0680191634455696e-06
( O 0 9.293962821566026e-10
patient O 0 1.2448806430143122e-08
4 O 0 1.5249511875481403e-08
) O 0 1.328326554653203e-12
of O 0 5.451563644953694e-10
patient O 0 4.858196334112108e-08
1 O 0 1.7221854164972683e-08
was O 0 1.5106148554266952e-09
classified O 0 1.0722084331504789e-09
as O 0 4.420401111121519e-12
having O 0 2.1517444943885966e-12
an O 0 1.238350784762976e-13
adolescent O 0 7.2740218293176895e-09
form O 0 1.4898346445413324e-10
. O 0 1.7440801580725918e-10

The O 0 1.5820008414380027e-08
tau O 0 9.498606345914595e-10
level O 0 1.8199773632598948e-10
in O 0 1.6297890771330148e-12
the O 0 6.776270950609176e-12
cerebrospinal O 0 3.674457682567578e-10
fluid O 0 4.5044790120130074e-10
( O 0 2.7811486447149036e-10
CSF O 1 1.0
) O 0 2.46843327028623e-11
in O 0 3.446864668688043e-11
patient O 0 5.840917971511317e-09
1 O 0 1.2144591998719534e-09
was O 0 1.9732661338256463e-10
as O 0 1.0802081885225023e-12
high O 0 5.13798829870904e-11
as O 0 4.837081933996637e-14
that O 0 9.51400641245831e-16
of O 0 1.4253608059469625e-12
patients O 0 3.34959989432837e-12
with O 0 4.5267151138617123e-11
Alzheimers B-Disease 1 1.0
disease I-Disease 1 0.9998787641525269
( O 0 2.4745273104892496e-12
AD B-Disease 0 6.502559557475251e-08
) O 0 5.46356059352715e-12
. O 0 1.9245787255539604e-11

His O 0 1.7713566649035783e-06
brain O 0 3.94925973523641e-06
magnetic O 0 2.431034999972326e-07
resonance O 0 9.040173942764795e-09
image O 0 7.255371414771616e-09
( O 0 3.20640944351247e-11
MRI O 1 0.9911805987358093
) O 0 8.426163412844634e-12
showed O 0 1.9109068494227444e-10
abnormalities B-Disease 0 3.8564041915378766e-07
in I-Disease 0 1.6206978467603328e-11
the I-Disease 0 1.2125121739980926e-10
bilateral I-Disease 0 6.910672567528309e-08
cerebellar I-Disease 1 0.9999961853027344
hemispheres I-Disease 0 2.428088464512257e-06
and O 0 2.9234907827913048e-08
brain O 0 0.00453208340331912
stem O 0 3.0669535799887626e-09
, O 0 1.8838140682791993e-12
but O 0 5.412286084257624e-14
not O 0 3.989064734457627e-14
in O 0 2.797713449798067e-12
the O 0 1.2422299300318684e-10
cerebral O 0 2.0600646166712977e-07
white O 0 9.903103510844335e-12
matter O 0 1.818931181889194e-12
, O 0 8.864216733675198e-14
where O 0 3.1619966925832896e-14
marked O 0 1.275432992726977e-12
reductions O 0 1.3779058449792103e-10
of O 0 1.9897365699517167e-10
the O 0 1.040238797878068e-10
cerebral O 0 5.217992082862111e-08
blood O 0 1.4393940206414158e-10
flow O 0 2.0347733914460875e-11
and O 0 3.642177184848272e-11
oxygen O 0 1.0815416340292927e-09
metabolism O 0 1.4361052080857917e-07
were O 0 1.6406039027305752e-10
clearly O 0 4.667921431333877e-12
demonstrated O 0 4.602435511695535e-13
by O 0 1.6284762370511428e-14
positron O 0 5.977004915308504e-12
emission O 0 3.238951329365136e-10
tomography O 0 2.92663027146034e-09
( O 0 1.6097956301308614e-10
PET O 0 1.2726413842756301e-05
) O 0 2.828717989011853e-11
. O 0 4.716133386595267e-11

In O 0 3.1511793174843206e-09
patients O 0 7.561456322191518e-11
2 O 0 7.080163122452632e-10
and O 0 2.3505529120337876e-11
3 O 0 1.4138500370464158e-09
, O 0 1.3071941532688536e-12
the O 0 2.32973883240728e-12
autopsy O 0 1.5738926606445602e-08
findings O 0 1.263572024789994e-10
showed O 0 1.312434327882528e-10
massive O 0 6.059015067449991e-09
demyelination B-Disease 1 1.0
of I-Disease 0 0.00010322114394512028
the I-Disease 0 2.3004177762686595e-07
cerebral I-Disease 0 0.00022729742340743542
white I-Disease 0 4.650605733846902e-10
matter I-Disease 0 1.627158997818956e-11
with O 0 4.928753802660446e-13
sparing O 0 1.265982041420699e-10
of O 0 2.627230211160736e-09
the O 0 2.0374124609645605e-09
U O 0 6.603123620152473e-05
- O 0 1.6619948439711152e-07
fibers O 0 1.16069918476569e-06
, O 0 1.3369515564076728e-11
compatible O 0 1.0075559275790624e-09
with O 0 2.835607996239803e-13
the O 0 2.231497755675327e-12
findings O 0 3.906546960918966e-11
of O 0 2.242295460419541e-09
childhood O 1 0.991163969039917
ALD B-Disease 1 1.0
. O 0 2.283296751670605e-08

Oleic O 0 9.84803045867011e-05
and O 0 3.6793984747873765e-08
erucic O 0 3.472636308288202e-05
acids O 0 2.8950523756066104e-08
( O 0 5.51383383395887e-11
Lorenzos O 0 6.769255946892372e-07
Oil O 0 2.868415505119515e-09
) O 0 4.5293789877574875e-13
were O 0 3.3619770379092473e-13
administered O 0 8.291889744271863e-12
to O 0 1.9624982249086959e-13
patients O 0 5.274394202642307e-13
1 O 0 1.1227596109775195e-11
and O 0 1.7048341904857267e-12
4 O 0 2.9335253670659256e-10
, O 0 8.690645452629278e-14
but O 0 1.112830615553279e-15
sufficient O 0 1.1508257454634352e-12
effectiveness O 0 9.244049969936441e-11
was O 0 2.7545452030430795e-11
not O 0 2.0196328333679792e-14
obtained O 0 3.766130116100719e-11
. O 0 6.179183553722822e-11

The O 0 1.088736478749297e-08
findings O 0 3.91706916902379e-10
in O 0 6.218327068541196e-12
this O 0 1.0599167892108227e-13
family O 0 2.349430058053853e-13
suggest O 0 5.993360647181534e-13
that O 0 5.842326320941232e-15
delGAG291 O 0 3.2476182854068725e-10
is O 0 1.2143340803391633e-13
part O 0 1.900734127383008e-12
of O 0 1.7314585876171407e-10
the O 0 2.731342756134847e-11
cause O 0 3.1377864750936624e-09
of O 0 1.477971434127312e-08
Japanese O 0 0.09636294096708298
ALD B-Disease 1 1.0
with O 0 1.7393464446513462e-10
phenotypic O 0 1.2804910021202431e-08
variations O 0 4.0586250804608426e-08
. O 0 1.4768941625220577e-09

Moreover O 0 2.016921030190133e-08
, O 0 1.5142307546733846e-11
although O 0 7.614854385072645e-13
the O 0 2.276607179683976e-13
scale O 0 6.354099885141906e-11
of O 0 3.0837089826096786e-11
the O 0 7.376277865421554e-13
study O 0 1.0519894417387876e-13
is O 0 1.1381564771597089e-15
limited O 0 1.4119068869784812e-13
, O 0 1.3062837758096718e-13
there O 0 4.713050560717011e-14
is O 0 2.215756027821366e-14
a O 0 2.1025717245829606e-13
possibility O 0 1.8034797613641906e-11
that O 0 3.169112324993839e-12
PET O 1 0.9999614953994751
can O 0 5.934032779042475e-12
detect O 0 1.1608427286091683e-07
an O 0 6.51360649445154e-12
insidious B-Disease 0 1.4176467288962158e-07
lesion I-Disease 0 1.4526694940286689e-06
which O 0 6.376970566185358e-12
is O 0 2.552603582065688e-13
undetectable O 0 4.0899228448409986e-10
by O 0 7.794717697901313e-14
computed O 0 1.0647889688020218e-11
tomogram O 0 2.982101321435948e-08
( O 0 1.3485378612398957e-11
CT O 0 1.816631993278861e-05
) O 0 8.7603486747731e-13
or O 0 1.120602417283012e-12
MRI O 0 3.282441184637719e-06
analysis O 0 1.0191263631609271e-11
, O 0 1.3060594814852389e-13
and O 0 6.623535406128159e-14
that O 0 2.8324267183668346e-15
the O 0 4.1796768953869523e-13
higher O 0 4.160843978390227e-12
level O 0 1.8233921317278856e-11
of O 0 7.214692385182353e-12
tau O 0 8.661330333503692e-12
reflects O 0 3.394814269107316e-13
the O 0 6.446352376595146e-14
process O 0 2.148646793256534e-13
of O 0 2.9533250844870906e-11
neuronal B-Disease 0 9.112625320994994e-07
degeneration I-Disease 1 0.9999997615814209
in O 0 1.1477332151343944e-07
ALD B-Disease 1 1.0
. O 0 2.2792807641280888e-08

Lorenzos O 0 0.00014841812662780285
Oil O 0 2.3126672132889325e-08
should O 0 4.210878607607826e-12
be O 0 6.779211930317205e-14
given O 0 3.573497495633869e-14
in O 0 1.5220328252948945e-13
the O 0 2.2653710504694224e-13
early O 0 3.723205077577063e-11
stage O 0 9.584097404591319e-11
. O 0 2.996347473523814e-13
. O 0 6.613039976732793e-12

Nonsense O 0 9.542843145027291e-06
mutation O 0 8.807960472090315e-10
in O 0 1.7394558016192718e-10
exon O 0 8.400308892930752e-09
4 O 0 4.655089647087607e-09
of O 0 4.162610256486232e-10
human O 0 5.016775189714551e-11
complement O 0 5.6076925325498905e-09
C9 O 1 0.9999992847442627
gene O 0 1.5596552938035302e-09
is O 0 4.002663814544477e-13
the O 0 8.895995919078192e-13
major O 0 4.0199128747975266e-11
cause O 0 3.743222676266811e-10
of O 0 1.6663610491463032e-09
Japanese O 0 1.465423565605306e-06
complement B-Disease 0 6.559756002388895e-05
C9 I-Disease 1 1.0
deficiency I-Disease 1 0.9997277855873108
. O 0 3.3254214937272764e-09

Deficiency B-Disease 1 0.9998732805252075
of I-Disease 0 5.451041579362936e-05
the I-Disease 0 3.5262956998849404e-08
ninth I-Disease 0 1.2591362064995337e-05
component I-Disease 0 1.3435277335105411e-09
of I-Disease 0 4.982819157284268e-10
human I-Disease 0 2.646298284669779e-11
complement I-Disease 0 6.521171380668989e-10
( O 0 6.167444333016192e-11
C9 O 1 0.9999880790710449
) O 0 1.9810060709890553e-12
is O 0 1.2958307285548549e-14
the O 0 9.674684962662425e-14
most O 0 3.9836057765191626e-14
common O 0 3.268404713541173e-10
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.0289867569124311e-10
Japan O 0 5.278352688264931e-08
but O 0 2.283278004600736e-13
is O 0 5.366253570519321e-15
rare O 0 3.5715983122408534e-13
in O 0 7.475674267988508e-14
other O 0 1.4228069135195642e-13
countries O 0 3.0440090010262766e-13
. O 0 1.956117212653652e-11

We O 0 1.1245733511078271e-10
studied O 0 9.868683648051046e-10
the O 0 2.800863707630441e-12
molecular O 0 2.6667024491389135e-11
basis O 0 5.6168288770086505e-11
of O 0 9.13882036712721e-09
C9 B-Disease 1 1.0
deficiency I-Disease 0 0.007750823628157377
in O 0 3.2194272248098343e-10
four O 0 2.3875473820211823e-10
Japanese O 0 2.8656884296651697e-06
C9 B-Disease 1 1.0
- I-Disease 1 0.9999809265136719
deficient I-Disease 0 0.0012392009375616908
patients O 0 2.218172090451276e-09
who O 0 1.1796529898744357e-11
had O 0 4.542909104454651e-10
suffered O 1 0.999924898147583
from O 1 0.5425411462783813
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 3.8642483657369553e-10

Direct O 0 6.699146237743037e-10
sequencing O 0 1.196207910503233e-09
of O 0 1.554555817406822e-09
amplified O 0 1.0283113027753643e-07
C9 O 0 0.0005203692126087844
cDNA O 0 7.294682191627544e-09
and O 0 7.656617007079092e-11
DNA O 0 3.138865878327124e-08
revealed O 0 1.0091614349727607e-10
a O 0 2.8118473261590227e-12
nonsense O 0 2.646501628955633e-10
substitution O 0 1.4445040996680092e-10
( O 0 5.987536421531159e-12
CGA O 0 2.1314134812655539e-07
- O 0 1.5328064373321126e-09
- O 0 2.137809096414145e-10
> O 0 4.2057992505339925e-11
TGA O 0 9.173957593588966e-09
) O 0 1.0208548822899718e-13
at O 0 1.6168776387215367e-12
codon O 0 7.604684243434079e-12
95 O 0 1.584547076882714e-11
in O 0 7.966034516054821e-13
exon O 0 2.3456186992731887e-10
4 O 0 2.0357177055174702e-10
in O 0 6.385441654599422e-12
the O 0 9.950381664458607e-12
four O 0 4.531500868987237e-11
C9 B-Disease 1 0.9999998807907104
- I-Disease 0 2.4484766072419006e-06
deficient I-Disease 0 1.0239780579013313e-07
individuals O 0 1.0278230523630416e-11
. O 0 1.778011071706942e-10

An O 0 1.2079601208192514e-10
allele O 0 1.3492607205123353e-11
- O 0 7.724281630983043e-11
specific O 0 3.180702879898578e-12
polymerase O 0 7.506566479520416e-10
chain O 0 1.9308597776213077e-10
reaction O 0 7.487736559258495e-13
system O 0 3.6165639927254745e-11
designed O 0 3.850475494004968e-10
to O 0 1.3306923922137837e-12
detect O 0 1.152525408443239e-09
exclusively O 0 3.297073378205617e-11
only O 0 2.403451752669341e-14
one O 0 1.0251411908755986e-14
of O 0 6.570703182939841e-13
the O 0 2.0794241437256666e-13
normal O 0 6.586089746490886e-12
and O 0 9.861518069156916e-13
mutant O 0 1.460658503871226e-11
alleles O 0 3.6707236642646857e-14
indicated O 0 1.1045682597743411e-12
that O 0 2.5363683321590752e-14
all O 0 4.4058368607081955e-13
the O 0 3.948901969308416e-12
four O 0 1.1264913698030843e-12
patients O 0 3.205843251453955e-13
were O 0 9.551841739438571e-13
homozygous O 0 5.468867112640163e-12
for O 0 1.155433387856064e-12
the O 0 1.9979575285877793e-11
mutation O 0 1.1178230650138454e-12
in O 0 5.148413813327313e-12
exon O 0 5.302513983451718e-10
4 O 0 4.540916531681205e-10
and O 0 1.1281642937552294e-12
that O 0 4.6770309081514954e-15
the O 0 7.836222447842045e-13
parents O 0 3.6857742877725863e-13
of O 0 1.8332680859489692e-11
patient O 0 2.7564334148522107e-10
2 O 0 2.0939514566720163e-09
were O 0 2.395027232093838e-10
heterozygous O 0 3.047487817653405e-10
. O 0 3.005097559682923e-10

The O 0 4.696282474014879e-09
common O 0 1.532665383496834e-10
mutation O 0 4.959819881189542e-12
at O 0 4.788629562324509e-11
codon O 0 7.640758858951102e-11
95 O 0 1.0730875216191649e-10
in O 0 4.448006633156476e-12
exon O 0 9.72244951213952e-10
4 O 0 8.239257609510275e-10
might O 0 1.2710009910862907e-12
be O 0 1.8894051091473268e-13
responsible O 0 1.8644762816988347e-11
for O 0 1.059250343687923e-12
most O 0 1.2482406601399543e-11
Japanese O 0 4.772104512085207e-05
C9 B-Disease 1 1.0
deficiency I-Disease 0 0.00049415766261518
. O 0 6.565235161071215e-11
. O 0 7.904667892466577e-11

BRCA1 O 0 1.697732017191811e-07
required O 0 4.747561788143173e-10
for O 0 2.5079941595729238e-11
transcription O 0 7.704679205744469e-08
- O 0 4.03820870076288e-08
coupled O 0 2.5413976700860985e-08
repair O 0 2.0654068066505715e-05
of O 0 1.1580568504143685e-08
oxidative O 0 1.1127622201456688e-06
DNA O 0 0.002910420298576355
damage O 0 1.817794873204548e-05
. O 0 8.141605722933321e-10

The O 0 1.0336918421671726e-05
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 0 2.839988337655086e-05
gene O 0 4.829119770732859e-09
BRCA1 O 0 3.5403517895105097e-09
encodes O 0 3.5302136214276914e-11
a O 0 1.6882295561515548e-10
zinc O 0 1.5150455112689087e-07
finger O 0 1.7743074920417712e-07
protein O 0 2.3610369215276705e-10
of O 0 2.559925882383851e-10
unknown O 0 3.722580230181016e-11
function O 0 7.921599140536806e-12
. O 0 1.1366314139893419e-11

Association O 0 1.7844530475485954e-06
of O 0 2.7590294493506917e-08
the O 0 5.46956091529438e-10
BRCA1 O 0 2.952751931850628e-10
protein O 0 1.0826632992899654e-11
with O 0 7.607784844806953e-13
the O 0 4.111798054817761e-11
DNA O 0 1.174030188622055e-07
repair O 0 1.9740159018510894e-07
protein O 0 8.970537646035837e-10
Rad51 O 0 2.9239147991688696e-08
and O 0 5.158282221501276e-12
changes O 0 3.440916171784658e-13
in O 0 3.2247010508905383e-13
the O 0 1.0733480212488447e-13
phosphorylation O 0 1.160730257569742e-12
and O 0 2.341986413828545e-12
cellular O 0 1.1644502029284354e-10
localization O 0 5.85986548173878e-09
of O 0 2.728126335949099e-10
the O 0 1.2598797873020207e-11
protein O 0 1.972853954854137e-12
after O 0 8.705070518588709e-12
exposure O 0 1.0679773732036324e-09
to O 0 5.370101498897162e-12
DNA O 0 9.620059699955164e-07
- O 0 3.898660505541329e-09
damaging O 0 3.591321728890762e-08
agents O 0 7.262854206935287e-11
are O 0 2.5933403102924857e-13
consistent O 0 7.632224019449296e-11
with O 0 8.725491032826604e-14
a O 0 9.910241030586242e-13
role O 0 3.894849286839586e-12
for O 0 5.3181473981533944e-12
BRCA1 O 0 2.1164170416199113e-09
in O 0 1.393076903832835e-10
DNA O 0 1.2182424143247772e-05
repair O 0 8.569292549509555e-05
. O 0 3.275071103203686e-09

Here O 0 7.452715777844787e-09
, O 0 1.1224512638796647e-11
it O 0 3.869373896812911e-14
is O 0 1.6082518007761414e-14
shown O 0 1.435394500742121e-13
that O 0 1.2961107068252403e-13
mouse O 0 2.4768245787676335e-10
embryonic O 0 1.0987704079923333e-09
stem O 0 2.9500499265644464e-10
cells O 0 6.492920090472865e-11
deficient B-Disease 0 2.350882599699844e-09
in I-Disease 0 5.4955342360107906e-11
BRCA1 I-Disease 0 1.3358822936737624e-09
are O 0 1.099276052130005e-12
defective O 0 1.0855411680665839e-08
in O 0 2.838727863885282e-11
the O 0 2.0331712008436753e-11
ability O 0 4.419741211469236e-13
to O 0 1.0724311927867367e-13
carry O 0 3.526443026480308e-12
out O 0 6.786514926415688e-12
transcription O 0 1.1081846551519448e-09
- O 0 1.0780240033980704e-09
coupled O 0 2.0249995014154365e-09
repair O 0 8.633981565253634e-07
of O 0 8.454380306943676e-09
oxidative O 0 1.9719623267633324e-08
DNA O 0 3.5958055377705023e-06
damage O 0 3.1856868645263603e-06
, O 0 7.683678346359635e-12
and O 0 4.1842419286342025e-12
are O 0 5.437225105917043e-13
hypersensitive O 0 5.825430804407006e-09
to O 0 1.1339529142062599e-11
ionizing O 0 2.344231461393065e-06
radiation O 0 1.6107421743072337e-06
and O 0 3.642649723523128e-11
hydrogen O 0 3.654719027412767e-10
peroxide O 0 2.4054495284531185e-08
. O 0 8.6832729895292e-10

These O 0 1.9127164296861565e-09
results O 0 3.50490830802741e-10
suggest O 0 5.126603655480899e-11
that O 0 8.772454334129987e-13
BRCA1 O 0 9.082530283421875e-10
participates O 0 9.225713248905976e-11
, O 0 1.9589390873320234e-12
directly O 0 1.6309271641534728e-12
or O 0 1.0206179434577023e-12
indirectly O 0 6.386635144350894e-12
, O 0 6.679525639194384e-13
in O 0 1.8480226030015423e-12
transcription O 0 2.185457592673856e-09
- O 0 4.939633146960887e-09
coupled O 0 7.683073732778212e-09
repair O 0 1.4070265024201944e-06
of O 0 9.68172386706101e-09
oxidative O 0 3.205302050446335e-07
DNA O 0 0.00016732406220398843
damage O 0 6.486012807727093e-06
. O 0 7.065738272249433e-11
. O 0 1.1087020884703591e-10

Truncation O 0 3.1626927921024617e-06
mutations O 0 3.6307294948301205e-09
in O 0 7.568569382332413e-11
the O 0 5.5135500331982e-11
transactivation O 0 2.379916566042084e-07
region O 0 3.592772301885816e-09
of O 0 2.025166523367261e-08
PAX6 O 1 0.9999865293502808
result O 0 1.77986803073793e-09
in O 0 1.1441470687545419e-10
dominant O 0 4.416262022743922e-09
- O 0 9.476076590075877e-10
negative O 0 2.1055315477247483e-11
mutants O 0 4.71286476511068e-09
. O 0 4.710757478543215e-11

PAX6 O 1 0.9997404217720032
is O 0 1.0258028870779867e-09
a O 0 4.655999544245226e-11
transcription O 0 9.184913940529782e-10
factor O 0 3.564775558073663e-11
with O 0 2.73497858475219e-13
two O 0 9.433718996948448e-13
DNA O 0 9.687412649839189e-09
- O 0 3.265575587718672e-10
binding O 0 9.827821889629718e-11
domains O 0 1.41252856633578e-10
( O 0 1.0283818935308275e-11
paired O 0 3.24439280996458e-10
box O 0 4.677937592845183e-09
and O 0 9.530304323490668e-11
homeobox O 0 1.359810819501206e-09
) O 0 4.997383258077692e-13
and O 0 1.5236689947933924e-12
a O 0 5.0321253240726005e-12
proline O 0 6.028906085475683e-08
- O 0 6.1614069402082805e-09
serine O 0 1.930452953047279e-08
- O 0 2.3374335800241397e-09
threonine O 0 5.709927464181419e-08
( O 0 3.421717770235588e-11
PST O 0 0.23150797188282013
) O 0 3.424630024007058e-11
- O 0 3.3778585484256496e-10
rich O 0 1.1375921905865116e-11
transactivation O 0 4.133104880565952e-08
domain O 0 4.0137398960027326e-10
. O 0 5.1032188891353414e-11

PAX6 O 1 0.9999998807907104
regulates O 0 0.00025313609512522817
eye O 0 0.43182769417762756
development O 0 1.955261286212817e-09
in O 0 1.61116484737045e-11
animals O 0 1.675797001166046e-11
ranging O 0 6.555690990062146e-10
from O 0 1.6938343089245578e-11
jellyfish O 0 3.9559731358773664e-12
to O 0 2.9100758803558835e-13
Drosophila O 0 1.4864852404539164e-10
to O 0 2.8335875312812675e-12
humans O 0 7.882535596470674e-11
. O 0 1.225073861799153e-11

Heterozygous O 0 3.102486090256207e-08
mutations O 0 2.0943948797480516e-09
in O 0 7.689399811328101e-11
the O 0 1.8670645585139312e-10
human O 0 1.0569713992936158e-09
PAX6 O 1 0.9996688365936279
gene O 0 7.969248871919632e-11
result O 0 2.3162602478393746e-12
in O 0 4.234111162810389e-13
various O 0 2.8776447370815195e-12
phenotypes O 0 3.561134720442283e-10
, O 0 1.6324209779067234e-12
including O 0 1.88321955252313e-10
aniridia B-Disease 1 1.0
, O 0 2.5093424227407013e-08
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 9.131223777103514e-09
autosomal B-Disease 1 0.9996891021728516
dominant I-Disease 0 0.0002846262068487704
keratitis I-Disease 1 0.9999523162841797
, O 0 8.902256154463828e-10
and O 0 8.411178420431042e-09
familial B-Disease 1 1.0
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 2.0183506421744823e-06

It O 0 5.213072751253378e-10
is O 0 3.4091562038651713e-12
believed O 0 1.2664233377257528e-11
that O 0 1.5720277591604534e-14
the O 0 1.1905406131426655e-12
mutated O 0 3.6100449019027536e-11
allele O 0 1.1014928552599557e-11
of O 0 2.545053723324031e-09
PAX6 O 0 0.0028814971446990967
produces O 0 7.675028945719475e-10
an O 0 6.269115001428238e-13
inactive O 0 8.022788655637214e-09
protein O 0 6.909730565496375e-10
and O 0 5.926031332315063e-10
aniridia B-Disease 1 1.0
is O 0 1.655048147142235e-11
caused O 0 2.617445704622412e-10
due O 0 4.3751022249516325e-10
to O 0 3.938959228233507e-11
genetic O 0 2.2716248437859576e-08
haploinsufficiency O 0 9.737564141687471e-06
. O 0 1.1646550390764787e-09

However O 0 5.3144444400743396e-09
, O 0 1.3932569507824066e-11
several O 0 3.1296829277466243e-12
truncation O 0 9.052493865624456e-09
mutations O 0 1.4477229137721537e-10
have O 0 4.792763950468848e-13
been O 0 9.911223317754514e-13
found O 0 6.243268705838356e-13
to O 0 6.428793722411744e-14
occur O 0 1.0025256991751108e-13
in O 0 2.0172545003773606e-13
the O 0 3.903342059297099e-12
C O 0 6.82950940245064e-08
- O 0 1.9241319648699573e-10
terminal O 0 8.610717000534507e-11
half O 0 3.934407053624023e-12
of O 0 3.3668959981136837e-11
PAX6 O 0 8.088513277471066e-05
in O 0 7.194098095020252e-11
patients O 0 2.465186908773287e-11
with O 0 6.6830842075649155e-12
Aniridia B-Disease 1 1.0
resulting O 0 2.3101796031710364e-09
in O 0 2.4878552343232663e-11
mutant O 0 3.4742764221107336e-11
proteins O 0 2.1955054690502712e-13
that O 0 2.3899342926772885e-14
retain O 0 6.192433371632333e-11
the O 0 3.664880898757161e-11
DNA O 0 2.2160376644819735e-08
- O 0 2.1059665122891147e-10
binding O 0 1.7410746455670534e-11
domains O 0 3.905770238482598e-12
but O 0 5.3670545248742443e-14
have O 0 2.0340137587464627e-14
lost O 0 2.4044596175221145e-11
most O 0 4.331741061225185e-14
of O 0 4.005491684860862e-12
the O 0 5.198303159453799e-12
transactivation O 0 1.9598809686272034e-08
domain O 0 3.831720218894219e-10
. O 0 1.4121460945037967e-10

It O 0 2.371304264059404e-10
is O 0 2.5339047266675907e-12
not O 0 7.995728780680125e-14
clear O 0 3.782426628851088e-12
whether O 0 5.342178522466101e-13
such O 0 2.5377561163608675e-11
mutants O 0 1.0520301962912981e-08
really O 0 3.364707124031696e-11
behave O 0 5.2800029973210094e-12
as O 0 4.647985121786213e-12
loss O 0 1.2437455509939355e-09
- O 0 6.916969219616931e-10
of O 0 1.1533236587979445e-09
- O 0 6.707892019619521e-10
function O 0 1.2873231126919737e-12
mutants O 0 9.748515189533791e-11
as O 0 5.521142354067421e-13
predicted O 0 3.994993138384251e-12
by O 0 2.1054301965056643e-12
haploinsufficiency O 0 4.0081240513245575e-06
. O 0 1.6081760367825382e-09

Contrary O 0 1.220689966885402e-07
to O 0 1.7628013632142725e-11
this O 0 8.694308700719564e-14
theory O 0 1.4516929325303352e-11
, O 0 5.198052275071086e-13
our O 0 1.6942664719105105e-12
data O 0 5.9200261880165694e-12
showed O 0 4.664975437190799e-12
that O 0 3.1235477071734014e-15
these O 0 6.465388933864918e-14
mutants O 0 1.1631072494022732e-10
are O 0 2.0824882345903822e-13
dominant O 0 6.220655240918305e-11
- O 0 1.935755548909679e-11
negative O 0 4.528627635651955e-13
in O 0 3.986024834853885e-13
transient O 0 1.189329884576651e-10
transfection O 0 2.7917048672776446e-09
assays O 0 3.085492972232373e-10
when O 0 2.1272072645017737e-12
they O 0 1.0369607733248798e-13
are O 0 8.267828967029739e-14
coexpressed O 0 4.0240461629537094e-08
with O 0 2.227624855410948e-11
wild O 0 1.8636548304584721e-07
- O 0 1.1808214139819029e-07
type O 0 7.374958954642352e-07
PAX6 O 1 0.9999856948852539
. O 0 7.17749415457547e-09

We O 0 4.4543616017911347e-10
found O 0 3.8692320181166195e-11
that O 0 6.00719425375082e-14
the O 0 7.867932000360511e-12
dominant O 0 4.456809088448921e-10
- O 0 2.7496593890674603e-10
negative O 0 3.4959582971560987e-12
effects O 0 6.787143624897851e-10
result O 0 1.2940266263042344e-12
from O 0 7.320885434328184e-13
the O 0 3.1618230169477846e-13
enhanced O 0 4.218621979523718e-11
DNA O 0 1.3086778327675574e-09
binding O 0 7.317093111969264e-12
ability O 0 4.904206381273202e-12
of O 0 4.891559379771593e-11
these O 0 3.59071843439307e-12
mutants O 0 7.483725639190197e-09
. O 0 1.8562520964771068e-10

Kinetic O 0 1.6803325308956119e-07
studies O 0 9.625926722378608e-10
of O 0 1.676063315914078e-10
binding O 0 2.5237975598280116e-10
and O 0 8.866361117521038e-11
dissociation O 0 1.4944316895082466e-09
revealed O 0 1.449787095930688e-10
that O 0 2.5550035652184382e-14
various O 0 7.946598240549108e-12
truncation O 0 4.515587015418987e-09
mutants O 0 6.682275843772345e-10
have O 0 1.763990022845066e-13
3 O 0 2.61897743075723e-11
- O 0 3.5763395717092195e-11
5 O 0 3.13682031738427e-11
- O 0 9.423616401105228e-12
fold O 0 1.0803647473162092e-12
higher O 0 8.631624603440413e-13
affinity O 0 8.751959795988765e-14
to O 0 1.1024964578429386e-13
various O 0 1.3022518176655784e-12
DNA O 0 1.1301021229925823e-09
- O 0 3.97477536995261e-12
binding O 0 2.4650480224749916e-13
sites O 0 2.1634223004631664e-13
when O 0 1.3825785914083673e-14
compared O 0 7.354523653762494e-15
with O 0 7.239700714465648e-15
the O 0 4.796250636235344e-12
wild O 0 4.7954253901139055e-09
- O 0 6.452396394962534e-09
type O 0 4.2298601954371406e-08
PAX6 O 1 0.9680222868919373
. O 0 3.8074770003504455e-09

These O 0 5.147200998756318e-10
results O 0 9.095024039451616e-11
provide O 0 3.673655130098652e-12
a O 0 1.3525014441739813e-12
new O 0 2.2750369296775652e-12
insight O 0 1.5514353690626592e-11
into O 0 1.092891293956455e-12
the O 0 1.070812926176612e-12
role O 0 3.378331685580105e-12
of O 0 8.45176012509441e-11
mutant O 0 2.2052801806893285e-09
PAX6 O 0 0.0063112354837358
in O 0 7.788834022193214e-10
causing O 0 3.933409686851519e-07
aniridia B-Disease 1 1.0
. O 0 3.865789077739379e-10
. O 0 3.683397475917616e-10

Reversal O 0 3.4349627640040126e-06
of O 0 2.6698609872255474e-05
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 6.481099262600765e-05
excellent O 0 3.195531462552026e-05
neuropsychologic O 0 0.04823999106884003
outcome O 0 7.67529968470626e-08
in O 0 6.586912681960655e-10
very B-Disease 0 9.748775398055187e-11
- I-Disease 0 5.1927344202340464e-08
long I-Disease 0 3.7836717092787353e-10
- I-Disease 0 2.0670482214768526e-08
chain I-Disease 0 5.678005621234661e-09
acyl I-Disease 0 2.0575017245505478e-08
- I-Disease 0 1.0056925248136395e-07
coenzyme I-Disease 0 5.541610725856572e-09
A I-Disease 0 8.543590411136393e-06
dehydrogenase I-Disease 0 0.0005357259069569409
deficiency I-Disease 0 0.43812301754951477
. O 0 5.07841502184192e-09

Very B-Disease 0 5.6822450744675734e-08
- I-Disease 0 5.624233949674817e-07
long I-Disease 0 2.175136071258521e-09
- I-Disease 0 1.599196330914765e-08
chain I-Disease 0 2.3862782860817333e-09
acyl I-Disease 0 8.62806603940669e-10
- I-Disease 0 1.684852701799855e-09
coenzyme I-Disease 0 3.627071212819466e-11
A I-Disease 0 2.277680266615789e-09
dehydrogenase I-Disease 0 1.44211531605265e-09
( I-Disease 0 7.945605839942971e-10
VLCAD I-Disease 1 1.0
) I-Disease 0 1.5283369236840372e-07
deficiency I-Disease 0 0.006452065892517567
is O 0 2.774300754404546e-12
a O 0 5.325224983199206e-11
disorder O 1 0.9999632835388184
of O 0 0.4612787365913391
fatty O 0 3.004510472237598e-05
acid O 0 4.081666205024703e-08
beta O 0 4.1943459816451423e-10
oxidation O 0 2.1415717810224777e-10
that O 0 2.4835003302990655e-13
reportedly O 0 5.151293974714477e-11
has O 0 6.304425568832289e-14
high O 0 9.539034145911174e-11
rates O 0 2.5338576722933048e-11
of O 0 2.947393717978031e-11
morbidity O 0 1.4013282623182022e-07
and O 0 2.47784515128302e-10
mortality O 0 1.9847693266683564e-08
. O 0 3.657380995281123e-11

We O 0 5.959844284753046e-10
describe O 0 5.982622730549281e-10
the O 0 2.812959240539037e-11
outcome O 0 1.645156927354563e-10
of O 0 7.876077567914308e-10
a O 0 1.510601713161641e-11
5 O 0 3.382332469659133e-10
- O 0 1.549076422691087e-10
year O 0 3.910055872829998e-12
- O 0 9.072436690793495e-10
old O 0 2.5983410978369648e-09
girl O 0 5.519992796187978e-10
with O 0 5.2018268165143766e-11
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 3.256402925089219e-09
was O 0 1.1616245743084619e-09
first O 0 9.547988788494166e-11
seen O 0 4.0073354357073043e-11
at O 0 1.0103978764774979e-10
5 O 0 4.2918120446433505e-11
months O 0 5.088673081000972e-13
of O 0 3.3536225879648995e-11
age O 0 6.478582947888611e-11
with O 0 4.1865271666052806e-11
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 0 0.01021061185747385
hepatomegaly B-Disease 1 1.0
, O 1 0.9999991655349731
encephalopathy B-Disease 1 1.0
, O 0 4.7059508290203667e-08
and O 0 7.117682230273203e-07
hypotonia B-Disease 1 1.0
. O 0 2.2404204003123596e-07

Biochemical O 0 0.0002403276157565415
studies O 0 9.132772902376018e-06
indicated O 1 1.0
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 0.02788420580327511
by O 0 2.815186625482191e-11
a O 0 3.284645125334329e-11
stable O 0 5.643732703397575e-10
yet O 0 3.6622812421560624e-11
inactive O 0 4.2377092057677146e-08
enzyme O 0 3.4007381355394273e-09
. O 0 5.52811629805916e-10

Molecular O 0 2.003932024763344e-07
genetic O 0 2.638156804124492e-09
analysis O 0 1.6914171452331317e-10
of O 0 2.2764206075720494e-09
her O 0 2.6747131176563244e-09
VLCAD O 1 1.0
gene O 0 3.553545724344076e-08
revealed O 0 3.0498965575276316e-09
a O 0 5.264559621576126e-11
T1372C O 0 5.7279692100564716e-08
( O 0 1.0742712275302324e-10
F458L O 0 1.708212096218631e-07
) O 0 7.479637048612986e-11
missense O 0 3.927456759811321e-08
mutation O 0 1.1789816900531491e-09
and O 0 4.896695826595021e-10
a O 0 2.0514816512218204e-09
1668 O 1 0.8512884378433228
ACAG O 1 1.0
1669 O 0 0.0003147267852909863
splice O 0 2.0296045477152802e-05
site O 0 4.740716619267005e-08
mutation O 0 8.723948674571602e-09
. O 0 9.864166150563847e-10

After O 0 4.534021158519863e-09
initial O 0 2.8376681560082773e-10
treatment O 0 1.1309494452049762e-09
with O 0 1.5719222798415977e-11
intravenous O 0 6.303431554499639e-09
glucose O 0 4.5984066332493967e-07
and O 0 2.4224319772336855e-10
carnitine O 0 3.2493254309429176e-08
, O 0 1.9352719080045766e-11
the O 0 1.0638004366292364e-11
patient O 0 8.067869150529816e-10
has O 0 4.73056110342901e-13
thrived O 0 2.541816757073434e-10
on O 0 4.666134492681273e-11
a O 0 4.9241986356529655e-12
low O 0 1.527215021113193e-09
- O 0 1.4876687659537424e-09
fat O 0 2.2361834606243747e-09
diet O 0 9.435761894049932e-11
supplemented O 0 3.3121567988292355e-11
with O 0 1.6145193363660548e-13
medium O 0 2.1451664888871846e-09
- O 0 4.789438179386707e-09
chain O 0 7.626625442291868e-10
triglyceride O 0 1.002646299319565e-09
oil O 0 2.3327603737577363e-10
and O 0 1.425842863916893e-11
carnitine O 0 1.3763384876241957e-09
and O 0 5.212202631305063e-12
avoidance O 0 6.69648230200437e-08
of O 0 3.5803289222258172e-09
fasting O 0 4.842383383163451e-09
. O 0 8.967897952016912e-11

Her O 0 1.857089955592528e-05
ventricular O 1 0.9999997615814209
hypertrophy O 1 0.9970594048500061
resolved O 0 2.0982108139833144e-07
significantly O 0 4.40512099020296e-10
over O 0 4.2423935892044184e-11
1 O 0 4.002919870571553e-11
year O 0 3.3391751820197046e-13
, O 0 1.4339058911592983e-13
and O 0 8.215392342109107e-13
cognitively O 0 1.845673480715959e-08
, O 0 5.829479260421877e-12
she O 0 1.15444153260362e-13
is O 0 3.056561165330979e-15
in O 0 7.194910628654377e-14
the O 0 1.3670694350848e-12
superior O 0 8.784795113569999e-09
range O 0 3.3915787955862697e-09
for O 0 1.0890463877921697e-11
age O 0 1.6290199744695144e-10
. O 0 2.6169550901289362e-11

Clinical O 0 1.1895614989043679e-05
recognition O 0 3.165243924740935e-07
of O 1 0.9999998807907104
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 2.883444039092353e-10
important O 0 8.781364524423907e-12
because O 0 5.901691353497884e-13
it O 0 2.7886642105755255e-14
is O 0 2.3085779215879917e-15
one O 0 1.1070939155114097e-14
of O 0 4.501331165446265e-12
the O 0 7.192859589194578e-12
few O 0 6.572348568156805e-12
directly O 0 1.712430197642334e-09
treatable O 1 1.0
causes O 0 4.2168429104094685e-07
of O 0 0.0034619031939655542
cardiomyopathy B-Disease 1 1.0
in O 0 9.225212593833021e-09
children O 0 5.923982832056751e-11
. O 0 3.955082789053321e-12
. O 0 4.0715205512631414e-11

Cloning O 0 2.8975699706279556e-07
of O 0 1.5565060351718785e-08
a O 0 1.772595785431985e-11
novel O 0 3.1777577097491516e-11
member O 0 1.2896191926847766e-11
of O 0 3.681295546176244e-11
the O 0 9.444706301764416e-12
low O 0 4.88049045621608e-10
- O 0 3.0381711035865067e-11
density O 0 6.352081404273346e-13
lipoprotein O 0 1.4104246659485398e-08
receptor O 0 2.839054269454522e-10
family O 0 2.3306123697608427e-10
. O 0 3.186936547994179e-10

A O 0 3.475641108252603e-07
gene O 0 8.443462595764117e-11
encoding O 0 8.376679558330657e-12
a O 0 9.417400886890803e-12
novel O 0 1.6787883583280205e-11
transmembrane O 0 2.876423821351892e-10
protein O 0 1.5962417498904813e-10
was O 0 2.0028423364237824e-10
identified O 0 1.5373365557999619e-12
by O 0 8.849216118992503e-14
DNA O 0 6.156423149050738e-10
sequence O 0 1.1221931587104828e-13
analysis O 0 4.442033221287167e-14
within O 0 5.402006966748196e-13
the O 0 1.6957924864682838e-12
insulin B-Disease 0 5.590356977336342e-07
- I-Disease 0 2.2029744286555797e-05
dependent I-Disease 0 0.040813155472278595
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 2.1436298069943405e-08
IDDM B-Disease 1 1.0
) O 0 2.244364069592386e-11
locus O 0 4.098403283414598e-10
IDDM4 O 0 0.0018708130810409784
on O 0 1.5736825176304592e-08
chromosome O 0 3.053064290270413e-08
11q13 O 0 3.377611221822008e-07
. O 0 1.194500276469057e-09

Based O 0 3.004664961281378e-08
on O 0 1.4610944676363147e-09
its O 0 5.7324960750504417e-11
chromosomal O 0 2.1890881996000644e-08
position O 0 2.16819384668554e-09
, O 0 2.633959673634112e-12
this O 0 3.2412501773260854e-14
gene O 0 1.7877484432063384e-12
is O 0 2.443061215568615e-14
a O 0 4.511228020374729e-14
candidate O 0 6.780401842201508e-14
for O 0 3.053755436455835e-13
conferring O 0 4.34047962016848e-08
susceptibility O 0 5.568490087171085e-05
to O 0 1.3792120512334805e-07
diabetes B-Disease 1 1.0
. O 0 1.357815815339336e-08

The O 0 6.14626785022665e-08
gene O 0 1.1814399458742741e-09
, O 0 9.714858258125236e-12
termed O 0 1.4872715281555315e-09
low O 0 1.3292790201901994e-09
- O 0 2.7075090433537063e-11
density O 0 1.8616388270352446e-13
lipoprotein O 0 1.1786571718630512e-10
receptor O 0 1.7687615695011205e-12
related O 0 2.597720372143897e-10
protein O 0 4.096963393540598e-11
5 O 0 1.5298030897614723e-10
( O 0 1.902148360696798e-12
LRP5 O 0 0.00016747090558055788
) O 0 2.1318405753808362e-13
, O 0 3.4243434639518594e-14
encodes O 0 2.4728732177735878e-14
a O 0 7.13233183451123e-14
protein O 0 4.13117326805712e-12
of O 0 1.8077270236283027e-10
1615 O 0 6.183483236554821e-08
amino O 0 2.3268367788098487e-10
acids O 0 1.1008081599039876e-11
that O 0 2.7801018933249107e-15
contains O 0 2.9804958956609895e-13
conserved O 0 7.553005096361254e-12
modules O 0 1.9630318204288955e-11
which O 0 2.8633355858868545e-14
are O 0 6.6252757200215874e-15
characteristic O 0 9.035299418369558e-12
of O 0 1.2544150614079985e-11
the O 0 1.0243155065467469e-12
low O 0 9.67959115638628e-11
- O 0 1.0853304366342797e-11
density O 0 8.909308837554142e-13
lipoprotein O 0 1.0864629196305486e-08
( O 0 5.007578379734312e-11
LDL O 0 1.65224253123597e-06
) O 0 5.3633759759808e-12
receptor O 0 5.127640326230143e-11
family O 0 1.858568160484353e-11
. O 0 6.801187391047847e-11

These O 0 1.4088745448059825e-10
modules O 0 6.806333274766985e-09
include O 0 1.4009267357284472e-10
a O 0 1.8076640878605943e-11
putative O 0 4.5048487162802076e-10
signal O 0 6.155390086526324e-10
peptide O 0 8.088109348936001e-11
for O 0 2.8730650671049407e-12
protein O 0 6.317022425983421e-12
export O 0 1.3755924177516476e-10
, O 0 4.109966761454281e-13
four O 0 1.5829141654117446e-13
epidermal O 0 1.6168941185945584e-11
growth O 0 1.3387984297563715e-12
factor O 0 1.797335284076107e-12
( O 0 6.180253357690457e-12
EGF O 0 6.494006754564907e-08
) O 0 7.941867649630119e-13
repeats O 0 7.884697235394089e-12
with O 0 1.7652624696197494e-13
associated O 0 1.2716837305415396e-10
spacer O 0 4.886417048766134e-09
domains O 0 2.7960520010417156e-10
, O 0 7.691390926933828e-12
three O 0 2.658793541235327e-12
LDL O 0 1.7461131562868104e-07
- O 0 2.8062474566326046e-09
receptor O 0 4.319454516288346e-11
( O 0 7.903473014936324e-12
LDLR O 1 0.9999583959579468
) O 0 1.6757172038861512e-11
repeats O 0 7.992356082509033e-11
, O 0 4.68503599630743e-13
a O 0 5.552550064701067e-13
single O 0 5.359451771269619e-11
transmembrane O 0 7.727896100817588e-10
spanning O 0 2.2280775002769815e-09
domain O 0 2.5563334435374507e-11
, O 0 1.2399112769498344e-12
and O 0 5.972204068088738e-13
a O 0 2.880065977373114e-12
cytoplasmic O 0 1.4119305724591413e-10
domain O 0 2.9024027625723647e-10
. O 0 1.4613084353687356e-10

The O 0 1.2301263119240957e-08
encoded O 0 4.804339703845528e-10
protein O 0 1.2662693116283208e-10
has O 0 7.108808713126441e-14
a O 0 3.0793960724461236e-14
unique O 0 3.154510344344913e-13
organization O 0 1.8043124286326595e-11
of O 0 3.974066631329265e-10
EGF O 0 3.4733216125459876e-07
and O 0 2.960822143016628e-10
LDLR O 1 0.9999208450317383
repeats O 0 2.7489779896860966e-10
; O 0 6.337148687751704e-13
therefore O 0 6.7152455471286565e-12
, O 0 8.577404411735934e-12
LRP5 O 1 0.997809112071991
likely O 0 1.4370594991763852e-10
represents O 0 1.7595788107810373e-12
a O 0 8.632740247475901e-14
new O 0 5.014532083839895e-13
category O 0 7.402119195365486e-11
of O 0 1.6518353351813175e-10
the O 0 1.6988438433784836e-10
LDLR O 1 0.9999982118606567
family O 0 1.3074429316972669e-09
. O 0 5.646219602972735e-10

Both O 0 1.503896340793176e-09
human O 0 1.1513368036730753e-09
and O 0 1.4582240970284488e-09
mouse O 0 1.947900045706774e-07
LRP5 O 1 0.9999995231628418
cDNAs O 0 1.3394111419984256e-06
have O 0 1.261288057503862e-12
been O 0 6.546747193837688e-13
isolated O 0 3.0974615233825276e-11
and O 0 1.2559011990098679e-12
the O 0 1.6805782026424465e-12
encoded O 0 1.0731786553169753e-12
mature O 0 4.1621771133815155e-12
proteins O 0 4.8302135132339413e-14
are O 0 7.158604933062574e-15
95 O 0 6.4189122767066564e-12
% O 0 1.1391474210047017e-14
identical O 0 5.8654925534640245e-12
, O 0 3.9058423921371765e-13
indicating O 0 1.6900361318739066e-11
a O 0 7.045652039225359e-13
high O 0 6.285416631612861e-11
degree O 0 7.805490143120153e-10
of O 0 1.3610582105805236e-10
evolutionary O 0 4.1201115436040325e-11
conservation O 0 3.399653336622066e-10
. O 0 6.222761021745793e-13
. O 0 8.140122256805604e-12

The O 0 9.200456929647771e-08
APC B-Disease 0 4.185719149063516e-07
variants O 0 8.12901035374125e-09
I1307K O 0 1.0759625013179175e-07
and O 0 7.136479601710377e-11
E1317Q O 0 1.3205662341420066e-08
are O 0 1.496916956708616e-12
associated O 0 5.844063366566843e-08
with O 0 0.004704796243458986
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 3.3998479032071316e-10
but O 0 1.7765033422188076e-13
not O 0 1.1307746189057055e-13
always O 0 9.738618331894822e-13
with O 0 1.473970142988612e-13
a O 0 4.427961903391564e-12
family O 0 8.566793975595122e-12
history O 0 3.770216139287186e-09
. O 0 3.845279372693966e-10

Classical O 1 0.9999978542327881
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 2.4012649646465434e-07
FAP B-Disease 0 8.115817763609812e-05
) O 0 6.317098233399321e-11
is O 0 2.7918907962408424e-13
a O 0 8.10500017794924e-12
high O 1 0.9962401390075684
- O 1 1.0
penetrance O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.9999966621398926
that O 0 3.448912704907825e-13
predisposes O 0 4.559863320263702e-10
to O 0 2.5692219619150025e-12
hundreds O 0 1.985035226470533e-11
or O 0 1.5320800184071004e-11
thousands O 0 1.3053989833533564e-10
of O 0 5.913964196224697e-05
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.89129638671875
carcinoma I-Disease 1 1.0
and O 0 4.241378359637338e-09
that O 0 1.008771625260474e-12
results O 0 1.3843916291111924e-10
from O 0 1.4218215493855269e-10
truncating O 0 2.2026497958904656e-08
mutations O 0 8.166266968201441e-11
in O 0 6.755562081961486e-11
the O 0 1.2232118651311907e-09
APC B-Disease 0 1.5948503460094798e-06
gene O 0 1.850922615176387e-08
. O 0 1.4006149573475568e-09

A O 0 3.207941006166948e-07
variant O 0 2.0642909248635988e-07
of O 0 3.649804725114336e-08
FAP B-Disease 0 0.0004019334737677127
is O 0 2.1651025416957737e-09
attenuated B-Disease 1 0.9999723434448242
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 0.9999997615814209
coli I-Disease 1 0.9999998807907104
, O 0 2.4706471243862715e-11
which O 0 3.4306669375976095e-13
results O 0 8.200069963326673e-12
from O 0 5.541298669919925e-11
germ O 0 1.5858662663958967e-05
- O 0 1.514923475554042e-08
line O 0 9.553021707020548e-10
mutations O 0 1.8551529670091105e-12
in O 0 1.4903928785559017e-12
the O 0 3.1497866381097195e-12
5 O 0 1.8401766221920468e-11
and O 0 8.840920075019187e-13
3 O 0 4.8860301221642644e-11
regions O 0 5.634702773815725e-12
of O 0 2.153321965181476e-11
the O 0 7.120218997735961e-11
APC B-Disease 0 4.3914516822951555e-07
gene O 0 4.23988977260592e-09
. O 0 4.769034611662448e-10

Attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 0 3.0184562547219684e-06
have O 0 3.524562239287654e-11
" O 0 3.743660048627362e-09
multiple O 0 9.643951489124447e-05
" O 1 0.9999998807907104
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 3.9359795978022305e-10
typically O 0 1.090018960508976e-11
fewer O 0 6.945143787330521e-13
than O 0 2.634369027716861e-14
100 O 0 2.690731144838754e-11
) O 0 1.1682012778999051e-13
without O 0 6.743067475917242e-13
the O 0 2.8870070396813663e-12
florid O 0 2.4970626455456113e-08
phenotype O 0 1.080889405757901e-10
of O 0 1.484875694623966e-10
classical O 0 3.1257936683459775e-08
FAP B-Disease 0 4.7874591473373584e-06
. O 0 9.002057432816457e-10

Another O 0 3.143551197126726e-08
group O 0 5.277662196156996e-10
of O 0 1.4127987668643982e-09
patients O 0 8.669169548891631e-11
with O 0 7.608644617129734e-12
multiple O 0 3.989042397734011e-06
adenomas B-Disease 0 0.16526766121387482
has O 0 2.6549587181512457e-11
no O 0 9.657843101640307e-12
mutations O 0 3.324059343751129e-12
in O 0 6.897990425386302e-12
the O 0 2.0837191694322854e-10
APC B-Disease 0 5.580814477212925e-09
gene O 0 2.7863824095253342e-11
, O 0 8.394941100782483e-13
and O 0 8.182333391566765e-13
their O 0 9.105799447794993e-12
phenotype O 0 4.1505895942428594e-11
probably O 0 4.764820048935858e-12
results O 0 5.140289235927575e-12
from O 0 1.9230962308713906e-11
variation O 0 2.4419807842512853e-10
at O 0 1.2631576340460526e-10
a O 0 1.2876227861724487e-12
locus O 0 5.648260505142222e-12
, O 0 6.687225100922289e-13
or O 0 9.959394420278045e-13
loci O 0 5.447400776986688e-12
, O 0 2.2854827297184854e-13
elsewhere O 0 7.086073047779529e-12
in O 0 1.310486875266692e-12
the O 0 1.4816554233521018e-11
genome O 0 1.565853696705588e-11
. O 0 5.378068476669107e-11

Recently O 0 7.591278716745364e-08
, O 0 1.4019953600841184e-11
however O 0 9.104561722594884e-13
, O 0 1.687644165040969e-13
a O 0 9.334591069944456e-14
missense O 0 5.315881068668205e-10
variant O 0 2.815534649869278e-08
of O 0 6.206477678460942e-07
APC B-Disease 0 5.501286068465561e-06
( O 0 2.372843921349954e-09
I1307K O 0 1.3924509403295815e-06
) O 0 3.305555135169058e-11
was O 0 2.920105268700013e-10
described O 0 3.7668632102416666e-11
that O 0 3.247332890326908e-14
confers O 0 6.946233952614955e-12
an O 0 4.602204779920703e-14
increased O 0 4.866867325814539e-12
risk O 0 1.1809335731527426e-08
of O 1 0.9032572507858276
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.2232928559008371e-10
including O 0 1.6109313535905834e-11
multiple O 0 1.0020006158129036e-08
adenomas B-Disease 0 5.815591521241004e-06
, O 0 9.764090924679891e-11
in O 0 4.896855143599055e-10
Ashkenazim O 0 6.972919072723016e-05
. O 0 1.3979333246538772e-08

We O 0 6.117351625256617e-10
have O 0 3.166887054244921e-13
studied O 0 2.666322440614266e-10
a O 0 1.2818765146582756e-12
set O 0 2.2905037241893744e-11
of O 0 3.784116769933732e-11
164 O 0 1.027798623987053e-09
patients O 0 1.7290485015974966e-11
with O 0 2.1432135580146117e-11
multiple O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 2.3426846382790245e-06
/ I-Disease 0 0.422731876373291
or I-Disease 0 6.971491984586464e-06
carcinoma I-Disease 1 1.0
and O 0 2.781425978426455e-09
analyzed O 0 2.3113576830269267e-08
codons O 0 9.545049195480715e-09
1263 O 0 8.24242306407541e-07
- O 0 2.463215187376022e-09
1377 O 0 8.042924548590236e-08
( O 0 1.2479502674300758e-11
exon O 0 1.1218701523318941e-09
15G O 0 1.6741669384146007e-08
) O 0 2.808479631580957e-13
of O 0 2.1967058380645277e-11
the O 0 1.9538390003126516e-11
APC B-Disease 0 4.3848558561876416e-08
gene O 0 7.987936700981635e-11
for O 0 5.501698055465631e-12
germ O 0 4.429867840372026e-05
- O 0 7.810546520659045e-08
line O 0 6.450907363841907e-09
variants O 0 4.24217105887692e-09
. O 0 1.1790619869334051e-10

Three O 0 2.653878006242394e-09
patients O 0 2.3122403297604066e-11
with O 0 1.3372695962729497e-12
the O 0 5.127075985988938e-10
I1307K O 0 1.5365971250957955e-07
allele O 0 9.73929183828437e-12
were O 0 2.3851233488247914e-12
detected O 0 1.7567670929086177e-10
, O 0 1.2854307733251719e-13
each O 0 4.857076654936343e-15
of O 0 1.6395926283330198e-11
Ashkenazi O 0 3.004309689913498e-08
descent O 0 3.23656514922277e-08
. O 0 1.2787745307107912e-09

Four O 0 6.660089724164209e-08
patients O 0 2.2964812274040014e-09
had O 0 1.0988621124141673e-10
a O 0 8.199105283601682e-11
germ O 0 0.07143215090036392
- O 0 2.1967377961118473e-06
line O 0 3.594227138137285e-08
E1317Q O 0 3.299506801113239e-08
missense O 0 3.859175201625931e-09
variant O 0 1.2173773988877201e-08
of O 0 4.451291601981211e-08
APC O 0 4.3985934894408274e-08
that O 0 1.2957331605237266e-12
was O 0 5.415423318111401e-11
not O 0 2.865482645001555e-14
present O 0 6.55982158783569e-13
in O 0 5.349590670618298e-13
controls O 0 6.476037761604658e-11
; O 0 5.170730380324451e-13
one O 0 2.9274117309928405e-13
of O 0 3.513485726316934e-12
these O 0 1.2132273809715988e-13
individuals O 0 4.2441836042806866e-14
had O 0 2.8161735096676743e-12
an O 0 2.0455463494925552e-13
unusually O 0 2.630396421510195e-11
large O 0 1.0789274204961452e-12
number O 0 2.522437770810515e-12
of O 0 5.247880463521426e-10
metaplastic B-Disease 0 2.001459324674215e-05
polyps I-Disease 0 4.611665005427312e-08
of I-Disease 0 5.1863664474183224e-09
the I-Disease 0 1.593696286050772e-09
colorectum I-Disease 0 1.736877311486751e-05
. O 0 2.821274325270906e-09

There O 0 1.8247359179213163e-10
is O 0 5.009235756227304e-13
increasing O 0 3.4776191258287237e-14
evidence O 0 3.5156038236811016e-12
that O 0 2.266215898071673e-15
there O 0 1.1990099498925943e-14
exist O 0 9.080489723860274e-13
germ O 0 1.9582106602911153e-08
- O 0 5.188600660233078e-10
line O 0 6.56092957740384e-11
variants O 0 2.8653284606106055e-11
of O 0 1.0383457288432041e-10
the O 0 6.380392741922591e-11
APC B-Disease 0 9.896777442008897e-08
gene O 0 1.5943735220957933e-10
that O 0 1.2052793658956507e-13
predispose O 0 1.873416699549324e-11
to O 0 1.246786202925565e-12
the O 0 7.086208356210655e-12
development O 0 6.257688811572848e-11
of O 0 1.5934834562969513e-09
multiple O 1 0.9999990463256836
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.8564028143882751
carcinoma I-Disease 1 1.0
, O 0 3.9639982962746956e-10
but O 0 5.48551655488172e-13
without O 0 2.9446781384806497e-12
the O 0 1.4755750440964555e-11
florid O 0 2.598397053077406e-08
phenotype O 0 1.0793133747855066e-10
of O 0 3.594765318748472e-10
classical O 0 2.0749602924752253e-08
FAP B-Disease 0 1.2716444075522304e-07
, O 0 1.3958123936189115e-12
and O 0 2.414973331987119e-13
possibly O 0 6.571019769974207e-12
with O 0 2.7833199070168013e-13
importance O 0 5.985319351253793e-09
for O 0 0.006935465149581432
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 1.7248004413605855e-10
in O 0 1.0463348937284067e-12
the O 0 5.834058821978239e-13
general O 0 1.2349406436698573e-12
population O 0 1.626742974707e-15
. O 0 1.7859676140329767e-14
. O 0 2.37725702838254e-12

Genomic O 0 3.2099631397386474e-08
structure O 0 1.7487179482245097e-09
of O 0 3.479784460580504e-09
the O 0 9.599799843940104e-10
human O 0 0.29226136207580566
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 1.9575539056404523e-07
CLD B-Disease 1 1.0
) O 0 1.2400780402543887e-10
gene O 0 6.68130717418336e-10
. O 0 7.818210662202674e-11

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999885559082031
CLD B-Disease 1 1.0
) O 0 5.9115614625682156e-09
is O 0 2.9111543904669634e-12
caused O 0 2.9872787576934456e-10
by O 0 8.423720922190459e-12
mutations O 0 1.0793772126094225e-10
in O 0 1.1198551634616916e-11
a O 0 2.5832901356243054e-12
gene O 0 3.2540513252715675e-12
which O 0 2.0544456164495878e-13
encodes O 0 1.6238717185160234e-12
an O 0 4.925426928294174e-13
intestinal O 0 2.3493150536069152e-08
anion O 0 2.5861830454942947e-09
transporter O 0 3.161504764648271e-06
. O 0 1.8672969837041364e-09

We O 0 8.145815133531187e-10
report O 0 3.633386300161412e-11
here O 0 1.6829969492690444e-12
the O 0 2.4902641255521163e-13
complete O 0 8.600092860078234e-12
genomic O 0 9.897594549501676e-11
organization O 0 6.773095279077879e-11
of O 0 6.60177607025858e-11
the O 0 3.39348410482998e-11
human O 0 2.1604565358934735e-10
CLD B-Disease 1 0.9995961785316467
gene O 0 3.3046537728509406e-11
which O 0 4.385999213558228e-13
spans O 0 8.011984131695016e-11
approximately O 0 3.969608496079413e-12
39kb O 0 2.7195154572723368e-08
, O 0 8.361515473065406e-12
and O 0 2.241254057344655e-11
comprises O 0 1.7439480970438126e-09
21 O 0 1.693326545648688e-08
exons O 0 5.179232331897765e-08
. O 0 2.276232813347434e-10

All O 0 2.2575823876991308e-08
exon O 0 9.013419912662357e-07
/ O 0 2.9744873586423637e-07
intron O 0 1.0192702148970056e-07
boundaries O 0 1.6944305958332961e-09
conform O 0 1.22653864842448e-09
to O 0 2.116826505749181e-11
the O 0 3.75616066028428e-10
GT O 0 0.00033855182118713856
/ O 0 1.816089752537664e-05
AG O 1 1.0
rule O 0 1.5490610394408577e-07
. O 0 2.6315882806215996e-09

An O 0 3.2827726648143596e-11
analysis O 0 2.3383810512922487e-11
of O 0 1.8283452529743727e-10
the O 0 2.3175076441228626e-11
putative O 0 1.076196021188025e-08
promoter O 0 1.4993000149843283e-05
region O 0 1.4982989293699234e-09
sequence O 0 5.633780941760591e-11
shows O 0 3.0094492869947587e-11
a O 0 1.8131334975080016e-11
putative O 0 3.757862643283261e-08
TATA O 1 0.9970779418945312
box O 0 1.7364517646001332e-07
and O 0 4.696833200146244e-11
predicts O 0 3.630319378444824e-10
multiple O 0 2.3157446446542274e-11
transcription O 0 5.8635327704337215e-09
factor O 0 8.581352989311952e-11
binding O 0 5.293096516645335e-10
sites O 0 2.2973136726278653e-09
. O 0 2.2984258940539348e-10

The O 0 2.865429671317088e-09
genomic O 0 2.7264317470354626e-09
structure O 0 6.529696783275085e-10
was O 0 5.8044628131748155e-11
determined O 0 9.694658270609224e-13
using O 0 1.880833271246385e-13
DNA O 0 4.797435781966897e-10
from O 0 2.171218662760238e-13
several O 0 4.9954344046726495e-15
sources O 0 7.380833682950338e-14
including O 0 4.1438773528031103e-13
multiple O 0 1.0502743640061762e-11
large O 0 1.3327106085370133e-10
- O 0 8.97033984870177e-08
insert O 0 2.2427029122695785e-08
libaries O 0 1.7685636066744337e-07
and O 0 1.1989660132771807e-11
genomic O 0 4.026214917018933e-10
DNA O 0 2.535244192358732e-08
from O 0 9.55666171198466e-11
Finnish O 0 0.0035982360132038593
CLD B-Disease 1 1.0
patients O 0 4.315720225633868e-09
and O 0 4.309326784301959e-10
controls O 0 4.4786884245695546e-07
. O 0 3.035886209090677e-09

Exon O 0 1.8903886029875139e-06
- O 0 1.003693483880852e-08
specific O 0 2.4063407516594637e-11
primers O 0 3.6672760383993364e-09
developed O 0 1.0103304304287519e-10
in O 0 2.026664697608177e-13
this O 0 2.3520730634295e-15
study O 0 2.6990848859859314e-14
will O 0 1.4983229331452363e-15
facilitate O 0 3.863034024609302e-13
mutation O 0 1.2852028198184068e-13
screening O 0 8.461752349156471e-13
studies O 0 2.1267678644663196e-13
of O 0 3.4049581730533074e-12
patients O 0 1.8655673793971372e-12
with O 0 2.061464931049639e-12
the O 0 7.217073516585515e-08
disease O 0 0.14960069954395294
. O 0 1.0519870391467734e-10

Genomic O 0 7.60260743248864e-09
sequencing O 0 8.440197984960207e-10
of O 0 1.792418546919805e-09
a O 0 5.278699144461996e-10
BAC O 1 0.999997615814209
clone O 0 1.2821713426092174e-05
H O 1 1.0
_ O 0 8.771112725014518e-10
RG364P16 O 0 2.5550599858092937e-08
revealed O 0 1.4227766187424606e-10
the O 0 3.868876139595523e-12
presence O 0 1.1883197334125462e-12
of O 0 3.6773445399873594e-11
another O 0 1.34530776275954e-12
, O 0 3.5022099153028674e-13
highly O 0 1.0872095758396316e-11
homologous O 0 1.1226031389199864e-11
gene O 0 1.1874502249542562e-11
3 O 0 1.4208997867193318e-10
of O 0 7.00346863835577e-11
the O 0 2.0995052918415524e-10
CLD B-Disease 1 0.9999996423721313
gene O 0 4.4782311192648194e-10
, O 0 1.4414475472609989e-12
with O 0 3.941959199381742e-14
a O 0 1.1329680276632795e-13
similar O 0 4.933945504763393e-13
genomic O 0 7.672083801590901e-11
structure O 0 1.6187985674154248e-10
, O 0 1.8057953136280114e-12
recently O 0 3.975526071536839e-12
identified O 0 3.4167922397659867e-12
as O 0 9.105204654483168e-13
the O 0 4.805027487009284e-10
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 3.742789189686846e-09
( O 0 4.19188087019684e-11
PDS B-Disease 0 1.6991140000754967e-05
) O 0 9.234053625906125e-12
. O 0 1.4188185131977504e-12
. O 0 1.850849161433299e-11

The O 0 2.3010497329778445e-07
APCI1307K O 1 1.0
allele O 0 1.3165524670455397e-08
and O 0 2.4431561218563047e-09
cancer B-Disease 0 9.434197068003414e-07
risk O 0 6.016995929281066e-11
in O 0 5.303824220093123e-12
a O 0 7.49970398283839e-12
community O 0 1.1248553087248037e-12
- O 0 4.894490021611908e-11
based O 0 4.251544862693413e-12
study O 0 1.1492704574470047e-12
of O 0 5.177661251132282e-12
Ashkenazi O 0 5.595939711611209e-09
Jews O 0 1.8984616101391794e-09
. O 0 2.84290174734636e-10

Mutations O 0 2.173895552459726e-07
in O 0 7.143336588910643e-09
APC O 0 1.298073016187118e-06
are O 0 1.2499321890013793e-11
classically O 0 1.5592388535878854e-06
associated O 0 8.391888428604943e-08
with O 0 2.621793555590557e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 3.4926102898680256e-07
FAP B-Disease 0 0.0121584702283144
) O 0 2.350805383688481e-10
, O 0 3.315479618279382e-12
a O 0 7.500476802146938e-12
highly O 1 0.57291179895401
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9562253355979919
by O 0 1.4881483823003805e-09
multiple O 0 0.018257131800055504
intestinal O 1 0.9999998807907104
polyps B-Disease 0 6.1533924053946976e-06
and O 0 1.6254629586764935e-10
, O 0 2.5534812979344235e-12
without O 0 5.111955130032708e-12
surgical O 0 0.008614114485681057
intervention O 0 5.151184367946371e-08
, O 0 4.7726609990472735e-12
the O 0 5.6411117096977215e-12
development O 0 4.6314496682242634e-10
of O 0 1.4909972378518432e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.2196613718984395e-09
CRC B-Disease 1 0.9999997615814209
) O 0 2.955257566439329e-11
. O 0 4.7007227971240795e-11

APC B-Disease 0 6.28682755632326e-05
is O 0 3.1543905265607464e-09
a O 0 5.78987024990596e-10
tumour O 1 1.0
- O 0 1.1596243609801604e-07
suppressor O 0 7.912460020520484e-09
gene O 0 3.222927480450721e-11
, O 0 5.909238484820556e-13
and O 0 4.189960010891891e-12
somatic O 0 1.2005991720798193e-06
loss O 0 1.2284401691431412e-06
occurs O 0 8.106106896832443e-10
in O 0 1.1956422518721865e-09
tumours B-Disease 1 1.0
. O 0 6.103555438841113e-09

The O 0 6.299600130432736e-08
germline O 0 8.524843906343449e-07
T O 0 6.88052659825189e-06
- O 0 1.4811086801458373e-09
to O 0 3.550164936333422e-12
- O 0 2.6698948607517536e-10
A O 0 5.372350342369714e-10
transversion O 0 8.295018005810562e-09
responsible O 0 1.1445159403544736e-10
for O 0 1.0657536051589256e-12
the O 0 5.984536477487978e-11
APC O 0 2.9221361330655782e-08
I1307K O 0 1.7960024578655975e-08
allele O 0 2.791924460718298e-12
converts O 0 7.848252429887292e-12
the O 0 2.6497617034576537e-12
wild O 0 1.3785289576517812e-10
- O 0 5.705019789914445e-11
type O 0 3.730640449339795e-11
sequence O 0 7.134049752853533e-13
to O 0 1.1465898759957516e-13
a O 0 6.9725427688516195e-12
homopolymer O 0 4.201462616038043e-06
tract O 0 6.296119863691274e-06
( O 0 1.5929183527774171e-09
A8 O 0 0.00044823906500823796
) O 0 1.0312851267402223e-11
that O 0 2.44976809020761e-13
is O 0 2.8288571572027132e-12
genetically O 0 9.44025487115141e-07
unstable O 0 1.221404363604961e-05
and O 0 2.576760493866459e-08
prone O 0 3.021319025720004e-05
to O 0 4.1834480324354217e-10
somatic O 0 5.290559056447819e-05
mutation O 0 2.7447422112913955e-08
. O 0 7.901446164026993e-10

The O 0 4.2399811661653075e-08
I1307K O 0 6.664232046205143e-07
allele O 0 3.2321875731433636e-10
was O 0 4.752762072790517e-10
found O 0 1.1184975688693921e-11
in O 0 9.7721344904933e-12
6 O 0 1.6641543254536373e-08
. O 0 2.5296192918133897e-10

1 O 0 3.072763732347994e-08
% O 0 1.223245636727821e-11
of O 0 4.8862632689994356e-11
unselected O 0 1.4152395806377172e-06
Ashkenazi O 0 3.6558940763598e-08
Jews O 0 1.0220883028821959e-09
and O 0 6.01396710209201e-11
higher O 0 1.9440372922563398e-10
proportions O 0 3.665693582011187e-10
of O 0 1.4042179641293728e-09
Ashkenazim O 0 6.924302198285659e-08
with O 0 8.442573029565636e-12
family O 0 3.3560717139363705e-12
or O 0 7.257270305538466e-12
personal O 0 5.94018834121357e-10
histories O 0 4.021805821707858e-08
of O 0 9.498955364506401e-07
CRC B-Disease 1 0.9999929666519165
( O 0 1.644956115764984e-10
ref O 0 5.135243341669593e-08
. O 0 7.441880445213656e-12
2 O 0 6.864581680865456e-10
) O 0 2.021473049715339e-12
. O 0 1.3091883480087496e-11

To O 0 2.87506352059097e-10
evaluate O 0 5.935027136416693e-09
the O 0 1.9006052287551256e-10
role O 0 7.047285671690773e-11
of O 0 5.691719318079436e-10
I1307K O 0 4.135738862487415e-08
in O 0 1.4415425797498216e-10
cancer B-Disease 0 1.593994980453317e-08
, O 0 2.6758775317076156e-12
we O 0 7.045463930148432e-13
genotyped O 0 4.5289848316087955e-08
5 O 0 3.101472856315013e-09
, O 0 2.7059705171028625e-11
081 O 0 4.1653811422293074e-06
Ashkenazi O 0 3.121319380738896e-08
volunteers O 0 4.3279840822307847e-10
in O 0 9.922370217130272e-12
a O 0 4.30205437246256e-12
community O 0 5.8584708265141394e-12
survey O 0 2.5884516752228137e-10
. O 0 1.935941268405017e-10

Risk O 0 4.6284876020763477e-07
of O 0 2.259655957459472e-06
developing O 1 0.9963244795799255
colorectal B-Disease 1 1.0
, I-Disease 0 2.4278398313981597e-07
breast I-Disease 0 0.0011251844698563218
and I-Disease 0 1.7378715133631317e-09
other I-Disease 0 2.5701718531223605e-09
cancers I-Disease 1 0.9992759823799133
were O 0 1.4406079107409653e-10
compared O 0 2.2148215553241535e-11
between O 0 1.5994958829645967e-11
genotyped O 0 1.711896260303547e-07
I1307K O 0 4.338747583432223e-09
carriers O 0 1.1417218082412917e-12
and O 0 1.2533598291175618e-12
non O 0 1.4449593743748324e-09
- O 0 5.6350282079398184e-11
carriers O 0 2.9402429926536633e-13
and O 0 3.5539502113782206e-13
their O 0 2.2433174296041664e-13
first O 0 3.451053245256963e-12
- O 0 8.903877635191293e-12
degree O 0 9.378310628083142e-11
relatives O 0 1.1582103331964078e-10
. O 0 1.3991777181310283e-10

Sperm O 0 1.0798966165737056e-09
DNA O 0 4.460654956517374e-09
analysis O 0 2.254140233845514e-12
in O 0 3.1163637208980743e-12
a O 0 1.918276093526572e-10
Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
premutation O 1 0.9999629259109497
carrier O 0 1.8318645800263766e-07
suggests O 0 2.1557529095161954e-09
both O 0 3.7066880814728975e-11
meiotic O 0 1.357209242769386e-07
and O 0 1.164154883603885e-10
mitotic O 0 2.1120536430885295e-09
expansion O 0 8.044052091094045e-10
in O 0 5.459583826694647e-11
the O 0 6.696437848674464e-10
FRDA B-Disease 1 0.999901533126831
gene O 0 6.900738647175331e-09
. O 0 1.5877608949832478e-10

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 3.603683751407516e-07
usually O 0 5.496263000281942e-09
caused O 0 2.3662181103389912e-09
by O 0 2.855272225252281e-12
an O 0 7.410329403052807e-14
expansion O 0 1.8656227951385773e-10
of O 0 1.6133068214685409e-09
a O 0 2.2447763092792172e-10
GAA O 0 0.000558411527890712
trinucleotide O 0 1.0319793091184692e-06
repeat O 0 5.21441501089015e-10
in O 0 4.226224925574229e-11
intron O 0 8.62816929014798e-09
1 O 0 1.17542497957146e-09
of O 0 5.763173827055823e-10
the O 0 2.0211166074091125e-10
FRDA B-Disease 1 0.9999998807907104
gene O 0 6.028030075100332e-09
. O 0 1.1213583533953297e-10

Occasionally O 0 1.8870404971949029e-07
, O 0 1.5517409579501873e-10
a O 0 4.7829127811094274e-12
fully O 0 6.767233301507858e-11
expanded O 0 6.414228176376824e-11
allele O 0 1.4266936156775989e-12
has O 0 1.6516366589279172e-14
been O 0 5.0474429052604214e-14
found O 0 1.4856552674278461e-13
to O 0 4.521720386898957e-14
arise O 0 5.078252054979693e-12
from O 0 2.505684722209356e-11
a O 0 6.136288092234432e-12
premutation O 0 4.614929594026762e-08
of O 0 1.5310971379633997e-09
100 O 0 1.1915869679857138e-10
or O 0 7.980105291849338e-12
less O 0 2.8195392201557645e-11
triplet O 0 5.412214250100078e-07
repeats O 0 6.879530189962679e-08
. O 0 2.3350406053168626e-09

We O 0 1.4352222743596599e-09
have O 0 6.28966767991096e-13
examined O 0 7.735771467842767e-10
the O 0 6.884452643379779e-12
sperm O 0 4.111599949396805e-12
DNA O 0 5.344207298918491e-09
of O 0 8.234492948622218e-11
a O 0 4.938432648926572e-11
premutation O 0 1.110010884985968e-06
carrier O 0 2.1866386035185315e-08
. O 0 2.002289445357519e-09

This O 0 5.837484939874571e-10
mans O 0 2.6346262416154786e-07
leucocyte O 0 2.2698502561979694e-06
DNA O 0 2.0614383799966163e-07
showed O 0 1.525909815169868e-10
one O 0 4.427419260204235e-13
normal O 0 1.87366684667456e-11
allele O 0 6.625370824880905e-13
and O 0 7.38387920685285e-13
one O 0 1.7379474866619643e-13
allele O 0 2.639339484813985e-13
of O 0 4.588317573106515e-12
approximately O 0 2.0318443108569006e-12
100 O 0 1.8030608950336813e-10
repeats O 0 7.694186399120895e-10
. O 0 1.9211028601251456e-10

His O 0 8.138632523468914e-08
sperm O 0 3.5965208589061604e-10
showed O 0 6.238465993790854e-11
an O 0 3.311103290420253e-14
expanded O 0 6.532555746341373e-12
allele O 0 1.1745022272455219e-12
in O 0 3.720462739970065e-12
a O 0 1.560129803124255e-11
tight O 0 2.14809814380601e-09
range O 0 4.786725682492943e-09
centering O 0 5.25132692885677e-09
on O 0 5.413636552931145e-11
a O 0 2.521248455237407e-13
size O 0 4.3940374884650357e-13
of O 0 5.010549614103965e-11
approximately O 0 3.1614707379779006e-11
320 O 0 1.0294903596275162e-08
trinucleotide O 0 8.671133400639519e-06
repeats O 0 1.2262731274859107e-07
. O 0 5.801800817550884e-09

His O 0 4.7549070814056904e-07
affected O 0 1.0772828318295069e-07
son O 0 1.1772496009143651e-06
has O 0 1.4458974382375311e-12
repeat O 0 2.8925918951760998e-11
sizes O 0 8.68770888562409e-11
of O 0 3.5865623804198776e-09
1040 O 0 2.8265217721923364e-08
and O 0 3.885504140654916e-10
540 O 0 1.7371599270177285e-08
. O 0 2.548098121391007e-10

These O 0 5.530982269408291e-11
data O 0 1.1818448997225062e-10
suggest O 0 2.7509314270979246e-12
that O 0 5.73586402035026e-15
expansion O 0 3.4373497971584843e-12
occurs O 0 3.137145762350385e-13
in O 0 5.583110606862188e-14
two O 0 5.11048722871138e-14
stages O 0 1.2098716473118998e-10
, O 0 2.226131605442827e-13
the O 0 6.064482683393324e-13
first O 0 1.3376701005554659e-12
during O 0 6.010432603009708e-12
meiosis O 0 4.839682127277811e-11
followed O 0 5.1957756673493005e-12
by O 0 1.5469304439838516e-13
a O 0 1.2568692831296802e-12
second O 0 3.697952707937269e-11
mitotic O 0 3.531900993891668e-09
expansion O 0 8.143659968595784e-09
. O 0 9.119974775373407e-10

We O 0 5.280995640788433e-10
also O 0 4.7408700229456535e-12
show O 0 2.726999832544652e-12
that O 0 4.692525681855618e-15
in O 0 1.0918115099078224e-13
all O 0 3.3105601728944736e-14
informative O 0 4.464512960711264e-12
carrier O 0 9.832036226842256e-12
father O 0 9.351713153860075e-11
to O 0 1.7623902554345094e-12
affected O 0 3.905660517222742e-11
child O 0 6.02149718975653e-11
transmissions O 0 2.6433485955656977e-10
, O 0 3.3845344062088945e-13
with O 0 1.8609988089402993e-14
the O 0 5.751229028606863e-13
notable O 0 4.514331616856104e-12
exception O 0 1.3817134068838666e-11
of O 0 5.395617286296783e-11
the O 0 1.8020253692019317e-11
premutation O 0 3.206450926995785e-08
carrier O 0 1.5623938254272218e-10
, O 0 1.962693896295775e-12
the O 0 9.413371774777413e-13
expansion O 0 4.351918998779514e-12
size O 0 3.858463028250103e-12
decreases O 0 6.429833748766711e-11
. O 0 6.528881168338385e-12
. O 0 6.211478553730387e-11

The O 0 8.766822645611683e-08
R496H O 0 2.129831500496948e-06
mutation O 0 3.408134219284875e-09
of O 0 6.658487095023702e-09
arylsulfatase O 0 0.0004262064176145941
A O 0 2.378351609877427e-06
does O 0 1.8869831044932006e-11
not O 0 1.4635140321850315e-11
cause O 0 2.3526847144239582e-05
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 1.305649277583143e-08

Deficiency B-Disease 1 0.9999998807907104
of I-Disease 1 0.8351938128471375
arylsulfatase I-Disease 1 0.9999657869338989
A I-Disease 0 0.17753207683563232
( O 0 1.3822769595606132e-08
ARSA O 1 1.0
) O 0 4.876617512583614e-11
enzyme O 0 1.2219007750058353e-10
activity O 0 2.8017013153913695e-09
causes O 0 2.61869473661136e-07
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 2.4147491117787467e-08
MLD B-Disease 1 1.0
) O 0 1.5648035645021707e-10
. O 0 7.341559998819136e-11

A O 0 8.379604565789123e-08
number O 0 3.534168097063528e-11
of O 0 3.9047702848904464e-09
ARSA O 1 1.0
gene O 0 2.8309731447961894e-08
mutations O 0 4.839333933581713e-10
responsible O 0 8.160234266085808e-09
for O 0 2.289667344612667e-09
MLD B-Disease 1 1.0
have O 0 3.292743508409579e-11
been O 0 5.799479819990072e-12
identified O 0 3.640607607047208e-11
. O 0 6.107053751591707e-11

Recently O 0 1.0251348925294224e-07
, O 0 1.0321789950529237e-10
the O 0 4.7371932765383207e-11
R496H O 0 5.835909888673996e-08
mutation O 0 6.41191988393075e-10
of O 0 1.177209352221098e-08
ARSA O 1 0.9999626874923706
was O 0 9.671627942964278e-09
proposed O 0 5.434638503110101e-11
to O 0 4.9071445691606375e-12
be O 0 9.220567018242143e-13
a O 0 1.3879443601372277e-11
cause O 0 3.1296876201736268e-09
of O 0 1.690200548409848e-07
MLD B-Disease 1 1.0
( O 0 8.007695062595133e-10
Draghia O 0 1.180992057925323e-06
et O 0 6.256539819560203e-08
al O 0 2.5403556591641063e-08
. O 0 3.699720109266724e-13
, O 0 3.9139861057052583e-13
1997 O 0 6.106937872063511e-11
) O 0 1.508591212021071e-12
. O 0 2.174358089412909e-11

We O 0 1.720930287163469e-09
have O 0 1.1280287684836687e-12
investigated O 0 1.3361014516988234e-09
the O 0 2.417603894855347e-10
R496H O 0 1.587965492433341e-08
mutation O 0 2.420895948984647e-12
and O 0 5.422694628401392e-13
found O 0 2.574562741816666e-13
this O 0 3.5171277071039796e-15
mutation O 0 1.5451463893090267e-13
at O 0 6.2572798505133864e-12
a O 0 4.6830320518794974e-14
relatively O 0 1.1168229020622547e-13
high O 0 1.6852808211453851e-12
frequency O 0 3.9392856923496644e-13
in O 0 3.5790364134825545e-14
an O 0 1.0356555802564556e-14
African O 0 1.810312018563423e-13
American O 0 1.5773988289603108e-13
population O 0 8.482160140535982e-17
( O 0 1.847283354996826e-15
f O 0 2.666346483881643e-11
= O 0 4.609562731516803e-12
0 O 0 4.3143886900576245e-12
. O 0 4.9312713201049574e-14
09 O 0 8.996303008101947e-11
, O 0 1.7730910869314526e-13
n O 0 6.90635970721637e-13
= O 0 4.7075932561868594e-12
61 O 0 6.15120870905983e-11
subjects O 0 2.2992634185481364e-10
) O 0 2.4469159337625612e-12
. O 0 2.2182628997557963e-11

The O 0 1.6868736452124722e-07
ARSA O 0 0.0016181629616767168
enzyme O 0 1.9581565535720102e-10
activity O 0 3.169343607001274e-11
in O 0 2.619379322818527e-13
subjects O 0 1.6623055362763317e-11
with O 0 2.8060488503102443e-13
and O 0 2.941579488671686e-12
without O 0 6.51901362752616e-12
the O 0 1.1275388608900094e-11
R496H O 0 3.3377809405266134e-09
mutation O 0 2.813048839006571e-12
was O 0 8.945342730437567e-12
determined O 0 2.600052551732235e-12
and O 0 2.6827765269715753e-12
found O 0 4.400715902797003e-12
to O 0 7.833652346592168e-13
be O 0 1.9438424394419007e-12
normal O 0 3.1241289555339335e-09
. O 0 3.0600805223102157e-10

It O 0 8.616027891150679e-10
is O 0 2.1211743299331953e-12
therefore O 0 2.0964900822317833e-12
concluded O 0 6.529457530213278e-11
that O 0 2.1503716911503226e-14
the O 0 1.4103438469165175e-12
R496H O 0 4.896978822443998e-09
mutation O 0 2.4992934805068145e-11
of O 0 8.435160903097483e-10
ARSA O 1 0.8842390775680542
does O 0 4.448956827940442e-12
not O 0 1.4374603124565205e-13
negatively O 0 4.947631714047329e-12
influence O 0 2.0747356957451224e-11
the O 0 1.0421050307407587e-11
activity O 0 9.779560494749262e-11
of O 0 5.004688330423335e-10
ARSA O 0 0.043523941189050674
and O 0 5.215805218283798e-11
is O 0 1.2222719310197444e-13
not O 0 3.3996595686161535e-14
a O 0 4.71370295226925e-12
cause O 0 1.3634942064300049e-08
of O 0 1.0902472240559291e-06
MLD B-Disease 1 1.0

Down O 0 4.034085577586666e-06
- O 0 2.218207129089933e-08
regulation O 0 1.6056789675644723e-08
of O 0 2.4797566222645173e-09
transmembrane O 0 1.3492902439793397e-07
carbonic O 0 0.00016685422451701015
anhydrases O 0 0.0003118710301350802
in O 0 5.993386764657771e-08
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999997615814209
lines O 0 3.087875199980772e-07
by O 0 8.067017887025685e-11
wild O 0 4.227198928674625e-07
- O 0 1.359889267860126e-08
type O 0 2.9899666742494446e-08
von B-Disease 1 0.9999984502792358
Hippel I-Disease 1 1.0
- I-Disease 0 0.4764091372489929
Lindau I-Disease 1 0.9950962662696838
transgenes O 0 4.669465124607086e-05
. O 0 4.045731749613424e-09

To O 0 1.3619807504028358e-09
discover O 0 2.366532803055321e-10
genes O 0 9.074555343269175e-12
involved O 0 1.6563491897492177e-11
in O 0 2.855409832192013e-11
von B-Disease 1 0.9976202845573425
Hippel I-Disease 1 0.9999998807907104
- I-Disease 1 0.7784538269042969
Lindau I-Disease 1 0.9999464750289917
( O 0 1.9157990749363307e-08
VHL B-Disease 1 1.0
) O 0 1.630194867985324e-10
- O 0 4.781405493758939e-09
mediated O 0 5.807594405382588e-08
carcinogenesis O 0 0.009288649074733257
, O 0 4.3589326592652355e-11
we O 0 4.186147413952346e-13
used O 0 1.576695218830082e-09
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999951124191284
lines O 0 1.0051945537270512e-05
stably O 0 5.164621597941732e-06
transfected O 0 8.181963551123772e-08
with O 0 1.7638841776079772e-11
wild O 0 1.3733674109062122e-07
- O 0 9.34855179934857e-08
type O 0 1.1644311825875775e-06
VHL O 1 1.0
- O 0 2.134295726818891e-07
expressing O 0 5.216397092056013e-09
transgenes O 0 3.844080765702529e-06
. O 0 2.763842044117837e-09

Large O 0 7.902049570240877e-10
- O 0 1.450750519715882e-09
scale O 0 1.5048489121483044e-09
RNA O 0 3.15982656706737e-10
differential O 0 1.4772927672823677e-11
display O 0 1.7580208122591756e-10
technology O 0 3.7679696168746446e-11
applied O 0 1.579381590788298e-11
to O 0 1.2767102642013278e-13
these O 0 1.7260548730319708e-13
cell O 0 2.5724805619020685e-10
lines O 0 1.3199145769415832e-11
identified O 0 6.284763291383721e-13
several O 0 1.2330994515405425e-13
differentially O 0 1.8528316381161147e-10
expressed O 0 7.664162815675113e-13
genes O 0 5.985226962483547e-13
, O 0 1.0840589900361006e-13
including O 0 9.48427209164493e-13
an O 0 1.8786389815745458e-13
alpha O 0 9.518175136946638e-10
carbonic O 0 2.117478459240374e-07
anhydrase O 0 2.5214098968717735e-06
gene O 0 3.589642139090188e-09
, O 0 8.700311304732367e-11
termed O 0 8.13253166143113e-07
CA12 O 1 0.9999998807907104
. O 0 1.1325128390637929e-08

The O 0 1.756768952532184e-08
deduced O 0 8.96978846753882e-09
protein O 0 6.047489176097542e-10
sequence O 0 6.263312785081965e-11
was O 0 4.964213762281844e-11
classified O 0 7.852314631850987e-11
as O 0 4.997766957226535e-12
a O 0 4.229811379624637e-12
one O 0 9.129572965671517e-12
- O 0 1.0224709967587842e-08
pass O 0 2.9123432554456485e-08
transmembrane O 0 7.445145229212358e-07
CA O 0 0.00014152184303384274
possessing O 0 4.4279630628807354e-07
an O 0 2.5900209060791823e-11
apparently O 0 2.0772232545152036e-10
intact O 0 1.5225207761204729e-09
catalytic O 0 8.180754407227653e-10
domain O 0 1.9009388507740255e-10
in O 0 5.161611416060197e-11
the O 0 2.2674320754312305e-10
extracellular O 0 8.936322615227255e-08
CA O 0 6.641279469477013e-05
module O 0 3.641106616214529e-07
. O 0 3.883164900742031e-09

Reintroduced O 0 8.86928035015444e-07
wild O 0 6.359776989484089e-07
- O 0 1.0250547433088286e-07
type O 0 2.181919001031929e-07
VHL B-Disease 1 0.9990019202232361
strongly O 0 3.1160873881219686e-10
inhibited O 0 2.417336331106412e-10
the O 0 1.3303682808163408e-11
overexpression O 0 4.30829122377574e-10
of O 0 4.914155193880276e-10
the O 0 6.892220821841377e-11
CA12 O 1 0.6598604321479797
gene O 0 9.534571916713919e-12
in O 0 6.761394829440937e-13
the O 0 1.3638094126244837e-11
parental O 0 5.390481305767025e-07
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999997615814209
lines O 0 3.4376113035250455e-05
. O 0 4.298370104294236e-09

Similar O 0 6.401511765119494e-09
results O 0 5.349283238587077e-10
were O 0 2.7644032896123605e-11
obtained O 0 2.4393169775760448e-11
with O 0 4.707539479759104e-12
CA9 O 1 0.9507299661636353
, O 0 7.143029917555666e-11
encoding O 0 7.12971834349041e-11
another O 0 1.964579610103101e-10
transmembrane O 0 1.4071605392018682e-07
CA O 0 1.7465008568251505e-05
with O 0 2.276492189201562e-11
an O 0 1.2725584475070661e-12
intact O 0 3.167195616882168e-09
catalytic O 0 4.912273698920444e-09
domain O 0 2.364476836547169e-09
. O 0 1.0595444660532749e-10

Although O 0 1.3567148515747363e-09
both O 0 1.1767809816876085e-11
domains O 0 1.3621490047022178e-10
of O 0 1.3380830887754769e-09
the O 0 9.645150234049993e-10
VHL B-Disease 0 0.0013705035671591759
protein O 0 1.1718630232859795e-10
contribute O 0 2.343925834674687e-12
to O 0 1.9537895606935862e-12
regulation O 0 5.969176264386533e-09
of O 0 6.084202919254267e-09
CA12 O 1 0.9999961853027344
expression O 0 2.0293676461502486e-10
, O 0 2.5354902639246335e-12
the O 0 2.11355759283105e-12
elongin O 0 1.229790846934975e-08
binding O 0 3.477645948990471e-10
domain O 0 1.4300596817840017e-10
alone O 0 6.685366669978432e-12
could O 0 1.3494298994193299e-12
effectively O 0 5.784461243329986e-10
regulate O 0 1.1444519998349278e-07
CA9 O 1 0.9937276840209961
expression O 0 1.6484252185478e-08
. O 0 1.065080468265478e-09

We O 0 1.537462779310772e-08
mapped O 0 9.39868982641201e-07
CA12 O 1 0.9999887943267822
and O 0 2.2286734235876793e-08
CA9 O 1 0.9985931515693665
loci O 0 2.1615871315106006e-09
to O 0 6.768472587959096e-11
chromosome O 0 4.969638034424406e-09
bands O 0 3.428845047892537e-07
15q22 O 0 3.4869256637648505e-07
and O 0 4.549802756770305e-10
17q21 O 0 8.136604492392507e-07
. O 0 1.2853329511841594e-09

2 O 0 1.5226994776185165e-07
respectively O 0 1.121476467247362e-09
, O 0 2.076489501179335e-11
regions O 0 3.199946696508249e-10
prone O 0 2.2596293547394453e-07
to O 0 5.5480352950665335e-11
amplification O 0 6.666559215773304e-08
in O 0 4.900412367558893e-11
some O 0 1.2226788158320456e-11
human O 0 3.506949841636242e-09
cancers B-Disease 0 0.010354348458349705
. O 0 1.6549826786782518e-10

Additional O 0 1.270483718229798e-10
experiments O 0 4.38152625292787e-09
are O 0 2.2612094759556084e-13
needed O 0 3.548993781146703e-12
to O 0 3.593662910653106e-13
define O 0 1.2374736652054352e-11
the O 0 4.659106433990701e-12
role O 0 1.9593210734414335e-11
of O 0 1.6277568182232471e-09
CA O 0 3.3018193335010437e-06
IX O 1 0.9999995231628418
and O 0 8.628218139961064e-09
CA O 0 4.783342774317134e-06
XII O 1 0.9999808073043823
enzymes O 0 1.9962319991462252e-11
in O 0 3.6247667194178046e-12
the O 0 8.318688619890491e-13
regulation O 0 6.310378608542777e-11
of O 0 2.1628797711170655e-11
pH O 0 5.966494659448429e-11
in O 0 2.7845588248393005e-12
the O 0 8.293186450070156e-12
extracellular O 0 2.2087520701319363e-10
microenvironment O 0 3.930234804272459e-09
and O 0 1.0583623387405705e-11
its O 0 2.8243822211559966e-12
potential O 0 4.67459491254596e-12
impact O 0 1.2869568744022786e-09
on O 0 5.3082164441775603e-08
cancer B-Disease 0 1.0382318578194827e-06
cell O 0 1.1948859679478119e-08
growth O 0 1.2858422659967061e-10
. O 0 4.3859870596518746e-11

A O 0 4.0728750150265114e-07
gene O 0 1.594577109242934e-10
encoding O 0 2.4774942514182996e-11
a O 0 1.4279031082531368e-11
transmembrane O 0 2.749844574267968e-09
protein O 0 1.7330553658823078e-09
is O 0 7.735832916085095e-13
mutated O 0 1.826120851755597e-11
in O 0 1.3153600387713626e-12
patients O 0 1.6625315013563124e-10
with O 0 8.239312165869705e-08
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.5917525887489319
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 1.1224298400447363e-11
. O 0 9.41650143276851e-12

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 3.699493618114502e-06
WFS B-Disease 1 1.0
; O 0 6.699509924601443e-08
OMIM O 1 1.0
222300 O 0 0.0005354579188860953
) O 0 1.8433662582473254e-11
is O 0 3.408588786658201e-13
an O 0 2.2158485116219317e-11
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 0 2.5779844037288058e-08
by O 0 7.680502761564512e-11
young O 0 1.2663569082249637e-09
- O 0 6.839298549721207e-08
onset O 1 0.9883161187171936
non O 1 0.9991372227668762
- O 0 0.06819017231464386
immune O 1 0.9922487735748291
insulin B-Disease 1 1.0
- I-Disease 1 0.9999117851257324
dependent I-Disease 1 0.9999973773956299
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9874556064605713
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
. O 0 5.550464532433352e-09

Linkage O 0 1.3811195458401926e-06
to O 0 4.604110426242869e-10
markers O 0 1.9178280297182937e-08
on O 0 1.603120658444368e-08
chromosome O 0 5.589531681948756e-08
4p O 0 2.4928783659561304e-06
was O 0 3.166283457645136e-09
confirmed O 0 8.298918496851826e-11
in O 0 8.381794390499575e-12
five O 0 6.424803831311943e-12
families O 0 2.5869080098536723e-13
. O 0 5.671451849820208e-11

On O 0 2.003814891793354e-08
the O 0 3.291148256701071e-11
basis O 0 1.1247126840974175e-10
of O 0 3.555800098808959e-10
meiotic O 0 1.3765325093118008e-05
recombinants O 0 0.04106643795967102
and O 0 4.243549156512927e-08
disease O 0 0.01551405806094408
- O 0 3.0708755538455534e-09
associated O 0 1.1327666582516827e-10
haplotypes O 0 9.667786571299075e-10
, O 0 6.070144820818912e-12
the O 0 8.443961502235808e-11
WFS B-Disease 1 0.9986948370933533
gene O 0 8.377679105997515e-10
was O 0 1.3096634887688197e-10
localized O 0 3.1918656606677587e-09
to O 0 3.0552851915111034e-11
a O 0 8.873386470042988e-10
BAC O 1 0.9999697208404541
/ O 0 2.0477402529195388e-07
P1 O 0 9.340348697151057e-06
contig O 0 1.417210114595946e-06
of O 0 5.9359552828652795e-09
less O 0 3.908788223649928e-12
than O 0 4.671188024059358e-13
250 O 0 1.482057393475955e-10
kb O 0 9.782670673530447e-08
. O 0 8.361810688306548e-10

Mutations O 0 4.4778513341725557e-08
in O 0 3.4347907851284276e-10
a O 0 3.034742596108586e-11
novel O 0 1.874654320666025e-10
gene O 0 6.504981275856636e-11
( O 0 2.6801078717442195e-11
WFS1 O 1 0.9266972541809082
) O 0 4.131410057811591e-12
encoding O 0 4.505161868562091e-12
a O 0 4.708347860898909e-12
putative O 0 6.907805993883187e-10
transmembrane O 0 1.3706276114078264e-09
protein O 0 1.050847950323508e-10
were O 0 2.0502747069550686e-11
found O 0 1.0309462701932337e-12
in O 0 2.258795635343841e-13
all O 0 1.4216512895289662e-13
affected O 0 3.721953734797667e-12
individuals O 0 5.059027944286608e-14
in O 0 1.2475670670142325e-11
six O 0 3.4067154652817067e-10
WFS B-Disease 0 6.872779340483248e-05
families O 0 1.6758505390693235e-12
, O 0 1.6270682717811624e-12
and O 0 1.1423251667502798e-12
these O 0 3.6331259723777765e-13
mutations O 0 1.0115465756688202e-11
were O 0 1.6089905449656605e-11
associated O 0 8.981438509580997e-11
with O 0 1.853863070000461e-11
the O 0 2.935772869250286e-08
disease O 0 0.00016900997434277087
phenotype O 0 1.7482910674715413e-09
. O 0 9.528559885563226e-11

WFS1 O 1 0.9999995231628418
appears O 0 3.3228979567923034e-09
to O 0 1.8144057220212395e-12
function O 0 1.0784850660097711e-12
in O 0 1.9443617722825213e-12
survival O 0 5.407303493853988e-10
of O 0 5.4452737457966194e-11
islet O 0 1.3317812408430996e-09
beta O 0 4.760128957670418e-10
- O 0 8.908370152660439e-10
cells O 0 1.8589227379628426e-11
and O 0 2.991393938112097e-11
neurons O 0 1.065543764333654e-09
. O 0 7.36871588052912e-12
. O 0 7.918913441651299e-11

Stable O 0 4.472098567021021e-07
interaction O 0 1.0311602682833154e-09
between O 0 2.128837106596393e-10
the O 0 3.746270654803041e-11
products O 0 5.677472381115933e-10
of O 0 6.638511407253134e-10
the O 0 1.7499648952146174e-10
BRCA1 O 0 3.754601074490438e-09
and O 0 2.7905749933054835e-10
BRCA2 O 0 1.1729196280896304e-08
tumor B-Disease 0 1.9998354083838876e-09
suppressor O 0 2.2263357823959495e-09
genes O 0 6.117741729871895e-12
in O 0 5.74184927035204e-12
mitotic O 0 2.9733986384172795e-09
and O 0 7.737659957207654e-10
meiotic O 0 6.423434570024256e-06
cells O 0 1.7717601608069344e-08
. O 0 1.3772601947792396e-09

BRCA1 O 0 4.960509613738395e-05
and O 0 4.284114396568839e-08
BRCA2 O 0 1.885845435367628e-08
account O 0 3.089058522864896e-12
for O 0 9.754755597030096e-13
most O 0 7.490647099990533e-14
cases O 0 4.864164626638967e-13
of O 0 1.5435722144907515e-11
familial O 0 8.379229532451404e-10
, O 0 5.9896497484057676e-12
early O 0 4.006384113353079e-09
onset O 0 0.00013152802421245724
breast B-Disease 0 9.410415202637523e-08
and I-Disease 0 1.7544451225148805e-08
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 3.034147932901021e-10
encode O 0 1.7057587980984223e-11
products O 0 2.05814337794763e-10
that O 0 2.187437175295813e-14
each O 0 1.3611514530515595e-14
interact O 0 7.864057170216265e-13
with O 0 7.308193980537503e-12
hRAD51 O 0 2.1586036780263385e-07
. O 0 4.272180387232538e-10

Results O 0 5.35375939136884e-08
presented O 0 2.5825517724342717e-08
here O 0 1.36966521457893e-10
show O 0 6.391354112622594e-11
that O 0 4.932270954507989e-13
BRCA1 O 0 4.690159371989466e-09
and O 0 5.668231994881978e-10
BRCA2 O 0 2.3343961430555282e-08
coexist O 0 3.8755415543434424e-10
in O 0 7.169642917553842e-12
a O 0 1.865649345081377e-12
biochemical O 0 2.920368391556849e-09
complex O 0 2.5397451253184045e-08
and O 0 2.484337735531028e-10
colocalize O 0 6.748616669938201e-07
in O 0 2.1407835226749938e-10
subnuclear O 0 1.939184812727035e-07
foci O 0 1.918944114720489e-08
in O 0 6.866512566872096e-12
somatic O 0 9.877199502739131e-09
cells O 0 3.2626477908248575e-11
and O 0 9.398182752862194e-12
on O 0 1.4676602988483722e-10
the O 0 7.206780745089292e-13
axial O 0 1.777127815565105e-12
elements O 0 3.555201619209747e-11
of O 0 2.0110725584832068e-10
developing O 0 4.360048988516496e-10
synaptonemal O 0 7.965435884216276e-07
complexes O 0 1.6605111952117113e-08
. O 0 9.260237021635476e-10

Like O 0 1.172047291220224e-06
BRCA1 O 0 1.0865561534956214e-06
and O 0 6.809062114143671e-08
RAD51 O 1 0.9997575879096985
, O 0 8.582867749851175e-09
BRCA2 O 0 4.6303945566705806e-08
relocates O 0 1.555639350669935e-08
to O 0 4.035548561986957e-10
PCNA O 0 2.620220766402781e-05
+ O 0 2.3404425966710996e-11
replication O 0 2.3249312631340446e-12
sites O 0 6.05709601399218e-13
following O 0 1.321619354753556e-12
exposure O 0 5.695650617809633e-10
of O 0 6.082424564013422e-10
S O 0 1.6945758716246928e-06
phase O 0 3.2244081182852824e-08
cells O 0 5.848582035339334e-11
to O 0 4.2301739368311164e-12
hydroxyurea O 0 1.787322645441236e-08
or O 0 1.1146178424681352e-10
UV O 0 0.021868763491511345
irradiation O 0 4.610644666058761e-08
. O 0 8.568694365163054e-11

Thus O 0 2.820318201202099e-08
, O 0 7.057915918373681e-10
BRCA1 O 0 4.7138177805550185e-09
and O 0 1.7355850090439162e-10
BRCA2 O 0 1.140393779408555e-09
participate O 0 6.486940845595868e-11
, O 0 9.868371744770066e-12
together O 0 6.285433870427404e-13
, O 0 1.9758240182854436e-13
in O 0 1.4901106607304038e-13
a O 0 8.328562991176403e-13
pathway O 0 6.116691354807191e-12
( O 0 5.277442979151337e-13
s O 0 4.7799604552256625e-11
) O 0 8.579212508593934e-14
associated O 0 4.461567400249056e-12
with O 0 2.280810089405616e-13
the O 0 5.368514226916643e-12
activation O 0 3.0812705165139676e-10
of O 0 1.3089574979474605e-09
double O 0 5.08836028867421e-10
- O 0 2.730491166502702e-09
strand O 0 3.1470573369496435e-10
break O 0 2.389948239311934e-10
repair O 0 2.8622684666856912e-08
and O 0 1.2979951835578873e-10
/ O 0 3.4828722128565914e-09
or O 0 1.15560590610575e-11
homologous O 0 1.718311881671042e-10
recombination O 0 7.646463462407382e-10
. O 0 1.5967380195824887e-10

Dysfunction O 0 0.08572538942098618
of O 0 1.864283694885671e-05
this O 0 3.6878524539707414e-11
pathway O 0 2.838723978104696e-10
may O 0 3.3078114899942612e-12
be O 0 2.757081401291023e-13
a O 0 7.425542385836037e-13
general O 0 1.4621441210560526e-11
phenomenon O 0 1.242051600458538e-11
in O 0 1.3751548727861107e-13
the O 0 4.757026478459381e-13
majority O 0 7.977932279645134e-15
of O 0 2.6469671181479637e-13
cases O 0 9.121700790537535e-13
of O 0 1.0042654485786784e-09
hereditary B-Disease 1 1.0
breast I-Disease 1 0.9999996423721313
and I-Disease 1 0.9995286464691162
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.8236016863237836e-10
. O 0 6.981488998025753e-11

A O 0 8.251766416833561e-07
novel O 0 2.5900630529207547e-09
Arg362Ser O 0 1.1306069609418046e-06
mutation O 0 1.8498116233223172e-11
in O 0 7.506373127241783e-12
the O 0 9.440455361886535e-12
sterol O 0 1.122033310707593e-08
27 O 0 1.6323308926757818e-08
- O 0 2.4356092698241127e-09
hydroxylase O 0 2.2240962493924599e-07
gene O 0 5.561164306833177e-10
( O 0 8.755374897306822e-12
CYP27 O 1 0.9985791444778442
) O 0 4.7087876133000695e-12
: O 0 8.434644313288359e-14
its O 0 1.4168516620366445e-13
effects O 0 2.2323257131695584e-10
on O 0 3.749916349660154e-11
pre O 0 7.43937977887299e-09
- O 0 2.4725565345162792e-11
mRNA O 0 8.611628120672177e-13
splicing O 0 3.915020738154418e-11
and O 0 2.705849053933479e-13
enzyme O 0 1.0057903294946602e-11
activity O 0 4.35867453241201e-11
. O 0 2.352032978103491e-11

A O 0 4.331159573212062e-07
novel O 0 1.0579819242906296e-09
C O 0 9.109794518735725e-08
to O 0 3.301709600167513e-12
A O 0 6.40113018146593e-10
mutation O 0 2.223446687182884e-12
in O 0 1.0181175564075162e-12
the O 0 1.8786901288120328e-12
sterol O 0 4.764173056059917e-09
27 O 0 2.1044055387164917e-09
- O 0 6.028302856897483e-10
hydroxylase O 0 1.0059937238793282e-07
gene O 0 9.931084427039494e-11
( O 0 1.8796004249560516e-12
CYP27 O 0 0.11676941812038422
) O 0 7.534311174083042e-13
was O 0 2.3070321694684814e-12
identified O 0 6.401519939136513e-14
by O 0 3.863341328162566e-14
sequencing O 0 1.1952516754121234e-10
amplified O 0 6.6018991162764e-08
CYP27 O 1 0.9993698000907898
gene O 0 3.498323020156846e-10
products O 0 4.3325512621983364e-10
from O 0 4.525558400247931e-11
a O 0 1.2294934167988991e-11
patient O 0 2.0171511128097563e-09
with O 0 1.829981444156914e-10
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 1.2015296313450108e-08
CTX B-Disease 1 0.999992847442627
) O 0 2.331577153569242e-10
. O 0 1.3061136894254588e-10

The O 0 1.1603320082542723e-08
mutation O 0 3.3634062202025916e-10
changed O 0 7.489172476615735e-11
the O 0 3.8400591734211176e-11
adrenodoxin O 0 3.8830780368925844e-08
cofactor O 0 5.744590914069647e-11
binding O 0 2.1711392406142949e-10
residue O 0 3.439960494233674e-08
362Arg O 0 2.373261587251818e-08
to O 0 1.9199076356501976e-11
362Ser O 0 1.1420076617696395e-07
( O 0 5.711130457441982e-10
CGT O 0 0.0007799066370353103
362Arg O 0 3.3398180221411167e-07
to O 0 9.157707925311342e-11
AGT O 0 0.00047267237096093595
362Ser O 0 5.3910170549897884e-08
) O 0 1.4011525229992716e-12
, O 0 1.7020975286771017e-13
and O 0 3.4888688075704333e-13
was O 0 7.074800467687936e-11
responsible O 0 8.869984746695536e-10
for O 0 5.467829522487477e-10
deficiency O 0 1.0327984227842535e-06
in O 0 6.207573344241268e-10
the O 0 8.313926769254465e-10
sterol O 0 5.2160618935204184e-08
27 O 0 1.387099501926059e-08
- O 0 1.6567260063826694e-10
hydroxylase O 0 1.0736210143136304e-08
activity O 0 8.025014680557163e-11
, O 0 2.2267048773415288e-13
as O 0 2.3620547114381815e-14
confirmed O 0 2.2544441899245704e-13
by O 0 1.0280783623234976e-14
expression O 0 1.376722303866873e-12
of O 0 2.1205929373602217e-11
mutant O 0 7.836689630558169e-12
cDNA O 0 1.957718535894326e-11
into O 0 3.509990909034144e-11
COS O 0 3.0115441404632293e-05
- O 0 2.7866631668871378e-08
1 O 0 4.81229367466085e-09
cells O 0 5.733493679827006e-10
. O 0 6.589636475373695e-11

Quantitative O 0 8.18273981906259e-09
analysis O 0 1.5144076270789952e-10
showed O 0 1.6363372462580017e-11
that O 0 5.098140114142549e-15
the O 0 2.474120084153264e-13
expression O 0 1.2414660228651786e-12
of O 0 7.294855691730717e-11
CYP27 O 0 0.0005734674050472677
gene O 0 3.2994999961399873e-12
mRNA O 0 1.1429855542935408e-12
in O 0 3.9171530602510884e-13
the O 0 1.4591317520559755e-12
patient O 0 3.900873027373741e-11
represented O 0 7.293464443502984e-11
52 O 0 3.1078919437987906e-09
. O 0 2.7007177050286657e-10

5 O 0 1.6909059041836372e-08
% O 0 5.645051266711665e-12
of O 0 4.392919014661878e-11
the O 0 1.3300333924493035e-11
normal O 0 2.946755950361535e-09
level O 0 1.3334772397399774e-08
. O 0 1.353078205035274e-10

As O 0 3.2049130016531535e-10
the O 0 5.245275394583082e-11
mutation O 0 5.702786333439125e-12
occurred O 0 6.868795116021786e-11
at O 0 2.4674118651035748e-11
the O 0 4.147564236500756e-12
penultimate O 0 2.0328010386094775e-09
nucleotide O 0 6.585954004378891e-11
of O 0 1.9933756034706818e-10
exon O 0 1.220627154907561e-09
6 O 0 5.857887952487317e-09
( O 0 8.276972857101939e-12
- O 0 3.194324527111547e-10
2 O 0 8.003706031267654e-11
position O 0 4.493655447745937e-11
of O 0 7.539177615534243e-11
exon O 0 1.2389320680483706e-09
6 O 0 4.93213025976047e-09
- O 0 1.9764838654623418e-09
intron O 0 3.5803904285813815e-09
6 O 0 5.672882719132133e-10
splice O 0 8.742317425536328e-10
site O 0 7.089916848057598e-11
) O 0 1.2861886306437392e-13
of O 0 3.968321764941107e-12
the O 0 2.557913603151718e-11
gene O 0 3.7594413693220474e-11
, O 0 6.243117134374643e-12
we O 0 4.1003517855381366e-13
hypothesized O 0 4.1663712410655585e-12
that O 0 1.0394716500310847e-13
the O 0 1.484634290505049e-11
mutation O 0 1.1353855355888953e-11
may O 0 2.2118990666841754e-12
partially O 0 7.327448647842516e-10
affect O 0 9.351833543669308e-12
the O 0 7.29752369643677e-12
normal O 0 9.295118928026591e-13
splicing O 0 4.584037685030629e-13
efficiency O 0 1.1017697171267216e-12
in O 0 7.852426391410927e-13
exon O 0 1.2965353790583833e-10
6 O 0 2.064107079702282e-10
and O 0 6.434170145459828e-13
cause O 0 2.148836447321556e-12
alternative O 0 1.2298967400070637e-11
splicing O 0 2.82451267236139e-11
elsewhere O 0 1.234800022648086e-11
, O 0 3.997153560290727e-14
which O 0 1.4550079975632563e-15
resulted O 0 6.43041555333651e-13
in O 0 1.8734254599028777e-13
decreased O 0 8.379811601566534e-12
transcript O 0 3.081623012324286e-10
in O 0 3.082983954932894e-12
the O 0 3.1958768964557294e-11
patient O 0 2.6731574731542196e-09
. O 0 1.865234910969349e-10

Transfection O 0 8.02041085989913e-06
of O 0 1.5191979230166908e-07
constructed O 0 4.47877397391494e-07
minigenes O 0 4.454902864381438e-06
, O 0 1.215530974485457e-11
with O 0 1.121934237679166e-13
or O 0 1.7678745837038101e-12
without O 0 3.762567080817236e-12
the O 0 5.181969003204001e-12
mutation O 0 9.484109461319057e-13
, O 0 4.122827567624304e-13
into O 0 7.58603943551428e-12
COS O 0 0.00010064372327178717
- O 0 2.9797249112561985e-08
1 O 0 6.474657476829293e-10
cells O 0 1.118689516022009e-11
confirmed O 0 5.426991321610952e-12
that O 0 8.078319236421924e-15
the O 0 1.6373041160713808e-12
mutant O 0 5.665051414083244e-11
minigene O 0 5.7486522209160285e-09
was O 0 3.1273750950022716e-11
responsible O 0 2.6179933221293084e-11
for O 0 5.273036239421269e-13
a O 0 4.308646538511707e-13
mRNA O 0 1.404393355081135e-11
species O 0 2.197355931108161e-14
alternatively O 0 7.544524900648941e-12
spliced O 0 1.3931201747752198e-09
at O 0 5.222098864443581e-10
an O 0 1.2636647370861676e-12
activated O 0 1.24604923712468e-06
cryptic O 0 4.8851152456563796e-08
5 O 0 3.876393872559447e-09
splice O 0 4.0441207715957717e-08
site O 0 4.471413905804411e-09
88 O 0 7.539803448253224e-09
bp O 0 9.556411217914729e-10
upstream O 0 2.535725240893072e-10
from O 0 4.793198477015537e-11
the O 0 2.6983477952047252e-11
3 O 0 1.6528438340213114e-10
end O 0 1.5013212895098604e-11
of O 0 4.323608832068615e-11
exon O 0 5.219233933928535e-09
6 O 0 2.822023859039291e-08
. O 0 2.421651212891618e-10

Our O 0 8.80771366951194e-09
data O 0 2.1496052160507872e-10
suggest O 0 3.1299097428411082e-12
that O 0 2.0514999069095805e-14
the O 0 2.8576258113283126e-12
C O 0 9.98913129990342e-09
to O 0 4.2585545007890746e-13
A O 0 3.223949718300645e-10
mutation O 0 7.389768050952705e-13
at O 0 1.5901967242992754e-11
the O 0 3.1196226157881313e-12
penultimate O 0 7.831736925645316e-10
nucleotide O 0 2.8488820677519122e-11
of O 0 3.48174614139829e-11
exon O 0 2.4939281195734964e-10
6 O 0 1.4668326553390898e-09
of O 0 1.9652843241679818e-10
the O 0 5.5954116340295457e-11
CYP27 O 1 0.9999998807907104
gene O 0 3.84587917068302e-11
not O 0 1.021959548778463e-13
only O 0 3.6089946135742235e-13
causes O 0 2.601101833921149e-10
the O 0 2.31051022758777e-09
deficiency B-Disease 0 1.7668940088810814e-08
in I-Disease 0 6.648201433812062e-11
the I-Disease 0 1.261806631402962e-10
sterol I-Disease 0 1.0495269542332153e-08
27 I-Disease 0 9.726107919050264e-09
- I-Disease 0 1.38468209121001e-10
hydroxylase I-Disease 0 5.0958703923242865e-09
activity I-Disease 0 4.797845107318288e-11
, O 0 9.799823577410702e-14
but O 0 8.94788918930382e-15
also O 0 4.9692749779428266e-14
partially O 0 3.2248476111718105e-10
leads O 0 4.324983947368022e-12
to O 0 3.3771301862850836e-14
alternative O 0 1.0063468287857535e-11
pre O 0 4.471337078371107e-09
- O 0 1.7955133907454623e-11
mRNA O 0 8.388362704100927e-13
splicing O 0 2.847692047447392e-11
of O 0 9.449318931487038e-12
the O 0 1.5070698595326393e-12
gene O 0 3.427204353645408e-11
. O 0 2.8368443011350664e-11

To O 0 5.867086816380152e-10
our O 0 1.9223013458802285e-10
knowledge O 0 1.3896164774429565e-10
, O 0 6.040620477779091e-13
this O 0 5.46585575127048e-15
is O 0 1.1603483168612979e-14
the O 0 1.57989791496789e-13
first O 0 8.037169020591595e-13
report O 0 2.5993719980285657e-13
regarding O 0 4.1508824155656043e-11
effects O 0 2.0430159786144486e-09
on O 0 1.601126592420954e-10
pre O 0 5.265790026243167e-09
- O 0 1.266703495567123e-11
mRNA O 0 2.901059112988408e-13
splicing O 0 1.6384548232051266e-11
of O 0 3.417241749986699e-12
a O 0 9.388515220245738e-14
mutation O 0 1.2400573189824682e-13
at O 0 7.129646265729983e-12
the O 0 1.0354675450408024e-11
- O 0 2.1299335906110883e-10
2 O 0 6.510592065467335e-11
position O 0 4.993367871963805e-11
of O 0 9.290767460923277e-11
a O 0 1.3935015467925194e-11
5 O 0 1.3668655096665816e-09
splice O 0 3.210012948784424e-07
site O 0 7.014250957837476e-09
. O 0 3.2250752068918587e-10

ATM O 0 0.000481420720461756
germline O 0 5.962806426396128e-07
mutations O 0 3.366481982070013e-09
in O 0 1.8562593129267668e-10
classical O 1 0.9999998807907104
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 1.6018590542898892e-07
in O 0 3.683529176123912e-11
the O 0 1.691084078325744e-11
Dutch O 0 1.0809115025267602e-07
population O 0 5.11183231703162e-14
. O 0 1.3910682501727667e-12

Germline O 0 1.125503422372276e-05
mutations O 0 7.57218732161391e-09
in O 0 7.662168122202218e-11
the O 0 3.268671097678144e-11
ATM O 0 5.306776074576192e-06
gene O 0 6.526929691164085e-11
are O 0 2.957068929456373e-14
responsible O 0 1.773065895493975e-11
for O 0 5.154918592681357e-12
the O 0 5.241143412604288e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 4.974457169737434e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 4.1025641217551367e-10
. O 0 4.8276879022202124e-11

In O 0 6.079249548207599e-09
our O 0 2.845342850221755e-10
study O 0 1.842318658740183e-11
, O 0 5.578621874342826e-13
we O 0 2.041067340911428e-14
have O 0 2.1477062478719028e-15
determined O 0 1.7888877228491862e-12
the O 0 2.4290873132382096e-12
ATM O 0 5.616301734789886e-08
mutation O 0 1.1787894445280944e-11
spectrum O 0 1.2066958543499595e-10
in O 0 2.7302122368455528e-11
19 O 0 8.435835918696455e-10
classical O 0 2.2874951355333906e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.1749162753815767e-09
, O 0 1.5801692365615544e-13
including O 0 3.5420266979863113e-13
some O 0 8.547162984155494e-15
immigrant O 0 1.700008000040179e-13
populations O 0 4.727004920303257e-14
, O 0 3.760853814379879e-15
as O 0 2.1421763085724584e-14
well O 0 1.4463765200724982e-13
as O 0 2.62045376717146e-13
12 O 0 1.438232432454667e-11
of O 0 2.701611503952428e-12
Dutch O 0 2.1530777161160586e-09
ethnic O 0 1.4295884625831895e-13
origin O 0 2.935095092318485e-12
. O 0 1.129590171400352e-11

Both O 0 4.887645288498277e-10
the O 0 1.215958306266529e-10
protein O 0 1.2818501468614407e-11
truncation O 0 7.033498228281587e-10
test O 0 1.377993386064702e-09
( O 0 4.738148675492715e-12
PTT O 0 1.5388218344014604e-07
) O 0 2.3697997774199675e-13
and O 0 5.973443040121346e-14
the O 0 1.2994473390110645e-13
restriction O 0 1.1208412941266649e-13
endonuclease O 0 1.3779559437931965e-10
fingerprinting O 0 1.946702576915982e-09
( O 0 4.4359247178271666e-12
REF O 0 1.0314248299891915e-07
) O 0 2.972268427475083e-14
method O 0 3.4801737771976426e-14
were O 0 6.527314665605733e-15
used O 0 2.9407855680783565e-14
and O 0 7.524397635993649e-14
compared O 0 4.9023119412646907e-14
for O 0 8.403744212559343e-15
their O 0 2.1125882618787395e-14
detection O 0 7.262175583111485e-11
efficiency O 0 8.957191759140226e-12
, O 0 1.0540903544985214e-13
identifying O 0 3.625776328480823e-12
76 O 0 2.168745738551081e-11
% O 0 3.453905803195629e-15
and O 0 3.0094619830021985e-14
60 O 0 1.2503274240613371e-12
% O 0 1.4928410206139012e-14
of O 0 6.270657821119685e-13
the O 0 1.5333245740808965e-12
mutations O 0 1.8441083729503482e-11
, O 0 1.845269249900472e-11
respectively O 0 6.200520652477337e-10
. O 0 1.5160665778335414e-10

Most O 0 1.3256734598954267e-09
patients O 0 8.838045573167364e-11
were O 0 2.830769126049848e-11
found O 0 3.2409506935809906e-12
to O 0 2.908627657303986e-13
be O 0 7.850209740069281e-13
compound O 0 4.619145510531553e-09
heterozygote O 0 4.342832085058035e-07
. O 0 2.363683249129167e-09

Seventeen O 0 8.807211315797758e-07
mutations O 0 5.527683866191069e-10
were O 0 4.5867361991858147e-11
distinct O 0 2.2387845050042543e-11
, O 0 1.2160335672445344e-12
of O 0 9.335567041635073e-11
which O 0 4.487809592262221e-13
10 O 0 1.0407701610259945e-11
were O 0 8.823231858676173e-13
not O 0 3.6939432090411783e-14
reported O 0 2.250249292456985e-11
previously O 0 3.831174044677255e-09
. O 0 6.033295529839222e-10

Mutations O 0 1.2056645459779247e-07
are O 0 2.0198053299336216e-11
small O 0 1.3800988130086012e-11
deletions O 0 4.878371040462071e-09
or O 0 5.626570764860617e-09
point O 0 6.607980829187454e-09
mutations O 0 6.074911129694271e-10
frequently O 0 1.2941167581992374e-10
affecting O 0 1.0271088424218533e-09
splice O 0 2.6433318112140114e-07
sites O 0 6.1244995741560615e-09
. O 0 4.868487835096857e-10

Moreover O 0 1.1395326282581664e-07
, O 0 4.920936436114687e-10
a O 0 2.8461949463931546e-10
16 O 0 2.083164929445047e-08
. O 0 4.4393405618237125e-10

7 O 0 2.756481762844487e-07
- O 0 5.820865567329747e-09
kb O 0 6.566030830157388e-09
genomic O 0 2.1796119076267217e-10
deletion O 0 1.2104556246228526e-10
of O 0 1.7743464475472592e-09
the O 0 1.0973665726110582e-10
3 O 0 4.951063448110915e-10
end O 0 1.746632699584083e-11
of O 0 1.7700754056937384e-11
the O 0 4.134373832870297e-12
gene O 0 3.3820452948613022e-12
, O 0 1.1678670725802365e-13
most O 0 3.373949408161554e-14
likely O 0 1.1351137992878998e-13
a O 0 1.1330674354499692e-13
result O 0 9.716483260341358e-13
of O 0 7.276036544101583e-12
recombination O 0 6.559345623081969e-13
between O 0 1.3476550604629711e-12
two O 0 7.288061755657271e-13
LINE O 0 7.027698245565261e-08
elements O 0 2.19479281970969e-10
, O 0 8.749098667770738e-12
was O 0 1.3850387503566708e-10
identified O 0 2.344169858226053e-10
. O 0 2.556388156715883e-10

The O 0 3.159762007598488e-09
most O 0 1.8590034026044755e-12
frequently O 0 7.479828930713472e-13
found O 0 6.351596765902245e-13
mutation O 0 3.0858532417722684e-13
, O 0 9.22573446132148e-14
identified O 0 5.497226480445649e-13
in O 0 9.828581091358979e-13
three O 0 7.8959657822536e-13
unrelated O 0 2.0818560764190863e-10
Turkish O 0 6.2479159623762826e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999995231628418
T I-Disease 1 1.0
individuals O 0 5.095522528225649e-12
, O 0 7.815597995175505e-12
was O 0 7.383238465052955e-11
previously O 0 5.1410372486904166e-11
described O 0 5.007232475873202e-12
to O 0 1.1789636107650825e-13
be O 0 1.3597509348952513e-13
a O 0 1.1401897221513524e-12
Turkish O 0 5.776831790704762e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
founder O 0 0.001470184768550098
mutation O 0 5.171727046615615e-09
. O 0 1.4309546603197276e-10

The O 0 8.544581042713162e-09
presence O 0 3.212452803769139e-10
of O 0 3.1927060994974e-09
a O 0 1.9750620583458556e-10
founder O 0 1.4008755897521041e-06
mutation O 0 9.432001707443405e-11
among O 0 8.09949492457801e-13
relatively O 0 5.324945128934444e-13
small O 0 1.6970201760220342e-14
ethnic O 0 1.1839198673548458e-15
population O 0 1.1999278007499395e-17
groups O 0 1.9629957119755133e-17
in O 0 3.882353067366983e-15
Western O 0 3.354275190936562e-11
Europe O 0 1.3514429852978793e-10
could O 0 2.5631870757825137e-12
indicate O 0 2.017559513553535e-12
a O 0 2.960930654306859e-13
high O 0 2.2001523866665984e-11
carrier O 0 1.9806472000699626e-12
frequency O 0 4.2622624180088664e-12
in O 0 2.2081715254050616e-13
such O 0 1.513710164158244e-12
communities O 0 3.404472884160903e-11
. O 0 9.946268114680024e-11

In O 0 2.4345503391032253e-09
patients O 0 8.447988836257636e-11
of O 0 4.3981021602412795e-10
Dutch O 0 5.518176635632699e-07
ethnic O 0 7.82387121669309e-13
origin O 0 1.3687809566342857e-12
, O 0 5.651768048248011e-14
however O 0 5.783875711273118e-14
, O 0 8.178351116987226e-14
no O 0 2.0671337634236425e-13
significant O 0 1.3376707727608128e-11
founder O 0 1.3647853336351545e-07
effect O 0 1.1943771527356262e-09
could O 0 2.5229972624996044e-11
be O 0 3.96327588803036e-12
identified O 0 3.181179208944229e-10
. O 0 2.1898294289002251e-10

The O 0 3.6487723953371187e-09
observed O 0 4.910688522485884e-10
genetic O 0 7.557188208551224e-11
heterogeneity O 0 1.4353529476096583e-10
including O 0 9.31294017597617e-12
the O 0 5.88707945239908e-12
relative O 0 1.6352265028163337e-11
high O 0 4.2373007880236457e-10
percentage O 0 2.6133836414365952e-11
of O 0 1.3428455569730602e-10
splice O 0 6.557372671522899e-07
- O 0 1.3086362216085945e-08
site O 0 3.4305953633406716e-09
mutations O 0 1.3684221811249841e-10
had O 0 1.6750779582852537e-11
no O 0 3.348118006799017e-12
reflection O 0 1.3560003120360875e-10
on O 0 1.0118023086036487e-09
the O 0 1.3908044160793054e-10
phenotype O 0 1.689280493266665e-09
. O 0 1.5991824531269572e-10

All O 0 4.833377253987692e-09
patients O 0 5.570432448642748e-10
manifested O 0 4.23609858302143e-09
classical O 0 6.574914550583344e-06
A B-Disease 1 1.0
- I-Disease 1 0.9999899864196777
T I-Disease 1 1.0
and O 0 6.013232967116977e-11
increased O 0 1.4364422845636327e-11
cellular O 0 4.274921305835733e-09
radioresistant O 0 2.9320105454644363e-07
DNA O 0 3.054415742553829e-08
synthesis O 0 2.2797055354573104e-09
. O 0 1.3981819174668786e-11

Determination O 0 1.1646561404177191e-07
of O 0 1.121293191630457e-08
the O 0 1.51201134945822e-11
genomic O 0 8.016600577809285e-11
structure O 0 7.729838297221292e-11
of O 0 2.8157573495057875e-10
the O 0 4.115195337273114e-11
COL4A4 O 1 1.0
gene O 0 4.842664810822406e-11
and O 0 1.2235694228646121e-12
of O 0 2.300415934131106e-11
novel O 0 1.7302181909428782e-09
mutations O 0 3.144623860862339e-06
causing O 1 0.9998430013656616
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 4.450527413268901e-08

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 3.064801745722434e-09
a O 0 1.1061980664806015e-08
progressive O 1 1.0
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 0 0.0021606353111565113
by O 0 3.2526228377349753e-09
glomerular B-Disease 1 0.5200228095054626
basement I-Disease 1 1.0
membrane I-Disease 0 4.548180368146859e-05
abnormalities I-Disease 1 0.9999996423721313
and O 0 6.865419344137536e-10
associated O 0 2.5097290912157177e-09
with O 0 2.3082084854575413e-11
mutations O 0 6.9889233289544e-11
in O 0 1.8791032965759236e-11
either O 0 1.5767906424990485e-10
the O 0 8.507741733332352e-10
COL4A3 O 1 1.0
or O 0 4.0776548804188906e-10
the O 0 1.9905298243028113e-10
COL4A4 O 1 0.9999723434448242
gene O 0 3.799956529992876e-11
, O 0 1.1372570636949964e-13
which O 0 8.415164757787173e-15
encode O 0 1.874634779006068e-12
the O 0 1.200734997541808e-11
alpha3 O 0 1.2198870535939932e-07
and O 0 1.573587926628761e-10
alpha4 O 0 1.6857218270160956e-06
type O 0 1.5619966688973363e-06
IV O 1 1.0
collagen O 1 1.0
chains O 0 5.211502138990909e-05
, O 0 5.149783932623109e-10
respectively O 0 1.272094429793924e-09
. O 0 2.2205244587514272e-10

To O 0 2.6974589228956347e-10
date O 0 3.5531644293484987e-09
, O 0 2.2496429632340442e-12
mutation O 0 1.949931644103231e-13
screening O 0 4.845646887213784e-12
in O 0 5.98724791533306e-13
the O 0 1.142299037477923e-12
two O 0 3.0455537180715253e-13
genes O 0 2.179119081360814e-12
has O 0 1.5763672105931908e-13
been O 0 1.3280453126096603e-12
hampered O 0 3.7784952944264205e-09
by O 0 4.973306922534393e-13
the O 0 1.1469360617494262e-12
lack O 0 3.4584069549120633e-12
of O 0 2.4104828376392273e-12
genomic O 0 2.5107653803257968e-11
structure O 0 1.2163983362234454e-11
information O 0 5.919755137473448e-12
. O 0 9.45651820738469e-11

We O 0 5.411481263095652e-10
report O 0 3.505187112784469e-11
here O 0 9.41175631354041e-13
the O 0 7.470575265171309e-13
complete O 0 6.117298508023783e-12
characterization O 0 1.707139707374239e-10
of O 0 2.3226998102643392e-10
the O 0 7.099443255498272e-11
48 O 0 1.5507830575245407e-09
exons O 0 1.1338610050870557e-09
of O 0 5.018356841191007e-10
the O 0 5.303819050617165e-10
COL4A4 O 1 1.0
gene O 0 5.028676364204898e-10
, O 0 9.154118435494851e-13
a O 0 2.2167548829540862e-13
comprehensive O 0 1.875952865271202e-10
gene O 0 7.706090106307517e-12
screen O 0 4.340762818633159e-11
, O 0 7.064168043927066e-13
and O 0 4.3742361620878467e-13
the O 0 5.685298152396934e-13
subsequent O 0 1.370348387715048e-12
detection O 0 4.5734536158192896e-09
of O 0 5.971936833937264e-11
10 O 0 8.277825473690381e-12
novel O 0 3.0326520374795995e-12
mutations O 0 5.583180185536607e-12
in O 0 2.002423834385203e-12
eight O 0 5.127456792486385e-10
patients O 0 4.777033169034439e-08
diagnosed O 1 0.931419312953949
with O 0 9.744603630679194e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.6503481958807242e-07

Furthermore O 0 6.455279333295039e-08
, O 0 1.035578775510082e-10
we O 0 9.501237687239983e-13
identified O 0 2.6148783659196706e-12
a O 0 2.012064126422075e-12
glycine O 0 8.66543781175011e-10
to O 0 4.559206744775279e-12
alanine O 0 1.072957167558286e-09
substitution O 0 7.477871655225954e-10
in O 0 3.144619634132262e-11
the O 0 2.868095171082441e-11
collagenous O 0 3.921020663710806e-07
domain O 0 1.483069222985023e-11
that O 0 1.5809614156551445e-14
is O 0 4.240938790466345e-14
apparently O 0 2.1225584224265903e-12
silent O 0 1.386582376694534e-10
in O 0 7.752893921471327e-13
the O 0 1.6111700732249212e-12
heterozygous O 0 4.713700133343601e-13
carriers O 0 1.583881571905199e-12
, O 0 1.6569329458829274e-12
in O 0 1.5507786027546544e-11
11 O 0 2.553806499605571e-09
. O 0 2.441482571668985e-10

5 O 0 8.994081035496038e-09
% O 0 1.672057457768883e-12
of O 0 1.872362855037668e-11
all O 0 3.1585742051379317e-13
control O 0 1.529866511251754e-11
individuals O 0 4.241820721171026e-14
, O 0 1.5163484617247702e-12
and O 0 7.335113961538797e-13
in O 0 9.387768340474167e-13
one O 0 1.892716127056826e-13
control O 0 4.5455050314002765e-12
individual O 0 6.124670947271413e-14
homozygous O 0 1.7902940414871171e-12
for O 0 2.485888827685051e-13
this O 0 1.9057971617931352e-13
glycine O 0 6.0260987311266945e-09
substitution O 0 1.2403869042998394e-08
. O 0 8.644076565644809e-10

There O 0 7.34436511606873e-10
has O 0 3.069020731993888e-12
been O 0 6.651771147780927e-13
no O 0 2.0415160989668835e-13
previous O 0 2.398573700768125e-11
finding O 0 3.84650774773454e-12
of O 0 1.1504026030395575e-11
a O 0 1.4474315843115981e-12
glycine O 0 4.840829403995883e-10
substitution O 0 1.822662853978585e-10
that O 0 2.090044852682063e-13
is O 0 1.1730240802136638e-13
not O 0 4.1468795086187227e-14
associated O 0 3.9073445867732204e-11
with O 0 1.0856115268895183e-12
any O 0 1.4263678779768973e-11
obvious O 0 2.8385668815467113e-10
phenotype O 0 7.218054626223491e-11
in O 0 5.965661124818222e-12
homozygous O 0 1.5900156191683834e-10
individuals O 0 1.008448424592856e-12
. O 0 2.5694352201455217e-10

Founder O 0 0.4242529273033142
BRCA1 O 0 7.77577133703744e-06
and O 0 4.8300435651071894e-08
BRCA2 O 0 5.850610023117042e-07
mutations O 0 9.12310560430285e-10
in O 0 3.032597506447132e-10
French O 0 6.867055617476581e-06
Canadian O 1 0.9999998807907104
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.949288729903188e-11
. O 0 8.135267459685736e-11

We O 0 2.946591581842739e-10
have O 0 5.149245830074478e-13
identified O 0 6.461672776708616e-12
four O 0 3.3596133687530116e-12
mutations O 0 1.4679135728126735e-12
in O 0 1.7376435576879623e-12
each O 0 2.408753806224656e-13
of O 0 1.0048479825996992e-09
the O 0 3.6735222863626404e-08
breast B-Disease 1 0.9999949932098389
cancer I-Disease 0 0.00016252254135906696
- O 0 8.758647140894027e-07
susceptibility O 0 2.7553639370125893e-08
genes O 0 1.1124747650859135e-10
, O 0 2.1856304960321538e-11
BRCA1 O 0 1.640792390844581e-09
and O 0 2.266342530310439e-10
BRCA2 O 0 7.648538691285012e-09
, O 0 2.6160256686585948e-12
in O 0 5.4618202321998766e-12
French O 0 3.685017873067409e-07
Canadian O 1 0.993548572063446
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9909732937812805
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 9.162888546868087e-13
from O 0 9.054471061809011e-11
Quebec O 0 2.0629448727049748e-07
. O 0 1.4988190688569603e-09

To O 0 1.9152792685162012e-09
identify O 0 3.004550208629553e-08
founder O 0 4.959384568792302e-06
effects O 0 0.007033074740320444
, O 0 1.1473397926176077e-10
we O 0 1.0683505946226801e-12
examined O 0 5.373723688251175e-10
independently O 0 2.1590973453555762e-10
ascertained O 0 1.6103616218288153e-09
French O 0 1.4782900237264585e-08
Canadian O 0 5.769502990915498e-07
cancer B-Disease 0 1.9259918104808094e-08
families O 0 1.024894873694537e-14
for O 0 4.6951598696182845e-14
the O 0 8.015368967509429e-13
distribution O 0 6.9450946729721075e-12
of O 0 4.523530161559819e-11
these O 0 6.457492418392163e-13
eight O 0 3.7625260546070294e-11
mutations O 0 2.1178293840851126e-10
. O 0 2.866794857059318e-10

Mutations O 0 9.12119713092352e-09
were O 0 3.011667581986899e-10
found O 0 3.8828185458528175e-12
in O 0 1.1340431631950976e-12
41 O 0 1.1523599435792065e-10
of O 0 5.862431373682142e-11
97 O 0 7.612850794203041e-09
families O 0 1.5612184938937346e-12
. O 0 1.3440677737452944e-10

Six O 0 4.607620596175366e-08
of O 0 8.385340422023546e-09
eight O 0 4.5403883430772396e-10
mutations O 0 8.855240152261246e-11
were O 0 8.577982074653434e-11
observed O 0 2.130494114460646e-10
at O 0 3.485176314210747e-10
least O 0 1.1192267815665624e-12
twice O 0 3.320216324098624e-10
. O 0 1.8535775692107848e-10

The O 0 3.352747171447845e-06
BRCA1 O 0 1.2931928722537123e-05
C4446T O 0 8.02226259111194e-06
mutation O 0 6.889818715549723e-10
was O 0 5.141186920631924e-10
the O 0 6.958367042286806e-12
most O 0 8.591083844756292e-14
common O 0 6.095747821441289e-13
mutation O 0 5.530754890528677e-13
found O 0 9.681742170128405e-13
, O 0 1.0033559269886916e-13
followed O 0 3.4770920951526785e-12
by O 0 1.1751162109358004e-12
the O 0 2.9796137779314336e-10
BRCA2 O 0 2.0914983167585888e-07
8765delAG O 0 4.259150898633379e-07
mutation O 0 4.374211659552429e-09
. O 0 7.674985091910003e-10

Together O 0 5.480225606646627e-09
, O 0 2.880715804787215e-11
these O 0 3.3285177457147153e-13
mutations O 0 4.440089788892987e-12
were O 0 1.1869045676848877e-11
found O 0 1.84351991137921e-12
in O 0 4.768399759248754e-13
28 O 0 7.10288355909583e-11
of O 0 7.731106033137536e-11
41 O 0 7.033963689284661e-11
families O 0 1.3149021835820538e-14
identified O 0 1.6729506235185765e-12
to O 0 1.506383125876587e-12
have O 0 4.929600022456071e-13
a O 0 6.247218020671852e-11
mutation O 0 2.834963375164534e-10
. O 0 4.170621070720415e-10

The O 0 1.2302294294386229e-08
odds O 0 1.5941409969855158e-08
of O 0 4.70189109869068e-10
detection O 0 1.8832933434964616e-08
of O 0 7.718233274722763e-10
any O 0 2.3444189298227336e-11
of O 0 1.638946978133049e-09
the O 0 1.9681764551471304e-10
four O 0 5.879496889349412e-11
BRCA1 O 0 2.4117974284365573e-09
mutations O 0 1.6611621800333154e-10
was O 0 3.700849626753211e-09
18 O 0 1.451113718076158e-08
. O 0 2.0881234241709734e-10

7x O 0 0.00110304553527385
greater O 0 3.634708889421745e-08
if O 0 6.676564856533673e-11
one O 0 5.342486869563956e-12
or O 0 3.3203652501090364e-12
more O 0 1.7382052896097906e-14
cases O 0 1.625629665602535e-11
of O 0 2.5324661123704573e-07
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 6.603237401314743e-11
also O 0 4.478597939554241e-14
present O 0 1.178500385386888e-13
in O 0 8.301554430857616e-13
the O 0 1.54655750012056e-11
family O 0 1.2702891689919671e-11
. O 0 1.0373817083131343e-10

The O 0 3.0740594070266525e-08
odds O 0 1.4252278468518398e-08
of O 0 5.306743378064027e-10
detection O 0 7.118325040522677e-09
of O 0 3.6909927891848326e-10
any O 0 6.4269123876969925e-12
of O 0 7.553186409658963e-10
the O 0 9.134802636534545e-11
four O 0 9.331757588881828e-11
BRCA2 O 0 7.964850112784916e-09
mutations O 0 9.652287302763796e-11
was O 0 3.4829052975027253e-09
5 O 0 1.0371808301101737e-08
. O 0 1.196195920094567e-10

3x O 0 8.776725735515356e-06
greater O 0 1.6227751364894516e-09
if O 0 3.8936683738333144e-12
there O 0 5.417194470780373e-13
were O 0 1.093448595557156e-11
at O 0 4.190154126448853e-11
least O 0 2.3922328012829577e-14
five O 0 9.145737281650995e-14
cases O 0 1.003021559038697e-12
of O 0 3.3269633714638758e-09
breast B-Disease 0 0.18919259309768677
cancer I-Disease 0 1.629735635333418e-07
in O 0 1.166012564279839e-10
the O 0 8.92621254688919e-10
family O 0 1.3989241709477795e-10
. O 0 1.7080158121185463e-10

Interestingly O 0 2.9741034524022325e-08
, O 0 5.171613831622679e-11
the O 0 7.442107693989009e-12
presence O 0 2.1656539408998476e-11
of O 0 1.9538892725989854e-09
a O 0 6.030628885156375e-09
breast B-Disease 1 0.9822809100151062
cancer I-Disease 0 1.3327849046618212e-07
case O 0 1.457189091613742e-10
< O 0 6.422565257402368e-11
36 O 0 1.2164917684298615e-10
years O 0 7.54303900157155e-13
of O 0 1.1319410686549958e-11
age O 0 1.788567015846565e-12
was O 0 5.2995971326630364e-12
strongly O 0 1.6274336750183444e-13
predictive O 0 6.2727544512808375e-12
of O 0 1.1377180447746937e-11
the O 0 5.906308428449414e-13
presence O 0 5.785974997729593e-13
of O 0 1.0631899007018664e-11
any O 0 2.188653772106086e-12
of O 0 1.362801260729185e-10
the O 0 2.338920723765625e-11
eight O 0 4.0344148161119975e-11
mutations O 0 4.55380282093909e-11
screened O 0 1.866845522613403e-08
. O 0 1.465859322813401e-09

Carriers O 0 1.6679064795965814e-09
of O 0 1.075568079045297e-08
the O 0 2.0292814303934925e-11
same O 0 9.489971742465686e-13
mutation O 0 3.405255136028351e-13
, O 0 3.371440835384966e-14
from O 0 3.6652528478649596e-14
different O 0 6.576276134572347e-15
families O 0 5.1890026089439385e-15
, O 0 7.710918356737193e-14
shared O 0 7.353660866002421e-13
similar O 0 3.2181713890966357e-12
haplotypes O 0 1.0173731995744006e-10
, O 0 4.200666290504751e-12
indicating O 0 1.5060936872646202e-11
that O 0 5.164026148428251e-14
the O 0 1.3277066078509758e-11
mutant O 0 8.431343817560943e-11
alleles O 0 8.498139935893614e-14
were O 0 3.4238835724953454e-12
likely O 0 7.444019901360621e-13
to O 0 2.1611785440672077e-13
be O 0 1.7966968787318932e-13
identical O 0 3.006746934763882e-11
by O 0 1.1946601477172414e-12
descent O 0 4.920005028385965e-11
for O 0 2.5290075480847996e-13
a O 0 1.2866039613909641e-12
mutation O 0 1.545742808924111e-12
in O 0 1.839186138455351e-12
the O 0 3.386552496764672e-11
founder O 0 7.863532935914463e-09
population O 0 8.738115211872483e-14
. O 0 3.785024810937232e-12

The O 0 1.0981670017784495e-09
identification O 0 1.5647565465570779e-09
of O 0 2.7651603229372768e-09
common O 0 5.4412820915672455e-09
BRCA1 O 0 2.0977446979486558e-07
and O 0 1.0179913800811846e-08
BRCA2 O 0 2.0871485162388126e-07
mutations O 0 1.4536913339746604e-10
will O 0 2.1497465266251403e-12
facilitate O 0 1.187681897274473e-10
carrier O 0 4.9822937442378645e-11
detection O 0 7.374956201289251e-09
in O 0 9.674178125251842e-12
French O 0 4.5204579635083064e-08
Canadian O 0 0.42281800508499146
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999921321868896
and O 0 0.09582476317882538
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.611759072901343e-11
. O 0 5.47344079782075e-11

Are O 0 6.588524392725503e-09
Dp71 O 0 0.00010689296323107556
and O 0 2.0389530064335304e-08
Dp140 O 0 5.553773371502757e-05
brain O 0 0.0001032867148751393
dystrophin O 0 5.718815145883127e-07
isoforms O 0 5.977557893110941e-10
related O 0 4.356335292499125e-09
to O 0 2.4403046250398575e-10
cognitive B-Disease 0 0.0035035100299865007
impairment I-Disease 1 0.9999997615814209
in O 0 0.001857831608504057
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 0 0.0001681660214671865

Molecular O 0 1.2672123261836532e-07
study O 0 1.830501722421829e-10
and O 0 7.844076950480616e-12
neuropsychological O 0 2.2027785462341853e-07
analysis O 0 3.637504880638076e-11
were O 0 1.0609939142536273e-11
performed O 0 1.035207475297284e-10
concurrently O 0 2.7406837216359392e-11
on O 0 1.0915174319947596e-10
49 O 0 3.8947567393421423e-10
patients O 0 6.922879630666401e-11
with O 0 5.820477433360338e-09
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.8497244715690613
DMD B-Disease 1 1.0
) O 0 1.727620217023551e-12
in O 0 2.398264692306945e-13
order O 0 2.1955273970392097e-12
to O 0 2.267671049853079e-13
find O 0 2.698623117504406e-13
a O 0 9.289637337367776e-14
molecular O 0 8.643837381971942e-12
explanation O 0 9.305389575206546e-13
for O 0 3.477906168353889e-13
the O 0 5.847623080201814e-11
cognitive B-Disease 0 5.65296659260639e-06
impairment I-Disease 0 3.5959324122813996e-06
observed O 0 1.1186116477546193e-09
in O 0 7.139883823059634e-11
most O 0 6.743013925003538e-10
DMD B-Disease 1 1.0
patients O 0 1.8798193224256465e-08
. O 0 5.591967999762915e-10

Complete O 0 1.3155433187250765e-08
analysis O 0 1.5508620776483184e-10
of O 0 8.23179580056177e-10
the O 0 6.018981840716364e-11
dystrophin O 0 6.104558991637532e-08
gene O 0 5.388904322778387e-10
was O 0 8.076213586782899e-10
performed O 0 9.854199678471787e-10
to O 0 7.51831919203888e-13
define O 0 3.675065807229316e-11
the O 0 5.322115144423822e-12
localization O 0 5.006762560100242e-09
of O 0 4.871559752817056e-11
deletions O 0 1.7593156098616447e-10
and O 0 3.041354321164924e-11
duplications O 0 2.6727902113776736e-09
in O 0 1.0006163432552118e-11
relation O 0 4.0312305576994945e-11
to O 0 2.9795024954204496e-12
the O 0 1.992082367119341e-11
different O 0 4.5304573981219676e-10
DMD B-Disease 1 1.0
promoters O 0 4.449250263860449e-05
. O 0 8.852952149140947e-09

Qualitative O 0 2.27932410723497e-08
analysis O 0 5.505503275493595e-10
of O 0 3.2423652651658585e-09
the O 0 8.007248336605599e-11
Dp71 O 0 9.032848993228981e-07
transcript O 0 5.059011876085151e-09
and O 0 4.362989570322329e-12
testing O 0 5.5166534534967226e-11
for O 0 4.8987506759412547e-14
the O 0 2.0326263187788601e-13
specific O 0 7.308353412466967e-14
first O 0 8.49536066493961e-12
exon O 0 3.8199862717469557e-10
of O 0 9.644630927230224e-11
Dp140 O 0 1.2430512619232559e-08
were O 0 5.602224587009097e-11
also O 0 1.0049039508505664e-12
carried O 0 6.117185230580802e-11
out O 0 2.984464064770265e-11
. O 0 3.907143011905312e-11

Neuropsychological O 0 6.400773418135941e-05
analysis O 0 1.2878997868170927e-09
assessed O 0 9.850595894533853e-09
verbal O 0 4.000322917363519e-08
and O 0 2.8223440251551324e-10
visuospatial O 0 1.6948119707649312e-07
intelligence O 0 3.1343592166166445e-09
, O 0 4.2312958692392044e-12
verbal O 0 2.563293355350993e-09
memory O 0 8.386102194890555e-07
, O 0 1.772037898362111e-11
and O 0 2.8468559107319713e-11
reading O 0 1.7309517374997085e-08
skills O 0 1.0663515404019108e-08
. O 0 1.8958044856187684e-10

Comparison O 0 2.0476631945598456e-08
of O 0 1.9010061080848573e-08
molecular O 0 3.1481892648344e-08
and O 0 3.3161154378014146e-10
psychometric O 0 3.363004225320765e-06
findings O 0 1.9509027726627437e-09
demonstrated O 0 1.3194922932058262e-10
that O 0 7.206117213359731e-14
deletions O 0 2.5578258261438336e-11
and O 0 2.7703785446253626e-11
duplications O 0 3.4953768768275495e-09
that O 0 5.09587001502193e-13
were O 0 1.5070274889117385e-11
localized O 0 1.280004435777471e-09
in O 0 1.5443967285588833e-11
the O 0 3.633171194450391e-11
distal O 0 1.3546023192034795e-09
part O 0 1.0777315151422329e-10
of O 0 4.895895688861174e-09
the O 0 2.159213696728557e-09
gene O 0 2.2196777749172725e-10
seemed O 0 1.1709060804276916e-11
to O 0 1.22073886914785e-13
be O 0 1.5266871019334674e-14
preferentially O 0 1.3447543426026165e-11
associated O 0 7.978526173069156e-11
with O 0 1.1305521102622507e-10
cognitive B-Disease 1 0.9920324087142944
impairment I-Disease 1 0.9996895790100098
. O 0 6.519746875710553e-08

Two O 0 5.29569454954526e-09
altered O 0 1.1754899986726741e-07
Dp71 O 0 5.746621809521457e-06
transcripts O 0 1.580059318939675e-07
and O 0 4.172148737602299e-10
two O 0 7.589295511478689e-12
deleted O 0 2.2916234188041784e-10
Dp140 O 0 1.1984557346522706e-08
DNA O 0 1.2971105967096719e-08
sequences O 0 1.0060090781249809e-11
were O 0 1.2560377000633838e-12
found O 0 3.5336054286620733e-13
in O 0 1.393813721124043e-13
four O 0 2.133867518447352e-12
patients O 0 5.025873814346049e-11
with O 0 6.013224918000049e-10
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 0 1.7325579904081678e-07

These O 0 3.611492771504743e-10
findings O 0 2.525555042875993e-10
suggest O 0 2.602086731848252e-12
that O 0 6.960759212407651e-15
some O 0 8.358058643516235e-15
sequences O 0 6.201196782636142e-13
located O 0 1.0425384514012315e-11
in O 0 3.2574214593045214e-13
the O 0 4.201788656593708e-12
distal O 0 1.508402847072432e-10
part O 0 2.2410575131748267e-11
of O 0 3.2288235973787494e-10
the O 0 5.202868691434048e-11
gene O 0 3.0889229975933352e-12
and O 0 4.968512146846793e-12
, O 0 2.005346843442224e-13
in O 0 2.291873559424201e-13
particular O 0 3.660392030712528e-13
, O 0 2.1665399238101485e-13
some O 0 6.719803207801134e-13
DMD B-Disease 1 1.0
isoforms O 0 5.957295073910629e-11
expressed O 0 1.1869226088090379e-11
in O 0 5.5587229264020266e-11
the O 0 2.252102060396055e-09
brain O 0 1.4858915164950304e-05
may O 0 3.612915088629931e-12
be O 0 6.036598494294984e-14
related O 0 2.51748864810164e-11
to O 0 9.769258969491434e-13
the O 0 1.4069672510386155e-11
cognitive B-Disease 0 8.081181022134842e-07
impairment I-Disease 0 4.979839559382526e-06
associated O 0 1.9865039391220307e-08
with O 0 6.573473765314475e-09
DMD B-Disease 1 1.0
. O 0 9.157101188428385e-10
. O 0 4.107810203102247e-10

I1307K O 0 0.00017836311599239707
APC O 0 1.5011656614660751e-05
and O 0 5.542160508298366e-09
hMLH1 O 0 7.48712579934363e-07
mutations O 0 5.660625856940271e-10
in O 0 2.793593134597927e-11
a O 0 5.147784976067271e-12
non O 0 7.582158900731883e-09
- O 0 2.3140857285941507e-10
Jewish O 0 7.804622920160043e-11
family O 0 2.3219445029892816e-12
with O 0 5.0539598547838516e-12
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.2299221197054067e-08

We O 0 6.039512223665611e-10
describe O 0 1.2701669716008723e-09
a O 0 1.274677325496798e-11
French O 0 3.8817006497993134e-08
Canadian O 0 0.00015733242616988719
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 3.147562210870092e-07
HNPCC B-Disease 1 1.0
) O 0 5.036547290337978e-10
kindred O 0 8.390207995034871e-08
which O 0 3.707627087290444e-12
carries O 0 2.7424302412315527e-11
a O 0 1.917985301830294e-12
novel O 0 4.039789683329964e-11
truncating O 0 3.078663768363299e-09
mutation O 0 4.400583716868134e-11
in O 0 2.5996770708358596e-11
hMLH1 O 0 2.417385474018374e-07
. O 0 1.9243382443079327e-09

Interestingly O 0 5.486765175533037e-08
, O 0 1.2025347384536644e-10
the O 0 4.0103708548455685e-11
I1307K O 0 3.026694628260884e-08
APC O 0 1.1475203898214659e-08
polymorphism O 0 1.0770067060406063e-09
, O 0 2.5525998415681928e-12
associated O 0 7.899388608512137e-12
with O 0 1.7939027542081265e-13
an O 0 7.310277193696771e-14
increased O 0 2.8085830102581033e-12
risk O 0 8.980145516090943e-09
of O 0 0.020085955038666725
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.602454974269918e-11
is O 0 2.970432398858615e-14
also O 0 8.507184723110985e-15
present O 0 1.6259102354407307e-13
in O 0 3.5073639413803204e-13
this O 0 1.1393217912072234e-13
family O 0 1.152748469596121e-11
. O 0 1.0885527201853762e-10

The O 0 3.6542765258218424e-08
I1307K O 0 2.825924525495793e-07
polymorphism O 0 9.33598620633802e-09
has O 0 2.7996726031237484e-12
previously O 0 5.3903097263496846e-11
only O 0 1.0782925930191006e-14
been O 0 4.414481611205237e-14
identified O 0 1.0343157265998298e-13
in O 0 3.028475839788984e-14
individuals O 0 9.400587642029775e-15
of O 0 5.860373991639634e-11
self O 0 1.002914551406775e-08
- O 0 1.2071460275819845e-08
reported O 0 8.199355083782223e-11
Ashkenazi O 0 6.889480985705632e-09
Jewish O 0 1.4444881957231814e-09
origins O 0 3.347090427041621e-08
. O 0 4.550887999776876e-10

In O 0 4.764698080528262e-10
addition O 0 1.5654295568157117e-11
, O 0 5.398257795635741e-13
in O 0 1.2368612265032525e-13
this O 0 5.975787796725935e-15
family O 0 2.0080031387648134e-13
, O 0 3.540000324125936e-13
there O 0 5.4559841751932944e-14
appears O 0 2.4376494204246535e-13
to O 0 3.050028762538459e-14
be O 0 1.3248164501197812e-13
no O 0 2.542381669773386e-12
relationship O 0 1.1436201378250965e-12
between O 0 7.316422641345799e-12
the O 0 1.583184625064682e-11
I1307K O 0 1.758806433826976e-09
polymorphism O 0 1.2805678739624682e-10
and O 0 9.56172098963426e-13
the O 0 1.991769813317057e-12
presence O 0 3.5920199106809214e-12
or O 0 2.241198372721076e-11
absence O 0 5.482160059244734e-09
of O 0 1.52658099494829e-08
cancer B-Disease 0 1.0582493104038804e-07
. O 0 1.1849387790419108e-11
. O 0 5.6084147742607726e-11

Identification O 0 9.885042828727819e-08
of O 0 1.3967181189400435e-08
a O 0 1.2556958077503122e-11
novel O 0 1.6785642320549243e-11
mutation O 0 2.906510752562208e-12
of O 0 3.9241132565592807e-10
the O 0 2.9815638846741876e-10
CPO O 1 0.9991430044174194
gene O 0 8.218598024356538e-11
in O 0 2.34248232790224e-12
a O 0 1.1313366909959655e-11
Japanese O 0 5.042646762376535e-07
hereditary B-Disease 1 0.9999951124191284
coproporphyria I-Disease 1 0.9784132242202759
family O 0 1.5135631414864292e-08
. O 0 3.8433896065726e-09

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 1.5846735550439917e-05
HCP B-Disease 1 1.0
) O 0 2.4044253255084413e-09
is O 0 5.304491654950505e-12
an O 0 5.144185424854619e-11
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
characterized O 0 3.4249925118245983e-09
by O 0 1.457989111386393e-11
a O 0 2.4979567303518024e-09
deficiency B-Disease 1 0.7331517934799194
of I-Disease 0 0.29812052845954895
coproporphyrinogen I-Disease 1 0.999091625213623
oxidase I-Disease 0 1.8265508572312683e-07
( O 0 9.598902783736207e-10
CPO O 1 1.0
) O 0 1.2579060189310542e-11
caused O 0 2.4874661358476047e-11
by O 0 1.9742642579350517e-13
a O 0 5.396970305555915e-13
mutation O 0 8.426206780931533e-13
in O 0 1.0780037886654048e-12
the O 0 9.563810160484465e-11
CPO O 0 0.4795430600643158
gene O 0 2.470267768117651e-09
. O 0 1.1399125393607434e-10

Only O 0 8.770728032736486e-10
11 O 0 4.3270289573627e-09
mutations O 0 1.0251881982226152e-10
of O 0 6.062341184609465e-10
the O 0 9.078091750547301e-11
gene O 0 1.5692801225153374e-11
have O 0 3.5390666227675185e-14
been O 0 4.1713147150811147e-13
reported O 0 6.70489141638142e-12
in O 0 1.3085799110967855e-10
HCP B-Disease 1 1.0
patients O 0 2.0311549775442472e-08
. O 0 1.0274928685660711e-09

We O 0 4.2853440240797624e-10
report O 0 8.449853663994311e-12
another O 0 1.9435644500048754e-12
mutation O 0 1.1376589774403367e-12
in O 0 7.167834576750354e-13
a O 0 3.619750549646583e-12
Japanese O 0 1.4891599064981165e-08
family O 0 7.172806099076112e-11
. O 0 2.3409391092243936e-10

Polymerase O 0 2.130879920514417e-06
chain O 0 2.5842220807703598e-08
reaction O 0 2.2883257788652855e-10
- O 0 1.7132468776992482e-09
single O 0 2.5519976756815943e-11
strand O 0 4.290614738500231e-12
conformational O 0 3.818234357161332e-12
polymorphism O 0 2.918839822618757e-11
and O 0 2.1354787512958828e-13
direct O 0 1.2856937736671625e-12
sequence O 0 8.471004930496462e-13
analyses O 0 8.762642521309427e-12
demonstrated O 0 4.323260499594639e-12
a O 0 2.4456795096050588e-12
C O 0 5.1117963195679295e-09
to O 0 2.5275669144481094e-12
T O 0 3.1505964503963924e-09
substitution O 0 1.1639943349461834e-11
in O 0 6.484584462278231e-13
exon O 0 2.005226540369165e-11
1 O 0 1.4359025253540825e-11
of O 0 1.2197392401658291e-11
the O 0 4.928069671089608e-12
CPO O 0 5.8487080423219595e-06
gene O 0 6.256396876264114e-12
at O 0 8.547386756707631e-12
nucleotide O 0 2.2202607807830788e-11
position O 0 4.062189126741167e-11
85 O 0 2.4358914885169725e-10
, O 0 2.584708163645699e-13
which O 0 4.274298674874187e-14
lies O 0 8.644022997383871e-11
in O 0 4.309977667728976e-13
the O 0 2.271910524292986e-12
putative O 0 1.918942088563469e-10
presequence O 0 5.555823801017823e-09
for O 0 5.805719403492726e-13
targeting O 0 5.0993851502534326e-11
to O 0 1.523483769694245e-11
mitochondria O 0 6.980137801093633e-09
. O 0 3.905848700025416e-10

This O 0 4.4194255893748036e-11
mutation O 0 1.6711241765388074e-11
changes O 0 1.3529943224815932e-12
the O 0 3.6240752152721933e-12
codon O 0 1.1205687419635346e-11
for O 0 7.691265159481819e-14
glutamine O 0 1.5236726810807788e-11
to O 0 2.373291721567e-13
a O 0 8.809207703575073e-13
termination O 0 4.87039186758409e-10
codon O 0 5.485022991358335e-10
at O 0 3.2945166039688445e-10
amino O 0 1.5002027398125506e-10
acid O 0 1.4732697006802908e-10
position O 0 3.4873171017579807e-10
29 O 0 2.4054173763943254e-08
. O 0 1.0183517223927296e-10

MaeI O 0 2.1129040760570206e-05
restriction O 0 3.070510790070813e-10
analysis O 0 1.1086830759010624e-10
showed O 0 3.866797507190434e-11
two O 0 1.1162670451609485e-13
other O 0 2.8187713190593218e-14
carriers O 0 1.49882181861051e-13
in O 0 1.4301565574165176e-12
the O 0 2.179772855270823e-11
family O 0 1.6984087747307086e-11
. O 0 6.698223226075939e-11

The O 0 1.5046781243199803e-07
C O 0 0.350039005279541
- O 0 2.7900465283892117e-05
T O 0 1.344497923128074e-05
mutation O 0 3.816057279198981e-12
is O 0 1.731197447223977e-14
located O 0 1.7733127466446064e-11
within O 0 6.765448878204294e-12
a O 0 1.0800598696653063e-12
recently O 0 3.3001923676473366e-12
proposed O 0 3.359427753341082e-12
putative O 0 6.927251133825862e-11
alternative O 0 8.198776380030637e-11
translation O 0 2.3053794984129183e-11
initiation O 0 8.831721812208038e-12
codon O 0 5.384986553891302e-11
( O 0 1.0151449993112127e-12
TIC O 0 1.0978806308514777e-08
- O 0 5.746215725466186e-10
1 O 0 6.641243804894614e-11
) O 0 4.6429382555409834e-14
, O 0 5.912617942992193e-14
supporting O 0 1.093297869771137e-12
that O 0 7.60773686886082e-14
TIC O 0 9.607575179870764e-08
- O 0 2.30107666254753e-09
1 O 0 1.4022527583534838e-10
is O 0 7.415348581485057e-14
the O 0 1.9917734996044434e-12
real O 0 7.289350789640991e-10
TIC O 0 3.833442292489053e-07
rather O 0 3.2281382428278604e-11
than O 0 1.6911476559411387e-12
TIC O 0 1.556447273287631e-07
- O 0 9.314287119366327e-09
2 O 0 8.241693993937815e-10
. O 0 9.339226440807646e-13
. O 0 9.593475319702449e-12

Human B-Disease 0 1.1841477132179534e-08
complement I-Disease 0 8.81474235825408e-08
factor I-Disease 0 7.076772817526944e-06
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 0.00010282033326802775
with O 1 0.9952479004859924
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 2.5006095256685512e-06

This O 0 4.329847938522313e-11
study O 0 1.8427686460098514e-11
reports O 0 1.5224379049105785e-11
on O 0 6.25957480293593e-11
six O 0 1.2477067989902224e-12
cases O 0 1.6814343970980583e-12
of O 0 3.194166042774782e-10
deficiency B-Disease 0 1.3667881049173047e-08
in I-Disease 0 7.361303233643923e-11
the I-Disease 0 9.070424966672874e-11
human I-Disease 0 1.1621968578484632e-12
complement I-Disease 0 1.868847524649775e-12
regulatory I-Disease 0 9.519943861002744e-12
protein I-Disease 0 9.860055480426233e-12
Factor I-Disease 0 4.918475349224849e-11
H I-Disease 1 0.9967750906944275
( O 0 1.130948373145868e-11
FH O 0 1.4555426730566978e-07
) O 0 2.347986341217235e-14
in O 0 6.989282199873492e-15
the O 0 1.8070890581991204e-14
context O 0 3.932094179339568e-13
of O 0 6.1592120292885966e-12
an O 0 1.6103967118152873e-11
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 3.741062126749739e-09

Five O 0 1.2754818534688184e-08
of O 0 4.994182400963609e-09
the O 0 1.1235864669223439e-11
cases O 0 1.0895902236018884e-12
were O 0 2.3906012803012744e-13
observed O 0 2.3666377017839135e-13
in O 0 7.936259613892938e-14
children O 0 3.8437169300273993e-14
presenting O 0 7.467022139495683e-11
with O 0 1.2975157615002786e-09
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9942759871482849
HUS B-Disease 1 1.0
) O 0 1.5025916866306943e-07
. O 0 4.5800794268302525e-09

Two O 0 4.684641008445567e-10
of O 0 1.608697619559507e-09
the O 0 4.0750867957850545e-11
children O 0 3.3957355156932767e-12
exhibited O 0 3.469657672283688e-09
a O 0 1.9353367797236842e-09
homozygous O 0 2.530476194806397e-05
deficiency O 1 0.5758613348007202
characterized O 0 1.0583235621197673e-08
by O 0 1.460636125938386e-11
the O 0 1.6162134131025852e-10
absence O 0 7.336132812341134e-10
of O 0 4.069830583652845e-10
the O 0 9.844834149286275e-12
150 O 0 1.2327737788919713e-11
- O 0 1.5989621085510386e-11
kD O 0 4.667062847296677e-10
form O 0 3.339565386381582e-12
of O 0 5.102819902735867e-11
Factor O 0 1.4135366488421397e-10
H O 1 0.9999998807907104
and O 0 5.099927424812023e-12
the O 0 2.822831161528039e-12
presence O 0 5.292806123935456e-13
, O 0 4.0626556345414386e-14
upon O 0 1.1283321282515302e-12
immunoblotting O 0 1.4502110623482167e-09
, O 0 4.5031066007138187e-13
of O 0 8.338804473317918e-12
the O 0 5.015624634369109e-12
42 O 0 1.2620136879970545e-10
- O 0 5.762896410077545e-11
kD O 0 3.021346284270976e-09
Factor O 0 2.315639902050748e-10
H O 0 0.02326587215065956
- O 0 1.3262247966494556e-09
like O 0 9.883497666118846e-12
protein O 0 4.160026489952173e-12
1 O 0 6.340346997424362e-11
( O 0 7.202713360639212e-13
FHL O 0 1.6434340750492993e-06
- O 0 2.3741736354665477e-10
1 O 0 2.0722677046558502e-11
) O 0 1.212190460178229e-14
and O 0 1.7550888585342317e-14
other O 0 1.1853129697377007e-13
FH O 0 2.1757476531547582e-07
- O 0 6.507090699603424e-11
related O 0 1.408270028369074e-10
protein O 0 7.866780837861853e-11
( O 0 4.791093737022134e-12
FHR O 1 0.641502320766449
) O 0 9.120069283108378e-12
bands O 0 6.454084910956226e-08
. O 0 3.443848331508015e-11

Southern O 0 3.191198061358591e-07
blot O 0 8.563752658119483e-07
and O 0 1.0824408730458757e-10
PCR O 0 3.971901474386641e-09
analysis O 0 4.401832631034663e-12
of O 0 1.7039378588656895e-11
DNA O 0 6.5179790453839814e-09
of O 0 9.275416545939663e-11
one O 0 1.0162918683692679e-12
patient O 0 8.140379481602622e-10
with O 0 1.275062139205474e-10
homozygous O 0 9.588181274011731e-05
deficiency O 0 0.3152574300765991
ruled O 0 1.7475657898557984e-07
out O 0 1.5781046608376315e-11
the O 0 1.7396996386878638e-12
presence O 0 3.784935960569197e-13
of O 0 1.459761651834146e-11
a O 0 1.0299316195901131e-13
large O 0 1.4665051399805062e-13
deletion O 0 1.4150221792907924e-11
of O 0 1.1552296619310454e-10
the O 0 6.452906264886593e-11
FH O 0 4.1095638152910396e-05
gene O 0 2.5157809169229495e-10
as O 0 2.268983178427275e-12
the O 0 2.4169572593324418e-11
underlying O 0 2.674714316697191e-08
defect O 0 1.3988882940907388e-08
for O 0 4.12627779167174e-11
the O 0 8.990654976059886e-08
deficiency O 1 0.9956119060516357
. O 0 6.9364203270083635e-09

The O 0 1.1180000925037348e-08
other O 0 8.614606424039994e-12
four O 0 3.950966290244828e-12
children O 0 1.5986646414219846e-13
presented O 0 3.562376435506387e-11
with O 0 9.555897045876449e-11
heterozygous O 0 2.532610778871458e-07
deficiency O 0 0.0003007175400853157
and O 0 3.5494662764534723e-09
exhibited O 0 7.902929155534366e-07
a O 0 4.4382145181209864e-10
normal O 0 4.442587187014624e-09
immunoblotting O 0 9.451500204704644e-08
pattern O 0 8.843125676172292e-10
of O 0 1.4468366782427466e-10
proteins O 0 2.217212741531527e-12
of O 0 1.9742522894272696e-10
the O 0 1.721119774478197e-10
FH O 0 3.3715288736857474e-05
family O 0 2.4741428350516514e-10
. O 0 2.805181087417452e-10

Factor B-Disease 1 0.9998136162757874
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 1.186938481528843e-11
the O 0 1.0775541917085185e-11
only O 0 4.931482739528592e-12
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 1.9414183327626233e-07
with O 0 1.0742190248436145e-08
HUS B-Disease 1 1.0
. O 0 7.655763134550853e-09

These O 0 7.765658949221432e-11
observations O 0 2.0780168696887813e-09
suggest O 0 4.090450894667086e-11
a O 0 1.2218178942549618e-12
role O 0 1.2695472928134222e-12
for O 0 8.644162317363036e-13
FH O 0 1.309964204665448e-06
and O 0 2.8874561075475924e-10
/ O 0 5.871053421202532e-09
or O 0 4.9805836538352466e-11
FH O 0 1.0884343737416202e-06
receptors O 0 3.444058579993303e-11
in O 0 3.5689576294295478e-12
the O 0 8.552833788422198e-12
pathogenesis O 0 4.483380777742241e-08
of O 0 3.914322643794321e-09
idiopathic O 1 0.9613399505615234
HUS B-Disease 1 1.0
. O 0 1.173576902324669e-09
. O 0 4.370857009661222e-10

Further O 0 1.2111304181772198e-09
evidence O 0 3.3051722470034406e-10
for O 0 1.45692648483714e-12
a O 0 6.065824925682861e-13
major O 0 2.5508976875254774e-11
ancient O 0 1.4178123564079215e-08
mutation O 0 1.0300583852540512e-07
underlying O 0 0.10362859070301056
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 5.7210357340409246e-08
linkage O 0 1.7458326340147323e-08
disequilibrium O 0 1.4997779018699475e-08
studies O 0 4.780158473910445e-12
in O 0 1.969048432333767e-13
the O 0 1.0898832834491112e-12
Japanese O 0 6.207975800087695e-10
population O 0 3.151171272704201e-14
. O 0 2.196017456421173e-12

The O 0 5.3936248150421306e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.0015513121616095304
DM B-Disease 1 1.0
) O 0 2.0733126326888396e-10
mutation O 0 1.5505655787118044e-11
is O 0 4.833493902432068e-14
an O 0 7.956494214563306e-14
unstable O 0 8.708786580768901e-09
( O 0 1.3896667150348208e-10
CTG O 0 0.00019922280625905842
) O 0 6.548623622537608e-12
n O 0 6.466061627102837e-12
repeat O 0 2.3483435682147835e-11
, O 0 5.062843590544763e-13
present O 0 1.3739050045216694e-12
at O 0 2.289629943974525e-11
a O 0 1.263579762740899e-13
copy O 0 1.3436954673928803e-11
number O 0 1.6385624682178218e-13
of O 0 2.403065767209167e-11
5 O 0 4.90190804613988e-11
- O 0 2.5944721371296e-10
37 O 0 2.1921446602402028e-10
repeats O 0 1.1367181501631407e-11
on O 0 1.582363580443502e-11
normal O 0 1.8287350800338942e-11
chromosomes O 0 9.40816652014731e-13
but O 0 3.7939107151024887e-14
amplified O 0 1.732727156200653e-10
to O 0 1.527259330287578e-12
50 O 0 2.3558762579645176e-11
- O 0 3.184042959847311e-11
3000 O 0 4.527049308339359e-12
copies O 0 6.087176769586922e-12
on O 0 6.203028646289965e-10
DM B-Disease 1 1.0
chromosomes O 0 1.0948922657405546e-08
. O 0 1.9449980515062748e-10

Previous O 0 2.4616054972170787e-08
findings O 0 8.679493235241864e-11
in O 0 5.9587699358099044e-12
Caucasian O 0 1.5888999838065132e-10
populations O 0 1.493033344526773e-12
of O 0 2.911255958526482e-11
a O 0 7.167421656184558e-10
DM B-Disease 1 1.0
founder O 1 0.9999991655349731
chromosome O 0 3.882211530026325e-08
raise O 0 1.9137810780556208e-10
a O 0 9.413557607029777e-12
question O 0 3.480635267852361e-12
about O 0 4.5932950097551245e-14
the O 0 8.827440189408675e-13
molecular O 0 3.1341287204389445e-11
events O 0 1.2352515928529262e-12
involved O 0 1.3611684479206132e-12
in O 0 6.668209279019066e-13
the O 0 2.3051319967409833e-12
expansion O 0 2.7348626141510124e-10
mutation O 0 1.313473496633577e-10
. O 0 7.86846143796538e-11

To O 0 7.373643917674144e-10
investigate O 0 3.3011984257313998e-09
whether O 0 6.307405986394343e-11
a O 0 4.477170023609034e-11
founder O 0 7.001141000273492e-08
chromosome O 0 4.0589617777975207e-10
for O 0 5.7117127867656325e-12
the O 0 7.391062206707488e-10
DM B-Disease 1 1.0
mutation O 0 5.673778114001493e-11
exists O 0 8.727959761173354e-13
in O 0 5.3795272544291534e-14
the O 0 9.844279932240754e-14
Japanese O 0 2.3259569617573028e-11
population O 0 5.402565131814284e-16
, O 0 8.699994832894482e-15
we O 0 1.5037176012830042e-14
genotyped O 0 8.345144575372387e-10
families O 0 1.1917862623359965e-15
using O 0 4.4666717156569e-14
polymorphic O 0 1.5147392021241934e-11
markers O 0 9.9944053033596e-10
near O 0 2.0866087524495924e-08
the O 0 1.6722441487093676e-10
( O 0 3.0998377475999206e-11
CTG O 0 1.3051650057605002e-05
) O 0 1.3511278033895291e-11
n O 0 2.2598192414569063e-11
repeat O 0 1.6201887054201336e-10
region O 0 4.3913608860357556e-11
and O 0 6.1313159410714135e-12
constructed O 0 5.1292033731442643e-08
haplotypes O 0 1.643273783713539e-08
. O 0 1.8268637991258885e-10

Six O 0 8.270925277997776e-09
different O 0 9.754257297711622e-12
haplotypes O 0 5.640966582731721e-10
were O 0 2.8266361473683332e-11
found O 0 2.43456661080943e-11
and O 0 1.1842751779234106e-10
DM B-Disease 1 1.0
alleles O 0 1.4989270935572563e-10
were O 0 1.98933050588046e-10
always O 0 7.672127516622496e-11
haplotype O 0 1.4206573695219049e-08
A O 0 7.420435821359206e-08
. O 0 7.609450292100917e-10

To O 0 2.6895524696257667e-10
find O 0 2.469185229544979e-12
an O 0 2.435138747006356e-14
origin O 0 9.846839055943635e-13
of O 0 3.169276993619796e-11
the O 0 3.730896841469544e-11
( O 0 2.5415829163488723e-11
CTG O 0 9.46785894484492e-06
) O 0 5.907122881121385e-12
n O 0 1.3390492707709978e-11
repeat O 0 3.614226626313943e-11
mutation O 0 2.6154868201788695e-12
and O 0 6.94045623923778e-13
to O 0 1.3925064443545687e-13
investigate O 0 1.982299741021265e-11
the O 0 3.24136485881088e-12
mechanism O 0 8.293771919243298e-12
of O 0 3.632213453619304e-12
the O 0 7.474790643217932e-14
expansion O 0 1.2448591419841892e-12
mutation O 0 2.45657477920911e-14
in O 0 3.846562621916995e-14
the O 0 1.2928244900404368e-13
Japanese O 0 1.5684301080121088e-11
population O 0 1.4788733361406034e-16
we O 0 2.5258991002222186e-16
have O 0 2.5883254284348605e-16
studied O 0 1.4176480302163785e-11
90 O 0 2.4794086922463876e-11
Japanese O 0 2.8188109624238677e-09
DM B-Disease 1 1.0
families O 0 1.2058961685115777e-12
comprising O 0 6.939404606498556e-11
190 O 0 4.978306655800679e-10
affected O 0 4.124184327380931e-11
and O 0 3.0302718667662987e-11
130 O 0 4.114289353651657e-09
unaffected O 0 2.083319827761443e-08
members O 0 8.313557481320899e-11
. O 0 2.0892906849034887e-10

The O 0 4.217067584022516e-08
results O 0 1.7735275470442957e-09
suggest O 0 5.015302062538751e-11
that O 0 4.5156444501617127e-14
a O 0 3.725751261327015e-13
few O 0 4.333363095437859e-13
common O 0 1.2121963589156737e-12
ancestral O 0 3.4689130040677085e-11
mutations O 0 9.730113850053845e-13
in O 0 1.1430575453177938e-12
both O 0 5.592453149877441e-12
Caucasian O 0 2.2112178754696288e-10
and O 0 8.185631859836118e-12
Japanese O 0 2.2854089731794147e-09
populations O 0 1.0581594330144953e-13
have O 0 4.1065912229276073e-16
originated O 0 9.511150005601932e-14
by O 0 1.8725768175930236e-15
expansion O 0 2.543094424281578e-12
of O 0 1.0735210463630462e-11
an O 0 1.0974612196660086e-13
ancestral O 0 3.6941037034887714e-11
n O 0 3.3156947239904033e-12
= O 0 3.0137504904853563e-12
5 O 0 1.2667856347237105e-11
repeat O 0 1.2747258977541254e-11
to O 0 3.926834985651384e-12
n O 0 4.52165839492924e-11
= O 0 6.450359690823859e-11
19 O 0 7.545626345972778e-10
- O 0 7.127314849419975e-10
37 O 0 3.211919619161563e-10
copies O 0 7.383717248732324e-11
. O 0 4.911163489773607e-11

These O 0 1.6775632272203467e-10
data O 0 2.0471653539022583e-10
support O 0 3.743954365281743e-12
multistep O 0 1.4696247552237196e-09
models O 0 1.547027228543385e-10
of O 0 9.900620323577414e-10
triplet O 0 6.152554732352655e-08
repeat O 0 1.3640970575323763e-09
expansion O 0 3.908874335323276e-10
that O 0 6.796534770528093e-14
have O 0 5.5440783969164676e-15
been O 0 2.5024043438532512e-14
proposed O 0 1.7711576834073678e-13
for O 0 1.840069437965275e-13
both O 0 2.517080294195395e-11
DM B-Disease 1 1.0
and O 0 4.391233687783824e-08
Friedreichs B-Disease 1 0.9999998807907104
ataxia I-Disease 1 1.0
. O 0 1.991985687510578e-09
. O 0 1.1459165838445529e-09

The O 0 1.6078510745032304e-09
molecular O 0 2.5441171391804573e-09
basis O 0 4.220606086846601e-09
of O 0 5.332497494237032e-06
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 2.0068421924257507e-10
the O 0 1.2244432030794616e-11
western O 0 1.5659858132455184e-10
Cape O 0 7.92956278417023e-09
, O 0 6.714012483997889e-13
South O 0 1.1902830110432916e-10
Africa O 0 4.509436921096288e-11
. O 0 4.317121746894026e-12

Deficiency B-Disease 1 0.997794508934021
of I-Disease 0 2.968975604744628e-05
the I-Disease 0 1.5974617184610906e-08
sixth I-Disease 0 7.327035405069182e-07
component I-Disease 0 1.5261493180318553e-09
of I-Disease 0 5.154864313183793e-10
human I-Disease 0 1.0208111266007958e-11
complement I-Disease 0 3.2147515205416255e-10
( O 0 3.158674016789931e-11
C6 O 0 3.236579505028203e-05
) O 0 4.790417628547372e-12
has O 0 2.828163389785067e-14
been O 0 2.0017153760281195e-14
reported O 0 7.382382059177919e-14
in O 0 2.7378478241577194e-14
a O 0 4.6766501668417046e-14
number O 0 1.5470301228210845e-14
of O 0 4.741979920709627e-13
families O 0 5.347573105900574e-16
from O 0 8.025247540078759e-14
the O 0 4.646404788699598e-13
western O 0 4.0315535632107213e-11
Cape O 0 6.864925072846972e-09
, O 0 2.2207001862395437e-12
South O 0 1.319930414966919e-10
Africa O 0 5.5739052262637756e-11
. O 0 2.448084096551284e-11

Meningococcal B-Disease 1 1.0
disease I-Disease 1 0.9999088048934937
is O 0 3.763995191918834e-12
endemic O 0 4.132602246520456e-11
in O 0 1.5275097809894223e-12
the O 0 1.65071012414586e-11
Cape O 0 1.3513515639829166e-08
and O 0 4.127965872770256e-13
almost O 0 4.6585687239232565e-14
all O 0 6.25987248283966e-15
pedigrees O 0 3.7515192341519565e-11
of O 0 1.1216277906456185e-10
total O 0 1.1884898398761834e-08
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 1.2438189855856763e-07
C6Q0 O 1 1.0
) O 0 1.1247722371543478e-11
have O 0 1.0159186961458937e-14
been O 0 2.5963380954180902e-14
ascertained O 0 5.102449712746093e-11
because O 0 1.5243026025429929e-12
of O 0 2.1019865847904384e-09
recurrent O 1 1.0
disease O 1 0.9999992847442627
. O 0 9.176437942848281e-10

We O 0 3.1538713307632804e-10
have O 0 6.933919584339865e-13
sequenced O 0 1.7094660409444629e-10
the O 0 7.01168506936356e-12
expressed O 0 3.2639344785950763e-12
exons O 0 1.4334057274467682e-09
of O 0 9.50612810690643e-10
the O 0 3.5033709266940605e-10
C6 O 0 8.260358299594373e-05
gene O 0 5.052189222531922e-11
from O 0 2.0713617453205213e-12
selected O 0 7.392125973837427e-12
cases O 0 4.77058334242414e-13
and O 0 2.4418233277381796e-13
have O 0 4.9332845480139914e-14
found O 0 1.5022569776687589e-12
three O 0 8.806267889384378e-13
molecular O 0 6.540621910744449e-08
defects O 0 5.769218478235416e-05
leading O 0 1.317052156224463e-08
to O 0 2.9014384644865387e-11
total O 0 1.1182895720551755e-09
deficiency O 0 1.3714928172703367e-05
879delG O 0 5.729618806071812e-07
, O 0 1.0854546428351597e-11
which O 0 2.308844576030117e-13
is O 0 2.286842082073557e-14
the O 0 6.362825305701592e-13
common O 0 5.83914947643871e-12
defect O 0 2.692488454414388e-10
in O 0 6.838698878020022e-12
the O 0 4.554584487337365e-11
Cape O 0 3.904407464005999e-08
and O 0 4.446869955598842e-12
hitherto O 0 1.0032655956004888e-10
unreported O 0 7.556626158145008e-11
, O 0 3.9467160008882507e-13
and O 0 6.584629217744331e-13
1195delC O 0 1.315951680957994e-09
and O 0 1.1661365449666672e-11
1936delG O 0 3.575572282699113e-09
, O 0 1.1495203660477626e-12
which O 0 1.69545435091574e-14
have O 0 2.1861846253250607e-15
been O 0 5.385409728841245e-14
previously O 0 3.8620929371235846e-12
reported O 0 9.092934196396063e-13
in O 0 3.892948029909915e-12
African O 0 9.276247825429351e-11
- O 0 5.064387242903479e-10
Americans O 0 6.384759908273363e-12
. O 0 2.9919473149009335e-11

We O 0 8.440439458468063e-10
also O 0 8.505607676512206e-12
show O 0 6.075275699179983e-12
that O 0 2.160443929332713e-14
the O 0 1.7761924743509017e-12
879delG O 0 6.702472354902511e-09
and O 0 2.352909256320146e-10
1195delC O 0 2.477090447428054e-06
defects O 0 1.408115053891379e-06
are O 0 8.250787748333155e-13
associated O 0 1.1176919806343832e-10
with O 0 5.4588653042308977e-11
characteristic O 0 0.0038110169116407633
C6 O 1 1.0
/ O 1 0.9999910593032837
C7 O 1 0.9999998807907104
region O 0 3.098967127357355e-08
DNA O 0 5.1926726882811636e-06
marker O 0 5.5941895560351895e-09
haplotypes O 0 2.5613175469452187e-10
, O 0 2.5661842984782413e-13
although O 0 1.4173949828503313e-13
small O 0 3.329787888559782e-13
variations O 0 2.6097088379195554e-10
were O 0 1.288447126768233e-10
observed O 0 2.7004098956950884e-09
. O 0 2.7103780331216853e-10

The O 0 1.0492951219021052e-07
1936delG O 0 8.840974260238e-06
defect O 0 1.6152555417647818e-06
was O 0 2.3078190469760784e-09
observed O 0 3.398471781768109e-11
only O 0 2.2300199610091748e-13
once O 0 6.025534346650041e-13
in O 0 3.997719852637943e-13
the O 0 5.901874475244817e-12
Cape O 0 7.15323578148741e-09
, O 0 9.82074325832881e-14
but O 0 2.0353399158803314e-15
its O 0 7.326720474895229e-14
associated O 0 1.5497436667288866e-11
haplotype O 0 4.733077263452401e-10
could O 0 8.662421474570081e-12
be O 0 2.99309318649299e-12
deduced O 0 6.937743712853717e-09
. O 0 5.272048353432979e-10

The O 0 6.703060329016353e-09
data O 0 2.7175420247438353e-10
from O 0 2.194933991506165e-11
the O 0 2.7410901239782737e-12
haplotypes O 0 3.238257925697319e-11
indicate O 0 1.4034874607979364e-12
that O 0 4.826176893020506e-15
these O 0 1.6611564283407904e-13
three O 0 1.3857586952936707e-12
molecular O 0 7.456270267880427e-09
defects O 0 1.0096344738030893e-07
account O 0 4.1412403020690824e-12
for O 0 2.7729213022964494e-11
the O 0 5.262175584164197e-09
defects O 0 5.08603579874034e-06
in O 0 1.354136663911376e-10
all O 0 1.3030822948456589e-11
the O 0 9.019084784567255e-11
38 O 0 1.287386419690506e-09
unrelated O 0 7.668214507816629e-09
C6Q0 O 1 0.6781694293022156
individuals O 0 3.5362145611901596e-13
we O 0 1.7499021708663326e-13
have O 0 5.0397058522103164e-15
studied O 0 3.639149745437997e-11
from O 0 1.0219878762707246e-11
the O 0 1.8453292713327407e-11
Cape O 0 5.877643971530233e-08
. O 0 8.301072329519599e-11

We O 0 9.749394624947172e-10
have O 0 7.659253006137012e-13
also O 0 3.4783441860315734e-13
observed O 0 6.762390994397016e-12
the O 0 6.987666955476923e-12
879delG O 0 2.476798677264469e-08
defect O 0 2.0771846465095223e-09
in O 0 4.1437152320522586e-11
two O 0 6.59996293728149e-11
Dutch O 1 0.8638378977775574
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 0 4.011672444903525e-06
, O 0 1.2099124653552895e-11
but O 0 8.165943778375845e-14
the O 0 5.921358889326989e-12
879delG O 0 2.303211665832805e-08
defect O 0 3.2448090880876634e-09
in O 0 2.2707202437799445e-11
the O 0 1.7251094996950656e-10
Cape O 0 1.9632618375453603e-07
probably O 0 2.3371771531999208e-11
did O 0 5.491253068576341e-13
not O 0 1.714406374297376e-14
come O 0 7.647483042877781e-14
from O 0 8.834817643091353e-13
The O 0 4.8627196019834784e-12
Netherlands O 0 5.198053099064737e-09
. O 0 1.8638745061250184e-12
. O 0 1.693608274455638e-11

Complement B-Disease 1 1.0
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 1.4576519546949385e-08
seven O 0 3.6202860154155303e-10
further O 0 1.940091490237883e-11
molecular O 0 5.602477699540032e-07
defects O 0 0.0018493377137929201
and O 0 2.0290502611430838e-10
their O 0 4.1046382959208927e-10
associated O 0 8.683641361528771e-09
marker O 0 7.20892842309695e-07
haplotypes O 0 8.50343511160645e-08
. O 0 1.2811034455495474e-09

Seven O 0 9.698728042906168e-09
further O 0 4.515106170888128e-12
molecular O 0 1.5061324409870736e-09
bases O 0 5.0286814712308114e-08
of O 1 0.5314829349517822
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 3.457407971030335e-10
described O 0 1.0608411926682493e-09
. O 0 1.5192362645688462e-10

All O 0 6.650893724646778e-10
these O 0 5.3998975430014085e-12
new O 0 3.782313004463411e-11
molecular O 0 3.827414474244506e-08
defects O 0 2.6960685772792203e-07
involve O 0 4.683113341563683e-10
single O 0 1.6285486292844098e-09
- O 0 7.869471185806276e-10
nucleotide O 0 1.1377512126875544e-10
events O 0 4.840187712434885e-12
, O 0 5.51229363803668e-13
deletions O 0 2.099920758114049e-11
and O 0 1.8182963815172037e-12
substitutions O 0 6.029878263369426e-10
, O 0 9.171245577213605e-13
some O 0 5.098472913387525e-14
of O 0 8.09224128678343e-12
which O 0 1.683673545634784e-13
alter O 0 3.5293132305547203e-10
splice O 0 7.135915414124838e-09
sites O 0 1.5942548670100365e-10
, O 0 5.401421931255923e-12
and O 0 5.969713005177235e-12
others O 0 4.7527960733706465e-11
codons O 0 1.7452865819223007e-08
. O 0 7.584194383625231e-10

They O 0 4.8879126440803944e-11
are O 0 1.0640204944336804e-13
distributed O 0 3.092069243877671e-13
along O 0 1.3776186788549971e-11
the O 0 6.286435955127345e-11
C7 O 0 8.164162136381492e-05
gene O 0 5.722631396531952e-11
, O 0 2.0723841479691751e-13
but O 0 3.238671554924759e-15
predominantly O 0 1.0784247979215081e-13
towards O 0 2.6202603455038886e-12
the O 0 3.4385432869099564e-12
3 O 0 6.105613237217256e-10
end O 0 1.9445713095311845e-10
. O 0 7.352728842446865e-11

All O 0 6.960298448710489e-10
were O 0 5.333733107959482e-11
found O 0 1.2561982704051289e-12
in O 0 2.5429864377451983e-13
compound O 0 6.997780827022737e-11
heterozygous O 0 1.368191844541844e-11
individuals O 0 6.281144224531965e-13
. O 0 7.217934028247441e-10

The O 0 2.9792413442919496e-06
C6 O 1 1.0
/ O 1 0.9997252821922302
C7 O 1 0.9999877214431763
marker O 0 4.946075478073908e-07
haplotypes O 0 5.980925976700746e-09
associated O 0 3.97690269604567e-10
with O 0 2.6641045272612907e-11
most O 0 3.755145083772504e-09
C7 B-Disease 1 1.0
defects I-Disease 1 0.9999998807907104
are O 0 1.2589770892468266e-10
tabulated O 0 6.577653266504058e-08
. O 0 5.1570255010791044e-11
. O 0 9.875267964476464e-11

A O 0 2.1177440885367105e-06
genome O 0 6.004376995605298e-10
- O 0 9.305031190010027e-10
wide O 0 4.2273854555796575e-11
search O 0 2.0094178057594725e-12
for O 0 1.9228595224320827e-13
chromosomal O 0 6.761307957958707e-08
loci O 0 3.71680153321563e-09
linked O 0 2.5548072812853206e-07
to O 0 3.577050600167553e-10
mental O 1 0.9999990463256836
health O 0 5.048214575253951e-07
wellness O 0 2.6195566533715464e-06
in O 0 1.8096095802389023e-11
relatives O 0 8.619129715503604e-11
at O 0 8.161086251234906e-10
high O 0 7.608224450450507e-08
risk O 0 4.7807495739959904e-09
for O 0 7.036631188839237e-08
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 0 1.7656464068593891e-09
the O 0 9.639430365027124e-10
Old O 0 3.339317444783774e-08
Order O 0 2.689384492882141e-09
Amish O 0 6.827997367508942e-07
. O 0 2.8415084174504557e-10

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.5302575826644897
BPAD B-Disease 1 1.0
; O 1 0.9999998807907104
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 5.443773432034504e-09
is O 0 6.1474055013110984e-12
characterized O 0 1.9811552398607546e-10
by O 0 3.5505441902533574e-12
episodes O 0 9.640778841912834e-09
of O 0 2.126606979402368e-08
mania B-Disease 0 7.235901193780592e-07
and O 0 3.156370720347468e-09
/ O 0 2.8669594485108973e-06
or O 0 8.747742974435369e-09
hypomania B-Disease 1 0.9999920129776001
interspersed O 0 1.1540343791693886e-07
with O 0 4.5123774508604164e-12
periods O 0 5.8454237006344556e-08
of O 0 7.567858517631976e-08
depression B-Disease 1 0.9999557733535767
. O 0 1.8730934581157044e-09

Compelling O 0 4.121627128483851e-08
evidence O 0 8.27286594784482e-09
supports O 0 1.6704906902198502e-10
a O 0 8.349685960001851e-13
significant O 0 6.258481688621587e-13
genetic O 0 3.7301141342371835e-11
component O 0 6.892312415240909e-11
in O 0 1.019611912261853e-12
the O 0 2.346923003160306e-12
susceptibility O 0 5.081348120050677e-10
to O 0 2.8815731051290427e-11
develop O 0 3.074835603911197e-06
BPAD B-Disease 1 1.0
. O 0 1.6505582678405517e-08

To O 0 9.456319755019038e-11
date O 0 1.5556473886846334e-09
, O 0 8.788079313738761e-13
however O 0 9.070410980464849e-14
, O 0 6.954551816156992e-14
linkage O 0 1.235379507025236e-11
studies O 0 9.465115323459283e-13
have O 0 9.222703099809847e-15
attempted O 0 4.306769177397918e-11
only O 0 3.8026985125236626e-14
to O 0 7.523124918168422e-13
identify O 0 2.3746990485129515e-10
chromosomal O 0 2.6857418333747773e-07
loci O 0 4.661102059877464e-10
that O 0 8.409653724263111e-13
cause O 0 3.3103772500986395e-10
or O 0 4.452930212062167e-12
increase O 0 7.857670135218153e-13
the O 0 8.393216677227144e-12
risk O 0 5.3807566041674804e-11
of O 0 9.336711404017706e-10
developing O 0 3.136244970391999e-07
BPAD B-Disease 1 1.0
. O 0 6.4062879445714316e-09

To O 0 1.3922833996815598e-09
determine O 0 8.444013821495844e-10
whether O 0 3.704596351905565e-11
there O 0 8.937578867100615e-13
could O 0 1.3547062777119478e-12
be O 0 1.0525037872494147e-12
protective O 0 6.555134035579613e-08
alleles O 0 6.162757478812841e-13
that O 0 1.3701065394798161e-14
prevent O 0 1.1726493907848745e-11
or O 0 3.655482166964319e-12
reduce O 0 2.932444218006758e-11
the O 0 6.731057117931316e-12
risk O 0 6.708357827567291e-12
of O 0 2.523494191386533e-10
developing O 0 8.09734856943578e-09
BPAD B-Disease 1 1.0
, O 0 7.60140648342622e-12
similar O 0 7.138106295281887e-13
to O 0 1.4214343135691976e-13
what O 0 2.0572600697640886e-14
is O 0 4.170435325475275e-15
observed O 0 1.4247621366123703e-13
in O 0 2.7287154198522845e-13
other O 0 3.153510508280277e-10
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 1.7391971196545342e-10
we O 0 5.600989507262288e-13
used O 0 3.3993874382076683e-10
mental O 1 0.7316468954086304
health O 0 7.816343128297376e-08
wellness O 0 2.4677889086888172e-05
( O 0 2.1355870197248272e-11
absence O 0 6.001632080199215e-09
of O 0 2.3968154128084507e-09
any O 0 1.294895080050651e-09
psychiatric B-Disease 1 1.0
disorder I-Disease 1 1.0
) O 0 3.801114804857786e-12
as O 0 1.046484622048427e-12
the O 0 1.080938290265454e-11
phenotype O 0 2.602217052949385e-11
in O 0 7.389461438578326e-12
our O 0 8.48603687320093e-11
genome O 0 1.3080002359000531e-11
- O 0 6.17751350073803e-10
wide O 0 1.9495030589844475e-10
linkage O 0 5.805196323649398e-10
scan O 0 5.2639927972109035e-09
of O 0 1.5352343007979385e-10
several O 0 2.7682433168668696e-12
large O 0 2.632504457478202e-11
multigeneration O 0 2.3256645818037214e-06
Old O 0 3.024882389013328e-08
Order O 0 3.495401468267545e-10
Amish O 0 1.1853152415142176e-07
pedigrees O 0 1.77100343279335e-08
exhibiting O 0 3.9874468171774424e-09
an O 0 3.834092331816974e-12
extremely O 0 1.3501193496523456e-09
high O 0 1.5997905222775444e-07
incidence O 0 4.3934119275945704e-07
of O 0 1.0782839865441929e-07
BPAD B-Disease 1 1.0
. O 0 3.74079256459936e-08

We O 0 7.529380452453438e-10
have O 0 1.5056936817151034e-12
found O 0 7.456656819782026e-12
strong O 0 5.091947263141661e-12
evidence O 0 2.4956970517964194e-11
for O 0 5.935682717908564e-13
a O 0 1.1901842358885695e-12
locus O 0 9.662449659830763e-12
on O 0 1.3188689029774991e-09
chromosome O 0 7.023246872961408e-09
4p O 0 9.67411892816017e-07
at O 0 1.1003333355574796e-08
D4S2949 O 0 6.195265456199195e-08
( O 0 1.1715964136349566e-11
maximum O 0 4.26932073027686e-10
GENEHUNTER O 0 0.018721893429756165
- O 0 2.322374292873519e-08
PLUS O 0 1.6736880326106984e-08
nonparametric O 0 1.556969309035594e-08
linkage O 0 8.184422584101014e-10
score O 0 2.1600940480759334e-10
= O 0 3.808814808686778e-12
4 O 0 1.1286297417478774e-11
. O 0 6.37861820112183e-14
05 O 0 1.0010794415649116e-09
, O 0 1.884942505900322e-12
P O 0 4.385345142576824e-10
= O 0 2.1826132481223004e-12
5 O 0 5.821156490865009e-12
. O 0 2.6685962738626917e-14
22 O 0 1.4408703180243676e-12
x O 0 1.95323813546866e-12
10 O 0 5.8706628967841734e-12
( O 0 3.993391175464295e-13
- O 0 5.245315640167725e-11
4 O 0 4.045179122225129e-11
) O 0 5.1400683297349314e-14
; O 0 3.0079140133504323e-13
SIBPAL O 0 3.3732474093994824e-06
Pempirical O 0 2.261603526676481e-08
value O 0 2.5744755719619983e-12
< O 0 8.528252756767607e-12
3 O 0 7.803993562482958e-12
x O 0 7.49677230016399e-12
10 O 0 4.752521726852921e-12
( O 0 1.0308513618455598e-13
- O 0 1.1766396017243164e-11
5 O 0 5.5777626441211314e-12
) O 0 2.8819865737590364e-14
) O 0 1.5489964251048406e-14
and O 0 1.8705654700971325e-13
suggestive O 0 3.7497754901139047e-10
evidence O 0 2.0290413446644173e-11
for O 0 2.0283971171545373e-13
a O 0 7.440031663669133e-13
locus O 0 9.54620063553513e-12
on O 0 1.0239205039397348e-09
chromosome O 0 5.292856819494318e-09
4q O 0 3.8283019421214703e-07
at O 0 2.408303556578062e-09
D4S397 O 0 2.245956132185256e-08
( O 0 9.291737518291043e-12
maximum O 0 4.868088709919505e-10
GENEHUNTER O 0 0.059413909912109375
- O 0 1.2866900434005402e-08
PLUS O 0 1.2370602320288526e-08
nonparametric O 0 7.775375010510288e-09
linkage O 0 5.368581135201111e-10
score O 0 5.1207791479379594e-11
= O 0 9.278256331637924e-13
3 O 0 3.1066427642195693e-12
. O 0 3.23119487980264e-14
29 O 0 3.379493559996227e-11
, O 0 7.491122522643168e-13
P O 0 3.542356408203773e-10
= O 0 1.1153227863838766e-12
2 O 0 3.3957097116815715e-12
. O 0 1.6111623753894966e-14
57 O 0 4.209328632182041e-12
x O 0 1.6708872783641193e-12
10 O 0 4.679661606138419e-12
( O 0 2.9098373558779367e-13
- O 0 4.90260922136887e-11
3 O 0 1.1654916615144728e-11
) O 0 1.1845710027572239e-14
; O 0 6.310284326321858e-14
SIBPAL O 0 2.456271658957121e-06
Pempirical O 0 6.806047725405051e-09
value O 0 9.201030779296127e-13
< O 0 6.437573564499477e-12
1 O 0 1.4660229627483368e-11
x O 0 1.286754296864201e-11
10 O 0 2.0835036820820996e-11
( O 0 8.015246452663938e-13
- O 0 7.601265450407624e-11
3 O 0 3.487728161832848e-11
) O 0 1.345565538602312e-14
) O 0 1.1486068520255772e-15
that O 0 1.7120190225234516e-16
are O 0 1.3154614794371258e-14
linked O 0 2.8511517591311986e-09
to O 0 2.265037463144992e-10
mental O 1 0.9999998807907104
health O 0 1.4748655303264968e-05
wellness O 0 0.0017408907879143953
. O 0 8.342630475333124e-10

These O 0 1.099156099471088e-09
findings O 0 7.292869086406029e-10
are O 0 1.9551389587174617e-12
consistent O 0 3.371608270352766e-10
with O 0 1.1957087880584694e-12
the O 0 5.524526582728617e-12
hypothesis O 0 1.3457935287009004e-11
that O 0 2.8368818999111554e-15
certain O 0 2.0214498477888476e-12
alleles O 0 9.19883852250336e-13
could O 0 2.4465052379796237e-12
prevent O 0 2.0420799773379628e-10
or O 0 2.3231859144767775e-11
modify O 0 1.459545817539265e-09
the O 0 5.7973150585644007e-11
clinical O 0 1.794211712535798e-08
manifestations O 0 8.979925041785464e-06
of O 0 1.1168309583808878e-06
BPAD B-Disease 1 1.0
and O 0 3.6941480430208173e-10
perhaps O 0 4.333671008854845e-12
other O 0 2.3128389394638793e-12
related O 0 2.1586854927591048e-05
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 0 3.270602988436622e-08

Segregation O 0 0.024916868656873703
distortion O 0 0.0013910540146753192
in O 0 8.38563039451401e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 4.8653458861736e-07

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9994137287139893
DM B-Disease 1 1.0
) O 0 1.2927530157469391e-09
is O 0 8.113905597753601e-13
an O 0 1.1256709540191645e-12
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.9999322891235352
which O 0 5.406067845985241e-13
, O 0 3.820765386475418e-14
in O 0 7.80279500408633e-14
the O 0 1.8491263208131326e-12
typical O 0 1.0376863951444548e-10
pedigree O 0 2.239229912603946e-10
, O 0 1.1174734098132189e-12
shows O 0 2.3967431771881875e-12
a O 0 9.413264438762337e-13
three O 0 2.301389114001129e-12
generation O 0 6.388615192420843e-10
anticipation O 0 4.1862538324721754e-08
cascade O 0 4.824542338610627e-05
. O 0 2.1007652506455088e-08

This O 0 1.2444038854919626e-11
results O 0 1.6456841445133819e-10
in O 0 1.8539983437371177e-10
infertility B-Disease 1 0.999995231628418
and O 1 0.9756070375442505
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.42979581344116e-06
CDM B-Disease 1 0.6009175181388855
) O 0 1.5300175406143812e-12
with O 0 5.140989901581544e-14
the O 0 1.1365229937720933e-11
disappearance O 0 7.167011428776959e-10
of O 0 1.8280053026842324e-08
DM B-Disease 1 1.0
in O 0 8.858488387275543e-10
that O 0 8.341667634415018e-12
pedigree O 0 1.3305784030137602e-08
. O 0 2.037391921838605e-10

The O 0 2.3195796394759327e-09
concept O 0 5.272661751654084e-10
of O 0 6.634207627698174e-10
segregation O 0 2.9719826599716725e-08
distortion O 0 1.7494926396466326e-08
, O 0 2.352299670153879e-13
where O 0 6.649712789956463e-14
there O 0 5.967174001047951e-16
is O 0 5.768005850204127e-16
preferential O 0 3.1166133042381805e-12
transmission O 0 6.158076132356527e-11
of O 0 1.1077820952221096e-11
the O 0 7.865557163921899e-13
larger O 0 1.225526624626383e-12
allele O 0 1.5495653805236431e-12
at O 0 4.581000509484845e-11
the O 0 3.522223485097342e-11
DM B-Disease 1 1.0
locus O 0 9.610292422967959e-11
, O 0 1.0423669306175443e-12
has O 0 1.88570286366015e-14
been O 0 2.859969205903923e-13
put O 0 1.3619923765195718e-11
forward O 0 2.8469265139774436e-11
to O 0 5.914707200578573e-13
explain O 0 1.656529254046024e-11
partially O 0 1.3265208931301231e-09
the O 0 1.6312640474525075e-11
maintenance O 0 3.698297632581671e-07
of O 0 6.690520137908607e-08
DM B-Disease 1 1.0
in O 0 1.6363504995453582e-10
the O 0 1.8437354074030132e-11
population O 0 5.207457254578947e-14
. O 0 1.5752169534033467e-12

In O 0 1.9223060920836588e-09
a O 0 2.1402763242250877e-11
survey O 0 4.441480863648373e-11
of O 0 1.3904841722478523e-09
DM B-Disease 1 1.0
in O 0 8.220640279610336e-10
Northern O 0 2.725071368558929e-08
Ireland O 0 7.882394292835215e-09
, O 0 1.1144493314296788e-11
59 O 0 5.944449932293594e-10
pedigrees O 0 6.522655304763703e-09
were O 0 1.9431402320524427e-10
ascertained O 0 6.636200566845218e-08
. O 0 1.6397255775402186e-09

Sibships O 0 3.1453582778340206e-05
where O 0 3.69069691474877e-10
the O 0 4.576806381800802e-12
status O 0 9.545198832727753e-12
of O 0 2.3753591107955607e-11
all O 0 1.6879950399690397e-13
the O 0 1.1228596177859096e-12
members O 0 9.038237280996342e-14
had O 0 1.3049290651951512e-13
been O 0 9.478262765578657e-14
identified O 0 5.004479903397696e-13
were O 0 1.780473121368309e-12
examined O 0 3.732436026915309e-10
to O 0 1.3319875801290348e-12
determine O 0 1.963788333336769e-11
the O 0 1.2309199666493686e-11
transmission O 0 3.8247982558914373e-10
of O 0 3.999632569584577e-10
the O 0 4.6157083710696156e-10
DM B-Disease 1 1.0
expansion O 0 3.141918947235922e-09
from O 0 5.947509151837949e-11
affected O 0 2.1032398045406353e-11
parents O 0 1.1298848141827467e-12
to O 0 1.4336496399758314e-12
their O 0 3.4741570731355864e-11
offspring O 0 2.6312219070234732e-09
. O 0 2.1499782509870613e-10

Where O 0 2.473256710544547e-09
the O 0 2.787574615581434e-10
transmitting O 0 1.2861359266480576e-07
parent O 0 1.6847980788270434e-09
was O 0 6.447918199370406e-09
male O 0 1.685526856975983e-10
, O 0 9.61881529287778e-12
58 O 0 3.749705879130261e-09
. O 0 9.369227615962927e-11

3 O 0 1.102757973825419e-08
% O 0 1.9433272265695356e-12
of O 0 1.4265854123007848e-11
the O 0 1.8571639451986366e-12
offspring O 0 4.5446029751927686e-12
were O 0 2.9834719764143536e-12
affected O 0 1.0068037549493258e-11
, O 0 7.366801396332945e-13
and O 0 3.1763117526797946e-13
in O 0 7.975535921793397e-13
the O 0 3.9985357147727385e-13
case O 0 1.7484341611247872e-13
of O 0 2.266629809191678e-12
a O 0 2.6190497253580913e-13
female O 0 1.5675800501407933e-12
transmitting O 0 8.8753031590727e-09
parent O 0 2.3408019966808524e-09
, O 0 2.9898095110780787e-10
68 O 0 2.408264379027969e-07
. O 0 5.689700377509155e-10

7 O 0 2.483237437900243e-07
% O 0 3.379345414611379e-11
were O 0 4.878747753012114e-11
affected O 0 1.465892962571047e-09
. O 0 6.144223463344645e-10

Studies O 0 1.2280890082649876e-08
on O 0 6.904135041452264e-09
meiotic O 0 2.7468902885630087e-07
drive O 0 2.88049895047493e-09
in O 0 1.3397295772765716e-10
DM B-Disease 1 1.0
have O 0 4.137337987399764e-13
shown O 0 2.5064279536406164e-13
increased O 0 4.072213554318256e-14
transmission O 0 1.700386012548627e-11
of O 0 2.7071615348733813e-12
the O 0 2.304937382451022e-13
larger O 0 3.3489912774388453e-13
allele O 0 1.8752344512276697e-13
at O 0 1.6644279704491893e-11
the O 0 1.3764683837180769e-11
DM B-Disease 1 1.0
locus O 0 1.2571919894011074e-10
in O 0 7.015109847186007e-12
non O 0 4.673721889503213e-07
- O 0 6.7219357333669905e-06
DM O 1 1.0
heterozygotes O 0 1.4073161480609997e-07
for O 0 4.103878903372049e-10
CTGn O 0 0.00010733849194366485
. O 0 2.2585717740497557e-09

This O 0 1.020511366384147e-11
study O 0 3.871312125036663e-12
provides O 0 1.5009044354585832e-13
further O 0 4.9324188803418975e-14
evidence O 0 5.60263814508577e-12
that O 0 2.6992597135862446e-14
the O 0 1.7390668766159578e-11
DM B-Disease 1 1.0
expansion O 0 7.692237957712678e-09
tends O 0 6.3015745399575e-11
to O 0 4.06237137028434e-13
be O 0 8.077526278058023e-13
transmitted O 0 8.306872967267509e-10
preferentially O 0 1.576027641725375e-09
. O 0 1.0782599119130154e-10

Diagnosis O 1 1.0
of O 1 0.9984344840049744
hemochromatosis B-Disease 1 1.0
. O 0 4.237653001837316e-07

If O 0 6.414739459614793e-07
untreated O 1 1.0
, O 0 2.8303305953158997e-05
hemochromatosis B-Disease 1 1.0
can O 0 2.982701801101939e-07
cause O 1 0.9999908208847046
serious O 1 1.0
illness O 1 1.0
and O 0 8.48788261897937e-11
early B-Disease 0 1.3084632266568974e-09
death I-Disease 0 2.0269934619676633e-09
, O 0 1.9696156055952485e-13
but O 0 1.764857520108326e-14
the O 0 1.4024606996565492e-11
disease O 0 6.287824305672984e-08
is O 0 2.5751900544174026e-14
still O 0 1.2845607010817522e-13
substantially O 0 6.560115645148912e-11
under O 0 3.073760694860539e-07
- O 1 0.999448835849762
diagnosed O 0 2.646135544637218e-05
. O 0 6.92557677872685e-10

The O 0 1.5361351302090043e-08
cornerstone O 0 1.1184148206666578e-05
of O 0 2.6084561177697196e-09
screening O 0 1.7251063078038698e-10
and O 0 8.64135965474716e-13
case O 0 3.7841420535283943e-13
detection O 0 8.818097363416655e-10
is O 0 1.732340433483002e-14
the O 0 4.262453088513425e-14
measurement O 0 5.0890760355803977e-11
of O 0 1.9858227909286263e-11
serum O 0 2.023916104154644e-11
transferrin O 0 4.975702835863238e-11
saturation O 0 2.0975710751658383e-11
and O 0 2.5676201616253724e-12
the O 0 1.0998595263711497e-11
serum O 0 1.0475825762412683e-09
ferritin O 0 4.3138459915326166e-08
level O 0 1.1988436909859956e-09
. O 0 2.595975691355168e-11

Once O 0 7.063174933819028e-08
the O 0 4.93376506316423e-10
diagnosis O 0 3.9788648109606584e-07
is O 0 3.94929152314899e-13
suspected O 0 2.779124486096407e-09
, O 0 5.495227103219369e-12
physicians O 0 3.7558595122888505e-10
must O 0 4.4663695485114285e-12
use O 0 2.5978194595488446e-10
serum O 0 4.6606444925600954e-08
ferritin O 0 3.8458080098280334e-07
levels O 0 5.042076534067519e-09
and O 0 5.806281566655969e-10
hepatic O 0 1.538839569548145e-05
iron O 0 2.6854530005948618e-05
stores O 0 3.4967452933187815e-08
on O 0 2.4838902490387227e-08
liver O 0 5.709044330615143e-07
biopsy O 0 1.8536040258254616e-08
specimens O 0 3.216505395364777e-10
to O 0 4.259361092995295e-12
assess O 0 4.50473880420077e-09
patients O 0 6.072498753839639e-11
for O 0 3.4995073245475128e-12
the O 0 7.081212699544537e-11
presence O 0 3.2161190377522075e-10
of O 0 2.1143446815585776e-07
iron B-Disease 1 0.6547905206680298
overload I-Disease 0 1.4909220226400066e-05
. O 0 2.1350026191413463e-09

Liver O 1 0.8900861740112305
biopsy O 0 6.054709228919819e-05
is O 0 7.959208292440678e-11
also O 0 1.1732842345249517e-12
used O 0 1.9634389600287072e-12
to O 0 5.218904735454499e-13
establish O 0 6.769814570040111e-11
the O 0 8.410412123682764e-12
presence O 0 2.082092311062045e-12
or O 0 7.024656030474308e-12
absence O 0 2.202106941240345e-09
of O 0 1.028877871789291e-08
cirrhosis B-Disease 1 1.0
, O 0 2.0962619660946924e-12
which O 0 9.171555523509664e-14
can O 0 1.3315245444862206e-13
affect O 0 1.8476474517026276e-10
prognosis O 0 1.975991636982144e-07
and O 0 9.316449833818297e-10
management O 0 1.0082754897666746e-06
. O 0 3.131413350843104e-09

A O 0 2.6940841735267895e-07
DNA O 0 5.4776890578978055e-08
- O 0 1.5504746098127242e-10
based O 0 6.096704738278724e-12
test O 0 1.1616234016353921e-11
for O 0 3.7540903409993484e-14
the O 0 1.7779923583774448e-12
HFE O 0 2.5572950107743964e-05
gene O 0 1.6349333345488937e-11
is O 0 6.600528805434606e-15
commercially O 0 7.454268105555606e-12
available O 0 1.1731314162287398e-13
, O 0 3.911021490389868e-14
but O 0 1.7497735573836215e-15
its O 0 2.175719660316676e-14
place O 0 7.191401879373671e-13
in O 0 6.178172936351783e-14
the O 0 4.758388236388023e-13
diagnosis O 0 6.061190305217679e-08
of O 0 7.524905143441174e-09
hemochromatosis B-Disease 1 1.0
is O 0 1.307803258049356e-11
still O 0 3.1351316941846674e-12
being O 0 9.413700721716545e-12
evaluated O 0 9.916406362719954e-09
. O 0 1.700112051139513e-09

Currently O 0 2.445367286441069e-08
, O 0 9.154436757252693e-12
the O 0 4.6011562615522195e-12
most O 0 4.545508799002826e-14
useful O 0 5.46919822798364e-13
role O 0 4.985672790412676e-13
for O 0 8.226411766414435e-14
this O 0 7.177472591962664e-15
test O 0 6.662923251327113e-12
is O 0 2.571095666556965e-15
in O 0 8.087662009830139e-15
the O 0 3.3974877761393935e-14
detection O 0 2.796922693448778e-09
of O 0 7.902998810926931e-10
hemochromatosis B-Disease 1 1.0
in O 0 1.554880529885949e-11
the O 0 2.0529161703919385e-11
family O 0 5.171737062041604e-13
members O 0 4.970064073836489e-13
of O 0 3.3040567504194485e-10
patients O 0 6.710831890188729e-11
with O 0 7.726827858101082e-12
a O 0 2.8530158791006954e-10
proven O 0 2.530568394831789e-07
case O 0 1.13280396174531e-09
of O 0 3.0346487989163506e-08
the O 0 5.781941325722073e-08
disease O 0 1.5674355381634086e-05
. O 0 3.1134303468682845e-11

It O 0 7.923661726749742e-10
is O 0 1.713137270931142e-11
crucial O 0 4.9449031536141774e-09
to O 0 3.4678644400543135e-09
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 1.0
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 0.00015880283899605274
because O 0 1.2894293632825793e-08
phlebotomy O 1 1.0
therapy O 1 1.0
can O 0 5.2172430820007776e-09
avert O 1 1.0
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 0 4.660451191629278e-11
can O 0 6.043559207767613e-13
even O 0 4.282545238570856e-12
lead O 0 6.567239113630663e-11
to O 0 5.485328445804794e-13
normal O 0 1.901239859991577e-10
life O 0 1.1072982808446596e-11
expectancy O 0 1.1782408382288168e-11
. O 0 1.0236938656786251e-13
. O 0 3.054444501146558e-12

Prevalence O 0 1.6254450656560948e-06
of O 0 2.6633925287455895e-08
the O 0 1.0888813184450896e-09
I1307K O 0 7.948279403535707e-07
APC B-Disease 0 2.182306104714371e-07
gene O 0 2.182723723986868e-10
variant O 0 1.235311852809673e-10
in O 0 5.454290990213051e-13
Israeli O 0 3.55771141713479e-11
Jews O 0 2.128478643337317e-11
of O 0 7.879826131873546e-12
differing O 0 1.48121302007663e-13
ethnic O 0 6.663879246592702e-15
origin O 0 1.3121945750035197e-13
and O 0 2.3029169717025955e-12
risk O 0 8.867515055577257e-10
for O 0 4.291176196602464e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.685261677574772e-09

BACKGROUND O 0 0.00021847461175639182
& O 0 4.6137683966662735e-06
AIMS O 0 3.621277144816304e-08
Israeli O 0 3.5499247985626425e-10
Jews O 0 2.6392829588495204e-10
of O 0 1.5773020389797665e-10
European O 0 5.196573171772911e-10
birth O 0 5.508467904036252e-09
, O 0 8.760319726575094e-12
i O 0 2.9711207452653987e-12
. O 0 9.809622732170897e-14
e O 0 6.693260854416516e-13
. O 0 1.360588887649311e-13
, O 0 2.936050924953748e-13
Ashkenazim O 0 1.0369474168214765e-08
, O 0 2.4849373860685864e-12
have O 0 4.790138690433446e-14
the O 0 4.213507667771843e-11
highest O 1 0.9999920129776001
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 6.397144858283355e-08
of O 0 8.083021058036266e-11
any O 0 8.857731171804661e-13
Israeli O 0 3.930107794758442e-09
ethnic O 0 8.903028488049802e-12
group O 0 7.153460462872019e-11
. O 0 3.66407008900449e-11

The O 0 3.733002174044486e-08
I1307K O 0 1.910750370370806e-06
APC B-Disease 0 3.4855392527788354e-07
gene O 0 4.406213449659191e-10
variant O 0 5.042682715838964e-09
was O 0 5.353600895929844e-10
found O 0 2.9280777021772897e-12
in O 0 7.232148907521108e-12
6 O 0 1.987720565921336e-08
. O 0 2.823620226521939e-10

1 O 0 4.812752862903835e-09
% O 0 2.1405529258833322e-12
of O 0 8.662454434316125e-12
American O 0 7.333159253442023e-12
Jews O 0 1.1618250632394744e-11
, O 0 3.0120591893063875e-13
28 O 0 1.2312580642548365e-11
% O 0 1.487548589352867e-14
of O 0 1.937797578649425e-12
their O 0 1.3261919340479267e-09
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 2.9479363394813163e-09
, O 0 5.319504060331826e-13
but O 0 6.194263851844184e-15
not O 0 5.5916337911906394e-15
in O 0 5.498337787672447e-13
non O 0 8.989707644957434e-09
- O 0 1.2427069373543986e-09
Jews O 0 7.24387716477537e-10
. O 0 1.1430367763409777e-10

We O 0 1.348654965482865e-09
assessed O 0 2.9120656108716503e-08
the O 0 8.483355129484949e-10
I1307K O 0 4.762349448128589e-08
prevalence O 0 1.0016919932409607e-10
in O 0 3.4218298089775875e-14
Israeli O 0 3.369470501224381e-12
Jews O 0 4.809148738960101e-12
of O 0 2.9810487845588485e-12
differing O 0 5.614295378424117e-13
ethnic O 0 1.2182029541477242e-14
origin O 0 2.279509859950263e-13
and O 0 2.490835662727342e-12
risk O 0 1.3282475119780202e-09
for O 0 4.883848419012793e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 7.856007400164344e-09

METHODS O 0 1.8783267705657636e-06
DNA O 0 3.162374184739747e-08
samples O 0 1.1597976051769265e-10
from O 0 1.1977334271953688e-12
500 O 0 7.123471192256592e-13
unrelated O 0 4.01117984313859e-12
Jews O 0 1.5892174728970865e-11
of O 0 7.451272238112594e-11
European O 0 5.169749697775394e-11
or O 0 8.851487251493317e-12
non O 0 3.8998653195676525e-09
- O 0 1.591790727006881e-10
European O 0 4.780395263664916e-12
origin O 0 1.2181994779245087e-12
, O 0 3.365465864975034e-14
with O 0 2.15506781121649e-15
or O 0 3.3957401777626184e-13
without O 0 4.838551976617256e-13
a O 0 3.066941774328147e-13
personal O 0 1.2860303967576758e-11
and O 0 4.6750964211028645e-11
/ O 0 6.657645545971036e-10
or O 0 1.9115247579248873e-12
family O 0 3.7368182550026607e-13
history O 0 1.8277036828440174e-10
of O 0 7.594428419466226e-10
neoplasia B-Disease 0 8.474615242448635e-06
, O 0 3.941153306485923e-11
were O 0 1.970015817143178e-11
examined O 0 1.9221080282960656e-09
for O 0 1.8019565006799354e-11
the O 0 1.276541650163665e-10
I1307K O 0 1.524451143097849e-08
variant O 0 2.389848041683962e-10
by O 0 1.0582850784937592e-12
the O 0 5.73762348396456e-12
allele O 0 7.676569341134865e-13
- O 0 1.374967414230488e-11
specific O 0 9.09286534955811e-13
oligonucleotide O 0 1.7407518981826797e-08
( O 0 2.9585583982694175e-10
ASO O 0 0.007864902727305889
) O 0 4.117626812433217e-12
method O 0 6.755703635397126e-11
. O 0 1.7444653360731976e-11

RESULTS O 0 3.878163852277794e-07
In O 0 1.7532256202379415e-10
persons O 0 6.4817313842613355e-12
at O 0 2.9025120848458208e-11
average O 0 8.316598278101939e-12
risk O 0 3.290566430447228e-10
for O 0 4.897560401673218e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 2.4291871292270173e-10
I1307K O 0 3.0428271458049494e-08
was O 0 1.9450016597311048e-10
found O 0 1.8796147364247284e-12
in O 0 1.8165595980570992e-12
5 O 0 1.9748032098476642e-09
. O 0 1.7556349429792562e-10

0 O 0 3.1882028128649154e-09
% O 0 2.54261911004916e-12
of O 0 6.237892147265001e-12
120 O 0 3.618634211721705e-11
European O 0 1.3522526154385872e-10
and O 0 1.7833366727781907e-10
1 O 0 1.3603977500054043e-08
. O 0 2.3025505113682954e-10

6 O 0 1.677664727139927e-07
% O 0 9.23785874185068e-12
of O 0 4.140050108292215e-11
188 O 0 5.229334743006575e-10
non O 0 1.2274497862563294e-08
- O 0 1.5871167713399359e-09
European O 0 9.20765963474679e-11
Jews O 0 5.285167303803462e-10
( O 0 1.377166870125679e-11
P O 0 1.4397799397158906e-08
= O 0 2.8791779724257616e-11
0 O 0 8.94597503714456e-12
. O 0 4.396264981828407e-14
08 O 0 1.2211877342682698e-10
) O 0 5.359272596018594e-13
. O 0 2.7659209558134057e-12

It O 0 1.610004490837369e-10
occurred O 0 8.958158104199754e-10
in O 0 3.319568925297389e-11
15 O 0 1.1306432456947846e-09
. O 0 5.613144671290371e-11

4 O 0 2.8362103776657932e-08
% O 0 4.917562884676485e-12
of O 0 4.885033003110273e-11
52 O 0 1.1179137476835521e-10
Ashkenazi O 0 3.554540661809824e-09
Israelis O 0 1.9905072035086846e-10
with O 0 1.8678374125169483e-10
familial O 0 0.0017300064209848642
cancer B-Disease 0 0.03292034938931465
( O 0 3.2110988867906087e-10
P O 0 3.0094861358520575e-07
= O 0 4.2923768706071286e-11
0 O 0 7.384460230797085e-12
. O 0 4.212954515954957e-14
02 O 0 1.332939314480086e-10
) O 0 8.064124658291837e-15
and O 0 4.408692649230522e-14
was O 0 8.69019006061178e-12
not O 0 2.1729244515907367e-14
detected O 0 2.4159384562350006e-11
in O 0 2.6639101081277206e-12
51 O 0 6.232733773536836e-11
non O 0 1.2273321248201796e-09
- O 0 3.343099685970685e-10
European O 0 2.3341478055938225e-11
Jews O 0 5.863996788146864e-11
at O 0 1.2186562869942463e-10
increased O 0 5.6552915128627035e-11
cancer B-Disease 0 9.606695527963893e-08
risk O 0 3.7176078881984154e-10
. O 0 2.1999185806365062e-10

Colorectal B-Disease 1 0.9999998807907104
neoplasia I-Disease 1 0.9990288019180298
occurred O 0 1.11892256882129e-06
personally O 0 2.1655941484510777e-09
or O 0 1.0918542112103857e-11
in O 0 2.9879482135036772e-12
the O 0 3.274728795424342e-12
families O 0 2.3993248387437285e-14
of O 0 1.1819209673469278e-11
13 O 0 1.2079047484458982e-10
of O 0 1.6270822189579093e-10
20 O 0 6.797659657387101e-11
Ashkenazi O 0 8.689536312722623e-10
I1307K O 0 1.5146656151543425e-09
carriers O 0 5.140563755917649e-12
, O 0 1.4555487891365626e-12
8 O 0 1.500846530388955e-10
of O 0 1.09167987150105e-10
whom O 0 1.1774321101443164e-11
also O 0 1.2396445848994464e-11
had O 0 6.690022234107085e-12
a O 0 1.1395852794401917e-12
personal O 0 1.2127271409312357e-10
or O 0 4.4452101721770276e-11
family O 0 5.344708616655813e-12
history O 0 8.592165867682411e-10
of O 0 3.2057032584020817e-09
noncolonic O 0 6.957469304325059e-05
neoplasia B-Disease 0 0.46795427799224854
. O 0 4.978985757020382e-08

CONCLUSIONS O 0 5.726530434913002e-05
The O 0 1.2349177325177152e-07
I1307K O 0 1.1875506970682181e-05
APC O 0 1.876314513538091e-06
variant O 0 5.5068216653353375e-08
may O 0 5.137596251203469e-11
represent O 0 1.3782416180552204e-11
a O 0 1.3337880279407077e-11
susceptibility O 0 8.241351601157021e-09
gene O 0 4.21207957401748e-10
for O 0 3.9657602202147757e-10
colorectal B-Disease 1 1.0
, I-Disease 0 1.7445260513948568e-10
or I-Disease 0 1.2739675633866021e-11
other I-Disease 0 1.4443848027345663e-11
, I-Disease 0 3.7101259564575884e-11
cancers I-Disease 0 2.2456825377048517e-07
in O 0 6.0085066262705045e-12
Ashkenazi O 0 2.9014193270171518e-09
Jews O 0 5.315921591808603e-10
, O 0 3.1708188158452444e-11
and O 0 3.977659521203769e-11
partially O 0 1.130725095777052e-07
explains O 0 1.1235763014427746e-10
the O 0 1.7363457893715406e-11
higher O 0 7.25970061843384e-10
incidence O 0 1.720393498771955e-07
of O 0 1.5334951513068518e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 3.4307948842959846e-11
European O 0 4.449572654774414e-10
Israelis O 0 1.9136277285003445e-10
. O 0 2.341662697080693e-10

Systematic O 0 1.389328319056915e-09
analysis O 0 1.683053280077118e-10
of O 0 2.2222035322982947e-09
coproporphyrinogen O 0 6.88278887537308e-05
oxidase O 0 1.884094308479689e-05
gene O 0 9.059481271833647e-07
defects O 0 0.0001004638324957341
in O 0 2.689923173093689e-09
hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 0.9999984502792358
and O 0 2.6250225104718083e-08
mutation O 0 5.207559272690787e-09
update O 0 6.251637074683458e-08
. O 0 2.2377322217437268e-09

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 1.2820258234569337e-05
HC B-Disease 1 1.0
) O 0 2.562840073494499e-08
is O 0 1.4901350986473716e-11
an O 0 4.9505795296500565e-11
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9983140230178833
autosomal O 1 1.0
dominant O 1 1.0
inheritance O 0 2.6764196263684426e-06
caused O 0 8.551301533543665e-08
by O 0 8.090728607912379e-12
deficient B-Disease 0 2.585877290073313e-09
activity I-Disease 0 2.1181119358448797e-10
of I-Disease 0 5.031573491187658e-10
coproporphyrinogen I-Disease 0 2.1717851268476807e-06
III I-Disease 1 1.0
oxidase I-Disease 0 1.6698784577329207e-07
( O 0 8.997234068885973e-10
CPO O 0 0.04005490243434906
) O 0 6.299495647343889e-11
. O 0 5.419380569304799e-11

Clinical O 0 0.003021822776645422
manifestations O 1 0.9999861717224121
of O 0 0.20453929901123047
the O 0 0.0012842707801610231
disease O 1 1.0
are O 0 2.437100814125376e-13
characterized O 0 9.739984513368327e-11
by O 0 8.324009016791312e-12
acute O 0 3.521089820424095e-05
attacks O 0 3.8490819420644584e-09
of O 1 0.9931475520133972
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 3.5138527643141515e-09
precipitated O 0 1.8589495498488873e-09
by O 0 6.704866262891018e-12
drugs O 0 4.249946172762975e-09
, O 0 9.280083645979431e-12
fasting O 0 1.0342132705787321e-09
, O 0 1.7868460183700918e-11
cyclical O 0 3.6971939607610693e-06
hormonal O 0 9.183533620671369e-06
changes O 0 5.929479685029548e-10
, O 0 3.944810311740099e-10
or O 0 3.66118752026523e-06
infectious B-Disease 1 1.0
diseases I-Disease 1 1.0
. O 0 8.193997147465382e-10

Skin O 1 1.0
photosensitivity O 1 1.0
may O 0 1.6264765179130336e-07
also O 0 4.799254396670172e-11
be O 0 6.579256453878579e-13
present O 0 5.854910306579697e-11
. O 0 2.3396179438250897e-10

The O 0 2.3293035056326516e-08
seven O 0 3.507498291810407e-09
exons O 0 2.327068759910844e-09
, O 0 2.386679612623177e-12
the O 0 9.54012042975183e-12
exon O 0 3.9427967557514876e-09
/ O 0 2.3785533542763915e-09
intron O 0 1.5136260023140835e-09
boundaries O 0 4.200061964887425e-10
and O 0 1.5788233350896852e-12
part O 0 1.820434948618388e-11
of O 0 5.242377643099871e-10
3 O 0 9.480921603355341e-10
noncoding O 0 9.857659133416519e-10
sequence O 0 1.9981583661982105e-12
of O 0 2.7794874041253692e-11
the O 0 3.00881229653438e-11
CPO O 0 0.000681919336784631
gene O 0 3.123315842068486e-11
were O 0 2.4944059404813368e-12
systematically O 0 1.6595778570827058e-11
analyzed O 0 1.087433615376554e-11
by O 0 1.4614176568113896e-13
an O 0 7.980583831583218e-14
exon O 0 1.4047958629692658e-10
- O 0 1.130828070072809e-10
by O 0 1.0371793701668963e-11
- O 0 6.032308430548028e-09
exon O 0 2.123680431509456e-08
denaturing O 0 8.721996209715144e-07
gradient O 0 4.158660082964616e-09
gel O 0 2.9330347040001925e-09
electrophoresis O 0 1.123643289524523e-09
( O 0 5.945093028980608e-11
DGGE O 1 0.9992157220840454
) O 0 2.5651921992803084e-12
strategy O 0 3.3786734261048723e-12
followed O 0 4.670154237287893e-13
by O 0 4.851761946708796e-15
direct O 0 8.302135156646254e-14
sequencing O 0 3.144054244383354e-12
in O 0 9.066040019406474e-13
seven O 0 8.713359894718664e-12
unrelated O 0 5.969172933717459e-10
heterozygous O 0 2.7756228426767393e-09
HC B-Disease 1 1.0
patients O 0 7.708184646126881e-10
from O 0 5.208607503637275e-11
France O 0 1.706672492218786e-08
, O 0 2.5321135813105577e-11
Holland O 0 5.431589755744426e-08
, O 0 2.0519128930696073e-12
and O 0 1.885467693432674e-12
Czech O 0 6.413638402591459e-07
Republic O 0 7.8411437698378e-07
. O 0 6.188602075241079e-09

Seven O 0 4.6609464732227934e-08
novel O 0 1.1759363482966023e-09
mutations O 0 1.0900278596404078e-10
and O 0 2.4826125530341692e-11
two O 0 3.1123777600311486e-12
new O 0 3.4419831568266446e-11
polymorphisms O 0 9.109027310216788e-09
were O 0 4.6144846277407225e-10
detected O 0 4.052421331834921e-08
. O 0 3.485342570108685e-10

Among O 0 4.5408410365155305e-09
these O 0 2.9181993627114267e-11
mutations O 0 8.763850062321055e-11
two O 0 3.828699076530162e-12
are O 0 4.636799299552463e-13
missense O 0 2.1619994683419463e-09
( O 0 4.770087796979183e-11
G197W O 0 6.911357530725581e-08
, O 0 4.471835748920405e-11
W427R O 0 1.3070097892864396e-08
) O 0 1.615841791965944e-12
, O 0 3.0029386095808963e-13
two O 0 2.24124755213162e-13
are O 0 3.727393285517244e-13
nonsense O 0 2.3917566593922857e-08
( O 0 1.5596247904259286e-10
Q306X O 0 1.3333303172657907e-07
, O 0 5.424675639242871e-11
Q385X O 0 1.496740154038889e-08
) O 0 2.979650597437211e-12
, O 0 3.754643351869952e-13
two O 0 3.850129647064472e-14
are O 0 1.1797052219917215e-14
small O 0 9.860614928747236e-13
deletions O 0 1.0810672357308704e-09
( O 0 1.952219358392071e-10
662de14bp O 0 7.575007288096458e-08
; O 0 1.35812527890522e-10
1168del3bp O 0 4.143785758969898e-07
removing O 0 1.9166138898185636e-08
a O 0 1.239179731049589e-10
glycine O 0 2.2372799168834945e-09
at O 0 4.0953165858503837e-10
position O 0 5.2857492688351826e-11
390 O 0 8.095116937889557e-11
) O 0 1.031213146557991e-13
, O 0 6.882974821608573e-14
and O 0 1.8109301493270114e-13
one O 0 6.733720840038787e-14
is O 0 1.2572899671251317e-14
a O 0 1.2678939387104904e-13
splicing O 0 6.386410289493938e-10
mutation O 0 1.9035214376961207e-11
( O 0 3.294450216101419e-12
IVS1 O 0 0.0002411725145066157
- O 0 1.6643536548954785e-09
15c O 0 2.3575779106721484e-09
- O 0 3.476107734989853e-10
- O 0 1.6309847916673448e-10
> O 0 4.084183338748382e-11
g O 0 9.318489035958777e-11
) O 0 1.3807424442072863e-13
which O 0 3.833803256412735e-14
creates O 0 2.8753442769119397e-13
a O 0 4.935995053445205e-14
new O 0 3.0856412802475475e-13
acceptor O 0 1.90477343099682e-12
splice O 0 6.09030124110177e-08
site O 0 5.096881583455115e-09
. O 0 2.437113844067085e-10

The O 0 3.4650944336078737e-09
pathological O 0 5.7471208236847815e-08
significance O 0 8.098460568817245e-09
of O 0 2.3916744140706214e-08
the O 0 5.133426461689794e-10
point O 0 4.775060347128601e-10
mutations O 0 2.4764690298439973e-11
G197W O 0 1.0563271146679654e-08
, O 0 9.939891791599376e-12
W427R O 0 6.4095875274006175e-09
, O 0 5.572201554338019e-12
and O 0 2.4749991552747153e-12
the O 0 7.612491366437713e-12
in O 0 7.68974727644034e-12
- O 0 2.0562060942808102e-09
frame O 0 9.430062286597263e-10
deletion O 0 1.0191619076449498e-10
390delGly O 0 3.0216287250084406e-09
were O 0 7.728817585928027e-12
assessed O 0 3.0218233471046574e-10
by O 0 1.504048947019443e-12
their O 0 6.705620867603068e-12
respective O 0 1.4294025685313017e-10
expression O 0 1.4639850746608896e-12
in O 0 6.164556170216995e-13
a O 0 1.397961743110701e-13
prokaryotic O 0 7.786700971512683e-12
system O 0 5.874875239064714e-12
using O 0 3.635157225147928e-13
site O 0 1.0341851680584213e-10
- O 0 2.0784123033745772e-10
directed O 0 5.2147109547151516e-11
mutagenesis O 0 4.2028631241919356e-08
. O 0 1.8291126946401448e-10

These O 0 1.5581150814014677e-09
mutations O 0 7.554511460838853e-10
resulted O 0 6.749576453302097e-10
in O 0 7.152433159629545e-12
the O 0 1.921849485109206e-11
absence O 0 2.835547630031243e-10
or O 0 2.927094981328149e-12
a O 0 8.896844307278162e-13
dramatic O 0 1.090589285546173e-10
decrease O 0 2.0588618310224405e-10
of O 0 6.045001388343962e-09
CPO O 0 0.08040802925825119
activity O 0 1.0495430302626119e-08
. O 0 5.595339191977189e-10

The O 0 1.2423425843621771e-08
two O 0 3.725805081122857e-11
polymorphisms O 0 2.358835904381351e-10
were O 0 1.4722324054305957e-11
localized O 0 1.0178433651475416e-09
in O 0 3.22603332936211e-11
noncoding O 0 1.9817119056853016e-09
part O 0 9.87108797478875e-11
of O 0 2.3523796799373997e-10
the O 0 1.8785155722622626e-11
gene O 0 6.764800308464713e-13
1 O 0 1.673194048590343e-11
) O 0 1.1102615646242566e-14
a O 0 3.173950089297578e-13
C O 0 3.811082294191692e-08
/ O 0 1.0625826885046763e-09
G O 0 1.1514053710470762e-08
polymorphism O 0 1.568017417297174e-11
in O 0 1.7632879748333274e-12
the O 0 9.03660913459392e-12
promotor O 0 1.5091949308043695e-06
region O 0 1.0102693126512463e-09
, O 0 8.942375485931908e-12
142 O 0 2.4188873126718136e-09
bp O 0 8.806164131236471e-10
upstream O 0 6.258512458279242e-11
from O 0 6.5066411460146245e-12
the O 0 5.167566136284052e-13
transcriptional O 0 3.497665698737329e-12
initiation O 0 1.9052203391323186e-12
site O 0 2.197631833456004e-11
( O 0 6.564373881707414e-14
- O 0 3.0527455563422734e-11
142C O 0 2.075541072343867e-09
/ O 0 5.40557099082406e-10
G O 0 1.6237418520859137e-08
) O 0 4.861409668918681e-13
, O 0 1.9615888503365236e-13
and O 0 7.288603856743514e-13
2 O 0 6.644803457467319e-11
) O 0 1.0308868017040729e-13
a O 0 8.506171027961029e-13
6 O 0 2.8096733273308416e-10
bp O 0 1.1365865193457836e-10
deletion O 0 1.3746501333067318e-11
polymorphism O 0 2.529839879250595e-11
in O 0 2.1913981046450814e-12
the O 0 4.2901567715025735e-12
3 O 0 1.0773122671725588e-10
noncoding O 0 1.285526574079654e-09
part O 0 3.349646601757961e-11
of O 0 1.9018020491756715e-10
the O 0 2.0512692933127852e-10
CPO O 0 0.00025550214922986925
gene O 0 2.419227596028861e-10
, O 0 3.731706350179609e-12
574 O 0 1.0824579010915159e-09
bp O 0 2.2753951500753544e-10
downstream O 0 1.420271261709516e-10
of O 0 1.2534519255869014e-10
the O 0 3.6163691399110354e-12
last O 0 1.9997521433917642e-12
base O 0 1.6957803217199086e-11
of O 0 2.491820465244654e-11
the O 0 4.570002362647152e-12
normal O 0 4.504631390123137e-11
termination O 0 1.0468435007737753e-09
codon O 0 5.010007964045826e-10
( O 0 1.1745229788751033e-11
+ O 0 4.8278995384842815e-11
574 O 0 1.2177814312508417e-08
delATTCTT O 0 1.737820269909207e-07
) O 0 2.7112761688541376e-11
. O 0 4.5414859373149596e-11

Five O 0 2.0898134778235544e-07
intragenic O 0 1.9218276065657847e-05
dimorphisms O 0 9.056328963197302e-06
are O 0 2.0937059377890144e-11
now O 0 3.5195956392397587e-12
well O 0 5.277707090800554e-12
characterized O 0 1.419973305605282e-10
and O 0 6.734228626126271e-12
the O 0 7.719535947969813e-12
high O 0 6.478138164789371e-11
degree O 0 7.580748528912551e-11
of O 0 4.7599084396221514e-11
allelic O 0 3.7041829603623455e-09
heterogeneity O 0 3.2707758723660163e-09
in O 0 5.898336263854276e-10
HC B-Disease 1 1.0
is O 0 4.4522021486193e-11
demonstrated O 0 6.454728418425759e-11
with O 0 9.529894234860947e-13
seven O 0 8.803098007492682e-12
new O 0 2.748522709341422e-13
different O 0 6.271970654425293e-14
mutations O 0 2.322617792538395e-12
making O 0 1.0926083822415666e-11
a O 0 2.2538520529080674e-12
total O 0 4.3587473040618274e-12
of O 0 8.866585243794134e-10
nineteen O 0 8.774949833423307e-07
CPO O 1 1.0
gene B-Disease 0 1.2262851669220254e-05
defects I-Disease 0 0.00021841003035660833
reported O 0 1.667690097129082e-09
so O 0 6.578243158528174e-12
far O 0 3.3893571976806314e-11
. O 0 2.4906741166036417e-12
. O 0 4.303632103463961e-11

Coincidence O 0 4.4041257751814555e-07
of O 0 9.180893556504088e-08
two O 0 4.753194712825426e-11
novel O 0 4.771746331400095e-10
arylsulfatase O 0 6.734099997629528e-07
A O 0 1.819132577907112e-08
alleles O 0 5.666431733553079e-12
and O 0 5.86805812274882e-11
mutation O 0 8.897736020196945e-11
459 O 0 1.754100509288037e-08
+ O 0 1.3762913031456492e-09
1G O 0 0.00012776028597727418
> O 0 1.3858434400049191e-08
A O 0 5.295825999951376e-09
within O 0 7.527940770746255e-11
a O 0 3.5433390162958878e-12
family O 0 4.718632602707107e-12
with O 0 1.7764653637009076e-10
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 7.817908646845506e-12
molecular O 0 2.4451862409846647e-11
basis O 0 3.125812803039807e-11
of O 0 2.0307061587843123e-11
phenotypic O 0 2.7645539191212265e-09
heterogeneity O 0 5.379410339401147e-08
. O 0 4.438377665394455e-09

In O 0 2.799158904664978e-09
a O 0 6.308717437342182e-11
family O 0 7.751922367904562e-12
with O 0 2.3139331162963517e-12
three O 0 3.956261707127595e-11
siblings O 0 3.322516151094135e-10
, O 0 1.2609008889080675e-12
one O 0 1.2529862943640863e-13
developed O 0 6.346662778655698e-11
classical O 0 5.1648395782422085e-08
late O 0 7.005831139395013e-05
infantile O 1 0.999998927116394
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 1.9053439714866727e-08
MLD B-Disease 1 1.0
) O 0 2.9977123561231167e-10
, O 0 1.5798997526905723e-11
fatal O 0 1.0372881575904103e-07
at O 0 1.114252690115336e-09
age O 0 3.919743002400722e-11
5 O 0 7.98284910397129e-11
years O 0 2.6267052768980115e-12
, O 0 7.905987062933884e-13
with O 0 1.5655840339412475e-12
deficient O 0 7.443384788530238e-07
arylsulfatase O 0 3.5383574868319556e-05
A O 0 2.704135795283946e-06
( O 0 2.2607558880505252e-10
ARSA O 0 0.000947787833865732
) O 0 9.635905354882235e-13
activity O 0 4.703446833398406e-12
and O 0 3.597441626274761e-13
increased O 0 1.384709729691791e-12
galactosylsulfatide O 0 2.760530435352848e-07
( O 0 5.66127367207514e-10
GS O 1 1.0
) O 0 6.339730129756305e-11
excretion O 0 8.711308341347035e-10
. O 0 9.587256336041072e-12

The O 0 6.522816953236088e-09
two O 0 9.182207078017868e-12
other O 0 1.5693929445934063e-12
siblings O 0 9.077001650314998e-11
, O 0 2.8688486048561446e-12
apparently O 0 9.892876101647019e-11
healthy O 0 1.1494052931659837e-10
at O 0 1.1916034825532051e-09
12 O 0 2.8789978734344857e-10
( O 0 1.3457209522074742e-12
1 O 0 3.734009768052715e-10
/ O 0 2.776330831899543e-10
2 O 0 1.0703443686921332e-10
) O 0 6.105845809425275e-14
and O 0 2.025551628552849e-13
15 O 0 9.554902442171498e-13
years O 0 5.855180977652058e-14
, O 0 1.5570061380606667e-14
respectively O 0 9.241095302175983e-13
, O 0 3.418783539686082e-14
and O 0 8.559353312925788e-14
their O 0 6.283300702653039e-13
father O 0 1.9444304499849352e-10
, O 0 4.880057729444998e-12
apparently O 0 1.1739928473808448e-10
healthy O 0 2.4606067183796654e-11
as O 0 1.3615397871646895e-12
well O 0 1.1070997417428341e-11
, O 0 2.415361313734543e-12
presented O 0 2.5849995477500443e-09
ARSA O 1 0.9888767600059509
and O 0 4.854710855539679e-09
GS O 1 1.0
values O 0 8.791893602033696e-11
within O 0 3.737007231441325e-11
the O 0 2.242146572573045e-12
range O 0 1.1085780071695694e-09
of O 0 5.960347326805504e-09
MLD B-Disease 1 1.0
patients O 0 1.7403136709503997e-08
. O 0 2.103320989599311e-10

Mutation O 0 7.91995968807413e-10
screening O 0 5.020147075818215e-10
and O 0 6.816794091007994e-12
sequence O 0 3.069266412206173e-12
analysis O 0 8.149485318346972e-13
disclosed O 0 5.20760413957877e-11
the O 0 5.484086275375777e-12
involvement O 0 8.967197123732618e-11
of O 0 3.729361819360122e-10
three O 0 3.95807128392156e-12
different O 0 3.839397983568249e-12
ARSA O 1 0.9998980760574341
mutations O 0 7.771912280407633e-11
being O 0 5.645654083119567e-12
the O 0 1.4341638770662413e-12
molecular O 0 3.879340945700527e-11
basis O 0 2.604074074430418e-11
of O 0 1.5256887420100895e-10
intrafamilial O 0 5.444335897664132e-07
phenotypic O 0 2.78450595914137e-08
heterogeneity O 0 7.099737331373035e-08
. O 0 1.999793441953557e-09

The O 0 1.9545312923696656e-08
late O 0 1.6876151676115114e-06
infantile O 0 0.012545723468065262
patient O 0 2.861859798031219e-07
inherited O 0 1.7332239110601222e-07
from O 0 6.547610009732807e-09
his O 0 1.6730760421523883e-07
mother O 0 2.1851698228658734e-09
the O 0 2.527270615004795e-10
frequent O 0 5.1018855806717056e-11
0 O 0 3.3593733350656407e-10
- O 0 1.5478006376579145e-10
type O 0 2.1800027061313898e-10
mutation O 0 8.260507729229705e-12
459 O 0 5.632774247033012e-10
+ O 0 2.809575662399144e-11
1G O 0 1.5419582268805243e-06
> O 0 1.8774418131251025e-10
A O 0 1.0514419335194702e-09
, O 0 4.162500693519894e-13
and O 0 8.516914251762916e-14
from O 0 3.3310598203384334e-12
his O 0 3.168207363124509e-11
father O 0 3.1633903829764165e-10
a O 0 1.8214863211490906e-12
novel O 0 3.1602752099263443e-12
, O 0 1.8524718976668797e-13
single O 0 5.40944329260884e-12
basepair O 0 3.026261907734806e-08
microdeletion O 0 2.1595508314931067e-07
of O 0 1.0552476226166618e-08
guanine O 0 3.2350881973286505e-09
at O 0 1.5001834219319221e-09
nucleotide O 0 3.136031989647847e-10
7 O 0 3.38242295283564e-10
in O 0 3.8760847829999445e-12
exon O 0 3.700875994550046e-10
1 O 0 8.442339050063197e-10
( O 0 1.6477059300301633e-11
7delG O 0 4.7273712056039585e-08
) O 0 3.643768620165133e-11
. O 0 8.47410058790743e-11

The O 0 2.4688796784744227e-08
two O 0 6.586762246740818e-10
clinically O 0 2.8009633297187975e-06
unaffected O 0 1.02781328337187e-07
siblings O 0 2.1042370068613536e-09
carried O 0 1.5537962583245246e-10
the O 0 1.0953173090744173e-10
maternal O 0 3.1147637802320105e-09
mutation O 0 1.7670294047422708e-11
459 O 0 1.6471420893893196e-09
+ O 0 8.03989097519775e-11
1G O 0 5.741516815760406e-06
> O 0 1.6470540487034668e-09
A O 0 5.556375359816457e-09
and O 0 6.986041085899064e-12
, O 0 1.712485405216957e-13
on O 0 1.0370601946640967e-12
their O 0 5.78716707801824e-13
paternal O 0 1.9053821020964534e-10
allele O 0 1.295849386996617e-12
, O 0 1.3479296075580988e-13
a O 0 6.337121040596305e-14
novel O 0 5.117454311871772e-13
cytosine O 0 1.0296032776357933e-10
to O 0 1.1237181568287194e-13
thymidine O 0 5.454340312738282e-10
transition O 0 9.579474019583145e-11
at O 0 1.6910396694047591e-10
nucleotide O 0 2.3321819475619066e-10
2435 O 0 6.042675977369072e-07
in O 0 1.814361681728993e-11
exon O 0 1.625780288172507e-09
8 O 0 6.477103298152542e-10
, O 0 2.296319330432478e-13
resulting O 0 5.648127907216527e-13
in O 0 1.0092330481525566e-13
substitution O 0 9.607836748415366e-11
of O 0 2.662358666860598e-10
alanine O 0 5.97798344159628e-09
464 O 0 7.1727450645653335e-09
by O 0 5.036948289016685e-11
valine O 0 7.842639320188027e-07
( O 0 3.693802763660159e-10
A464V O 0 6.063283422008681e-07
) O 0 1.0071807970968294e-10
. O 0 9.870033262915356e-11

The O 0 2.0242435283535087e-08
fathers O 0 1.3392071451789889e-08
genotype O 0 7.410839164556648e-10
thus O 0 8.43739314526637e-11
was O 0 1.6860485230196787e-09
7delG O 0 1.3425392353383359e-06
/ O 0 8.162772928699269e-07
A464V O 0 2.7393064101488562e-06
. O 0 1.6271546332546905e-09

Mutation O 0 1.1808619149178412e-07
A464V O 0 7.867081990298175e-07
was O 0 2.750190741807046e-09
not O 0 3.928188612063732e-13
found O 0 2.2087962969069563e-12
in O 0 3.1331291727720867e-12
18 O 0 3.3314445646581703e-10
unrelated O 0 1.2023346585010586e-07
MLD B-Disease 1 1.0
patients O 0 1.1652483422608384e-09
and O 0 6.341193542480639e-11
50 O 0 6.047835010569713e-10
controls O 0 3.7317423817739837e-08
. O 0 1.7231046589571974e-09

A464V O 0 1.1789881682489067e-05
, O 0 6.500221472194312e-10
although O 0 2.757115716289782e-11
clearly O 0 1.4133155756823612e-10
modifying O 0 9.41014590694067e-08
ARSA O 1 0.99681156873703
and O 0 4.897971450645855e-08
GS O 1 1.0
levels O 0 3.9504389093281134e-08
, O 0 1.4060738684484875e-11
apparently O 0 5.1600165112963836e-11
bears O 0 2.4575966262041504e-10
little O 0 6.455436228972045e-13
significance O 0 3.3167507369064042e-12
for O 0 3.3879575035179743e-13
clinical O 0 3.972212336833536e-09
manifestation O 0 2.808873489357211e-07
of O 0 9.837087873165729e-07
MLD B-Disease 1 1.0
, O 0 1.4589056629432662e-09
mimicking O 0 1.4946668613902148e-07
the O 0 3.3917321728971217e-10
frequent O 0 3.129486003672355e-08
ARSA O 1 0.9999992847442627
pseudodeficiency O 0 0.0006041566375643015
allele O 0 6.25764968731346e-08
. O 0 1.7569992127874912e-09

Our O 0 7.488355180385042e-08
results O 0 3.71716130098676e-10
demonstrate O 0 1.2674074290064397e-10
that O 0 5.493083879469854e-14
in O 0 1.577729781673462e-13
certain O 0 2.0170785614698206e-12
genetic O 0 6.560031406976918e-10
conditions O 0 1.6506251654391235e-07
MLD B-Disease 1 1.0
- O 0 1.0244542636428378e-06
like O 0 1.2580728681044206e-09
ARSA O 1 0.9993059635162354
and O 0 3.726889019617374e-09
GS O 1 1.0
values O 0 3.173567519887399e-10
need O 0 4.33980022057634e-12
not O 0 4.7625531990336256e-14
be O 0 1.5471075755137814e-13
paralleled O 0 8.922599464833425e-11
by O 0 2.4193171337810737e-12
clinical O 1 0.9999123811721802
disease O 0 0.18746043741703033
, O 0 7.385034424267634e-13
a O 0 4.638683100827157e-13
finding O 0 4.337557656802771e-12
with O 0 6.427938151372381e-13
serious O 0 1.3762735839861762e-08
diagnostic O 0 0.34257692098617554
and O 0 4.019671706601002e-09
prognostic O 0 8.975403034128249e-05
implications O 0 1.3715624902488344e-07
. O 0 2.075153160419063e-09

Moreover O 0 1.674135887697048e-07
, O 0 4.593725122514769e-10
further O 0 6.62440824417132e-10
ARSA O 1 0.9991317391395569
alleles O 0 2.623343209329221e-10
functionally O 0 1.92753057959294e-09
similar O 0 7.5220524253794e-12
to O 0 5.908091724182718e-12
A464V O 0 1.084992629074577e-08
might O 0 1.960306916792831e-12
exist O 0 1.3488818352211385e-12
which O 0 4.244153585433036e-13
, O 0 3.7738995956049237e-13
together O 0 2.116097824311075e-13
with O 0 1.6556684679942119e-13
0 O 0 1.9119750227503118e-10
- O 0 2.8362723281105673e-10
type O 0 1.8834864778938254e-09
mutations O 0 1.0540723849317146e-09
, O 0 3.4101464707614326e-11
may O 0 6.975738736647585e-11
cause O 0 4.4088910300388306e-08
pathological O 1 0.9984033703804016
ARSA O 1 1.0
and O 0 6.059364210386775e-08
GS O 1 1.0
levels O 0 2.8431811571749677e-08
, O 0 1.5175781638288033e-12
but O 0 7.823893408956308e-15
not O 0 1.0740437063490836e-14
clinical O 0 6.35089203449013e-10
outbreak O 0 1.6040581363174766e-10
of O 0 8.61457710721325e-11
the O 0 6.020363096936876e-10
disease O 0 1.8129691170543083e-07
. O 0 7.101521519274623e-13
. O 0 1.787988160306675e-11

Human O 1 0.9999996423721313
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 0 0.0004412129637785256
to O 0 3.794291458802945e-08
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 0 1.4591449826184544e-07
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.878481924533844
1 I-Disease 0 6.886746996315196e-05
. O 0 6.755040526940093e-09

Heterozygous O 0 2.773444691683835e-07
germ O 0 0.0001970955345313996
- O 0 6.1309890497796e-07
line O 0 1.170213526080488e-08
mutations O 0 1.3607771159884763e-11
in O 0 3.523075060851699e-12
the O 0 6.460616069903224e-11
DNA O 0 6.7200448938820045e-06
mismatch O 0 0.000866488553583622
repair O 1 0.9766112565994263
genes O 0 2.4398046249984873e-08
lead O 0 4.2847762671271994e-08
to O 0 3.84051679347408e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.177117336936817e-08

The O 0 1.323884703197109e-06
disease O 0 0.00018841044220607728
susceptibility O 0 7.967569715106038e-09
of O 0 7.653953026931504e-09
individuals O 0 2.5580880729653144e-12
who O 0 9.824898533628001e-11
constitutionally O 0 1.9676741658258834e-07
lack O 0 1.0708784969892804e-08
both O 0 5.914002620954761e-11
wild O 0 1.4867760356196413e-08
- O 0 4.424724198148766e-10
type O 0 1.321159431855179e-10
alleles O 0 4.60384009560999e-13
is O 0 1.540341205280571e-13
unknown O 0 6.384592160513236e-11
. O 0 4.245809606673312e-11

We O 0 7.294581050310001e-10
have O 0 9.844097108649419e-13
identified O 0 2.7774787678125357e-11
three O 0 1.3472824201762879e-12
offspring O 0 1.0955215033747745e-11
in O 0 4.20265428360822e-12
a O 0 1.5800278863054018e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 8.967924181035869e-09
who O 0 3.641102419571496e-10
developed O 0 5.404544367593189e-07
hematological B-Disease 1 1.0
malignancy I-Disease 1 0.9999759197235107
at O 0 9.05781316618004e-09
a O 0 1.4262888613225666e-11
very O 0 3.270856892625962e-13
early O 0 8.160443848437282e-11
age O 0 3.305969647343643e-12
, O 0 3.871145550925388e-14
and O 0 2.099878430861235e-13
at O 0 1.6696935500881693e-11
least O 0 4.685301422551781e-14
two O 0 4.499875746002448e-14
of O 0 1.1298961766215143e-11
them O 0 5.741759064731289e-13
displayed O 0 4.146020415873863e-09
signs O 0 2.25463470115983e-08
of O 0 2.9062835693594025e-08
neurofibromatosis B-Disease 1 0.9946879148483276
type I-Disease 0 3.645905508165015e-06
1 I-Disease 0 1.4252938171921414e-06
( O 0 9.277491552772688e-10
NF1 B-Disease 1 0.9972022771835327
) O 0 2.2688424750061387e-10
. O 0 1.0693852747767352e-10

DNA O 0 1.9993659350348025e-07
sequence O 0 5.827600121216525e-12
analysis O 0 1.2293708802693648e-12
and O 0 8.728425426006436e-13
allele O 0 6.264346138172561e-13
- O 0 8.489043669401841e-12
specific O 0 5.5926628345776e-13
amplification O 0 5.576396011619522e-10
in O 0 7.563442927516206e-12
two O 0 8.101862930542936e-12
siblings O 0 9.084851759766366e-10
revealed O 0 6.366841498461895e-10
a O 0 6.920621020700679e-11
homozygous O 0 6.056798440567945e-08
MLH1 O 1 0.9999943971633911
mutation O 0 1.7093887416663733e-09
( O 0 6.176485711772983e-11
C676T O 0 6.789143469632108e-08
- O 0 6.534624219511898e-08
- O 0 1.2005238581025424e-08
> O 0 1.6291140658708514e-09
Arg226Stop O 0 1.428340510756243e-06
) O 0 1.57459895816503e-11
. O 0 1.8165812604165055e-11

Thus O 0 3.082602262338696e-08
, O 0 9.994648164646236e-11
a O 0 8.85577635528767e-12
homozygous O 0 2.792876596657834e-09
germ O 0 0.3860985338687897
- O 0 1.645673910388723e-05
line O 0 1.5785021787451115e-06
MLH1 O 1 1.0
mutation O 0 2.0155126456700145e-09
and O 0 3.966039996416981e-10
consequent O 1 0.7709255814552307
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 1.0646184733786868e-07
in O 0 4.6409115439516313e-10
a O 0 1.1197148069852503e-10
mutator O 0 0.00017160148127004504
phenotype O 0 3.553998428884597e-09
characterized O 0 2.2845533798054873e-10
by O 0 1.0306676519189484e-11
leukemia B-Disease 1 0.9999986886978149
and O 0 2.156485834348132e-08
/ O 1 0.9967986345291138
or O 0 0.001313155284151435
lymphoma B-Disease 1 1.0
associated O 0 0.00012396277452353388
with O 0 1.2538238003401148e-08
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9979054927825928
1 I-Disease 0 2.869544232453336e-06
. O 0 1.918582480386899e-11
. O 0 5.456741655751607e-11

Missense O 0 3.742335320566781e-05
mutations O 0 2.0895917884899973e-08
in O 0 2.7732560692328434e-10
the O 0 5.0767830911402356e-11
most O 0 1.385935094987134e-13
ancient O 0 8.758853364820851e-11
residues O 0 3.3251930098288085e-09
of O 0 4.351176363659448e-10
the O 0 3.683193749992597e-10
PAX6 O 1 0.999745786190033
paired O 0 3.810253801361796e-08
domain O 0 1.0440119879717713e-09
underlie O 0 5.118326384945249e-08
a O 0 5.434389743763646e-11
spectrum O 0 2.8981684607742864e-08
of O 0 3.6109216239310626e-07
human O 1 0.9999998807907104
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 0 3.5482841553857725e-07

Mutations O 0 1.0751500667538494e-07
of O 0 2.815276900491881e-08
the O 0 4.6484419091719076e-10
human O 0 1.5451790957854428e-09
PAX6 O 1 1.0
gene O 0 5.243282998890209e-07
underlie O 1 0.9952372312545776
aniridia B-Disease 1 1.0
( O 1 0.975857675075531
congenital B-Disease 1 1.0
absence I-Disease 1 0.9381818771362305
of I-Disease 0 0.11573942005634308
the I-Disease 0 4.609844594938295e-08
iris I-Disease 0 6.657892299699597e-07
) O 0 4.125333408211418e-11
, O 0 7.283757798293156e-12
a O 0 1.2413648234343988e-11
rare O 0 8.286497887866062e-08
dominant O 1 0.992931604385376
malformation B-Disease 1 1.0
of I-Disease 1 0.9999992847442627
the I-Disease 0 0.39522913098335266
eye I-Disease 1 1.0
. O 0 2.188144776482659e-08

The O 0 7.658421452561015e-09
spectrum O 0 2.1661611171452932e-08
of O 0 5.4540656435619894e-08
PAX6 O 1 0.9999998807907104
mutations O 0 9.756578656094916e-09
in O 0 1.4124349467792285e-09
aniridia B-Disease 1 1.0
patients O 0 2.4158579581268214e-09
is O 0 3.2966739147571866e-13
highly O 0 5.755272647345322e-11
biased O 0 4.050361990248774e-10
, O 0 1.2073944274937354e-12
with O 0 5.2395679347961785e-14
92 O 0 1.9646732851708038e-10
% O 0 1.2434530063053749e-14
of O 0 6.517940484215834e-13
all O 0 8.458939928721043e-14
reported O 0 2.6185727197702846e-11
mutations O 0 5.308363193456955e-10
leading O 0 9.775504850040306e-09
to O 0 8.875718215950457e-11
premature O 0 1.0656053817115207e-08
truncation O 0 2.751467143013997e-08
of O 0 3.769384093743611e-08
the O 0 6.847921119046418e-10
protein O 0 2.5526900038208566e-10
( O 0 1.0222764475209534e-11
nonsense O 0 5.34489030812324e-09
, O 0 1.7028939022778466e-12
splicing O 0 6.880333802694594e-11
, O 0 5.378770887888573e-13
insertions O 0 6.574182170870913e-11
and O 0 3.147324414976005e-12
deletions O 0 1.1448171577388422e-10
) O 0 7.122710082331507e-13
and O 0 3.4709563782181485e-12
just O 0 2.647634932476106e-12
2 O 0 5.0996283584847646e-11
% O 0 7.248298776506637e-14
leading O 0 2.9894645786621155e-12
to O 0 1.7203286592579886e-14
substitution O 0 7.545824382004795e-11
of O 0 8.721249278309529e-10
one O 0 3.750214982306543e-12
amino O 0 1.4389466007624918e-10
acid O 0 1.4140751937452567e-11
by O 0 5.479629337085123e-13
another O 0 5.543008326641674e-12
( O 0 6.654896685803768e-12
missense O 0 1.3292872580450421e-08
) O 0 4.4002315680025106e-11
. O 0 1.2591380715853973e-10

The O 0 1.4106829482329886e-08
extraordinary O 0 1.902035196010843e-09
conservation O 0 7.758619524622645e-09
of O 0 5.634987476632602e-10
the O 0 6.090524612423209e-11
PAX6 O 0 3.904335244442336e-05
protein O 0 5.721935703029146e-10
at O 0 5.774385969381512e-10
the O 0 5.256312052281942e-11
amino O 0 1.1915284314767405e-09
acid O 0 3.674361481742494e-09
level O 0 2.089598716281671e-09
amongst O 0 1.3252487995885076e-09
vertebrates O 0 4.4260964671138936e-08
predicts O 0 2.936213938653509e-09
that O 0 5.9343042632664655e-12
pathological O 0 4.634808283299208e-05
missense O 0 7.058581559249433e-07
mutations O 0 2.473063531738262e-09
should O 0 9.328834579824807e-12
in O 0 2.4715521296236886e-11
fact O 0 1.0466388172813978e-11
be O 0 1.3912645991862038e-12
common O 0 9.66307589500559e-12
even O 0 5.232689823976566e-13
though O 0 1.8133739410237937e-13
they O 0 1.695273255271617e-14
are O 0 5.0136300276323875e-14
hardly O 0 3.936600698195569e-11
ever O 0 2.0197205019556463e-11
seen O 0 3.3027695162113346e-11
in O 0 1.8213108798903477e-10
aniridia B-Disease 1 1.0
patients O 0 2.3103746471520026e-08
. O 0 9.061161265755402e-10

This O 0 6.95729585054039e-11
indicates O 0 4.099589764883227e-11
that O 0 4.825976993244954e-14
there O 0 1.312998104338603e-13
is O 0 3.6304990860391156e-14
a O 0 1.0191959038882703e-12
heavy O 0 3.7571177813333634e-07
ascertainment O 0 3.126243609585799e-05
bias O 0 4.558178723357287e-09
in O 0 1.5733891620128837e-11
the O 0 2.0384510052151583e-12
selection O 0 1.3295845327498945e-11
of O 0 6.650002076780126e-11
patients O 0 4.592738949565911e-12
for O 0 1.0923166884890811e-11
PAX6 O 1 0.9999459981918335
mutation O 0 6.578283751057512e-11
analysis O 0 1.2540347232858906e-11
and O 0 5.799944292200765e-12
that O 0 3.6230504815888687e-13
the O 0 1.0724471311007733e-10
missing O 0 6.876355485019303e-08
PAX6 O 1 1.0
missense O 0 1.7115879018092528e-05
mutations O 0 1.3774138096778188e-07
frequently O 0 6.467523183673052e-10
may O 0 7.112064270842211e-10
underlie O 0 2.1346470475691603e-06
phenotypes O 0 5.430667826544777e-08
distinct O 0 8.636397152983477e-10
from O 0 2.1712893705228e-09
textbook O 0 1.8471881048753858e-05
aniridia B-Disease 1 1.0
. O 0 3.407915016850893e-08

Here O 0 1.0767359448493607e-08
we O 0 2.4560397118844612e-11
present O 0 2.0641571785162682e-11
four O 0 2.0736832390122473e-11
novel O 0 1.8308099480890405e-09
PAX6 O 1 0.9991167187690735
missense O 0 1.2129270317018381e-06
mutations O 0 7.832577253452655e-09
, O 0 1.0443600151344157e-10
two O 0 4.3930002864567275e-12
in O 0 4.346131440846612e-11
association O 0 1.8564415782407195e-08
with O 0 2.915195515540425e-11
atypical O 0 1.2400743116813828e-06
phenotypes O 0 4.489465084134281e-07
ectopia B-Disease 0 1.7032607502187602e-05
pupillae I-Disease 0 4.936457116855308e-06
( O 0 1.966869549174799e-11
displaced B-Disease 0 1.2197363345040069e-12
pupils I-Disease 0 9.346078772010102e-11
) O 0 7.774299259910578e-11
and O 0 2.6625525606505107e-07
congenital B-Disease 1 1.0
nystagmus I-Disease 1 1.0
( O 0 3.3060629789360974e-09
searching B-Disease 0 4.1812482365344295e-09
gaze I-Disease 0 2.9400597512108106e-08
) O 0 3.4063483370788683e-12
, O 0 9.881156223107146e-13
and O 0 1.949939992459959e-12
two O 0 1.2732163413853304e-12
in O 0 1.372056895182494e-11
association O 0 3.5647316209974633e-09
with O 0 7.68622838986932e-12
more O 0 6.809971857257846e-12
recognizable O 0 0.00015472795348614454
aniridia B-Disease 1 1.0
phenotypes O 0 3.387751576156006e-06
. O 0 4.101627482100412e-09

Strikingly O 0 1.6426163256255677e-06
, O 0 4.081024129742872e-10
all O 0 3.586338040775794e-12
four O 0 1.3856609002577125e-12
mutations O 0 1.5514256546111937e-12
are O 0 5.3301452336042277e-14
located O 0 1.7720221123784796e-10
within O 0 2.8761273918043173e-10
the O 0 2.6791397989001098e-09
PAX6 O 1 0.910198986530304
paired O 0 1.4183207497353578e-08
domain O 0 2.620242633977199e-10
and O 0 3.674918355733858e-11
affect O 0 1.6028499361109283e-10
amino O 0 2.331399240329546e-10
acids O 0 3.5457477232103685e-11
which O 0 1.0743740830798307e-13
are O 0 8.361247722562647e-15
highly O 0 4.333737362027801e-12
conserved O 0 3.754052971260968e-11
in O 0 9.198311600247533e-13
all O 0 2.3842080111406705e-13
known O 0 5.971091242978899e-12
paired O 0 6.106902483704602e-11
domain O 0 9.731882834318473e-12
proteins O 0 3.472984400065826e-11
. O 0 5.903881550306522e-11

Our O 0 6.392156137735583e-08
results O 0 6.228292326326823e-10
support O 0 2.8391558201668055e-11
the O 0 6.15493767064379e-12
hypothesis O 0 4.6092287972476775e-12
that O 0 6.298268486338698e-15
the O 0 2.5050323143940845e-13
under O 0 9.473193930686907e-12
- O 0 3.862470412951957e-11
representation O 0 1.267350482371532e-12
of O 0 2.9207330998204384e-11
missense O 0 2.1298220076459984e-08
mutations O 0 1.2256313741687563e-09
is O 0 6.400195477762605e-12
caused O 0 2.6772789540885356e-10
by O 0 2.3706611326779203e-11
ascertainment O 0 0.0001741244486765936
bias O 0 3.471188492198962e-08
and O 0 7.92843499186624e-11
suggest O 0 1.1599650927285321e-11
that O 0 6.190366229737393e-15
a O 0 5.2085001215436064e-14
substantial O 0 2.7923665983642376e-12
burden O 0 2.8847215727267894e-09
of O 0 8.683991268298996e-07
PAX6 B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
related I-Disease 1 1.0
disease I-Disease 1 0.9999997615814209
remains O 0 8.081772057133563e-11
to O 0 1.1599152627966847e-13
be O 0 8.725525591770852e-14
uncovered O 0 8.317955213499317e-10
. O 0 4.082460064447346e-12
. O 0 4.469951492280799e-11

The O 0 1.2129874882305103e-08
chromosomal O 0 1.260913506939687e-07
order O 0 5.2940585248961725e-09
of O 0 3.295374639833426e-08
genes O 0 4.509998208224175e-10
controlling O 0 2.2033640689755885e-08
the O 0 1.1734022642428954e-09
major O 0 1.1496805285560185e-08
histocompatibility O 0 1.476681063650176e-05
complex O 0 1.2997998055652715e-06
, O 0 4.2735554678374754e-11
properdin O 0 1.6425499183014836e-08
factor O 0 6.873696750675506e-11
B O 0 1.1487340856319861e-07
, O 0 1.668196613832662e-12
and O 0 2.7754187836848132e-11
deficiency B-Disease 0 1.4138055348666967e-07
of I-Disease 0 3.970956541365922e-08
the I-Disease 0 8.975585830128807e-10
second I-Disease 0 5.216861942436424e-10
component I-Disease 0 8.142816976253187e-10
of I-Disease 0 1.0726625143675506e-09
complement I-Disease 0 1.1514163844594805e-08
. O 0 1.7678604136150966e-09

The O 0 3.954862659583114e-09
relationship O 0 4.225708671867778e-11
of O 0 3.1607849670933774e-10
the O 0 7.819310303414095e-12
genes O 0 3.221031297587218e-13
coding O 0 6.757169043053457e-12
for O 0 3.236513433559768e-13
HLA O 0 8.877093504722211e-10
to O 0 5.70106570459139e-13
those O 0 1.9728264703290643e-13
coding O 0 5.409680949725049e-12
for O 0 5.534807096148342e-13
properdin O 0 7.974365168195163e-09
Factor O 0 1.5366960481877356e-10
B O 0 5.247595069590716e-08
allotypes O 0 1.563704188356496e-08
and O 0 5.286915870372777e-12
for O 0 1.370811710671438e-11
deficiency B-Disease 0 2.337305282651414e-08
of I-Disease 0 8.581361399251364e-09
the I-Disease 0 8.659848532710512e-11
second I-Disease 0 7.390452139155457e-11
component I-Disease 0 4.9284108044611585e-11
of I-Disease 0 1.0533723893146885e-10
complement I-Disease 0 7.019800851715274e-10
( O 0 1.4523111879771733e-10
C2 O 0 1.0580691878203652e-06
) O 0 5.194950372655605e-13
was O 0 3.314922988884028e-12
studied O 0 7.317930116046423e-12
in O 0 2.1265519388274055e-14
families O 0 4.52952139093658e-15
of O 0 7.724351540339125e-12
patients O 0 6.825826709411231e-11
with O 0 6.898685622758194e-09
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 0 7.161590929172235e-06

Patients O 0 1.9358071767783258e-07
were O 0 1.6190898621815109e-09
selected O 0 8.226601067029549e-10
because O 0 5.6381214801060064e-12
they O 0 3.6447448249592174e-13
were O 0 6.542281473509437e-12
heterozygous O 0 1.0553225827936163e-11
or O 0 3.635458947770509e-11
homozygous O 0 5.7016126930875544e-08
for O 0 9.458025260755676e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.5687399468333751e-07

12 O 0 1.2391612358442217e-07
families O 0 4.4902263331147996e-12
with O 0 2.4206003954724276e-12
15 O 0 2.7628549448266426e-10
matings O 0 1.4765457301280094e-08
informative O 0 2.4844446500082995e-08
for O 0 4.224317251555476e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 3.216374011572043e-08
found O 0 6.669949037529932e-10
. O 0 7.938134177765122e-11

Of O 0 3.554309614628437e-06
57 O 0 6.177012323860254e-08
informative O 0 2.3429818085674015e-09
meioses O 0 1.0852244258785504e-06
, O 0 1.2676630578578596e-11
two O 0 6.403474213552418e-14
crossovers O 0 1.9515771377404123e-12
were O 0 4.3796815132890465e-12
noted O 0 3.1223372411876005e-12
between O 0 3.249320604248318e-11
the O 0 3.3032847568392754e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 5.909976674711714e-11
and O 0 3.384678171416966e-12
the O 0 1.4743426965391215e-11
HLA O 0 4.164899536363009e-09
- O 0 1.1117669007632003e-09
B O 0 3.983670993079613e-08
gene O 0 6.72336752244318e-13
, O 0 1.7513937620051295e-14
with O 0 5.385098783046308e-15
a O 0 5.181825359968674e-14
recombinant O 0 7.951328831468096e-12
fraction O 0 4.023376141797097e-13
of O 0 5.036660324919673e-11
0 O 0 4.752363502724677e-10
. O 0 2.1625210303022335e-11

035 O 0 0.02309230901300907
. O 0 3.259505945152341e-07

A O 0 9.237503491021926e-07
lod O 0 3.3526287097629393e-06
score O 0 3.235009771174191e-08
of O 0 2.2874888649937475e-09
13 O 0 2.8709370991641947e-10
was O 0 6.088523348685149e-12
calculated O 0 4.874092665932417e-13
for O 0 3.111766270005867e-12
linkage O 0 9.99302258719581e-08
between O 0 1.2528577144621522e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 4.874173842317475e-10
HLA O 0 8.850149946226793e-09
- O 0 4.769498684886742e-10
B O 0 2.8650908312499723e-09
at O 0 4.787017136853589e-13
a O 0 7.689556206983263e-16
maximum O 0 4.034914712595797e-15
likelihood O 0 2.3166069892466626e-14
value O 0 4.089181318317654e-14
of O 0 2.082394152946865e-12
the O 0 1.36394069866555e-13
recombinant O 0 9.333261160454631e-13
fraction O 0 1.4836051766449476e-13
of O 0 9.61259804393988e-12
0 O 0 1.5126004615506616e-10
. O 0 1.3252675866437524e-11

04 O 0 0.0007633417844772339
. O 0 4.273235987284352e-08

18 O 0 6.183459788644541e-08
families O 0 1.9021774173150208e-12
with O 0 1.90987004856924e-12
21 O 0 1.6495440569030961e-09
informative O 0 1.363261309395014e-10
matings O 0 5.158976024155493e-10
for O 0 2.2309231285239095e-12
both O 0 1.9337287847365214e-12
properdin O 0 7.038322280550346e-08
Factor O 0 9.403910983252217e-10
B O 0 2.3655881875583873e-07
allotype O 0 4.443927892339161e-08
and O 0 2.240151467103324e-11
HLA O 0 3.906589896018886e-08
- O 0 5.29782617775254e-09
B O 0 3.5845875601125954e-08
were O 0 6.962867782345228e-12
found O 0 6.698334161642228e-12
. O 0 1.676468339151249e-11

Of O 0 9.233873242919799e-06
72 O 0 4.4156743683743116e-07
informative O 0 1.0340677647491248e-08
meioses O 0 3.1539134397462476e-06
, O 0 9.592492078436266e-11
three O 0 1.0115890763939817e-11
recombinants O 0 7.99431916220783e-08
were O 0 9.247400067913247e-11
found O 0 6.580178762982669e-11
, O 0 1.089806413515082e-12
giving O 0 3.6722800364832886e-13
a O 0 2.219432997845397e-13
recombinant O 0 2.3231017803881926e-11
fraction O 0 4.375740655232496e-12
of O 0 3.8136527269472253e-10
0 O 0 1.5927086316480654e-09
. O 0 4.573125905737996e-11

042 O 0 0.015124909579753876
. O 0 1.6512171896465588e-07

A O 0 1.5626582694494573e-07
lod O 0 7.832638857507845e-07
score O 0 1.9814748952740047e-08
of O 0 1.7373678051768593e-09
16 O 0 1.6419687831614738e-10
between O 0 5.465582413738401e-12
HLA O 0 6.379730077554768e-09
- O 0 1.0419549667517458e-09
B O 0 4.2013619250269585e-09
and O 0 8.77493119399303e-13
Factor O 0 2.9037860657665782e-11
B O 0 1.4894666833242809e-08
allotypes O 0 6.951333730853548e-09
was O 0 8.453448878398273e-12
calculated O 0 5.106300039921241e-13
at O 0 1.5774960547901284e-12
a O 0 9.521090784270908e-15
maximum O 0 4.965153315621487e-14
likelihood O 0 1.485989743798058e-13
value O 0 2.2727848249248783e-13
of O 0 8.573119644750271e-12
the O 0 6.173475359388947e-13
recombinant O 0 4.655926252178366e-12
fraction O 0 5.924903037808626e-13
of O 0 1.881674677184364e-11
0 O 0 1.8491670694675832e-10
. O 0 1.7501241775241816e-11

04 O 0 0.0006731628673151135
. O 0 1.880099098627852e-08

A O 0 9.045766091730911e-08
crossover O 0 1.340267008487217e-09
was O 0 6.609969238624558e-10
shown O 0 2.99592598992926e-12
to O 0 1.5043034092693253e-13
have O 0 2.1538269079487624e-15
occurred O 0 1.1481136137289627e-12
between O 0 3.081270386951808e-14
genes O 0 4.6760322563066826e-15
for O 0 1.411849593669929e-14
Factor O 0 5.221894531365345e-12
B O 0 5.029292982072775e-09
and O 0 7.949490133003778e-13
HLA O 0 2.960868883405965e-09
- O 0 1.1839685898351604e-09
D O 0 7.994773731923033e-09
, O 0 2.478706530393421e-13
in O 0 6.424344427746406e-14
which O 0 1.6608491925501623e-13
HLA O 0 1.3263924181217135e-08
- O 0 4.939906705914154e-09
D O 0 5.1714835080929333e-08
segregared O 0 9.928162114647421e-08
with O 0 8.460384302855228e-12
HLA O 0 1.208535564956037e-07
- O 0 1.9623711544625166e-09
A O 0 2.892506678620066e-09
and O 0 4.681128401573531e-11
B O 0 3.4486987487980514e-07
. O 0 2.438874970034366e-11

These O 0 2.6335153502365927e-10
studies O 0 6.907210220452598e-11
suggest O 0 1.2663308986485267e-12
that O 0 7.054264450004474e-15
the O 0 3.459381490034802e-13
genes O 0 1.784442277101561e-14
for O 0 4.2354659411875453e-14
Factor O 0 1.8485110664379079e-10
B O 0 0.0005078076501376927
and O 0 6.650087414072914e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 3.267308841016503e-13
located O 0 2.6401478225857034e-11
outside O 0 1.2529540772965309e-11
those O 0 1.6099098508297327e-13
for O 0 7.821424714490877e-13
HLA O 0 7.123717171708677e-09
, O 0 1.0031249919259522e-12
that O 0 3.624982106343764e-15
the O 0 1.160698734391577e-13
order O 0 1.5877078297921177e-12
of O 0 4.457742161512179e-11
genese O 0 4.126228603240634e-08
is O 0 9.073582271819369e-13
HLA O 0 1.0983262077601808e-09
- O 0 2.0946375189900834e-10
A O 0 1.0709290121369008e-09
, O 0 1.0065843557977017e-12
- O 0 4.089499225368165e-11
B O 0 2.7078266295887943e-09
, O 0 1.6671016509536146e-13
- O 0 4.8692376519721137e-11
D O 0 1.5791028484812841e-09
, O 0 4.743056533466905e-13
Factor O 0 7.701714960228756e-11
B O 0 1.4506537127090269e-06
allotype O 0 0.00010999134974554181
, O 0 1.4751178412097943e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 5.132226674892104e-12
that O 0 3.867335596728638e-15
the O 0 1.5628026216879531e-13
genes O 0 1.937247020786237e-12
coding O 0 4.953897292381271e-10
for O 0 2.1175918796245696e-09
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 3.7747907577490025e-10
Factor O 0 6.431308818832804e-10
B O 0 4.185710977822055e-08
allotypes O 0 3.262850434282427e-09
are O 0 1.1548461602425234e-14
approximately O 0 1.8100184708252226e-13
3 O 0 5.001524368275501e-12
- O 0 3.8350083525484635e-11
- O 0 4.3234110735923537e-11
5 O 0 1.1123533517898299e-11
centimorgans O 0 1.1338026073559604e-09
from O 0 1.8467647116410246e-12
the O 0 1.828528214259384e-12
HLA O 0 3.049511199115784e-10
- O 0 3.1970474878573185e-11
A O 0 1.3703392587327556e-10
and O 0 1.2363784041707904e-12
HLA O 0 5.10119013696908e-09
- O 0 7.093166054517042e-10
B O 0 6.5328147336174425e-09
loci O 0 1.6004135950514753e-12
, O 0 5.584282561648009e-14
and O 0 5.203595123152646e-14
that O 0 2.812229217739556e-15
the O 0 5.727714309788912e-13
apparent O 0 4.009850784747471e-11
lack O 0 3.0766428293915737e-10
of O 0 1.3302275947424391e-09
recombinants O 0 2.6357641402796617e-08
between O 0 1.729674346459542e-12
the O 0 1.2902730099628723e-12
Factor O 0 5.274107539587902e-11
B O 0 2.9146911401767284e-05
gene O 0 2.3553766936856846e-08
and O 0 1.0405652801637189e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 4.160437327982436e-09
suggests O 0 4.847643553934633e-12
that O 0 1.1330014346427192e-15
these O 0 2.2481523275484118e-14
two O 0 2.0308514798225014e-13
genes O 0 1.0085214998192815e-12
lie O 0 1.3007264709763433e-10
in O 0 2.407202475546155e-12
close O 0 2.96651869735598e-11
proximity O 0 3.705848683477342e-10
to O 0 3.970865736918627e-12
one O 0 1.4325050694263819e-11
another O 0 7.560446713128499e-11
. O 0 2.2202661931203238e-10

Distribution O 0 5.9110792705041604e-08
of O 0 5.901706501276749e-08
emerin O 0 7.2497682594985235e-06
and O 0 1.5515136952970465e-09
lamins O 0 3.9168226066976786e-06
in O 0 3.5191766167841365e-10
the O 0 7.99931454409375e-10
heart O 0 2.3120306025248283e-07
and O 0 1.927716146432612e-11
implications O 0 2.6221227966694016e-10
for O 0 5.383384710233585e-11
Emery B-Disease 1 0.9999990463256836
- I-Disease 1 0.9999998807907104
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 1.0211090994971528e-07

Emerin O 0 0.00033607438672333956
is O 0 1.2456749520772803e-10
a O 0 1.0839547141816563e-11
nuclear O 0 1.606775690277118e-08
membrane O 0 6.551478803906718e-10
protein O 0 8.322584982289882e-11
which O 0 7.654959023432883e-13
is O 0 2.689107075036501e-13
missing O 0 4.008351983664227e-11
or O 0 1.8600862169981802e-11
defective O 0 5.294243123898923e-07
in O 0 1.4062603304054733e-09
Emery B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.289931151404744e-05
EDMD B-Disease 1 1.0
) O 0 1.0913160375380926e-09
. O 0 5.892204779645027e-11

It O 0 3.1733979333203877e-10
is O 0 1.4843332726138803e-12
one O 0 2.615485410716045e-13
member O 0 2.261676523146461e-12
of O 0 6.00892252622387e-11
a O 0 7.170326832284246e-12
family O 0 8.369174277211844e-12
of O 0 1.5342054737743638e-08
lamina O 0 0.3198721408843994
- O 0 1.948187957623304e-07
associated O 0 2.1212899492528692e-10
proteins O 0 3.899710849381011e-12
which O 0 6.663466978716615e-13
includes O 0 4.124994790188907e-11
LAP1 O 1 0.9966589212417603
, O 0 9.426228547715354e-11
LAP2 O 0 0.3146447539329529
and O 0 1.3013201627387616e-09
lamin O 0 1.909234924823977e-06
B O 0 2.0109573597437702e-06
receptor O 0 8.20594592276791e-10
( O 0 9.750113910689251e-11
LBR O 0 0.0008072996861301363
) O 0 1.6266230029593487e-10
. O 0 1.0358928298481729e-10

A O 0 3.3910876027221093e-06
panel O 0 3.7504229055684846e-08
of O 0 2.74452105486489e-09
16 O 0 3.6597136432447996e-10
monoclonal O 0 1.651564440763309e-10
antibodies O 0 3.805294621073152e-11
( O 0 3.063312624396186e-12
mAbs O 0 8.462059497560404e-09
) O 0 5.658619731639669e-13
has O 0 1.6122076140464084e-14
been O 0 5.432101234212512e-14
mapped O 0 2.1009863987453414e-11
to O 0 3.147658728715891e-13
six O 0 4.873209583262927e-13
specific O 0 3.8492633017660205e-14
sites O 0 6.6884020023805224e-12
throughout O 0 1.3279852044412177e-11
the O 0 7.873306173689087e-12
emerin O 0 2.6223290205962257e-09
molecule O 0 1.578654850072081e-12
using O 0 9.784961469555542e-13
phage O 0 4.259021954555742e-11
- O 0 2.4116889041359002e-11
displayed O 0 2.7823675655125335e-11
peptide O 0 1.9922332013255772e-12
libraries O 0 6.258995600451345e-13
and O 0 1.1884551231588353e-13
has O 0 1.6367832797472789e-15
been O 0 2.8790950573869944e-15
used O 0 4.251459278484422e-14
to O 0 3.561047940900397e-13
localize O 0 5.572361772010481e-08
emerin O 0 1.8796765743900323e-07
in O 0 1.9597247435942933e-11
human O 0 4.9205490376680316e-11
and O 0 2.939181953376391e-10
rabbit O 0 3.234642917959718e-07
heart O 0 4.7280838089136523e-07
. O 0 8.547380025980544e-10

Several O 0 4.9776538446622e-09
mAbs O 0 3.2712773645471316e-07
against O 0 5.519785073460071e-09
different O 0 9.614265980562031e-12
emerin O 0 2.8257358053451753e-07
epitopes O 0 4.581654522439749e-08
did O 0 2.6820870177579614e-11
not O 0 2.317474283222015e-13
recognize O 0 8.309335858269762e-12
intercalated O 0 1.120102499641007e-08
discs O 0 1.3923963138040563e-07
in O 0 3.795060099509584e-11
the O 0 9.239131681937351e-11
heart O 0 1.927160120374083e-08
, O 0 1.618951500637067e-12
though O 0 8.901049114353604e-14
they O 0 4.4398986982600863e-14
recognized O 0 8.868436367215349e-12
cardiomyocyte O 0 1.1801499333330412e-08
nuclei O 0 9.002524947732127e-09
strongly O 0 3.0994132260708795e-10
, O 0 9.709633271015594e-12
both O 0 4.702460209421444e-12
at O 0 6.665930030180789e-10
the O 0 2.3335969268067913e-10
rim O 0 1.583824449369331e-08
and O 0 9.225973283955025e-12
in O 0 1.4189546239384843e-11
intranuclear O 0 2.420659086510568e-07
spots O 0 1.6017230874965094e-09
or O 0 4.315419549483224e-11
channels O 0 1.6653751988560117e-10
. O 0 2.238226409767563e-10

A O 0 3.934448159270687e-06
polyclonal O 0 2.0363222574815154e-05
rabbit O 0 3.6438646588976553e-07
antiserum O 0 2.429788139579614e-07
against O 0 5.5303679857843235e-08
emerin O 0 1.6190556380024645e-06
did O 0 1.8257586414938132e-11
recognize O 0 2.476875302082071e-11
both O 0 2.6378007850907936e-12
nuclear O 0 2.6961089361066115e-08
membrane O 0 4.851514745496388e-10
and O 0 7.90391016525227e-12
intercalated O 0 5.045905471234846e-09
discs O 0 1.180429087810353e-08
but O 0 8.336950243657479e-14
, O 0 9.940823561722673e-15
after O 0 4.622861880625162e-14
affinity O 0 3.334871034920209e-14
purification O 0 2.049560382522131e-10
against O 0 1.448261371939097e-10
a O 0 4.2732514575483105e-12
pure O 0 5.3076973927090876e-09
- O 0 4.964824995568051e-09
emerin O 0 6.547530801981338e-07
band O 0 2.2306297253749108e-08
on O 0 5.750927511982695e-11
a O 0 5.273327889805668e-13
western O 0 1.5457177204858397e-10
blot O 0 5.046067599323578e-07
, O 0 6.169715432990941e-11
it O 0 1.3118999159580924e-12
stained O 0 4.822725259145955e-07
only O 0 6.870635787734058e-13
the O 0 2.5443850585477046e-12
nuclear O 0 3.6792091151482964e-08
membrane O 0 1.1664631038854623e-08
. O 0 3.554525285220933e-10

These O 0 5.791692681000882e-10
results O 0 1.489439682700322e-10
would O 0 3.65782355576591e-13
not O 0 5.479470027128404e-14
be O 0 9.016336397112135e-14
expected O 0 2.3340396455850954e-12
if O 0 4.601961715346159e-13
immunostaining O 0 4.02193620629987e-08
at O 0 2.536934551322645e-10
intercalated O 0 6.379583972204728e-09
discs O 0 6.099774907397659e-08
were O 0 2.2980039746101077e-11
due O 0 4.525428642931928e-11
to O 0 3.490366361821179e-13
a O 0 6.320466068923669e-13
product O 0 3.7288887255737535e-12
of O 0 6.342499442313354e-11
the O 0 9.94624521633014e-12
emerin O 0 7.52282787175318e-08
gene O 0 1.3011525884509823e-11
and O 0 3.9073497042074745e-12
, O 0 9.4825709784363e-13
therefore O 0 9.397908883393424e-13
, O 0 6.838538524518711e-13
cast O 0 5.919168367257699e-12
some O 0 1.3947152352304648e-13
doubt O 0 2.2557884379881266e-11
upon O 0 8.575441572122866e-12
the O 0 6.338892518525929e-12
hypothesis O 0 9.308078613434745e-11
that O 0 1.7429810849831084e-12
cardiac B-Disease 1 1.0
defects I-Disease 1 0.9999998807907104
in O 0 4.780131916959363e-07
EDMD B-Disease 1 1.0
are O 0 1.133864738211976e-10
caused O 0 1.4055094865739193e-09
by O 0 3.98000989804137e-12
absence O 0 2.9618304253631322e-08
of O 0 6.404347629995755e-08
emerin O 0 8.15059775050031e-06
from O 0 2.051826042404059e-09
intercalated O 0 1.6127464732562657e-06
discs O 0 7.036980241537094e-05
. O 0 3.2166176389125667e-09

Although O 0 6.5555822992280355e-09
emerin O 0 2.121568741131341e-06
was O 0 1.1868446225804519e-09
abundant O 0 1.2800403792478932e-10
in O 0 1.721617098014716e-12
the O 0 5.2925662984149024e-12
membranes O 0 3.0971028519566346e-10
of O 0 1.5387234819641549e-09
cardiomyocyte O 0 7.123597356439859e-08
nuclei O 0 4.6989910629235965e-08
, O 0 2.5739516421041664e-11
it O 0 1.1739154570297727e-12
was O 0 3.6747802023562315e-10
absent O 0 8.593592504269054e-10
from O 0 1.2620154921094695e-11
many O 0 1.4959486828534235e-13
non O 0 9.99736560203246e-09
- O 0 9.700171332838181e-09
myocyte O 0 3.098784588928538e-07
cells O 0 1.5634639416450824e-10
in O 0 2.6639013911422538e-11
the O 0 7.96361587784844e-10
heart O 0 1.2242952607266488e-06
. O 0 1.0500430525084425e-09

This O 0 4.76572904403727e-12
distribution O 0 1.0803823807803425e-10
of O 0 7.085405040463399e-10
emerin O 0 3.3460474924140726e-07
was O 0 1.1366364099929527e-10
similar O 0 5.946459145401983e-13
to O 0 2.561172302885384e-13
that O 0 3.861352155989234e-14
of O 0 7.460031897776886e-11
lamin O 0 4.2004586475741235e-08
A O 0 2.30337420248361e-08
, O 0 3.5072721636664195e-12
a O 0 4.1712271657556865e-13
candidate O 0 2.457209999709442e-12
gene O 0 1.1834346003158913e-11
for O 0 9.311265950981418e-13
an O 0 8.461106164661669e-13
autosomal O 0 3.195480076101376e-07
form O 0 1.5109216633391043e-07
of O 0 0.00031439599115401506
EDMD B-Disease 1 1.0
. O 0 7.381419209195883e-08

In O 0 2.9582722937959716e-09
contrast O 0 1.296679541518131e-09
, O 0 3.6298761219022424e-10
lamin O 0 1.1797492334153503e-06
B1 O 0 0.0013512057485058904
was O 0 2.5090075794764743e-08
absent O 0 1.5414325815754637e-08
from O 0 4.4863188164434575e-10
cardiomyocyte O 0 1.6949881853633997e-07
nuclei O 0 1.4641059919995314e-07
, O 0 7.850816524657134e-11
showing O 0 1.4664689462762226e-09
that O 0 6.4020026259437035e-12
lamin O 0 1.46995012073603e-06
B1 O 0 0.0001221468555741012
is O 0 3.149341898378566e-12
not O 0 3.829462043151467e-14
essential O 0 5.667469531872582e-12
for O 0 6.246901325217269e-13
localization O 0 3.389582303725547e-08
of O 0 1.5216033988352251e-09
emerin O 0 1.3512206464838528e-07
to O 0 2.648166581853406e-11
the O 0 1.1200394778310141e-10
nuclear O 0 2.427451818221016e-06
lamina O 1 0.9912002682685852
. O 0 3.843030338401832e-09

Lamin O 1 0.909620463848114
B1 O 1 0.9999440908432007
is O 0 2.6299675770502517e-09
also O 0 7.809473553943569e-12
almost O 0 1.3984112479104027e-11
completely O 0 4.1102263814707385e-09
absent O 0 7.555351011490075e-09
from O 0 1.757424983317435e-09
skeletal O 0 3.5789180401479825e-05
muscle O 0 3.38610425387742e-06
nuclei O 0 0.0004479655472096056
. O 0 1.979703156962387e-08

In O 0 1.9143239171626192e-07
EDMD B-Disease 1 1.0
, O 0 1.7003155827755023e-10
the O 0 2.9518987081089687e-12
additional O 0 2.5973116886401915e-12
absence O 0 4.4573469359932005e-09
of O 0 2.9101277831955485e-08
lamin O 0 2.9985792934894562e-05
B1 O 1 0.9939259886741638
from O 0 1.8618641206558095e-07
heart O 1 0.7150367498397827
and O 0 3.3895082651724806e-07
skeletal O 1 1.0
muscle O 0 0.0048343646340072155
nuclei O 0 0.052015673369169235
which O 0 8.225941594552921e-10
already O 0 5.397678970453512e-10
lack O 0 2.051154091020635e-08
emerin O 0 1.3401738215179648e-05
may O 0 2.1263320965081434e-11
offer O 0 8.354465123178167e-13
an O 0 2.874876579199784e-14
alternative O 0 1.8401414073054845e-11
explanation O 0 2.5357143468296428e-11
of O 0 6.825010556710254e-10
why O 0 1.8459627923461674e-11
these O 0 5.354289494413633e-12
tissues O 0 1.1076379813346193e-08
are O 0 8.168907716064877e-13
particularly O 0 1.953361951356758e-11
affected O 0 1.1847496594885598e-10
. O 0 6.8369385673727745e-12
. O 0 1.1619962630993186e-10

Genetic O 0 6.57150920346794e-08
mapping O 0 7.198579954348361e-09
of O 0 1.4455418195780112e-08
the O 0 1.4175655094206263e-09
copper B-Disease 0 7.637826229256461e-07
toxicosis I-Disease 0 0.00011093926150351763
locus O 0 9.618292828861286e-10
in O 0 1.4867602982082673e-10
Bedlington O 0 7.932407015687204e-07
terriers O 0 5.6635798273418914e-08
to O 0 5.4458031834014875e-11
dog O 0 2.1079257450651312e-08
chromosome O 0 9.9957916943616e-11
10 O 0 6.849720790569336e-11
, O 0 4.040880043770789e-13
in O 0 5.605157722514409e-13
a O 0 3.967216312406041e-12
region O 0 1.402739591149782e-10
syntenic O 0 3.668012880098104e-07
to O 0 1.737985796945729e-11
human O 0 2.496807760543618e-10
chromosome O 0 1.2629726153789989e-09
region O 0 6.4997385251786e-10
2p13 O 0 5.787010195490438e-07
- O 0 8.034062659589836e-08
p16 O 0 6.418765963189799e-08
. O 0 1.9841202292258941e-10

Abnormal O 1 1.0
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9501348733901978
accumulation I-Disease 0 0.0001861577620729804
is O 0 7.775885491057011e-11
recognized O 0 9.204691869824089e-11
as O 0 5.963067279540768e-12
an O 0 3.0506323162038385e-11
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 1.9446511956289214e-08
man O 0 1.881627298416788e-08
, O 0 2.4110451482539652e-11
mouse O 0 6.219922910055686e-10
, O 0 1.931050111481092e-11
rat O 0 2.7890672527064453e-07
and O 0 2.574735091798175e-09
dog O 0 1.0743915481725708e-05
. O 0 3.5409259968588458e-09

The O 0 3.709147833319548e-08
major O 0 3.6327470809283113e-08
cause O 0 1.3485239378496772e-06
of O 0 0.05366171523928642
hepatic B-Disease 1 0.9999998807907104
copper I-Disease 0 0.12834514677524567
accumulation I-Disease 0 1.3637014490086585e-05
in O 0 1.5687556143006987e-08
man O 0 4.416969456855213e-09
is O 0 4.566540830371058e-13
a O 0 7.0445671865315695e-12
dysfunctional O 0 1.0687913487572587e-07
ATP7B O 1 1.0
gene O 0 5.597935892609485e-09
, O 0 1.5614426418508742e-11
causing O 0 4.638013706426136e-08
Wilson B-Disease 0 8.50895230541937e-06
disease I-Disease 0 0.000120253607747145
( O 0 7.230718107598122e-11
WD B-Disease 0 0.0033694824669510126
) O 0 1.0094328151133425e-10
. O 0 8.290407249589293e-11

Mutations O 0 3.990522756680548e-08
in O 0 7.008228997129606e-10
the O 0 1.1795732168806694e-09
ATP7B O 1 0.999998927116394
genes O 0 1.9223627897857476e-11
have O 0 4.7252380095752847e-14
also O 0 1.092496793443469e-13
been O 0 1.2396409853482337e-13
demonstrated O 0 1.7172265345810622e-11
in O 0 2.5341669734890715e-11
mouse O 0 1.5545795761795489e-09
and O 0 3.2748320721864843e-10
rat O 0 2.3286312966774858e-07
. O 0 1.3222131722834263e-10

The O 0 6.992399903538171e-08
ATP7B O 1 0.9999998807907104
gene O 0 1.438884122961781e-09
has O 0 2.6898559876871453e-13
been O 0 6.525400879364707e-14
excluded O 0 9.40435056218103e-12
in O 0 6.213344725877756e-13
the O 0 3.565487748796725e-12
much O 0 2.4654911359028864e-12
rarer O 0 7.844986882332705e-09
human O 0 1.46015919355591e-08
copper B-Disease 0 0.000387848645914346
overload I-Disease 1 0.9991311430931091
disease O 0 9.409509948454797e-05
non B-Disease 0 1.067996606707311e-07
- I-Disease 0 1.1217979434263725e-08
Indian I-Disease 0 4.5183329300257924e-10
childhood I-Disease 0 4.354333213996142e-06
cirrhosis I-Disease 1 0.9999967813491821
, O 0 9.807425704888573e-12
indicating O 0 3.9525224759806576e-10
genetic O 0 3.1194489213959287e-09
heterogeneity O 0 4.2818761869511945e-08
. O 0 3.303427975609452e-09

By O 0 5.066956854093974e-10
investigating O 0 3.101285273032772e-08
the O 0 1.3773626683644125e-09
common O 0 2.0482382012687594e-07
autosomal O 1 0.9999208450317383
recessive O 1 0.951601505279541
copper B-Disease 0 0.024526149034500122
toxicosis I-Disease 0 0.10422897338867188
( O 0 1.6524285273433748e-09
CT B-Disease 0 0.0016850146930664778
) O 0 8.23841602576314e-12
in O 0 7.998562923106078e-11
Bedlington O 0 1.2142824743932579e-05
terriers O 0 1.9068547771894373e-06
, O 0 1.2994760649476245e-11
we O 0 8.9770571076557e-14
have O 0 6.029253786906047e-15
identified O 0 1.475339896908276e-13
a O 0 6.18423294886962e-14
new O 0 5.631713086325096e-13
locus O 0 3.4372450632286222e-12
involved O 0 1.8741555616458294e-12
in O 0 2.692426837036521e-10
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 9.127562039523696e-10

We O 0 5.734347441332943e-10
examined O 0 7.041125904549972e-09
whether O 0 1.4713790949527628e-11
the O 0 6.563057042274778e-11
WD B-Disease 0 0.0003326752921566367
gene O 0 6.49331122204444e-09
ATP7B O 1 0.9999526739120483
was O 0 1.315402231583107e-09
also O 0 7.371776800102481e-13
causative O 0 9.725448918418422e-11
for O 0 5.415327474639353e-12
CT B-Disease 0 1.1433100553404074e-05
by O 0 2.527195466783816e-12
investigating O 0 9.59785917409306e-10
the O 0 1.0823499735357345e-10
chromosomal O 0 8.312650123798448e-08
co O 0 2.3812328109329428e-08
- O 0 8.949965213389532e-09
localization O 0 4.702330613781669e-07
of O 0 1.1320852699725492e-08
ATP7B O 1 0.9999988079071045
and O 0 1.8550630476177332e-10
C04107 O 0 1.4404171189141834e-08
, O 0 1.0435798275879038e-13
using O 0 3.657250080579301e-14
fluorescence O 0 1.5856658000523716e-11
in O 0 3.310725717013685e-13
situ O 0 1.4203693776693171e-09
hybridization O 0 2.972811580237433e-11
( O 0 3.533782207826297e-12
FISH O 0 5.1060595751550863e-08
) O 0 1.9141077611806168e-12
. O 0 8.358390368723434e-12

C04107 O 0 1.4354483028000686e-05
is O 0 5.4297063373232035e-11
an O 0 5.375806679148998e-13
anonymous O 0 1.0080013906899055e-10
microsatellite O 0 9.05710848542185e-08
marker O 0 1.2112656122553744e-07
closely O 0 1.0520778692679755e-09
linked O 0 2.9056961281526128e-08
to O 0 3.74070330266818e-10
CT B-Disease 1 0.9999986886978149
. O 0 3.1240694475798136e-09

However O 0 1.0871386457722565e-08
, O 0 7.193690088058702e-10
BAC O 0 0.193735271692276
clones O 0 2.574574331504209e-08
containing O 0 1.3073911730998589e-08
ATP7B O 1 0.9999986886978149
and O 0 2.4085837768694773e-09
C04107 O 0 3.0686263130519364e-07
mapped O 0 2.936667575781371e-09
to O 0 7.0859386067101404e-12
the O 0 4.243437545792261e-11
canine O 0 3.37220988910758e-08
chromosome O 0 8.746003921089596e-10
regions O 0 2.7436927729773686e-10
CFA22q11 O 0 8.055234275161638e-07
and O 0 1.9335795464758831e-10
CFA10q26 O 0 2.70783903033589e-06
, O 0 1.326904124770989e-11
respectively O 0 1.3304875430553142e-11
, O 0 4.319153541765264e-13
demonstrating O 0 9.600229465556165e-12
that O 0 3.4920845512140253e-13
WD B-Disease 0 2.338131480428274e-06
cannot O 0 9.164820291562847e-11
be O 0 1.7850568028929259e-12
homologous O 0 6.088375636981169e-11
to O 0 1.6407572522858516e-10
CT B-Disease 0 0.03977753221988678
. O 0 2.8393698503492715e-09

The O 0 9.021574243206487e-08
copper O 0 6.020035669962454e-08
transport O 0 2.2896815110584612e-08
genes O 0 1.2081288192078432e-09
CTR1 O 1 0.9942634701728821
and O 0 5.762800237008037e-10
CTR2 O 1 0.9999653100967407
were O 0 7.768888310444311e-11
also O 0 5.881217821773754e-13
excluded O 0 4.7574010703099745e-12
as O 0 2.0226367510121218e-13
candidate O 0 2.382480606029358e-13
genes O 0 3.504976257145964e-13
for O 0 2.336502736080548e-12
CT B-Disease 0 0.00018745892157312483
since O 0 4.452490459661007e-11
they O 0 2.0460536205840069e-13
both O 0 3.196379792791415e-13
mapped O 0 5.138314218555706e-10
to O 0 5.1410566775933475e-11
canine O 0 2.2186866317497334e-06
chromosome O 0 7.564121062841878e-08
region O 0 1.2093260615131385e-08
CFA11q22 O 0 0.0005226279026828706
. O 0 8.048614219546835e-09

2 O 0 4.953277311869897e-06
- O 0 3.264657664203696e-07
22 O 0 1.9259330130694252e-08
. O 0 1.6523268864254703e-10

5 O 0 5.789064289274393e-06
. O 0 1.1321500181793454e-08

A O 0 3.288468519713206e-07
transcribed O 0 1.043041208959039e-08
sequence O 0 7.960877790313958e-11
identified O 0 1.2389048120731161e-11
from O 0 6.33053158505259e-12
the O 0 6.654198459604688e-12
C04107 O 0 9.877406448310921e-09
- O 0 6.644781946896217e-10
containing O 0 4.976246081866975e-10
BAC O 1 0.9794256091117859
was O 0 9.877566126137438e-11
found O 0 9.486111711681094e-14
to O 0 7.07417904162737e-15
be O 0 7.328813662714484e-15
homologous O 0 3.125231193626399e-13
to O 0 2.5612698810809076e-13
a O 0 2.681671508117378e-12
gene O 0 5.9725262929744005e-12
expressed O 0 3.1665907960012896e-13
from O 0 6.672592339773686e-11
human O 0 2.892312223057303e-10
chromosome O 0 9.717628923766597e-10
2p13 O 0 1.8256951506145924e-08
- O 0 2.7551996240049448e-09
p16 O 0 3.6986180784737144e-10
, O 0 1.1031533759392476e-12
a O 0 5.64963657453954e-13
region O 0 1.482995497237294e-11
devoid O 0 7.80217490614632e-09
of O 0 8.750888208508556e-11
any O 0 2.895902484825741e-12
positional O 0 2.7167061489308253e-07
candidate O 0 1.124691784148979e-09
genes O 0 1.5761569827077437e-09
. O 0 1.0795692118037437e-09

Molecular O 0 1.5998338653844257e-08
analysis O 0 2.1673988992443327e-10
of O 0 1.4999916864155693e-09
the O 0 2.407507804225162e-10
APC B-Disease 0 2.9140489132828407e-08
gene O 0 1.3442901306004451e-11
in O 0 1.909316454939969e-12
205 O 0 2.7154474849244714e-11
families O 0 2.6854564646777886e-14
: O 0 8.344459698954657e-14
extended O 0 2.277530074257239e-11
genotype O 0 9.510697784875788e-10
- O 0 3.1080578111186696e-09
phenotype O 0 1.0315807236205288e-10
correlations O 0 1.5196305325204662e-10
in O 0 9.624963152876642e-12
FAP B-Disease 0 2.031119983314511e-08
and O 0 1.6223115515898168e-12
evidence O 0 3.661175963093344e-12
for O 0 8.024508080315806e-15
the O 0 1.461972497273159e-13
role O 0 1.8698816366818916e-12
of O 0 1.9064654022127314e-10
APC B-Disease 0 1.3678344146228483e-07
amino O 0 5.1477142548606025e-09
acid O 0 1.6634141841720407e-09
changes O 0 4.1290426633366906e-10
in O 0 1.329563247054466e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 0 0.0003913372056558728
. O 0 4.808951570289821e-10

BACKGROUND O 0 0.0001668547047302127
/ O 0 8.768742532083706e-07
AIMS O 0 5.649802048424135e-08
The O 0 1.6979423075880185e-11
development O 0 1.6090068166718652e-10
of O 0 9.372329259349499e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.7573761890155026e-11
a O 0 3.6128513917522975e-13
variable O 0 5.866051568104158e-12
range O 0 3.247440316656025e-09
of O 0 2.3992121622740115e-09
extracolonic O 0 9.408112418896053e-06
manifestations O 0 9.386773854203057e-06
in O 0 5.8615423625951735e-09
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.7961798715049326e-09
FAP B-Disease 0 1.743172788337688e-06
) O 0 3.145625903852589e-12
is O 0 3.719366394733248e-14
the O 0 1.906957122592423e-13
result O 0 3.663355643140909e-12
of O 0 1.3042765478754603e-10
the O 0 2.0289330979195164e-11
dominant O 0 1.222533074773935e-09
inheritance O 0 6.256188345155067e-10
of O 0 1.1050597947814822e-07
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 0.9999997615814209
coli I-Disease 1 1.0
( O 0 3.7005249975408105e-09
APC B-Disease 0 1.6218913287957548e-06
) O 0 5.2809445705293e-10
gene O 0 2.6955933041250546e-09
mutations O 0 6.709123034909226e-09
. O 0 1.4178089813299266e-09

In O 0 2.7625812748510725e-10
this O 0 7.254052501910746e-14
study O 0 2.601375874693862e-13
, O 0 3.966363065625086e-15
direct O 0 2.0633353288749753e-14
mutation O 0 6.763583833627185e-14
analysis O 0 5.107030792185496e-13
of O 0 3.7481288905905075e-11
the O 0 5.118162144102101e-11
APC B-Disease 0 5.3883542960875275e-08
gene O 0 1.1679401890063446e-10
was O 0 1.0480536577484045e-10
performed O 0 4.945900911046408e-10
to O 0 4.5444014220089035e-13
determine O 0 3.2527060905840344e-11
genotype O 0 3.5382996532717925e-09
- O 0 6.0364175880067705e-09
phenotype O 0 1.0587222765146009e-10
correlations O 0 3.181215846304042e-10
for O 0 2.976817403688159e-11
nine O 0 4.6202972003861476e-10
extracolonic O 0 2.563187990745064e-07
manifestations O 0 1.3057783689873759e-06
and O 0 6.753152897998049e-11
to O 0 1.2685089523928328e-12
investigate O 0 4.3818646627835633e-11
the O 0 3.2930321663959816e-11
incidence O 0 5.122737789520215e-09
of O 0 8.299650966492322e-10
APC B-Disease 0 1.0652379245357224e-07
mutations O 0 5.641935252320707e-10
in O 0 1.4958340122106506e-10
non O 1 0.9999921321868896
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.2285107093011902e-09

METHODS O 0 3.705072231241502e-06
The O 0 6.547234754350484e-09
APC B-Disease 0 8.899836245745973e-08
gene O 0 1.1539062066967531e-10
was O 0 7.901683474198506e-11
analysed O 0 6.3319866017153e-10
in O 0 6.914601270030518e-12
190 O 0 1.638958829763837e-10
unrelated O 0 9.852564319956514e-10
FAP B-Disease 0 1.5690167742832273e-07
and O 0 1.6512273492974572e-10
15 O 0 2.0438188919058575e-09
non O 1 0.8737472295761108
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 4.450650403775569e-10
using O 0 5.7272832310051314e-11
denaturing O 0 3.0682710985274753e-06
gradient O 0 3.6167195904823757e-09
gel O 0 1.4944857573695458e-09
electrophoresis O 0 2.524327136210758e-10
, O 0 7.448039580915111e-13
the O 0 1.342685294544732e-12
protein O 0 3.886018676985126e-12
truncation O 0 3.488860866873722e-10
test O 0 2.119421305124547e-10
, O 0 8.125919777552185e-14
and O 0 6.315956058936673e-14
direct O 0 1.6536430428107374e-12
sequencing O 0 2.2280083333825473e-10
. O 0 3.9386736927493615e-11

RESULTS O 0 0.00014192453818395734
Chain O 0 3.375997721377644e-07
terminating O 0 2.019962508370554e-08
signals O 0 4.245360507582063e-09
were O 0 1.1650360363935075e-11
only O 0 2.358795328657147e-14
identified O 0 2.1053166534331508e-13
in O 0 2.816891956237272e-13
patients O 0 8.078558438526229e-13
belonging O 0 1.598709775674223e-10
to O 0 1.4911415852081333e-11
the O 0 4.419461463456287e-10
FAP B-Disease 0 2.251941623399034e-06
group O 0 4.4856171554918944e-10
( O 0 6.4884725196889814e-12
105 O 0 1.3618568495132877e-08
patients O 0 7.337850466138107e-11
) O 0 1.5075881515391742e-11
. O 0 3.286176053496348e-10

Amino O 0 5.456577696349996e-07
acid O 0 3.7082195092352777e-09
changes O 0 1.624575821090879e-11
were O 0 1.4049507217339663e-11
identified O 0 7.903197952845165e-13
in O 0 3.2863590863387027e-13
four O 0 1.0941886502760512e-12
patients O 0 4.183776534851663e-13
, O 0 2.826644083728236e-13
three O 0 5.193057897763531e-13
of O 0 5.06119035570407e-10
whom O 0 4.709050510642854e-11
belonged O 0 1.3987927616199158e-07
to O 0 1.6120263457430895e-10
the O 0 1.2972262153354563e-09
non O 0 4.777868525707163e-05
- O 0 2.274713096994674e-06
FAP O 0 9.661458170739934e-05
group O 0 1.615826761280914e-08
of O 0 0.0011707224184647202
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 2.879284579648811e-07
. O 0 2.9786365041140073e-10

Genotype O 0 7.421934424201027e-05
- O 0 6.904433575982694e-06
phenotype O 0 1.8310622351691563e-08
correlations O 0 9.444144133397003e-09
identified O 0 2.316165592652908e-10
significant O 0 1.4076437064580727e-11
differences O 0 4.2427009822043615e-11
in O 0 8.248164304336392e-12
the O 0 1.4401621388493435e-11
nature O 0 3.00061281377495e-10
of O 0 6.420593223754878e-11
certain O 0 2.2551733050435452e-11
extracolonic O 0 2.781136117846472e-06
manifestations O 0 6.045292479939235e-07
in O 0 9.269208317563837e-11
FAP B-Disease 0 8.897814609554189e-07
patients O 0 3.5553712751656974e-11
belonging O 0 2.582199176703881e-10
to O 0 9.73880871779631e-12
three O 0 8.69569902195444e-11
mutation O 0 4.1409994877561473e-10
subgroups O 0 1.799297599802685e-08
. O 0 4.369858253028269e-09

CONCLUSIONS O 0 6.98109806762659e-06
Extended O 0 1.6690488280346472e-07
genotype O 0 7.764130316445517e-08
- O 0 1.5475128734010468e-08
phenotype O 0 2.2118420983652243e-10
correlations O 0 1.820119888140681e-10
made O 0 2.0295987113172487e-11
in O 0 1.5272477293243325e-12
this O 0 4.529659457306982e-15
study O 0 2.077291382527116e-13
may O 0 2.4127680647682836e-13
have O 0 1.6436386350267632e-14
the O 0 5.862894805058749e-13
potential O 0 2.5608546316488456e-13
to O 0 1.5703982710578435e-13
determine O 0 2.373909749331382e-11
the O 0 2.173067498514869e-12
most O 0 1.933708286539198e-14
appropriate O 0 1.825534948901586e-12
surveillance O 0 1.2109272473637134e-09
and O 0 2.4341704867036906e-12
prophylactic O 0 1.8035397886251303e-07
treatment O 0 3.6217517873637917e-09
regimens O 0 1.7460549672776438e-09
for O 0 5.782334788935473e-13
those O 0 2.5179757909797595e-13
patients O 0 6.607639782552077e-13
with O 0 1.9695592270822793e-13
mutations O 0 4.580251455887918e-10
associated O 0 5.112303913534788e-09
with O 0 1.9971774234406325e-10
life O 0 3.994490427317032e-08
threatening O 0 9.783096857063356e-07
conditions O 0 3.2094603739096783e-06
. O 0 2.2678225963801424e-09

This O 0 1.1863681044499419e-11
study O 0 1.5758607960214555e-11
also O 0 1.7406246528763741e-13
provided O 0 6.716113125707079e-13
evidence O 0 3.958450581209583e-11
for O 0 6.313634511034838e-13
the O 0 4.800515453901033e-12
pathological O 0 6.978007949243192e-09
nature O 0 6.529721763293139e-10
of O 0 1.377885583409011e-09
amino O 0 3.0908944848029307e-10
acid O 0 3.423369226984718e-11
changes O 0 2.7729251186880965e-12
in O 0 1.1078559944421862e-11
APC O 0 1.3934717379981976e-08
associated O 0 1.917295905373706e-10
with O 0 4.826497708443345e-12
both O 0 3.1059096267105346e-11
FAP B-Disease 0 1.8662530010260525e-06
and O 0 1.0331171473865197e-09
non O 1 0.9999998807907104
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.0999740007733294e-09
. O 0 2.7011528864334666e-12
. O 0 4.232589626007588e-11

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 0.0005688835517503321
cancer B-Disease 1 0.9999938011169434
risk O 0 4.577758261348208e-08
of O 0 4.381301550893113e-05
the O 0 2.9735249427176313e-06
APC O 0 0.0008383619133383036
I1307K O 0 1.3042281352682039e-05
polymorphism O 0 2.604754172352841e-07
. O 0 6.566841515009969e-10

Germ O 0 0.0020539057441055775
- O 0 7.975941684890131e-07
line O 0 8.620931524205844e-09
and O 0 2.5868810565876643e-11
somatic O 0 9.893758345924653e-08
truncating O 0 9.720398708168432e-08
mutations O 0 1.7613344116540475e-09
of O 0 7.892533737674512e-09
the O 0 1.925314796480393e-09
APC B-Disease 0 5.939111815678189e-07
gene O 0 6.1103311299604e-10
are O 0 7.448550782239438e-13
thought O 0 9.155153198048271e-12
to O 0 6.191606949368378e-11
initiate O 0 0.00024117504653986543
colorectal B-Disease 1 1.0
tumor I-Disease 0 0.0005708029493689537
formation O 0 0.0002593527897261083
in O 0 4.3945348693341657e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 5.311981112754438e-06
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 0.9999972581863403
, O 0 1.1527100385322342e-09
respectively O 0 4.1352476998213206e-09
. O 0 5.9281790587562e-10

Recently O 0 3.717448393558698e-08
, O 0 5.813459089121231e-11
an O 0 1.2859218898042535e-12
isoleucine O 0 6.579704745490744e-07
- O 0 2.839533763676627e-08
- O 0 7.718339745110825e-09
> O 0 3.8847036698541615e-10
lysine O 0 1.1418824774622749e-09
polymorphism O 0 1.5199753955474904e-10
at O 0 2.40006087920408e-11
codon O 0 1.7288516451774427e-10
1307 O 0 6.324485468667262e-08
( O 0 2.9856922056231694e-12
I1307K O 0 1.6773112898604836e-09
) O 0 2.4737991603102083e-13
of O 0 2.7016590353756698e-11
the O 0 5.215695583760116e-11
APC B-Disease 0 3.0650021187739185e-08
gene O 0 9.353229302178079e-11
has O 0 1.9831788392477706e-13
been O 0 4.6975871272319364e-14
identified O 0 2.1572785333275057e-13
in O 0 3.6893966072308604e-13
6 O 0 9.286869884217452e-11
% O 0 2.5381491342273826e-14
- O 0 3.5553962118156646e-12
7 O 0 3.7885222736733226e-11
% O 0 3.274950568978724e-14
of O 0 4.449922147344715e-13
the O 0 3.479571502890827e-13
Ashkenazi O 0 2.6868349212172404e-10
Jewish O 0 1.4619133681392782e-10
population O 0 3.2614126785519837e-13
. O 0 1.1549846148928289e-11

To O 0 2.88883333920964e-10
assess O 0 7.65722418805126e-09
the O 0 9.575382153848011e-11
risk O 0 4.633276401433406e-11
of O 0 2.976437152302225e-11
this O 0 6.271540361688088e-14
common O 0 6.101825988924503e-11
APC B-Disease 0 1.3066949122730875e-07
allelic O 0 2.9706404802709585e-07
variant O 0 9.003050536193768e-07
in O 0 3.369695633637093e-08
colorectal O 1 1.0
carcinogenesis O 1 0.943705141544342
, O 0 4.826888888587177e-10
we O 0 1.347760553334354e-12
have O 0 1.3511154678793116e-14
analyzed O 0 1.638654663349559e-11
a O 0 4.3086709330605877e-13
large O 0 6.650781813298534e-13
cohort O 0 4.3217149303664826e-10
of O 0 1.7026391407881647e-10
unselected O 0 2.7595772280619713e-06
Ashkenazi O 0 6.789143469632108e-08
Jewish O 0 3.0598543698800995e-09
subjects O 0 1.2720494169116137e-07
with O 0 2.640049512336873e-09
adenomatous B-Disease 0 0.01922871731221676
polyps I-Disease 0 1.7757091086423316e-07
and O 0 2.897883599750628e-10
. O 0 9.307404152947285e-11
or O 1 0.785308301448822
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 8.911879914585974e-12
for O 0 2.810238803815923e-12
the O 0 2.2234912522289818e-10
APC O 0 6.385417350429634e-07
I1307K O 0 6.703619419567985e-07
polymorphism O 0 3.9478852187357916e-08
. O 0 3.350900668053214e-10

The O 0 2.2196591942247323e-07
APC O 0 9.910413609759416e-07
I1307K O 0 2.653434592048143e-07
allele O 0 5.5340107496526514e-11
was O 0 6.68392910463389e-11
identified O 0 2.7453597121335216e-12
in O 0 1.1694905027032076e-12
48 O 0 8.82574915928025e-11
( O 0 1.1965020716830227e-13
10 O 0 1.2561598896482229e-12
. O 0 7.539277633184654e-15
1 O 0 3.0358237625149886e-12
% O 0 2.228207750959183e-14
) O 0 1.5891938982760985e-14
of O 0 4.191782337903405e-12
476 O 0 7.296393267353096e-09
patients O 0 7.051753070363986e-10
. O 0 5.302271399720837e-10

Compared O 0 2.5498008149327234e-09
with O 0 3.068973677619602e-12
the O 0 3.4334312736666872e-12
frequency O 0 3.5946176590861967e-12
in O 0 1.4173300662452537e-13
two O 0 5.5707900044246056e-15
separate O 0 5.542548231897253e-14
population O 0 7.329983838731116e-16
control O 0 8.502797532901341e-13
groups O 0 6.155659478240122e-14
, O 0 1.5298796029929868e-13
the O 0 9.242616220983546e-12
APC O 0 1.7438658517221484e-08
I1307K O 0 6.3714482578802745e-09
allele O 0 5.119175049139724e-12
is O 0 3.6195950615025216e-14
associated O 0 1.631817077296649e-12
with O 0 1.0578607353159755e-13
an O 0 2.2841305602028066e-14
estimated O 0 2.298763223773214e-14
relative O 0 1.1794753541904957e-11
risk O 0 6.655560130797156e-11
of O 0 5.261423297042711e-09
1 O 0 6.18550117792438e-08
. O 0 1.3949654764644492e-09

5 O 0 1.5223495211103e-06
- O 0 2.1018558982177638e-07
1 O 0 1.8550789349092156e-08
. O 0 2.2994037229828734e-10

7 O 0 2.8701520022877958e-06
for O 0 7.176371497052969e-09
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.6331306099891663
( O 0 1.6854184714532039e-09
both O 0 4.2586503767871875e-10
P O 0 8.455898523607175e-07
= O 0 5.476732956033459e-10
. O 0 5.513231798176532e-12
01 O 0 4.1303465536657313e-08
) O 0 1.5552623208389682e-12
. O 0 7.2556370633858336e-12

Furthermore O 0 4.120526853057527e-08
, O 0 3.794119185496214e-11
compared O 0 1.161058575671614e-11
with O 0 9.231428989286972e-12
noncarriers O 0 1.1409050785005093e-05
, O 0 3.994244490712617e-09
APC O 0 5.825722269037215e-07
I1307K O 0 1.2145866890023171e-07
carriers O 0 3.1308608483548994e-11
had O 0 1.4986939640693198e-12
increased O 0 1.354638379550896e-13
numbers O 0 2.591916210738926e-13
of O 0 1.1525248810873023e-10
adenomas B-Disease 0 3.104771167272702e-05
and O 0 2.2142351099319058e-06
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.6376683712005615
per O 0 8.382534250062079e-11
patient O 0 1.4668781744830994e-08
( O 0 2.0526196020664855e-10
P O 0 7.007219551269372e-07
= O 0 2.2218547834906843e-10
. O 0 1.5765876017898028e-12
03 O 0 5.514478318424665e-10
) O 0 5.444860599716772e-14
, O 0 1.2581391176547541e-14
as O 0 2.399864906950898e-14
well O 0 2.984210372303925e-13
as O 0 3.0511240777832127e-13
a O 0 9.878876145938409e-13
younger O 0 1.7782782191222424e-11
age O 0 6.5245985697570674e-12
at O 0 1.8729960638008691e-10
diagnosis O 0 1.2777601909874647e-07
. O 0 2.847905522518346e-10

We O 0 1.1636492880384708e-09
conclude O 0 3.907460133234508e-09
that O 0 1.9528805655921744e-12
the O 0 1.0734397398737272e-10
APC O 0 6.116061967986752e-08
I1307K O 0 1.0772293990157777e-07
variant O 0 1.6594981389062013e-08
leads O 0 1.372431890356296e-10
to O 0 1.9601273729130675e-12
increased O 0 1.4954887328499922e-10
adenoma B-Disease 1 1.0
formation O 0 4.6682966967637185e-06
and O 0 6.154354109666471e-11
directly O 0 1.3245095124847506e-11
contributes O 0 4.16974777189133e-13
to O 0 2.411976326131826e-13
3 O 0 1.4508624336662113e-11
% O 0 7.121807280735006e-15
- O 0 3.477959294260341e-13
4 O 0 1.2547519447070332e-12
% O 0 1.5229287108673817e-15
of O 0 7.476815390775049e-14
all O 0 1.9708632512452362e-13
Ashkenazi O 0 3.661372431906784e-07
Jewish O 1 0.9997863173484802
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.1744597233919194e-09

The O 0 1.9369912340749806e-09
estimated O 0 6.231410786677882e-12
relative O 0 6.25888299521371e-11
risk O 0 2.804628404518006e-11
for O 0 3.0514863639391487e-12
carriers O 0 2.9529927114690935e-11
may O 0 7.435468039884707e-12
justify O 0 3.7965228183445276e-11
specific O 0 2.7063253981579605e-12
clinical O 0 1.2849890596022817e-10
screening O 0 2.5272245234020385e-12
for O 0 7.380073386176883e-14
the O 0 5.318529904679847e-13
360 O 0 1.0614392177699106e-11
, O 0 3.0150466406300355e-14
000 O 0 1.7785689370927726e-12
Americans O 0 2.4575214232309614e-14
expected O 0 1.1458423185978228e-13
to O 0 3.965716372910516e-13
harbor O 0 2.8225015658023267e-09
this O 0 2.4804030018614996e-14
allele O 0 1.5278150110060312e-13
, O 0 9.131078190652633e-14
and O 0 3.621986337156574e-13
genetic O 0 6.82312973482313e-12
testing O 0 3.654389638119149e-11
in O 0 2.670308364618318e-13
the O 0 5.508289137312605e-13
setting O 0 7.447620992140358e-11
of O 0 4.834322178681738e-11
long O 0 8.826973006692551e-12
- O 0 2.584840397279464e-10
term O 0 6.675304059511333e-11
- O 0 8.753826830076861e-11
outcome O 0 4.179918564051199e-12
studies O 0 1.5299709199209643e-12
may O 0 2.320787605061131e-13
impact O 0 8.335325485386846e-11
significantly O 0 5.334060970696441e-10
on O 1 0.8823821544647217
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 8.613173285709763e-09
in O 0 1.148686282540206e-14
this O 0 6.361286784702352e-16
population O 0 4.363879333540673e-16
. O 0 2.6908209276206574e-13

Localization O 0 5.830218924529618e-06
of O 0 8.79244339557772e-08
human O 0 2.0531727429329294e-09
BRCA1 O 0 2.270367449597188e-09
and O 0 2.9717232147286055e-11
its O 0 4.139899881239195e-11
loss O 0 3.2937139682331917e-09
in O 0 2.535482240828557e-11
high O 0 9.208581452924136e-09
- O 0 1.2705109186939012e-09
grade O 0 2.606769911039919e-09
, O 0 3.6575399826876964e-12
non B-Disease 0 9.457165106141474e-06
- I-Disease 0 0.27930283546447754
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 1.2744122557251103e-07

Although O 0 8.369820947429218e-10
the O 0 9.055282912395768e-11
link O 0 2.50903353649079e-10
between O 0 2.1529894186911314e-11
the O 0 3.201601483926453e-10
BRCA1 O 0 4.262506791974374e-08
tumour B-Disease 1 1.0
- O 0 1.2944160232564172e-07
suppressor O 0 1.2010465866296727e-07
gene O 0 6.813035025032832e-09
and O 0 4.605448022942937e-09
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 1.1381234496510295e-12
established O 0 7.312659505709362e-11
, O 0 6.418281704723139e-14
the O 0 2.63695451108506e-13
role O 0 1.2809452934123278e-12
, O 0 9.181216442492868e-14
if O 0 6.342003338504279e-15
any O 0 4.875272819997167e-13
, O 0 1.2930963808402418e-12
of O 0 1.0019345769718413e-10
BRCA1 O 0 2.3555100092664816e-09
in O 0 1.0522760440778711e-10
non B-Disease 1 0.9996893405914307
- I-Disease 1 0.9999611377716064
familial I-Disease 1 0.9999960660934448
cancers I-Disease 1 1.0
is O 0 1.9333571202317934e-11
unclear O 0 5.516287981954804e-10
. O 0 4.536475362026948e-10

BRCA1 O 0 0.00025170849403366446
mutations O 0 5.778005629508698e-08
are O 0 2.418755647159987e-11
rare O 0 5.16521880822296e-10
in O 0 1.8592499761993508e-10
sporadic B-Disease 0 1.5731471648905426e-05
cancers I-Disease 1 0.9988962411880493
, O 0 8.309574382747709e-12
but O 0 6.027442542473616e-13
loss O 0 2.2635456176089974e-08
of O 0 7.712735055065423e-07
BRCA1 O 0 1.2638051316571364e-07
resulting O 0 2.657798647831555e-09
from O 0 3.703432283064245e-10
reduced O 0 9.999128608439989e-11
expression O 0 8.203433592146592e-12
or O 0 1.9007521251390713e-12
incorrect O 0 2.0369685105325885e-10
subcellular O 0 1.64593068063823e-08
localization O 0 1.7634160798252196e-08
is O 0 1.3196515820206034e-13
postulated O 0 9.78649713351265e-12
to O 0 2.650346847370144e-13
be O 0 1.0668900387710706e-13
important O 0 2.9103813543179813e-13
in O 0 3.819064422344587e-12
non B-Disease 0 2.082528590108268e-05
- I-Disease 0 0.0018389979377388954
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 2.4475042437188677e-08

Epigenetic O 0 8.40036227600649e-06
loss O 0 3.3756728953449056e-05
, O 0 9.22873999442686e-11
however O 0 3.6185219317447226e-12
, O 0 4.737297251526662e-13
has O 0 1.5885929284000216e-15
not O 0 1.1338099275908734e-15
received O 0 1.935760986183574e-13
general O 0 1.5625837429533718e-11
acceptance O 0 1.3245607388689962e-10
due O 0 3.6768973976641917e-10
to O 0 2.573444712536399e-12
controversy O 0 3.4329615539174796e-11
regarding O 0 5.107610515087124e-11
the O 0 1.0788250501270191e-11
subcellular O 0 3.774547785440063e-09
localization O 0 1.7512221006654727e-08
of O 0 1.020344919666627e-09
BRCA1 O 0 3.6170147432734723e-10
proteins O 0 2.362219144250166e-12
, O 0 6.276472939471811e-13
reports O 0 5.208754001034821e-12
of O 0 4.012153456689482e-11
which O 0 1.0394280108936421e-13
have O 0 1.3145560859198057e-14
ranged O 0 6.129401847188021e-11
from O 0 9.773154507897175e-13
exclusively O 0 6.072333174483857e-12
nuclear O 0 4.89092988331663e-09
, O 0 1.1046987977159084e-12
to O 0 1.504673664311229e-13
conditionally O 0 3.6978720086011663e-09
nuclear O 0 4.3684774908570034e-08
, O 0 4.614937772207117e-12
to O 0 6.10095903918334e-13
the O 0 2.811666524604739e-11
ER O 0 4.6512530389009044e-05
/ O 0 4.276127896218895e-09
golgi O 0 2.7714397887734776e-08
, O 0 3.2200745975902167e-12
to O 0 1.5177113038555845e-12
cytoplasmic O 0 3.619941013610628e-10
invaginations O 0 4.5680160098982014e-08
into O 0 5.0481532148927144e-11
the O 0 3.648316371229754e-11
nucleus O 0 4.637745742996913e-09
. O 0 1.0131227107246232e-10

In O 0 1.7848994504632287e-09
an O 0 2.02206328937804e-12
attempt O 0 4.962301750066622e-11
to O 0 4.788152079687746e-12
resolve O 0 7.305187010864245e-11
this O 0 3.316716069541939e-14
issue O 0 9.026939894359043e-13
, O 0 1.0713850596630325e-12
we O 0 6.707622060867988e-14
have O 0 4.706044242990502e-14
comprehensively O 0 3.1631099517426264e-08
characterized O 0 9.06175312564983e-09
19 O 0 1.1604492478056727e-08
anti O 0 2.562786960425001e-07
- O 0 1.4477069498752826e-07
BRCA1 O 0 6.800843888044028e-09
antibodies O 0 5.380615952788048e-10
. O 0 1.6573328820435052e-10

These O 0 2.046986580239718e-09
reagents O 0 1.382147019057811e-07
detect O 0 7.54079962916876e-08
a O 0 4.077691309611886e-11
220 O 0 1.316872583201345e-10
- O 0 4.595758218428614e-10
kD O 0 4.927616981120764e-09
protein O 0 7.718902773901082e-12
localized O 0 2.1687718287921598e-10
in O 0 4.113590436165271e-13
discrete O 0 9.47572402487662e-12
nuclear O 0 2.2848521297191837e-08
foci O 0 4.679100129578728e-08
in O 0 2.186539317661218e-11
all O 0 3.0741407683332334e-12
epithelial O 0 1.8939830259689927e-10
cell O 0 3.8246761313587285e-09
lines O 0 1.3409515164930497e-10
, O 0 1.7034485801092902e-13
including O 0 1.3975912170182542e-13
those O 0 9.389912485795529e-14
derived O 0 1.4573829990038867e-11
from O 0 7.609827212817777e-10
breast B-Disease 0 1.3330293313629227e-06
malignancies I-Disease 0 1.4502702470053919e-05
. O 0 9.901753861285556e-10

Immunohistochemical O 0 3.618369373725727e-05
staining O 0 3.474651066426304e-06
of O 0 2.0896182206797675e-07
human O 0 7.0736099644364e-08
breast O 0 1.7320205643045483e-06
specimens O 0 7.56569420445885e-08
also O 0 2.0939065759062458e-10
revealed O 0 3.306657347934561e-08
BRCA1 O 0 3.393587064692838e-07
nuclear O 0 0.00016182793478947133
foci O 0 0.0004205610021017492
in O 0 3.2170976993484146e-08
benign O 1 1.0
breast O 1 1.0
, O 0 1.956538042691136e-08
invasive B-Disease 1 1.0
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 6.952993913955652e-08
low B-Disease 1 0.999998927116394
- I-Disease 1 0.800440788269043
grade I-Disease 1 0.998908519744873
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 8.497062964352153e-08

Conversely O 0 5.119752017890278e-07
, O 0 1.4912283630152956e-09
BRCA1 O 0 1.6100299982113597e-09
expression O 0 5.339830314032845e-11
was O 0 3.219783328844983e-10
reduced O 0 1.66183629357608e-11
or O 0 1.522332715615804e-12
undetectable O 0 4.1208447765228584e-10
in O 0 5.488695571176719e-14
the O 0 6.834075948376761e-14
majority O 0 4.737831674259238e-16
of O 0 4.234531291152227e-13
high O 0 3.6640857015157735e-10
- O 0 8.721420918789136e-09
grade O 0 1.1224062745895935e-07
, O 0 4.896042460345029e-10
ductal B-Disease 1 0.9999972581863403
carcinomas I-Disease 1 1.0
, O 0 4.265316155827037e-10
suggesting O 0 1.8035632709523242e-10
that O 0 4.149682713335684e-13
absence O 0 9.8308508000855e-09
of O 0 1.0364432228016085e-06
BRCA1 O 0 1.0108156089927434e-07
may O 0 4.3489340600944004e-11
contribute O 0 6.4966213832173825e-12
to O 0 1.4984803328732532e-11
the O 0 1.6305991279441656e-10
pathogenesis O 0 5.8397848334834634e-08
of O 0 4.5757111988287136e-10
a O 0 7.452032155415289e-13
significant O 0 1.0609792124721684e-12
percentage O 0 8.71820185488481e-11
of O 0 9.489642405213772e-10
sporadic B-Disease 1 0.727725088596344
breast I-Disease 1 0.9999998807907104
cancers I-Disease 1 0.9999351501464844
. O 0 1.9571630427428488e-10
. O 0 4.641257100868046e-10

